Citrus Sinensis ID: 009979
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 521 | 2.2.26 [Sep-21-2011] | |||||||
| Q3EDL4 | 472 | Probable serine/threonine | no | no | 0.869 | 0.959 | 0.615 | 1e-174 | |
| Q6NKZ9 | 437 | Probable receptor-like se | no | no | 0.811 | 0.967 | 0.552 | 1e-142 | |
| Q9SJG2 | 494 | Probable receptor-like pr | no | no | 0.838 | 0.884 | 0.536 | 1e-139 | |
| Q8LEB6 | 484 | Probable receptor-like pr | no | no | 0.848 | 0.913 | 0.540 | 1e-135 | |
| Q9LRP3 | 467 | Probable receptor-like pr | no | no | 0.813 | 0.907 | 0.512 | 1e-129 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.568 | 0.411 | 0.475 | 4e-78 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.673 | 0.494 | 0.427 | 3e-76 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.558 | 0.381 | 0.460 | 1e-74 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.715 | 0.547 | 0.362 | 2e-74 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.571 | 0.415 | 0.455 | 8e-74 |
| >sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 611 bits (1575), Expect = e-174, Method: Compositional matrix adjust.
Identities = 317/515 (61%), Positives = 374/515 (72%), Gaps = 62/515 (12%)
Query: 1 MSHY--SFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQL 58
MS Y +FLN +LSK TSIFGLRLWVV+GI +G+ IV+ LFL+SL TS+R + +
Sbjct: 1 MSVYDAAFLNTELSKPTSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRKNRKPRADF 60
Query: 59 NAAKSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPI 118
+A ++ P ISKEI+EI P
Sbjct: 61 ASAAIAT--------------PPISKEIKEI--------------------------VPA 80
Query: 119 LVEDSPASGRNRIHIEIGK-DHRIAYPER-AAGSHHGSGDQTVAAAIT------PEVSHL 170
+ PA I ++IGK +HR+ + +R ++G G+ + A+ + PEVSHL
Sbjct: 81 QNQSVPAE----IQVDIGKIEHRVVFSDRVSSGESRGTASASETASYSGSGNCGPEVSHL 136
Query: 171 GWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFK 230
GWG WYTLRELE +TNG +ENVIGEGGYGIVY G+L D T VAVKNLLNNRGQAEKEFK
Sbjct: 137 GWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAEKEFK 196
Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
VEVE IGRVRHKNLVRLLGYC EGA+RMLVY+++DNGNLEQW+HGDVG SPLTW+IRMN
Sbjct: 197 VEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLTWDIRMN 256
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
IILG AKGL YLHEGLEPKVVHRDIKSSNILLD+QWN K+SDFGLAKLLG+E SYVTTRV
Sbjct: 257 IILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESSYVTTRV 316
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410
MGTFGYVAPEYA TGMLNE+SD+YSFGILIME+I+GRNPVDYSRP GE NLV+WLK+MV
Sbjct: 317 MGTFGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETNLVDWLKSMVG 376
Query: 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDER 470
NR +E V+DP++ E P S+ALKR LLVALRCVDP+A+KRPKMGH+IHMLEAE+ +RDER
Sbjct: 377 NRRSEEVVDPKIPEPPSSKALKRVLLVALRCVDPDANKRPKMGHIIHMLEAEDLLYRDER 436
Query: 471 RAGREHGRSPHNGIKGRLMEKGVSESGDSSGYESG 505
R R+HG E V +G SG ESG
Sbjct: 437 RTTRDHGSRERQ-------ETAVVAAGSESG-ESG 463
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6NKZ9|Y4345_ARATH Probable receptor-like serine/threonine-protein kinase At4g34500 OS=Arabidopsis thaliana GN=At4g34500 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 504 bits (1299), Expect = e-142, Method: Compositional matrix adjust.
Identities = 259/469 (55%), Positives = 326/469 (69%), Gaps = 46/469 (9%)
Query: 12 SKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSSSLCSNYN 71
+ + S+FGL L++V+ IC + ++L + ++ N + R++ SS
Sbjct: 13 TTKPSVFGLNLYLVIAIC---SVFILLISLLIFLFVCLNRVSRARRMRVKHSSG------ 63
Query: 72 SSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILVEDSPASGRNRI 131
+IP +SKEI EI+ + I +DS N +
Sbjct: 64 ------SIPLVSKEISEIKT----------------------VGKFINSDDSKGKIGNEV 95
Query: 132 HIEIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADE 191
+ + + A S SGD + A +GWG WY+L++LE++T GF+D+
Sbjct: 96 VVVVSATSKEATSGFDTLSVASSGDVGTSEA-------MGWGKWYSLKDLEIATRGFSDD 148
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
N+IGEGGYG+VY D + AVKNLLNN+GQAEKEFKVEVEAIG+VRHKNLV L+GYC
Sbjct: 149 NMIGEGGYGVVYRADFSDGSVAAVKNLLNNKGQAEKEFKVEVEAIGKVRHKNLVGLMGYC 208
Query: 252 AEGAH--RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
A+ A RMLVYEYIDNGNLEQWLHGDVGP SPLTW+IRM I +GTAKGL YLHEGLEPK
Sbjct: 209 ADSAQSQRMLVYEYIDNGNLEQWLHGDVGPVSPLTWDIRMKIAIGTAKGLAYLHEGLEPK 268
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
VVHRD+KSSNILLDK+WN K+SDFGLAKLLG+E SYVTTRVMGTFGYV+PEYASTGMLNE
Sbjct: 269 VVHRDVKSSNILLDKKWNAKVSDFGLAKLLGSETSYVTTRVMGTFGYVSPEYASTGMLNE 328
Query: 370 RSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429
SDVYSFG+L+ME+I+GR+PVDYSRPPGE+NLV+W K MV +R E V+DP+++ P R
Sbjct: 329 CSDVYSFGVLLMEIITGRSPVDYSRPPGEMNLVDWFKGMVASRRGEEVIDPKIKTSPPPR 388
Query: 430 ALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDERRAGREHGR 478
ALKRALLV LRC+D ++ KRPKMG +IHMLEAE+FPFR E R+ +E +
Sbjct: 389 ALKRALLVCLRCIDLDSSKRPKMGQIIHMLEAEDFPFRPEHRSNQERSK 437
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SJG2|Y2296_ARATH Probable receptor-like protein kinase At2g42960 OS=Arabidopsis thaliana GN=At2g42960 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 496 bits (1277), Expect = e-139, Method: Compositional matrix adjust.
Identities = 267/498 (53%), Positives = 332/498 (66%), Gaps = 61/498 (12%)
Query: 5 SFLNDQLSKRTSIFGLR---LWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAA 61
S LN ++SK+ S FGL+ LWV + + VG IV++L ++SLW T +R S S +
Sbjct: 5 SSLNAEMSKKISFFGLKGLKLWVWVCLVVGVFIVMILCILSLWITFRRKSRRSSSKFP-- 62
Query: 62 KSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILVE 121
+N IP++SK+I R+D N P PE + +E
Sbjct: 63 --------FNQ------IPHVSKDI---RVDRAGFQN--------------PHPESLYIE 91
Query: 122 DSPASGRNRIHIEIGKDHR-----------IAYPERAAGSHHG-------SGDQTVAAAI 163
+ S + +G+ + + ERA SH G +G Q +
Sbjct: 92 MNDKSTGKTMMSHLGRTKSSDNDTLSQCSSVNHHERACSSHSGEEGGFGSAGRQYGGGPV 151
Query: 164 T-------PEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVK 216
T PE+SHLGWGHW+TLR+LE++TN FA NV+GEGGYG+VY G L + T VAVK
Sbjct: 152 TASPLVGLPEISHLGWGHWFTLRDLELATNRFAPVNVLGEGGYGVVYRGKLVNGTEVAVK 211
Query: 217 NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGD 276
LLNN GQAEKEF+VEVEAIG VRHKNLVRLLGYC EG HRMLVYEY+++GNLEQWLHG
Sbjct: 212 KLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNSGNLEQWLHGA 271
Query: 277 VGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336
+ H LTWE RM II GTA+ L YLHE +EPKVVHRDIK+SNIL+D ++N KLSDFGLA
Sbjct: 272 MRQHGNLTWEARMKIITGTAQALAYLHEAIEPKVVHRDIKASNILIDDEFNAKLSDFGLA 331
Query: 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP 396
KLL + S++TTRVMGTFGYVAPEYA+TG+LNE+SD+YSFG+L++E I+GR+PVDY RP
Sbjct: 332 KLLDSGESHITTRVMGTFGYVAPEYANTGLLNEKSDIYSFGVLLLEAITGRDPVDYGRPA 391
Query: 397 GEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVI 456
EVNLVEWLK MV R AE V+DPRL+ +P ALKRALLV+LRCVDP A KRP+M V
Sbjct: 392 NEVNLVEWLKMMVGTRRAEEVVDPRLEPRPSKSALKRALLVSLRCVDPEAEKRPRMSQVA 451
Query: 457 HMLEAEEFPFRDERRAGR 474
MLE++E PF ERR R
Sbjct: 452 RMLESDEHPFHKERRNKR 469
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LEB6|Y5185_ARATH Probable receptor-like protein kinase At5g18500 OS=Arabidopsis thaliana GN=At5g18500 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 484 bits (1245), Expect = e-135, Method: Compositional matrix adjust.
Identities = 253/468 (54%), Positives = 323/468 (69%), Gaps = 26/468 (5%)
Query: 5 SFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSS 64
S LND LS+ + GL LW ++ I + A I +V+ ISLW T +R ++ S L
Sbjct: 3 SGLNDTLSRNYN--GLELWEIIVIVLSA-IFVVVLAISLWLTFRRKTSRSSSNLIPV--- 56
Query: 65 SLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILVEDSP 124
S P++P +EI+EIR+D S+SN S EPE + +S
Sbjct: 57 -------SRQIPPSVP---EEIKEIRVDEVSSSNGGNGYPSISEKFGDKEPEKGIKAESE 106
Query: 125 ASGRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAIT---PEVSHLGWGHWYTLREL 181
+R + E+ GS S + A + PE SHLGWGHW+TLR+L
Sbjct: 107 NGDSSR-------SGSFNHLEKKDGSSVSSANPLTAPSPLSGLPEFSHLGWGHWFTLRDL 159
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
+++TN F+ +N+IG+GGYG+VY G L + T VAVK LLNN GQA+K+F+VEVEAIG VRH
Sbjct: 160 QMATNQFSRDNIIGDGGYGVVYRGNLVNGTPVAVKKLLNNLGQADKDFRVEVEAIGHVRH 219
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
KNLVRLLGYC EG RMLVYEY++NGNLEQWL GD H LTWE R+ I++GTAK L Y
Sbjct: 220 KNLVRLLGYCMEGTQRMLVYEYVNNGNLEQWLRGDNQNHEYLTWEARVKILIGTAKALAY 279
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
LHE +EPKVVHRDIKSSNIL+D ++N K+SDFGLAKLLGA++S++TTRVMGTFGYVAPEY
Sbjct: 280 LHEAIEPKVVHRDIKSSNILIDDKFNSKISDFGLAKLLGADKSFITTRVMGTFGYVAPEY 339
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421
A++G+LNE+SDVYSFG++++E I+GR PVDY+RPP EV+LVEWLK MV R +E V+DP
Sbjct: 340 ANSGLLNEKSDVYSFGVVLLEAITGRYPVDYARPPPEVHLVEWLKMMVQQRRSEEVVDPN 399
Query: 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDE 469
L+ KP + ALKR LL ALRCVDP + KRP+M V MLE+EE+P E
Sbjct: 400 LETKPSTSALKRTLLTALRCVDPMSEKRPRMSQVARMLESEEYPIARE 447
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LRP3|Y3174_ARATH Probable receptor-like protein kinase At3g17420 OS=Arabidopsis thaliana GN=At3g17420 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 464 bits (1193), Expect = e-129, Method: Compositional matrix adjust.
Identities = 239/466 (51%), Positives = 314/466 (67%), Gaps = 42/466 (9%)
Query: 5 SFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSS 64
S L L+KR + L LW ++ I + A +++L L S+W + ++ S S S
Sbjct: 3 SQLKRTLTKRYGV--LELWEIIVIALFAAFIVILVL-SVWLSFRKKSKRSNATTLPVTQS 59
Query: 65 SLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILVEDSP 124
P ++EI+EI +D S++N+ + + VED
Sbjct: 60 ---------------PRFTEEIKEISVDHGSSNNNGTSYQTL---------DEKFVED-- 93
Query: 125 ASGRNRIHIEIGKDHRIAYPER-AAGSHHGSGDQTVAAAI----TPEVSHLGWGHWYTLR 179
IE G + ++ GSH + A PEVSH+GWGHW+TLR
Sbjct: 94 --------IENGDKFSGSLEKKPLVGSHLPPSTPSTTAPSPLLGLPEVSHIGWGHWFTLR 145
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
+L+++TN F+ E++IG+GGYG+VYHG L + T VAVK LLNN GQA+K+F+VEVEAIG V
Sbjct: 146 DLQLATNHFSKESIIGDGGYGVVYHGTLTNKTPVAVKKLLNNPGQADKDFRVEVEAIGHV 205
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
RHKNLVRLLGYC EG HRMLVYEY++NGNLEQWLHGD+ LTWE R+ +++GTAK L
Sbjct: 206 RHKNLVRLLGYCVEGTHRMLVYEYMNNGNLEQWLHGDMIHKGHLTWEARIKVLVGTAKAL 265
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
YLHE +EPKVVHRDIKSSNIL+D ++ KLSDFGLAKLLGA+ +YV+TRVMGTFGYVAP
Sbjct: 266 AYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLAKLLGADSNYVSTRVMGTFGYVAP 325
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419
EYA++G+LNE+SDVYS+G++++E I+GR PVDY+RP EV++VEWLK MV + E V+D
Sbjct: 326 EYANSGLLNEKSDVYSYGVVLLEAITGRYPVDYARPKEEVHMVEWLKLMVQQKQFEEVVD 385
Query: 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 465
L+ KP + LKRALL ALRCVDP+A KRPKM V MLE++E+P
Sbjct: 386 KELEIKPTTSELKRALLTALRCVDPDADKRPKMSQVARMLESDEYP 431
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 292 bits (748), Expect = 4e-78, Method: Compositional matrix adjust.
Identities = 145/305 (47%), Positives = 206/305 (67%), Gaps = 9/305 (2%)
Query: 164 TPEVSHLGWGHW-YTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR 222
TP+ + LG G ++ EL T GFA +N++GEGG+G VY G L+D VAVK L
Sbjct: 346 TPDSAILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGS 405
Query: 223 GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP 282
GQ ++EFK EVE I RV H++LV L+GYC HR+L+YEY+ N LE LHG P
Sbjct: 406 GQGDREFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPV-- 463
Query: 283 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
L W R+ I +G+AKGL YLHE PK++HRDIKS+NILLD ++ +++DFGLA+L
Sbjct: 464 LEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTT 523
Query: 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLV 402
+++V+TRVMGTFGY+APEYAS+G L +RSDV+SFG++++E+++GR PVD ++P GE +LV
Sbjct: 524 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLV 583
Query: 403 EW-----LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457
EW LK + T +E ++D RL+++ + R + A CV + KRP+M V+
Sbjct: 584 EWARPLLLKAIETGDLSE-LIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVR 642
Query: 458 MLEAE 462
L+ +
Sbjct: 643 ALDCD 647
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 286 bits (732), Expect = 3e-76, Method: Compositional matrix adjust.
Identities = 156/365 (42%), Positives = 226/365 (61%), Gaps = 14/365 (3%)
Query: 149 GSHHGSGDQTVAAAITPEVSHLGWGHW-YTLRELEVSTNGFADENVIGEGGYGIVYHGVL 207
GS G G T + + P+ + +G G +T EL T GF+ N++GEGG+G VY G L
Sbjct: 314 GSQRGGGGYTRSGS-APDSAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKL 372
Query: 208 EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267
D VAVK L GQ ++EFK EVE I RV H++LV L+GYC + R+L+YEY+ N
Sbjct: 373 NDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQ 432
Query: 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN 327
LE LHG P L W R+ I +G+AKGL YLHE PK++HRDIKS+NILLD ++
Sbjct: 433 TLEHHLHGKGRP--VLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFE 490
Query: 328 PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 387
+++DFGLAKL + +++V+TRVMGTFGY+APEYA +G L +RSDV+SFG++++E+I+GR
Sbjct: 491 AQVADFGLAKLNDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGR 550
Query: 388 NPVDYSRPPGEVNLVEWLKTMVTNRNAEG----VLDPRLQEKPCSRALKRALLVALRCVD 443
PVD +P GE +LVEW + ++ G ++D RL++ + R + A CV
Sbjct: 551 KPVDQYQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVR 610
Query: 444 PNAHKRPKMGHVIHMLEAEE--FPFRDERRAGR----EHGRSPHNGIKGRLMEKGVSESG 497
+ KRP+M V+ L++E + + G+ + G+ ++ +K R M G +S
Sbjct: 611 HSGPKRPRMVQVVRALDSEGDMGDISNGNKVGQSSAYDSGQYNNDTMKFRKMAFGFDDSS 670
Query: 498 DSSGY 502
DS Y
Sbjct: 671 DSGMY 675
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 280 bits (717), Expect = 1e-74, Method: Compositional matrix adjust.
Identities = 139/302 (46%), Positives = 198/302 (65%), Gaps = 11/302 (3%)
Query: 171 GWGH---WYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEK 227
G+G ++ EL ++TNGF+DEN++GEGG+G VY GVL D VAVK L GQ ++
Sbjct: 410 GFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDR 469
Query: 228 EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEI 287
EFK EV+ I RV H+NL+ ++GYC R+L+Y+Y+ N NL LH P L W
Sbjct: 470 EFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPG--LDWAT 527
Query: 288 RMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347
R+ I G A+GL YLHE P+++HRDIKSSNILL+ ++ +SDFGLAKL +++T
Sbjct: 528 RVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTHIT 587
Query: 348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407
TRVMGTFGY+APEYAS+G L E+SDV+SFG++++E+I+GR PVD S+P G+ +LVEW +
Sbjct: 588 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARP 647
Query: 408 MVTNRNA----EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE--A 461
+++N + DP+L + R + A C+ +A KRP+M ++ + A
Sbjct: 648 LLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFDSLA 707
Query: 462 EE 463
EE
Sbjct: 708 EE 709
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 280 bits (717), Expect = 2e-74, Method: Compositional matrix adjust.
Identities = 162/447 (36%), Positives = 241/447 (53%), Gaps = 74/447 (16%)
Query: 24 VVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSSSLCSNYNSSSGNPTIPNIS 83
V +G+ VG + L LF++ +WFT KR
Sbjct: 239 VAIGVIVGL-VFLSLFVMGVWFTRKRK--------------------------------- 264
Query: 84 KEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILVEDSPASGRNRIHIEIGKDHRIAY 143
R DP + P + +P + +++ +S +S ++ G D+ A
Sbjct: 265 ------RKDPGTFVGYTMPPSAYSSP----QGSDVVLFNSRSSAPPKMRSHSGSDYMYAS 314
Query: 144 PERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVY 203
+ S+ S W++ EL T+GF+++N++GEGG+G VY
Sbjct: 315 SDSGMVSNQRS--------------------WFSYDELSQVTSGFSEKNLLGEGGFGCVY 354
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263
GVL D VAVK L Q E+EFK EVE I RV H++LV L+GYC HR+LVY+Y
Sbjct: 355 KGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISRVHHRHLVTLVGYCISEQHRLLVYDY 414
Query: 264 IDNGNLEQWLHGDVGPHSP-LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL 322
+ N L LH P P +TWE R+ + G A+G+ YLHE P+++HRDIKSSNILL
Sbjct: 415 VPNNTLHYHLH---APGRPVMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILL 471
Query: 323 DKQWNPKLSDFGLAKLLGA--ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380
D + ++DFGLAK+ ++V+TRVMGTFGY+APEYA++G L+E++DVYS+G+++
Sbjct: 472 DNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVIL 531
Query: 381 MEVISGRNPVDYSRPPGEVNLVEWLKTM----VTNRNAEGVLDPRLQEKPCSRALKRALL 436
+E+I+GR PVD S+P G+ +LVEW + + + N + ++DPRL + + R +
Sbjct: 532 LELITGRKPVDTSQPLGDESLVEWARPLLGQAIENEEFDELVDPRLGKNFIPGEMFRMVE 591
Query: 437 VALRCVDPNAHKRPKMGHVIHMLEAEE 463
A CV +A KRPKM V+ L+ E
Sbjct: 592 AAAACVRHSAAKRPKMSQVVRALDTLE 618
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 278 bits (711), Expect = 8e-74, Method: Compositional matrix adjust.
Identities = 139/305 (45%), Positives = 197/305 (64%), Gaps = 7/305 (2%)
Query: 164 TPEVSHLGWGHW-YTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR 222
TP+ + +G +T EL T GF V+GEGG+G VY G+L + VA+K L +
Sbjct: 345 TPDSAVIGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVS 404
Query: 223 GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP 282
+ +EFK EVE I RV H++LV L+GYC HR L+YE++ N L+ LHG P
Sbjct: 405 AEGYREFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNLP--V 462
Query: 283 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
L W R+ I +G AKGL YLHE PK++HRDIKSSNILLD ++ +++DFGLA+L
Sbjct: 463 LEWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTA 522
Query: 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLV 402
+S+++TRVMGTFGY+APEYAS+G L +RSDV+SFG++++E+I+GR PVD S+P GE +LV
Sbjct: 523 QSHISTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLV 582
Query: 403 EWLKTMVTNRNAEG----VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458
EW + + +G V+DPRL+ + + + A CV +A KRP+M V+
Sbjct: 583 EWARPRLIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRA 642
Query: 459 LEAEE 463
L+ +
Sbjct: 643 LDTRD 647
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 521 | ||||||
| 255538254 | 528 | Serine/threonine-protein kinase PBS1, pu | 0.978 | 0.965 | 0.786 | 0.0 | |
| 449482676 | 521 | PREDICTED: probable serine/threonine-pro | 0.959 | 0.959 | 0.789 | 0.0 | |
| 225458659 | 519 | PREDICTED: probable serine/threonine-pro | 0.952 | 0.955 | 0.782 | 0.0 | |
| 359480850 | 516 | PREDICTED: probable serine/threonine-pro | 0.952 | 0.961 | 0.731 | 0.0 | |
| 449450231 | 842 | PREDICTED: uncharacterized protein LOC10 | 0.880 | 0.545 | 0.792 | 0.0 | |
| 307135852 | 842 | serine/threonine-protein kinase [Cucumis | 0.900 | 0.557 | 0.777 | 0.0 | |
| 356496904 | 503 | PREDICTED: probable serine/threonine-pro | 0.925 | 0.958 | 0.699 | 0.0 | |
| 224137574 | 469 | predicted protein [Populus trichocarpa] | 0.842 | 0.936 | 0.770 | 0.0 | |
| 255565232 | 509 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.923 | 0.944 | 0.695 | 0.0 | |
| 356541793 | 499 | PREDICTED: probable serine/threonine-pro | 0.909 | 0.949 | 0.707 | 0.0 |
| >gi|255538254|ref|XP_002510192.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223550893|gb|EEF52379.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 833 bits (2151), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/539 (78%), Positives = 456/539 (84%), Gaps = 29/539 (5%)
Query: 1 MSHYSFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNA 60
MS+YSFLNDQLSKRTSIFGLRLWVVLGICVGA IVLVLF+IS+WFTS+R+ N ++
Sbjct: 1 MSNYSFLNDQLSKRTSIFGLRLWVVLGICVGAAIVLVLFIISVWFTSRRSKTNKNSTSHS 60
Query: 61 AKSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILV 120
K S N N + NPTIPN+SKEIQEIR+DP+ N A +PDP+PE EP+L+
Sbjct: 61 TKFRSYLYNNNHNH-NPTIPNVSKEIQEIRLDPNPNPK-------ALSPDPVPESEPVLL 112
Query: 121 ED--SPASGRNRIHIEIGKDHRIAYPERAAGSHHGSG---------DQTVAAAITPEVSH 169
E+ SP GRNRIHIEIGKDHRI+YPERA GS +GSG DQ A + PEVSH
Sbjct: 113 EEENSPVGGRNRIHIEIGKDHRISYPERAGGSGNGSGETRSSPRSGDQAGGAIVVPEVSH 172
Query: 170 LGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN-------R 222
LGWGHWYTLRELEVSTN FADENVIGEGGYGIVY G+L+DNTNVAVK L
Sbjct: 173 LGWGHWYTLRELEVSTNCFADENVIGEGGYGIVYRGILDDNTNVAVKICLTTACTFWWCM 232
Query: 223 GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP 282
GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY+DNGNLEQWLHGDVGP SP
Sbjct: 233 GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVDNGNLEQWLHGDVGPCSP 292
Query: 283 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD+QWN K+SDFGLAKLLG+E
Sbjct: 293 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSE 352
Query: 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLV 402
RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL+ME+ISGRNPVDYSRPPGEVNLV
Sbjct: 353 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILLMEIISGRNPVDYSRPPGEVNLV 412
Query: 403 EWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462
EWLKTMVTNRNAEGVLDPRL EKP SRALKRALLVALRCVDPNA KRPKMGHVIHMLEA+
Sbjct: 413 EWLKTMVTNRNAEGVLDPRLPEKPSSRALKRALLVALRCVDPNAQKRPKMGHVIHMLEAD 472
Query: 463 EFPFRDERRAGREHGRSPHNGIKGRLMEKGVSESGDSSGYESGVQTNKPLWRKLEPEEQ 521
EFPFRD+RR GREH RS G+K +K VSESGDSSGYESG QTN+ LWRK E EEQ
Sbjct: 473 EFPFRDDRRTGREHVRSNREGMK---TDKRVSESGDSSGYESGAQTNRTLWRKQEGEEQ 528
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449482676|ref|XP_004156368.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 815 bits (2106), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/533 (78%), Positives = 454/533 (85%), Gaps = 33/533 (6%)
Query: 1 MSHYSFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNA 60
MS+Y+FLNDQLSKRTSIFGLRLWVVLGICVGA IV+VLFLISLWFTS+RNS
Sbjct: 1 MSNYAFLNDQLSKRTSIFGLRLWVVLGICVGAAIVIVLFLISLWFTSRRNS--------- 51
Query: 61 AKSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNS-NSNCKPHSAPNPDPLPEPEPIL 119
SN + S NP IPN+SKEIQEIRID N+ +S+ K A NP+PLPE EP+
Sbjct: 52 -------SNKSKPSLNPIIPNVSKEIQEIRIDHSRNTTHSDPKVQLASNPEPLPEAEPLA 104
Query: 120 V-----EDSPASGRNRIHIEIGKDHRIAYPERAAGSHHG-----SGDQTVAAAITPEVSH 169
E SP SGR+RIHIEIGKDHRI+YPER GS HG SGDQ A PEVSH
Sbjct: 105 TLLQTEEGSPPSGRHRIHIEIGKDHRISYPERGGGSSHGSGEARSGDQ--APMTVPEVSH 162
Query: 170 LGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEF 229
LGWGHWYTLRELE STN FADENVIGEGGYGIVY GVLEDNT VA+KNLLNNRGQAEKEF
Sbjct: 163 LGWGHWYTLRELEYSTNSFADENVIGEGGYGIVYRGVLEDNTVVAIKNLLNNRGQAEKEF 222
Query: 230 KVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM 289
KVEVEAIGRVRHKNLVRLLGYCAEGAHR+LVYEYIDNGNLEQWLHG+VGP SPLTW+IRM
Sbjct: 223 KVEVEAIGRVRHKNLVRLLGYCAEGAHRILVYEYIDNGNLEQWLHGEVGPCSPLTWDIRM 282
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR 349
NII+GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK+SDFGLAKLLG+ERSYVTTR
Sbjct: 283 NIIVGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSERSYVTTR 342
Query: 350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409
VMGTFGYVAPEYASTGMLNE+SDVYSFGILIME+ISGRNPVDYSRP GEVNLVEWLKTMV
Sbjct: 343 VMGTFGYVAPEYASTGMLNEKSDVYSFGILIMEIISGRNPVDYSRPSGEVNLVEWLKTMV 402
Query: 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDE 469
+NRNAEGVLDP+L EKP +RALKRALLVALRCVDPN KRPKMGHVIHMLEA+EFPFRD+
Sbjct: 403 SNRNAEGVLDPKLPEKPSTRALKRALLVALRCVDPNVQKRPKMGHVIHMLEADEFPFRDD 462
Query: 470 RRAGREHGRSPHNGIKGRLMEKGVSESGDSSGYESG-VQTNKPLWRKLEPEEQ 521
RR GRE GRS +K +LME+ VSESG+SSGYESG Q ++ LWRK E EEQ
Sbjct: 463 RRVGREPGRSL---LKEKLMERLVSESGESSGYESGATQASRHLWRKQELEEQ 512
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225458659|ref|XP_002282863.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 813 bits (2099), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/538 (78%), Positives = 452/538 (84%), Gaps = 42/538 (7%)
Query: 1 MSHYSFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNA 60
M +FLND+LSK TSIFGLRLWVV+GICVGAGIVLVLFLISLWFTS+RNS
Sbjct: 1 MPEGAFLNDELSKHTSIFGLRLWVVVGICVGAGIVLVLFLISLWFTSRRNS--------- 51
Query: 61 AKSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPD---SNSNSNCKPHSAPNPDPLPEPEP 117
AKSS PTIPN+SKEIQEIRID +N N + K H PN +PLPE +P
Sbjct: 52 AKSSH----------KPTIPNVSKEIQEIRIDHSRNPANPNPDPKTHHPPNANPLPESDP 101
Query: 118 ILV--------EDSPASGRNRIHIEIGKDHRIAYPERAAGSHHG-----SGDQTVAAAIT 164
E+SP G RIHIEIGKDHRI+YPER GS HG SGDQ A
Sbjct: 102 FAGAERLLQPGEESPV-GLQRIHIEIGKDHRISYPERGGGSSHGSGEARSGDQVTIA--V 158
Query: 165 PEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ 224
PEVSHLGWGHWYTLRELE+STNGFADENVIGEGGYGIVY GVLEDNT VAVKNLLNNRGQ
Sbjct: 159 PEVSHLGWGHWYTLRELELSTNGFADENVIGEGGYGIVYRGVLEDNTQVAVKNLLNNRGQ 218
Query: 225 AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT 284
AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY+DNGNLEQWLHGDVGPHSPLT
Sbjct: 219 AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVDNGNLEQWLHGDVGPHSPLT 278
Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344
W+IRMNII+GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK+SDFGLAKLLG+ERS
Sbjct: 279 WDIRMNIIIGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSERS 338
Query: 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEW 404
YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL+ME+ISGRNPVDYSRPPGEVNLVEW
Sbjct: 339 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILLMEIISGRNPVDYSRPPGEVNLVEW 398
Query: 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 464
LK MVTNRNAEGVLDP++ EKP SRALKRALLVALRCVDPNA KRPKMGHVIHMLEA++F
Sbjct: 399 LKAMVTNRNAEGVLDPKIPEKPSSRALKRALLVALRCVDPNAQKRPKMGHVIHMLEADDF 458
Query: 465 PFRD--ERRAGREHGRSPHNGIKGRLMEKGVSESGDSSGYESGVQTNKPLWRKLEPEE 520
PFRD +RRAGREHGR+ +G+K R +EK + ESGDSSGYESG Q N+ LW+K PEE
Sbjct: 459 PFRDFQDRRAGREHGRAQRDGMKDRFLEKRMIESGDSSGYESGAQNNRSLWKK--PEE 514
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359480850|ref|XP_002282732.2| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 738 bits (1904), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/529 (73%), Positives = 428/529 (80%), Gaps = 33/529 (6%)
Query: 5 SFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSS 64
+ +NDQLSK TSIFGLRLWVVLG+CVGA VL+LFLISLW TSKRN+++ R
Sbjct: 7 TLMNDQLSKPTSIFGLRLWVVLGVCVGAAFVLLLFLISLWLTSKRNNSSKIR-------- 58
Query: 65 SLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLP--EPEPILV-- 120
S PTIP +SKEIQEIRID S P P D L E + +L+
Sbjct: 59 --------PSQKPTIPAVSKEIQEIRIDHGHRSQIQADPF--PESDQLAGIEGQALLLPP 108
Query: 121 -EDSPASGRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLR 179
E+SP G +RIHIE+GKDHRI+YPER + +Q A+ + PEVSHLGWGHWYTLR
Sbjct: 109 GEESPG-GVHRIHIELGKDHRISYPERVVSGEARAVEQ--ASIVAPEVSHLGWGHWYTLR 165
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR-------GQAEKEFKVE 232
ELE STN FAD++VIGEGGYGIVYHGVLEDNT VAVKNLLNNR GQAEKEFKVE
Sbjct: 166 ELEASTNAFADDHVIGEGGYGIVYHGVLEDNTQVAVKNLLNNRCFLATTMGQAEKEFKVE 225
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY++NGNLEQWLHGDVGP SPLTWEIRMNII
Sbjct: 226 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYVNNGNLEQWLHGDVGPRSPLTWEIRMNII 285
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK+SDFGLAKLLG+E SYVTTRVMG
Sbjct: 286 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSEHSYVTTRVMG 345
Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412
TFGYVAPEYASTGMLNERSDVYSFGILIME+ISGRNPVDYSRPP EVNLV+WLK MVT+R
Sbjct: 346 TFGYVAPEYASTGMLNERSDVYSFGILIMEIISGRNPVDYSRPPEEVNLVDWLKRMVTSR 405
Query: 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDERRA 472
N EGVLDP++ EKP SRALKRALLVALRCVDPN+ KRPKMGHVIHMLEAEE PFRD+RRA
Sbjct: 406 NPEGVLDPKIPEKPTSRALKRALLVALRCVDPNSQKRPKMGHVIHMLEAEESPFRDDRRA 465
Query: 473 GREHGRSPHNGIKGRLMEKGVSESGDSSGYESGVQTNKPLWRKLEPEEQ 521
GR+ R+ + + LMEK V+ESGDSSGYESG N+ WR+ E + +
Sbjct: 466 GRDSVRAHRDSPRNGLMEKRVTESGDSSGYESGAHANRQRWRQEESQAE 514
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450231|ref|XP_004142867.1| PREDICTED: uncharacterized protein LOC101203008 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 735 bits (1898), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/476 (79%), Positives = 407/476 (85%), Gaps = 17/476 (3%)
Query: 58 LNAAKSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNS-NSNCKPHSAPNPDPLPEPE 116
+N S SN + S NP IPN+SKEIQEIRID N+ +S+ K A NP+PLPE E
Sbjct: 363 INQLLSRRNSSNKSKPSLNPIIPNVSKEIQEIRIDHSRNTTHSDPKVQLASNPEPLPEAE 422
Query: 117 PILV-----EDSPASGRNRIHIEIGKDHRIAYPERAAGSHHG-----SGDQTVAAAITPE 166
P+ E SP SGR+RIHIEIGKDHRI+YPER GS HG SGDQ A PE
Sbjct: 423 PLATLLQTEEGSPPSGRHRIHIEIGKDHRISYPERGGGSSHGSGEARSGDQ--APMTVPE 480
Query: 167 VSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAE 226
VSHLGWGHWYTLRELE STN FADENVIGEGGYGIVY GVLEDNT VA+KNLLNNRGQAE
Sbjct: 481 VSHLGWGHWYTLRELEYSTNSFADENVIGEGGYGIVYRGVLEDNTVVAIKNLLNNRGQAE 540
Query: 227 KEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWE 286
KEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR+LVYEYIDNGNLEQWLHG+VGP SPLTW+
Sbjct: 541 KEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRILVYEYIDNGNLEQWLHGEVGPCSPLTWD 600
Query: 287 IRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346
IRMNII+GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK+SDFGLAKLLG+ERSYV
Sbjct: 601 IRMNIIVGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDFGLAKLLGSERSYV 660
Query: 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK 406
TTRVMGTFGYVAPEYASTGMLNE+SDVYSFGILIME+ISGRNPVDYSRP GEVNLVEWLK
Sbjct: 661 TTRVMGTFGYVAPEYASTGMLNEKSDVYSFGILIMEIISGRNPVDYSRPSGEVNLVEWLK 720
Query: 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPF 466
TMV+NRNAEGVLDP+L EKP +RALKRALLVALRCVDPN KRPKMGHVIHMLEA+EFPF
Sbjct: 721 TMVSNRNAEGVLDPKLPEKPSTRALKRALLVALRCVDPNVQKRPKMGHVIHMLEADEFPF 780
Query: 467 RDERRAGREHGRSPHNGIKGRLMEKGVSESGDSSGYESG-VQTNKPLWRKLEPEEQ 521
RD+RR GRE GRS +K +LME+ VSESG+SSGYESG Q ++ LWRK E EEQ
Sbjct: 781 RDDRRVGREPGRS---LLKEKLMERLVSESGESSGYESGATQASRHLWRKQELEEQ 833
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|307135852|gb|ADN33721.1| serine/threonine-protein kinase [Cucumis melo subsp. melo] | Back alignment and taxonomy information |
|---|
Score = 734 bits (1895), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/489 (77%), Positives = 414/489 (84%), Gaps = 20/489 (4%)
Query: 45 FTSKRNSNNSKRQLNAAKSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNS-NSNCKP 103
+S N+ QL + ++SS N + S NP IPN+SKEIQEIRID N+ +S+ K
Sbjct: 353 LSSDFKVTNNINQLLSGRNSS---NKSKPSLNPIIPNVSKEIQEIRIDHSRNTTHSDPKV 409
Query: 104 HSAPNPDPLPEPEPILV-----EDSPASGRNRIHIEIGKDHRIAYPERAAGSHHG----- 153
A NP+PLPE EP+ E SP SGR+RIHIEIGKDHRI+YPER GS HG
Sbjct: 410 QLASNPEPLPEAEPLATLLETEEGSPPSGRHRIHIEIGKDHRISYPERGGGSSHGSGEAR 469
Query: 154 SGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNV 213
SGDQ A PEVSHLGWGHWYTLRELE STN FADENVIGEGGYGIVY GVLEDNT V
Sbjct: 470 SGDQ--APMTVPEVSHLGWGHWYTLRELEYSTNSFADENVIGEGGYGIVYRGVLEDNTVV 527
Query: 214 AVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL 273
A+KNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR+LVYEYIDNGNLEQWL
Sbjct: 528 AIKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRILVYEYIDNGNLEQWL 587
Query: 274 HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333
HG+VGP SPLTW+IRMNII+GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK+SDF
Sbjct: 588 HGEVGPCSPLTWDIRMNIIVGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKVSDF 647
Query: 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393
GLAKLLG+ERSYVTTRVMGTFGYVAPEYASTGMLNE+SDVYSFGILIME+ISGRNPVDYS
Sbjct: 648 GLAKLLGSERSYVTTRVMGTFGYVAPEYASTGMLNEKSDVYSFGILIMEIISGRNPVDYS 707
Query: 394 RPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMG 453
RP GEVNLVEWLKTMV+NRNAEGVLDP+L EKP +RALKRALLVALRCVDPN KRPKMG
Sbjct: 708 RPSGEVNLVEWLKTMVSNRNAEGVLDPKLPEKPSTRALKRALLVALRCVDPNVQKRPKMG 767
Query: 454 HVIHMLEAEEFPFRDERRAGREHGRSPHNGIKGRLMEKGVSESGDSSGYESG-VQTNKPL 512
HVIHMLEA+EFPFRD+RR GRE GRS +K +LME+ VSESG+SSGYESG Q ++ L
Sbjct: 768 HVIHMLEADEFPFRDDRRVGREPGRS---LLKEKLMERLVSESGESSGYESGATQASRHL 824
Query: 513 WRKLEPEEQ 521
WRK E EEQ
Sbjct: 825 WRKQELEEQ 833
|
Source: Cucumis melo subsp. melo Species: Cucumis melo Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356496904|ref|XP_003517305.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 711 bits (1835), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/515 (69%), Positives = 406/515 (78%), Gaps = 33/515 (6%)
Query: 2 SHYSFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAA 61
S + +NDQLS TSIFGLRLWVVLG+CVGA IVL+LFLIS+W KR+ N
Sbjct: 6 SAAAAMNDQLSNPTSIFGLRLWVVLGVCVGAAIVLILFLISVWLAFKRSKTNPV------ 59
Query: 62 KSSSLCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPI--L 119
+IP++SKEIQEIR+D N N +P PL EP+P+
Sbjct: 60 ----------------SIPDVSKEIQEIRLDHAPNLNPTLQPEP-----PLSEPDPVPPT 98
Query: 120 VEDSPASGRNRIHIEIGKDHRIAYPERA---AGSHHGSGDQTVAAAITPEVSHLGWGHWY 176
E++ G +RI EIGK+HRI+YPER + S+ S + + PEVSHLGWGHWY
Sbjct: 99 EEETTPLGYHRIQFEIGKNHRISYPERPLVRSSSNDPSSCEVQVPTVIPEVSHLGWGHWY 158
Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAI 236
TLRELE STN FA ENVIGEGGYGIVYHG+L DNTNVA+KNLLNNRGQAEKEFKVEVEAI
Sbjct: 159 TLRELEDSTNAFAPENVIGEGGYGIVYHGILNDNTNVAIKNLLNNRGQAEKEFKVEVEAI 218
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
GRVRHKNLVRLLGYCAEGAHRMLVYEY+DNGNLEQWLHGDVGP SPLTWEIRMNIILGTA
Sbjct: 219 GRVRHKNLVRLLGYCAEGAHRMLVYEYVDNGNLEQWLHGDVGPCSPLTWEIRMNIILGTA 278
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
KGLTYLHEGLEPKVVHRDIKSSNILL KQWN K+SDFGLAKLLG++ SY+TTRVMGTFGY
Sbjct: 279 KGLTYLHEGLEPKVVHRDIKSSNILLSKQWNAKVSDFGLAKLLGSDNSYITTRVMGTFGY 338
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416
VAPEYASTGMLNERSDVYSFGILIME+I+GRNPVDYSRPP EVNLV+WLK MV+NRN EG
Sbjct: 339 VAPEYASTGMLNERSDVYSFGILIMELITGRNPVDYSRPPEEVNLVDWLKKMVSNRNPEG 398
Query: 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDERRAGREH 476
VLDP+L EKP SRALKRALLVALRC DPNA KRPKMGHVIHMLEAE+ P++++RRA R+
Sbjct: 399 VLDPKLPEKPTSRALKRALLVALRCTDPNAQKRPKMGHVIHMLEAEDSPYKEDRRAKRDA 458
Query: 477 GRSPHNGIKGRLMEK-GVSESGDSSGYESGVQTNK 510
G SP++ + L E+ VS S D E+GV N+
Sbjct: 459 GHSPNDRVGDGLKEEVTVSVSVDDGKLENGVCANE 493
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224137574|ref|XP_002327160.1| predicted protein [Populus trichocarpa] gi|222835475|gb|EEE73910.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 709 bits (1831), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/480 (77%), Positives = 395/480 (82%), Gaps = 41/480 (8%)
Query: 1 MSHYSFLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNA 60
MS+Y FLND+LSK+TSIFGLRLWVVLGICVGA IVL+LFLISLW TSKRN ++K
Sbjct: 1 MSNY-FLNDELSKKTSIFGLRLWVVLGICVGAAIVLLLFLISLWLTSKRNKTSNKANKPM 59
Query: 61 AKSSSLCSNYNSS-SGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPIL 119
A +S+ + + SS + NPTIPNISKEIQEIR
Sbjct: 60 ATTSTATTKFVSSLNNNPTIPNISKEIQEIRTT--------------------------- 92
Query: 120 VEDSPASGRNRIHIEIGKDHRIAYPERAAGSHHGSG---------DQTVAAAITPEVSHL 170
SP G NRIHIEIGKDHRI+YPER G GSG DQ A PEVSHL
Sbjct: 93 ---SPVGGGNRIHIEIGKDHRISYPERVGGLGSGSGETRSGPRSGDQAGAVIAVPEVSHL 149
Query: 171 GWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFK 230
GWGHWYTLRELE STN FADENVIGEGGYGIVY G+LEDNTNVAVKNLLNNRGQAEKEFK
Sbjct: 150 GWGHWYTLRELEESTNYFADENVIGEGGYGIVYRGLLEDNTNVAVKNLLNNRGQAEKEFK 209
Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE+++NGNLEQWLHGDVGP SPLTWEIR+N
Sbjct: 210 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEFVENGNLEQWLHGDVGPCSPLTWEIRIN 269
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
II+GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN K+SDFGLAKLLG+E SYVTTRV
Sbjct: 270 IIIGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNSKVSDFGLAKLLGSESSYVTTRV 329
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410
MGTFGYVAPEYASTGMLNERSDVYSFGIL+ME+ISGRNPVDYSRP GEVNLVEWLKTMVT
Sbjct: 330 MGTFGYVAPEYASTGMLNERSDVYSFGILLMEIISGRNPVDYSRPAGEVNLVEWLKTMVT 389
Query: 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDER 470
RNAEGVLDPRL +KP RALKRALLVALRCVDPNA KRPKMGHV+HMLEA+EFPFRD R
Sbjct: 390 IRNAEGVLDPRLPKKPSPRALKRALLVALRCVDPNAQKRPKMGHVVHMLEADEFPFRDVR 449
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255565232|ref|XP_002523608.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223537170|gb|EEF38803.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 707 bits (1824), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/509 (69%), Positives = 404/509 (79%), Gaps = 28/509 (5%)
Query: 6 FLNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSSS 65
+NDQLSK TS+FGLR+WVVLG+CVGA VLVLFLI++W SKR+ ++K
Sbjct: 8 LMNDQLSKPTSVFGLRVWVVLGVCVGAAFVLVLFLITVWLASKRSKKDNK---------- 57
Query: 66 LCSNYNSSSGNPTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLP--EPEPILV--- 120
+ P IP +SKEIQEIR++P + + + H P+P+ E + +L+
Sbjct: 58 --------NSKPKIPVVSKEIQEIRVEPVKPNRAQIQTHPFPDPEIAAGNERQALLLMPP 109
Query: 121 -EDSPAS---GRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWY 176
E+SP G I IEIGK H I+YP + + G GDQ +A + P+VSHLGWGHWY
Sbjct: 110 EEESPMGYHHGTGNIQIEIGKGHLISYPVSSGEAPRGGGDQ-LAMVVGPDVSHLGWGHWY 168
Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAI 236
TLRELE STNGFADENVIG+GGYGIVY+GVL DNT VAVKNLLNNRGQAEKEFKVEVEAI
Sbjct: 169 TLRELEASTNGFADENVIGQGGYGIVYYGVLVDNTQVAVKNLLNNRGQAEKEFKVEVEAI 228
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
GRVRHKNLVRLLGYCAEG+HRMLVYEY++NGNLEQWLHGDVG SPLTWEIRMNIILGTA
Sbjct: 229 GRVRHKNLVRLLGYCAEGSHRMLVYEYVNNGNLEQWLHGDVGSCSPLTWEIRMNIILGTA 288
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
KGLTYLHEGLEPKVVHRDIKSSNILLDK WN K+SDFGLAKLL E SY+TTRVMGTFGY
Sbjct: 289 KGLTYLHEGLEPKVVHRDIKSSNILLDKLWNAKVSDFGLAKLLYPESSYITTRVMGTFGY 348
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416
VAPEYASTGM+NERSDV+ FGILIME+ISGRNPVDYSRPP EVNLVEWLK MVTNRN EG
Sbjct: 349 VAPEYASTGMVNERSDVFGFGILIMEIISGRNPVDYSRPPDEVNLVEWLKRMVTNRNPEG 408
Query: 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDERRAGREH 476
VLDP+L E+P SRALKR LLVALRCVDPNA KRPKMGHV+HMLEA+EFPFRD+RR G++
Sbjct: 409 VLDPKLPERPSSRALKRVLLVALRCVDPNAQKRPKMGHVVHMLEADEFPFRDDRRGGKDP 468
Query: 477 GRSPHNGIKGRLMEKGVSESGDSSGYESG 505
+ + K LME ++ESGD SG + G
Sbjct: 469 RGTQCDNNKDALMENSMTESGDRSGVQDG 497
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356541793|ref|XP_003539357.1| PREDICTED: probable serine/threonine-protein kinase At1g01540-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 696 bits (1796), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/509 (70%), Positives = 409/509 (80%), Gaps = 35/509 (6%)
Query: 7 LNDQLSKRTSIFGLRLWVVLGICVGAGIVLVLFLISLWFTSKRNSNNSKRQLNAAKSSSL 66
+NDQLS TSIFGLRLWVVLG+CVGA IVL+LFLIS+W KR
Sbjct: 11 MNDQLSNTTSIFGLRLWVVLGVCVGAAIVLILFLISVWLAFKR----------------- 53
Query: 67 CSNYNSSSGNP-TIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILVEDSPA 125
SS NP +IP++SKEIQEIR+D +N +P P PDP+P E E++ +
Sbjct: 54 -----SSKTNPVSIPDVSKEIQEIRLD----TNPTLQPEPYPEPDPVPPTE----EETNS 100
Query: 126 SGRNRIHIEIGKDHRIAYPERA---AGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELE 182
G +RI EIGK+HRI+YPERA + S+ S + + PEVSHLGWGHWYTLR+LE
Sbjct: 101 LGYHRIQFEIGKNHRISYPERALLRSSSNDPSSGEVQLPTVIPEVSHLGWGHWYTLRDLE 160
Query: 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK 242
+TNGFA ENVIGEGGYGIVYHG+L DNTNVA+KNLLNNRGQAEKEFKVEVEAIGRVRHK
Sbjct: 161 DATNGFAPENVIGEGGYGIVYHGILNDNTNVAIKNLLNNRGQAEKEFKVEVEAIGRVRHK 220
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
NLVRLLGYCAEGAHRMLVYEY+DNGNLEQWLHGDVGP SPLTWEIRMNIILGTAKGLTYL
Sbjct: 221 NLVRLLGYCAEGAHRMLVYEYVDNGNLEQWLHGDVGPCSPLTWEIRMNIILGTAKGLTYL 280
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
HEGLEPKVVHRDIKSSNILL K+WN K+SDFGLAKLLG++ SY+TTRVMGTFGYVAPEYA
Sbjct: 281 HEGLEPKVVHRDIKSSNILLSKKWNAKVSDFGLAKLLGSDSSYITTRVMGTFGYVAPEYA 340
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422
STGMLNERSDVYSFGILIME+I+GRNPVDYSRPP EVNLV+WLK MV+NRN EGVLDP+L
Sbjct: 341 STGMLNERSDVYSFGILIMELITGRNPVDYSRPPEEVNLVDWLKKMVSNRNPEGVLDPKL 400
Query: 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDERRAGREHGRSPHN 482
EKP SRALKRALLVALRC DPNA KRPKMGHVIHMLEAE+ P++++RRA R+ G SP++
Sbjct: 401 PEKPTSRALKRALLVALRCTDPNAQKRPKMGHVIHMLEAEDSPYKEDRRAKRDAGHSPND 460
Query: 483 GIKGRLMEK-GVSESGDSSGYESGVQTNK 510
+ L E+ VS S D E+G+ N+
Sbjct: 461 RVGDGLKEEVTVSVSVDDGKLENGMCANE 489
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 521 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-49 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-49 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-43 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-43 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-31 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-30 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-20 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-19 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 8e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.002 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 4e-49
Identities = 67/193 (34%), Positives = 106/193 (54%), Gaps = 11/193 (5%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
+GEGG+G VY + VA+K + + +E E+E + ++ H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
+ H LV EY + G+L+ L L+ + + I+L +GL YLH ++
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 312 HRDIKSSNILLDK-QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM-LNE 369
HRD+K NILLD KL+DFGL+KLL +++S + T V GT Y+APE +E
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSE 173
Query: 370 RSDVYSFGILIME 382
+SD++S G+++ E
Sbjct: 174 KSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 5e-49
Identities = 76/277 (27%), Positives = 124/277 (44%), Gaps = 31/277 (11%)
Query: 191 ENVIGEGGYGIVYHGVLEDN-----TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNL 244
+GEG +G VY G L+ VAVK L + Q +EF E + ++ H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
V+LLG C E +V EY++ G+L +L L+ ++ L A+G+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
+HRD+ + N L+ + K+SDFGL++ L + Y ++APE
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 365 GMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL- 422
G +SDV+SFG+L+ E+ + G +P ++ E + + N RL
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLG------EQPYPGMSNEE-VLEYLKNGY-------RLP 223
Query: 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459
Q C L + L+C + RP ++ +L
Sbjct: 224 QPPNCPPELYD---LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 4e-48
Identities = 79/278 (28%), Positives = 126/278 (45%), Gaps = 32/278 (11%)
Query: 191 ENVIGEGGYGIVYHGVLEDN-----TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNL 244
+GEG +G VY G L+ VAVK L + Q +EF E + ++ H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
V+LLG C E M+V EY+ G+L +L L+ ++ L A+G+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
+HRD+ + N L+ + K+SDFGL++ L + Y ++APE
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 365 GMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVN--LVEWLKTMVTNRNAEGVLDPR 421
G +SDV+SFG+L+ E+ + G P PG N ++E+LK R
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP-----YPGMSNAEVLEYLKKG--YR--------L 223
Query: 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459
+ C L + + L+C + RP ++ +L
Sbjct: 224 PKPPNCPPELYK---LMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 5e-46
Identities = 83/289 (28%), Positives = 127/289 (43%), Gaps = 47/289 (16%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN----VAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVR 246
+GEG +G VY G L+ VAVK L + + K+F E + ++ H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWL-----HGDVGPHSPLTWEIRMNIILGTAKGLTY 301
LLG C E LV EY++ G+L +L S L+ + ++ + AKG+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT-------RVMGTF 354
L K VHRD+ + N L+ + K+SDFGL++ + + Y R M
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM--- 174
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRN 413
APE G+ +SDV+SFG+L+ E+ + G P Y ++ E + +
Sbjct: 175 ---APESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--Y----PGLSNEE-VLEYLRKGY 224
Query: 414 AEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
RL KP C L + L C + RP ++ LE
Sbjct: 225 -------RL-PKPEYCPDELYE---LMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 5e-45
Identities = 70/207 (33%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV---EVEAIGRVRHKNLVRLL 248
+G G +G VY VAVK +L R + K+ + E+ + R+ H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVK-ILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
+ H LV EY + G+L +L PL+ + I L +GL YLH
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHSN--- 117
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE------YA 362
++HRD+K NILLD+ K++DFGLAK L S +TT V GT Y+APE
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGY 176
Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
+ DV+S G+++ E+++G+ P
Sbjct: 177 GP-----KVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 3e-43
Identities = 83/279 (29%), Positives = 126/279 (45%), Gaps = 38/279 (13%)
Query: 193 VIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVR 246
+GEG +G VY G L T VAVK L + E+ EF E + ++ H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
LLG C +G +V EY+ G+L +L LT + + + L AKG+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLESK- 121
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG---YVAPEYAS 363
VHRD+ + N L+ + K+SDFGL++ + + Y G ++APE
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPESLK 177
Query: 364 TGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422
G +SDV+SFG+L+ E+ + G P Y E ++E L+ RL
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQP--YPGMSNE-EVLELLED-----------GYRL 223
Query: 423 QEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459
+P C L + L+C + RP ++ L
Sbjct: 224 -PRPENCPDELYE---LMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 4e-43
Identities = 73/266 (27%), Positives = 118/266 (44%), Gaps = 26/266 (9%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
+ +GEG +G VY + VA+K + + + E++ + +++H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT-WEIRMNIILGTAKGLTYLHE 304
RL + LV EY + G+L L L+ E R + L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLK----KRGRLSEDEAR-FYLRQILSALEYLHS 115
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
+VHRD+K NILLD+ + KL+DFGLA+ L TT V GT Y+APE
Sbjct: 116 ---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFV-GTPEYMAPEVLLG 170
Query: 365 GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424
+ D++S G+++ E+++G+ P PG+ L+E K + + E
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPF-----PGDDQLLELFKKIGKPK-----PPFPPPE 220
Query: 425 KPCSRALKRALLVALRCVDPNAHKRP 450
S K L+ + + + KR
Sbjct: 221 WDISPEAK-DLI--RKLLVKDPEKRL 243
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 1e-31
Identities = 78/262 (29%), Positives = 129/262 (49%), Gaps = 27/262 (10%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
++IG G +G+VY G+ LE VA+K +L + +A K E++ + ++H N+V+ +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
G ++ EY +NG+L Q + P + + +GL YLHE
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIK----KFGPFPESLVAVYVYQVLQGLAYLHE---Q 118
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
V+HRDIK++NIL K KL+DFG+A L + V+GT ++APE +
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS-VVGTPYWMAPEVIEMSGAS 177
Query: 369 ERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCS 428
SD++S G ++E+++G NP P ++N + L +V + P L E S
Sbjct: 178 TASDIWSLGCTVIELLTG-NP-----PYYDLNPMAALFRIVQDD------HPPLPEG-IS 224
Query: 429 RALKRALLVALRCVDPNAHKRP 450
LK L ++C + + RP
Sbjct: 225 PELKDFL---MQCFQKDPNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 70/206 (33%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
IG+G +G V G VAVK L ++ A+ F E + +RH NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDYRGQK-VAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
G +V EY+ G+L +L G +T ++ L +G+ YL E VHR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSR-GRAV-ITLAQQLGFALDVCEGMEYLE---EKNFVHR 126
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERS 371
D+ + N+L+ + K+SDFGLAK + G + APE + +S
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK---EASQGQDS---GKLPVKWTAPEALREKKFSTKS 180
Query: 372 DVYSFGILIMEVIS-GRNPVDYSRPP 396
DV+SFGIL+ E+ S GR P Y R P
Sbjct: 181 DVWSFGILLWEIYSFGRVP--YPRIP 204
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (311), Expect = 3e-31
Identities = 78/279 (27%), Positives = 125/279 (44%), Gaps = 23/279 (8%)
Query: 187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRH-K 242
+ +GEG +G VY D VA+K L L ++ + + F E++ + + H
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
N+V+L + + LV EY+D G+LE L +G PL+ + I+ L YL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYL 117
Query: 303 HEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFGLAKLLGAERS-----YVTTRVMGTFGY 356
H ++HRDIK NILLD+ KL DFGLAKLL S + + +GT GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 357 VAPEYA---STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413
+APE S + SD++S GI + E+++G P + + LK ++
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP--FEGEKNSSATSQTLK-IILELP 231
Query: 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM 452
+ P P + + L+ + + + R
Sbjct: 232 TPSLASPLSPSNPELISKAASDLL-KKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN-VAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
++G G +G VY + +D +AVK L + + + + E+ + ++H N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 249 GYCAEGAHRML-VY-EYIDNGNLEQWLHGDVGPHSPLTWEIR--MNIILGTAKGLTYLHE 304
G + L ++ EY+ G+L L P+ IR IL +GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQIL---EGLAYLHS 119
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM-GTFGYVAPEYAS 363
+VHRDIK +NIL+D KL+DFG AK LG + T + GT ++APE
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 364 TGMLNERSDVYSFGILIMEVISGRNP 389
+D++S G ++E+ +G+ P
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 6e-30
Identities = 67/211 (31%), Positives = 112/211 (53%), Gaps = 17/211 (8%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNV-AVKNL-LNNRGQAEKEFKV-EVEAIGRVRHKNL 244
F N IG+G +G+V+ V + + V A+K + L+ + E+E + E + ++ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT----WEIRMNIILGTAKGLT 300
+R + +V EY +NG+L + L G PL W + I+LG L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLG----LA 115
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
+LH K++HRDIKS N+ LD N K+ D G+AKLL ++ T ++GT Y++PE
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPE 171
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVD 391
NE+SDV++ G+++ E +G++P D
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 8e-30
Identities = 66/201 (32%), Positives = 117/201 (58%), Gaps = 12/201 (5%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
F E +G G +G V+ G+ ++ VA+K L ++ +++F+ EV+A+ R+RHK+L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWL---HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
C+ G ++ E ++ G+L +L G V P + L +++ A+G+ YL
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQVAEGMAYLE- 121
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
E +HRD+ + NIL+ + K++DFGLA+L+ E Y+++ + + APE AS
Sbjct: 122 --EQNSIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKIPYKWTAPEAASH 178
Query: 365 GMLNERSDVYSFGILIMEVIS 385
G + +SDV+SFGIL+ E+ +
Sbjct: 179 GTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 80/288 (27%), Positives = 140/288 (48%), Gaps = 32/288 (11%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEKE---FKVEVE 234
E+ + + VIG G +G V+ G+L+ VA+K L G EK+ F E
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL--KPGYTEKQRQDFLSEAS 58
Query: 235 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
+G+ H N++RL G + M++ EY++NG L+++L G S + ++ G
Sbjct: 59 IMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL---VGMLRG 115
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMG 352
A G+ YL + VHRD+ + NIL++ K+SDFGL+++L E +Y T+
Sbjct: 116 IAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172
Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412
+ APE + SDV+SFGI++ EV+S RP +++ E +K +
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFG-----ERPYWDMSNHEVMKAINDGF 227
Query: 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+D C A+ + + L+C + +RP+ ++++L+
Sbjct: 228 RLPAPMD-------CPSAVYQLM---LQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 83/273 (30%), Positives = 121/273 (44%), Gaps = 41/273 (15%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
+ + IGEG G VY VA+K + R Q ++ E+ + +H N+V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVD 79
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTW-EIRMN------IILGTAKGL 299
G +V EY+D G+L D+ +T +RMN + +GL
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLT-----DI-----ITQNFVRMNEPQIAYVCREVLQGL 129
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
YLH V+HRDIKS NILL K + KL+DFG A L E+S + V GT ++AP
Sbjct: 130 EYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAP 185
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR-PPGEVNLVEWLKTMVTNRNAEGVL 418
E + D++S GI+ +E+ G P Y R PP + L + T G+
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPP--YLREPP-----LRALFLITTK----GI- 233
Query: 419 DPRLQEKPC-SRALKRALLVALRCVDPNAHKRP 450
P L+ S K L +C+ + KRP
Sbjct: 234 -PPLKNPEKWSPEFKDFL---NKCLVKDPEKRP 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-28
Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 9/209 (4%)
Query: 188 FADENVIGEGGYGIVYHG-VLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
F IG+GG+G VY VA+K + + +++ E++ + + +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
G + +V E+ G+L+ L LT + KGL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT---LTESQIAYVCKELLKGLEYLHSN- 117
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
++HRDIK++NILL KL DFGL+ L ++ ++GT ++APE +
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGKP 173
Query: 367 LNERSDVYSFGILIMEVISGRNPVDYSRP 395
+ ++D++S GI +E+ G+ P P
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPP 202
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 75/223 (33%), Positives = 111/223 (49%), Gaps = 18/223 (8%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVR 240
E+ E +G G +G V+ G T VAVK L G E F E + + ++R
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL--KPGTMSPEAFLQEAQIMKKLR 59
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
H LV+L C+E +V EY+ G+L +L G L + M + A+G+
Sbjct: 60 HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI--AEGMA 117
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVA 358
YL +HRD+ + NIL+ + K++DFGLA+L+ + Y T R F + A
Sbjct: 118 YLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLI-EDDEY-TAREGAKFPIKWTA 172
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVN 400
PE A+ G +SDV+SFGIL+ E+++ GR P Y PG N
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVTYGRVP--Y---PGMTN 210
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 188 FADENVIGEGGYGIVY---HGVLEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVRHK 242
+ IG+G +G VY D +K + L+N + E+E + EV+ + ++ H
Sbjct: 2 YEIIKQIGKGSFGKVYLVRR--KSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHP 59
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
N+++ E +V EY D G+L Q + P E ++ + L YL
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-- 360
H K++HRDIK NI L KL DFG++K+L + T V GT Y++PE
Sbjct: 120 HS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELC 175
Query: 361 ----YASTGMLNERSDVYSFGILIMEVISGRNP 389
Y N +SD++S G ++ E+ + ++P
Sbjct: 176 QNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 65/270 (24%), Positives = 118/270 (43%), Gaps = 41/270 (15%)
Query: 193 VIGEGGYGIVYHGVL-EDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG- 249
V+G+G G+VY A+K + ++ + K+ E++ + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP-----LTWEIRMNIILGTAKGLTYLHE 304
+ EG +V EY+D G+L L VG + +I KGL YLH
Sbjct: 68 FYKEGEIS-IVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQI--------LKGLDYLHT 117
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL----GAERSYVTTRVMGTFGYVAPE 360
++HRDIK SN+L++ + K++DFG++K+L ++V GT Y++PE
Sbjct: 118 KR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPE 170
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
+ +D++S G+ ++E G+ P P L++ + + P
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ----AICDGPP-----P 221
Query: 421 RLQEKPCSRALKRALLVALRCVDPNAHKRP 450
L + S + ++ C+ + KRP
Sbjct: 222 SLPAEEFSPEFRD--FIS-ACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 70/213 (32%), Positives = 110/213 (51%), Gaps = 27/213 (12%)
Query: 191 ENVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKN 243
E VIG G +G V G L + +VA+K L G ++K+ F E +G+ H N
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL--KAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
++RL G + M++ EY++NG+L+++L + G T + ++ G A G+ YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGMKYLS 123
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG------YV 357
E VHRD+ + NIL++ K+SDFGL++ L + TT+ G +
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-----GGKIPIRWT 175
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
APE + SDV+SFGI++ EV+S G P
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 62/207 (29%), Positives = 109/207 (52%), Gaps = 9/207 (4%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
IG G +G+V+ G + VA+K + +E++F E + + ++ H LV+L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
+ LV+E++++G L +L G S E + + L +G+ YL V+HR
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQ---ETLLGMCLDVCEGMAYLESS---NVIHR 124
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDV 373
D+ + N L+ + K+SDFG+ + + ++ +T + +PE S + +SDV
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 374 YSFGILIMEVIS-GRNPVDYSRPPGEV 399
+SFG+L+ EV S G+ P + +R EV
Sbjct: 185 WSFGVLMWEVFSEGKTPYE-NRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 79/278 (28%), Positives = 134/278 (48%), Gaps = 27/278 (9%)
Query: 190 DENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
+ENVI G G Y G N ++ ++ E+ +G+++H N+V+L+G
Sbjct: 694 EENVISRGKKGASYKGKSIKN---GMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIG 750
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
C L++EYI+ NL + L L+WE R I +G AK L +LH P
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPA 803
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
VV ++ I++D + P L L LL + T+ + YVAPE T + E
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITE 857
Query: 370 RSDVYSFGILIMEVISGRNPVDYSRPPGEVN--LVEWLKTMVTNRNAEGVLDPRLQEKPC 427
+SD+Y FG++++E+++G++P D V+ +VEW + ++ + + +DP ++
Sbjct: 858 KSDIYGFGLILIELLTGKSPAD---AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS 914
Query: 428 S--RALKRALLVALRC--VDPNAHKRPKMGHVIHMLEA 461
+ + +AL C DP A RP V+ LE+
Sbjct: 915 VNQNEIVEVMNLALHCTATDPTA--RPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 193 VIGEGGYGIVYHGV-LEDNTN----VAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVR 246
V+G G +G VY GV + + VA+K L +A KE E + V H ++VR
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
LLG C L+ + + G L ++ ++G L W +++ AKG++YL
Sbjct: 74 LLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE 126
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYA 362
E ++VHRD+ + N+L+ + K++DFGLAKLL E+ Y ++A E
Sbjct: 127 E---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 363 STGMLNERSDVYSFGILIMEVIS-GRNPVD 391
+ +SDV+S+G+ + E+++ G P +
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 70/210 (33%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
N IG G +G VY V L+ +AVK + +N + KE E++ + ++H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 249 GYCAEGAHRMLVY---EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
G E HR VY EY G LE+ L G + L +GL YLH
Sbjct: 66 G--VE-VHREKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQL--LEGLAYLHSH 118
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV---MGTFGYVAPEYA 362
+VHRDIK +NI LD KL DFG A L + + V GT Y+APE
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 363 STGMLNER---SDVYSFGILIMEVISGRNP 389
+ G +D++S G +++E+ +G+ P
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 71/227 (31%), Positives = 110/227 (48%), Gaps = 38/227 (16%)
Query: 192 NVIGEGGYGIVY---HGVLEDNTN--VAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLV 245
+GEG +G V + L DNT VAVK+L ++ Q +F+ E+E + + H+N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 246 RLLGYCAEGAHR---MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT------- 295
+ G E L+ EY+ +G+L +L H I L
Sbjct: 70 KYKG-VCEKPGGRSLRLIMEYLPSGSLRDYLQR----HRD-------QINLKRLLLFSSQ 117
Query: 296 -AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG-- 352
KG+ YL + +HRD+ + NIL++ + K+SDFGLAK+L ++ Y + G
Sbjct: 118 ICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 353 -TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE 398
F Y APE T + SDV+SFG+ + E+ + +P S PP E
Sbjct: 175 PIFWY-APECLRTSKFSSASDVWSFGVTLYELFTYGDP-SQS-PPAE 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 62/201 (30%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTN----VAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLL 248
+G G +G V GV + VAVK L A +KEF E + ++ H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
G C +G MLV E G L ++L ++ A G+ YL
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES-- 113
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYAST 364
VHRD+ + N+LL + K+SDFG+++ LGA Y G + + APE +
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 365 GMLNERSDVYSFGILIMEVIS 385
G + +SDV+S+G+ + E S
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 11/199 (5%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
+G G +G V+ G+ + T VAVK L + +F E + + ++RH L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
+V E + G+L ++L G G L I M + A G+ YL +HR
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV--ASGMAYLE---AQNYIHR 127
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERS 371
D+ + N+L+ + K++DFGLA+++ E Y R F + APE A + +S
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIK-EDIY-EAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 372 DVYSFGILIMEVIS-GRNP 389
DV+SFGIL+ E+++ GR P
Sbjct: 186 DVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 64/232 (27%), Positives = 101/232 (43%), Gaps = 43/232 (18%)
Query: 188 FADENVIGEGGYGIVYHGVL-EDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRV-RHK 242
F +IGEG + V E N A+K L + + K K+E E + R+ H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 243 NLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
+++L Y + + V EY NG L Q++ + L + L Y
Sbjct: 63 GIIKLY-YTFQDEENLYFVLEYAPNGELLQYIR----KYGSLDEKCTRFYAAEILLALEY 117
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM---------- 351
LH ++HRD+K NILLDK + K++DFG AK+L S + +
Sbjct: 118 LHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 352 ---------GTFGYVAPEYASTGMLNE-----RSDVYSFGILIMEVISGRNP 389
GT YV+PE +LNE SD+++ G +I ++++G+ P
Sbjct: 175 NRRRFASFVGTAEYVSPE-----LLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 70/229 (30%), Positives = 115/229 (50%), Gaps = 31/229 (13%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLL-NNRGQAEKEFKVE 232
E+ +S F +E +GEG +G VY G L T+VA+K L N + ++EF+ E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL-----HGDVGP-------H 280
E + ++H N+V LLG C + +++EY+ +G+L ++L H DVG
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 281 SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340
S L ++I + A G+ YL VHRD+ + N L+ + K+SDFGL++ +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 341 AERSYVTTRVMGT----FGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
+ Y RV ++ PE G SD++SFG+++ E+ S
Sbjct: 176 SADYY---RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 2e-23
Identities = 77/278 (27%), Positives = 124/278 (44%), Gaps = 29/278 (10%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR 238
E E + + V+G+G YGIVY L +A+K + + + E+
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP--HSPLTWEIRMNIILGTA 296
++H+N+V+ LG +E + E + G+L L GP + T IL
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL--- 118
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRVMGTFG 355
+GL YLH+ ++VHRDIK N+L++ K+SDFG +K L A + T GT
Sbjct: 119 EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQ 174
Query: 356 YVAPEYASTGM--LNERSDVYSFGILIMEVISGRNP-VDYSRPPGEVNLVEWLKTMVTNR 412
Y+APE G +D++S G I+E+ +G+ P ++ P + V K
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI----- 229
Query: 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP 450
P + E + A + + LRC +P+ KR
Sbjct: 230 ------HPEIPESLSAEA--KNFI--LRCFEPDPDKRA 257
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 8e-23
Identities = 82/287 (28%), Positives = 127/287 (44%), Gaps = 38/287 (13%)
Query: 192 NVIGEGGYGIVYHGVL----EDNT--NVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNL 244
+G G +G VY G+ D VAVK L + Q E +F +E + + H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPH----SPLTWEIRMNIILGTAKGLT 300
VRL+G E R ++ E + G+L+ +L + P S LT + + AKG
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLR-ENRPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNP----KLSDFGLAK-LLGAERSYVTTRVMGTFG 355
YL E +HRDI + N LL + P K++DFG+A+ + A R M
Sbjct: 131 YLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414
++ PE G+ ++DV+SFG+L+ E+ S G P PG N + + VT
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY-----PGRTN--QEVMEFVT---G 236
Query: 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
G LDP K C + R + C RP ++ ++
Sbjct: 237 GGRLDP---PKGCPGPVYR---IMTDCWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 22/216 (10%)
Query: 193 VIGEGGYGIVYHGVL------EDNTNVAVKNLLN-NRGQAEKEFKVEVEAIGRVRHKNLV 245
+GEG +G V+ G D VAVK L A K+F+ E E + +H+N+V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWL--HG--------DVGPHSPLTWEIRMNIILGT 295
+ G C EG ++V+EY+++G+L ++L HG P LT + I +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTF 354
A G+ YL VHRD+ + N L+ K+ DFG+++ + Y V M
Sbjct: 132 ASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
++ PE SDV+SFG+++ E+ + G+ P
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 7e-22
Identities = 83/283 (29%), Positives = 131/283 (46%), Gaps = 38/283 (13%)
Query: 191 ENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEK---EFKVEVEAIGRVRHKN 243
E VIG G +G V G L+ VA+K L G EK +F E +G+ H N
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
++ L G + M++ E+++NG L+ +L + G + + + ++ G A G+ YL
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYLS 123
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT-TRVMG---TFGYVAP 359
E VHRD+ + NIL++ K+SDFGL++ L + S T T +G + AP
Sbjct: 124 ---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418
E + SDV+S+GI++ EV+S G P +N +E
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-------------- 226
Query: 419 DPRLQEKP-CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
D RL C AL + + L C + + RPK G ++ L+
Sbjct: 227 DYRLPPPMDCPTALHQLM---LDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
+GEG YG VY + E VA+K + + +E E+ + + +V+ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 252 AEGAHRMLVYEYIDNG------NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
+ +V EY G + LT E I+ T KGL YLH
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITN---------KTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
K +HRDIK+ NILL+++ KL+DFG++ L + T V+GT ++APE
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEI 174
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
N ++D++S GI +E+ G+ P
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVR 246
+G G G+V VL T +AVK + E K E++ + + +V
Sbjct: 7 GELGAGNSGVVSK-VLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIVG 63
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVG--PHSPLTWEIRMNIILGTAKGLTYLHE 304
G + EY+D G+L++ L G P L I + KGLTYLHE
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHE 118
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEYA 362
K++HRD+K SNIL++ + KL DFG++ L +++V GT Y+APE
Sbjct: 119 KH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERI 171
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVD 391
+ +SD++S G+ ++E+ +GR P
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 67/212 (31%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVRHKNLVRLL 248
IG+G +G V D + K + N + EK+ V EV + ++H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR-- 63
Query: 249 GYCAEGAHRM---------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
Y R+ +V EY + G+L Q + + E I+ L
Sbjct: 64 -YY----DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 300 TYLHEGLEPK--VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
H +P V+HRD+K +NI LD N KL DFGLAK+LG + S+ T V GT Y+
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYM 177
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
+PE + +E+SD++S G LI E+ + P
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV----EVEAIGRVRHKNLVRLL 248
IGEG YG+VY VA+K + + E++ + + H N+++LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIK--LRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
LV+E++D +L + + L + + + +GL + H
Sbjct: 65 DVFRHKGDLYLVFEFMDT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH--- 117
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GML 367
++HRD+K N+L++ + KL+DFGLA+ G+ T V+ T Y APE
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGY 176
Query: 368 NERSDVYSFGILIMEVISGR 387
+ D++S G + E++S R
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAE---KEFKVEVEAIGRVRHKNLVRL 247
+G G +G VY G+ L+D AVK +L ++ + K+ + E+ + +++H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
LG E + + E + G+L + L G + GL YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAK-LLKKYGS---FPEPVIRLYTRQILLGLEYLHDR-- 121
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY-ASTGM 366
VHRDIK +NIL+D KL+DFG+AK + G+ ++APE A G
Sbjct: 122 -NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIAQQGG 178
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
+D++S G ++E+ +G+ P
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 65/199 (32%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLGYCA 252
IG+G +G VY GVL+ NT VAVK + K F E E + + H N+V+L+G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VV 311
+ +V E + G+L +L + LT + + + L A G+ Y LE K +
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLR---KKKNRLTVKKLLQMSLDAAAGMEY----LESKNCI 115
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT----FGYVAPEYASTGML 367
HRD+ + N L+ + K+SDFG+++ E + T G + APE + G
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 368 NERSDVYSFGILIMEVISG 386
SDV+S+GIL+ E S
Sbjct: 173 TSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 194 IGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVR 246
+G+G +G+VY G+ E T VA+K + N E+ EF E + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHG------DVGPHSPLTWEIRMNIILGTAKGLT 300
LLG + G ++V E + G+L+ +L + P T + + + A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVA 358
YL K VHRD+ + N ++ + K+ DFG+ + + E Y + + ++A
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMA 189
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS 385
PE G+ +SDV+SFG+++ E+ +
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-21
Identities = 70/222 (31%), Positives = 112/222 (50%), Gaps = 14/222 (6%)
Query: 194 IGEGGYGIVYHGVLE---DNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLG 249
+G G +G V GV + +VA+K L N ++ + E E E + ++ + +VR++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
C E MLV E G L ++L G +T + ++ + G+ YL
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEG---KN 115
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGML 367
VHRD+ + N+LL Q K+SDFGL+K LGA+ SY R G + + APE +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 368 NERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTM 408
+ RSDV+S+GI + E S G+ P + P ++ +E K +
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL 217
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 4e-21
Identities = 73/270 (27%), Positives = 119/270 (44%), Gaps = 29/270 (10%)
Query: 193 VIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLV 245
+G G +G V+ T V VK L + + + EF+ E++ ++ HKN+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWL-----HGDVGPHSPLTWEIRMNIILGTAKGLT 300
RLLG C E ++ EY D G+L+Q+L + PL+ + ++ + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
+L + VHRD+ + N L+ Q K+S L+K + Y + ++APE
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
+ +SDV+SFG+L+ EV + GE+ V NR G L+
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT----------QGELPFYGLSDEEVLNRLQAGKLEL 238
Query: 421 RLQEKPCSRALKRALLVALRCVDPNAHKRP 450
+ E C L + + RC N RP
Sbjct: 239 PVPEG-CPSRLYKLM---TRCWAVNPKDRP 264
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 5e-21
Identities = 83/280 (29%), Positives = 136/280 (48%), Gaps = 34/280 (12%)
Query: 191 ENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKN 243
E VIG G +G V G L+ VA+K L G EK+ F E +G+ H N
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
++ L G + M+V EY++NG+L+ +L G + + + ++ G A G+ YL
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGMKYLS 123
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEY 361
+ VHRD+ + NIL++ K+SDFGL+++L E +Y T + APE
Sbjct: 124 ---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 180
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDY-SRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
+ SDV+S+GI++ EV+S Y RP E++ + +K + EG P
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMS------YGERPYWEMSNQDVIKAI-----EEGYRLP 229
Query: 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+ C AL + + L C + ++RPK ++ +L+
Sbjct: 230 APMD--CPAALHQLM---LDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 6e-21
Identities = 69/202 (34%), Positives = 105/202 (51%), Gaps = 22/202 (10%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
+IGEG +G V G VAVKN+ + QA F E + ++ HKNLVRLLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 252 A-EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
G + +V E + GNL +L + ++ + L A+G+ YL K+
Sbjct: 69 LHNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQFS--LDVAEGMEYLES---KKL 121
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKL--LGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
VHRD+ + NIL+ + K+SDFGLA++ +G + S + + + APE +
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFS 175
Query: 369 ERSDVYSFGILIMEVIS-GRNP 389
+SDV+S+G+L+ EV S GR P
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 6e-21
Identities = 66/211 (31%), Positives = 110/211 (52%), Gaps = 19/211 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLGYCA 252
+G G +G V+ G +T VA+K+L +G E F E + +++H LVRL
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL--KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
+ ++ EY++NG+L +L G + I M + A+G+ ++ +H
Sbjct: 72 QEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQI--AEGMAFIER---KNYIH 125
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNER 370
RD++++NIL+ + K++DFGLA+L+ E + T R F + APE + G +
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 371 SDVYSFGILIMEVIS-GRNPVDYSRPPGEVN 400
SDV+SFGIL+ E+++ GR P PG N
Sbjct: 184 SDVWSFGILLTEIVTYGRIPY-----PGMTN 209
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 8e-21
Identities = 70/278 (25%), Positives = 119/278 (42%), Gaps = 31/278 (11%)
Query: 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAE--KEFKVEVEAIGRVRHKN 243
+ + +GEG G V L++ + + + K+ E+E +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 244 LVRLLGYCAEGAHRML--VYEYIDNGNLEQWLHGDVGPHSPLTWE-IRMNIILGTAKGLT 300
+V+ G + + + EY + G+L+ ++ V E + I KGL+
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
YLH K++HRDIK SNILL ++ KL DFG++ L S T GT Y+APE
Sbjct: 120 YLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGTFT-GTSFYMAPE 173
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPV--DYSRPPGEVNLVEWLKTMVTNRNAEGVL 418
+ SDV+S G+ ++EV R P + P G + L+ ++ M
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN-------- 225
Query: 419 DPRLQEKP-----CSRALKRALLVALRCVDPNAHKRPK 451
P L+++P S K + +C++ + +RP
Sbjct: 226 -PELKDEPGNGIKWSEEFKDFI---KQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 8e-21
Identities = 71/210 (33%), Positives = 111/210 (52%), Gaps = 17/210 (8%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
+G+G +G V+ G T VA+K L E F E + + ++RH+ LV+L +E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
+V EY+ G+L +L G++G + L + M + A G+ Y+ VHR
Sbjct: 73 EP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVER---MNYVHR 126
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERS 371
D++++NIL+ + K++DFGLA+L+ E + T R F + APE A G +S
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 372 DVYSFGILIMEVIS-GRNPVDYSRPPGEVN 400
DV+SFGIL+ E+ + GR P PG VN
Sbjct: 185 DVWSFGILLTELTTKGRVPY-----PGMVN 209
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 8e-21
Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 18/209 (8%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLL---NNRGQAEKEFKV---EVEAIGRVRHKNLV 245
V+G+G YG VY G+ +AVK + +N AEKE++ EV+ + ++H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
+ LG C + + E++ G++ L+ GP + IL G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPVFCKYTKQIL---DGVAYLHNN 121
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-----AERSYVTTRVMGTFGYVAPE 360
VVHRDIK +N++L KL DFG A+ L S + + GT ++APE
Sbjct: 122 ---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNP 389
+ +SD++S G + E+ +G+ P
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 1e-20
Identities = 70/284 (24%), Positives = 112/284 (39%), Gaps = 49/284 (17%)
Query: 194 IGEGGYGIV----YHGVLEDNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLL 248
+G+G +G+V + VAVK L +++ +F E + + H+NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT--WEIRMNIILGTAKGLTYLHEGL 306
G M+V E G+L L D H ++ + + I A G+ YL
Sbjct: 63 GVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLES-- 115
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT----RVMGTFGYVAPEYA 362
+ +HRD+ + NILL K+ DFGL + L + +V F + APE
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESL 172
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL---D 419
T + SDV+ FG+ + E+ + Y P W + +L D
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT------YGEEP-------WA-----GLSGSQILKKID 214
Query: 420 PRLQ--EKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459
+ E+P C + V L+C N RP + L
Sbjct: 215 KEGERLERPEACP---QDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 1e-20
Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 26/205 (12%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV----EVEAIGRVRHKNLVRLL 248
+GEG YG+VY + VA+K + + E+ E+ + ++H N+V+LL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
LV+EY D +L+++L I+ +I+ +GL Y H
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLD-KRPGPLSPN-LIK-SIMYQLLRGLAYCHSH--- 117
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-AERSYVTTRVMGTFGYVAPEYASTGML 367
+++HRD+K NIL+++ KL+DFGLA+ G R+Y T V+ T Y APE +L
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAPEI----LL 171
Query: 368 NERS-----DVYSFGILIMEVISGR 387
+ D++S G + E+I+G+
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 9/199 (4%)
Query: 194 IGEGGYGIVYH-GVLEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGY 250
+G+G YG VY L DN A+K + L + Q E+E V E+ + V H N++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
+G +V EY G+L + + + + I + +GL LHE K+
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KI 124
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNER 370
+HRD+KS+NILL K+ D G++K+L + + +GT Y+APE + +
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWKGRPYSYK 181
Query: 371 SDVYSFGILIMEVISGRNP 389
SD++S G L+ E+ + P
Sbjct: 182 SDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 67/223 (30%), Positives = 95/223 (42%), Gaps = 44/223 (19%)
Query: 190 DENVIGEGGYGIVY---HGVLEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRH-KNL 244
D IG G +G V H T +AVK + + +K ++++ + R +
Sbjct: 8 DLGEIGRGAFGTVNKMLHK--PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYI 65
Query: 245 VRLLG---------YCAE------GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM 289
V+ G C E VYE + + + EI
Sbjct: 66 VKFYGALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPE--------------EILG 110
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR 349
I + T K L YL E L K++HRD+K SNILLD+ N KL DFG++ L S TR
Sbjct: 111 KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTR 166
Query: 350 VMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVISGRNP 389
G Y+APE + RSDV+S GI + EV +G+ P
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 67/215 (31%), Positives = 100/215 (46%), Gaps = 39/215 (18%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNLVRL 247
IGEG YG VY + VA+K + R + EKE F + E++ + ++RH N+VRL
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 248 LGYCAEGAHR--MLVYEYID---NGNLEQWLHGDVGPHSPLTW-EIR--MNIILGTAKGL 299
+V+EY+D G L+ P T +I+ M +L +GL
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDS-------PEVKFTESQIKCYMKQLL---EGL 113
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
YLH ++HRDIK SNIL++ KL+DFGLA+ S T + T Y P
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPP 170
Query: 360 EYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
E +L D++S G ++ E+ G+
Sbjct: 171 EL----LLGATRYGPEVDMWSVGCILAELFLGKPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 4e-20
Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 27/207 (13%)
Query: 194 IGEGGYGIV---YHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
+G+G +G V + L+DNT VAVK L ++ + ++F+ E+E + ++H N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 249 GYCAEGAHR--MLVYEYIDNGNLEQWL--HGDVGPHSPL---TWEIRMNIILGTAKGLTY 301
G C R LV EY+ G+L +L H + H L +I KG+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI--------CKGMEY 123
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG---TFGYVA 358
L + VHRD+ + NIL++ + K+ DFGL K+L ++ Y R G F Y A
Sbjct: 124 LGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-A 179
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS 385
PE + + SDV+SFG+++ E+ +
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 194 IGEGGYGIVY----HGVL--EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
+GEG +G V+ H +L +D VAVK L A ++F+ E E + ++H+++VR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLH-----------GDVGPHSPLTWEIRMNIILGTA 296
G C EG ++V+EY+ +G+L ++L G+ LT + I A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFG 355
G+ YL L VHRD+ + N L+ + K+ DFG+++ + + Y V R M
Sbjct: 133 SGMVYL-ASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
++ PE SD++SFG+++ E+ + G+ P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 5e-20
Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE---------FKVEVEAIGRVRHK 242
+IG G +G VY G+ +AVK + A + E+ + ++H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
N+V+ LG + H + EY+ G++ L+ L +R N + KGL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL---VR-NFVRQILKGLNYL 122
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR-----VMGTFGYV 357
H ++HRDIK +NIL+D + K+SDFG++K L A T + G+ ++
Sbjct: 123 HN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
APE ++D++S G L++E+++G++P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 80/267 (29%), Positives = 130/267 (48%), Gaps = 25/267 (9%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
VIG G +VY + L +N VA+K + L + E + EV+A+ + H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEP 308
G LV Y+ G+L + P L I ++ KGL YLH G
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLL---GAERSYVTTRVMGTFGYVAPEYASTG 365
+HRDIK+ NILL + + K++DFG++ L G V +GT ++APE
Sbjct: 124 --IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 366 M-LNERSDVYSFGILIMEVISGRNPVDYSR-PPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423
+ ++D++SFGI +E+ +G P YS+ PP +V M+T +N L+
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAP--YSKYPPMKV-------LMLTLQNDPPSLETGAD 232
Query: 424 EKPCSRALKRALLVALRCVDPNAHKRP 450
K S++ ++ +++L C+ + KRP
Sbjct: 233 YKKYSKSFRK--MISL-CLQKDPSKRP 256
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
+G G +G+V+ G +VA+K ++ +E +F E + + ++ H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK-MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA----KGLTYLHEGLEPK 309
+V EY+ NG L +L G ++ +L + + YL
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKG-------KLGTEWLLDMCSDVCEAMEYLESN---G 120
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEYASTGM 366
+HRD+ + N L+ + K+SDFGLA+ + + Y ++ GT + PE
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYV-LDDQYTSS--QGTKFPVKWAPPEVFDYSR 177
Query: 367 LNERSDVYSFGILIMEVIS-GRNPVD 391
+ +SDV+SFG+L+ EV S G+ P +
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 27/207 (13%)
Query: 193 VIGEGGYGIVYHG-VLEDNTNVAVKNLLNNRGQAE-KEFKV-EVEAIGRVRHKNLVRLLG 249
V+GEG YG+V VA+K + + K+ + EV+ + ++RH+N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
LV+EY++ L + L G + P +R I + + Y H
Sbjct: 68 AFRRKGRLYLVFEYVER-TLLELLEASPGGLPPD-----AVRS-YIWQLLQAIAYCHSH- 119
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAER---SYVTTRVMGTFGYVAPE- 360
++HRDIK NIL+ + KL DFG A+ L YV TR Y APE
Sbjct: 120 --NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR-----WYRAPEL 172
Query: 361 YASTGMLNERSDVYSFGILIMEVISGR 387
+ DV++ G ++ E++ G
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 65/236 (27%), Positives = 103/236 (43%), Gaps = 41/236 (17%)
Query: 182 EVSTNGFADENVIGEGGYGIVYH----GVL--EDNTNVAVKNLLNNRG-QAEKEFKVEVE 234
E N IG+G +G V+ G+L E T VAVK L + +F+ E
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 235 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL------------HGDV----- 277
+ H N+V+LLG CA G L++EY+ G+L ++L H
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 278 -GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336
PL+ ++ I A G+ YL E K VHRD+ + N L+ + K++DFGL+
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 337 KLL-------GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
+ + +E + R M PE SDV+++G+++ E+ S
Sbjct: 178 RNIYSADYYKASENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 57/212 (26%), Positives = 106/212 (50%), Gaps = 11/212 (5%)
Query: 193 VIGEGGYGI-VYHGVLEDNTNVAVKNLLNNRGQAEKEFKV---EVEAIGRVRHKNLVRLL 248
V+G+G +G + ED++ V K + N +EKE + E+ + ++H N++
Sbjct: 7 VLGKGAFGEATLYRRTEDDSLVVWKEV-NLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
+ + ++ EY + G L + G E+ + + ++Y+H+
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL--FEEEMVLWYLFQIVSAVSYIHKA--- 120
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
++HRDIK+ NI L K KL DFG++K+LG+E S T V+GT Y++PE N
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYN 179
Query: 369 ERSDVYSFGILIMEVISGRNPVDYSRPPGEVN 400
+SD+++ G ++ E+++ + D + P V
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLNLVV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 4e-19
Identities = 66/222 (29%), Positives = 112/222 (50%), Gaps = 21/222 (9%)
Query: 193 VIGEGGYGIVYHGVL--EDNT---NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVR 246
++G G +G V+ G+ E ++ VA+K + + G Q +E + A+G + H +VR
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
LLG C GA LV + G+L + + P L W +++ AKG+ YL
Sbjct: 74 LLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYLE 126
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYA 362
E ++VHR++ + NILL +++DFG+A LL ++ Y + ++A E
Sbjct: 127 E---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 363 STGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVE 403
G +SDV+S+G+ + E++S G P RP +L+E
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-19
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 193 VIGEGGYG---IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
V+GEG +G +V H V D + L A ++ + E + +++H N+V
Sbjct: 7 VVGEGSFGRALLVQH-VNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP----LTWEIRMNIILGTAKGLTYLHEG 305
H +V EY D G+L Q + G P L W ++M + G+ ++HE
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHE- 118
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
+V+HRDIKS NI L + KL DFG A+LL + +Y T V GT YV PE
Sbjct: 119 --KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
N +SD++S G ++ E+ + ++P
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
IG G YG VY + VA+K + G + + E+ + RH N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
+V EY G+L+ GP S L +I + T KGL YLHE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL--QIAY-VCRETLKGLAYLHE---TGK 122
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA---STGML 367
+HRDIK +NILL + + KL+DFG++ L A + + + GT ++APE A G
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGY 181
Query: 368 NERSDVYSFGILIMEVISGRNP 389
+ + D+++ GI +E+ + P
Sbjct: 182 DGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 5e-19
Identities = 80/294 (27%), Positives = 131/294 (44%), Gaps = 49/294 (16%)
Query: 192 NVIGEGGYGIVYHGVLED-------NTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRH 241
N +G G +G VY G D VAVK L +G Q +KEF E + H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNFNH 58
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG---DVGPHSPLTWEIRMNIILGTAKG 298
N+V+LLG C + ++ E ++ G+L +L + LT + ++I L AKG
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 299 LTYLHEGLEPKVVHRDIKSSNILL-DKQWNP----KLSDFGLAKLLGAERSYVTTRVMG- 352
YL + +HRD+ + N L+ +K ++ K+ DFGLA+ + Y R G
Sbjct: 119 CVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGE 172
Query: 353 ---TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTM 408
++APE G +SDV+SFG+L+ E+++ G+ P P N +
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY-----PALNNQ-----EV 222
Query: 409 VTNRNAEGVLDPRLQEKP-CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
+ + A G RLQ+ C + + + C + +RP + +L+
Sbjct: 223 LQHVTAGG----RLQKPENCPDKIYQLM---TNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 6e-19
Identities = 81/299 (27%), Positives = 129/299 (43%), Gaps = 52/299 (17%)
Query: 193 VIGEGGYGIVYHGV------LEDNTNVAVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNLV 245
+GEG +G V T VAVK L N +E ++ E + +V H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGD--VGP------------------HSPLTW 285
+L G C++ +L+ EY G+L +L VGP LT
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 286 EIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345
++ ++G+ YL E K+VHRD+ + N+L+ + K+SDFGL++ + E SY
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 346 VT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVE 403
V ++ ++A E + +SDV+SFG+L+ E+++ G NP Y E L
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--YPGIAPE-RLFN 240
Query: 404 WLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
LKT E+P CS + + L C KRP + LE
Sbjct: 241 LLKT------------GYRMERPENCSEEMYN---LMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 68/210 (32%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLG- 249
VIGEG YG VY + VA+K +++ E+E K E + + H N+ G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 250 YCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
+ + LV E G++ + G L E I+ T +GL YLHE
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE 131
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE---- 360
KV+HRDIK NILL K KL DFG++ L + T + GT ++APE
Sbjct: 132 N---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAPEVIAC 187
Query: 361 -YASTGMLNERSDVYSFGILIMEVISGRNP 389
+ RSDV+S GI +E+ G+ P
Sbjct: 188 DEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 65/270 (24%), Positives = 124/270 (45%), Gaps = 30/270 (11%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLL---NNRGQAEK---EFKVEVEAIGRVRHKNLV 245
+G G + Y ++ T +AVK + N + E+ + E+ + R+ H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
R+LG E +H L E++ G++ L G + +N +GL+YLHE
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYGAFKE---AVIINYTEQLLRGLSYLHEN 122
Query: 306 LEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERS---YVTTRVMGTFGYVAPEY 361
+++HRD+K +N+L+D +++DFG A L A+ + +++GT ++APE
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421
DV+S G +I+E+ + + P + + + L+ + + T + L P
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239
Query: 422 LQEKPCSRALKRALLVALRCVDPNAHKRPK 451
L++ V LRC++ RP
Sbjct: 240 LRD------------VTLRCLELQPEDRPP 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 1e-18
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 194 IGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
+GEG +G V+ +D VAVK L + A K+F E E + ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWL--HG-------DVGPHSPLTWEIRMNIILGTAKG 298
G C EG ++V+EY+ +G+L ++L HG + + LT ++I A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYV 357
+ YL VHRD+ + N L+ + K+ DFG+++ + + Y V M ++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
PE SDV+S G+++ E+ + G+ P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 69/211 (32%), Positives = 104/211 (49%), Gaps = 12/211 (5%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
E+ +G G +G V+ G NT VAVK L E F E + + ++RH
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRH 60
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
LV+L +E +V EY+ G+L +L G L + M + A G+ Y
Sbjct: 61 DKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQV--AAGMAY 117
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAP 359
+ +HRD++S+NIL+ K++DFGLA+L+ E + T R F + AP
Sbjct: 118 IER---MNYIHRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAP 172
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
E A G +SDV+SFGIL+ E+++ GR P
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 65/226 (28%), Positives = 114/226 (50%), Gaps = 25/226 (11%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLN-NRGQAEKEFKVEV 233
EL +S F +E +GE +G +Y G L + VA+K L + N Q EF+ E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL-----HGDVGPHSPLTWEIR 288
+ + H N+V LLG + +++EY++ G+L ++L H DVG S ++
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 289 --------MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340
++I + A G+ YL VH+D+ + NIL+ +Q + K+SD GL++ +
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 341 AERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
+ Y V + + ++ PE G + SD++SFG+++ E+ S
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 52/194 (26%), Positives = 95/194 (48%), Gaps = 7/194 (3%)
Query: 191 ENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
++ +G G YG VY GV + + VAVK L + +EF E + ++H NLV+LLG
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
C ++ E++ GNL +L + + + + + + YL +
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---N 124
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
+HRD+ + N L+ + K++DFGL++L+ + + APE + +
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 370 RSDVYSFGILIMEV 383
+SDV++FG+L+ E+
Sbjct: 185 KSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 194 IGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRV-RHKN 243
+GEG +G V + + VAVK L ++ EK+ E+E + + +HKN
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKN 77
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLH------------GDVGPHSPLTWEIRMNI 291
++ LLG C + +V EY +GNL +L P LT + ++
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
A+G+ +L K +HRD+ + N+L+ + K++DFGLA+ + Y TT
Sbjct: 138 AYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
++APE + +SDV+SFG+L+ E+ +
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 82/271 (30%), Positives = 133/271 (49%), Gaps = 36/271 (13%)
Query: 192 NVIGEGGYGIVYHGVLEDN----TNVAVKNL--LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
VIG+G +G VYHG L D+ + AVK+L + + + E+ F E + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVL 59
Query: 246 RLLGYC--AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
LLG C +EG+ ++V Y+ +G+L ++ + H+P T + + L AKG+ YL
Sbjct: 60 SLLGICLPSEGS-PLVVLPYMKHGDLRNFIRSE--THNP-TVKDLIGFGLQVAKGMEYL- 114
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPE 360
K VHRD+ + N +LD+ + K++DFGLA+ + + Y G ++A E
Sbjct: 115 --ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
T +SDV+SFG+L+ E+++ P P +V+ + +T +G
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVDSFD-----ITVYLLQG---R 219
Query: 421 RL-QEKPCSRALKRALLVALRCVDPNAHKRP 450
RL Q + C L V L C P RP
Sbjct: 220 RLLQPEYCPDPLYE---VMLSCWHPKPEMRP 247
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 66/209 (31%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 194 IGEGGYGIVYHG-VLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR-VRHKNLVRLLGYC 251
IGEG GIV VAVK + + R Q +E I R +H N+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
G +V E+++ G L D+ H+ + E + L K L++LH V+
Sbjct: 86 LVGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLAVLKALSFLHA---QGVI 137
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAE----RSYVTTRVMGTFGYVAPEYASTGML 367
HRDIKS +ILL KLSDFG + E +S V GT ++APE S
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYWMAPEVISRLPY 192
Query: 368 NERSDVYSFGILIMEVISGRNPVDYSRPP 396
D++S GI+++E++ G P ++ PP
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPY-FNEPP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 3e-18
Identities = 79/271 (29%), Positives = 127/271 (46%), Gaps = 30/271 (11%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
+G+G +G V+ G T VA+K L E F E + + ++RH LV L +E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
+V E++ G+L +L G + L + M + A G+ Y+ +HR
Sbjct: 73 EP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQI--ADGMAYIER---MNYIHR 126
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERS 371
D++++NIL+ K++DFGLA+L+ E + T R F + APE A G +S
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 372 DVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRA 430
DV+SFGIL+ E+++ GR P PG VN E L+ + R PC +
Sbjct: 185 DVWSFGILLTELVTKGRVPY-----PGMVNR-EVLEQV-----------ERGYRMPCPQG 227
Query: 431 LKRALLVALR-CVDPNAHKRPKMGHVIHMLE 460
+L ++ C + +RP ++ LE
Sbjct: 228 CPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
+G G +G V+ G ++T VAVK L + F E + ++H LVRL +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
++ EY+ G+L +L D G L I + + A+G+ Y+ +HR
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIER---KNYIHR 127
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLNERS 371
D++++N+L+ + K++DFGLA+++ E + T R F + APE + G +S
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 372 DVYSFGILIMEVIS-GRNPVDYSRPPGEVN 400
DV+SFGIL+ E+++ G+ P PG N
Sbjct: 186 DVWSFGILLYEIVTYGKIPY-----PGMSN 210
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 52/172 (30%), Positives = 88/172 (51%), Gaps = 14/172 (8%)
Query: 194 IGEGGYGIVYH-GVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
IGEG +GIV+ E VA+K + R G + E++A+ +H +V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR--MNIILGTAKGLTYLHEGLEP 308
G+ +LV EY+ + L + L + P +++ M ++L KG+ Y+H
Sbjct: 68 FPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEA--QVKSYMRMLL---KGVAYMHAN--- 118
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
++HRD+K +N+L+ K++DFGLA+L E + + + T Y APE
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 21/210 (10%)
Query: 193 VIGEGGYGIVYHGVL--EDNT---NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVR 246
V+G G +G VY G+ E T VA+K L G +A EF E + + H +LVR
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
LLG C + LV + + +G L ++H ++G L W +++ AKG+ YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL-GAERSYVTTRVMGTFGYVAPEYA 362
E ++VHRD+ + N+L+ + K++DFGLA+LL G E+ Y ++A E
Sbjct: 127 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 363 STGMLNERSDVYSFGILIMEVIS-GRNPVD 391
+SDV+S+G+ I E+++ G P D
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 31/208 (14%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV------EVEAIGRVRHKNLVR 246
IGEG YG+VY VA+K + R + E E V E+ + + H N+VR
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI---RLETEDE-GVPSTAIREISLLKELNHPNIVR 62
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
LL LV+E++D +L++++ D P + L + + + +G+ Y H
Sbjct: 63 LLDVVHSENKLYLVFEFLDL-DLKKYM--DSSPLTGLDPPLIKSYLYQLLQGIAYCHSH- 118
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE----- 360
+V+HRD+K N+L+D++ KL+DFGLA+ G R+Y T V+ T Y APE
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY-THEVV-TLWYRAPEILLGS 174
Query: 361 -YASTGMLNERSDVYSFGILIMEVISGR 387
ST + D++S G + E+++ R
Sbjct: 175 RQYSTPV-----DIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 5e-18
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV---EVEAIGRVRHKN 243
F IG+G +G VY + N VA+K + + +AE E + E++ + + R
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI--DLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+ + G +G+ ++ EY G+ D+ L I+ GL YLH
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCL-----DLLKPGKLDETYIAFILREVLLGLEYLH 115
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
E +HRDIK++NILL ++ + KL+DFG++ L + S T V GT ++APE
Sbjct: 116 EE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIK 171
Query: 364 TGMLNERSDVYSFGILIMEVISGRNP 389
+E++D++S GI +E+ G P
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 6e-18
Identities = 64/268 (23%), Positives = 125/268 (46%), Gaps = 27/268 (10%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKNLVRLLG 249
V+G G +GIV+ + + + + + + E + E + + + H N++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
E M+V EY G L +++ +S L + ++ + L ++H L
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTKL--- 121
Query: 310 VVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
++HRD+K+ NILLDK K+ DFG++K+L ++ T V+GT Y++PE N
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGKPYN 179
Query: 369 ERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCS 428
++SD+++ G ++ E+ S + + + P V LK M + R
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAANLPALV-----LKIM---SGTFAPISDRYSPD--- 228
Query: 429 RALKRALLVALRCVDPNAHKRPKMGHVI 456
R L++++ +DP+ KRP++ ++
Sbjct: 229 ---LRQLILSMLNLDPS--KRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 8e-18
Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 194 IGEGGYGIVYHGVLE---DNTNVAVKNLLN--NRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
+G G +G V G+ + VAVK L N N + E E + ++ + +VR++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWL----HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
G C E MLV E + G L ++L H + L ++ M G+ YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM--------GMKYLEE 113
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYA 362
VHRD+ + N+LL Q K+SDFGL+K LGA+ +Y + G + + APE
Sbjct: 114 T---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170
Query: 363 STGMLNERSDVYSFGILIMEVIS-GRNP 389
+ + +SDV+SFG+L+ E S G+ P
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 9e-18
Identities = 65/204 (31%), Positives = 107/204 (52%), Gaps = 23/204 (11%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
+GEG Y VY G VA+K +L G + E+ + ++H+N+VRL
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLHDV 66
Query: 251 CAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
MLV+EY+D +L++++ HG G P T + +L KG+ + HE
Sbjct: 67 IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLL---KGIAFCHEN--- 119
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
+V+HRD+K N+L++K+ KL+DFGLA+ G + + V+ T Y AP+ +L
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDV----LLG 174
Query: 369 ERS-----DVYSFGILIMEVISGR 387
R+ D++S G ++ E+I+GR
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 56/202 (27%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
+G G +G+V +G +VA+K ++ +E EF E + + ++ H+ LV+L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
+V EY+ NG L +L ++ + + +G+ YL + +HR
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLRE--HGKRFQPSQL-LEMCKDVCEGMAYLE---SKQFIHR 124
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEYASTGMLNER 370
D+ + N L+D Q K+SDFGL++ + + Y ++ +G+ + PE + +
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSS--VGSKFPVRWSPPEVLLYSKFSSK 181
Query: 371 SDVYSFGILIMEVIS-GRNPVD 391
SDV++FG+L+ EV S G+ P +
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 65/197 (32%), Positives = 100/197 (50%), Gaps = 13/197 (6%)
Query: 194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLGYC 251
IG G +G V+ G L DNT VAVK+ K +F E + + H N+VRL+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-V 310
+ +V E + G+ +L + GP + I+M + A G+ YL E K
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQM--VENAAAGMEYL----ESKHC 115
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLN 368
+HRD+ + N L+ ++ K+SDFG+++ + Y +T M + APE + G +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 369 ERSDVYSFGILIMEVIS 385
SDV+SFGIL+ E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 193 VIGEGGYGIVYHGVLE-DNTNVAVKNL-LNNRGQAEKEF-KVEVEAIGRVRHKNLVRLLG 249
IGEG +G +Y + D+ + +K + L EKE K EV + +++H N+V
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVG----PHSPLTWEIRMNIILGTAKGLTYLHEG 305
E +V EY D G+L + ++ G L+W +++++ GL ++H+
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHD- 119
Query: 306 LEPKVVHRDIKSSNILLDKQWN-PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
K++HRDIKS NI L K KL DFG+A+ L T +GT Y++PE
Sbjct: 120 --RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPEICQN 176
Query: 365 GMLNERSDVYSFGILIMEVISGRNPVD 391
N ++D++S G ++ E+ + ++P +
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 74/273 (27%), Positives = 129/273 (47%), Gaps = 28/273 (10%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
E +G G +G V+ +T VAVK + E F E + ++H LV+L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 69
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
+ ++ E++ G+L +L D G PL I + + A+G+ ++ +
Sbjct: 70 VTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQ---RNY 123
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYASTGMLN 368
+HRD++++NIL+ K++DFGLA+++ E + T R F + APE + G
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFT 181
Query: 369 ERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPC 427
+SDV+SFGIL+ME+++ GR P PG N E ++ + G PR + P
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPY-----PGMSN-PEVIRAL-----ERGYRMPRPENCP- 229
Query: 428 SRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+ + +RC +RP ++ +L+
Sbjct: 230 ----EELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
IG+G +G V G VAVK + N+ + F E + ++RH NLV+LLG
Sbjct: 11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 251 CAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
E + +V EY+ G+L +L S L + + L + + YL
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---N 122
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
VHRD+ + N+L+ + K+SDFGL K + + V T APE +
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 178
Query: 370 RSDVYSFGILIMEVIS-GRNPVDYSRPP 396
+SDV+SFGIL+ E+ S GR P Y R P
Sbjct: 179 KSDVWSFGILLWEIYSFGRVP--YPRIP 204
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 61/218 (27%), Positives = 92/218 (42%), Gaps = 51/218 (23%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------- 237
IGEG YG VY ++L R A K+ +V + G
Sbjct: 5 AEIGEGAYGTVYKA----------RDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQ 54
Query: 238 --RVRHKNLVRLLGYCA-----EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
H N+VRLL C LV+E++D +L +L P L E +
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL--SKCPKPGLPPETIKD 111
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
++ +G+ +LH ++VHRD+K NIL+ K++DFGLA++ E + T V
Sbjct: 112 LMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TSV 166
Query: 351 MGTFGYVAPE------YASTGMLNERSDVYSFGILIME 382
+ T Y APE YA+ D++S G + E
Sbjct: 167 VVTLWYRAPEVLLQSSYATP------VDMWSVGCIFAE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 75/253 (29%), Positives = 117/253 (46%), Gaps = 22/253 (8%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYCA 252
IGEG GIV ++ + + ++ R Q +E EV + +H+N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
G +V E+++ G L D+ H+ + E + L K L+ LH V+H
Sbjct: 88 VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIAAVCLAVLKALSVLHA---QGVIH 139
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAPEYASTGMLNER 370
RDIKS +ILL KLSDFG + E V R ++GT ++APE S
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKE---VPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 371 SDVYSFGILIMEVISGRNPVDYSRPPGEV------NLVEWLKTM-VTNRNAEGVLDPRLQ 423
D++S GI+++E++ G P ++ PP + NL LK + + + +G LD L
Sbjct: 197 VDIWSLGIMVIEMVDGEPPY-FNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255
Query: 424 EKPCSRALKRALL 436
P RA LL
Sbjct: 256 RDPAQRATAAELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRH---KNLVRL 247
+IG G YG VY G + VA+K + L+ + + EV + ++R N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
G +G ++ EY + G++ + P+ + II L Y+H+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV-- 120
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-M 366
V+HRDIK++NIL+ N KL DFG+A LL S +T V GT ++APE + G
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
+ ++D++S GI I E+ +G P
Sbjct: 179 YDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 74/255 (29%), Positives = 116/255 (45%), Gaps = 26/255 (10%)
Query: 194 IGEGGYGIVYHGVLEDN-TNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
IGEG GIV + VAVK + + Q + EV + H+N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
G +V E+++ G L D+ H+ + E + L + L+YLH V+H
Sbjct: 90 VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLSVLRALSYLHN---QGVIH 141
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAPEYASTGMLNER 370
RDIKS +ILL KLSDFG + E V R ++GT ++APE S
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKE---VPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 371 SDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRA 430
D++S GI+++E+I G P ++ PP L+ M R L PR+++ +
Sbjct: 199 VDIWSLGIMVIEMIDGEPPY-FNEPP--------LQAM---RRIRDNLPPRVKDSHKVSS 246
Query: 431 LKRALLVALRCVDPN 445
+ R L + +P+
Sbjct: 247 VLRGFLDLMLVREPS 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 5e-17
Identities = 63/222 (28%), Positives = 95/222 (42%), Gaps = 37/222 (16%)
Query: 194 IGEGGYGIVYHGVLEDNTN------VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
+G+G +G V V + +T V K + R + E E + R+ H +V+L
Sbjct: 1 LGKGSFGKVL-LVRKKDTGKLYAMKVLKKKKIIKRKEVEH-TLTERNILSRINHPFIVKL 58
Query: 248 LGYCA--EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK-------- 297
+ A LV EY G L + H A+
Sbjct: 59 --HYAFQTEEKLYLVLEYAPGGEL--FSH----------LSKEGRFSEERARFYAAEIVL 104
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L YLH +++RD+K NILLD + KL+DFGLAK L +E S T GT Y+
Sbjct: 105 ALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYL 160
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
APE + D +S G+L+ E+++G+ P Y+ E+
Sbjct: 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDRKEI 201
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 68/229 (29%), Positives = 113/229 (49%), Gaps = 31/229 (13%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNN-RGQAEKEFKVE 232
E+ +ST F +E +GE +G VY G L E VA+K L + G +EFK E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL-----HGDVGP-------H 280
R++H N+V LLG + +++ Y + +L ++L H DVG
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 281 SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340
S L ++I+ A G+ +L VVH+D+ + N+L+ + N K+SD GL + +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 341 AERSYVTTRVMGT----FGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
A Y ++MG +++PE G + SD++S+G+++ EV S
Sbjct: 176 AADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 45/132 (34%), Positives = 72/132 (54%), Gaps = 9/132 (6%)
Query: 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321
E++D G+L+ P+ EI I + +GLTYL+ +++HRDIK SNIL
Sbjct: 83 EFMDCGSLD----RIYKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNIL 136
Query: 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 381
++ + KL DFG++ G + + +GT Y++PE G +SDV+S GI I+
Sbjct: 137 VNSRGQIKLCDFGVS---GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISII 193
Query: 382 EVISGRNPVDYS 393
E+ G+ P +S
Sbjct: 194 ELALGKFPFAFS 205
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 8e-17
Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKE---FKVEVEAIGRVRHKNLVRL 247
+G+G +G VY ++ +AVK + + +KE + E++ + ++H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
G + + EY+ G+++ L + LT + +G+ YLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN-- 123
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT--TRVMGTFGYVAPEYASTG 365
+VHRDIK +NIL D N KL DFG +K L S T V GT +++PE S
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
++DV+S G ++E+++ + P
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 9e-17
Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 23/216 (10%)
Query: 194 IGEGGYGIVYHG------VLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
+GEG +G V+ +D VAVK L + A K+F+ E E + ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWL--HG-------DVGP---HSPLTWEIRMNIILGT 295
G C +G ++V+EY+ +G+L ++L HG D P L ++I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTF 354
A G+ YL VHRD+ + N L+ K+ DFG+++ + + Y V M
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
++ PE SDV+SFG+++ E+ + G+ P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYC 251
IG+G G VY + + VA+K + N + Q +KE + E+ + +H N+V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
G +V EY+ G+L DV + + + + L +LH +V+
Sbjct: 86 LVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 137
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
HRDIKS NILL + KL+DFG + E+S +T V GT ++APE + +
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 372 DVYSFGILIMEVISGRNP 389
D++S GI+ +E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 26/214 (12%)
Query: 191 ENVIGEGGYGIVYHGVLEDN---TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKNLV 245
E+VIGEG +G V +++ + N A+K L + + ++F E+E + ++ H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHG------------DVGPHSPLTWEIRMNIIL 293
LLG C + + EY GNL +L + G S LT + +
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
A G+ YL E + +HRD+ + N+L+ + K++DFGL++ E YV + MG
Sbjct: 127 DVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYV-KKTMGR 179
Query: 354 FG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
++A E + + +SDV+SFG+L+ E++S
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 54/180 (30%), Positives = 84/180 (46%), Gaps = 28/180 (15%)
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
I + K L YLH L V+HRD+K SN+L+++ KL DFG++ L S T
Sbjct: 108 IAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTID 163
Query: 351 MGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK 406
G Y+APE + + + +SDV+S GI ++E+ +GR P D + P + LK
Sbjct: 164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLK 218
Query: 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPF 466
+V + P+L + S + V +C+ N +RP E + PF
Sbjct: 219 QVVEEPS------PQLPAEKFSPEFQD--FVN-KCLKKNYKERPN------YPELLQHPF 263
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 76/281 (27%), Positives = 127/281 (45%), Gaps = 25/281 (8%)
Query: 193 VIGEGGYG--IVY-HGVLEDNTN--VAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVR 246
V+GEG +G +Y + D T VAVK L GQ +K E+ + + H+N+V+
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 247 LLGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
G C+E + L+ EY+ G+L +L P L + +G+ YLH
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG---TFGYVAPEY 361
+HRD+ + N+LLD K+ DFGLAK + Y R G F Y A E
Sbjct: 126 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVEC 181
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE-VNLVEWLKTMVTNRNAEGVLDP 420
+ SDV+SFG+ + E+++ + PP + ++ + +T +L+
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDS--KQSPPKKFEEMIGPKQGQMTVVRLIELLE- 238
Query: 421 RLQEKPCSRALKRALLVALR-CVDPNAHKRPKMGHVIHMLE 460
R PC + + + + ++ C + A RP +I +L+
Sbjct: 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 2e-16
Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 8/197 (4%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253
+G G +G+V+ G VA+K + N +E++F E + + ++ H LV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313
+V E+++NG L +L G S ++ +++ +G+ YL +HR
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSK---DMLLSMCQDVCEGMEYLERN---SFIHR 124
Query: 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDV 373
D+ + N L+ K+SDFG+ + + + ++ + PE + + +SDV
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184
Query: 374 YSFGILIMEVIS-GRNP 389
+SFG+L+ EV + G+ P
Sbjct: 185 WSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 62/220 (28%), Positives = 110/220 (50%), Gaps = 27/220 (12%)
Query: 194 IGEGGYGIVYH----GVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
+GEG +G V G+ +D VAVK L ++ + + + E+E + + +HKN
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----------DVG--PHSPLTWEIRMNI 291
++ LLG C + ++ EY GNL ++L D+ P +T++ ++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
A+G+ YL K +HRD+ + N+L+ + K++DFGLA+ + Y TT
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
++APE + +SDV+SFG+L+ E+ + G +P
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLL-GYC 251
+G+G +G VY ++ A ++ + E E F VE++ + +H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTW-EIRMNIILGTAKGLTYLHEGLEPKV 310
E +L+ E+ D G L+ + + LT +IR + + L +LH KV
Sbjct: 73 YENKLWILI-EFCDGGALDSIM---LELERGLTEPQIRY-VCRQMLEALNFLHSH---KV 124
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML--- 367
+HRD+K+ NILL + KL+DFG++ + T + GT ++APE +
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDN 183
Query: 368 --NERSDVYSFGILIMEVISGRNP 389
+ ++D++S GI ++E+ P
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 69/225 (30%), Positives = 113/225 (50%), Gaps = 26/225 (11%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTN----VAVKNLLNNRG-QAEKEFKV 231
L+E E F V+G G +G VY G+ + + VA+K L +A KE
Sbjct: 4 LKETE-----FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 58
Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGD-VGPHSPLTWEIR 288
E + V + ++ RLLG C + L+ + + G L ++ H D +G L W ++
Sbjct: 59 EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 117
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVT 347
+ AKG+ YL E ++VHRD+ + N+L+ + K++DFGLAKLLGA E+ Y
Sbjct: 118 I------AKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA 168
Query: 348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391
++A E + +SDV+S+G+ + E+++ G P D
Sbjct: 169 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 4e-16
Identities = 73/273 (26%), Positives = 118/273 (43%), Gaps = 28/273 (10%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLGYC 251
++G+G +G V+ G L+D T VAVK + Q K +F E + + H N+V+L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
+ +V E + G+ +L L + + L A G+ YL +
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLES---KNCI 115
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
HRD+ + N L+ + K+SDFG+++ G S ++ + APE + G +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSS 173
Query: 370 RSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCS 428
SDV+S+GIL+ E S G P PG +TN+ A ++ +
Sbjct: 174 ESDVWSYGILLWETFSLGVCPY-----PG-----------MTNQQAREQVEKGYRMSCPQ 217
Query: 429 RALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
+ V RC D RPK + L A
Sbjct: 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 5e-16
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTN---VAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKN 243
F IG+G +G V+ G+ DN VA+K + + E E + E+ + +
Sbjct: 6 FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+ + G +G ++ EY+ G+ L GP + IL KGL YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEIL---KGLDYLH 118
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
K +HRDIK++N+LL +Q + KL+DFG+A L + T V GT ++APE
Sbjct: 119 S---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQ 174
Query: 364 TGMLNERSDVYSFGILIMEVISGRNP 389
+ ++D++S GI +E+ G P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 43/214 (20%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------RVR 240
IGEG YG+VY +N L A K+ +++ E G +
Sbjct: 8 IGEGTYGVVYKA----------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 57
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
H N+V+LL LV+E++ + +L++++ D P S + + + + +GL
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM--DASPLSGIPLPLIKSYLFQLLQGLA 114
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAP 359
+ H +V+HRD+K N+L++ + KL+DFGLA+ G R+Y T + T Y AP
Sbjct: 115 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAP 169
Query: 360 E------YASTGMLNERSDVYSFGILIMEVISGR 387
E Y ST + D++S G + E+++ R
Sbjct: 170 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 57/214 (26%), Positives = 110/214 (51%), Gaps = 26/214 (12%)
Query: 191 ENVIGEGGYGIVYHGVLEDN---TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKNLV 245
++VIGEG +G V ++ + + A+K + + + ++F E+E + ++ H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----DVGPH--------SPLTWEIRMNIIL 293
LLG C + L EY +GNL +L + P S L+ + ++
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
A+G+ YL + + +HRD+ + NIL+ + + K++DFGL++ + YV + MG
Sbjct: 132 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-KKTMGR 184
Query: 354 FG--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
++A E + + SDV+S+G+L+ E++S
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 13/203 (6%)
Query: 193 VIGEGGYGIVYHGVL----EDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRL 247
IGEG +G VY GV + VAVK N + +E F E + + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
+G E +V E G L +L + L + + L YL
Sbjct: 73 IGVITENP-VWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLES--- 125
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
+ VHRDI + N+L+ KL DFGL++ L E Y ++ ++APE +
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185
Query: 368 NERSDVYSFGILIMEVIS-GRNP 389
SDV+ FG+ + E++ G P
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 9e-16
Identities = 51/211 (24%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 193 VIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKE----------FKVEVEAIGRVRH 241
+IG+G YG VY + + AVK + A + + E+E + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
N+V+ LG+ + + EY+ G++ L + ++ +GL Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAY 123
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL-GAERSYVTTRVMGTFGYVAPE 360
LH ++HRD+K+ N+L+D K+SDFG++K + + G+ ++APE
Sbjct: 124 LHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 361 YASTGM--LNERSDVYSFGILIMEVISGRNP 389
+ + + D++S G +++E+ +GR P
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 12/205 (5%)
Query: 191 ENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 245
E ++G G +G + G L+ VA+ L ++ F E +G+ H N+V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
RL G G M+V EY+ NG L+ +L G L M ++ G A G+ YL E
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ---LVAGQLMGMLPGLASGMKYLSE- 125
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
VH+ + + +L++ K+S F + +E Y T + APE
Sbjct: 126 --MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 366 MLNERSDVYSFGILIMEVIS-GRNP 389
+ SDV+SFGI++ EV+S G P
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEF---KVEVEAIGRVRHKNL 244
F IG+G +G VY G+ ++ T V + + +AE E + E+ + + +
Sbjct: 6 FTKLERIGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
R G +G ++ EY+ G+ D+ PL I+ KGL YLH
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSAL-----DLLKPGPLEETYIATILREILKGLDYLHS 119
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
+ +HRDIK++N+LL +Q + KL+DFG+A L + T V GT ++APE
Sbjct: 120 ---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQ 175
Query: 365 GMLNERSDVYSFGILIMEVISGRNP 389
+ ++D++S GI +E+ G P
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 67/276 (24%), Positives = 122/276 (44%), Gaps = 23/276 (8%)
Query: 185 TNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNL----LNNRGQAEKEFKVEVEAIGRV 239
F E IG+G + +VY + L D VA+K + + + + K E++ + ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
H N+++ L E +V E D G+L + + + + L
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
++H +++HRDIK +N+ + KL D GL + ++ + + V GT Y++P
Sbjct: 120 EHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419
E N +SD++S G L+ E+ + ++P ++NL K E
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYSLCK------KIEKCDY 225
Query: 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHV 455
P L S L+ LV+ RC++P+ KRP + +V
Sbjct: 226 PPLPADHYSEELRD--LVS-RCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 21/201 (10%)
Query: 194 IGEGGYG---IVYHGVLEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
IGEG +G +V ED +K N+ + +E + EV + ++H N+V+
Sbjct: 8 IGEGSFGKAILVKSK--EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP----LTWEIRMNIILGTAKGLTYLHE 304
E + +V +Y + G+L + ++ G P L W +++ + L ++H+
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL------ALKHVHD 119
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
K++HRDIKS NI L K KL DFG+A++L + T +GT Y++PE
Sbjct: 120 ---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYLSPEICEN 175
Query: 365 GMLNERSDVYSFGILIMEVIS 385
N +SD+++ G ++ E+ +
Sbjct: 176 RPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 56/213 (26%), Positives = 107/213 (50%), Gaps = 26/213 (12%)
Query: 192 NVIGEGGYGIVYHGVLEDN---TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKNLVR 246
+VIGEG +G V ++ + + A+K + + + ++F E+E + ++ H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHG------------DVGPHSPLTWEIRMNIILG 294
LLG C + L EY +GNL +L S L+ + ++
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF 354
A+G+ YL + + +HRD+ + NIL+ + + K++DFGL++ + YV + MG
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-KKTMGRL 173
Query: 355 G--YVAPEYASTGMLNERSDVYSFGILIMEVIS 385
++A E + + SDV+S+G+L+ E++S
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 76/279 (27%), Positives = 125/279 (44%), Gaps = 32/279 (11%)
Query: 194 IGEGGYGIVYHGVLEDNT-------NVAVKNLLNNRGQAEKEFKV-----EVEAIG-RVR 240
+G G +G VY ++N + V N + + E++ + EV I ++R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
H N+VR E +V + I+ L + + T E NI + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
YLH+ E ++VHRD+ +NI+L + ++DFGLAK E S +T+ V+GT Y PE
Sbjct: 128 YLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-SKLTS-VVGTILYSCPE 183
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
E++DV++FG ++ ++ + P YS N++ +V E V +P
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCT-LQPPFYS-----TNMLSLATKIV-----EAVYEP 232
Query: 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459
L E S + V C+ P+A RP + V M+
Sbjct: 233 -LPEGMYSEDVT---DVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLL 248
N IG G G VY V+ T A+K + N ++ E+E + V H N+V+
Sbjct: 80 NRIGSGAGGTVYK-VIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
++ E++D G+LE D + + +I G+ YLH
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQI--------LSGIAYLHR---R 187
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
+VHRDIK SN+L++ N K++DFG++++L + V GT Y++PE +T LN
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTD-LN 245
Query: 369 E------RSDVYSFGILIMEVISGRNPVDYSR 394
D++S G+ I+E GR P R
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 193 VIGEGGYGIVY----HGVLEDNT--NVAVKNLLNNRGQAEKE-FKVEVEAIGRV-RHKNL 244
+G G +G V +G+ + + VAVK L +E+E E++ + + H+N+
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
V LLG C G +++ EY G+L +L S LT E ++ AKG+ +L
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV---TTRVMGTFGYVAPEY 361
+HRD+ + N+LL K+ DFGLA+ + + +YV R+ ++APE
Sbjct: 160 ---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPES 214
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNP 389
+ SDV+S+GIL+ E+ S G NP
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFSLGSNP 243
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 54/182 (29%), Positives = 92/182 (50%), Gaps = 12/182 (6%)
Query: 213 VAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQ 271
VAVK L + A ++F EV+ + R+ N+ RLLG C ++ EY++NG+L Q
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 272 WLHGDVGPHS-------PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK 324
+L V S L++ + + A G+ YL VHRD+ + N L+ K
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGK 165
Query: 325 QWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEV 383
+ K++DFG+++ L + Y V R ++A E G +SDV++FG+ + E+
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225
Query: 384 IS 385
++
Sbjct: 226 LT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 60/215 (27%), Positives = 89/215 (41%), Gaps = 29/215 (13%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEF-KVEVEAIGRVRHKNLVRLLGY 250
VIG+G +G V +++ K + A K K + G VR N++
Sbjct: 6 RVIGKGAFGKVC--IVQKRDT---KKMF-----AMKYMNKQKCVEKGSVR--NVLNERRI 53
Query: 251 CAEGAHRMLV---YEYIDNGNL----EQWLHGDVGPH----SPLTWEIRMNIILGTAKGL 299
E H LV Y + D N+ + L GD+ H + E I L
Sbjct: 54 LQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLAL 113
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
YLH ++HRDIK NILLD+Q + ++DF +A + +TT GT GY+AP
Sbjct: 114 EYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTSTSGTPGYMAP 168
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394
E + D +S G+ E + G+ P
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 31/210 (14%)
Query: 193 VIGEGGYGIVY---HGVLEDNTNVAVKNLLNNRGQAE--KEFKVEVEAIGRVRHKNLVRL 247
++GEG YG+V H E VA+K L + K E+ + ++RH+NLV L
Sbjct: 8 LVGEGSYGMVMKCKHK--ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 248 LGYCAEGAHRMLVYEYIDN---GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
+ LV+E++D+ +LE++ +G L + +G+ + H
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-------LDESRVRKYLFQILRGIEFCHS 118
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE----RSYVTTRVMGTFGYVAPE 360
++HRDIK NIL+ + KL DFG A+ L A YV TR Y APE
Sbjct: 119 H---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPE 170
Query: 361 YASTGMLNERS-DVYSFGILIMEVISGRNP 389
R+ D+++ G L+ E+++G P
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEMLTG-EP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 28/209 (13%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN---VAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKN 243
N IGEG YGIVY D T+ VA+K + R E++ + E+ + +RH N
Sbjct: 13 NRIGEGTYGIVYRA--RDTTSGEIVALKKV---RMDNERDGIPISSLREITLLLNLRHPN 67
Query: 244 LVRLLGYCAEGAHR---MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
+V L G H LV EY + +L L P S +++ ++L +GL
Sbjct: 68 IVELK-EVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFS--ESQVKC-LMLQLLRGLQ 122
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
YLHE ++HRD+K SN+LL + K++DFGLA+ G +T +V+ T Y APE
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPE 178
Query: 361 YASTGMLNERS--DVYSFGILIMEVISGR 387
G + D+++ G ++ E+++ +
Sbjct: 179 LL-LGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 34/212 (16%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAE--------KEFKVEVEAIGRVRHKN 243
+GEG Y +VY E VA+K + L R +A+ +E K+ E ++H N
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQE----LKHPN 63
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
++ LL ++ LV+E+++ +LE+ + +P +I+ + +L T +GL YLH
Sbjct: 64 IIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPA--DIK-SYMLMTLRGLEYLH 119
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE--- 360
++HRD+K +N+L+ KL+DFGLA+ G+ +T +V+ T Y APE
Sbjct: 120 SNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLF 175
Query: 361 ---YASTGMLNERSDVYSFGILIMEVISGRNP 389
+ G+ D++S G + E++ R P
Sbjct: 176 GARHYGVGV-----DMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 73/258 (28%), Positives = 118/258 (45%), Gaps = 26/258 (10%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYC 251
IG+G G VY + + VA++ + N + Q +KE + E+ + ++ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
G +V EY+ G+L DV + + + + L +LH +V+
Sbjct: 87 LVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
HRDIKS NILL + KL+DFG + E+S + ++GT ++APE + +
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 372 DVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRAL 431
D++S GI+ +E+I G P P + L + TN P LQ A+
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGT------PELQNPEKLSAI 245
Query: 432 KRALLVALRCVDPNAHKR 449
R L RC+D + KR
Sbjct: 246 FRDFLN--RCLDMDVEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYC 251
IG+G G V+ + + VA+K + N + Q +KE + E+ + +++ N+V L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQI-NLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
G +V EY+ G+L DV + + + + L +LH +V+
Sbjct: 86 LVGDELFVVMEYLAGGSLT-----DVVTETCMDEAQIAAVCRECLQALEFLHAN---QVI 137
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
HRDIKS N+LL + KL+DFG + E+S +T V GT ++APE + +
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 372 DVYSFGILIMEVISGRNP 389
D++S GI+ +E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 5e-15
Identities = 58/233 (24%), Positives = 95/233 (40%), Gaps = 67/233 (28%)
Query: 190 DENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEA---------IGRV 239
IG G YG+V V VA+K + N F ++A + +
Sbjct: 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHL 56
Query: 240 RHKNLVRLLG-------------YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWE 286
RH+N++ LL Y +V E ++ +L + + PLT +
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVY--------IVTELMET-DLHKVIKS----PQPLTDD 103
Query: 287 IRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-- 344
+ +GL YLH V+HRD+K SNIL++ + K+ DFGLA+ + +
Sbjct: 104 HIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160
Query: 345 -----YVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
YV TR Y APE +L+ D++S G + E+++ +
Sbjct: 161 GFLTEYVVTRW-----YRAPEL----LLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 46/214 (21%)
Query: 194 IGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKV------EVEAIGRVRHKNLVR 246
IGEG YG+V+ + VA+K + ++E + + E+ + +++H NLV
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFV----ESEDDPVIKKIALREIRMLKQLKHPNLVN 64
Query: 247 LLGYCAEGAHRMLVYEYIDN---GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
L+ LV+EY D+ LE+ G + + II T + + + H
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-------VPEHLIKKIIWQTLQAVNFCH 117
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL----GAERSYVTTRVMGTFGYVAP 359
+ +HRD+K NIL+ KQ KL DFG A++L YV TR Y AP
Sbjct: 118 KH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAP 169
Query: 360 E-------YASTGMLNERSDVYSFGILIMEVISG 386
E Y DV++ G + E+++G
Sbjct: 170 ELLVGDTQYGPP------VDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 9e-15
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYC 251
IG+G G VY + + VA+K + N + Q +KE + E+ + ++ N+V L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
G +V EY+ G+L DV + + + + L +LH +V+
Sbjct: 86 LVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALDFLHSN---QVI 137
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
HRDIKS NILL + KL+DFG + E+S +T V GT ++APE + +
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 372 DVYSFGILIMEVISGRNP 389
D++S GI+ +E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 68/211 (32%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKN 243
F D IG G +G VY + N VA+K + + Q+ ++++ EV + ++RH N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 244 LVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM-NIILGTAKGLTY 301
+ G C H LV EY G+ L +V H E+ + I G +GL Y
Sbjct: 77 TIEYKG-CYLREHTAWLVMEYC-LGSASDIL--EV--HKKPLQEVEIAAICHGALQGLAY 130
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
LH + +HRDIK+ NILL + KL+DFG A L+ S+V GT ++APE
Sbjct: 131 LH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEV 182
Query: 362 ---ASTGMLNERSDVYSFGILIMEVISGRNP 389
G + + DV+S GI +E+ + P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 194 IGEGGYGIV---YHGVLEDNTN--VAVKNLL-NNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
+GEG +G V + DNT VAVK+L + G + K E+E + + H+N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 248 LGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
G C E L+ E++ +G+L+++L + + + + ++ + KG+ YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGS- 127
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT---RVMGTFGYVAPEYA 362
+ VHRD+ + N+L++ + K+ DFGL K + ++ Y T F Y APE
Sbjct: 128 --RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECL 184
Query: 363 STGMLNERSDVYSFGILIMEVIS 385
SDV+SFG+ + E+++
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 64/220 (29%), Positives = 109/220 (49%), Gaps = 27/220 (12%)
Query: 194 IGEGGYGIVYH----GVLEDNTN----VAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
+GEG +G V G+ +D N VAVK L ++ + + E+E + + +HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG------DVG------PHSPLTWEIRMNI 291
++ LLG C + ++ EY GNL ++L D P LT++ ++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
A+G+ YL K +HRD+ + N+L+ + K++DFGLA+ + Y TT
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
++APE + +SDV+SFG+L+ E+ + G +P
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 1e-14
Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 58/228 (25%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV--------EVEAIGRV-RHKN 243
+G+G +G VY E VA+K + +K+F EV+++ ++ H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+V+L E V+EY++ GNL Q + G P + + +II +GL ++H
Sbjct: 60 IVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIH 116
Query: 304 E-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS------YVTTRVMGTFGY 356
+ G HRD+K N+L+ K++DFGLA+ + RS YV+TR Y
Sbjct: 117 KHGF----FHRDLKPENLLVSGPEVVKIADFGLAREI---RSRPPYTDYVSTR-----WY 164
Query: 357 VAPE-------YASTGMLNERSDVYSFGILIMEVIS------GRNPVD 391
APE Y+S D+++ G ++ E+ + G + +D
Sbjct: 165 RAPEILLRSTSYSSP------VDIWALGCIMAELYTLRPLFPGSSEID 206
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 193 VIGEGGYGIVYHGV-LEDNTN----VAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVR 246
V+G G +G VY G+ + D N VA+K L N +A KE E + V + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
LLG C + LV + + G L ++ +G L W +++ AKG++YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYA 362
E ++VHRD+ + N+L+ + K++DFGLA+LL E Y ++A E
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 363 STGMLNERSDVYSFGILIMEVIS-GRNPVD 391
+SDV+S+G+ + E+++ G P D
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 58/219 (26%), Positives = 104/219 (47%), Gaps = 32/219 (14%)
Query: 194 IGEGGYGIVY----HGVLE----------DNTN-VAVKNLLNN-RGQAEKEFKVEVEAIG 237
+GEG +G V+ G+ E VAVK L + A +F E++ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 238 RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL----------HGDVGPHSPLTWEI 287
R+++ N++RLLG C ++ EY++NG+L Q+L H + P + +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 288 RMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-V 346
M + + A G+ YL VHRD+ + N L+ + K++DFG+++ L + Y +
Sbjct: 133 YMAVQI--ASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187
Query: 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
R + ++A E G SDV++FG+ + E+ +
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 56/215 (26%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 193 VIGEGGYGIVYHGVL--EDNT--NVAVKNL-LNNRGQAE-KEFKVEVEAIGRVRHKNLVR 246
++GEG +G V G L +D + VAVK + L+ +E +EF E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 247 LLGYCAEGAHR------MLVYEYIDNGNLEQWLH----GDVGPHSPLTWEIRMNIILGTA 296
L+G C E + M++ ++ +G+L +L G + PL + + ++ A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKFMVDIA 123
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT-FG 355
G+ YL +HRD+ + N +L + ++DFGL+K + + Y R+
Sbjct: 124 LGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
++A E + + +SDV++FG+ + E+ + G+ P
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 20/190 (10%)
Query: 213 VAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQ 271
VAVK L + + A +F EV+ + R++ N++RLLG C + ++ EY++NG+L Q
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 272 WL------------HGDVGPHSPL---TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIK 316
+L + V P L ++ +++ L A G+ YL VHRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLA 165
Query: 317 SSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYS 375
+ N L+ + K++DFG+++ L A Y + R + ++A E G SDV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 376 FGILIMEVIS 385
FG+ + E++
Sbjct: 226 FGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 194 IGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVR 246
+G+G +G+VY G+ E T VA+K + E+ EF E + ++VR
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHG------DVGPHSPLTWEIRMNIILGTAKGLT 300
LLG ++G +++ E + G+L+ +L + +P + + + + A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG--YVA 358
YL+ K VHRD+ + N ++ + + K+ DFG+ + + E Y G +++
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMS 189
Query: 359 PEYASTGMLNERSDVYSFGILIMEV 383
PE G+ SDV+SFG+++ E+
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 6e-14
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 34/215 (15%)
Query: 194 IGEGGYGIVYHGVLEDNTN--VAVKNL----LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
I +G YG V+ + +T A+K + + + Q + + E + + + + +V+L
Sbjct: 1 ISKGAYGRVFL-AKKKSTGDIYAIKVIKKADMIRKNQVD-QVLTERDILSQAQSPYVVKL 58
Query: 248 LGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
Y +G + LV EY+ G+L L +VG L ++ I L YLH
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLLE-NVGS---LDEDVARIYIAEIVLALEYLHSN- 112
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--------TTRVMGTFGYVA 358
++HRD+K NIL+D + KL+DFGL+K +G R + R++GT Y+A
Sbjct: 113 --GIIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 359 PEYASTGMLNE----RSDVYSFGILIMEVISGRNP 389
PE +L + D +S G ++ E + G P
Sbjct: 170 PEV----ILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 30/208 (14%)
Query: 194 IGEGGYGIVYHGVLED---NTNVAVKNLLNNRGQAEKE-----FKVEVEAIGRVRHKNLV 245
IGEG YG+VY D N +A+K + R + E E E+ + ++H N+V
Sbjct: 10 IGEGTYGVVYKA--RDRVTNETIALKKI---RLEQEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
RL LV+EY+D L+ H D P + + +G+ Y H
Sbjct: 65 RLQDVVHSEKRLYLVFEYLD---LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 306 LEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
+V+HRD+K N+L+D++ N KL+DFGLA+ G T V+ T Y APE
Sbjct: 122 ---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEI--- 174
Query: 365 GMLNERS-----DVYSFGILIMEVISGR 387
+L R D++S G + E+++ +
Sbjct: 175 -LLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 7e-14
Identities = 67/235 (28%), Positives = 104/235 (44%), Gaps = 80/235 (34%)
Query: 194 IGEGGYGIVYHGVLEDNTN--VAVKNLLN---NRGQAEKEFKVEVEAIGRVR-HKNLVRL 247
+G+G YGIV+ + + T VA+K + + N A++ F+ E+ + + H N+V+L
Sbjct: 15 LGKGAYGIVWKAI-DRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKL 72
Query: 248 LGYCAEGAHRM-------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI--------- 291
L + LV+EY++ + L IR NI
Sbjct: 73 LN-----VIKAENDKDIYLVFEYME---------------TDLHAVIRANILEDVHKRYI 112
Query: 292 ---ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---- 344
+L K L Y+H G V+HRD+K SNILL+ KL+DFGLA+ L
Sbjct: 113 MYQLL---KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN 166
Query: 345 -----YVTTRVMGTFGYVAPE-------YASTGMLNERSDVYSFGILIMEVISGR 387
YV TR Y APE Y + G+ D++S G ++ E++ G+
Sbjct: 167 PVLTDYVATR-----WYRAPEILLGSTRY-TKGV-----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 194 IGEGGYGIVYHGVLED------NTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVR 246
+G+G +G+VY G D T VAVK + + E+ EF E + ++VR
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLH-----GDVGPHSPL-TWEIRMNIILGTAKGLT 300
LLG ++G ++V E + +G+L+ +L + P P T + + + A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVA 358
YL+ K VHRD+ + N ++ + K+ DFG+ + + E Y G ++A
Sbjct: 134 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMA 189
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS 385
PE G+ SD++SFG+++ E+ S
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKN 243
F+D IG G +G VY + ++ VA+K + + Q+ ++++ EV + ++RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYL 302
++ G LV EY G+ L H E+ + + G +GL YL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC-LGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY- 361
H ++HRD+K+ NILL + KL DFG A ++ +V GT ++APE
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 362 --ASTGMLNERSDVYSFGILIMEVISGRNPV 390
G + + DV+S GI +E+ + P+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 194 IGEGGYGIVYHGVLEDN-TNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYC 251
IGEG GIV + + VAVK +++ R Q +E EV + +H+N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
G ++ E++ G L D+ + L E + + L YLH V+
Sbjct: 88 LVGEELWVLMEFLQGGALT-----DIVSQTRLNEEQIATVCESVLQALCYLHS---QGVI 139
Query: 312 HRDIKSSNILLDKQWNPKLSDFG----LAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
HRDIKS +ILL KLSDFG ++K + +S V GT ++APE S
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISRTPY 194
Query: 368 NERSDVYSFGILIMEVISGRNP 389
D++S GI+++E++ G P
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 9e-14
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGY 250
IGEG YG V+ E + VA+K + L++ + + E+ + ++HKN+VRL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
LV+EY D +L+++ G P + M +L KGL + H V
Sbjct: 68 LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLL---KGLAFCHS---HNV 120
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYASTGMLNE 369
+HRD+K N+L++K KL+DFGLA+ G R Y V T Y P+ L
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYS 178
Query: 370 RS-DVYSFGILIMEVISGRNPV 390
S D++S G + E+ + P+
Sbjct: 179 TSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 48/128 (37%), Positives = 69/128 (53%), Gaps = 14/128 (10%)
Query: 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321
E++D G+L+ ++ + H + I + KGLTYL L K++HRD+K SN+L
Sbjct: 79 EFMDGGSLD--VYRKIPEH------VLGRIAVAVVKGLTYLW-SL--KILHRDVKPSNML 127
Query: 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 381
++ + KL DFG++ L S T V GT Y+APE S SDV+S GI M
Sbjct: 128 VNTRGQVKLCDFGVSTQL--VNSIAKTYV-GTNAYMAPERISGEQYGIHSDVWSLGISFM 184
Query: 382 EVISGRNP 389
E+ GR P
Sbjct: 185 ELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLG--Y 250
IG+G YG VY + + ++A +L+ ++E + E + + H N+V+ G Y
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89
Query: 251 CAE---GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
A+ G LV E + G++ + + G + L + I+ G GL +LH
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN-- 147
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM- 366
+++HRD+K +NILL + KL DFG++ L + R T V GT ++APE +
Sbjct: 148 -RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQ 205
Query: 367 ----LNERSDVYSFGILIMEVISGRNPV 390
+ R DV+S GI +E+ G P+
Sbjct: 206 YDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 59/215 (27%), Positives = 106/215 (49%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVY----HGVLEDN----TNVAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
+GEG +G V +G+ + VAVK L +N + + E+E + + +HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG----------DVG--PHSPLTWEIRMNI 291
++ LLG C + ++ EY GNL ++L D+ P L+++ ++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
A+G+ YL + +HRD+ + N+L+ + K++DFGLA+ + Y T+
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
++APE + +SDV+SFGIL+ E+ +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 54/218 (24%), Positives = 103/218 (47%), Gaps = 29/218 (13%)
Query: 194 IGEGGYGIVY-------------HGVLEDNTN----VAVKNLLNNRGQ-AEKEFKVEVEA 235
+GEG +G V+ L+ + N VAVK L + + A +F E++
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR------- 288
+ R++ N++RLL C ++ EY++NG+L Q+L + ++
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VT 347
+ + A G+ YL VHRD+ + N L+ K + K++DFG+++ L + Y +
Sbjct: 133 IFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
R + +++ E G SDV++FG+ + E+++
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 59/215 (27%), Positives = 106/215 (49%), Gaps = 26/215 (12%)
Query: 194 IGEGGYGIVYH----GVLEDNTN----VAVKNLLNNRGQAE-KEFKVEVEAIGRV-RHKN 243
+GEG +G V G+ ++ N VAVK L ++ + + + E+E + + +HKN
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG------------DVGPHSPLTWEIRMNI 291
++ LLG C + ++ EY GNL ++L P L+++ ++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRV 350
A+G+ YL K +HRD+ + N+L+ + K++DFGLA+ + Y TT
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
++APE + +SDV+SFG+L+ E+ +
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 31/212 (14%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK---NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
IG G YGIV E N VA+K N +NR A++ + E++ + + H+N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71
Query: 250 YCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
HR +VYE +D LH + L+ + + +GL Y+H
Sbjct: 72 -IMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
V+HRD+K SN+LL+ + K+ DFGLA+ + ++T V+ T Y APE
Sbjct: 126 SA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPEL-- 179
Query: 364 TGMLNERS-----DVYSFGILIMEVISGRNPV 390
+LN DV+S G + E++ GR P+
Sbjct: 180 --LLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 71/262 (27%), Positives = 108/262 (41%), Gaps = 34/262 (12%)
Query: 194 IGEGGYGIVYHGVLEDNTN--VAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLL 248
+G+GG+G V T A K L R + E+ E + + +V + L
Sbjct: 1 LGKGGFGEVC-ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSL 58
Query: 249 GYCAEG-AHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
Y E LV ++ G+L+ + G+ G II G L +LH+
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ- 113
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
++V+RD+K N+LLD N ++SD GLA L + GT GY+APE
Sbjct: 114 --RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGE 169
Query: 366 MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425
+ + D ++ G + E+I+GR+P R E E LK E +K
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF---RQRKEKVEKEELKRRTLEMAVE------YPDK 220
Query: 426 --PCSRALKRALLVALRCVDPN 445
P ++ L ALL DP
Sbjct: 221 FSPEAKDLCEALL----QKDPE 238
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 44/107 (41%), Positives = 57/107 (53%), Gaps = 13/107 (12%)
Query: 292 ILG-----TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346
ILG K L YL E + V+HRD+K SNILLD N KL DFG++ L S
Sbjct: 115 ILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKA 170
Query: 347 TTRVMGTFGYVAPEYASTGMLNE----RSDVYSFGILIMEVISGRNP 389
TR G Y+APE N R+DV+S GI ++E+ +G+ P
Sbjct: 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKN 243
F D IG G +G VY + N VA+K + + Q+ ++++ EV+ + R++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYL 302
+ G LV EY G+ L H E+ + I G +GL YL
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC-LGSASDLLE----VHKKPLQEVEIAAITHGALQGLAYL 141
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY- 361
H ++HRDIK+ NILL + KL+DFG A + S+V GT ++APE
Sbjct: 142 HSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVI 193
Query: 362 --ASTGMLNERSDVYSFGILIMEVISGRNPV 390
G + + DV+S GI +E+ + P+
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 55/214 (25%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 194 IGEGGYGIVYHGVLEDNTN---VAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
+GEG +G V G L + + VAVK + + R + E +F E + H N++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME-DFLSEAVCMKEFDHPNVMRL 65
Query: 248 LGYCAEGAHR------MLVYEYIDNGNLEQWLH----GDVGPHSPLTWEIRMNIILGTAK 297
+G C + +++ ++ +G+L +L GD + P ++ + + A
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPT--QMLVKFMTDIAS 123
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT-FGY 356
G+ YL +HRD+ + N +L++ N ++DFGL+K + Y R+ +
Sbjct: 124 GMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
+A E + + +SDV+SFG+ + E+ + G+ P
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 67/275 (24%), Positives = 123/275 (44%), Gaps = 21/275 (7%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLL---NNRGQAEKEFKVEVEAIGRVRHKN 243
F E IG G + VY L D VA+K + +A ++ E++ + ++ H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+++ L E +V E D G+L Q + + + + ++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
+V+HRDIK +N+ + KL D GL + ++ + + V GT Y++PE
Sbjct: 124 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423
N +SD++S G L+ E+ + ++P Y ++NL + + E P L
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF-YG---DKMNLFSLCQKI------EQCDYPPLP 229
Query: 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458
+ S L+ LV++ C+ P+ +RP +G+V +
Sbjct: 230 TEHYSEKLRE--LVSM-CIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 5e-13
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 19/203 (9%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAV------KNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
+G GG+G V V + N K + GQ ++ E E + H +V+L
Sbjct: 1 LGVGGFGRVEL-VKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKL 58
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
+ + ++ EY G L L D G + R I YLH
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTILR-DRGLFD--EYTARF-YIACVVLAFEYLHN--- 111
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-AERSYVTTRVMGTFGYVAPEYASTGM 366
+++RD+K N+LLD KL DFG AK L ++++ GT YVAPE
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKG 168
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
+ D +S GIL+ E+++GR P
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 67/277 (24%), Positives = 124/277 (44%), Gaps = 25/277 (9%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKEFKVEVEAIGRVRH 241
F E IG G + VY L D VA+K +L++ +A + E++ + ++ H
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD--AKARADCIKEIDLLKQLNH 61
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
N+++ E +V E D G+L + + + + + L +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
+H +V+HRDIK +N+ + KL D GL + + ++ ++GT Y++PE
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPER 177
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421
N +SD++S G L+ E+ + ++P Y ++NL K + E P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF-YG---DKMNLYSLCKKI------EQCDYPP 227
Query: 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458
L S L++ LV + C++P+ KRP + +V +
Sbjct: 228 LPSDHYSEELRQ--LVNM-CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 71/232 (30%), Positives = 110/232 (47%), Gaps = 45/232 (19%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKE-FKV----EVEA 235
+ + F IGEG YG VY +D VA+K + R EKE F + E++
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV---RLDNEKEGFPITAIREIKI 59
Query: 236 IGRVRHKNLVRL----------LGYCAEGAHRMLVYEYIDN---GNLEQWLHGDVGPHSP 282
+ ++ H+N+V L L + + LV+EY+D+ G LE L
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-------VH 112
Query: 283 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
+ + + + +GL Y H+ +HRDIK SNILL+ + KL+DFGLA+L +E
Sbjct: 113 FSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
Query: 343 --RSYVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
R Y T +V+ T Y PE +L E DV+S G ++ E+ + +
Sbjct: 170 ESRPY-TNKVI-TLWYRPPEL----LLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 8e-13
Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 25/207 (12%)
Query: 194 IGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQ---AEKEFKVEVEAIGRVRHKNLVRLL 248
+G+GG+G V V NT A K L R + EK +E E + +V +V L
Sbjct: 1 LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLH--GDVGPHSPLTWEIRMN-IILGTAK---GLTYL 302
H LV ++ G+L+ ++ G+ G + M +I +A+ G+ +L
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERG--------LEMERVIHYSAQITCGILHL 111
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
H +V+RD+K N+LLD Q N +LSD GLA L ++ T+ GT GY+APE
Sbjct: 112 HS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEIL 166
Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
+ D ++ G I E+++GR P
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 55/161 (34%), Positives = 75/161 (46%), Gaps = 19/161 (11%)
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL 293
E RH LV L H V EY G+L +H DV P ++L
Sbjct: 54 ETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-EPRAVFYAACVVL 112
Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
G L YLHE K+V+RD+K N+LLD + K++DFGL K G T+ GT
Sbjct: 113 G----LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGT 164
Query: 354 FGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
++APE +L E S D + G+LI E++ G +P
Sbjct: 165 PEFLAPE-----VLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEF---KVEVEAIGRVRHKNLVRLLGY 250
IG+G +G V+ G+ ++ T V + + +AE E + E+ + + + + G
Sbjct: 12 IGKGSFGEVFKGI-DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
+ ++ EY+ G+ L PL I+ KGL YLH K
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHS---EKK 122
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNER 370
+HRDIK++N+LL + KL+DFG+A L + +GT ++APE + +
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 371 SDVYSFGILIMEVISGRNP 389
+D++S GI +E+ G P
Sbjct: 182 ADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 52/224 (23%), Positives = 111/224 (49%), Gaps = 29/224 (12%)
Query: 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTN-----VAVKNLLNNRGQAEKEFKV-EVE 234
+ +S + +++ EG +G +++G+L D V VK + ++ + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 235 AIGRVRHKNLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWL----HGDVGPHSPLTWEIRM 289
+ + H+N++ +L C E G ++Y Y++ GNL+ +L G+ L+ + +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--------LLGA 341
++ + A G++YLH+ V+H+DI + N ++D++ K++D L++ LG
Sbjct: 121 HMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG- 176
Query: 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
+ + M A E + SDV+SFG+L+ E+++
Sbjct: 177 DNENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLVR 246
++G+G +G VY ++ +A K + + E +V E++ + ++H+ +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 247 LLGYCAEGAHRMLV--YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
G + A + L EY+ G+++ L + LT + +G++YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHS 124
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT--TRVMGTFGYVAPEYA 362
+ +VHRDIK +NIL D N KL DFG +K L T V GT +++PE
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
S ++DV+S G ++E+++ + P
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 40/213 (18%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------RVR 240
IGEG YG+VY G +N + A K+ ++E E G ++
Sbjct: 8 IGEGTYGVVYKG----------RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ 57
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
H N+V L + + L++E++ +L+++L + + E+ + + +G+
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLD-SLPKGQYMDAELVKSYLYQILQGIL 115
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
+ H +V+HRD+K N+L+D + KL+DFGLA+ G T V+ T Y APE
Sbjct: 116 FCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPE 171
Query: 361 YA------STGMLNERSDVYSFGILIMEVISGR 387
ST + D++S G + E+ + +
Sbjct: 172 VLLGSPRYSTPV-----DIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 66/235 (28%), Positives = 109/235 (46%), Gaps = 47/235 (20%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKE-FKV----EVEA 235
EVS + IG+G +G V+ + VA+K +L EKE F + E++
Sbjct: 10 EVSK--YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN---EKEGFPITALREIKI 64
Query: 236 IGRVRHKNLVRLLGYC---AEGAHR-----MLVYEYIDN---GNLEQWLHGDVGPHSPLT 284
+ ++H+N+V L+ C A +R LV+E+ ++ G L + T
Sbjct: 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN-------KNVKFT 117
Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL----G 340
++ GL Y+H K++HRD+K++NIL+ K KL+DFGLA+
Sbjct: 118 LSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174
Query: 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPV 390
++ + T RV+ T Y PE +L ER D++ G IM + R+P+
Sbjct: 175 SKPNRYTNRVV-TLWYRPPEL----LLGERDYGPPIDMWGAGC-IMAEMWTRSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 53/228 (23%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNLVRL 247
+GEG +G VY ++ VA+K +L EK+ F + E++ + +++H N+V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILM---HNEKDGFPITALREIKILKKLKHPNVVPL 72
Query: 248 LG----YCAEGAHRM----LVYEYID---NGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
+ + + +V Y+D +G LE P LT +L
Sbjct: 73 IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN-------PSVKLTESQIKCYMLQLL 125
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL------------GAERS 344
+G+ YLHE ++HRDIK++NIL+D Q K++DFGLA+ G R
Sbjct: 126 EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 345 YVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
Y T ++ T Y PE +L ER D++ G + E+ + R
Sbjct: 183 Y--TNLVVTRWYRPPEL----LLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 185 TNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVR 240
TN + D +G G +G+V NVA+K ++ A++ ++ E++ + +R
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLR 67
Query: 241 HKNLVRLLG-YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
H+N++ L + + V E + +L + L P + + IL +GL
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGT-DLHRLL--TSRPLEKQFIQYFLYQIL---RGL 121
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVA 358
Y+H VVHRD+K SNIL+++ + K+ DFGLA++ + + YV+TR Y A
Sbjct: 122 KYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRA 173
Query: 359 PEYASTGM-LNERSDVYSFGILIMEVISGR 387
PE T + D++S G + E++ G+
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 33/219 (15%)
Query: 189 ADENVIGEGGYGIVYHGVLEDNTN--VAVK---NLLNNRGQAEKEFKVEVEAIGRVRHKN 243
EN IG G YG+V + + + VA+K + + A++ + E++ + +H N
Sbjct: 9 PIEN-IGSGAYGVVCSAI-DTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDN 65
Query: 244 LVRLLG-YCAEGAHRMLVYEYID--NGNLEQWLHGDVGPHSPLTWE-IR--MNIILGTAK 297
++ + GA VY +D +L +H D PLT E IR + +L +
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSD----QPLTEEHIRYFLYQLL---R 118
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG---AERSYVTTRVMGTF 354
GL Y+H V+HRD+K SN+L+++ ++ DFG+A+ L E Y T + T
Sbjct: 119 GLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 355 GYVAPEYASTGMLNERS---DVYSFGILIMEVISGRNPV 390
Y APE + L E + D++S G + E++ GR +
Sbjct: 176 WYRAPELLLS--LPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 22/213 (10%)
Query: 194 IGEGGYGIVYHGVLEDNTNV--AVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNLVRLLG- 249
+G+G YG VY VL T V A+K + +++ + +E++ + + +V G
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
+ EGA M + EY+D G+L++ L+ + ++ I KGL +L E E
Sbjct: 68 FFIEGAVYMCM-EYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHN 123
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
++HRD+K +N+L++ KL DFG++ L S T + G Y+APE +G N+
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL--VASLAKTNI-GCQSYMAPERIKSGGPNQ 180
Query: 370 R------SDVYSFGILIMEVISGRNPVDYSRPP 396
SDV+S G+ I+E+ GR Y PP
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGR----YPYPP 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV--EVEAIGRVR---HKNLVRL 247
IG G YG VY VA+K++ + EV + R+ H N+VRL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 248 LGYCA-----EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
+ CA LV+E++D +L +L P P E +++ +GL +L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPA--ETIKDLMRQFLRGLDFL 124
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
H +VHRD+K NIL+ KL+DFGLA++ + + T V+ T Y APE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL--TPVVVTLWYRAPEVL 179
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPV 390
D++S G + E+ R P+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 12/160 (7%)
Query: 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321
E++D G+L+Q L + +I + + KGLTYL E + K++HRD+K SNIL
Sbjct: 83 EHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNIL 136
Query: 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 381
++ + KL DFG++ G + +GT Y++PE + +SD++S G+ ++
Sbjct: 137 VNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 193
Query: 382 EVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421
E+ GR P+ PP L V AE PR
Sbjct: 194 EMAIGRYPIP---PPDAKELELMFGCPVEGDPAESETSPR 230
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 3e-12
Identities = 72/270 (26%), Positives = 119/270 (44%), Gaps = 33/270 (12%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLG-Y 250
++G G YG VY G +A +++ G E+E K E+ + + H+N+ G +
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 251 CAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
+ M LV E+ G++ + G + L E I +GL++LH+
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH 130
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST- 364
KV+HRDIK N+LL + KL DFG++ L T +GT ++APE +
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIACD 186
Query: 365 ----GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
+ +SD++S GI +E+ G P+ P + L+ RN P
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--------RNPA----P 234
Query: 421 RLQEKPCSRALKRALLVALRCVDPNAHKRP 450
RL+ K S+ + + C+ N +RP
Sbjct: 235 RLKSKKWSKKFQSFI---ESCLVKNHSQRP 261
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 8/96 (8%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--LLGAERSYVTTRVMGTFG 355
GL +LHE +++RD+K N+LLD + + K++DFG+ K +LG T+ GT
Sbjct: 108 GLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPD 161
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
Y+APE S D ++ G+L+ E+++G++P +
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 3e-12
Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 31/209 (14%)
Query: 193 VIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEFKV-----------EVEAIGRVR 240
+G G +G V + + A+K L K K+ E + +R
Sbjct: 8 TLGTGSFGRVMLVRHKGSGKYYALKIL-------SKA-KIVKLKQVEHVLNEKRILQSIR 59
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
H LV L G + ++ LV EY+ G L L P+ ++L L
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA----LE 115
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
YLH +V+RD+K N+LLD K++DFG AK + R+Y GT Y+APE
Sbjct: 116 YLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGRTYTLC---GTPEYLAPE 168
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNP 389
+ + D ++ GILI E+++G P
Sbjct: 169 IILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 64/213 (30%), Positives = 95/213 (44%), Gaps = 29/213 (13%)
Query: 194 IGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAIGRV---------RHK 242
IGEG YG V+ N VA+K + R Q +E + + I V H
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEE-GMPLSTIREVAVLRHLETFEHP 64
Query: 243 NLVRLLGYCA-----EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
N+VRL C LV+E++D +L +L D P + E +++ +
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMMFQLLR 121
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
GL +LH +VVHRD+K NIL+ KL+DFGLA++ + T V+ T Y
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYR 176
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNPV 390
APE D++S G + E+ R P+
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 193 VIGEGGYGIVY----HGVLEDNTNVAVKNL----LNNRGQAEKEFKVEVEAIGRVRHKNL 244
V+G G YG V+ G + A+K L + + + + + E + + VR
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 245 VRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG-TAKGLTYL 302
+ L Y + ++ L+ +Y++ G L L+ E + + + L +L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLY-----QREHFTESEVRVYIAEIVLALDHL 121
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
H+ +++RDIK NILLD + + L+DFGL+K AE GT Y+APE
Sbjct: 122 HQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178
Query: 363 STGML--NERSDVYSFGILIMEVISGRNP 389
G ++ D +S G+L E+++G +P
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGY-- 250
IG+G YG V+ + + N + A +L+ ++E + E + + H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 251 ---CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
G LV E + G++ + G + + I I+ GL +LH
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN-- 143
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST--- 364
K +HRD+K +NILL + KL DFG++ L + R T V GT ++APE +
Sbjct: 144 -KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQ 201
Query: 365 --GMLNERSDVYSFGILIMEVISGRNPV 390
+ R DV+S GI +E+ G P+
Sbjct: 202 LDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-12
Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 38/214 (17%)
Query: 213 VAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKNLVRLL--GYCAEGAHRMLVYEYIDNG 267
VA+K L + + E + F+ E R+ H N+V LL G G V+EY+
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFEYVPGR 64
Query: 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DK 324
L + L D G M +L L H +VHRD+K NI++
Sbjct: 65 TLREVLAAD-GALPAGETGRLMLQVL---DALACAHNQ---GIVHRDLKPQNIMVSQTGV 117
Query: 325 QWNPKLSDFGLAKLL-GAE-----RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 378
+ + K+ DFG+ LL G TT V+GT Y APE + SD+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 379 LIMEVISGR----------------NPVDYSRPP 396
+ +E ++G+ +PVD S PP
Sbjct: 178 IFLECLTGQRVVQGASVAEILYQQLSPVDVSLPP 211
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 64/250 (25%), Positives = 110/250 (44%), Gaps = 45/250 (18%)
Query: 193 VIGEGGYG---IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL- 248
V+G+G YG +V H + NL N + K + E + + +++H N+V
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP----LTWEIRMNIILGTAKGLTYLHE 304
+ E +V + + G+L L G P + W +++ A L YLHE
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI------AMALQYLHE 120
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
++HRD+K+ N+ L + K+ D G+A++L + +T ++GT Y++PE S
Sbjct: 121 ---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFSN 176
Query: 365 GMLNERSDVYSFGI-------------------LIMEVISGR---NPVDYSRPPGEVNLV 402
N +SDV++ G L+ +I G+ P DYS L
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSP-----ELG 231
Query: 403 EWLKTMVTNR 412
E + TM++ R
Sbjct: 232 ELIATMLSKR 241
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKN 243
F + IG G +G VY N VAVK + + Q ++++ EV+ + +++H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYL 302
+ G + LV EY G+ L H E+ + I G +GL YL
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYC-LGSASDLLE----VHKKPLQEVEIAAITHGALQGLAYL 137
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY- 361
H ++HRDIK+ NILL + KL+DFG A S+V GT ++APE
Sbjct: 138 HSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVI 189
Query: 362 --ASTGMLNERSDVYSFGILIMEVISGRNPV 390
G + + DV+S GI +E+ + P+
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 54/200 (27%), Positives = 103/200 (51%), Gaps = 21/200 (10%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLGYCA 252
+G+G +G VY ++ +A +++ + + E E + VE++ + H N+V+LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG-TAKGLTYLHEGLEPKVV 311
+ ++ E+ G ++ + + PLT E ++ ++ T + L YLHE K++
Sbjct: 73 YENNLWILIEFCAGGAVDAVM---LELERPLT-EPQIRVVCKQTLEALNYLHEN---KII 125
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR---VMGTFGYVAPEYASTGMLN 368
HRD+K+ NIL + KL+DFG++ A+ + R +GT ++APE
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 369 ER-----SDVYSFGILIMEV 383
+R +DV+S GI ++E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 193 VIGEGGYGIVYHGVLEDN-TNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLVR 246
++G+G +G VY D +AVK + + E +V E++ + + H+ +V+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 247 LLGYCAEGAHRML--VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
G + R L E++ G+++ L + LT + +G++YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHS 124
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT--TRVMGTFGYVAPEYA 362
+ +VHRDIK +NIL D N KL DFG +K L T V GT +++PE
Sbjct: 125 NM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
S ++D++S G ++E+++ + P
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 69/212 (32%), Positives = 97/212 (45%), Gaps = 37/212 (17%)
Query: 193 VIGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
IG G GIV Y V NVA+K L N A++ ++ E+ + V HKN++
Sbjct: 23 PIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIG 79
Query: 247 LLGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGL 299
LL E LV E +D NL Q + D+ H RM+ +L G+
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLD-HE------RMSYLLYQMLCGI 131
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---YVTTRVMGTFGY 356
+LH ++HRD+K SNI++ K+ DFGLA+ G YV TR Y
Sbjct: 132 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----Y 183
Query: 357 VAPEYASTGM-LNERSDVYSFGILIMEVISGR 387
APE GM E D++S G ++ E+I G
Sbjct: 184 RAPEVI-LGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 27/205 (13%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
IG G GIV + VL NVAVK L N+ A++ ++ E+ + V HKN++ L
Sbjct: 29 IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISL 85
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
L E LV E +D NL Q +H ++ H +++ ++ G+ +
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELD-HERMSY-----LLYQMLCGIKH 138
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
LH ++HRD+K SNI++ K+ DFGLA+ A +++ T + T Y APE
Sbjct: 139 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPYVVTRYYRAPEV 193
Query: 362 ASTGMLNERSDVYSFGILIMEVISG 386
E D++S G ++ E++ G
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 48/142 (33%), Positives = 75/142 (52%), Gaps = 16/142 (11%)
Query: 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321
E++D G+L+Q L G + I I + +GLTYL E + K++HRD+K SNIL
Sbjct: 79 EHMDGGSLDQVLK-KAGR---IPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNIL 132
Query: 322 LDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL 379
++ + KL DFG++ L S+V TR Y++PE +SD++S G+
Sbjct: 133 VNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQGTHYTVQSDIWSLGLS 187
Query: 380 IMEVISGRNPVDYSRPPGEVNL 401
++E+ GR P+ PP L
Sbjct: 188 LVEMAIGRYPIP---PPDAKEL 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 55/202 (27%), Positives = 104/202 (51%), Gaps = 25/202 (12%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLG-YC 251
+G+G +G VY ++ +A ++ + + E E + VE+E + H +V+LLG +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 252 AEGAHRMLVYEYIDNGNLEQ-WLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
+G +++ E+ G ++ L D G P +I++ I + L YLH K+
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHS---MKI 131
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLA----KLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
+HRD+K+ N+LL + KL+DFG++ K L S++ GT ++APE
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCET 186
Query: 367 LNE-----RSDVYSFGILIMEV 383
+ + ++D++S GI ++E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 51/161 (31%), Positives = 79/161 (49%), Gaps = 17/161 (10%)
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM-GTFGYV 357
L +H ++HRDIKS+NILL KL DFG +K+ A S R GT YV
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417
APE ++++D++S G+L+ E+++ + P D GE N+ E V ++ G
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD-----GE-NMEE-----VMHKTLAGR 261
Query: 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458
DP P + ++ AL DP +RP +++M
Sbjct: 262 YDPL---PPSISPEMQEIVTALLSSDP--KRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
+G G YG VY L AVK + G + E+ + +H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
+ EY G+L+ H GP S L + T +GL YLH + +H
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHV-TGPLSELQIAY---VCRETLQGLAYLHSKGK---MH 129
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGA----ERSYVTTRVMGTFGYVAPEYAS---TG 365
RDIK +NILL + KL+DFG+A + A +S++ GT ++APE A+ G
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-----GTPYWMAPEVAAVEKNG 184
Query: 366 MLNERSDVYSFGILIMEVISGRNPV 390
N+ D+++ GI +E+ + P+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 58/170 (34%), Positives = 87/170 (51%), Gaps = 15/170 (8%)
Query: 222 RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML--VYEYIDNGNLEQWLHGDVGP 279
R + E+ E + V H ++RL + E R L + EY+ G L +L + G
Sbjct: 41 RLKQEQHVHNEKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLR-NSGR 97
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339
S T + I+ L YLH E +V+RD+K NILLDK+ + KL+DFG AK L
Sbjct: 98 FSNSTGLFYASEIVC---ALEYLH-SKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKL 151
Query: 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
+R++ + GT Y+APE + N+ D ++ GILI E++ G P
Sbjct: 152 -RDRTWT---LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 8/94 (8%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--LLGAERSYVTTRVMGTFG 355
GL +LH +V+RD+K NILLD + K++DFG+ K +LG + T GT
Sbjct: 108 GLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGTPD 161
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
Y+APE N D +SFG+L+ E++ G++P
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 193 VIGEGGYGIVYHGVLEDN-TNVAVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLVR 246
++G G +G VY D +AVK + + E +V E++ + +RH +V+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 247 LLGYCAEGAHRML--VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
G + + L EY+ G+++ L + LT + +G++YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHS 124
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT--TRVMGTFGYVAPEYA 362
+ +VHRDIK +NIL D N KL DFG +K + T V GT +++PE
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
S ++DV+S ++E+++ + P
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 42/137 (30%), Positives = 66/137 (48%), Gaps = 12/137 (8%)
Query: 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318
LV EY++ G+ L +G P W + I G+ LH+ ++HRDIK
Sbjct: 74 LVMEYLNGGDCAS-LIKTLGG-LPEDW-AK-QYIAEVVLGVEDLHQR---GIIHRDIKPE 126
Query: 319 NILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGI 378
N+L+D+ + KL+DFGL++ + +GT Y+APE ++ SD +S G
Sbjct: 127 NLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGC 181
Query: 379 LIMEVISGRNPVDYSRP 395
+I E + G P P
Sbjct: 182 VIFEFLFGYPPFHAETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 47/163 (28%), Positives = 84/163 (51%), Gaps = 16/163 (9%)
Query: 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321
E++D G+L+Q L + EI + + +GL YL E + +++HRD+K SNIL
Sbjct: 83 EHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNIL 136
Query: 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIM 381
++ + KL DFG++ G + +GT Y++PE + +SD++S G+ ++
Sbjct: 137 VNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 193
Query: 382 EVISGRNPVDYSRPPGEVNLVEWL--KTMVTNRNAEG-VLDPR 421
E+ GR P+ PP + +E + + +V E + PR
Sbjct: 194 ELAIGRYPI----PPPDAKELEAIFGRPVVDGEEGEPHSISPR 232
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYC 251
V+G G YG VY G +A +++ E+E K+E+ + + H+N+ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 252 AEGA------HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
+ + LV E+ G++ + G W I +GL +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW--IAYICREILRGLAHLHAH 140
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFG----LAKLLGAERSYVTTRVMGTFGYVAPEY 361
KV+HRDIK N+LL + KL DFG L + +G +++ GT ++APE
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPEV 192
Query: 362 AST-----GMLNERSDVYSFGILIMEVISGRNPV 390
+ + RSD++S GI +E+ G P+
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 7e-11
Identities = 66/227 (29%), Positives = 110/227 (48%), Gaps = 32/227 (14%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
IG G GIV Y VL+ NVA+K L N+ A++ ++ E+ + V HKN++ L
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
L E LV E +D NL Q + ++ H +++ ++ G+ +
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 134
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
LH ++HRD+K SNI++ K+ DFGLA+ G S++ T + T Y APE
Sbjct: 135 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 189
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408
E D++S G ++ E++ R+ + + PG + +W K +
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV--RHKILF---PGRDYIDQWNKVI 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 49/225 (21%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVK-------NLLNNRGQAEKEFKVEVEAIGRV 239
+ + + IGEG YG+V VA+K R +E K+ + R
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQR--TLREIKI----LRRF 60
Query: 240 RHKNLVRLLG-YCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
+H+N++ +L +V E +E L+ + L+ + +
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQEL-----METDLY-KLIKTQHLSNDHIQYFLYQ 114
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER-------SYVT 347
+GL Y+H V+HRD+K SN+LL+ + K+ DFGLA++ E YV
Sbjct: 115 ILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 348 TRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
TR Y APE MLN + D++S G ++ E++S R
Sbjct: 172 TR-----WYRAPEI----MLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 33/92 (35%), Positives = 53/92 (57%), Gaps = 4/92 (4%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
GL +LH+ +++RD+K N+LLDK + K++DFG+ K + GT Y+
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCK-ENMNGEGKASTFCGTPDYI 163
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
APE NE D +SFG+L+ E++ G++P
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 13/228 (5%)
Query: 194 IGEGGYGIVYHG--VLEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
+GEG Y V+ G L +N VA+K + L + A EV + ++H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
LV+EY+D +L+Q++ S +I + IL +GL Y H KV
Sbjct: 73 VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQIL---RGLAYCHR---RKV 125
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-YASTGMLNE 369
+HRD+K N+L++++ KL+DFGLA+ + V+ T Y P+ + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184
Query: 370 RSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417
+ D++ G + E+ SGR S E++L+ L T G+
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI 232
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 30/89 (33%), Positives = 52/89 (58%), Gaps = 7/89 (7%)
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
YLH +++RD+K N+LLD + + K++DFG AK + +R++ + GT Y+APE
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTFT---LCGTPEYLAPE 185
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNP 389
+ + D ++ G+L+ E I+G P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 55/285 (19%), Positives = 120/285 (42%), Gaps = 51/285 (17%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKV-------EVEAIGRVRHKNLV 245
+I E +Y G+ +N V ++ + K KV E++ + R+ N++
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTF----KKFHKGHKVLIDITENEIKNLRRIDSNNIL 81
Query: 246 RLLGY----CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
++ G+ + L+ EY G L + L + L+++ ++++ + KGL
Sbjct: 82 KIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYN 137
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY----- 356
L++ ++++ S + L+ + + K+ GL K+L + + M F Y
Sbjct: 138 LYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKIL-SSPPFKNVNFMVYFSYKMLND 194
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNL-VEWLKTMVTNRNAE 415
+ EY + D+YS G+++ E+ +G+ P + NL + + ++ N+N
Sbjct: 195 IFSEY------TIKDDIYSLGVVLWEIFTGKIPFE--------NLTTKEIYDLIINKNNS 240
Query: 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
L C +K + C ++ KRP + +++ L
Sbjct: 241 LKLPLD-----CPLEIKC---IVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 51/203 (25%), Positives = 88/203 (43%), Gaps = 16/203 (7%)
Query: 194 IGEGGYGIVYHG---VLEDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLG 249
IG G +G V G V VK L + E+ F EV+ + H N+++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTW-EIRMNIILGTAKGLTYLHEGLEP 308
C E +LV E+ G+L+ +L + G + + ++ + A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT-FGYVAPEYAS---- 363
+H D+ N L + K+ D+GLA E Y+T ++APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 364 ---TGMLNERSDVYSFGILIMEV 383
++S+++S G+ + E+
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 194 IGEGGYGIVYHGVLEDN---TNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLG 249
IG G +G V G + V VK L + Q + +F E + ++H NL++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLH----GDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
C E +LV E+ G+L+ +L ++ P T + RM + A GL +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-RMACEI--ALGLLHLHKN 119
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT-RVMGTFGYVAPEYAST 364
+H D+ N LL K+ D+GL+ E YVT ++ ++APE
Sbjct: 120 ---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 365 GMLN-------ERSDVYSFGILIMEV 383
N + S+V+S G+ I E+
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 27/206 (13%)
Query: 194 IGEGGYGIV---YHGVLEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
IG G GIV Y +LE NVA+K L N+ A++ ++ E+ + V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 248 LGY------CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
L E +V E +D NL Q + ++ H +++ ++ G+ +
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELD-HERMSY-----LLYQMLCGIKH 141
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
LH ++HRD+K SNI++ K+ DFGLA+ G S++ T + T Y APE
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEV 196
Query: 362 ASTGMLNERSDVYSFGILIMEVISGR 387
E D++S G ++ E+I G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 48/147 (32%), Positives = 73/147 (49%), Gaps = 16/147 (10%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
GL LH+ ++V+RD+K NILLD + ++SD GLA + E + RV GT GY+
Sbjct: 114 GLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRV-GTVGYM 168
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417
APE D ++ G L+ E+I+G++P + + VE L V +E
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSE-- 226
Query: 418 LDPRLQEKPCSRALKRALLVALRCVDP 444
+ P +R+L + LL C DP
Sbjct: 227 -----KFSPDARSLCKMLL----CKDP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 23/203 (11%)
Query: 194 IGEGGYGIVYHGVLEDNTN-VAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
+GEG Y V+ G + N VA+K + L + A EV + ++H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
LV+EY+D+ +L+Q+L S +I M +L +GL+Y H+ K++
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLL---RGLSYCHK---RKIL 125
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP-------EYAST 364
HRD+K N+L++++ KL+DFGLA+ + V+ T Y P EY++
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTP 184
Query: 365 GMLNERSDVYSFGILIMEVISGR 387
D++ G ++ E+ +GR
Sbjct: 185 ------IDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 62/224 (27%), Positives = 113/224 (50%), Gaps = 44/224 (19%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNL 244
N I EG YG+VY + T VA+K L + EKE F + E+ + +++H N+
Sbjct: 11 NRIEEGTYGVVYRA-RDKKTGEIVALKKLKMEK---EKEGFPITSLREINILLKLQHPNI 66
Query: 245 VRLLGYCAE---GAHR---MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
V + E G++ +V EY+++ +L+ + + L E++ ++L G
Sbjct: 67 VTV----KEVVVGSNLDKIYMVMEYVEH-DLKSLM--ETMKQPFLQSEVK-CLMLQLLSG 118
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
+ +LH+ ++HRD+K+SN+LL+ + K+ DFGLA+ G+ T V+ T Y A
Sbjct: 119 VAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRA 174
Query: 359 PEYASTGMLNERS-----DVYSFGILIMEVIS------GRNPVD 391
PE +L + D++S G + E+++ G++ +D
Sbjct: 175 PEL----LLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 74/281 (26%), Positives = 118/281 (41%), Gaps = 36/281 (12%)
Query: 193 VIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEA-----IGRVRHKNLVR 246
VIG+G +G V + D + AVK +L + +K+ + + A + ++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 247 LLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
L Y + A ++ V +Y++ G L L + P + A + YLH
Sbjct: 61 L-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEV----ASAIGYLHS- 114
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
+++RD+K NILLD Q + L+DFGL K G E T+ GT Y+APE
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKE 171
Query: 366 MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425
+ D + G ++ E++ G P YSR ++ + +L LQ
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPF-YSRDVSQM--------------YDNILHKPLQLP 216
Query: 426 PCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPF 466
LLV L D +R ++G LE + F
Sbjct: 217 GGKTVAACDLLVGLLHKD----QRRRLGAKADFLEIKNHVF 253
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 70/216 (32%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 193 VIGEGGYGIVY---HGVLEDNTNVAVKNLLNNRGQAEKEFK-VEVEA---IGRVRHKNLV 245
VIG+G +G V H D AVK L +KE K + E + V+H LV
Sbjct: 2 VIGKGSFGKVLLAKHK--ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 246 RLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG-TAKGLTYLH 303
L Y + A ++ V +Y++ G L + H P E R A L YLH
Sbjct: 60 GL-HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFP---EPRARFYAAEIASALGYLH 113
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
+++RD+K NILLD Q + L+DFGL K G E S T+ GT Y+APE
Sbjct: 114 S---LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLR 169
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
+ D + G ++ E++ G P YSR E+
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRDTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 62/199 (31%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 194 IGEGGYGIVYHG--VLEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
+GEG Y VY G L DN VA+K + L + A EV + ++H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
LV+EY+D +L+Q+L D G +S +++ + +GL Y H KV
Sbjct: 73 IHTEKSLTLVFEYLDK-DLKQYLD-DCG-NSINMHNVKL-FLFQLLRGLNYCHR---RKV 125
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE--YASTGMLN 368
+HRD+K N+L++++ KL+DFGLA+ + V+ T Y P+ ST +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDY-S 183
Query: 369 ERSDVYSFGILIMEVISGR 387
+ D++ G + E+ +GR
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 33/85 (38%), Positives = 48/85 (56%), Gaps = 6/85 (7%)
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST------ 364
VHRDIK N+L+D+ + KL+DFG A L A + + +GT Y+APE +T
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 365 GMLNERSDVYSFGILIMEVISGRNP 389
G D +S G++ E+I GR+P
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 194 IGEGGYGIVYHGVLEDNTNV----AVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
IG G YG VY N N A+K + G+ + E+ + +H N+V G
Sbjct: 17 IGSGTYGDVYKA---RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
+ E+ G+L+ H GP S + T +GL YLH +
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHV-TGPLSESQIAY---VSRETLQGLYYLHSKGK-- 127
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST---GM 366
+HRDIK +NILL + KL+DFG++ + A + + +GT ++APE A+ G
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS-FIGTPYWMAPEVAAVERKGG 185
Query: 367 LNERSDVYSFGILIMEVISGRNPV 390
N+ D+++ GI +E+ + P+
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 34/99 (34%), Positives = 58/99 (58%), Gaps = 10/99 (10%)
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY--VTTRVM-G 352
A GL +LH +++RD+K N++LD + + K++DFG+ K E + TTR G
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK----ENIFGGKTTRTFCG 163
Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
T Y+APE + + D ++FG+L+ E+++G+ P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 8e-10
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 194 IGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLLG 249
+G+GG+G V + + A K L R + K ++ VE + +V + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK---GLTYLHEGL 306
LV ++ G+L ++ +V +P E R TA+ GL +LH+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRA--CFYTAQIISGLEHLHQR- 116
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
++++RD+K N+LLD N ++SD GLA L +S T GT G++APE
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEE 173
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
+ D ++ G+ + E+I+ R P
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 9e-10
Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 30/227 (13%)
Query: 194 IGEGGYGIVYHGVLEDNTN-VAVKNL-------LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
+G+GGYG V+ +D VA+K + LN E + + + LV
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT----KSEWLV 64
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLH--GDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+LL + + L EY+ G+ L+ G + + M + L Y
Sbjct: 65 KLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY-- 122
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
+HRD+K N L+D + KL+DFGL+K +Y + V+G+ Y+APE
Sbjct: 123 -------IHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANS-VVGSPDYMAPEVLR 171
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV--NLVEWLKTM 408
+ D +S G ++ E + G P S P E NL W +T+
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGST-PNETWENLKYWKETL 217
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 9e-10
Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 4/94 (4%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L YLHE +++RD+K N+LLD + + KL+D+G+ K G T+ GT Y+
Sbjct: 108 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYI 163
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
APE D ++ G+L+ E+++GR+P D
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 14/207 (6%)
Query: 186 NGFADENVIGEGGYGIVY---HGVLEDNTNVAVKNLLNNRGQAE-KEFKV-EVEAIGRVR 240
N F V+GEG YG+V H E VA+K ++ E KE + E++ + ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHK--ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK 58
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
+N+V L LV+EY++ LE + P+ ++R + I K +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVR-SYIYQLIKAIH 114
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
+ H+ +VHRDIK N+L+ KL DFG A+ L + T + T Y +PE
Sbjct: 115 WCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
Query: 361 YASTGMLNERSDVYSFGILIMEVISGR 387
+ D++S G ++ E+ G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 13/218 (5%)
Query: 193 VIGEGGYGIVYHGVLEDNTNV----AVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
VIG G Y V L+ N + VK L + + + E + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 249 GYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
C + R+ LV EY++ G+L H + L E L +LHE
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDL--MFH--MQRQRKLPEEHARFYAAEICIALNFLHE--- 114
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
+++RD+K N+LLD + KL+D+G+ K G T+ GT Y+APE
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 368 NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL 405
D ++ G+L+ E+++GR+P D ++N ++L
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL 211
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 31/212 (14%)
Query: 194 IGEGGYGIVYHGVLEDNTN-------VAVKNLLNNRGQAEKEFKVEVEAIG---RVRHKN 243
+G+G + +Y GVL ++ V +L G ++ E ++ HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
LV+L G C + M V EY+ G L+ +LH + + L W ++++ A L YL
Sbjct: 63 LVKLYGVCVRDENIM-VEEYVKFGPLDVFLHRE-KNNVSLHW--KLDVAKQLASALHYLE 118
Query: 304 EGLEPKVVHRDIKSSNILL-----DKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGY 356
+ K+VH ++ NIL+ ++ + P KLSD G+ + + R R+ +
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-REERVERI----PW 170
Query: 357 VAPEYASTGMLNERS--DVYSFGILIMEVISG 386
+APE G + D +SFG ++E+ S
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 33/99 (33%), Positives = 58/99 (58%), Gaps = 10/99 (10%)
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY--VTTRVM-G 352
+ GL +LH +++RD+K N++LD + + K++DFG+ K E VTTR G
Sbjct: 111 SVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK----EHMVDGVTTRTFCG 163
Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
T Y+APE + + D +++G+L+ E+++G+ P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 44/153 (28%), Positives = 79/153 (51%), Gaps = 25/153 (16%)
Query: 248 LGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVG----PHSPL-TWEIRMNIILGTAKGLTY 301
L C + R+ V EY++ G+L + VG PH+ EI + + +KG
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYQIQ-QVGRFKEPHAVFYAAEIAIGLFFLHSKG--- 121
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY--VTTRVM-GTFGYVA 358
+++RD+K N++LD + + K++DFG+ K E + VTT+ GT Y+A
Sbjct: 122 --------IIYRDLKLDNVMLDSEGHIKIADFGMCK----ENMWDGVTTKTFCGTPDYIA 169
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
PE + + D ++FG+L+ E+++G+ P +
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 43/225 (19%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
N+IG G +G+VY + ++ + VA+K +L + +E + + + H N++ L Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLNHINIIFLKDY 127
Query: 251 CAEGAHRM--------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII----LGTAKG 298
+ +V E+I Q +H + ++ + + ++ +
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFI-----PQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAK-LLGAER--SYVTTRVMGTF 354
L Y+H + HRD+K N+L+D + KL DFG AK LL +R SY+ +R
Sbjct: 183 LAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF---- 235
Query: 355 GYVAPEYASTGMLNERS--DVYSFGILIMEVI------SGRNPVD 391
Y APE G N + D++S G +I E+I SG++ VD
Sbjct: 236 -YRAPELM-LGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD 278
|
Length = 440 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 4/93 (4%)
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
L +LHE +++RD+K N+LLD + + KL+D+G+ K G T+ GT Y+A
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIA 164
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
PE D ++ G+L+ E+++GR+P D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 63/216 (29%), Positives = 93/216 (43%), Gaps = 38/216 (17%)
Query: 193 VIGEGGYGIVYHGVLEDNTN----VAVKNL------LNNRGQAEKEFKVEVEAIGRVRHK 242
V+G+GGYG V+ + A+K L N + A K E + V+H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHT--KAERNILEAVKHP 60
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAK---- 297
+V L+ G L+ EY+ G L L R I + TA
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLE-------------REGIFMEDTACFYLS 107
Query: 298 ----GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
L +LH+ +++RD+K NILLD Q + KL+DFGL K E + VT GT
Sbjct: 108 EISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGT 163
Query: 354 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
Y+APE + D +S G L+ ++++G P
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 35/96 (36%), Positives = 59/96 (61%), Gaps = 8/96 (8%)
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--LLGAERSYVTTRVMGT 353
A L +LH L +++RD+K NILLD++ + KL+DFGL+K + +++Y GT
Sbjct: 108 ALALDHLH-SL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGT 161
Query: 354 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
Y+APE + + +D +SFG+L+ E+++G P
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 32/93 (34%), Positives = 56/93 (60%), Gaps = 7/93 (7%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
GL ++H VV+RD+K +NILLD+ + ++SD GLA ++ + + +GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 162
Query: 358 APEYASTGMLNERS-DVYSFGILIMEVISGRNP 389
APE G+ + S D +S G ++ +++ G +P
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 32/93 (34%), Positives = 55/93 (59%), Gaps = 7/93 (7%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
GL ++H VV+RD+K +NILLD+ + ++SD GLA ++ + + +GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 162
Query: 358 APEYASTGMLNERS-DVYSFGILIMEVISGRNP 389
APE G + S D +S G ++ +++ G +P
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 29/209 (13%)
Query: 194 IGEGGYGIVYHGVLEDNTNVA---VKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLG 249
IG G +G V + +T VA VK L N E+ EF + + ++H N+++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 250 YCAEGAHRMLVYEYIDNGNL------EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
C E +LV+EY + G+L EQW + S L RM + A G+T++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRN----SQLLLLQRMACEI--AAGVTHMH 116
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT--RVMGTFGYVAPEY 361
+ +H D+ N L K+ D+G+ E Y+ T ++APE
Sbjct: 117 ---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE-DYIETEDDKCVPLRWLAPEL 172
Query: 362 AST---GML----NERSDVYSFGILIMEV 383
G++ + S+V++ G+ + E+
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 39/96 (40%), Positives = 53/96 (55%), Gaps = 13/96 (13%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
GL LH ++V+RD+K NILLD + ++SD GLA + E + RV GT GY+
Sbjct: 114 GLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRV-GTVGYM 168
Query: 358 APEYASTGMLNER----SDVYSFGILIMEVISGRNP 389
APE NER D + G LI E+I G++P
Sbjct: 169 APEVVK----NERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 193 VIGEGGYGIVY--HGVLEDNTN------VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
V+G G YG V+ V +T V K L + + + + E + VR
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 245 VRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM---NIILGTAKGLT 300
+ L Y + ++ L+ +Y+ G + L+ E+R IIL L
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED---EVRFYSGEIILA----LE 119
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
+LH+ +V+RDIK NILLD + + L+DFGL+K +E T GT Y+APE
Sbjct: 120 HLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176
Query: 361 YA-STGMLNERSDVYSFGILIMEVISGRNP 389
G + D +S GILI E+++G +P
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 38/139 (27%), Positives = 65/139 (46%), Gaps = 17/139 (12%)
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
L +LH+ +++RD+K N+LLD + + KL+DFG+ K G T+ GT Y+A
Sbjct: 109 LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIA 164
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP--------GEVNLVEWLKTMVT 410
PE + D ++ G+L+ E++ G P + EV WL
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL----- 219
Query: 411 NRNAEGVLDPRLQEKPCSR 429
+++A +L + + P R
Sbjct: 220 SQDAVDILKAFMTKNPTMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
+G G YG V + VA+K L + A++ ++ E+ + ++H+N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81
Query: 250 Y--CAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
A LV Y+ +L++ + PL+ + ++ GL Y+H
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIH 134
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYA 362
++HRD+K N+ +++ K+ DFGLA+ AE + YV TR Y APE
Sbjct: 135 SA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVI 186
Query: 363 STGM-LNERSDVYSFGILIMEVISGR 387
M N+ D++S G ++ E+++G+
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 18/97 (18%)
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFG 355
+GL Y+H ++HRD+K SNI +++ K+ DFGLA+ E + YV TR
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180
Query: 356 YVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
Y APE MLN D++S G ++ E+++G+
Sbjct: 181 YRAPEI----MLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 5/96 (5%)
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
L YLH VV+RD+K N++LDK + K++DFGL K G GT Y+A
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394
PE D + G+++ E++ GR P Y++
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 51/205 (24%)
Query: 187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE------------ 234
+ E IG G YG VY KN + + A K+FK + E
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKR--------KNGKDGKEYAIKKFKGDKEQYTGISQSACRE 52
Query: 235 -AIGR-VRHKNLVRLLGYCAEGAHRM--LVYEYI--DNGNLEQWLHGDVGPHS------- 281
A+ R ++H+N+V L+ E A + L+++Y D + ++ H S
Sbjct: 53 IALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKF-HRQAKRVSIPPSMVK 111
Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL----DKQWNPKLSDFGLAK 337
L W+I +N G+ YLH V+HRD+K +NIL+ ++ K+ D GLA+
Sbjct: 112 SLLWQI-LN-------GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
Query: 338 LLGA--ERSYVTTRVMGTFGYVAPE 360
L A + V+ T Y APE
Sbjct: 161 LFNAPLKPLADLDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 39/104 (37%), Positives = 53/104 (50%), Gaps = 5/104 (4%)
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
A L YLH +V+RD+K NILLD Q + L+DFGL K G +S TT GT
Sbjct: 106 ASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPE 161
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
Y+APE + D + G ++ E++ G P Y R E+
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF-YCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 9e-09
Identities = 65/221 (29%), Positives = 100/221 (45%), Gaps = 43/221 (19%)
Query: 194 IGEGGYGIV----YHGVLEDNTNVAVK---NLLNNRGQAEKEFKVEVEAIGRVR-HKNLV 245
+G+G YGIV + VA+K N+ + + A++ + E++ + R HKN+
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNIT 65
Query: 246 RL--LGYCAEGAHRML-VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
L + G L +YE + +L Q + PLT + I GL Y+
Sbjct: 66 CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYI 121
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA--------KLLGAERSYVTTRVMGTF 354
H V+HRD+K N+L++ K+ DFGLA + G YV TR
Sbjct: 122 HSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR----- 173
Query: 355 GYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPV 390
Y APE ML+ +S DV+S G ++ E++ GR PV
Sbjct: 174 WYRAPEI----MLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 9e-09
Identities = 36/92 (39%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
GL LH V+RD+K NILLD + ++SD GLA + E + RV GT GY+
Sbjct: 114 GLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESIRGRV-GTVGYM 168
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
APE + D + G LI E+I G++P
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 61/253 (24%), Positives = 95/253 (37%), Gaps = 87/253 (34%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAV-------KNLLNNRGQ-----AEKEFKVEVEAIGRVR 240
VIG G +G V+ ++ D V K+ + R Q AE++ + A
Sbjct: 8 VIGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD--ADSPW- 62
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAK-- 297
+V+L + H LV EY+ G+L + IR ++ TA+
Sbjct: 63 ---IVKLYYSFQDEEHLYLVMEYMPGGDL-------------MNLLIRKDVFPEETARFY 106
Query: 298 ------GLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTT 348
L +H+ G +HRDIK NIL+D + KL+DFGL K + +R Y
Sbjct: 107 IAELVLALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162
Query: 349 R--------------------------VMGTFGYVAPE------YASTGMLNERSDVYSF 376
+GT Y+APE Y D +S
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY------GLECDWWSL 216
Query: 377 GILIMEVISGRNP 389
G+++ E++ G P
Sbjct: 217 GVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L YLH G K+V+RD+K N++LDK + K++DFGL K G + GT Y+
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYL 162
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
APE D + G+++ E++ GR P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 33/81 (40%), Positives = 48/81 (59%), Gaps = 2/81 (2%)
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
++V+RD+K NILLD + + ++SD GLA + E V RV GT GY+APE +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRV-GTVGYMAPEVINNEKYT 179
Query: 369 ERSDVYSFGILIMEVISGRNP 389
D + G LI E+I G++P
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 29/157 (18%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE------AIGRV------R 240
+GEG Y VY G ++ L + A KE ++E E AI +
Sbjct: 12 KLGEGSYATVYKG----------RSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK 61
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
H N+V L LV+EY+D +L+Q++ G S + + +L +GL
Sbjct: 62 HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL---RGLA 117
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337
Y H+ +V+HRD+K N+L+ ++ KL+DFGLA+
Sbjct: 118 YCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
L +LH V++RD+K NILLD + + KL+DFG+ K G TT GT Y+A
Sbjct: 109 LMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIA 164
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNP 389
PE D ++ G+L+ E+++G+ P
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 8/94 (8%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK--LLGAERSYVTTRVMGTFG 355
GL +LH +++RD+K N++LD+ + K++DFG+ K + G R+ + GT
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA---STFCGTPD 161
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
Y+APE D +SFG+L+ E++ G++P
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 75/248 (30%), Positives = 111/248 (44%), Gaps = 22/248 (8%)
Query: 193 VIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGR-VRHKNLVRL 247
VIG+G +G V + + AVK L + + EK E + + V+H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 248 LGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
+ + A ++ V +YI+ G L L + P I A L YLH
Sbjct: 62 -HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI----ASALGYLHS-- 114
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
+V+RD+K NILLD Q + L+DFGL K E + T+ GT Y+APE
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 367 LNERSDVYSFGILIMEVISGRNPVDYSRPPGE-----VNLVEWLKTMVTNRNAEGVLDPR 421
+ D + G ++ E++ G P YSR E +N LK +TN +A +L+
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILNKPLQLKPNITN-SARHLLEGL 230
Query: 422 LQEKPCSR 429
LQ+ R
Sbjct: 231 LQKDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 39/113 (34%), Positives = 62/113 (54%), Gaps = 9/113 (7%)
Query: 281 SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340
SPLT E + A+G+ +L K +HRD+ + NILL + K+ DFGLA+ +
Sbjct: 169 SPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 225
Query: 341 AERSYV---TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
+ YV + R+ ++APE + +SDV+SFG+L+ E+ S G +P
Sbjct: 226 KDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 37/155 (23%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
+E + V H +++R+ GA +V + + +L +L P L + +
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRP---LPIDQALI 161
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
I +GL YLH +++HRD+K+ NI ++ + D G A+ +++ +
Sbjct: 162 IEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--L 216
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
GT APE + N ++D++S GI++ E+++
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 53/231 (22%), Positives = 96/231 (41%), Gaps = 49/231 (21%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAE------------------KEFKVE 232
+GEG YG V VA+K + + +E K+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
E ++H+N++ L+ EG LV + + +L++ + + LT I+
Sbjct: 75 NE----IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCIL 125
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG------------ 340
L GL LH+ +HRD+ +NI ++ + K++DFGLA+ G
Sbjct: 126 LQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 341 --AERSYVTTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGR 387
R +T++V+ T Y APE + + D++S G + E+++G+
Sbjct: 183 TMQRREEMTSKVV-TLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 64/255 (25%), Positives = 110/255 (43%), Gaps = 42/255 (16%)
Query: 194 IGEGGYGIVYHGVL--EDNTNVAVKNLLNNRGQAEKEFK---VEVEAIGRVRHKNLVRLL 248
+G G +G V ED VA+K ++ +K+ E + + + H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLH------GDVGPHSPLTWEIRMNIILGTAKGLTYL 302
G + ++ LV E++ G +L DVG A + +
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF--------------YAAQIVLI 143
Query: 303 HEGLEP-KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
E L+ +V+RD+K N+LLDK K++DFG AK++ R+Y + GT Y+APE
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-RTYT---LCGTPEYIAPEI 199
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD-P 420
+ +D ++ GI I E++ G P Y+ P ++ + EG++ P
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVGCPPF-YANEP----------LLIYQKILEGIIYFP 248
Query: 421 RLQEKPCSRALKRAL 435
+ + C +K+ L
Sbjct: 249 KFLDNNCKHLMKKLL 263
|
Length = 340 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVK---NLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
+ VIG+G YG+V + VA+K ++ + A + + E++ + +RH ++V
Sbjct: 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVE 63
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
+ + R Y+ +E LH + + LT E + + L Y+H
Sbjct: 64 IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA- 122
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-------RSYVTTRVMGTFGYVAP 359
V HRD+K NIL + K+ DFGLA++ + YV TR Y AP
Sbjct: 123 --NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR-----WYRAP 175
Query: 360 EYAST--GMLNERSDVYSFGILIMEVISGR 387
E + D++S G + EV++G+
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 4/91 (4%)
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
L LH+ V++RD+K NILLD Q + L DFGL K L + T GT Y+A
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLA 161
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNP 389
PE + D ++ G+L+ E+++G P
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 194 IGEGGYGIVYHGVLED--------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
+G+G + ++ G+ + T V +K L + + F + ++ HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
G C G ++V EY+ G+L+ +L + ++W+ L AK L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKN-KNLINISWK------LEVAKQLAWALHF 115
Query: 306 LEPK-VVHRDIKSSNILL-----DKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGY 356
LE K + H ++ + N+LL K NP KLSD G++ + + + R+ +
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP-KEILLERI----PW 170
Query: 357 VAPEYASTGM-LNERSDVYSFGILIMEVISGRN 388
V PE L+ +D +SFG + E+ SG +
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGD 203
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 38/113 (33%), Positives = 61/113 (53%), Gaps = 9/113 (7%)
Query: 281 SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340
PLT E ++ A+G+ +L K +HRD+ + NILL + K+ DFGLA+ +
Sbjct: 168 EPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 341 AERSYV---TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
+ YV R+ ++APE + +SDV+SFG+L+ E+ S G +P
Sbjct: 225 KDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKN 243
+ D +G G YG V + VA+K L + A++ ++ E+ + ++H+N
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHEN 75
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGP---HSPLTWEIRMNIILGTAKGLT 300
++ LL + + D + ++ D+G H L+ + ++ KGL
Sbjct: 76 VIGLLDVFTPDLS---LDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAP 359
Y+H ++HRD+K N+ +++ K+ DFGLA+ +E + YV TR Y AP
Sbjct: 133 YIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAP 184
Query: 360 EYASTGM-LNERSDVYSFGILIMEVISGR 387
E M + D++S G ++ E+++G+
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L YLH E VV+RD+K N++LDK + K++DFGL K G + GT Y+
Sbjct: 107 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 163
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNP 389
APE D + G+++ E++ GR P
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 10/99 (10%)
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTR 349
+I +GL Y+H ++HRD+K SN+ +++ K+ DFGLA+ E + YV TR
Sbjct: 125 LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 181
Query: 350 VMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGR 387
Y APE M N+ D++S G ++ E+++GR
Sbjct: 182 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 50/196 (25%), Positives = 92/196 (46%), Gaps = 11/196 (5%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEA--IGRVRHKNLVRLLGYC 251
+GEG Y VY G + N + ++ + + F EA + ++H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
LV+EY+ + +L Q++ G P ++ + +L +GL+Y+H+ ++
Sbjct: 73 HTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLL---RGLSYIHQRY---IL 125
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-YASTGMLNER 370
HRD+K N+L+ KL+DFGLA+ + V+ T Y P+ + +
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYSTC 184
Query: 371 SDVYSFGILIMEVISG 386
D++ G + +E+I G
Sbjct: 185 LDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 52/220 (23%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 188 FADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
+ D +G G G+V+ V D + VAVK ++ Q+ K E++ I R+ H N+V+
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 247 LLGYCAEGAHRM--------------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
+ + +V EY++ +L L PL+ E +
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLE-----QGPLSEEHARLFM 120
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERS---YVTT 348
+GL Y+H V+HRD+K +N+ ++ + K+ DFGLA+++ S Y++
Sbjct: 121 YQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177
Query: 349 RVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGR 387
++ + Y +P S + D+++ G + E+++G+
Sbjct: 178 GLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 8e-08
Identities = 48/172 (27%), Positives = 85/172 (49%), Gaps = 21/172 (12%)
Query: 236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
+ +V H +L + G C G+ ++V E++++G L+ L + G P+ W+I + L +
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG-RVPVAWKITVAQQLAS 128
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-----NP--KLSDFGLAKLLGAERSYVTT 348
A L+YL + +VH ++ + NILL + +P KLSD G++ R
Sbjct: 129 A--LSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREERVE 182
Query: 349 RVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEV-ISGRNPVDYSRPPGE 398
R+ ++APE L+ +D +SFG ++E+ G P+ R P E
Sbjct: 183 RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK-ERTPSE 229
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 9e-08
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 37/215 (17%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE-----FKVEVEAIGRVRHKN-LVRL 247
IGEG YG VY D + L R + ++E E+ + + +VRL
Sbjct: 9 IGEGTYGKVYKA--RDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 248 LGYCAEGAHR-------MLVYEYIDNGNLEQWLHGDV-GPHSPLTWEIRMNIILGTAKGL 299
L E LV+EY+D+ +L++++ + GP PL + + + KG+
Sbjct: 67 L--DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAE-RSYVTTRVMGTFGYV 357
+ H+ V+HRD+K N+L+DKQ K++D GL + +SY T + T Y
Sbjct: 124 AHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTLWYR 178
Query: 358 APE------YASTGMLNERSDVYSFGILIMEVISG 386
APE + ST + D++S G + E+
Sbjct: 179 APEVLLGSTHYSTPV-----DIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 193 VIGEGGYGIVY--HGVLEDNT------NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
V+G G YG V+ V ++ V K + + + + + E + + +R
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 245 VRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG-TAKGLTYL 302
+ L Y + ++ L+ +YI+ G L L E + I G L +L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK-----EQEVQIYSGEIVLALEHL 121
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
H+ +++RDIK NILLD + L+DFGL+K + GT Y+AP+
Sbjct: 122 HK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 363 STGML--NERSDVYSFGILIMEVISGRNP 389
G ++ D +S G+L+ E+++G +P
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 18/221 (8%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEA--IGRVRHKNLVRLLGYC 251
+GEG Y VY G+ N + +++ + + F EA + ++H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
V+EY+ +L Q++ G P + M +L +GL Y+H ++
Sbjct: 73 HTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLL---RGLAYIHG---QHIL 125
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
HRD+K N+L+ KL+DFGLA+ ++ V+ T Y P+ G + S
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPD-VLLGATDYSS 183
Query: 372 --DVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410
D++ G + +E++ G+ P PG ++ E L+ + T
Sbjct: 184 ALDIWGAGCIFIEMLQGQ-PAF----PGVSDVFEQLEKIWT 219
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 27/83 (32%), Positives = 41/83 (49%), Gaps = 4/83 (4%)
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY----ASTGM 366
+HRD+K N+LLDK + KL+DFG + A +GT Y++PE G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
D +S G+ + E++ G P
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 65/288 (22%), Positives = 122/288 (42%), Gaps = 41/288 (14%)
Query: 193 VIGEGGYGIVYHGVL--EDNT--NVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
++G+G +G V L ED + VAVK L + + E EF E + H N++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE-EFLREAACMKEFDHPNVI 64
Query: 246 RLLGYCAEGAHR------MLVYEYIDNGNLEQWLHGDVGPHSPLTW--EIRMNIILGTAK 297
+L+G + M++ ++ +G+L +L P T + + ++ A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG-TFGY 356
G+ YL +HRD+ + N +L++ ++DFGL+K + + Y +
Sbjct: 125 GMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVN--LVEWLKTMVTNRN 413
+A E + + SDV++FG+ + E+++ G+ P G N + +L
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY-----AGVENSEIYNYL-------- 228
Query: 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
+ RL++ P L+ + +C P RP H+ LE
Sbjct: 229 ---IKGNRLKQPP--DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 9/112 (8%)
Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341
LT E + AKG+ +L K +HRD+ + NILL + K+ DFGLA+ +
Sbjct: 175 VLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 342 ERSYV---TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
+ YV R+ ++APE + +SDV+SFG+L+ E+ S G +P
Sbjct: 232 DPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
+GL YLH ++HRDIK N+L++ K+ DFGLA++ + S T+ + T Y
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 357 VAPEYASTGMLNERS--DVYSFGILIMEVISGR 387
APE G + S D++S G + E++ R
Sbjct: 171 RAPEIL-MGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 33/91 (36%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
L YLH VV+RDIK N++LDK + K++DFGL K G GT Y+A
Sbjct: 108 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNP 389
PE D + G+++ E++ GR P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 31/218 (14%)
Query: 193 VIGEGGYGIVY---HGVLEDNTNVAVKNL----LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
+I G YG VY H E A+K + L R Q ++ F VE + + + +V
Sbjct: 8 LISNGAYGAVYLVRHK--ETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAENPFVV 64
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
+ H +V EY++ G+ L ++G L ++ T L YLH
Sbjct: 65 SMFCSFETKRHLCMVMEYVEGGDCATLLK-NIGA---LPVDMARMYFAETVLALEYLHN- 119
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL-------LGAE-------RSYVTTRVM 351
+VHRD+K N+L+ + KL+DFGL+K+ E R ++ +V
Sbjct: 120 --YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177
Query: 352 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
GT Y+APE + D ++ GI++ E + G P
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 56/231 (24%), Positives = 103/231 (44%), Gaps = 23/231 (9%)
Query: 218 LLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDV 277
+LN+ QA + E+ + H +V+ +L+ EY G+L + + +
Sbjct: 102 MLNDERQAAYA-RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRL 160
Query: 278 GPHSPLT-WEIRM---NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333
H P +E+ + I+L L E K++HRD+KS+NI L KL DF
Sbjct: 161 KEHLPFQEYEVGLLFYQIVLA-------LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDF 213
Query: 334 GLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY 392
G +K S V + GT Y+APE ++++D++S G+++ E+++ P
Sbjct: 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF-- 271
Query: 393 SRPPGEVNLVEWLK-------TMVTNRNAEGVLDPRLQEKPCSRALKRALL 436
+ P + +++ + + + +LDP L + P R + LL
Sbjct: 272 -KGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 26/172 (15%)
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT-- 353
AKG+++L +HRD+ + NILL K+ DFGLA+ + + +YV V G
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV---VKGNAR 277
Query: 354 --FGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVT 410
++APE + SDV+S+GIL+ E+ S G +P Y P + + +K
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP--YPGMPVDSKFYKMIK---- 331
Query: 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462
EG R+ C+ + ++ + C D + KRP ++ ++E +
Sbjct: 332 ----EGY---RMLSPECAPSEMYDIMKS--CWDADPLKRPTFKQIVQLIEQQ 374
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 18/221 (8%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE----FKVEV 233
+R+L++ + VIG G +G V + + V LL+ ++ F E
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG-DVGPHSPLTWEIRMNII 292
+ + +V+L + + +V EY+ G+L + DV P W
Sbjct: 95 DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV----PEKWAK----- 145
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
TA+ + L ++HRD+K N+LLDK + KL+DFG + +G
Sbjct: 146 FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVG 205
Query: 353 TFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRNP 389
T Y++PE + G D +S G+ + E++ G P
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 28/86 (32%), Positives = 49/86 (56%), Gaps = 5/86 (5%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
G+ Y+H+ +++HRD+K+ NI L K+ DFG+++LL TT GT Y+
Sbjct: 118 GVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-FTGTPYYM 172
Query: 358 APEYASTGMLNERSDVYSFGILIMEV 383
+PE + +SD++S G ++ E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 41/179 (22%), Positives = 80/179 (44%), Gaps = 19/179 (10%)
Query: 215 VKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL--------LGYCAEGAHRMLVYEYIDN 266
+ + +A + + E+ A+GR+ H+N++++ Y + +Y ++ +
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255
Query: 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW 326
W PL + R I+ + Y+H+ K++HRDIK NI L+
Sbjct: 256 EAF-DW------KDRPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDG 304
Query: 327 NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
L DFG A ER +GT +PE + E +D++S G+++++++S
Sbjct: 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 30/224 (13%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKNLVRLLGY 250
IG G +G V+ + ++ RG E+E +EV + ++HKN+VR +
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 251 CAEGAHRML--VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE- 307
A++ L + E+ D G+L + + + ++I L Y H +
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 308 ---PKVVHRDIKSSNILLDK----------QWN-------PKLSDFGLAKLLGAERSYVT 347
+V+HRD+K NI L Q N K+ DFGL+K +G E +
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MA 198
Query: 348 TRVMGTFGYVAPEYA--STGMLNERSDVYSFGILIMEVISGRNP 389
+GT Y +PE T +++SD+++ G +I E+ SG+ P
Sbjct: 199 HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 61/262 (23%), Positives = 101/262 (38%), Gaps = 48/262 (18%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE----FKVEVEAIGRVRHKN 243
F VIG G +G V +D +V +L EKE + E + +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+V++ + + L+ E++ G++ L LT E I T + +H
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIH 118
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL---------------------------- 335
+ +HRDIK N+LLD + + KLSDFGL
Sbjct: 119 Q---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 336 ------AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
A+ R + +GT Y+APE N+ D +S G+++ E++ G P
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 390 VDYSRPPGEV--NLVEWLKTMV 409
S P E ++ W +T++
Sbjct: 236 F-CSETPQETYKKVMNWKETLI 256
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 42/216 (19%)
Query: 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG---------------- 237
+G G +Y G+L + ++ EKE KV ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDE-----DDGYSYEKEIKVILKVLDPSHRDISLAFFETASM 57
Query: 238 --RVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
+V HK++V L G C ++V E+++ G L+ ++H LT + +
Sbjct: 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQL 114
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILL-----DKQWNP--KLSDFGLAKLLGAERSYVTT 348
A L+YL + +VH ++ + NILL D + P KLSD G+ + R
Sbjct: 115 ASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-ITVLSRQECVE 170
Query: 349 RVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEV 383
R+ ++APE + L+ +D +SFG + E+
Sbjct: 171 RI----PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 13/96 (13%)
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
L +LH+ +V+RD+K NILLD + L DFGL+K + T GT Y+A
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLA 164
Query: 359 PEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
PE +L+E+ D +S G+L+ E+ G +P
Sbjct: 165 PEV----LLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 29/84 (34%), Positives = 44/84 (52%), Gaps = 5/84 (5%)
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY-----ASTG 365
VHRDIK N+LLDK + +L+DFG L A+ + + +GT Y++PE G
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
D +S G+ + E++ G P
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 18/221 (8%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE----FKVEV 233
+R+L + + VIG G +G V + V LL+ ++ F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG-DVGPHSPLTWEIRMNII 292
+ + +V+L + + +V EY+ G+L + DV P W
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV----PEKWAR----- 145
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
TA+ + L +HRD+K N+LLDK + KL+DFG + E +G
Sbjct: 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 205
Query: 353 TFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRNP 389
T Y++PE + G D +S G+ + E++ G P
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 63/237 (26%), Positives = 92/237 (38%), Gaps = 53/237 (22%)
Query: 193 VIGEGGYGIVYHGVLEDNTNV--AVKNLLNNRGQAEKEFKV-----EVEAIGRVRHKNLV 245
++G+G G V+ V T A+K L + K KV E E + + H L
Sbjct: 8 LLGKGDVGRVFL-VRLKGTGKLFALKVLDKK--EMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWE-IRM---NIILGTAKGLTY 301
L + LV +Y G L + L P L+ E R ++L L Y
Sbjct: 65 TLYASFQTETYLCLVMDYCPGGELFRLL--QRQPGKCLSEEVARFYAAEVLLA----LEY 118
Query: 302 LH-EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-------------------- 340
LH G +V+RD+K NILL + + LSDF L+K
Sbjct: 119 LHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 341 --------AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
E S+ + +GT Y+APE S D ++ GIL+ E++ G P
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 11/99 (11%)
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT-- 353
A+G+ +L +HRD+ + N+LL K+ DFGLA+ + + +YV V G
Sbjct: 222 AQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNAR 275
Query: 354 --FGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389
++APE + +SDV+S+GIL+ E+ S G++P
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 194 IGEGGYGIVYHG-VLEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVR-HKNLVRLLG- 249
IGEG + V + A+K + + E+ + E++A+ R+ H N++RL+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 250 -YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
+ + LV+E +D NL + + G P + M +L K L ++H
Sbjct: 67 LFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLL---KSLDHMHRN--- 119
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-YASTGML 367
+ HRDIK NIL+ K KL+DFG + + ++ Y T + T Y APE + G
Sbjct: 120 GIFHRDIKPENILI-KDDILKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLLTDGYY 176
Query: 368 NERSDVYSFGILIMEVIS------GRNPVD 391
+ D+++ G + E++S G N +D
Sbjct: 177 GPKMDIWAVGCVFFEILSLFPLFPGTNELD 206
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 10/93 (10%)
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFG 355
+GL Y+H ++HRD+K SN+ +++ ++ DFGLA+ E + YV TR
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 356 YVAPEYASTGM-LNERSDVYSFGILIMEVISGR 387
Y APE M N+ D++S G ++ E++ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 8/93 (8%)
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF- 354
A+G+ +L VHRD+ + N+LL + K+ DFGLA+ + + +YV+ TF
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG--STFL 301
Query: 355 --GYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
++APE + SDV+S+GIL+ E+ S
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 62/263 (23%), Positives = 104/263 (39%), Gaps = 50/263 (19%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE----FKVEVEAIGRVRHKN 243
F VIG G +G V +D ++ +L EKE + E + +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+V++ + + L+ E++ G++ L L+ E I T + +H
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIH 118
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL---------------------------- 335
+ +HRDIK N+LLD + + KLSDFGL
Sbjct: 119 Q---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 336 ------AKLLGAERSYVTTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRN 388
A+ R + +GT Y+APE + TG N+ D +S G+++ E++ G
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYP 234
Query: 389 PVDYSRPPGEV--NLVEWLKTMV 409
P S P E ++ W +T+V
Sbjct: 235 PF-CSETPQETYRKVMNWKETLV 256
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 27/84 (32%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-----G 365
VHRDIK NIL+D + +L+DFG L + + ++ +GT Y++PE G
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
D +S G+ + E++ G P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 44/193 (22%), Positives = 75/193 (38%), Gaps = 34/193 (17%)
Query: 208 EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV------- 260
E V VK K E++ + + H+ ++ L+ + +V
Sbjct: 117 EQRKKVIVK-----AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCD 171
Query: 261 -YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN 319
+ Y+D PL E + I + L YLH ++HRD+K+ N
Sbjct: 172 LFTYVDR-------------SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTEN 215
Query: 320 ILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV---APEYASTGMLNERSDVYSF 376
I LD+ N L DFG A L A T + G G + +PE + ++D++S
Sbjct: 216 IFLDEPENAVLGDFGAACKLDA--HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSA 273
Query: 377 GILIMEVISGRNP 389
G+++ E+
Sbjct: 274 GLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 26/84 (30%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-----G 365
VHRDIK N+LLD + +L+DFG + + + ++ +GT Y++PE G
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
D +S G+ + E++ G P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 38/115 (33%), Positives = 57/115 (49%), Gaps = 25/115 (21%)
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR 349
NI+ G +GL YLH+ +HR+IK+S+IL+ LS GL+ L R+ +
Sbjct: 105 NILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAK 159
Query: 350 VMGTFGYVAPEYASTGML---------------NERSDVYSFGILIMEVISGRNP 389
V+ F P++ ST +L N +SD+YS GI E+ +GR P
Sbjct: 160 VVYDF----PQF-STSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF- 354
A G+ +L VHRD+ + N+L+ + K+ DFGLA+ + + +Y++ TF
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKG--STFL 303
Query: 355 --GYVAPEYASTGMLNERSDVYSFGILIMEVIS 385
++APE + SDV+SFGIL+ E+ +
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 40/141 (28%), Positives = 61/141 (43%), Gaps = 46/141 (32%)
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT---------------------- 348
+HRDIK N+LLD + + KLSDFGL G ++S+ T
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCT--GLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 349 ------------RVM-----GTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRNPV 390
R + GT Y+APE + TG N+ D +S G+++ E++ G P
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPF 239
Query: 391 DYSRPPGEV--NLVEWLKTMV 409
S P E ++ W +T+
Sbjct: 240 -CSDNPQETYRKIINWKETLQ 259
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 29/105 (27%), Positives = 49/105 (46%), Gaps = 19/105 (18%)
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER---------------SYVTT--RVMG 352
V+HRD+K NILL + D+G A E S +T +++G
Sbjct: 134 VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVG 193
Query: 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG 397
T Y+APE +E +D+Y+ G+++ ++++ P Y R G
Sbjct: 194 TPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP--YRRKKG 236
|
Length = 932 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 9/95 (9%)
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL---LGAERSYVTTRVMGT 353
+ + YLHE +++HRDIK+ NI ++ + L DFG A + A + Y GT
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA---GT 246
Query: 354 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRN 388
APE + D++S GI++ E+ + +
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD 281
|
Length = 391 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 5e-05
Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 11/106 (10%)
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTT 348
II + L LH+ ++H DIK N+L D + L D+GL K++G Y
Sbjct: 113 KIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY--- 166
Query: 349 RVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRNPVDYS 393
GT Y +PE G + S D ++ G+L E+++G++P
Sbjct: 167 --DGTLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTGKHPFKED 209
|
Length = 267 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 47/195 (24%), Positives = 84/195 (43%), Gaps = 25/195 (12%)
Query: 210 NTNVAVKNLLNNRGQAEKEFKV---EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266
NT VAVK + N ++++ K+ E+ +++H N++ + + +V +
Sbjct: 25 NTLVAVKKI-NLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83
Query: 267 GNLEQWL--HGDVG-PHSPLTWEIRMNIILGTAKGLTYLH-EGLEPKVVHRDIKSSNILL 322
G+ E L H G P + I+ L Y+H +G +HR +K+S+ILL
Sbjct: 84 GSCEDLLKTHFPEGLPELAIA-----FILKDVLNALDYIHSKGF----IHRSVKASHILL 134
Query: 323 DKQWNPKLSDFGLAKLL--GAERSYV----TTRVMGTFGYVAPEYASTGML--NERSDVY 374
LS + + +R V + +++PE + NE+SD+Y
Sbjct: 135 SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIY 194
Query: 375 SFGILIMEVISGRNP 389
S GI E+ +G P
Sbjct: 195 SVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 27/80 (33%), Positives = 44/80 (55%), Gaps = 7/80 (8%)
Query: 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318
LV EY+ G+++ LH + E+ + I A L YLH ++HRD+K
Sbjct: 81 LVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPD 133
Query: 319 NILLDKQWNPKLSDFGLAKL 338
N+L+ + + KL+DFGL+K+
Sbjct: 134 NMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 51/196 (26%), Positives = 78/196 (39%), Gaps = 30/196 (15%)
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP----LTWEIRMNIILGTAKG 298
N+V L Y LV ++ + G L W H + P W M + L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKL--WSHISKFLNIPEECVKRWAAEMVVALDA--- 100
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
LH +V RD+ +NILLD + + +L+ F + E S V Y A
Sbjct: 101 ---LHR---EGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM--YCA 150
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG-----EVNLVEWLKTMVTNRN 413
PE E D +S G ++ E+++G+ V+ P G +N+ EW+ +
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVE-CHPSGINTHTTLNIPEWV-----SEE 204
Query: 414 AEGVLDPRLQEKPCSR 429
A +L LQ P R
Sbjct: 205 ARSLLQQLLQFNPTER 220
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 36/142 (25%), Positives = 55/142 (38%), Gaps = 45/142 (31%)
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGL----------------------------------- 335
+HRDIK NIL+D+ + KL+DFGL
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 336 AKLLGAERSYVT--TRVM-----GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRN 388
+L ER R + GT Y+APE + D +S G+++ E++ G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 389 PVDYSRPPGEVNL--VEWLKTM 408
P + P E L + W T+
Sbjct: 243 PF-LADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 16/26 (61%), Positives = 21/26 (80%)
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLA 336
+HRDIK NIL+D+ + KLSDFGL+
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 27/84 (32%), Positives = 43/84 (51%), Gaps = 6/84 (7%)
Query: 301 YLH-EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL-GAERSYVTTRVMGTFGYVA 358
Y+H EG ++HRDIK+ N+L++ + L DFG A G+ + + GT A
Sbjct: 275 YIHGEG----IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNA 330
Query: 359 PEYASTGMLNERSDVYSFGILIME 382
PE + D++S G++I E
Sbjct: 331 PEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 51/235 (21%), Positives = 96/235 (40%), Gaps = 26/235 (11%)
Query: 173 GHWYTL--RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFK 230
GH+Y + +++VST F +++GEG +G V ++ N + ++ K
Sbjct: 114 GHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAK 173
Query: 231 VEVEAIGRVRHKN------LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT 284
+E++ + +VR + L+++ Y M + L W+ H P +
Sbjct: 174 IEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIM----KHGPFS 229
Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-----------KQWNPKLSDF 333
II T L Y H E ++H D+K NIL++ + P
Sbjct: 230 HRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287
Query: 334 GLAKLLG-AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 387
+ L G + + T ++ T Y +PE +D++S G +I E+ +G+
Sbjct: 288 RICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 521 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.65 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.45 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.43 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.39 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.37 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.32 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.28 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.2 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.2 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.19 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.05 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.05 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.02 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.99 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.8 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.75 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.71 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.61 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.52 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.47 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.45 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.4 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.35 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.29 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.25 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.21 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.16 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.15 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.14 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.08 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.98 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.94 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.92 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.84 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.82 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.72 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.7 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.56 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.51 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.44 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.43 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.32 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.3 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.09 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.04 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.9 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.81 | |
| PLN02236 | 344 | choline kinase | 96.73 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.69 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.67 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.5 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.43 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.37 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.35 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.25 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.23 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.06 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.93 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.7 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.53 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 95.43 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.27 | |
| PF12273 | 130 | RCR: Chitin synthesis regulation, resistance to Co | 95.14 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.11 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-56 Score=453.63 Aligned_cols=289 Identities=55% Similarity=0.946 Sum_probs=257.2
Q ss_pred CCcccchhhhhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEE
Q 009979 172 WGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251 (521)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~ 251 (521)
....|++.++..++++|...+.||+|+||.||+|...+++.||||++.....+...+|..|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56679999999999999999999999999999999998899999988765443156699999999999999999999999
Q ss_pred eeCC-eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceE
Q 009979 252 AEGA-HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKL 330 (521)
Q Consensus 252 ~~~~-~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL 330 (521)
.+.. +.+||||||++|+|.++|+..... +++|..+++|+.++|+||+|||+.+.+.|||||||++|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9988 599999999999999999987432 8999999999999999999999998889999999999999999999999
Q ss_pred eecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh
Q 009979 331 SDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410 (521)
Q Consensus 331 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (521)
+|||+|+..........+...||.+|+|||++..+..++|+|||||||+|.||+||+.|.+...+..+.++.+|.+..+.
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 99999976543112211111899999999999999999999999999999999999999988777778889999999999
Q ss_pred ccccccCCCcccC-CCccH-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 411 NRNAEGVLDPRLQ-EKPCS-RALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 411 ~~~~~~~~d~~l~-~~~~~-~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.+...+++|+.+. ..... ..+.++..++.+|++.+|.+||+|.||+++|+..
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 9999999999987 33332 6888899999999999999999999999999543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=402.11 Aligned_cols=262 Identities=32% Similarity=0.562 Sum_probs=214.7
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhh--HHHHHHHHHHHhcCCCCCeeeEEEEEeeCC-eee
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQA--EKEFKVEVEAIGRVRHKNLVRLLGYCAEGA-HRM 258 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~-~~~ 258 (521)
.+....+.+.+.||.|+||+||+|.+.....||||++....... .+.|.+|+.+|.+++|||||+|+|+|.+.. ..+
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 44445566677899999999999999744449999997653322 568999999999999999999999999887 789
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeecCCCCCCeEeCCCC-CceEeecccc
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VVHRDIKSSNILLDKQW-NPKLSDFGLA 336 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~-iiHrDik~~NILl~~~~-~vkL~DFGla 336 (521)
|||||+++|+|.++++.. ....+++..++.++.|||+||+|||++ + |||||||++|||++.++ ++||+|||++
T Consensus 117 iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred EEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 999999999999999884 357899999999999999999999998 7 99999999999999997 9999999999
Q ss_pred eecCCCCcceeeccccccccccccccc--CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYAS--TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
+...... ...+...||+.|||||++. ...|+.|+||||||++||||+||+.||....+ .+....++.....
T Consensus 192 r~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~R 264 (362)
T KOG0192|consen 192 REKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLR 264 (362)
T ss_pred eeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCC
Confidence 9764432 3344578999999999999 56999999999999999999999999975543 2333333333222
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 464 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 464 (521)
|.+... ++..+.. ++.+||+.||..||++.+++..|+....
T Consensus 265 -----p~~p~~-~~~~l~~---l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 265 -----PPIPKE-CPPHLSS---LMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred -----CCCCcc-CCHHHHH---HHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 222222 4444444 7779999999999999999999986554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=381.24 Aligned_cols=253 Identities=27% Similarity=0.451 Sum_probs=210.1
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC-eeeEEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA-HRMLVYE 262 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~-~~~lV~e 262 (521)
.+++..+.||+|..|+||++.++ +++-+|+|.+... .....+++.+|+++++..+|||||.++|.|..+. ...|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 35566889999999999999976 5777899999443 4455688999999999999999999999999988 4999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||++|+|.+++... +.+++...-+|+.++++||.|||+ . +||||||||+||||+..|+|||||||.++.+..
T Consensus 159 YMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred hcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 99999999999865 679999999999999999999996 5 999999999999999999999999999998744
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
. ...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||.... +...+.++.+...+.+ -.|.
T Consensus 232 S---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~-~~~~~~~~Ll~~Iv~~------ppP~ 301 (364)
T KOG0581|consen 232 S---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN-PPYLDIFELLCAIVDE------PPPR 301 (364)
T ss_pred h---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC-CCCCCHHHHHHHHhcC------CCCC
Confidence 3 4567899999999999999999999999999999999999999997541 1222333433333321 1233
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
+....++.++. .++..||++||.+||++.|++++
T Consensus 302 lP~~~fS~ef~---~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 302 LPEGEFSPEFR---SFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCcccCCHHHH---HHHHHHhcCCcccCCCHHHHhcC
Confidence 43333444444 47779999999999999999754
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-49 Score=395.75 Aligned_cols=264 Identities=27% Similarity=0.446 Sum_probs=221.9
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
...+++..+.+.+.+.||+|.||+||.|.++....||+|.++.. ....+.|.+|+++|++|+|+|||+++|+|..+..+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 44556777788899999999999999999988889999998765 44557788999999999999999999999998899
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
|||||||+.|+|.+||+.. ....+.....+.++.|||+|++||+++ ++|||||..+||||++++.+||+|||+|+
T Consensus 277 yIVtE~m~~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred EEEEEecccCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccc
Confidence 9999999999999999973 356788899999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
...++.........-...|+|||.+..+.++.|||||||||+||||+| |+.||.... ..+.+.......+
T Consensus 352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms------n~ev~~~le~GyR--- 422 (468)
T KOG0197|consen 352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS------NEEVLELLERGYR--- 422 (468)
T ss_pred ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC------HHHHHHHHhccCc---
Confidence 665554444444455779999999999999999999999999999999 999986443 3333333332221
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
.-.+..|+..+.+ +|..||+.+|++|||+..+...|+...
T Consensus 423 ----lp~P~~CP~~vY~---lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 423 ----LPRPEGCPDEVYE---LMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred ----CCCCCCCCHHHHH---HHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 1133447776665 888999999999999999998887643
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-49 Score=383.50 Aligned_cols=257 Identities=23% Similarity=0.367 Sum_probs=209.7
Q ss_pred cCCCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCChh-------hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC
Q 009979 184 STNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQ-------AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 255 (521)
..+.|.+.+.||+|+||.|-+|.. ++++.||||++.+.... ....+.+|+++|++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 345688899999999999999995 47999999999764321 2234679999999999999999999999999
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC---CCceEee
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ---WNPKLSD 332 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~---~~vkL~D 332 (521)
..||||||++||+|.+++-.+ ..+.+..-..++.|++.|+.|||+. ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 999999999999999999765 5677788899999999999999999 99999999999999655 7799999
Q ss_pred cccceecCCCCcceeecccccccccccccccCCC---CCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHh
Q 009979 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409 (521)
Q Consensus 333 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 409 (521)
||+|+..+ ....+.+.||||.|+|||++.++. +..++|+||+|||||-+|+|.+||...... ..+.+ ++
T Consensus 323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~sl~e----QI 394 (475)
T KOG0615|consen 323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PSLKE----QI 394 (475)
T ss_pred cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--ccHHH----HH
Confidence 99999875 344567899999999999997654 445889999999999999999999765432 22222 22
Q ss_pred hccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 410 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
..+.. .+.+....+...+.+++|.+||..||++||++.|++++-.-
T Consensus 395 ~~G~y------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~ 440 (475)
T KOG0615|consen 395 LKGRY------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWF 440 (475)
T ss_pred hcCcc------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence 22211 11222345666778889999999999999999999865443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=395.01 Aligned_cols=247 Identities=25% Similarity=0.423 Sum_probs=210.1
Q ss_pred CCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
.+|...+.||+|||..||.+++ ..|..||+|++.+. +....+.+.+||++.+.|+|||||+|+++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999997 78999999999663 3344577888999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
|+|..++|..+++.. .++++.+++.++.||+.||.|||++ +|+|||||..|+||+++.+|||+|||||..+..
T Consensus 98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 999999999999854 7899999999999999999999999 999999999999999999999999999999865
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
.... ..+.||||.|+|||++....++..+||||+|||||.||.|++||+... +-+...+...+ +..-|
T Consensus 171 ~~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------vkety~~Ik~~----~Y~~P- 238 (592)
T KOG0575|consen 171 DGER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------VKETYNKIKLN----EYSMP- 238 (592)
T ss_pred cccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------HHHHHHHHHhc----Ccccc-
Confidence 4333 345799999999999999999999999999999999999999996332 22222222221 11111
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
......+.+||.++|+.||.+|||+.+|+.
T Consensus 239 ------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 239 ------SHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ------cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 123334555888999999999999999984
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-48 Score=374.48 Aligned_cols=200 Identities=27% Similarity=0.515 Sum_probs=180.7
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
.+|...+.||.|+||+||+|+++ ++..||||.+.+. .....+-+..|+.+|+.++|||||+|+++++.++.+|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 47888889999999999999965 5889999999776 34455678889999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC------CCceEeecccc
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ------WNPKLSDFGLA 336 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~------~~vkL~DFGla 336 (521)
||+||||.+|++.. +.+++.++..++.|+|.||++||++ +||||||||.||||+.. -.+||+|||+|
T Consensus 90 yC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999976 5899999999999999999999999 99999999999999764 45899999999
Q ss_pred eecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~ 394 (521)
+.+.. .....+.+|++.|||||++..+.|+.|+|+||+|++||++++|+.||+...
T Consensus 163 R~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 163 RFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 98853 334466899999999999999999999999999999999999999997443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=362.41 Aligned_cols=257 Identities=24% Similarity=0.357 Sum_probs=208.5
Q ss_pred CccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEE-EEeeCCe-eeEEE
Q 009979 187 GFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLG-YCAEGAH-RMLVY 261 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~-~~~~~~~-~~lV~ 261 (521)
.|.+.++||+|.||+||++.+ .+|..+|.|.+.-.. ....+++..|+.+|++|+|||||++++ -+.++.. ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 688899999999999999994 479999999987442 334467888999999999999999998 4444444 89999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK--VVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~--iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
|||++|||.+.++........+++.++|+++.|++.||+.+|+.. +. |+||||||.||+|+.+|.|||+|||+++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999877667789999999999999999999999842 24 999999999999999999999999999988
Q ss_pred CCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
..... .....+|||.||+||.+....|+.||||||+||++|||+.-+.||.+. ++.+.-++ +..++
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~K-I~qgd------ 244 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKK-IEQGD------ 244 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHH-HHcCC------
Confidence 55433 345689999999999999999999999999999999999999999643 44443333 33222
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
+.+-+..-...++.+|+..|+..||+.||+.-.+++.+.
T Consensus 245 --~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 245 --YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred --CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 111122334445556888999999999998544444443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=363.24 Aligned_cols=243 Identities=25% Similarity=0.352 Sum_probs=202.2
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
..++|++.++||+|+||.||+++.+ +++.||+|++.+... ...+....|..+|..++||+||+++..|++..++||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3468999999999999999999955 578899999976533 234667889999999999999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
|+||+.||+|...|++. ..+++..+.-++.+|+.||.|||++ +||||||||+|||||++|+++|+|||+++..
T Consensus 103 Vld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 99999999999999875 6899999999999999999999999 9999999999999999999999999999965
Q ss_pred CCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
... ...+.+++||+.|||||++.+..|+..+|+||+|+++|||++|..||...+ ..++.+.......
T Consensus 176 ~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k~------ 242 (357)
T KOG0598|consen 176 LKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGKL------ 242 (357)
T ss_pred ccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCcC------
Confidence 332 334456899999999999999999999999999999999999999997443 3333333333220
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCC
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRP 450 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RP 450 (521)
...+...+ .++.+++.+.+..||++|-
T Consensus 243 -~~~p~~ls---~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 -PLPPGYLS---EEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCCccCC---HHHHHHHHHHhccCHHHhc
Confidence 01111122 2344477799999999995
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=369.97 Aligned_cols=268 Identities=27% Similarity=0.452 Sum_probs=218.0
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhh-HHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
.+++.....+.++||+|-||+|.++....+..||||+++...... ..+|..|+++|.+++||||++++|+|..++.++|
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 356778889999999999999999999878999999998765444 4899999999999999999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
|+|||++|+|.+||.....+. +.......|+.||+.|++||.+. ++|||||.+.|+|+|.++++||+|||+++.+
T Consensus 613 I~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccc
Confidence 999999999999998774332 44556677999999999999998 9999999999999999999999999999966
Q ss_pred CCCCccee-ecccccccccccccccCCCCCCcccchhHHHHHHHHHh--CCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 340 GAERSYVT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 340 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt--G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
-....+.. .+.+-...|||+|.+..+.++.+||||+||++|||+++ ...||..... ...++....+........
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQGRQV 764 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCCCcce
Confidence 55544443 35566789999999999999999999999999999977 7788864432 223333333333221111
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
++ .++..|+..+. +++++||..|-.+||+++++...|+..
T Consensus 765 ~l---~~P~~cp~~ly---elml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 VL---SRPPACPQGLY---ELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ec---cCCCcCcHHHH---HHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11 12333555544 588899999999999999999998764
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=392.34 Aligned_cols=262 Identities=28% Similarity=0.497 Sum_probs=217.7
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCCeeeEEEEEeeC
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~ 254 (521)
++.+.+....+.||+|+||+||+|... +.+-||||.++..... ...+|++|+++|..++|||||+|+|+|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 455667777899999999999999843 3456999999877665 678999999999999999999999999999
Q ss_pred CeeeEEEEeccCCchHHhhhcCCC------C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC
Q 009979 255 AHRMLVYEYIDNGNLEQWLHGDVG------P----HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK 324 (521)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~------~----~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~ 324 (521)
+..+||+|||..|||.+||+.... . ..+++..+.+.|+.|||.|++||-++ .+|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 999999999999999999965432 1 33488999999999999999999998 9999999999999999
Q ss_pred CCCceEeecccceecCCCCcceee-cccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHH
Q 009979 325 QWNPKLSDFGLAKLLGAERSYVTT-RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLV 402 (521)
Q Consensus 325 ~~~vkL~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~ 402 (521)
+..|||+|||+++..-..+.+... .-+-..+|||||.+..+.|+++||||||||||||++| |+.||......
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~------ 712 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ------ 712 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH------
Confidence 999999999999977555555443 3455789999999999999999999999999999999 99999755432
Q ss_pred HHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 403 EWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 403 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.+-..+..+.+-. .+..|+..+.+ ||..||+.+|++||+++||-..|+.-
T Consensus 713 -EVIe~i~~g~lL~------~Pe~CP~~vY~---LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 713 -EVIECIRAGQLLS------CPENCPTEVYS---LMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred -HHHHHHHcCCccc------CCCCCCHHHHH---HHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 2233344443211 22336665555 88899999999999999999998753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=347.96 Aligned_cols=262 Identities=23% Similarity=0.353 Sum_probs=206.9
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh--hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ--AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
+.|+...++|+|+||+||+++++ +|+-||||++.....+ ..+-..+||++|++++|+|+|.++++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888999999999999999976 5889999999765442 33556789999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
||+. ++.+-|... ...++.+...+++.|++.|+.|+|++ ++|||||||+||||+.+|.+||||||+|+.+..
T Consensus 82 ~~dh-TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDH-TVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecch-HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 9988 555555554 35688899999999999999999999 999999999999999999999999999998864
Q ss_pred CcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH------------h
Q 009979 343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM------------V 409 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~------------~ 409 (521)
.....+..+.|.+|.|||.+.+ ..|+..+|||++||++.||++|..-|.+....+. +. .+... -
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ--Ly-~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ--LY-LIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH--HH-HHHHHHcccCHHHHHHhc
Confidence 3334567788999999999877 7899999999999999999999998865432211 11 11111 1
Q ss_pred hccccccCCCcccC-----CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 410 TNRNAEGVLDPRLQ-----EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 410 ~~~~~~~~~d~~l~-----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+....++.-|... +.-.+....-+++++..||+.||.+|++-++++++
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 12222222222111 11123344457789999999999999999998754
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=366.80 Aligned_cols=256 Identities=24% Similarity=0.348 Sum_probs=212.7
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeee
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~ 258 (521)
..++|.+.+.||+|+|++|++|+.. .++.||||++.+. +....+.+..|-++|.+| .||.|++|+-.|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 4568999999999999999999954 6899999998654 233446678899999999 7999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+|+||+++|+|.++|++. +.+++..++.++.+|+.||+|||++ |||||||||+|||||+++++||+|||.|+.
T Consensus 151 FvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999986 6899999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCcc----------e--eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 009979 339 LGAERSY----------V--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK 406 (521)
Q Consensus 339 ~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~ 406 (521)
+.+.... . ...++||..|++||++..+..+..+|+|+|||+||+|+.|.+||.... +... ++
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N---eyli---Fq 297 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN---EYLI---FQ 297 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc---HHHH---HH
Confidence 8543221 1 145899999999999999999999999999999999999999997543 2222 33
Q ss_pred HHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 407 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
+.+. ++-.+.+.. ...+.+|+.+.|..||.+|+|..+|-++.=-..
T Consensus 298 kI~~-------l~y~fp~~f----p~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 298 KIQA-------LDYEFPEGF----PEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred HHHH-------hcccCCCCC----CHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 3332 112222222 234555888999999999999999976654333
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=361.39 Aligned_cols=264 Identities=24% Similarity=0.318 Sum_probs=209.9
Q ss_pred cCCCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC--Ceee
Q 009979 184 STNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRM 258 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~ 258 (521)
..+.|+.+++||+|.||.||+|++ .+|+.||+|++.... ........+||.+|++|.||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 345799999999999999999994 578999999997654 34456678899999999999999999998876 6899
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
||+|||++ ||..++... .-.+++.++..++.|++.||+|||+. +|+|||||.+|||||.+|.+||+|||||++
T Consensus 195 lVFeYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceee
Confidence 99999988 999988764 46899999999999999999999999 999999999999999999999999999999
Q ss_pred cCCCCcceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccc---c
Q 009979 339 LGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN---A 414 (521)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~ 414 (521)
+........+..+-|.+|.|||++.+. .|+.+.|+||.||||.||++|+..|.+.... .-.+.+-++..... +
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv---eQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV---EQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH---HHHHHHHHHhCCCChhcc
Confidence 877776667778889999999988765 6999999999999999999999999765422 11111112211110 0
Q ss_pred c-------cCCCcccCCCc-----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 415 E-------GVLDPRLQEKP-----CSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 415 ~-------~~~d~~l~~~~-----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
. ..+.+.-.-.. ........++|+..+|..||.+|.|+.+++.
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0 11111111000 1112234677888999999999999999873
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-46 Score=370.65 Aligned_cols=248 Identities=27% Similarity=0.503 Sum_probs=208.3
Q ss_pred hhhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
.|+++.+....++-||.|+.|.||+|+++ +..||||++..-+ ..+|+-|++|+||||+.|.|+|.....+||
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCI 189 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCI 189 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence 36777777888899999999999999986 6789999885322 237888999999999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
|||||..|-|...|+.. .+++......+..+||.|+.|||.+ +|||||||+-||||..+..|||+|||.++.+
T Consensus 190 iMEfCa~GqL~~VLka~----~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKAG----RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred eeeccccccHHHHHhcc----CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhh
Confidence 99999999999999876 6788899999999999999999999 9999999999999999999999999999976
Q ss_pred CCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
.+. .....++||..|||||++.+...++|+|||||||||||||||..||.+-+... ++ .++-.
T Consensus 263 ~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------II---------wGVGs 325 (904)
T KOG4721|consen 263 SDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------II---------WGVGS 325 (904)
T ss_pred hhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe------eE---------EeccC
Confidence 443 33445889999999999999999999999999999999999999997543211 11 11111
Q ss_pred cccC---CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 420 PRLQ---EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 420 ~~l~---~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
..+. +..|++.++- |++.||+..|..||++.+|+.+|+-.
T Consensus 326 NsL~LpvPstcP~Gfkl---L~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 326 NSLHLPVPSTCPDGFKL---LLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred CcccccCcccCchHHHH---HHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 1121 2235555554 78899999999999999999998643
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=363.33 Aligned_cols=268 Identities=27% Similarity=0.438 Sum_probs=217.1
Q ss_pred cchhhhhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEee
Q 009979 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253 (521)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~ 253 (521)
....+|++..+.+.+...||+|.||+||+|.|. | .||||++... ..+..+.|++|+..+++-+|.||+-|+|||..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 445788999999999999999999999999985 3 5999999754 34456889999999999999999999999998
Q ss_pred CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeec
Q 009979 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (521)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DF 333 (521)
... .||..+|+|-+|+.+||-. ...+.....+.|+.||++|+.|||.+ +|||||||..||++.+++.|||+||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred Cce-eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecc
Confidence 877 8999999999999999976 36788899999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCC-Ccceeeccccccccccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHh
Q 009979 334 GLAKLLGAE-RSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409 (521)
Q Consensus 334 Gla~~~~~~-~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 409 (521)
|++.....- .........|...|||||++. ..+|++.+||||||+|+|||+||..||...... .+.-+
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d-------qIifm- 604 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD-------QIIFM- 604 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh-------heEEE-
Confidence 999754211 111122345788999999885 356999999999999999999999999732211 11111
Q ss_pred hccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 009979 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 464 (521)
Q Consensus 410 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 464 (521)
-++.....|.......|+.++++ |+..||..++++||.+.+|+.+|+....
T Consensus 605 -VGrG~l~pd~s~~~s~~pk~mk~---Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 605 -VGRGYLMPDLSKIRSNCPKAMKR---LLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -ecccccCccchhhhccCHHHHHH---HHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 12222233433344457777776 6669999999999999999998876543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=363.19 Aligned_cols=262 Identities=23% Similarity=0.278 Sum_probs=210.4
Q ss_pred cchhhhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh---hHHHHHHHHHHHhcCCCCCeeeEEEEE
Q 009979 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ---AEKEFKVEVEAIGRVRHKNLVRLLGYC 251 (521)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~hpniv~l~~~~ 251 (521)
..++...+..++|+.+.+||+|+||.||+|+.+ +|..+|+|++++.... ..+.++.|-.+|....+|+||+|+..|
T Consensus 131 lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF 210 (550)
T KOG0605|consen 131 LRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF 210 (550)
T ss_pred HHhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe
Confidence 445556778899999999999999999999955 5888999999876433 346678899999999999999999999
Q ss_pred eeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEe
Q 009979 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLS 331 (521)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~ 331 (521)
++..++||||||++|||+..+|... ..|++..+..++.+++.|++.||+. |+|||||||+|+|||..|++||+
T Consensus 211 QD~~~LYLiMEylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLS 283 (550)
T KOG0605|consen 211 QDKEYLYLIMEYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLS 283 (550)
T ss_pred cCCCeeEEEEEecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeec
Confidence 9999999999999999999999876 6899999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCC-----------------------CCcc----e-------------------eecccccccccccccccCC
Q 009979 332 DFGLAKLLGA-----------------------ERSY----V-------------------TTRVMGTFGYVAPEYASTG 365 (521)
Q Consensus 332 DFGla~~~~~-----------------------~~~~----~-------------------~~~~~gt~~y~aPE~~~~~ 365 (521)
||||+.-+.. .... . ....+|||.|||||++.+.
T Consensus 284 DFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k 363 (550)
T KOG0605|consen 284 DFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK 363 (550)
T ss_pred cccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC
Confidence 9999854311 0000 0 0125799999999999999
Q ss_pred CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCC
Q 009979 366 MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPN 445 (521)
Q Consensus 366 ~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~d 445 (521)
.|+..+|+||||||+||||.|.+||....+..-...+...+..+. -| .......++.+||.+|+. |
T Consensus 364 gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~--------fP-----~~~~~s~eA~DLI~rll~-d 429 (550)
T KOG0605|consen 364 GYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK--------FP-----EEVDLSDEAKDLITRLLC-D 429 (550)
T ss_pred CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc--------CC-----CcCcccHHHHHHHHHHhc-C
Confidence 999999999999999999999999986665432222221111111 11 111122455668889999 9
Q ss_pred CCCCCC---HHHHHHH
Q 009979 446 AHKRPK---MGHVIHM 458 (521)
Q Consensus 446 P~~RPt---~~evl~~ 458 (521)
|++|-- +.||-++
T Consensus 430 ~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 430 PENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHhcCcccHHHHhcC
Confidence 999975 6666543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=363.69 Aligned_cols=250 Identities=25% Similarity=0.394 Sum_probs=204.8
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC----Ch-hhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCC
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN----RG-QAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGA 255 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~ 255 (521)
...++|.+.+.||+|.||.|++|... ++..||+|.+.+. .. ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568999999999999999999854 6899999966543 12 23456778999999999 999999999999999
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC-CCceEeecc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFG 334 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~-~~vkL~DFG 334 (521)
..|+||||+.||+|.+++... .++.+..+..++.|++.|++|||+. +|+||||||+|||+|.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 999999999999999999874 6788899999999999999999999 99999999999999999 999999999
Q ss_pred cceecCCCCcceeecccccccccccccccCCC-CC-CcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc
Q 009979 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGM-LN-ERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (521)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (521)
++.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++.. ....... +..+
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~~k-i~~~ 238 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLYRK-IRKG 238 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHHHH-HhcC
Confidence 999874 2334456789999999999999876 75 78999999999999999999998632 2222222 1111
Q ss_pred ccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 009979 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVI 456 (521)
Q Consensus 413 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl 456 (521)
. + .+... . . ..++..|+.+|+..||.+|+++.+|+
T Consensus 239 ~---~---~~p~~-~-~-S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 239 E---F---KIPSY-L-L-SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred C---c---cCCCC-c-C-CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1 1 11111 1 0 33445588899999999999999998
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=361.39 Aligned_cols=264 Identities=22% Similarity=0.299 Sum_probs=208.1
Q ss_pred cCCCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCChhhHH-HHHHHHHHHhcCC-CCCeeeEEEEEeeCC-eeeE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVR-HKNLVRLLGYCAEGA-HRML 259 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~-~~~~Ei~~l~~l~-hpniv~l~~~~~~~~-~~~l 259 (521)
..++|...++||.|.||.||+|+. ..+..||||++++.-....+ .=.+|++.|++|+ |||||++.+++.+.+ .+|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 346899999999999999999994 46888999999765443332 2346999999998 999999999998888 8999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
|||||+. +|+++++.+ ...+++..++.|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+|+..
T Consensus 88 VfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 9999976 999999887 57999999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCcceeecccccccccccccc-cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccc-----
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN----- 413 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~----- 413 (521)
..... .|..+.|.+|.|||++ ..+.|+.+.|+|++|||++|+.+-+.-|.+....+....+. .++....
T Consensus 161 ~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc---~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 161 RSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKIC---EVLGTPDKDSWP 235 (538)
T ss_pred ccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHH---HHhCCCccccch
Confidence 55444 3567889999999976 66789999999999999999999999886554322211111 0000000
Q ss_pred ----c---ccCCCcccCCC----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 414 ----A---EGVLDPRLQEK----PCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 414 ----~---~~~~d~~l~~~----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
. ..+.-|..... ..+....+++.++.+|+++||.+|||+.|.+++-
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 0 00111111111 1122556677799999999999999999998654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=351.12 Aligned_cols=254 Identities=27% Similarity=0.413 Sum_probs=201.6
Q ss_pred CccccceEccCCcEEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC--eeeEEEEe
Q 009979 187 GFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA--HRMLVYEY 263 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~--~~~lV~e~ 263 (521)
+|...+.||+|+||.||++.+.+ |...|||.+........+.+..|+.+|++++|||||+++|...... .++++|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 57778999999999999999754 8889999987654444677899999999999999999999754444 68899999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-CCCceEeecccceecCC-
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAKLLGA- 341 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~-~~~vkL~DFGla~~~~~- 341 (521)
+++|+|.+++.... ..+++..+..+..|+++||+|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 98 ~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 98 APGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred cCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 99999999998873 2799999999999999999999999 9999999999999999 79999999999987653
Q ss_pred -CCcceeecccccccccccccccCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 342 -ERSYVTTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 342 -~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
..........||+.|||||++..+. ...++|||||||++.||+||+.||... ....+++-...... .-
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~-----~~ 241 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED-----SL 241 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC-----CC
Confidence 2222234578999999999998643 345999999999999999999999643 11222222222221 11
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
|.+... .+.. +.+++.+|+..||++|||+.+++.+.-
T Consensus 242 P~ip~~-ls~~---a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 242 PEIPDS-LSDE---AKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CCCCcc-cCHH---HHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 222222 2333 444777999999999999999986553
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=364.85 Aligned_cols=251 Identities=27% Similarity=0.432 Sum_probs=212.6
Q ss_pred cCCCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
....|....+||+|+.|.||.|.. .+++.||||++........+-+.+|+.+|+..+|+|||++++.|...+.+++|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 345788889999999999999984 4688899999988777777888999999999999999999999998899999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
||+||+|.+.+... .+++.++..|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+...
T Consensus 351 ym~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred ecCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 99999999998765 589999999999999999999999 9999999999999999999999999999987655
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
.. ...+.+|||+|||||+.....|++|.||||||+|++||+-|..||-..++ +..+.....++. |.+
T Consensus 423 ~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P------lrAlyLIa~ng~------P~l 489 (550)
T KOG0578|consen 423 QS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYLIATNGT------PKL 489 (550)
T ss_pred cC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh------HHHHHHHhhcCC------CCc
Confidence 44 45667899999999999999999999999999999999999999965433 233333333322 122
Q ss_pred CC-CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 423 QE-KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 423 ~~-~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
+. .-.+..+++ ++.+||..|+++||++.|+|++
T Consensus 490 k~~~klS~~~kd---FL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 KNPEKLSPELKD---FLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCccccCHHHHH---HHHHHhhcchhcCCCHHHHhcC
Confidence 21 113344455 6669999999999999999853
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=362.77 Aligned_cols=264 Identities=27% Similarity=0.417 Sum_probs=205.3
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcC-CCCCeeeEEEEEe
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLGYCA 252 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~ 252 (521)
++++.++|++.++||+|+||.||+|.+. ++..||+|++..... .....+..|+.++..+ +||||++++++|.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 3567789999999999999999999742 245799999875432 3346788999999999 8999999999887
Q ss_pred eCC-eeeEEEEeccCCchHHhhhcCCCC----------------------------------------------------
Q 009979 253 EGA-HRMLVYEYIDNGNLEQWLHGDVGP---------------------------------------------------- 279 (521)
Q Consensus 253 ~~~-~~~lV~e~~~~g~L~~~l~~~~~~---------------------------------------------------- 279 (521)
... ..++||||+++|+|.++++.....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 644 578999999999999999753210
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce-eecccc
Q 009979 280 ------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMG 352 (521)
Q Consensus 280 ------~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~g 352 (521)
..++++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......... .....+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 23578889999999999999999998 99999999999999999999999999998653322221 223456
Q ss_pred cccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHH
Q 009979 353 TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRAL 431 (521)
Q Consensus 353 t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 431 (521)
++.|+|||++.+..++.++|||||||+||||++ |..||....... .+......... ... ...++.
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~-----~~~-~~~~~~-- 304 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTR-----MRA-PENATP-- 304 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCC-----CCC-CCCCCH--
Confidence 788999999999999999999999999999997 999997543211 11111111111 111 111233
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 432 KRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 432 ~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.+.+++.+||+.||++|||+.++++.|+..
T Consensus 305 -~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 305 -EIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred -HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 345588899999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=332.83 Aligned_cols=237 Identities=25% Similarity=0.375 Sum_probs=199.5
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
.++|+..+.||.|+||.|.+++.+ ++..+|+|.+.+..- ...+...+|..+|+.+.||+++++++.|.+..++|||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 347888999999999999999965 578899999976533 3345677899999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||++||.|+.+|++. +++++..++.++.||+.||+|||+. +|++|||||+|||||.+|++||+|||+|+...
T Consensus 123 meyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 9999999999999986 6899999999999999999999999 99999999999999999999999999999864
Q ss_pred CCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
.. +-+.||||.|+|||++....|+.++|+|+|||++|||+.|..||....+ .....+.+... +
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~iY~KI~~~~----v--- 258 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQIYEKILEGK----V--- 258 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HHHHHHHHhCc----c---
Confidence 33 5568999999999999999999999999999999999999999976654 23333333211 1
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCC
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKR 449 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~R 449 (521)
.++.. ....++ +|+...++.|-.+|
T Consensus 259 ~fP~~-fs~~~k---dLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 KFPSY-FSSDAK---DLLKKLLQVDLTKR 283 (355)
T ss_pred cCCcc-cCHHHH---HHHHHHHhhhhHhh
Confidence 11111 223333 47778888998888
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=342.88 Aligned_cols=263 Identities=24% Similarity=0.335 Sum_probs=209.4
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
...+.|++.++||.|..++||+|++. .+..||||++.-. .....+.+..|+..|+.++||||++++..|..+..+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 45568999999999999999999954 6789999999543 333368899999999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|.||.+|++.++++... ...+.+..+..|+.++++||.|||.+ |.||||||+.||||+.+|.|||+|||.+-.+.
T Consensus 103 mpfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred ehhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999998874 34589999999999999999999999 99999999999999999999999999987764
Q ss_pred CCCccee---eccccccccccccccc--CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 341 AERSYVT---TRVMGTFGYVAPEYAS--TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 341 ~~~~~~~---~~~~gt~~y~aPE~~~--~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
....... ..++||++|||||++. ...|+.|+||||||++..||.+|..||....+ .+.+..-+.+.- .
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP------mkvLl~tLqn~p-p 250 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP------MKVLLLTLQNDP-P 250 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh------HHHHHHHhcCCC-C
Confidence 4332221 4578999999999953 35699999999999999999999999975543 222222222111 1
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
...-..+..+......+.+.+++..||+.||++|||++++++
T Consensus 251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 011001111112233345666888999999999999999974
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=361.01 Aligned_cols=265 Identities=29% Similarity=0.437 Sum_probs=213.5
Q ss_pred chhhhhhcCCCccccceEccCCcEEEEEEEEcC--C--cE-EEEEEecc---CChhhHHHHHHHHHHHhcCCCCCeeeEE
Q 009979 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLED--N--TN-VAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKNLVRLL 248 (521)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~Ei~~l~~l~hpniv~l~ 248 (521)
....|++..++..+.++||+|+||.||+|.+.. + .. ||||..+. .......+|..|+++|++++|||||+|+
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 355578888899999999999999999999653 2 23 89998874 2356668899999999999999999999
Q ss_pred EEEeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCc
Q 009979 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328 (521)
Q Consensus 249 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~v 328 (521)
|++.....+|+|||+|.||+|.++|++.. ..++..+++.++.+.|.||+|||++ ++|||||..+|+|++.++.+
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~v 301 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVV 301 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeE
Confidence 99999999999999999999999999873 3699999999999999999999999 99999999999999999999
Q ss_pred eEeecccceecCCCCcceeec--ccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHH
Q 009979 329 KLSDFGLAKLLGAERSYVTTR--VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWL 405 (521)
Q Consensus 329 kL~DFGla~~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~ 405 (521)
||+|||+++.-. .+.... ..-...|+|||.+..+.|+.++|||||||++||+++ |..||.... ..+..
T Consensus 302 KISDFGLs~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~------~~~v~ 372 (474)
T KOG0194|consen 302 KISDFGLSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK------NYEVK 372 (474)
T ss_pred EeCccccccCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC------HHHHH
Confidence 999999998532 222221 124679999999999999999999999999999999 888986443 22222
Q ss_pred HHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 009979 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 465 (521)
Q Consensus 406 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 465 (521)
.....++... . .+...+.. +..++.+||..||++||+|.++.+.|+.....
T Consensus 373 ~kI~~~~~r~-----~-~~~~~p~~---~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 373 AKIVKNGYRM-----P-IPSKTPKE---LAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred HHHHhcCccC-----C-CCCCCHHH---HHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 2222222110 0 11123334 44477799999999999999999999875543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=319.48 Aligned_cols=264 Identities=22% Similarity=0.309 Sum_probs=206.2
Q ss_pred CCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
.+|...++||+|.||.||+|++ .+|+.||||+++.... .......+||++|+.++|+||+.++++|-..+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999995 4799999999975422 223456779999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
||+. +|+..++.. ...++...+..++.++++||+|||++ .|+||||||.|+||+.+|.+||+|||+++.++..
T Consensus 82 fm~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9986 999999876 57889999999999999999999999 9999999999999999999999999999998765
Q ss_pred CcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccc---c---c
Q 009979 343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN---A---E 415 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~---~ 415 (521)
...... .+-|.+|.|||.+.+ ..|+...|+||.||++.||+-|.+-|.+...- .++...+. ...... + .
T Consensus 155 ~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi--dQL~~If~-~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 155 NRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI--DQLSKIFR-ALGTPTPDQWPEMT 230 (318)
T ss_pred Cccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH--HHHHHHHH-HcCCCCcccCcccc
Confidence 444333 367999999998866 56999999999999999999987766543211 11111111 111000 0 0
Q ss_pred cCCC--------cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 416 GVLD--------PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 416 ~~~d--------~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
.+-| +.......+.+..++++++..+|..||.+|.++.|++++=-
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 0000 00001123445566788999999999999999999986543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=343.93 Aligned_cols=265 Identities=25% Similarity=0.441 Sum_probs=204.0
Q ss_pred cCCCccccceEccCCcEEEEEEEEcC-----------------CcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCee
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLED-----------------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLV 245 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv 245 (521)
..++|.+.++||+|+||.||+|.+.+ +..||+|.+.... .....+|.+|++++.+++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 45688999999999999999998542 2369999887643 33456789999999999999999
Q ss_pred eEEEEEeeCCeeeEEEEeccCCchHHhhhcCC---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 009979 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDV---------------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310 (521)
Q Consensus 246 ~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~---------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~i 310 (521)
++++++.+....++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+. +|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence 99999999999999999999999999986532 1123578889999999999999999998 99
Q ss_pred eecCCCCCCeEeCCCCCceEeecccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh--CC
Q 009979 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GR 387 (521)
Q Consensus 311 iHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt--G~ 387 (521)
+||||||+|||++.++.+||+|||+++.+...... ......++..|+|||++.++.++.++|||||||++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 99999999999999999999999999865433222 2233456889999999988899999999999999999987 55
Q ss_pred CCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 388 NPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 388 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
.||..... ....+............. .. .....++.. +.+++.+||+.||++|||+.+|.+.|+
T Consensus 240 ~p~~~~~~---~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~---~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTD---EQVIENAGEFFRDQGRQV--YL-FRPPPCPQG---LYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCH---HHHHHHHHHHhhhccccc--cc-cCCCCCCHH---HHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 67754332 122222222221111000 00 011224444 445888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=354.58 Aligned_cols=246 Identities=29% Similarity=0.426 Sum_probs=208.2
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh--hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ--AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
++|.+.+.||+|.||.||+|+.+ +.+.||+|.+.+.... ..+.+.+|+++++.++|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57899999999999999999965 5777899988765332 34668899999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+.| +|+.+|... ..++++.+..++.+++.||.|||+. +|+|||+||.|||++.++.+|+||||+|+.+..
T Consensus 82 ~a~g-~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD----GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9976 999999875 6899999999999999999999999 999999999999999999999999999998755
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
+....+.+.|||.|||||+..+..|+..+|+||+||++||+++|++||... ...+.++....+ +-
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d--------~v- 217 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKD--------PV- 217 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcC--------CC-
Confidence 344567789999999999999999999999999999999999999999522 233333333221 11
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.+.+.....+..++...|.+||.+|-+-.+++.
T Consensus 218 --~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 --KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred --CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 122344455666778999999999999988864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=365.06 Aligned_cols=258 Identities=30% Similarity=0.518 Sum_probs=214.3
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcC----CcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLED----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 256 (521)
++......+.++||.|-||+||+|.++- ...||||.++..-. ....+|..|+.+|.++.||||++|.|+......
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 4555677889999999999999999752 34589999986533 345789999999999999999999999999999
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.+||.|||++|+|..||+.+. +.+++.+..-++.+||.|+.||-+. ++|||||..+|||++.+..+|++|||++
T Consensus 705 vMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccce
Confidence 999999999999999999873 5689999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCcceeecccc--cccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccc
Q 009979 337 KLLGAERSYVTTRVMG--TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (521)
+.+.++.....+..-| ...|.|||.+....++.+||||||||||||.++ |..||-+.... +.++.....-
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ------dVIkaIe~gy- 851 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ------DVIKAIEQGY- 851 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH------HHHHHHHhcc-
Confidence 9886655333333334 469999999999999999999999999999998 99998655432 2222222211
Q ss_pred cccCCCcccC-CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 414 AEGVLDPRLQ-EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 414 ~~~~~d~~l~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
++. +-.|+..+.+ ||+.||++|-.+||++.+|+..|...
T Consensus 852 -------RLPpPmDCP~aL~q---LMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 852 -------RLPPPMDCPAALYQ---LMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred -------CCCCCCCCcHHHHH---HHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 121 1235555555 88899999999999999999999764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=380.49 Aligned_cols=262 Identities=29% Similarity=0.509 Sum_probs=216.1
Q ss_pred hcCCCccccceEccCCcEEEEEEEEcC--Cc----EEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLED--NT----NVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 255 (521)
+.....++.+.||+|+||.||.|.+.+ +. .||||.+.+. +.+...+|..|..+|+.++|||||+++|+|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 446677888999999999999999653 33 4899999765 4556688999999999999999999999999999
Q ss_pred eeeEEEEeccCCchHHhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEee
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~D 332 (521)
..+|++|||++|||..||++.+. ....++....+.++.|||+|+.||+++ ++|||||..+|+||++...|||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence 99999999999999999987632 246789999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCcceeecc-cccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhh
Q 009979 333 FGLAKLLGAERSYVTTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVT 410 (521)
Q Consensus 333 FGla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (521)
||+|+.+.....+..... +-...|||||.+..+.++.|+|||||||+|||++| |..||...+. .+.+.....
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n------~~v~~~~~~ 919 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN------FEVLLDVLE 919 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch------HHHHHHHHh
Confidence 999996544444443332 34569999999999999999999999999999999 9999964432 233333333
Q ss_pred ccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 411 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
.++ ++ ++..|++.+.+ +|..||+.+|++||++..|++.+....
T Consensus 920 ggR----L~---~P~~CP~~ly~---lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 920 GGR----LD---PPSYCPEKLYQ---LMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred CCc----cC---CCCCCChHHHH---HHHHHccCChhhCccHHHHHhhhhhhh
Confidence 331 11 34457766654 888999999999999999999777644
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=347.03 Aligned_cols=248 Identities=24% Similarity=0.394 Sum_probs=192.8
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
++|+..+.||+|+||.||+|.+. +++.||||.+..... .....+.+|+++++.++|+||+++++++......++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45677889999999999999965 688999999865433 3346788999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++|+|.+. ....+..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.+....
T Consensus 154 ~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 999998653 2345677889999999999999998 99999999999999999999999999998764322
Q ss_pred cceeecccccccccccccccC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCC
Q 009979 344 SYVTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (521)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||....... ............
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~------ 292 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAICMSQ------ 292 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhccC------
Confidence 12234579999999998743 334568999999999999999999997433221 111111111100
Q ss_pred CcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 419 d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+.. ....+ .++.+++.+||+.||++||++.|++++
T Consensus 293 ~~~~-~~~~~---~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 PPEA-PATAS---REFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCC-CCccC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011 11122 345558889999999999999999853
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=338.22 Aligned_cols=245 Identities=19% Similarity=0.386 Sum_probs=197.6
Q ss_pred ceEccCCcEEEEEEEEcCCcEEEEEEeccCChhh---HHHHHHHHHHHhcCCCCCeeeEEEEEee----CCeeeEEEEec
Q 009979 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQA---EKEFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRMLVYEYI 264 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~Ei~~l~~l~hpniv~l~~~~~~----~~~~~lV~e~~ 264 (521)
..||+|++|.||+|.+ +|+.||||.+....... .+.+.+|+.+|++++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 58899999987543322 4678899999999999999999999876 34678999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~ 344 (521)
++|+|.+++... ..+++.....++.+++.||.|||+.. +++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999999765 46888999999999999999999732 78899999999999999999999999998653321
Q ss_pred ceeecccccccccccccccC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 345 YVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
....||..|+|||++.+ ..++.++|||||||++|||++|+.||..... .+.......... .+.+
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~------~~~~~~i~~~~~-----~~~~ 243 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT------KEIYDLIINKNN-----SLKL 243 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCC-----CCCC
Confidence 23468999999999976 6899999999999999999999999974431 222222222111 1111
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
. ..++..+. +++.+||+.||++|||+.++++.|+..
T Consensus 244 ~-~~~~~~l~---~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 244 P-LDCPLEIK---CIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred C-CcCcHHHH---HHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1 12444444 477899999999999999999999753
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=355.21 Aligned_cols=246 Identities=25% Similarity=0.358 Sum_probs=203.0
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCC
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGA 255 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~ 255 (521)
..+..++|.+.++||+|.||.|+++..+ +++.||||.+++.. .+..+..+.|.+++.... ||.+++++..|+..+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 3456679999999999999999999976 57789999998763 345567788988888775 999999999999999
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
++|+||||+.||++..+.+. ..+++..+..++..++.||.|||++ +|||||||.+|||||.+|++||+|||+
T Consensus 443 ~l~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred eEEEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccc
Confidence 99999999999996555443 4799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
++..- .....+.++||||.|||||++.+..|+.++|+|||||+|||||.|..||.+.+.. .+.+ ..+.
T Consensus 515 cKe~m-~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---e~Fd---sI~~----- 582 (694)
T KOG0694|consen 515 CKEGM-GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---EVFD---SIVN----- 582 (694)
T ss_pred ccccC-CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHH---HHhc-----
Confidence 99643 2334567899999999999999999999999999999999999999999755432 2222 2211
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCH
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM 452 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~ 452 (521)
.|+.+. ... ..+++.++.++|..||++|.-+
T Consensus 583 --d~~~yP-~~l---s~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 --DEVRYP-RFL---SKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --CCCCCC-Ccc---cHHHHHHHHHHhccCcccccCC
Confidence 111111 122 3445558889999999999876
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=336.83 Aligned_cols=252 Identities=24% Similarity=0.297 Sum_probs=200.2
Q ss_pred CccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 187 GFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
.|+..+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999996 4688999998865322 223457789999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 999999998886432 34688999999999999999999998 9999999999999999999999999999875332
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
. ......||..|+|||++.+..++.++|||||||++|||++|+.||........ .+.+........ ..+
T Consensus 156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~------~~~ 224 (285)
T cd05631 156 E--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKEDQ------EEY 224 (285)
T ss_pred C--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhccc------ccC
Confidence 2 22345799999999999999999999999999999999999999975443211 111111111100 011
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRPK-----MGHVIHM 458 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~ 458 (521)
... .+ ..+.+|+.+||+.||.+||+ +.+++++
T Consensus 225 ~~~-~s---~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 225 SEK-FS---EDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred Ccc-CC---HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 111 22 34455888999999999997 7888754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=338.43 Aligned_cols=257 Identities=26% Similarity=0.428 Sum_probs=204.0
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc----CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
+..++|++.+.||+|+||.||+|.++ .+..||+|.+..... .....+..|+.+++.++||||+++++++..+...
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 34567899999999999999999853 356799998876532 3346788999999999999999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+|||++.++.+|++|||.+.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 9999999999999999764 24689999999999999999999998 99999999999999999999999999876
Q ss_pred ecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
..............++..|+|||.+.+..++.++|||||||++||+++ |..||..... .+.++... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~------~~~~~~~~-~~~--- 225 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG------QDVIKAVE-DGF--- 225 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHHHH-CCC---
Confidence 543222222222345678999999999999999999999999999875 9999964432 12222221 110
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
..+ . ...++.. +.+++.+||+.+|.+||++.+|++.|..
T Consensus 226 -~~~-~-~~~~~~~---~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 226 -RLP-A-PRNCPNL---LHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred -CCC-C-CCCCCHH---HHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 001 1 1123333 4448889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=345.63 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=210.3
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
...|+..+.||+|.||.||+|.+. .++.||+|++.-. ..+..+++..|+.+|.+++++||.++++.+..+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 346777899999999999999965 5788999998543 34456889999999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
||.||++.++|... ..+.+..+.-++.++..||.|||.. +.+|||||+.|||+..+|.|||+|||++-.+...
T Consensus 92 y~~gGsv~~lL~~~----~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSG----NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HhcCcchhhhhccC----CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence 99999999999754 4457788888999999999999999 9999999999999999999999999999887554
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
.... .+++|||.|||||++....|+.|+||||||++.+||.+|.+|+....|..... .+..-..|.+
T Consensus 165 ~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf------------lIpk~~PP~L 231 (467)
T KOG0201|consen 165 VKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF------------LIPKSAPPRL 231 (467)
T ss_pred hhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE------------eccCCCCCcc
Confidence 4433 67899999999999998899999999999999999999999998766521111 1123334455
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.. .++..+++ ++..||+.||+.||++.+++++
T Consensus 232 ~~-~~S~~~kE---FV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 232 DG-DFSPPFKE---FVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cc-ccCHHHHH---HHHHHhhcCcccCcCHHHHhhh
Confidence 54 35556666 6669999999999999999843
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=354.50 Aligned_cols=262 Identities=26% Similarity=0.429 Sum_probs=205.2
Q ss_pred hhcCCCccccceEccCCcEEEEEEEE------cCCcEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEee
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE 253 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~ 253 (521)
.+..++|++.+.||+|+||.||+|.+ .++..||||++.... ....+.+.+|+.+++.+ +||||++++++|..
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 45566899999999999999999973 235579999986543 23346788899999999 89999999999999
Q ss_pred CCeeeEEEEeccCCchHHhhhcCCC-------------------------------------------------------
Q 009979 254 GAHRMLVYEYIDNGNLEQWLHGDVG------------------------------------------------------- 278 (521)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~------------------------------------------------------- 278 (521)
....++||||+++|+|.++++....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999999975321
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 279 ----------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 279 ----------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
....+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 012578889999999999999999998 9999999999999999999999999999876443
Q ss_pred Ccce-eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 343 RSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 343 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
.... .....++..|+|||++.+..++.++|||||||++|||++ |..||...... ..... .+..... ..
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~----~~~~~~~--~~-- 337 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYK----MIKEGYR--ML-- 337 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHH----HHHhCcc--CC--
Confidence 2221 122345678999999999999999999999999999998 88998643221 11111 1211110 00
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
.....+. ++.+++.+||+.||++||++.+|+++|+.
T Consensus 338 --~~~~~~~---~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 338 --SPECAPS---EMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred --CCCCCCH---HHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1111223 45568889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=332.05 Aligned_cols=258 Identities=24% Similarity=0.442 Sum_probs=208.7
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
.+..++|++.++||+|+||.||+|...++..||+|.+.... ...+.+..|+.+++.++|+||+++++++......++||
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 45567899999999999999999998888889999876543 23567889999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++++|.++++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 81 EYMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred ecCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 9999999999997652 35688889999999999999999998 999999999999999999999999999987644
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
..........++..|+|||++....++.++|||||||++|+|+| |..||..... .+....... .. ..+
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~------~~~~~~~~~-~~----~~~ 224 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN------SDVMSALQR-GY----RMP 224 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH------HHHHHHHHc-CC----CCC
Confidence 33222233446778999999998899999999999999999998 9999964321 111111111 10 011
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
.. ...+ ..+.+++.+||+.+|++||++.++++.|+.
T Consensus 225 ~~--~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 RM--ENCP---DELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CC--CCCC---HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11 1122 335558889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=363.60 Aligned_cols=261 Identities=24% Similarity=0.348 Sum_probs=217.1
Q ss_pred hhhhhcCCCccccceEccCCcEEEEEEEEcCC-cEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCCeeeEEE-EEee--
Q 009979 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDN-TNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLG-YCAE-- 253 (521)
Q Consensus 179 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~-~~~~-- 253 (521)
..+++...++++.+.|.+|||+.||+|.+..+ .+||+|++...+....+.+++||++|+.|+ |+|||.+++ ....
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 34566777889999999999999999998766 999999998888888899999999999997 999999999 3221
Q ss_pred ----CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCce
Q 009979 254 ----GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK 329 (521)
Q Consensus 254 ----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vk 329 (521)
.-+++|.||||.||.|-++++.+.. ..|++.++++|+.++++|+++||.. .++|||||||-+||||+.+++.|
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEE
Confidence 1356899999999999999987743 4499999999999999999999986 78899999999999999999999
Q ss_pred EeecccceecCCCC-c-ceee------cccccccccccccc---cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCc
Q 009979 330 LSDFGLAKLLGAER-S-YVTT------RVMGTFGYVAPEYA---STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE 398 (521)
Q Consensus 330 L~DFGla~~~~~~~-~-~~~~------~~~gt~~y~aPE~~---~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~ 398 (521)
|||||.+.-..... . .... ...-|+.|.|||++ .+...++|+|||+|||+||-|+....||+.....
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-- 264 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-- 264 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--
Confidence 99999997432211 0 0000 12248999999976 6788999999999999999999999999755322
Q ss_pred ccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 399 VNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
.+++..+...+.+.....+..||..||+.||.+||++.+|++.+-.
T Consensus 265 -----------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 265 -----------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred -----------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 3455555555567777788889999999999999999999877754
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=335.12 Aligned_cols=249 Identities=22% Similarity=0.364 Sum_probs=208.8
Q ss_pred CCCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCChhh---HHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQA---EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
..+|++.+.||+|.||.|-+|.. ..|+.||||.+.++.... .-.+.+||++|..|+||||+.++.+|++.+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 34899999999999999999994 679999999998765443 34577899999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||..+|.|++|+.+. +.+++..+..++.||+.|+.|+|.+ +++|||||.+|||+|.++++||+|||++.++.
T Consensus 132 MEYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 9999999999999876 6899999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCcceeecccccccccccccccCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
.. ...+++||+|-|.+||++++..|. +..|-|||||+||.|+.|..||++.+. ..++ +++..+ ...+
T Consensus 205 ~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lv----rQIs~G---aYrE 272 (668)
T KOG0611|consen 205 DK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLV----RQISRG---AYRE 272 (668)
T ss_pred cc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHH----HHhhcc---cccC
Confidence 43 345678999999999999998875 689999999999999999999986542 1222 222222 2222
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
|.- +. .+--||..||-.||++|.|+.+|..+..
T Consensus 273 P~~-----PS---dA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 273 PET-----PS---DASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred CCC-----Cc---hHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 211 11 1222788999999999999999987653
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=337.44 Aligned_cols=265 Identities=22% Similarity=0.285 Sum_probs=201.0
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
++|++.+.||+|+||.||+|++. ++..||+|++.... ....+.+..|+++++.++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999976 57789999986542 2234667889999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|++++.+..+... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9998766655432 24688999999999999999999998 9999999999999999999999999999876443
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHH---------HHHHHhhccc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVE---------WLKTMVTNRN 413 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~---------~~~~~~~~~~ 413 (521)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||............. ..+.......
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 3333344678999999999998899999999999999999999999997543211110000 0010011100
Q ss_pred cccCCCcccCCCc------cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 414 AEGVLDPRLQEKP------CSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 414 ~~~~~d~~l~~~~------~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
......+...... .......+.+++.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000001000000 0012234667899999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=331.24 Aligned_cols=252 Identities=23% Similarity=0.430 Sum_probs=203.6
Q ss_pred CCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEecc
Q 009979 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (521)
++|++.+.||+|+||.||++.++++..+|+|.+.... .....+..|+++++.++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4688899999999999999998888889999876433 234678889999999999999999999999999999999999
Q ss_pred CCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcc
Q 009979 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (521)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~ 345 (521)
+|+|.++++... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 999999997642 3688999999999999999999998 9999999999999999999999999999865433222
Q ss_pred eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCC
Q 009979 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (521)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 424 (521)
......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+.+........ ...+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~------~~~~~~i~~~~~---~~~~~--- 224 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN------YEVVEMISRGFR---LYRPK--- 224 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHCCCC---CCCCC---
Confidence 2223345678999999988889999999999999999999 8999964332 222222221111 11111
Q ss_pred CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 425 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
..+ ..+.+++.+||+.+|++||++.++++.|.
T Consensus 225 -~~~---~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 -LAS---MTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -CCC---HHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 122 34556888999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=343.47 Aligned_cols=202 Identities=25% Similarity=0.389 Sum_probs=177.3
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
+..++|++.+.||+|+||.||++.+. ++..||+|.+.... ......+.+|+++|+.++||||+++++++..+...++|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 34578999999999999999999976 57788999886542 33446789999999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++....
T Consensus 82 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 82 MEHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred eecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 9999999999999764 46889999999999999999999752 69999999999999999999999999998653
Q ss_pred CCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~ 393 (521)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 156 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred cc---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 22 223457999999999999999999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=343.66 Aligned_cols=255 Identities=22% Similarity=0.301 Sum_probs=204.2
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+..|++++..++||||+++++++.+....||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999976 57899999986542 233456888999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 999999999999754 4688999999999999999999998 999999999999999999999999999986533
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.......... .+..+.
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~~~--~~~~~~ 221 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN------ETWENLKYWKE--TLQRPV 221 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH------HHHHHHHhccc--cccCCC
Confidence 234467999999999999999999999999999999999999999754321 11111111000 011111
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
.. .+......++.+++.+||..+|.+||++.+++.+--
T Consensus 222 ~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 222 YD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred CC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence 11 000112334555888999999999999999987643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=332.41 Aligned_cols=258 Identities=27% Similarity=0.456 Sum_probs=208.0
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++..++|++.+.||+|+||.||+|.+.+++.||+|.+.... ...+++..|++++++++||||+++++++......++||
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 45677899999999999999999998778889999986543 33567889999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 81 ELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred ecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999999997652 35689999999999999999999998 999999999999999999999999999987753
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
..........++..|+|||++.+..++.++||||||+++|||+| |+.||..... .+.......... . +
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~~~~~~~----~-~ 224 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN------AEVLQQVDQGYR----M-P 224 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCCC----C-C
Confidence 22221122223458999999999999999999999999999999 9999964321 111111111100 0 0
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
. ....+ ..+.+++.+||+.+|++||++.++++.|+.
T Consensus 225 -~-~~~~~---~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 225 -C-PPGCP---KELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -C-CCcCC---HHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0 11122 345558889999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=346.85 Aligned_cols=247 Identities=20% Similarity=0.299 Sum_probs=201.3
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
.++|++.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+..|+.+++.++||||+++++++.++...|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 357899999999999999999975 57889999986532 22345688899999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 97 LEFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EcCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 9999999999999764 4688899999999999999999998 99999999999999999999999999998764
Q ss_pred CCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....+ .+....... ...
T Consensus 170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~-~~~------ 232 (329)
T PTZ00263 170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIYEKILA-GRL------ 232 (329)
T ss_pred CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHHHHHHhc-CCc------
Confidence 322 235799999999999999999999999999999999999999964321 222222221 110
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHh
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPK-----MGHVIHML 459 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~L 459 (521)
.+.. ..+. ++.+++.+||+.||.+||+ +.+++.+-
T Consensus 233 ~~p~-~~~~---~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 233 KFPN-WFDG---RARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred CCCC-CCCH---HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 1111 1222 3445888999999999997 67777553
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=346.24 Aligned_cols=242 Identities=22% Similarity=0.273 Sum_probs=195.5
Q ss_pred ceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCC
Q 009979 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 267 (521)
+.||+|+||.||+|... +++.||+|++.... ......+..|+++++.++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 68889999986532 223356778999999999999999999999999999999999999
Q ss_pred chHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCccee
Q 009979 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347 (521)
Q Consensus 268 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 347 (521)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~ 152 (323)
T cd05571 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcc
Confidence 999998764 5789999999999999999999998 9999999999999999999999999999753222 1223
Q ss_pred ecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCcc
Q 009979 348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPC 427 (521)
Q Consensus 348 ~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 427 (521)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .......... . ..+... .
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~~~~~-~------~~~p~~-~ 218 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILME-E------IRFPRT-L 218 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH------HHHHHHHHcC-C------CCCCCC-C
Confidence 346799999999999999999999999999999999999999964321 1112222111 1 111111 2
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 009979 428 SRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (521)
Q Consensus 428 ~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~ 458 (521)
+ ..+.+++.+||+.||++|| ++.+++++
T Consensus 219 ~---~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 219 S---PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred C---HHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 2 3345588899999999999 79988754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=340.31 Aligned_cols=246 Identities=24% Similarity=0.302 Sum_probs=201.2
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999975 58889999986432 223456888999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 999999999999765 4688999999999999999999998 999999999999999999999999999986533
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... ..
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~------~~~~~~~i~~~~-------~~ 216 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN------PFGIYEKILAGK-------LE 216 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCC-------cC
Confidence 2 223579999999999999999999999999999999999999996432 222222222211 01
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHh
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPK-----MGHVIHML 459 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~L 459 (521)
+... .+ ..+.+++.+||+.||.+||+ +.+++++-
T Consensus 217 ~~~~-~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 217 FPRH-LD---LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred CCcc-CC---HHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 1111 12 23445888999999999995 88887554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=350.11 Aligned_cols=247 Identities=25% Similarity=0.364 Sum_probs=204.1
Q ss_pred CccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 187 GFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
-|++++.||.|+-|.|-+|++ .+|+.+|||++.+.. ......+.+||-+|+-+.|||++++++++++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 467789999999999999995 479999999996652 2223567889999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+++|.|+++|... +++++..+.+++.||+.|+.|+|.. +|+|||+||+|+|||.++++||+|||+|.+-..
T Consensus 93 yv~gGELFdylv~k----G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~- 164 (786)
T KOG0588|consen 93 YVPGGELFDYLVRK----GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP- 164 (786)
T ss_pred ecCCchhHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC-
Confidence 99999999999876 7899999999999999999999998 999999999999999999999999999987433
Q ss_pred CcceeecccccccccccccccCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
.....+.||.|.|.|||++.+..|. .++||||+|||||.||||++||++. |+-..+.++. .+.. +
T Consensus 165 -gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------Nir~LLlKV~-~G~f----~-- 230 (786)
T KOG0588|consen 165 -GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------NIRVLLLKVQ-RGVF----E-- 230 (786)
T ss_pred -CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------cHHHHHHHHH-cCcc----c--
Confidence 2334567999999999999998764 6899999999999999999999732 3332222222 2211 1
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
+. ...+.+ +.+|+.+|++.||++|-|++||+++.
T Consensus 231 MP-s~Is~e---aQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 231 MP-SNISSE---AQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred CC-CcCCHH---HHHHHHHHhccCccccccHHHHhhCc
Confidence 11 112333 44477799999999999999998764
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=351.45 Aligned_cols=262 Identities=24% Similarity=0.410 Sum_probs=204.5
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEee
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE 253 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~ 253 (521)
....++|.+.+.||+|+||.||+|++. ++..||+|.+.... ......+..|+++++.+ +|+||++++++|..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 455668999999999999999998842 23479999987543 33346688899999999 89999999999999
Q ss_pred CCeeeEEEEeccCCchHHhhhcCCC-------------------------------------------------------
Q 009979 254 GAHRMLVYEYIDNGNLEQWLHGDVG------------------------------------------------------- 278 (521)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~------------------------------------------------------- 278 (521)
....++||||+++|+|.++++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999999864311
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce-
Q 009979 279 -----------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV- 346 (521)
Q Consensus 279 -----------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~- 346 (521)
...++++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 123578889999999999999999998 99999999999999999999999999998654332221
Q ss_pred eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCC
Q 009979 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 425 (521)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||....... . +........ .+... .
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~----~~~~~~~~~-----~~~~~-~ 338 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K----FYKMVKRGY-----QMSRP-D 338 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H----HHHHHHccc-----CccCC-C
Confidence 122345678999999998999999999999999999998 999996543211 1 111111110 11111 1
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 426 PCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 426 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
..+ .++.+++.+||+.||++||++.+|+++|+.
T Consensus 339 ~~~---~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 339 FAP---PEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred CCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 122 344558889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=357.14 Aligned_cols=252 Identities=21% Similarity=0.320 Sum_probs=205.0
Q ss_pred CccccceEccCCcEEEEEEEEc-C-CcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-D-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
.|.+.+.||+|+||.||+|... + +..||+|.+..........+..|+.+++.++||||+++++++..++..||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999854 3 5678888876655555567888999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~ 344 (521)
++|+|.++++.......++++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999998876443456789999999999999999999998 999999999999999999999999999997644322
Q ss_pred -ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 345 -YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 345 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+....... .++ +
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~------~~~~~~~~~~~~-----~~~-~- 291 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS------QREIMQQVLYGK-----YDP-F- 291 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCC-----CCC-C-
Confidence 22345679999999999999999999999999999999999999996432 222223222211 111 1
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
....+ ..+.+++.+||+.||++||++.+++.
T Consensus 292 ~~~~s---~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 PCPVS---SGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CccCC---HHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11122 34555888999999999999999874
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=333.23 Aligned_cols=257 Identities=28% Similarity=0.502 Sum_probs=211.1
Q ss_pred hcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
.+..+|++.++||.|+||.||+|.+.++..+|+|.+..........+..|+.+++.++|+||+++++++.+....++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 45567999999999999999999988888999999877666566788999999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+++++|.++++... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 999999999998653 35689999999999999999999998 9999999999999999999999999999876432
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
. .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... .+.+........ ..
T Consensus 158 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~~~------~~ 224 (261)
T cd05148 158 V-YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN------HEVYDQITAGYR------MP 224 (261)
T ss_pred c-ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHHHhCCc------CC
Confidence 2 22223456778999999988899999999999999999998 8999964431 122222221100 01
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
. ...++. .+.+++.+||+.||++|||+.++++.|+.
T Consensus 225 ~-~~~~~~---~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 225 C-PAKCPQ---EIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred C-CCCCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1 112333 34558889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=334.46 Aligned_cols=262 Identities=22% Similarity=0.338 Sum_probs=199.8
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
.++|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 357899999999999999999965 57889999886443 2234567789999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+++ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 84 YLDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 9975 999988754 24578899999999999999999998 9999999999999999999999999999865332
Q ss_pred CcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh-----------
Q 009979 343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT----------- 410 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----------- 410 (521)
.. ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||......... ..+.....
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 157 TK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL---HLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred Cc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHHhhccc
Confidence 21 2234568999999998865 56899999999999999999999999754322111 11111110
Q ss_pred -ccccccCCCcccCCCcc----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 411 -NRNAEGVLDPRLQEKPC----SRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 411 -~~~~~~~~d~~l~~~~~----~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.........+.....+. +....++.+++.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00001111111111110 112234567899999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=382.66 Aligned_cols=258 Identities=29% Similarity=0.556 Sum_probs=211.0
Q ss_pred CccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEecc
Q 009979 187 GFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (521)
.|...++||+|+||.||+|.. .++..||||++....... ..|++.+++++|||||+++|+|.+....|+||||++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 466678999999999999996 478899999886543222 246889999999999999999999999999999999
Q ss_pred CCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcc
Q 009979 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (521)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~ 345 (521)
+|+|.++++ .++|..+..++.|++.||+|||..+.++|+||||||+||+++.++..++. ||.......
T Consensus 767 ~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 767 GKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred CCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 999999995 37899999999999999999996656699999999999999999888876 666543321
Q ss_pred eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCC
Q 009979 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425 (521)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 425 (521)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||+... .......+|.+...........+|+.+...
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 122368999999999999999999999999999999999999995432 234556677666555444555666665432
Q ss_pred --ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 426 --PCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 426 --~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.......++.+++.+||+.||++||+|.||++.|+..
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 2345666788899999999999999999999999864
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=343.78 Aligned_cols=249 Identities=21% Similarity=0.301 Sum_probs=202.0
Q ss_pred hcCCCccccceEccCCcEEEEEEEEcC--CcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLED--NTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
+..++|++.+.||+|+||.||+|.+.+ +..||+|.+.... ....+.+..|+++++.++||||+++++++.++...
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 345689999999999999999998643 3579999886432 23345688899999999999999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+.+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~ 179 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAK 179 (340)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence 9999999999999999765 4688999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+ ....+..... ..
T Consensus 180 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~~~~~i~~~-~~--- 245 (340)
T PTZ00426 180 VVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP------LLIYQKILEG-II--- 245 (340)
T ss_pred ecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH------HHHHHHHhcC-CC---
Confidence 75332 2345799999999999988899999999999999999999999974432 1112222211 10
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHML 459 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L 459 (521)
.+.. ..+. .+.+++.+||+.||++|+ ++++++++-
T Consensus 246 ---~~p~-~~~~---~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 246 ---YFPK-FLDN---NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred ---CCCC-CCCH---HHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 1111 1222 344588899999999995 899987653
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=333.74 Aligned_cols=256 Identities=24% Similarity=0.324 Sum_probs=201.0
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--------------hhhHHHHHHHHHHHhcCCCCCeee
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--------------GQAEKEFKVEVEAIGRVRHKNLVR 246 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~~Ei~~l~~l~hpniv~ 246 (521)
....+.|++.+.||+|.||.|-+|+.. +++.||||++.+.. ....+.+.+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345678999999999999999999954 68899999995431 112357889999999999999999
Q ss_pred EEEEEeeC--CeeeEEEEeccCCchHHhhhcCCCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC
Q 009979 247 LLGYCAEG--AHRMLVYEYIDNGNLEQWLHGDVGPHSP-LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD 323 (521)
Q Consensus 247 l~~~~~~~--~~~~lV~e~~~~g~L~~~l~~~~~~~~~-l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~ 323 (521)
|+++..+. +.+|||+|||..|.+...= ...+ +++.++++++.+++.||+|||.+ +||||||||+|+||+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLS 244 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEc
Confidence 99998764 5789999999988876532 2344 99999999999999999999999 999999999999999
Q ss_pred CCCCceEeecccceecCCC----CcceeecccccccccccccccCCC----CCCcccchhHHHHHHHHHhCCCCCCCCCC
Q 009979 324 KQWNPKLSDFGLAKLLGAE----RSYVTTRVMGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRNPVDYSRP 395 (521)
Q Consensus 324 ~~~~vkL~DFGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwS~Gvvl~elltG~~Pf~~~~~ 395 (521)
++|+|||+|||.+...... .........|||.|+|||...++. .+.+.||||+||+||.|+.|+.||-+.
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~-- 322 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD-- 322 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc--
Confidence 9999999999999876221 122233468999999999886632 456889999999999999999999533
Q ss_pred CCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
...+...+.+. ..+.....++.-..+.+||+++|++||++|.+..+|..+..
T Consensus 323 ----~~~~l~~KIvn---------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 323 ----FELELFDKIVN---------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred ----hHHHHHHHHhc---------CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 22333333322 12222222233344556888999999999999999976654
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=339.21 Aligned_cols=243 Identities=23% Similarity=0.274 Sum_probs=195.2
Q ss_pred ceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCC
Q 009979 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 267 (521)
+.||+|+||.||++... ++..||+|.+.... ......+..|+++++.++||||+++++++......|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999964 68899999986542 223456778999999999999999999999999999999999999
Q ss_pred chHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCccee
Q 009979 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347 (521)
Q Consensus 268 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 347 (521)
+|..++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~ 152 (323)
T cd05595 81 ELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcc
Confidence 999988754 4689999999999999999999998 9999999999999999999999999998753222 1222
Q ss_pred ecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCcc
Q 009979 348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPC 427 (521)
Q Consensus 348 ~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 427 (521)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+......... ..+.. ..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~~~~~~-------~~~p~-~~ 218 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEE-------IRFPR-TL 218 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCC-------CCCCC-CC
Confidence 346799999999999999999999999999999999999999964332 11122221111 01111 12
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 009979 428 SRALKRALLVALRCVDPNAHKRP-----KMGHVIHML 459 (521)
Q Consensus 428 ~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L 459 (521)
+. .+.+++.+||+.||++|| ++.+++++-
T Consensus 219 ~~---~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 219 SP---EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred CH---HHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 23 344588899999999998 888887543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=340.77 Aligned_cols=253 Identities=25% Similarity=0.281 Sum_probs=199.2
Q ss_pred CccccceEccCCcEEEEEEEEc----CCcEEEEEEeccCC----hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCee
Q 009979 187 GFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~ 257 (521)
+|++.+.||+|+||.||+++.. ++..||+|.+.+.. ....+.+..|+++++.+ +||||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788999999999999999852 57889999986432 22345678899999999 599999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 9999999999999998764 4688999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCcceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
..............||+.|+|||++.+. .++.++|||||||++|||+||+.||........ ..........
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~------ 225 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSEVSRRILK------ 225 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHHHHHHHhc------
Confidence 6544333333456799999999998765 488999999999999999999999975432211 1111111111
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHML 459 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L 459 (521)
.++.+... .+. .+.+++.+||+.||++|| ++.+++++-
T Consensus 226 -~~~~~~~~-~~~---~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 226 -CDPPFPSF-IGP---EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred -CCCCCCCC-CCH---HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 11112111 223 344578899999999999 677877543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=339.04 Aligned_cols=202 Identities=26% Similarity=0.407 Sum_probs=176.5
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
+..++|++.+.||+|+||.||++.+. ++..+|+|.+.... ......+..|+++++.++||||++++++|.++...++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 34578999999999999999999976 57788999876542 33446788999999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+++|+|.+++... ..+++..+..++.+++.||.|||+.. +|+||||||+|||++.++.+||+|||++....
T Consensus 82 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 82 MEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 9999999999999764 46888999999999999999999742 79999999999999999999999999997653
Q ss_pred CCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~ 393 (521)
.. ......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 156 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 22 123456899999999999889999999999999999999999999744
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=325.98 Aligned_cols=252 Identities=24% Similarity=0.404 Sum_probs=203.2
Q ss_pred CCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEecc
Q 009979 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (521)
++|++.+.||+|+||.||+|.+.++..+|+|.+.... ...+.+..|+.+++.++||||+++++++.+....++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4688899999999999999998777779999886543 234678899999999999999999999998888999999999
Q ss_pred CCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcc
Q 009979 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (521)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~ 345 (521)
+|+|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 999999997652 3689999999999999999999998 9999999999999999999999999999876443322
Q ss_pred eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCC
Q 009979 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (521)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 424 (521)
......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+........ .. . . ..
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~-~~----~-~-~~ 223 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN------SETVEKVSQG-LR----L-Y-RP 223 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHHHhcC-CC----C-C-CC
Confidence 2222345678999999988889999999999999999999 9999864332 1112222111 10 0 0 01
Q ss_pred CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 425 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
... ...+.+++.+||+.||.+||++.+++..|+
T Consensus 224 ~~~---~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLA---SEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCC---CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112 244556888999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=345.80 Aligned_cols=259 Identities=20% Similarity=0.270 Sum_probs=204.4
Q ss_pred hhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC
Q 009979 180 ELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (521)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 255 (521)
..+...++|++.+.||+|+||.||++... ++..||+|.+.+.. ......+..|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 34556678999999999999999999965 58889999986432 223355778999999999999999999999999
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..|+||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~ 188 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccc
Confidence 999999999999999998653 578888999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccCC----CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhc
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTG----MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN 411 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (521)
+...............||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..........
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~ 262 (370)
T cd05596 189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDH 262 (370)
T ss_pred eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcC
Confidence 987644333233456799999999988643 488999999999999999999999974432 2222222221
Q ss_pred cccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHh
Q 009979 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHK--RPKMGHVIHML 459 (521)
Q Consensus 412 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~evl~~L 459 (521)
.. .+ .+.. .......+.+++.+||+.+|.+ ||++.+++.+-
T Consensus 263 ~~--~~---~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 263 KN--SL---TFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred CC--cC---CCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 11 01 1111 1111234445888999999988 99999998653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=313.50 Aligned_cols=267 Identities=23% Similarity=0.312 Sum_probs=214.5
Q ss_pred hhhcCCCccccceEccCCcEEEEEEE-EcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC----
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA---- 255 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~---- 255 (521)
+.+..++|++.+.||+|||+-||+++ ..++.-||+|++.....+..+...+|++..++++|||++++++++..+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 35677899999999999999999999 4568889999998888778888999999999999999999998875443
Q ss_pred -eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecc
Q 009979 256 -HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (521)
Q Consensus 256 -~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFG 334 (521)
..||+++|...|+|.+.+.........+++..++.|+.++++||++||+. .+++.||||||.|||+.+.+.++|.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence 48999999999999999987766667899999999999999999999997 5569999999999999999999999999
Q ss_pred cceecCCCCcce--------eeccccccccccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHH
Q 009979 335 LAKLLGAERSYV--------TTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVE 403 (521)
Q Consensus 335 la~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~ 403 (521)
.++.....-... -.....|..|.|||.+. +...++++|||||||+||+|+.|..||+..-..+..-
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl--- 251 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL--- 251 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE---
Confidence 998653211110 01234689999999884 5678999999999999999999999997432211110
Q ss_pred HHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 404 WLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 404 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
.-.+..+.+......+....+.+++..|++.||.+||++.+++..++.
T Consensus 252 ----------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 252 ----------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred ----------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 011222223222233344555668889999999999999999988864
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=337.03 Aligned_cols=242 Identities=26% Similarity=0.350 Sum_probs=194.4
Q ss_pred ceEccCCcEEEEEEEE----cCCcEEEEEEeccCC----hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 192 NVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
+.||+|+||.||+++. .+++.||+|.+.... ......+..|+++|+.++||||+++++++..+...|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 257789999986532 12235577899999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++++|.+++... ..+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 9999999999764 4678889999999999999999998 99999999999999999999999999997543222
Q ss_pred cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.+....... . .+.
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~~~~-~------~~~ 220 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKILKGK-L------NLP 220 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC-C------CCC
Confidence 223346799999999999988899999999999999999999999964332 12222222211 0 111
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~ 458 (521)
. ..+ ..+.+++.+||+.||++|| ++.+++.+
T Consensus 221 ~-~~~---~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 221 P-YLT---PEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred C-CCC---HHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1 122 2345588899999999999 78888754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=345.63 Aligned_cols=261 Identities=18% Similarity=0.245 Sum_probs=198.5
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
+..++|++.+.||+|+||.||+|... +++.||+|.... ..+.+|+++++.++||||+++++++......++||
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 44568999999999999999999964 578899996532 34678999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
|++. ++|..++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 163 e~~~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 163 PRYK-TDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred ecCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 9995 6899888654 4688999999999999999999998 999999999999999999999999999975433
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCC-cccHHHHHHHHhhcc--------
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG-EVNLVEWLKTMVTNR-------- 412 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~-------- 412 (521)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+.......
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 22223345679999999999999999999999999999999999998875332111 000001111110000
Q ss_pred --------------ccccCCCcccCCC--ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 413 --------------NAEGVLDPRLQEK--PCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 413 --------------~~~~~~d~~l~~~--~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.......+..... .......++.+++.+||+.||++|||+.|+++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000000 01122345667899999999999999999984
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=313.11 Aligned_cols=250 Identities=27% Similarity=0.373 Sum_probs=208.8
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
..++|++.+.||+|.||.||+|+.+ ++--||+|++.+.. ......+.+|+++-..|+||||++++++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3468899999999999999999965 56778999997653 3345788999999999999999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
++||..+|+|+..|+... ...+++.....++.|+|.||.|+|.. +||||||||+|+|++..+.+||+|||.+-.-
T Consensus 100 ilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 999999999999998652 46788899999999999999999998 9999999999999999999999999999864
Q ss_pred CCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
. .......|||..|.|||...+..++...|+|++|++.||++.|..||+... . .+-.++.... ++.+
T Consensus 175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~---~etYkrI~k~----~~~~ 241 (281)
T KOG0580|consen 175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---H---SETYKRIRKV----DLKF 241 (281)
T ss_pred C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---h---HHHHHHHHHc----cccC
Confidence 2 344567899999999999999999999999999999999999999997443 1 1112222211 2222
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
| +.....+.++|.+|+..+|.+|.+..|++.+
T Consensus 242 p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 P-------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred C-------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2 2222344558889999999999999999865
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=333.23 Aligned_cols=258 Identities=28% Similarity=0.495 Sum_probs=205.0
Q ss_pred CCCccccceEccCCcEEEEEEEEcCC------cEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLEDN------TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~~~------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
.++|++.+.||+|+||.||+|..... ..||+|.+.... ......+.+|+++++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 34788899999999999999986432 468999886543 33446789999999999999999999999998899
Q ss_pred eEEEEeccCCchHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC
Q 009979 258 MLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ 325 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~ 325 (521)
+++|||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence 999999999999999976421 114688899999999999999999998 99999999999999999
Q ss_pred CCceEeecccceecCCCCc-ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHH
Q 009979 326 WNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVE 403 (521)
Q Consensus 326 ~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~ 403 (521)
+.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||...... +
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~------~ 234 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ------E 234 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH------H
Confidence 9999999999986533222 22234457889999999988899999999999999999998 99999644321 1
Q ss_pred HHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 404 WLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 404 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
.. ..+....... ....++ .++.+++.+||+.||.+||++.+|++.|+.
T Consensus 235 ~~-~~i~~~~~~~------~~~~~~---~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VI-EMIRSRQLLP------CPEDCP---ARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HH-HHHHcCCcCC------CcccCC---HHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 1222211111 111233 445558889999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=327.94 Aligned_cols=257 Identities=28% Similarity=0.440 Sum_probs=205.5
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++..++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.. ...++||
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVT 79 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEE
Confidence 345668999999999999999999988888899999876443 34678899999999999999999998854 5678999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++++|.++++... ...+++..++.++.+++.||+|||+. +++||||||+||++++++.+||+|||++..+..
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 80 EYMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 9999999999997642 34688999999999999999999998 999999999999999999999999999987644
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
..........++..|+|||++.+..++.++||||||+++|||++ |..||.... ..+.......... .
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~------~~~~~~~~~~~~~------~ 222 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN------NREVLEQVERGYR------M 222 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHHHcCCC------C
Confidence 32222222345678999999988899999999999999999999 899996432 1222222211100 0
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
... ...+ ..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 223 ~~~-~~~~---~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCP-QDCP---ISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCC-CcCC---HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111 1122 345558889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=341.58 Aligned_cols=243 Identities=23% Similarity=0.292 Sum_probs=196.1
Q ss_pred ceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCC
Q 009979 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 267 (521)
+.||+|+||.||++... ++..||+|++.... ......+..|+++++.++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999965 58899999986542 233456788999999999999999999999999999999999999
Q ss_pred chHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCccee
Q 009979 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347 (521)
Q Consensus 268 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 347 (521)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~ 152 (328)
T cd05593 81 ELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATM 152 (328)
T ss_pred CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccc
Confidence 999988754 4689999999999999999999998 9999999999999999999999999999753222 1223
Q ss_pred ecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCcc
Q 009979 348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPC 427 (521)
Q Consensus 348 ~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 427 (521)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+........ +..+... .
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~------~~~~~~~~~~-------~~~~p~~-~ 218 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILME-------DIKFPRT-L 218 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH------HHHHHHhccC-------CccCCCC-C
Confidence 346799999999999999999999999999999999999999964322 1222221111 0111111 2
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 009979 428 SRALKRALLVALRCVDPNAHKRP-----KMGHVIHML 459 (521)
Q Consensus 428 ~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L 459 (521)
+ .++.+++.+||+.||++|| ++.+++++-
T Consensus 219 ~---~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 219 S---ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred C---HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 2 2344588899999999997 899988653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=328.60 Aligned_cols=256 Identities=27% Similarity=0.415 Sum_probs=204.9
Q ss_pred hcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
+..++|++.++||+|+||.||+|.+.+...||+|++..... ..+.+..|+++++.++||||+++++++.+ ...++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 80 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence 45668999999999999999999987777899998875332 34678899999999999999999998754 55799999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+++|+|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||.++.+...
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 81 YMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred cCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999999997642 34678999999999999999999998 9999999999999999999999999999876543
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
.........++..|+|||+..+..++.++|||||||++|||+| |..||...... +......... ...
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~------~~~~~~~~~~------~~~ 223 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVERGY------RMP 223 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH------HHHHHHhcCC------CCC
Confidence 3222223446778999999988899999999999999999999 88898644321 1111111110 000
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
. .......+.+++.+||+.||++||++.+++++|+.
T Consensus 224 ~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 224 C----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred C----ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1 11233445668999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=327.66 Aligned_cols=257 Identities=26% Similarity=0.442 Sum_probs=207.1
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++..++|++.++||+|+||.||+|...+++.||+|.+..... ....+..|+.+++.++|+||+++++++. ....++||
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 456778999999999999999999988889999999875443 3467888999999999999999999875 45689999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+.+++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 9999999999987652 35788999999999999999999998 999999999999999999999999999987653
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
..........++..|+|||++.+..++.++||||||+++|||++ |+.||...... +....+.. .. ..
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~-~~-----~~ 222 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP------EVIQNLER-GY-----RM 222 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH------HHHHHHHc-CC-----CC
Confidence 32222233456778999999998999999999999999999999 99999644321 11222111 10 00
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
... ...+ .++.+++.+||+.+|++||++.+++..|+.
T Consensus 223 ~~~-~~~~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRP-DNCP---EELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCC-CCCC---HHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 011 1122 345568889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=339.18 Aligned_cols=239 Identities=23% Similarity=0.282 Sum_probs=192.4
Q ss_pred EccCCcEEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCCch
Q 009979 194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL 269 (521)
Q Consensus 194 LG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L 269 (521)
||+|+||.||+|... ++..||+|.+... .......+..|+.+++.++||||+++++++.+....++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999975 5778999998643 223345677899999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcceeec
Q 009979 270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR 349 (521)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 349 (521)
.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQRE----GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 9999764 4688999999999999999999998 99999999999999999999999999998643222 22344
Q ss_pred ccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHH
Q 009979 350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429 (521)
Q Consensus 350 ~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 429 (521)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+..+...... ..+.. ..+.
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~~~~-------~~~~~-~~~~ 218 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKILQEP-------LRFPD-GFDR 218 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHHcCC-------CCCCC-cCCH
Confidence 679999999999999999999999999999999999999996432 222233322211 01111 1223
Q ss_pred HHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 009979 430 ALKRALLVALRCVDPNAHKRPK---MGHVIH 457 (521)
Q Consensus 430 ~~~~~~~li~~cl~~dP~~RPt---~~evl~ 457 (521)
.+.+++.+||+.||++||+ +.+++.
T Consensus 219 ---~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 219 ---DAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred ---HHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 3445788999999999986 455553
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=332.84 Aligned_cols=260 Identities=22% Similarity=0.321 Sum_probs=197.9
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
.++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999975 688899999865432 223457789999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+. ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 5888888654 35688899999999999999999998 9999999999999999999999999999865322
Q ss_pred CcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh---ccccc---
Q 009979 343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT---NRNAE--- 415 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~--- 415 (521)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..+.+..... .....
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD-----IQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc-----HHHHHHHHHHHhCCCChhhcc
Confidence 2 22234568999999998865 4588999999999999999999999975422 1111111110 00000
Q ss_pred -----cCCCc-cc---CCCccH------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 416 -----GVLDP-RL---QEKPCS------RALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 416 -----~~~d~-~l---~~~~~~------~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
...++ .+ ...... .....+.+++.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 00 000000 01134556888999999999999999984
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=343.08 Aligned_cols=259 Identities=20% Similarity=0.292 Sum_probs=202.5
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEee
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~ 253 (521)
++.+....++|++.+.||+|+||.||++... +++.||+|.+.+. .......+..|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred HHhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 3445667789999999999999999999976 5778999988542 22234567889999999999999999999999
Q ss_pred CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeec
Q 009979 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (521)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DF 333 (521)
+...|+||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DF 186 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADF 186 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEec
Confidence 99999999999999999999653 578889999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCcceeecccccccccccccccCC----CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHh
Q 009979 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTG----MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409 (521)
Q Consensus 334 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 409 (521)
|++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ........
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~ 260 (370)
T cd05621 187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIM 260 (370)
T ss_pred ccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHH
Confidence 99987644333333456799999999998653 378999999999999999999999964321 22222222
Q ss_pred hccccccCCCcccCCC-ccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 009979 410 TNRNAEGVLDPRLQEK-PCSRALKRALLVALRCVDPNAHK--RPKMGHVIHM 458 (521)
Q Consensus 410 ~~~~~~~~~d~~l~~~-~~~~~~~~~~~li~~cl~~dP~~--RPt~~evl~~ 458 (521)
..... ..+... ..+.. +.+++.+|+..++.+ |+++.+++++
T Consensus 261 ~~~~~-----~~~p~~~~~s~~---~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 261 DHKNS-----LNFPEDVEISKH---AKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred hCCcc-----cCCCCcccCCHH---HHHHHHHHccCchhccCCCCHHHHhcC
Confidence 21110 011111 12333 334677888755544 8899999865
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=327.91 Aligned_cols=251 Identities=24% Similarity=0.410 Sum_probs=201.4
Q ss_pred CCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEecc
Q 009979 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (521)
.+|++.+.||+|+||.||+|.+.++..+|+|.+..... ....+..|+++++.++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 46788999999999999999987777899998864332 34567889999999999999999999999999999999999
Q ss_pred CCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcc
Q 009979 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (521)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~ 345 (521)
+++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 83 NGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 999999997652 3689999999999999999999998 9999999999999999999999999999875432222
Q ss_pred eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCC
Q 009979 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (521)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 424 (521)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +........ ..... .
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~------~~~~~-~ 223 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS------EVVESVSAG------YRLYR-P 223 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH------HHHHHHHcC------CcCCC-C
Confidence 1222234567999999998899999999999999999999 89999644321 111211111 11111 1
Q ss_pred CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 425 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
..++. .+.+++.+||..+|++||++.++++.|
T Consensus 224 ~~~~~---~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPT---EVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCH---HHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11333 455588899999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=338.26 Aligned_cols=253 Identities=21% Similarity=0.277 Sum_probs=202.7
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|.+.+.||+|+||+||+|... +++.||+|.+.... ....+.+..|+.+++.++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999965 68889999987542 234466888999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999765 34789999999999999999999998 999999999999999999999999999987754
Q ss_pred CCcceeeccccccccccccccc------CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYAS------TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||..... .+.+.........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~~~- 227 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------AKTYNNIMNFQRF- 227 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH------HHHHHHHHcCCCc-
Confidence 4433344457999999999986 45688999999999999999999999964332 2222222221110
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
+ .+.. .......+.+++.+|++ +|.+||++.+++.+
T Consensus 228 --~--~~~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 228 --L--KFPE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred --c--CCCC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 0111 11122334457779997 99999999998754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=344.37 Aligned_cols=253 Identities=25% Similarity=0.330 Sum_probs=199.6
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|++.+.||+|+||+||+|... +++.||||++.... ......+..|+.++..++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999975 58899999986532 233456788999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 999999999999764 4689999999999999999999998 999999999999999999999999999976532
Q ss_pred CCcc-------------------------------------eeecccccccccccccccCCCCCCcccchhHHHHHHHHH
Q 009979 342 ERSY-------------------------------------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 384 (521)
Q Consensus 342 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ell 384 (521)
.... .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011246999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHHh
Q 009979 385 SGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK---MGHVIHML 459 (521)
Q Consensus 385 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt---~~evl~~L 459 (521)
+|..||....+ .+.......... .+.-+ .....+.. +.+++.+|+. +|.+|++ +.+++.+-
T Consensus 234 ~G~~Pf~~~~~------~~~~~~i~~~~~--~~~~~--~~~~~s~~---~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 234 VGYPPFCSDNP------QETYRKIINWKE--TLQFP--DEVPLSPE---AKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred cCCCCCCCCCH------HHHHHHHHcCCC--ccCCC--CCCCCCHH---HHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 99999964432 222222221111 00000 01112333 3447778886 9999998 88887643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=347.78 Aligned_cols=263 Identities=25% Similarity=0.409 Sum_probs=206.3
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEcC------CcEEEEEEeccCCh-hhHHHHHHHHHHHhcCC-CCCeeeEEEEEe
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVR-HKNLVRLLGYCA 252 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~ 252 (521)
+++..++|.+.+.||+|+||.||+|.+.. +..||||++..... ...+.+..|+++|+++. ||||++++++|.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 45667899999999999999999998531 24699999865433 33467889999999996 999999999999
Q ss_pred eCCeeeEEEEeccCCchHHhhhcCCC------------------------------------------------------
Q 009979 253 EGAHRMLVYEYIDNGNLEQWLHGDVG------------------------------------------------------ 278 (521)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~~------------------------------------------------------ 278 (521)
+....|||||||++|+|.++|+....
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 99999999999999999999875321
Q ss_pred --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 009979 279 --------------------------------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320 (521)
Q Consensus 279 --------------------------------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NI 320 (521)
....+++..+..++.|++.||+|||+. +|+||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhE
Confidence 013478888999999999999999998 999999999999
Q ss_pred EeCCCCCceEeecccceecCCCCcce-eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCc
Q 009979 321 LLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGE 398 (521)
Q Consensus 321 Ll~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~ 398 (521)
|+++++.+||+|||+++......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-- 346 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-- 346 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--
Confidence 99999999999999998764332221 223457788999999999999999999999999999997 99998643211
Q ss_pred ccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 399 VNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
..+...+.... .... ...++ ..+.+++.+||+.||++||++.+|+++|+.
T Consensus 347 ----~~~~~~~~~~~-----~~~~-~~~~~---~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 347 ----STFYNKIKSGY-----RMAK-PDHAT---QEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred ----HHHHHHHhcCC-----CCCC-CccCC---HHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 11111111111 0001 11123 345568889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=332.60 Aligned_cols=261 Identities=24% Similarity=0.335 Sum_probs=193.7
Q ss_pred CCccccceEccCCcEEEEEEEEc--CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcC---CCCCeeeEEEEEe-----e
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE--DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRV---RHKNLVRLLGYCA-----E 253 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~hpniv~l~~~~~-----~ 253 (521)
++|++.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.+++.+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999863 467899998864322 2234455677777665 6999999999985 2
Q ss_pred CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeec
Q 009979 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (521)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DF 333 (521)
....++||||++ ++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 356899999996 59999987652 34688999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc-
Q 009979 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR- 412 (521)
Q Consensus 334 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~- 412 (521)
|+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+.......
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~ 229 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPG 229 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCC
Confidence 999876433 22344678999999999988899999999999999999999999997543211 111111111000
Q ss_pred --cc-------ccCCCcccCCC---ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 413 --NA-------EGVLDPRLQEK---PCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 413 --~~-------~~~~d~~l~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.. ...+.+..... ..+.....+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 00000000000 00112233456888999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=346.30 Aligned_cols=252 Identities=21% Similarity=0.288 Sum_probs=196.1
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
.|+..+.||+|+||+||+|... +++.||+|++.... ......+..|+++++.++||||+++++++.+....|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788999999999999999864 57889999986532 2334678899999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++.+...
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 99999999999764 4688899999999999999999998 9999999999999999999999999997643110
Q ss_pred C----------------------------------------------cceeecccccccccccccccCCCCCCcccchhH
Q 009979 343 R----------------------------------------------SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSF 376 (521)
Q Consensus 343 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~ 376 (521)
. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 0 001123579999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCC-CccHHHHHHHHHHHHh--ccCCCCCCCCCHH
Q 009979 377 GILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE-KPCSRALKRALLVALR--CVDPNAHKRPKMG 453 (521)
Q Consensus 377 Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~~~~li~~--cl~~dP~~RPt~~ 453 (521)
||++|||+||+.||....+. +.......... .. .+.. ...+.. +.+++.+ |+..++..||++.
T Consensus 235 G~il~elltG~~Pf~~~~~~------~~~~~i~~~~~--~~---~~~~~~~~s~~---~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPT------ETQLKVINWEN--TL---HIPPQVKLSPE---AVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHH------HHHHHHHcccc--cc---CCCCCCCCCHH---HHHHHHHHccCcccccCCCCHH
Confidence 99999999999999754321 11111111100 00 1111 012233 3345555 5667777799999
Q ss_pred HHHHHh
Q 009979 454 HVIHML 459 (521)
Q Consensus 454 evl~~L 459 (521)
+++.+-
T Consensus 301 ~~l~hp 306 (381)
T cd05626 301 DIKAHP 306 (381)
T ss_pred HHhcCc
Confidence 998653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=328.32 Aligned_cols=257 Identities=24% Similarity=0.424 Sum_probs=205.9
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
+...+|.+.+.||+|+||.||+|.+. .++.||+|.+... .....++..|+++++.++|+||+++++++..+...++||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 44557888999999999999999965 4788999988654 334567889999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 82 EFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EeCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999999997652 35688999999999999999999998 999999999999999999999999999987644
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
..........++..|+|||++.+..++.++|||||||++|||++ |..||.... ..+........ ..+
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~------~~~~~~~~~~~------~~~ 224 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLEKG------YRM 224 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHHCC------CCC
Confidence 32222222334678999999999999999999999999999998 999986432 12222222111 011
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
... ..++. .+.+++.+||+.||++||++.+++++|+.
T Consensus 225 ~~~-~~~~~---~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 225 ERP-EGCPP---KVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CCC-CCCCH---HHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 111 11333 34458889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=336.57 Aligned_cols=245 Identities=27% Similarity=0.351 Sum_probs=193.3
Q ss_pred ccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHH---hcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAI---GRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l---~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
|++.+.||+|+||.||+|.+. +++.||||.+.+.. ....+.+..|++++ +.++||||+++++++......|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567899999999999999965 58899999986532 22334566666655 567899999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+++|+|..+++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988864 3689999999999999999999998 99999999999999999999999999987532
Q ss_pred CCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......... .
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~------~~~~~~i~~~~-------~ 218 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE------EEVFDSIVNDE-------V 218 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-------C
Confidence 221 223446799999999999999999999999999999999999999964432 12222222111 0
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~ 458 (521)
.+.. ..+ ..+.+++.+||+.||.+|| ++.++++.
T Consensus 219 ~~p~-~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 219 RYPR-FLS---REAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCCC-CCC---HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1111 122 3344588899999999999 56666644
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=328.82 Aligned_cols=257 Identities=26% Similarity=0.494 Sum_probs=205.3
Q ss_pred CCCccccceEccCCcEEEEEEEEcC------CcEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.+...... ..+.+.+|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4578889999999999999998633 467999998765443 457899999999999999999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCC
Q 009979 258 MLVYEYIDNGNLEQWLHGDV----------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN 327 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~ 327 (521)
++||||+++++|.++++... .....+++..+..++.|++.||.|||++ +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999997642 1234578899999999999999999998 9999999999999999999
Q ss_pred ceEeecccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHH
Q 009979 328 PKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWL 405 (521)
Q Consensus 328 vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~ 405 (521)
+||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||...... +..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~------~~~ 234 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE------EVI 234 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH------HHH
Confidence 999999999865332221 1223446789999999999999999999999999999999 99998644321 111
Q ss_pred HHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 406 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
.... ... ... .....+. .+.+++.+||+.||++||++.||++.|+
T Consensus 235 ~~~~-~~~----~~~--~~~~~~~---~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 ECIT-QGR----LLQ--RPRTCPS---EVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHH-cCC----cCC--CCCCCCH---HHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 2111 111 100 0111333 3455888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=343.49 Aligned_cols=254 Identities=23% Similarity=0.290 Sum_probs=204.3
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|.+.+.||+|+||+||+|... +++.||+|++.... ......+..|++++..++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47889999999999999999975 68899999986532 234467888999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999765 5788999999999999999999998 999999999999999999999999999987644
Q ss_pred CC----------------------------cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 009979 342 ER----------------------------SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393 (521)
Q Consensus 342 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~ 393 (521)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11223457999999999999999999999999999999999999999754
Q ss_pred CCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHhh
Q 009979 394 RPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK-MGHVIHMLE 460 (521)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt-~~evl~~L~ 460 (521)
.. .+.......... ....+. .......+.+++.+|+. ||.+||+ +.+++++.-
T Consensus 234 ~~------~~~~~~i~~~~~--~~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 234 TL------QETYNKIINWKE--SLRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred CH------HHHHHHHhccCC--cccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 31 222222222100 000111 01122344457889997 9999999 999987643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=342.85 Aligned_cols=260 Identities=28% Similarity=0.472 Sum_probs=217.1
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEcC---Cc--EEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCCeeeEEEEE
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLED---NT--NVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~---~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~ 251 (521)
.+.+++..+..+..+.||+|.||.||+|.+.+ |. .||||.++.+ ..+..+.|..|..+|++++||||++++|+|
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 44566777788889999999999999999643 22 4899999874 455668899999999999999999999999
Q ss_pred eeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEe
Q 009979 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLS 331 (521)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~ 331 (521)
.+ ...+||||+++-|.|..||+.+ ...++......++.||+.||+|||+. .+|||||..+|||+....-|||+
T Consensus 461 ~e-~P~WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 461 VE-QPMWIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred ec-cceeEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeec
Confidence 87 5579999999999999999887 46788899999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhh
Q 009979 332 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVT 410 (521)
Q Consensus 332 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (521)
|||+++.+.++..+..+...-...|||||.++...++.+||||-|||++||+++ |..||.+-...+..-.+ .
T Consensus 534 DFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-------E 606 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-------E 606 (974)
T ss_pred ccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-------c
Confidence 999999998888777776666789999999999999999999999999999998 99999755433221111 1
Q ss_pred ccccccCCCcccC-CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 411 NRNAEGVLDPRLQ-EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 411 ~~~~~~~~d~~l~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
++. ++. +..|+..+. .|+.+||+.+|.+||.+.++...|..
T Consensus 607 nGe-------RlP~P~nCPp~LY---slmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 607 NGE-------RLPCPPNCPPALY---SLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred CCC-------CCCCCCCCChHHH---HHHHHHhccCcccCCcHHHHHHHHHH
Confidence 111 111 223555554 58889999999999999999877764
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=340.77 Aligned_cols=261 Identities=20% Similarity=0.257 Sum_probs=196.4
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
..+|.+.+.||+|+||.||+|.+. .++.||||.... ..+.+|+++|++++|+|||++++++..+...++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999975 477899996422 3356799999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+. ++|.+++... ...+++..++.|+.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 242 ~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 6999988654 24789999999999999999999998 99999999999999999999999999998764322
Q ss_pred cc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC-CCCCcccHHHHHHHHhhcccc--ccC--
Q 009979 344 SY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS-RPPGEVNLVEWLKTMVTNRNA--EGV-- 417 (521)
Q Consensus 344 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~--~~~-- 417 (521)
.. ......||+.|+|||++.+..++.++|||||||+||||++|..|+-.. ...........+.+.+..... ..+
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 21 123457999999999999999999999999999999999988765322 111111111111111111000 000
Q ss_pred -----------------CCcccCCCccH---HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 418 -----------------LDPRLQEKPCS---RALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 418 -----------------~d~~l~~~~~~---~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
..+........ .....+.+|+.+||+.||++|||+.|++++
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000000000 111245668889999999999999999864
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=353.19 Aligned_cols=258 Identities=24% Similarity=0.330 Sum_probs=205.8
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC---
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA--- 255 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~--- 255 (521)
+...++|.+.+.||+|+||+||+|... +++.||||.+.... ......+..|+.++..++|+||+++++.+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 345579999999999999999999854 68899999986542 334466788999999999999999988765332
Q ss_pred -----eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceE
Q 009979 256 -----HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKL 330 (521)
Q Consensus 256 -----~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL 330 (521)
..++||||+++|+|.++++........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 36799999999999999976554556899999999999999999999998 9999999999999999999999
Q ss_pred eecccceecCCCC-cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHh
Q 009979 331 SDFGLAKLLGAER-SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409 (521)
Q Consensus 331 ~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 409 (521)
+|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~~~ 258 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHKTL 258 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHh
Confidence 9999998764322 122344679999999999999999999999999999999999999996432 223333322
Q ss_pred hccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 410 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
... .++ +. ...+ ..+.+++.+||+.||.+||++.+++.+
T Consensus 259 ~~~-----~~~-~~-~~~~---~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGR-----YDP-LP-PSIS---PEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCC-----CCC-CC-CCCC---HHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 211 111 11 1122 334558889999999999999999764
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=341.28 Aligned_cols=201 Identities=26% Similarity=0.350 Sum_probs=175.2
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|++.+.||+|+||+||+|... +++.||+|++.+.. ......+..|+.++..++|+||+++++++.+....||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999865 57889999986532 223356788999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 999999999999764 5789999999999999999999998 999999999999999999999999999975432
Q ss_pred CCc----------------------------------ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 009979 342 ERS----------------------------------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 387 (521)
Q Consensus 342 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~ 387 (521)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 100 0012357999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 009979 388 NPVDYS 393 (521)
Q Consensus 388 ~Pf~~~ 393 (521)
.||...
T Consensus 234 ~Pf~~~ 239 (363)
T cd05628 234 PPFCSE 239 (363)
T ss_pred CCCCCC
Confidence 999644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=344.49 Aligned_cols=251 Identities=24% Similarity=0.298 Sum_probs=195.4
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
+|++.+.||+|+||.||+|... +++.||+|.+.... ......+..|+++|+.++||||+++++.+.+++..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6899999999999999999965 58889999986432 2234567889999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999764 4688899999999999999999998 9999999999999999999999999997532100
Q ss_pred ------------------------------------------CcceeecccccccccccccccCCCCCCcccchhHHHHH
Q 009979 343 ------------------------------------------RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILI 380 (521)
Q Consensus 343 ------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl 380 (521)
........+||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00011235799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCC---CHHHHHH
Q 009979 381 MEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP---KMGHVIH 457 (521)
Q Consensus 381 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RP---t~~evl~ 457 (521)
|||++|+.||....+. +.......... ....+. . ...+.. +.+++.+|+ .+|.+|+ ++.+++.
T Consensus 235 yell~G~~Pf~~~~~~------~~~~~i~~~~~--~~~~~~-~-~~~s~~---~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPA------ETQLKVINWET--TLHIPS-Q-AKLSRE---ASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHH------HHHHHHhccCc--cccCCC-C-CCCCHH---HHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999999754321 11111111100 000010 0 112233 334666765 4999999 8899886
Q ss_pred H
Q 009979 458 M 458 (521)
Q Consensus 458 ~ 458 (521)
+
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=339.29 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=208.6
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe-eeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH-RMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~-~~lV~ 261 (521)
++|...+++|+|+||.+++++.+ +++.|++|++.-.+. ...+....|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999865 578899999864432 222456779999999999999999999998887 89999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
+||+||+|.+.+.+.. ...++++.+..++.|++.|+.|||++ .|+|||||+.|||++.++.|||+|||+|+.++.
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998774 47899999999999999999999988 999999999999999999999999999999876
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
... ......||+.||.||++.+..|+.|+|||||||++|||++-+.+|...+.. ..+.+... ..+.|.
T Consensus 159 ~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~------~Li~ki~~-----~~~~Pl 226 (426)
T KOG0589|consen 159 EDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS------ELILKINR-----GLYSPL 226 (426)
T ss_pred chh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH------HHHHHHhh-----ccCCCC
Confidence 543 345578999999999999999999999999999999999999999755432 22222221 112221
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
......++..++..|++.+|..||++.+++.+
T Consensus 227 -----p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 227 -----PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -----CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 22233344447889999999999999999866
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=321.72 Aligned_cols=260 Identities=23% Similarity=0.363 Sum_probs=207.9
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|++.+.||+|+||.||+|+.. +++.||||.+... .......+..|+++++.++||||+++++++......++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47899999999999999999964 6889999987542 2333456888999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++++|.+++.........+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998865433345688999999999999999999998 999999999999999999999999999987643
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
... ......|++.|+|||.+.+..++.++|+||||+++|||++|+.||..... +..++........ .+.
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~------~~~ 227 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIEQCD------YPP 227 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHhcCC------CCC
Confidence 321 12335688999999999888899999999999999999999999854321 2222222221111 111
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.. .......+.+++.+||+.+|++||++.+|++.+++.
T Consensus 228 ~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 LP---TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CC---hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11 112234455688899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=324.95 Aligned_cols=266 Identities=24% Similarity=0.367 Sum_probs=203.6
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEec--cCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEee-----CCe
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLL--NNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-----GAH 256 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-----~~~ 256 (521)
...|...+.||+|+||.|+.+.+. +|..||||++. .......+...+|+++|+.++|+||+.+++++.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 345666889999999999999965 68999999997 3445556777889999999999999999999865 346
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
+|+|+|+|+ -+|.+.++.. ..++...+..+++|+++||.|+|+. +|+||||||+|+|++.+..+||||||+|
T Consensus 101 vYiV~elMe-tDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 101 VYLVFELME-TDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eEEehhHHh-hHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence 799999995 4999999876 4599999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCC-Ccceeecccccccccccccc-cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH--------H
Q 009979 337 KLLGAE-RSYVTTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL--------K 406 (521)
Q Consensus 337 ~~~~~~-~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~--------~ 406 (521)
+..... ....++..+-|.+|.|||++ ....|+.+.||||.||++.||++|+.-|.+.+......++..+ .
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 987432 22334667789999999977 5578999999999999999999999999766532222111100 0
Q ss_pred HHhhccccccCCC--cccCCCc----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 407 TMVTNRNAEGVLD--PRLQEKP----CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 407 ~~~~~~~~~~~~d--~~l~~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
..+.+......+. |.....+ .+.....+++|+.+||..||.+|+|++|.+++
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0011000000000 1111111 12233456678889999999999999999854
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=322.22 Aligned_cols=255 Identities=29% Similarity=0.477 Sum_probs=203.9
Q ss_pred CCCccccceEccCCcEEEEEEEEcC----CcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLED----NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
.++|++.+.||+|+||.||+|.+.. ...||+|.+.... ......|..|+.+++.++||||+++++++.+....++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4578999999999999999999742 3578999886543 3344678889999999999999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+|+||||+|||+++++.+||+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 99999999999999765 24789999999999999999999998 9999999999999999999999999999987
Q ss_pred CCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 340 GAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 340 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... .+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~~----- 225 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN------QDVIKAVEDGY----- 225 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH------HHHHHHHHcCC-----
Confidence 522222 2222345678999999999999999999999999999998 9999854321 11111111110
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
..+. ...++. .+.+++.+||+.+|++||++.+|+++|+.
T Consensus 226 ~~~~--~~~~~~---~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 226 RLPP--PMDCPS---ALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred CCCC--CCCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0010 111233 34568889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=326.29 Aligned_cols=260 Identities=23% Similarity=0.439 Sum_probs=203.8
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~ 254 (521)
++..++|++.+.||+|+||.||+|.+. .+..||+|++.... .....++..|+.+++.++||||+++++++.++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 456778999999999999999999753 24579999885432 23345688999999999999999999999999
Q ss_pred CeeeEEEEeccCCchHHhhhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCc
Q 009979 255 AHRMLVYEYIDNGNLEQWLHGDVGP------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328 (521)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~v 328 (521)
...++||||+++++|.++++..... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence 9999999999999999999754221 23467888999999999999999998 99999999999999999999
Q ss_pred eEeecccceecCCCCcce-eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 009979 329 KLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLK 406 (521)
Q Consensus 329 kL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~ 406 (521)
||+|||+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||..... .+..+
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~------~~~~~ 232 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN------EQVLR 232 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHH
Confidence 999999997653322211 122345788999999999999999999999999999999 7889864322 12222
Q ss_pred HHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 407 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
.... .... + .. ..++. .+.+++.+||+.||++||++.+++++|+
T Consensus 233 ~~~~-~~~~---~--~~-~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 233 FVME-GGLL---D--KP-DNCPD---MLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHc-CCcC---C--CC-CCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 2221 1110 0 11 11233 3455888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=340.25 Aligned_cols=262 Identities=21% Similarity=0.288 Sum_probs=205.2
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEee
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~ 253 (521)
++++++..++|++.+.||+|+||.||+|.+. +++.||+|.+.... ......+..|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 5566777889999999999999999999976 57789999885422 2233557789999999999999999999999
Q ss_pred CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeec
Q 009979 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (521)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DF 333 (521)
+...++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999998653 478888999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCcceeecccccccccccccccCC----CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHh
Q 009979 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTG----MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409 (521)
Q Consensus 334 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 409 (521)
|+++..............||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .........
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~ 260 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------LVGTYSKIM 260 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC------HHHHHHHHH
Confidence 99987654433333456799999999998653 38899999999999999999999996433 222223332
Q ss_pred hccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHhh
Q 009979 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHK--RPKMGHVIHMLE 460 (521)
Q Consensus 410 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~evl~~L~ 460 (521)
.........+ ....+.. +.+++.+|+..++.+ ||++.+++++.-
T Consensus 261 ~~~~~~~~~~----~~~~s~~---~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 261 NHKNSLTFPD----DNDISKE---AKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred cCCCcccCCC----cCCCCHH---HHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 2111111110 0112333 444777999844443 789999987654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=332.54 Aligned_cols=249 Identities=23% Similarity=0.320 Sum_probs=196.0
Q ss_pred ceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
++||+|+||.||+|.+. ++..||+|.+.+.. ....+.+..|+.++..+ +||||+++++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999965 57889999997542 22345678899999988 699999999999999999999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~ 152 (329)
T cd05588 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT 152 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence 9999988654 5789999999999999999999998 9999999999999999999999999999753221 122
Q ss_pred eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCC--cccHHHHHHHHhhccccccCCCcccCC
Q 009979 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG--EVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~ 424 (521)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||+...... .....+++......... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p~ 226 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCCC
Confidence 344679999999999999999999999999999999999999997433221 11222333332222111 1111
Q ss_pred CccHHHHHHHHHHHHhccCCCCCCCCC------HHHHHHH
Q 009979 425 KPCSRALKRALLVALRCVDPNAHKRPK------MGHVIHM 458 (521)
Q Consensus 425 ~~~~~~~~~~~~li~~cl~~dP~~RPt------~~evl~~ 458 (521)
..+. .+.+++.+||+.||.+||+ +.+++.+
T Consensus 227 -~~~~---~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 227 -SLSV---KASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred -CCCH---HHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1222 3445888999999999997 5677643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=341.34 Aligned_cols=261 Identities=22% Similarity=0.344 Sum_probs=194.5
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC-----Ceee
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHRM 258 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----~~~~ 258 (521)
+|++.+.||+|+||.||+|... ++..||||++... .......+..|+++++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5788999999999999999965 6889999998643 223345688899999999999999999988543 2479
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+||||+. ++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 6999988754 4689999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCc--ceeecccccccccccccccC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHh-----
Q 009979 339 LGAERS--YVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV----- 409 (521)
Q Consensus 339 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~----- 409 (521)
...... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... ....+....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~ 229 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLITDLLGTPSP 229 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCH
Confidence 532211 11234579999999999865 678999999999999999999999996543211 111100000
Q ss_pred ------hccccccC---CCcccCCC---ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 410 ------TNRNAEGV---LDPRLQEK---PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 410 ------~~~~~~~~---~d~~l~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
........ +....... ..+.....+.+++.+||+.||++||++.+++++
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000 00000000 001112345568889999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=339.55 Aligned_cols=243 Identities=22% Similarity=0.265 Sum_probs=194.9
Q ss_pred ceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCC
Q 009979 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 267 (521)
+.||+|+||.||++... ++..||+|.+.... ......+..|+++++.++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 68899999986532 223456778999999999999999999999999999999999999
Q ss_pred chHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 268 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
+|..++... ..+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (325)
T cd05594 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT 152 (325)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence 999988754 468999999999999999999997 6 99999999999999999999999999997543222 22
Q ss_pred eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCc
Q 009979 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 426 (521)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+........ . ..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~------~~~~~~i~~~-~------~~~p~~- 218 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILME-E------IRFPRT- 218 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH------HHHHHHHhcC-C------CCCCCC-
Confidence 3345799999999999999999999999999999999999999964321 1112211111 0 011111
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 009979 427 CSRALKRALLVALRCVDPNAHKRP-----KMGHVIHML 459 (521)
Q Consensus 427 ~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L 459 (521)
.+ ..+.+++.+||+.||++|+ ++.+++++-
T Consensus 219 ~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 219 LS---PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred CC---HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 22 2344588899999999996 899998653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=315.69 Aligned_cols=268 Identities=23% Similarity=0.302 Sum_probs=205.4
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh--hHHHHHHHHHHHhcCCCCCeeeEEEEEeeC--CeeeEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ--AEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLV 260 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~lV 260 (521)
+.|+..+.|++|.||.||+|+++ ++.-||+|+++..... -.-.-.+||.+|.+++|||||.+..+.... +..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 46888999999999999999965 5778999999754321 112346799999999999999999987643 578999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
||||+. ||..+++.. ..++....+..+..|+++|++|||.+ .|+|||||++|+|++..|.+||+|||+|+.++
T Consensus 156 Me~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999987 999999887 36889999999999999999999999 99999999999999999999999999999986
Q ss_pred CCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh--ccccccC
Q 009979 341 AERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT--NRNAEGV 417 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 417 (521)
... ...+..+-|.+|.|||++.+ ..|++..|+||+|||+.||+++++-|.+....+ .+..+++.+-. +..+.++
T Consensus 229 sp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d--Ql~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 229 SPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID--QLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred CCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH--HHHHHHHHhCCCccccCCCc
Confidence 553 33466778999999998865 569999999999999999999999987554322 22222222111 1111111
Q ss_pred CCc------ccCCCcc---------HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 418 LDP------RLQEKPC---------SRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 418 ~d~------~l~~~~~---------~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
.+. .+...+. ......-++|+..+|..||.+|-|+.+.|.+=--.+
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 111 1111111 112345566888999999999999999986544333
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=335.99 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=211.0
Q ss_pred CCCccccceEccCCcEEEEEEEEcC-CcEEEEEEeccCChh---hHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCeeeE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQ---AEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~l 259 (521)
...|++.+.||+|.||.||+++.+. |+.+|+|.+.+.... ....+.+|+.+|+++. |||||.++++|++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4578889999999999999999764 999999999776543 3468999999999998 9999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC----CCCceEeeccc
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK----QWNPKLSDFGL 335 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~----~~~vkL~DFGl 335 (521)
|||+|.||.|.+.+... .+++..+..++.|++.++.|||+. +|+||||||+|+|+.. ++.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999765 299999999999999999999998 9999999999999953 35799999999
Q ss_pred ceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||......... . .+....
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~------~-~i~~~~-- 254 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF------L-AILRGD-- 254 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH------H-HHHcCC--
Confidence 998765 44567789999999999999999999999999999999999999999755432211 1 111111
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
..+...+.......+-+++.+|+..||.+|+|+.+++++
T Consensus 255 ----~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 255 ----FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ----CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 123333344444555568889999999999999999974
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=326.77 Aligned_cols=249 Identities=31% Similarity=0.565 Sum_probs=193.7
Q ss_pred ccceEccCCcEEEEEEEEc-----CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 190 DENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 190 ~~~~LG~G~fG~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
+.+.||.|.||.||+|.+. .+..|+||.+.... ....+.|..|++.+++++||||++++|++......++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999976 25679999996543 33468899999999999999999999999988889999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++|+|.++|+.. ....+++..++.|+.|++.||.|||+. +++|+||+++|||++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999876 246789999999999999999999998 99999999999999999999999999998763222
Q ss_pred c-ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 344 S-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 344 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
. .......+...|+|||.+.+..++.++||||||+++|||++ |+.||... +..+....... .....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~------~~~~~~~~~~~-~~~~~----- 225 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY------DNEEIIEKLKQ-GQRLP----- 225 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS------CHHHHHHHHHT-TEETT-----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccccccc-cccce-----
Confidence 2 22233457789999999999889999999999999999999 78898533 22233333322 11100
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
....++.. +..++.+||+.||++||++.++++.|
T Consensus 226 -~~~~~~~~---~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 -IPDNCPKD---IYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -SBTTSBHH---HHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -eccchhHH---HHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11113333 44588899999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=335.93 Aligned_cols=256 Identities=27% Similarity=0.462 Sum_probs=201.9
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCc----EEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNT----NVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
..+|+..+.||+|+||.||+|.+. ++. .||+|.+.... .....++..|+.+++.++||||++++|+|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 457999999999999999999854 333 38999886543 34456788999999999999999999999874 568
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+|+||+++|+|.++++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999999865 34688899999999999999999998 999999999999999999999999999997
Q ss_pred cCCCCcce-eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 339 LGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 339 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
+....... .....++..|+|||++.+..++.++|||||||++|||++ |+.||..... .++ ........ .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~------~~~-~~~~~~~~--~ 229 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------SEI-SSILEKGE--R 229 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------HHH-HHHHhCCC--C
Confidence 65433222 122335678999999999999999999999999999998 9999964321 111 11111111 0
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
... ...++ ..+..++.+||..||.+||++.+++..|....
T Consensus 230 ~~~----~~~~~---~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 230 LPQ----PPICT---IDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred CCC----CCCCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000 11122 23455888999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=326.91 Aligned_cols=248 Identities=22% Similarity=0.273 Sum_probs=195.1
Q ss_pred EccCCcEEEEEEEEc-CCcEEEEEEeccCChh---hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCCch
Q 009979 194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ---AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL 269 (521)
Q Consensus 194 LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L 269 (521)
||+|+||+||++.+. +++.||+|.+...... ..+.+..|+++++.++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999965 6789999998654322 235667899999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcceeec
Q 009979 270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR 349 (521)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 349 (521)
.+++.........+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++..+..... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988865433456789999999999999999999998 999999999999999999999999999987643322 2334
Q ss_pred ccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHH
Q 009979 350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429 (521)
Q Consensus 350 ~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 429 (521)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+....... .. ..+. ...+
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~-~~------~~~~-~~~~- 225 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRILN-DS------VTYP-DKFS- 225 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhcc-cC------CCCc-ccCC-
Confidence 5789999999999999999999999999999999999999975432111 1111111111 00 0111 1123
Q ss_pred HHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 009979 430 ALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (521)
Q Consensus 430 ~~~~~~~li~~cl~~dP~~RP-----t~~evl~~ 458 (521)
..+.+++.+||+.||++|| ++.+++.+
T Consensus 226 --~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 226 --PASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred --HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 3344588899999999999 66777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=342.17 Aligned_cols=260 Identities=25% Similarity=0.442 Sum_probs=216.5
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 256 (521)
.++|+....+....++||-|.||.||.|.|+. .-.||||.++.+ ....++|..|+.+|+.++|||+|+|+|+|..+..
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 46778888888999999999999999999874 445899988654 4456889999999999999999999999999999
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
+|||.|||..|+|.+||++. ....++....++++.||+.|++||..+ ++|||||..+|+|+.++..||++|||++
T Consensus 338 FYIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred eEEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence 99999999999999999987 456778888999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
+++..+.........-...|.|||-+....++.|+|||+|||+|||+.| |..||.+-+ +.+..
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lSqVY---------- 476 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVY---------- 476 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HHHHH----------
Confidence 9986554333233334679999999999999999999999999999999 889985332 22211
Q ss_pred cCCCcccC---CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 416 GVLDPRLQ---EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 416 ~~~d~~l~---~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
++++..++ +..|+.- +.+||+.||+++|.+||++.|+.+.++..
T Consensus 477 ~LLEkgyRM~~PeGCPpk---VYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 477 GLLEKGYRMDGPEGCPPK---VYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred HHHhccccccCCCCCCHH---HHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 12222222 2345544 45588899999999999999999888753
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=318.50 Aligned_cols=260 Identities=23% Similarity=0.388 Sum_probs=209.6
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+..|++++++++|+|++++++++......++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999976 7889999988542 2233567889999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++++|.+++.........+++..++.++.+++.||+|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999876443456789999999999999999999998 999999999999999999999999999986543
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.... .+..+....... . ..
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~-~----~~--- 225 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEK-C----DY--- 225 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhhc-C----CC---
Confidence 322 1233568999999999988889999999999999999999999996432 222222222111 1 11
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
...+.......+.+++.+||+.+|++||++.+|+++|+..
T Consensus 226 -~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 226 -PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1111112233455688899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.82 Aligned_cols=201 Identities=23% Similarity=0.335 Sum_probs=173.3
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
.|+..+.||+|+||+||+|... +++.||+|.+.... ......+..|+++++.++||||+++++++.++...|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999964 57889999986532 2334578889999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
||++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 99999999999764 4688899999999999999999998 9999999999999999999999999997532100
Q ss_pred C----------------------------------------------cceeecccccccccccccccCCCCCCcccchhH
Q 009979 343 R----------------------------------------------SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSF 376 (521)
Q Consensus 343 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~ 376 (521)
. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000123579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCC
Q 009979 377 GILIMEVISGRNPVDYSR 394 (521)
Q Consensus 377 Gvvl~elltG~~Pf~~~~ 394 (521)
||++|||++|+.||....
T Consensus 235 Gvil~elltG~~Pf~~~~ 252 (382)
T cd05625 235 GVILYEMLVGQPPFLAQT 252 (382)
T ss_pred hHHHHHHHhCCCCCCCCC
Confidence 999999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=323.38 Aligned_cols=256 Identities=25% Similarity=0.393 Sum_probs=203.3
Q ss_pred hcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
+..++|.+.+.||+|+||.||+|.+.++..+|+|.+.... ...+.+..|+++++.++|+|++++++++.. ...++|||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTE 80 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEE
Confidence 4456789999999999999999998777789999876543 234678889999999999999999998854 56789999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+.+++|.++++... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 81 FMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 999999999997642 34578999999999999999999998 9999999999999999999999999999876433
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
.........++..|+|||++.+..++.++||||||+++|||+| |..||...... +....... .. .+.
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~-~~-----~~~ 223 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR------EVLEQVER-GY-----RMP 223 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHc-CC-----CCC
Confidence 2222223346778999999998899999999999999999999 99999643321 11111111 10 000
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
. .......+.+++.+||+.||++||++.+|++.|+.
T Consensus 224 ~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 C----PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred C----CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1 11122345568889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=342.45 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=196.5
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|++.+.||+|+||.||++... +++.||||++.+.. ....+.+..|+++++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47889999999999999999864 68889999986532 233466888999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999999999754 5688999999999999999999998 999999999999999999999999999964321
Q ss_pred CCc------------c----------------------------------eeecccccccccccccccCCCCCCcccchh
Q 009979 342 ERS------------Y----------------------------------VTTRVMGTFGYVAPEYASTGMLNERSDVYS 375 (521)
Q Consensus 342 ~~~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 375 (521)
... . .....+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 000 0 001246999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCC---CCH
Q 009979 376 FGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKR---PKM 452 (521)
Q Consensus 376 ~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~R---Pt~ 452 (521)
|||++|||++|+.||....+ .+.......... .+ .+.. .......+.+++.+|+. +|.+| +++
T Consensus 234 lGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~--~~---~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENS------HETYRKIINWRE--TL---YFPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred cchhhhhhhcCCCCCCCCCH------HHHHHHHHccCC--cc---CCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 99999999999999964432 122222221111 00 0111 00112234457779997 66665 599
Q ss_pred HHHHHHh
Q 009979 453 GHVIHML 459 (521)
Q Consensus 453 ~evl~~L 459 (521)
.+++.+-
T Consensus 300 ~~~l~hp 306 (377)
T cd05629 300 HEIKSHP 306 (377)
T ss_pred HHHhcCC
Confidence 9988654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=320.12 Aligned_cols=258 Identities=28% Similarity=0.476 Sum_probs=208.9
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++..++|++.+.||+|+||.||+|.++++..||+|.+.... ...+++..|+.+++.++|+||+++++++......++||
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 46678999999999999999999998878889999887543 33467889999999999999999999999888999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++++|.+++.... ...+++..+..++.+++.||.|||+. +++|+||||+||++++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999999997752 35689999999999999999999998 999999999999999999999999999987643
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
..........++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ...+........ .
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------~~~~~~~~~~~~------~ 223 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN------REVLEQVERGYR------M 223 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCC------C
Confidence 22222222335678999999998899999999999999999999 9999964321 112222221100 0
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
.. ....+ ..+.+++.+||+.+|++||++.++++.|+.
T Consensus 224 ~~-~~~~~---~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PR-PPNCP---EELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CC-CCCCC---HHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00 11122 345568889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=334.11 Aligned_cols=248 Identities=24% Similarity=0.340 Sum_probs=194.2
Q ss_pred ceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
+.||+|+||.||+|... +++.||+|.+.+.. ......+..|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 57889999987542 23345677888888776 799999999999999999999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
|+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~ 152 (329)
T cd05618 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 152 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence 9999988654 4689999999999999999999998 99999999999999999999999999997532221 22
Q ss_pred eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCC--cccHHHHHHHHhhccccccCCCcccCC
Q 009979 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG--EVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~ 424 (521)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......++......... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~p~ 226 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RIPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CCCC
Confidence 334679999999999999999999999999999999999999996432211 11222333332222111 1111
Q ss_pred CccHHHHHHHHHHHHhccCCCCCCCCC------HHHHHH
Q 009979 425 KPCSRALKRALLVALRCVDPNAHKRPK------MGHVIH 457 (521)
Q Consensus 425 ~~~~~~~~~~~~li~~cl~~dP~~RPt------~~evl~ 457 (521)
..+ ..+.+++.+||+.||++||+ +.+++.
T Consensus 227 -~~~---~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 227 -SLS---VKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred -CCC---HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 122 23445888999999999998 456653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=335.57 Aligned_cols=241 Identities=23% Similarity=0.309 Sum_probs=192.8
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCC-CeeeEEEEEeeCCeeeEEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHK-NLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hp-niv~l~~~~~~~~~~~lV~ 261 (521)
+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+..|++++..+.|+ +|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999965 46789999986532 23345677899999999765 6888999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 999999999998764 4688999999999999999999998 999999999999999999999999999875322
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+........ . ..
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~------~~~~~~i~~~-~------~~ 219 (324)
T cd05587 154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE------DELFQSIMEH-N------VS 219 (324)
T ss_pred CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHcC-C------CC
Confidence 21 223346799999999999999999999999999999999999999964431 1222222211 0 11
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCH
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKM 452 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~ 452 (521)
+... .+ ..+.+++.+||+.||.+|++.
T Consensus 220 ~~~~-~~---~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 YPKS-LS---KEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCC-CC---HHHHHHHHHHhhcCHHHcCCC
Confidence 1111 22 344568889999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=326.22 Aligned_cols=261 Identities=25% Similarity=0.446 Sum_probs=207.1
Q ss_pred cCCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
..++|.+.+.||+|+||.||++... ++..+|+|.+..........+..|++++++++||||+++++++......
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3457899999999999999999842 2445899988766555667899999999999999999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCc
Q 009979 258 MLVYEYIDNGNLEQWLHGDV---------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~v 328 (521)
++||||+++++|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 99999999999999997542 1223589999999999999999999998 99999999999999999999
Q ss_pred eEeecccceecCCCCc-ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 009979 329 KLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLK 406 (521)
Q Consensus 329 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~ 406 (521)
||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~------~~~~~ 233 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------NEVIE 233 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHH
Confidence 9999999986533221 11223445778999999999999999999999999999999 9999864432 11222
Q ss_pred HHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 407 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
.... .... ... ...+. .+.+++.+||+.||.+|||+.++++.|+...
T Consensus 234 ~i~~-~~~~-----~~~-~~~~~---~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 234 CITQ-GRVL-----QRP-RTCPK---EVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHHc-CCcC-----CCC-CCCCH---HHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 2221 1110 011 11222 3556888999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=338.05 Aligned_cols=264 Identities=27% Similarity=0.415 Sum_probs=205.0
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcC-CCCCeeeEEEEEe
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLGYCA 252 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~ 252 (521)
|+++.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+..|++++.++ +|+||++++++|.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 3566778999999999999999999742 246799998865432 2345677899999999 8999999999886
Q ss_pred eC-CeeeEEEEeccCCchHHhhhcCCCC----------------------------------------------------
Q 009979 253 EG-AHRMLVYEYIDNGNLEQWLHGDVGP---------------------------------------------------- 279 (521)
Q Consensus 253 ~~-~~~~lV~e~~~~g~L~~~l~~~~~~---------------------------------------------------- 279 (521)
.. ...+++|||+++++|.+++......
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 54 5678999999999999998643210
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce-eeccccc
Q 009979 280 -----HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGT 353 (521)
Q Consensus 280 -----~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt 353 (521)
...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+....... .....++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 13688999999999999999999998 99999999999999999999999999998764332222 2234567
Q ss_pred ccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHH
Q 009979 354 FGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALK 432 (521)
Q Consensus 354 ~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 432 (521)
..|+|||++.+..++.++|||||||++|||++ |..||...... +.+.......... .. .... ..
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~~~-----~~-~~~~---~~ 303 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID------EEFCRRLKEGTRM-----RA-PEYA---TP 303 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc------HHHHHHHhccCCC-----CC-CccC---CH
Confidence 78999999999999999999999999999998 99999653321 1122222221110 00 1112 23
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 433 RALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 433 ~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
++.+++.+||+.+|++||++.+++++|+..
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 456688899999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=331.35 Aligned_cols=241 Identities=25% Similarity=0.362 Sum_probs=189.8
Q ss_pred ceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhc-CCCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGR-VRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~-l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
+.||+|+||.||+|.+. +++.||+|.+.... ....+.+..|..++.. .+||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 47789999986532 2233445567777765 4899999999999999999999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 9999998764 4688999999999999999999998 99999999999999999999999999998653322 22
Q ss_pred eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCc
Q 009979 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 426 (521)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........ .+.+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~-------~~~~~~-~ 218 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFDSILND-------RPHFPR-W 218 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcC-------CCCCCC-C
Confidence 3456799999999999999999999999999999999999999964331 2222222111 011111 1
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 009979 427 CSRALKRALLVALRCVDPNAHKRPKMG-HVIH 457 (521)
Q Consensus 427 ~~~~~~~~~~li~~cl~~dP~~RPt~~-evl~ 457 (521)
.+. .+.+++.+||+.||++||++. ++++
T Consensus 219 ~~~---~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 219 ISK---EAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCH---HHHHHHHHHccCCHHHcCCChHHHHc
Confidence 223 344578899999999999875 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=329.24 Aligned_cols=259 Identities=25% Similarity=0.460 Sum_probs=207.1
Q ss_pred CCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
..+|.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|+||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 346888899999999999999842 34568899887666666678999999999999999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC
Q 009979 259 LVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW 326 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~ 326 (521)
+||||+++++|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+|||++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999975421 224588999999999999999999998 999999999999999999
Q ss_pred CceEeecccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHH
Q 009979 327 NPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEW 404 (521)
Q Consensus 327 ~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~ 404 (521)
.+||+|||+++........ ......|+..|+|||++.+..++.++|||||||++|||+| |..||...... +.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------~~ 234 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT------EV 234 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HH
Confidence 9999999999865432211 1233456889999999999999999999999999999999 99998644321 11
Q ss_pred HHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 405 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
+.. +....... . ...++ ..+.+++.+||+.||++||++.+|+++|+..
T Consensus 235 ~~~-~~~~~~~~-----~-~~~~~---~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 235 IEC-ITQGRVLE-----R-PRVCP---KEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHH-HhCCCCCC-----C-CccCC---HHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111 11111111 0 11122 3455688899999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=326.02 Aligned_cols=253 Identities=23% Similarity=0.277 Sum_probs=200.6
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
.|+..+.||+|+||+||++... +++.||+|++..... .....+.+|+.+++.++||||+++++++..+...++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3778899999999999999964 588999999865322 223456789999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999999886542 35689999999999999999999998 9999999999999999999999999999875432
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
.. .....|++.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.+...+.... ..+
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~------~~~ 224 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKEDQ------EEY 224 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhcc------ccc
Confidence 21 233578999999999998899999999999999999999999997543211 1111111111110 011
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHML 459 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L 459 (521)
.......+.+++.+||+.||.+|| ++.+++.+-
T Consensus 225 ----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05605 225 ----SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHP 262 (285)
T ss_pred ----CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCc
Confidence 111223345588899999999999 888887553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=334.95 Aligned_cols=243 Identities=24% Similarity=0.319 Sum_probs=194.5
Q ss_pred ceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
++||+|+||.||+|... +++.||+|.+.... ......+..|++++..+ +||||+++++++......|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 47889999986542 23335567788888866 799999999999999999999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 9999998764 4688999999999999999999998 99999999999999999999999999998643222 22
Q ss_pred eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCc
Q 009979 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 426 (521)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......... ...+ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~------~~~~~~i~~~~----~~~p----~~ 218 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE------DDLFESILHDD----VLYP----VW 218 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC----CCCC----CC
Confidence 3446799999999999999999999999999999999999999974432 22222222211 1111 11
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCC-------CHHHHHHHh
Q 009979 427 CSRALKRALLVALRCVDPNAHKRP-------KMGHVIHML 459 (521)
Q Consensus 427 ~~~~~~~~~~li~~cl~~dP~~RP-------t~~evl~~L 459 (521)
.+. .+.+++.+||+.||++|| ++.+++++-
T Consensus 219 ~~~---~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 219 LSK---EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred CCH---HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 223 345588899999999999 788887553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=334.97 Aligned_cols=236 Identities=22% Similarity=0.318 Sum_probs=189.8
Q ss_pred ceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
+.||+|+||.||+|..+ +++.||+|.+.+.. ....+.+..|+.++..+ +||||+++++++......|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 57889999986532 23345667788888876 699999999999999999999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~ 152 (320)
T cd05590 81 GDLMFHIQKS----RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKT 152 (320)
T ss_pred chHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCc
Confidence 9999998765 4688999999999999999999998 9999999999999999999999999998864222 222
Q ss_pred eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCc
Q 009979 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 426 (521)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........ . .. +. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~-~---~~---~~-~~ 218 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILND-E---VV---YP-TW 218 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcC-C---CC---CC-CC
Confidence 3446799999999999999999999999999999999999999964432 2222222211 1 11 11 11
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCH
Q 009979 427 CSRALKRALLVALRCVDPNAHKRPKM 452 (521)
Q Consensus 427 ~~~~~~~~~~li~~cl~~dP~~RPt~ 452 (521)
.+. .+.+++.+||+.||++||++
T Consensus 219 ~~~---~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 LSQ---DAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCH---HHHHHHHHHcccCHHHCCCC
Confidence 223 34458889999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=321.38 Aligned_cols=257 Identities=24% Similarity=0.444 Sum_probs=206.2
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++..++|.+.+.||+|+||.||++.+.++..+|+|.+.... ...+.+.+|+++++.++|+||+++++++.+ ...+++|
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 45677999999999999999999998778889999876542 345678889999999999999999999887 7789999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 80 EFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999999997652 35678889999999999999999998 999999999999999999999999999987643
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
..........++..|+|||++....++.++|+|||||++|+++| |+.||...... ..... ...... .+
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~----~~~~~~----~~ 223 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRA----LERGYR----MP 223 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HhCCCC----CC
Confidence 32222223345678999999998899999999999999999999 99999643211 11111 111110 01
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
. .......+.+++.+||+.+|++||++.+++..|+.
T Consensus 224 ~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 R-----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred C-----cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 11222345568889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=322.44 Aligned_cols=255 Identities=26% Similarity=0.353 Sum_probs=202.7
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
.++|++.+.||+|+||.||+|... ++..||+|++..........+..|+.+++.++||||+++++++..+...++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 457999999999999999999964 6788999998765555556788899999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++++|.++++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 9999999998754 4688999999999999999999998 99999999999999999999999999998763322
Q ss_pred cceeeccccccccccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 344 SYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
. ......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+.... .... . .....+
T Consensus 161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~------~~~~-~---~~~~~~ 229 (267)
T cd06646 161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLMS-K---SNFQPP 229 (267)
T ss_pred c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh------eeee-c---CCCCCC
Confidence 1 123356889999999874 445788999999999999999999998644321111 0000 0 011111
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
.... .......+.+++.+||+.+|++||+++++++.|
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1111 112234555688899999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=325.02 Aligned_cols=266 Identities=24% Similarity=0.363 Sum_probs=198.3
Q ss_pred ccccceEccCCcEEEEEEEE-----cCCcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC--CeeeE
Q 009979 188 FADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRML 259 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~l 259 (521)
|.+.+.||+|+||+||++.+ .++..||+|.+..... .....+.+|+++++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988753 2567899999875433 3456788899999999999999999988653 35789
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
||||+++++|.+++... .+++..++.++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999999753 589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcce--eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 340 GAERSYV--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 340 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
....... .....++..|+|||.+.+..++.++||||||+++|||+||..||......- ...................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhh
Confidence 4322211 122345678999999988899999999999999999999999986432210 0000000000000000000
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
++..............+.+++.+||+.+|++||++.+++++|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111110000111223455688899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=329.14 Aligned_cols=263 Identities=25% Similarity=0.420 Sum_probs=207.3
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEcC------CcEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEe
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCA 252 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~ 252 (521)
+++..++|++.+.||+|+||.||++...+ ...+|+|.+.... ......+..|+++++.+ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 45667789999999999999999998642 3568999887543 23345688899999999 7999999999999
Q ss_pred eCCeeeEEEEeccCCchHHhhhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 009979 253 EGAHRMLVYEYIDNGNLEQWLHGDV------------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320 (521)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NI 320 (521)
.+...++||||+++|+|.++++... .....+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 9999999999999999999997532 2345789999999999999999999998 999999999999
Q ss_pred EeCCCCCceEeecccceecCCCCcce-eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCc
Q 009979 321 LLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGE 398 (521)
Q Consensus 321 Ll~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~ 398 (521)
|+++++.+||+|||+++.+....... .....++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--- 240 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--- 240 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---
Confidence 99999999999999998764332211 122345678999999988999999999999999999998 9999863321
Q ss_pred ccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 399 VNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.+..+....... . .. .......+.+++.+||+.||++|||+.++++.|+..
T Consensus 241 ---~~~~~~~~~~~~----~--~~----~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 241 ---EELFKLLKEGYR----M--EK----PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ---HHHHHHHHcCCc----C--CC----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 122222211110 0 01 111223455688899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=326.65 Aligned_cols=258 Identities=27% Similarity=0.449 Sum_probs=202.2
Q ss_pred CCCccccceEccCCcEEEEEEEE-----cCCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 185 TNGFADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
..+|++.+.||+|+||.||+|.+ .++..||+|.+.... ......+..|+++++.++||||+++++++..+...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 35788899999999999999984 245789999987533 334467889999999999999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC
Q 009979 259 LVYEYIDNGNLEQWLHGDVG-------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ 325 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~ 325 (521)
+||||+++++|.+++..... ....+++...+.++.|++.||+|||++ +++||||||+|||++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCC
Confidence 99999999999999864321 123578889999999999999999998 99999999999999999
Q ss_pred CCceEeecccceecCCCCc-ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHH
Q 009979 326 WNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVE 403 (521)
Q Consensus 326 ~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~ 403 (521)
+.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||....+ .+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~------~~ 234 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN------QE 234 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------HH
Confidence 9999999999986533221 11233446778999999988889999999999999999999 9999864321 11
Q ss_pred HHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 404 WLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 404 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
. ......... . + . ...++. .+.+++.+||+.||++||++.+|+++|..
T Consensus 235 ~-~~~~~~~~~---~-~-~-~~~~~~---~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 V-IEMVRKRQL---L-P-C-SEDCPP---RMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H-HHHHHcCCc---C-C-C-CCCCCH---HHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 111111110 0 0 1 111233 34458889999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=332.66 Aligned_cols=241 Identities=22% Similarity=0.311 Sum_probs=192.8
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeEEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~ 261 (521)
+|.+.+.||+|+||.||+|... ++..||+|.+.+.. ......+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999976 46789999987542 22234566788888777 5899999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 999999999998754 4688999999999999999999998 999999999999999999999999999985432
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
. ........||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+........ . ..
T Consensus 154 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~------~~~~~~i~~~-~------~~ 219 (323)
T cd05616 154 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEH-N------VA 219 (323)
T ss_pred C-CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH------HHHHHHHHhC-C------CC
Confidence 2 1223456799999999999999999999999999999999999999964332 1222222211 1 01
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCH
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKM 452 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~ 452 (521)
+.. ....++.+++.+|++.||.+|++.
T Consensus 220 ~p~----~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 YPK----SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCC----cCCHHHHHHHHHHcccCHHhcCCC
Confidence 111 122345568889999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=327.10 Aligned_cols=262 Identities=24% Similarity=0.403 Sum_probs=201.0
Q ss_pred CCccccceEccCCcEEEEEEEEc-----CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEee--CCeee
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRM 258 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~~ 258 (521)
.+|++.+.||+|+||.||++.+. ++..||+|.+........+.+..|+++++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 47888999999999999999742 477899999877666666789999999999999999999998754 34678
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999999764 24689999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCccee--ecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCC------c---ccHHHHHHH
Q 009979 339 LGAERSYVT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG------E---VNLVEWLKT 407 (521)
Q Consensus 339 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~------~---~~~~~~~~~ 407 (521)
......... ....++..|+|||++.+..++.++|||||||++|||++|..|+......- . ......+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 644332211 11223456999999998899999999999999999999887764321100 0 000011111
Q ss_pred HhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 408 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
...... .. .. ...++ ..+.+++.+||+.+|++|||+.+|+..|+..
T Consensus 238 ~~~~~~---~~--~~-~~~~~---~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLKNNG---RL--PA-PPGCP---AEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHhcCC---cC--CC-CCCCC---HHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111110 00 00 11122 3455588899999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=323.20 Aligned_cols=260 Identities=25% Similarity=0.453 Sum_probs=206.3
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcC------CcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~ 254 (521)
++..++|++.+.||+|+||.||+|...+ +..||+|.+.... ......+..|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 4566789999999999999999998642 3679999986543 23346788899999999999999999999999
Q ss_pred CeeeEEEEeccCCchHHhhhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCc
Q 009979 255 AHRMLVYEYIDNGNLEQWLHGDVG------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328 (521)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~v 328 (521)
...++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+|||++.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCE
Confidence 999999999999999999975432 123578899999999999999999998 99999999999999999999
Q ss_pred eEeecccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 009979 329 KLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLK 406 (521)
Q Consensus 329 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~ 406 (521)
||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||+| |..||..... .+..+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------~~~~~ 232 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN------EEVLK 232 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH------HHHHH
Confidence 99999999865433221 1233456889999999988889999999999999999998 9999864332 11122
Q ss_pred HHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 407 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
... .... +... ..++ ..+.+++.+||+.+|++|||+.+++..|+
T Consensus 233 ~~~-~~~~-----~~~~-~~~~---~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 FVI-DGGH-----LDLP-ENCP---DKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHh-cCCC-----CCCC-CCCC---HHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 211 1111 0111 1123 34556888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=322.25 Aligned_cols=260 Identities=25% Similarity=0.361 Sum_probs=201.1
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC-----eeeEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA-----HRMLV 260 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~-----~~~lV 260 (521)
+|...+++|.|.||.||+|... ++..||||++..++.- -.+|+++|+.+.|||||+|+-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 5777899999999999999965 4688999999776542 245999999999999999998886432 23589
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC-CCceEeecccceec
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFGLAKLL 339 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~-~~vkL~DFGla~~~ 339 (521)
||||+. +|.++++.....+..++...+.-+..|+++||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999987 99999986544567788888889999999999999998 99999999999999965 89999999999998
Q ss_pred CCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH-------hhc
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM-------VTN 411 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~-------~~~ 411 (521)
....... ....|..|.|||.+.+ ..|+.+.||||.|||+.||+-|+.-|.+... ...+.++++-+ +..
T Consensus 177 ~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 177 VKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHHHhCCCCHHHHhh
Confidence 6655443 3356889999998866 5699999999999999999999999976432 23333333321 111
Q ss_pred --cccccCCCcccCCCc-----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 412 --RNAEGVLDPRLQEKP-----CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 412 --~~~~~~~d~~l~~~~-----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+..+...|.+...+ ......++++++.+++..+|.+|.++.|++.+
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 111123333333322 22344567779999999999999999998743
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=323.66 Aligned_cols=265 Identities=25% Similarity=0.421 Sum_probs=202.6
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-----------------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCee
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-----------------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLV 245 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv 245 (521)
+.++|++.+.||+|+||.||++.+. +...||+|.+.... ......+..|+++++.++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 4567999999999999999998643 23358999887543 33456789999999999999999
Q ss_pred eEEEEEeeCCeeeEEEEeccCCchHHhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 009979 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVG-------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318 (521)
Q Consensus 246 ~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~ 318 (521)
++++++......++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence 999999999999999999999999999976432 123577889999999999999999998 9999999999
Q ss_pred CeEeCCCCCceEeecccceecCCCCcce-eecccccccccccccccCCCCCCcccchhHHHHHHHHHh--CCCCCCCCCC
Q 009979 319 NILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRNPVDYSRP 395 (521)
Q Consensus 319 NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt--G~~Pf~~~~~ 395 (521)
|||++.++.+||+|||+++.+....... .....+++.|+|||...++.++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 9999999999999999998653322211 222345678999999888889999999999999999998 7788854322
Q ss_pred CCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
.. .............. ....+ ....++ ..+.+++.+||+.||++||++.+|++.|+
T Consensus 240 ~~---~~~~~~~~~~~~~~-~~~~~--~~~~~~---~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 EQ---VIENTGEFFRDQGR-QVYLP--KPALCP---DSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HH---HHHHHHHHHhhccc-cccCC--CCCCCC---HHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11 11111111111100 01111 111233 34555888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=322.66 Aligned_cols=254 Identities=26% Similarity=0.456 Sum_probs=199.4
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCc----EEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNT----NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
++|++.+.||+|+||+||+|.+. ++. .+++|.+..... ....++..|+.+++.+.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46788899999999999999964 344 477787754332 234677888999999999999999998864 45789
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
++||+++|+|.++++.. ...+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999999765 35689999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCc-ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 340 GAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 340 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
..... .......++..|+|||++.++.++.++|||||||++|||++ |..||....+.. . ...+.... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~----~~~~~~~~--~~ 230 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---V----PDLLEKGE--RL 230 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHCCC--cC
Confidence 43322 22234557789999999998899999999999999999998 999996543211 1 11122111 11
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
..+ ..++. .+..++.+||+.||++||++.|+++.|...
T Consensus 231 ~~~----~~~~~---~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 231 AQP----QICTI---DVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred CCC----CCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111 11332 344588899999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=318.46 Aligned_cols=247 Identities=26% Similarity=0.426 Sum_probs=197.4
Q ss_pred ceEccCCcEEEEEEEEcCCcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCCchH
Q 009979 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLE 270 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L~ 270 (521)
++||+|+||.||+|...++..+|+|.+..... .....+..|+++++.++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988888999998865433 33456888999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcceeecc
Q 009979 271 QWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350 (521)
Q Consensus 271 ~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 350 (521)
+++... ...+++..++.++.+++.||.|||+. +++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 998764 24678999999999999999999998 999999999999999999999999999976433222222223
Q ss_pred cccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHH
Q 009979 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429 (521)
Q Consensus 351 ~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 429 (521)
.++..|+|||++.+..++.++||||||+++||+++ |..||...... ........ .. ..... ...+
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~------~~~~~~~~-~~-----~~~~~-~~~~- 220 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ------QAREQVEK-GY-----RMSCP-QKCP- 220 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHHc-CC-----CCCCC-CCCC-
Confidence 44678999999998899999999999999999999 99999644221 11111111 10 00111 1122
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 430 ALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 430 ~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
..+.+++.+||+.+|++||++.++++.|.
T Consensus 221 --~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 --DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred --HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 34555888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=318.87 Aligned_cols=259 Identities=23% Similarity=0.365 Sum_probs=207.3
Q ss_pred CCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|++.+.||+|+||.||+|.. .++..+|||.+.... .....++..|+.+++.++|+||+++++++.++...++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688899999999999999995 478899999876432 223467888999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999875433346789999999999999999999998 999999999999999999999999999886643
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||..... ...+..+.... ...+.
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~------~~~~~ 227 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQ------CDYPP 227 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhhhhc------CCCCC
Confidence 322 22345689999999999888899999999999999999999999964321 11222222111 11111
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
......+ ..+.+++.+||+.||++|||+.+|++++..
T Consensus 228 ~~~~~~~---~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 228 LPSDHYS---EELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCccccc---HHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 1111223 345558889999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=331.28 Aligned_cols=243 Identities=24% Similarity=0.325 Sum_probs=193.6
Q ss_pred ceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
+.||+|+||.||+|... +++.||+|.+..... ...+.+..|+.++.++ +||||+++++++......|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 578899999975422 2345678899999888 699999999999999999999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 9999988654 4689999999999999999999998 99999999999999999999999999997532221 22
Q ss_pred eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCc
Q 009979 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 426 (521)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.........+..+++......... .+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~p~-~ 225 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RIPR-F 225 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CCCC-C
Confidence 34567999999999999999999999999999999999999999754433333333333333322111 1111 1
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCH
Q 009979 427 CSRALKRALLVALRCVDPNAHKRPKM 452 (521)
Q Consensus 427 ~~~~~~~~~~li~~cl~~dP~~RPt~ 452 (521)
.+ ..+.+++.+||+.||.+|+++
T Consensus 226 ~~---~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 226 LS---VKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CC---HHHHHHHHHHhccCHHHcCCC
Confidence 22 234458889999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=324.02 Aligned_cols=265 Identities=25% Similarity=0.436 Sum_probs=201.5
Q ss_pred cCCCccccceEccCCcEEEEEEEEcC---------------CcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLED---------------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRL 247 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l 247 (521)
+.++|++.+.||+|+||.||++...+ ...||+|.+.... ......+..|++++++++|+|++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 45689999999999999999987542 1248999886543 3344678999999999999999999
Q ss_pred EEEEeeCCeeeEEEEeccCCchHHhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 009979 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVG--------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN 319 (521)
Q Consensus 248 ~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~N 319 (521)
++++......++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 9999999999999999999999999865311 112478889999999999999999998 99999999999
Q ss_pred eEeCCCCCceEeecccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh--CCCCCCCCCCC
Q 009979 320 ILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRNPVDYSRPP 396 (521)
Q Consensus 320 ILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt--G~~Pf~~~~~~ 396 (521)
||+++++.+||+|||++......... ......++..|+|||++.++.++.++|||||||++|||++ |..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 99999999999999999865332221 1223345779999999988899999999999999999998 66777543221
Q ss_pred CcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 397 GEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
................... . .....+. .+.+++.+||+.||++||++.+|++.|+
T Consensus 240 ---~~~~~~~~~~~~~~~~~~~--~-~~~~~~~---~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 ---QVIENTGEFFRNQGRQIYL--S-QTPLCPS---PVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ---HHHHHHHHhhhhccccccC--C-CCCCCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111111111000000 0 1111223 4556888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=332.32 Aligned_cols=240 Identities=21% Similarity=0.321 Sum_probs=190.5
Q ss_pred ceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
+.||+|+||.||+|.+. ++..||+|.+.... ......+..|..++..+ +||||+++++++.+....|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999975 57889999986532 22335566788888754 899999999999999999999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 9999998764 4688999999999999999999998 99999999999999999999999999987532221 22
Q ss_pred eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCc
Q 009979 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 426 (521)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........ .+.+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~------~~~~~~~~~~-------~~~~~~-~ 218 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE------DELFESIRVD-------TPHYPR-W 218 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC-------CCCCCC-C
Confidence 3456799999999999999999999999999999999999999964321 1222221111 111111 1
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 009979 427 CSRALKRALLVALRCVDPNAHKRPKMG-HVI 456 (521)
Q Consensus 427 ~~~~~~~~~~li~~cl~~dP~~RPt~~-evl 456 (521)
... ++.+++.+||+.||++||++. +++
T Consensus 219 ~~~---~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ITK---ESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCH---HHHHHHHHHccCCHHHcCCChHHHH
Confidence 233 344588899999999999984 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=327.01 Aligned_cols=256 Identities=23% Similarity=0.284 Sum_probs=197.6
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|++.+.||+|+||.||++... +++.||+|.+.+. .....+.+..|+.++..++|+||+++++++.++.+.|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999965 5888999998642 2223456888999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++|+|.+++.+. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999999764 35688999999999999999999998 999999999999999999999999999987644
Q ss_pred CCcceeecccccccccccccccC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||.... ..+.............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~------~~~~~~~i~~~~~~~~ 228 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKEHFQ 228 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC------HHHHHHHHHcCCCccc
Confidence 33333334579999999999863 457889999999999999999999996432 2222233222111111
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCC--CCCCCCCHHHHHHHh
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDP--NAHKRPKMGHVIHML 459 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~--dP~~RPt~~evl~~L 459 (521)
+ .+. ....+..... ++.+|+.. ++..||++.+++.+-
T Consensus 229 ~-~~~--~~~~~~~~~~---li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 229 F-PPD--VTDVSEEAKD---LIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred C-CCc--cCCCCHHHHH---HHHHHccCcccccCCCCHHHHhcCC
Confidence 1 111 0112334444 55566644 444488999988664
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=347.48 Aligned_cols=263 Identities=23% Similarity=0.307 Sum_probs=193.8
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC--------
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-------- 254 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-------- 254 (521)
..++|.+.+.||+|+||.||+|... ++..||||++.... ....+|+.+|+.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4568999999999999999999965 57899999886532 2345699999999999999999886432
Q ss_pred CeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC-CceEeec
Q 009979 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDF 333 (521)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~-~vkL~DF 333 (521)
..+++||||+++ +|.+++.........+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 246789999975 78877765433456789999999999999999999998 999999999999998665 6999999
Q ss_pred ccceecCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh--
Q 009979 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT-- 410 (521)
Q Consensus 334 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-- 410 (521)
|+++.+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||....... .+...++..-.
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~~~~~p~ 291 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQVLGTPT 291 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCC
Confidence 99987643222 234578999999998865 469999999999999999999999997543211 11111110000
Q ss_pred -------ccccccCCCcccCCC-----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 411 -------NRNAEGVLDPRLQEK-----PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 411 -------~~~~~~~~d~~l~~~-----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
......+.-+..... .......++.+|+.+||+.||.+|||+.|++.+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000000000111100 001122456678999999999999999999844
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=319.14 Aligned_cols=247 Identities=27% Similarity=0.429 Sum_probs=195.1
Q ss_pred ceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCCch
Q 009979 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL 269 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L 269 (521)
+.||+|+||.||+|.+. +++.||+|.+.... .+....+..|+++++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999964 68889999876543 34456789999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCccee-e
Q 009979 270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT-T 348 (521)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~-~ 348 (521)
.+++... ...+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++........... .
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9999754 34688999999999999999999998 999999999999999999999999999986532211111 1
Q ss_pred cccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCcc
Q 009979 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPC 427 (521)
Q Consensus 349 ~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 427 (521)
...++..|+|||.+.++.++.++|||||||++|||++ |..||...... . ......... .... ...+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~------~-~~~~~~~~~-----~~~~-~~~~ 221 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ------Q-TREAIEQGV-----RLPC-PELC 221 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH------H-HHHHHHcCC-----CCCC-cccC
Confidence 1123457999999999999999999999999999998 88898643211 1 111111110 0011 1112
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 428 SRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 428 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
+ ..+.+++.+||+.+|++||++.+++++|+
T Consensus 222 ~---~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 P---DAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred C---HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 3 34555888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=330.57 Aligned_cols=240 Identities=24% Similarity=0.338 Sum_probs=190.3
Q ss_pred ceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhc-CCCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGR-VRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~-l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
+.||+|+||+||+|.+. ++..||+|.+.... ......+..|..++.. ++||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 47789999986542 2233456667788875 4899999999999999999999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05619 81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence 9999999754 4688899999999999999999998 99999999999999999999999999997542221 22
Q ss_pred eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCc
Q 009979 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 426 (521)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........ .+.+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~i~~~-------~~~~~~-~ 218 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE------EELFQSIRMD-------NPCYPR-W 218 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC-------CCCCCc-c
Confidence 3346799999999999999999999999999999999999999964331 1222221111 111111 1
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHH-HHH
Q 009979 427 CSRALKRALLVALRCVDPNAHKRPKMG-HVI 456 (521)
Q Consensus 427 ~~~~~~~~~~li~~cl~~dP~~RPt~~-evl 456 (521)
.+. .+.+++.+||+.||++||++. ++.
T Consensus 219 ~~~---~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 219 LTR---EAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCH---HHHHHHHHHhccCHhhcCCChHHHH
Confidence 223 344578899999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=318.10 Aligned_cols=251 Identities=26% Similarity=0.388 Sum_probs=200.9
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh-----hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-----QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
++|...+.||+|+||.||+|... ++..||+|.+..... .....+.+|++++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999864 588999998864321 123568889999999999999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 99999999999998764 4688899999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCccee--ecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 340 GAERSYVT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 340 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
........ ....|+..|+|||++.+..++.++||||||+++|||++|+.||..... ............
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~---- 224 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQPT---- 224 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch------HHHHHHHhccCC----
Confidence 43222111 235678899999999998999999999999999999999999964321 111111111111
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+.+.. ..+. .+.+++.+||..+|.+|||+.+++.+
T Consensus 225 -~~~~~~-~~~~---~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 -NPQLPS-HVSP---DARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCCCc-cCCH---HHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111111 1223 34558889999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=332.27 Aligned_cols=238 Identities=25% Similarity=0.315 Sum_probs=191.4
Q ss_pred ceEccCCcEEEEEEEE----cCCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEecc
Q 009979 192 NVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (521)
+.||+|+||.||++.. .+++.||+|++..... .....+..|++++++++||||+++++++.++...|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 3578899999865432 223456779999999999999999999999999999999999
Q ss_pred CCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcc
Q 009979 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (521)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~ 345 (521)
+|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 153 (318)
T cd05582 82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K 153 (318)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence 99999999754 4689999999999999999999998 99999999999999999999999999998653322 2
Q ss_pred eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCC
Q 009979 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425 (521)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 425 (521)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+......... . .+..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~~~~-~------~~p~- 219 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMILKAK-L------GMPQ- 219 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHHcCC-C------CCCC-
Confidence 23346799999999999988899999999999999999999999964321 22222222111 0 1111
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 009979 426 PCSRALKRALLVALRCVDPNAHKRPKMGH 454 (521)
Q Consensus 426 ~~~~~~~~~~~li~~cl~~dP~~RPt~~e 454 (521)
..+. .+.+++.+||+.||++||++.+
T Consensus 220 ~~~~---~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSP---EAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCH---HHHHHHHHHhhcCHhHcCCCCC
Confidence 1222 3445888999999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=329.34 Aligned_cols=237 Identities=27% Similarity=0.317 Sum_probs=187.7
Q ss_pred ceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHH-HHhcCCCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVE-AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~-~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
+.||+|+||+||+|... +++.||+|.+..... .....+..|.. +++.++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 688999999864321 22234444444 56889999999999999999999999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
|+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (323)
T cd05575 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKT 152 (323)
T ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCc
Confidence 9999998764 4688999999999999999999998 9999999999999999999999999999753222 222
Q ss_pred eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCc
Q 009979 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 426 (521)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... ..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~-------~~~~~~- 218 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------TAEMYDNILNKP-------LRLKPN- 218 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC------HHHHHHHHHcCC-------CCCCCC-
Confidence 345679999999999999999999999999999999999999996432 222222222211 011111
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHH
Q 009979 427 CSRALKRALLVALRCVDPNAHKRPKMG 453 (521)
Q Consensus 427 ~~~~~~~~~~li~~cl~~dP~~RPt~~ 453 (521)
.+ ..+.+++.+||+.||.+||++.
T Consensus 219 ~~---~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 IS---VSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CC---HHHHHHHHHHhhcCHHhCCCCC
Confidence 12 3345588899999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=320.73 Aligned_cols=265 Identities=26% Similarity=0.442 Sum_probs=204.8
Q ss_pred cCCCccccceEccCCcEEEEEEEEcC-----------------CcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCee
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLED-----------------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLV 245 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv 245 (521)
...+|++.+.||+|+||.||+|...+ +..||+|.+.... ....+.+..|+++++.++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 34578999999999999999998542 2458999887543 33457788999999999999999
Q ss_pred eEEEEEeeCCeeeEEEEeccCCchHHhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 009979 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVG-------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318 (521)
Q Consensus 246 ~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~ 318 (521)
++++++..+...++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchh
Confidence 999999999999999999999999999976531 123689999999999999999999998 9999999999
Q ss_pred CeEeCCCCCceEeecccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh--CCCCCCCCCC
Q 009979 319 NILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS--GRNPVDYSRP 395 (521)
Q Consensus 319 NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt--G~~Pf~~~~~ 395 (521)
||++++++.++|+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 999999999999999999865433221 2234456789999999988889999999999999999998 6778753321
Q ss_pred CCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
......+.............+ ....++ .++.+++.+||+.||++||++.+|++.|+
T Consensus 240 ---~~~~~~~~~~~~~~~~~~~~~---~~~~~~---~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 ---QQVIENAGHFFRDDGRQIYLP---RPPNCP---KDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---HHHHHHHHhccccccccccCC---CccCCC---HHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111222221111111000000 011122 35566888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=338.53 Aligned_cols=261 Identities=23% Similarity=0.334 Sum_probs=198.3
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC-----eee
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA-----HRM 258 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~-----~~~ 258 (521)
+|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+++++.++||||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999964 6889999998643 2234467888999999999999999999998776 789
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+||||+. ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 5888887654 5789999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCcceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccc----
Q 009979 339 LGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN---- 413 (521)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---- 413 (521)
.............+|+.|+|||++.+. .++.++|||||||++|||++|+.||....+.... +.+........
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~g~~~~~~~ 229 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL---DLITDLLGTPSLEAM 229 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHcCCCCHHHH
Confidence 644333333445689999999998764 5899999999999999999999999755432111 11111000000
Q ss_pred -----------cccCCC-cccCC--CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 414 -----------AEGVLD-PRLQE--KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 414 -----------~~~~~d-~~l~~--~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
...... +.... .........+.+++.+||+.||++|||+.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000 00000 0001113345668889999999999999999865
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=324.00 Aligned_cols=259 Identities=27% Similarity=0.461 Sum_probs=201.8
Q ss_pred hcCCCccccceEccCCcEEEEEEEEcC------CcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 255 (521)
+..++|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ......+..|+.+++.++|+||+++++++.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 345678999999999999999999753 4568888876443 334467888999999999999999999999888
Q ss_pred eeeEEEEeccCCchHHhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC---Cce
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW---NPK 329 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~---~vk 329 (521)
..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|||++.++ .+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceE
Confidence 89999999999999999976531 123689999999999999999999998 999999999999998654 599
Q ss_pred EeecccceecCCCCcce-eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHH
Q 009979 330 LSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKT 407 (521)
Q Consensus 330 L~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 407 (521)
|+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||...... +....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~------~~~~~ 233 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ------EVMEF 233 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH
Confidence 99999998763222111 112234568999999998999999999999999999997 99999744321 11111
Q ss_pred HhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 408 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
....... .. ....+ ..+.+++.+||+.+|++||++.+|++.|+
T Consensus 234 ~~~~~~~------~~-~~~~~---~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGGGRL------DP-PKGCP---GPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcCCcC------CC-CCCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111110 01 11122 34555888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=312.77 Aligned_cols=250 Identities=26% Similarity=0.447 Sum_probs=203.4
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
+|++.+.||+|+||.||+|... ++..|++|.+... .......+..|+++++.++||||+++++++.+....++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999965 5888999988643 234456788999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++++|.++++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999998652 35788999999999999999999998 99999999999999999999999999998765432
Q ss_pred cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
.. .....|++.|+|||++.+..++.++|+|||||++|||++|+.||..... .+....... . ...+ +.
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~----~~~~-~~ 222 (256)
T cd08529 156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ------GALILKIIR-G----VFPP-VS 222 (256)
T ss_pred ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHc-C----CCCC-Cc
Confidence 22 2345689999999999999999999999999999999999999964431 111222211 1 1111 11
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
......+.+++.+||+.+|++||++.++++.
T Consensus 223 ----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 223 ----QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ----cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1222345568889999999999999999854
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=341.24 Aligned_cols=203 Identities=25% Similarity=0.363 Sum_probs=167.5
Q ss_pred hhhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCC------CCeeeEEEEE
Q 009979 179 RELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH------KNLVRLLGYC 251 (521)
Q Consensus 179 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h------pniv~l~~~~ 251 (521)
++++...++|++.++||+|+||+||+|.+. .++.||||++.... ....++..|+++++.++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 345566789999999999999999999965 57789999986432 223455667777776654 4588999988
Q ss_pred eeC-CeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEeCCCC---
Q 009979 252 AEG-AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQW--- 326 (521)
Q Consensus 252 ~~~-~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~iiHrDik~~NILl~~~~--- 326 (521)
... .+.++|||++ +++|.+++.+. ..+++..+..|+.|++.||+|||+ . +|+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence 764 5788999988 77999988754 478999999999999999999997 5 899999999999998665
Q ss_pred -------------CceEeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 009979 327 -------------NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393 (521)
Q Consensus 327 -------------~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~ 393 (521)
.+||+|||.+.... ...+..+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 49999999886432 2234568999999999999999999999999999999999999999754
Q ss_pred C
Q 009979 394 R 394 (521)
Q Consensus 394 ~ 394 (521)
.
T Consensus 349 ~ 349 (467)
T PTZ00284 349 D 349 (467)
T ss_pred C
Confidence 4
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=320.24 Aligned_cols=262 Identities=23% Similarity=0.367 Sum_probs=207.0
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcC-----CcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEee-C
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-G 254 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-~ 254 (521)
.+..++|.+.+.||+|+||.||+|.+.+ +..|++|.+.... ......+..|+.+++.++|+||+++++++.. +
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 3466789999999999999999999765 6778999886542 3345678889999999999999999998766 4
Q ss_pred CeeeEEEEeccCCchHHhhhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceE
Q 009979 255 AHRMLVYEYIDNGNLEQWLHGDVGP----HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKL 330 (521)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~----~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL 330 (521)
...++++||+.+++|.+++...... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEE
Confidence 6788999999999999999765321 15689999999999999999999998 9999999999999999999999
Q ss_pred eecccceecCCCCcce-eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHH
Q 009979 331 SDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTM 408 (521)
Q Consensus 331 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 408 (521)
+|||+++.+....... .....++..|+|||++.+..++.++|||||||++||+++ |+.||....+ .++....
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~ 232 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP------FEMAAYL 232 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH------HHHHHHH
Confidence 9999998654332221 122346778999999988889999999999999999999 9999964432 2222211
Q ss_pred hhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 409 VTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 409 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.. .. ..... ..++. .+.+++.+||..||++|||+.++++.|+..
T Consensus 233 ~~-~~-----~~~~~-~~~~~---~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 233 KD-GY-----RLAQP-INCPD---ELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred Hc-CC-----CCCCC-CcCCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11 10 00111 11233 345588899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=331.39 Aligned_cols=242 Identities=24% Similarity=0.331 Sum_probs=193.9
Q ss_pred ceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
+.||+|+||.||+|.+. ++..||+|.+.+.. ......+..|++++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 47789999987542 23345667788999888 699999999999999999999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (318)
T cd05570 81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT 152 (318)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence 9999988764 4689999999999999999999998 99999999999999999999999999997532221 22
Q ss_pred eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCc
Q 009979 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 426 (521)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ . ..+. ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~------~~~~~~~i~~~-~------~~~~-~~ 218 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD------EDELFQSILED-E------VRYP-RW 218 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC------HHHHHHHHHcC-C------CCCC-Cc
Confidence 334579999999999999999999999999999999999999996433 11222222111 1 0111 11
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 009979 427 CSRALKRALLVALRCVDPNAHKRPKM-----GHVIHM 458 (521)
Q Consensus 427 ~~~~~~~~~~li~~cl~~dP~~RPt~-----~evl~~ 458 (521)
.+ ..+.+++.+||+.||.+||++ .++++.
T Consensus 219 ~~---~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 219 LS---KEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CC---HHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 22 344558889999999999999 877654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=325.18 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=201.6
Q ss_pred CccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 187 GFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
+|++.+.||+|+||.||+|... ....+++|.+..... .....+..|+.+++.++||||+++++.+......++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999853 224688888765433 334678899999999999999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 009979 260 VYEYIDNGNLEQWLHGDVG--------------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN 319 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~N 319 (521)
||||+.+++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999999865321 124588999999999999999999998 99999999999
Q ss_pred eEeCCCCCceEeecccceecCCCCcce-eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 009979 320 ILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPG 397 (521)
Q Consensus 320 ILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~ 397 (521)
||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||+| |..||....+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 999999999999999998653332221 223346778999999988899999999999999999999 99999644321
Q ss_pred cccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 398 EVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.+.+. .... ..... ...++ ..+.+++.+||+.+|++||++.++++.|+..
T Consensus 237 --~~~~~----~~~~-----~~~~~-~~~~~---~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 237 --RLFNL----LKTG-----YRMER-PENCS---EEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred --HHHHH----HhCC-----CCCCC-CCCCC---HHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 11111 1111 00111 11122 3455688899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=321.16 Aligned_cols=257 Identities=25% Similarity=0.466 Sum_probs=204.0
Q ss_pred CCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
..+|...++||+|+||.||++... ++..+|+|.+..........+..|+++++.++|+||+++++++.+....+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 457788999999999999999742 35578999887766666678999999999999999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCC
Q 009979 259 LVYEYIDNGNLEQWLHGDVG-----------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN 327 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~ 327 (521)
+||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 99999999999999975421 113588999999999999999999998 9999999999999999999
Q ss_pred ceEeecccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHH
Q 009979 328 PKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWL 405 (521)
Q Consensus 328 vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~ 405 (521)
+||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||...... +.+
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~ 234 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT------EAI 234 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH------HHH
Confidence 999999999865432211 1122345788999999999999999999999999999998 99998643221 111
Q ss_pred HHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 406 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
........ . . ....++.. +.+++.+||+.||++||++.+|++.|+
T Consensus 235 ~~~~~~~~---~---~-~~~~~~~~---~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ECITQGRE---L---E-RPRTCPPE---VYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHcCcc---C---C-CCCCCCHH---HHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11111110 0 0 11123333 445888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=326.06 Aligned_cols=256 Identities=21% Similarity=0.261 Sum_probs=198.7
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|.+.+.||+|+||+||+++.. ++..||+|.+.+.. ......+..|+.++..++|+||+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999965 57789999886422 223355788999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999764 24688999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcceeecccccccccccccccC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
..........||+.|+|||++.+ +.++.++|||||||++|||++|+.||.... ..+............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~~~- 227 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHEERF- 227 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC------HHHHHHHHHcCCCcc-
Confidence 43333344679999999998865 568899999999999999999999996432 222223222211100
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHh
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHK--RPKMGHVIHML 459 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~evl~~L 459 (521)
-+... ......++.+++.+|+..++++ |+++.+++++-
T Consensus 228 ~~p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 228 QFPSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred cCCCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 01111 1112234455777888765544 46788887553
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=339.67 Aligned_cols=263 Identities=24% Similarity=0.411 Sum_probs=205.5
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcCC-CCCeeeEEEEEe
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVR-HKNLVRLLGYCA 252 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~ 252 (521)
+++..++|.+.+.||+|+||.||+|.+. .+..||+|++..... ...+.+..|+++|..+. ||||++++++|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4566678889999999999999999863 245799999975432 33456889999999997 999999999999
Q ss_pred eCCeeeEEEEeccCCchHHhhhcCCC------------------------------------------------------
Q 009979 253 EGAHRMLVYEYIDNGNLEQWLHGDVG------------------------------------------------------ 278 (521)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~~------------------------------------------------------ 278 (521)
.....++||||+.+|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999975421
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 009979 279 ----------------------------------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318 (521)
Q Consensus 279 ----------------------------------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~ 318 (521)
....+++...+.++.|++.||+|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 112467778899999999999999998 9999999999
Q ss_pred CeEeCCCCCceEeecccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCC
Q 009979 319 NILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPP 396 (521)
Q Consensus 319 NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~ 396 (521)
|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~- 347 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM- 347 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-
Confidence 999999999999999999865332211 1223457889999999998889999999999999999998 8999864321
Q ss_pred CcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 397 GEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
.+.......... .+.. +..++. .+.+++.+||..+|.+||++.+|++.|+.
T Consensus 348 -----~~~~~~~~~~~~-----~~~~-p~~~~~---~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 348 -----NEQFYNAIKRGY-----RMAK-PAHASD---EIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred -----hHHHHHHHHcCC-----CCCC-CCCCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111122222111 0011 111233 44558889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=321.32 Aligned_cols=266 Identities=26% Similarity=0.440 Sum_probs=206.4
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcC------CcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~ 254 (521)
++..++|++.+.||+|+||.||+|..++ +..||+|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 5667899999999999999999997532 4479999876443 22335678899999999999999999999998
Q ss_pred CeeeEEEEeccCCchHHhhhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCc
Q 009979 255 AHRMLVYEYIDNGNLEQWLHGDVG------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328 (521)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~v 328 (521)
...++||||+++|+|.++++.... ....+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 999999999999999999975321 124456788899999999999999998 99999999999999999999
Q ss_pred eEeecccceecCCCCcce-eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 009979 329 KLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLK 406 (521)
Q Consensus 329 kL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~ 406 (521)
||+|||+++......... .....++..|+|||.+.++.++.++|||||||++|||++ |..||..... .+..+
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~------~~~~~ 232 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN------EQVLK 232 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHH
Confidence 999999998653322211 122345778999999998899999999999999999999 7889864322 22222
Q ss_pred HHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCc
Q 009979 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPF 466 (521)
Q Consensus 407 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 466 (521)
........ ... ..++ ..+.+++.+||+.||++||++.++++.|+....++
T Consensus 233 ~~~~~~~~------~~~-~~~~---~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~ 282 (288)
T cd05061 233 FVMDGGYL------DQP-DNCP---ERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 282 (288)
T ss_pred HHHcCCCC------CCC-CCCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCC
Confidence 22211110 011 1122 34555888999999999999999999998765443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=328.20 Aligned_cols=255 Identities=22% Similarity=0.268 Sum_probs=196.7
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|++.++||+|+||+||++... ++..||+|.+.+.. ......+..|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999976 46779999885421 223345788999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++|+|.+++++. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999764 24688999999999999999999998 999999999999999999999999999986543
Q ss_pred CCcceeeccccccccccccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
.........+||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+.............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~~~~ 228 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKERFQ 228 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCcccc
Confidence 3333334467999999999885 3568899999999999999999999996432 2233333332211000
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCC--CCCCCHHHHHHH
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNA--HKRPKMGHVIHM 458 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP--~~RPt~~evl~~ 458 (521)
+... ....+.. +.+++.+|+..++ ..|+++.+++++
T Consensus 229 -~p~~--~~~~s~~---~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 -FPAQ--VTDVSED---AKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -CCCc--cccCCHH---HHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0000 0112333 4446667775544 447899998855
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=318.85 Aligned_cols=258 Identities=25% Similarity=0.398 Sum_probs=204.4
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcCC----cEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLEDN----TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 256 (521)
++..++|.+.+.||+|+||.||+|.+.+. ..||+|...... ....+.+..|+.+++.++||||+++++++.+ ..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 34566789999999999999999986432 468999886654 4455789999999999999999999999876 45
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.++||||+++|+|.+++... ...+++..++.++.+++.||+|||+. +++||||||+|||++.++.+||+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCcee
Confidence 78999999999999999765 24689999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
+..............++..|+|||.+....++.++||||||+++||+++ |..||...... +..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~~~~~~~-- 226 (270)
T cd05056 155 RYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN------DVIGRIENGER-- 226 (270)
T ss_pred eecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHcCCc--
Confidence 8765443333333345678999999988889999999999999999996 99999644321 11111111110
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
. .. ...++. .+.+++.+||..+|.+|||+.+++..|+..
T Consensus 227 -~---~~-~~~~~~---~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 227 -L---PM-PPNCPP---TLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred -C---CC-CCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 01 111333 445588899999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=319.05 Aligned_cols=248 Identities=25% Similarity=0.303 Sum_probs=194.2
Q ss_pred EccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCCch
Q 009979 194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL 269 (521)
Q Consensus 194 LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L 269 (521)
||+|+||.||++... +++.||+|.+..... .....+..|+++++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999965 588999999864321 2234556799999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcceeec
Q 009979 270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR 349 (521)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 349 (521)
.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....... ....
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 99886542 34688899999999999999999998 99999999999999999999999999998764322 2234
Q ss_pred ccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHH
Q 009979 350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429 (521)
Q Consensus 350 ~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 429 (521)
..|+..|+|||++.+..++.++|||||||++|||++|+.||...... ....+........ .+. ......+.
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~-----~~~--~~~~~~~~ 224 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--VAKEELKRRTLED-----EVK--FEHQNFTE 224 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch--hhHHHHHHHhhcc-----ccc--cccccCCH
Confidence 57899999999999888999999999999999999999999643321 1112222221111 010 11111233
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 430 ALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 430 ~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
++.+++.+||+.||++||++.|+++.+.
T Consensus 225 ---~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 225 ---ESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred ---HHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 3455888999999999999977664443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=315.70 Aligned_cols=255 Identities=22% Similarity=0.403 Sum_probs=199.5
Q ss_pred ccccceEccCCcEEEEEEEEcC----CcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe-----
Q 009979 188 FADENVIGEGGYGIVYHGVLED----NTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH----- 256 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~----- 256 (521)
|.+.+.||+|+||.||+|.... +..||+|.+.... ......+..|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998642 3679999987542 2334678899999999999999999998866554
Q ss_pred -eeEEEEeccCCchHHhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeec
Q 009979 257 -RMLVYEYIDNGNLEQWLHGDVG--PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (521)
Q Consensus 257 -~~lV~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DF 333 (521)
.++||||+++|+|..++..... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 6899999999999999855321 234689999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCcce-eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhc
Q 009979 334 GLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTN 411 (521)
Q Consensus 334 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (521)
|+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||..... .+..+.....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~------~~~~~~~~~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN------HEIYDYLRHG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcC
Confidence 9998764332221 122335678999999998999999999999999999999 8899864332 2222222221
Q ss_pred cccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 412 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
.. ... ...++ ..+.+++.+||+.||++||++.++++.|+.
T Consensus 232 ~~------~~~-~~~~~---~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 232 NR------LKQ-PEDCL---DELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred CC------CCC-CcCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11 011 11122 345568889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=322.45 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=202.1
Q ss_pred CCccccceEccCCcEEEEEEEEcC------CcEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 186 NGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
.+|.+.+.||+|+||.||+|.+.+ +..||+|.+...... ..+.+..|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 457888999999999999998632 467999998754332 3467889999999999999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC
Q 009979 259 LVYEYIDNGNLEQWLHGDV------------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW 326 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~ 326 (521)
+++||+.+++|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985321 1124578888999999999999999998 999999999999999999
Q ss_pred CceEeecccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHH
Q 009979 327 NPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEW 404 (521)
Q Consensus 327 ~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~ 404 (521)
.+||+|||+++........ ......+++.|+|||.+.++.++.++|||||||++|||++ |..||..... .++
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~ 235 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDV 235 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------HHH
Confidence 9999999998865433221 1233456789999999988889999999999999999998 8888864321 222
Q ss_pred HHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 405 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
...... ..... . ...++.. +.+++.+||+.+|.+||++.+|+..|+.
T Consensus 236 ~~~i~~-~~~~~-----~-~~~~~~~---~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRN-RQVLP-----C-PDDCPAW---VYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHc-CCcCC-----C-CCCCCHH---HHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 222221 11110 1 1123444 4458889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=316.15 Aligned_cols=256 Identities=28% Similarity=0.496 Sum_probs=203.0
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCc---EEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNT---NVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~---~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
..++|+..+.||+|+||.||+|... ++. .+|+|.+.... ....+.+..|+++++.++|+||+++++++......+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 4457888999999999999999965 232 68999886542 334567889999999999999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 83 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 83 IITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCcccee
Confidence 999999999999999764 35689999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCcceee--cccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 339 LGAERSYVTT--RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 339 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
.......... ....+..|+|||++.+..++.++|||||||++|||++ |+.||..... .+....... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------~~~~~~i~~-~~-- 227 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------HEVMKAIND-GF-- 227 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHHHHhc-CC--
Confidence 6433222111 1223457999999988889999999999999999998 9999964322 122222211 10
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
..+. ...++ ..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 228 --~~~~--~~~~~---~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 228 --RLPA--PMDCP---SAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred --CCCC--CCCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1111 11122 345568889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=328.47 Aligned_cols=237 Identities=23% Similarity=0.288 Sum_probs=186.2
Q ss_pred ceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHH-HHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEV-EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei-~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
++||+|+||.||+|+.. ++..||+|.+.+... .....+..|. .+++.++||||+++++++.+....|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 578899999865321 2223444454 467889999999999999999999999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (321)
T cd05603 81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EET 152 (321)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCc
Confidence 9999888654 4678889999999999999999998 9999999999999999999999999998753222 222
Q ss_pred eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCc
Q 009979 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 426 (521)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+ ..+......... ..+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~~-------~~~~~-~ 218 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDNILHKP-------LQLPG-G 218 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHHHhcCC-------CCCCC-C
Confidence 345679999999999999899999999999999999999999996432 222222222110 01111 1
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHH
Q 009979 427 CSRALKRALLVALRCVDPNAHKRPKMG 453 (521)
Q Consensus 427 ~~~~~~~~~~li~~cl~~dP~~RPt~~ 453 (521)
.. ..+.+++.+||+.||.+||++.
T Consensus 219 ~~---~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 KT---VAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CC---HHHHHHHHHHccCCHhhcCCCC
Confidence 22 2345588899999999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=324.72 Aligned_cols=262 Identities=26% Similarity=0.452 Sum_probs=204.4
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc--------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCCeeeEEEEE
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE--------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYC 251 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~ 251 (521)
++..++|.+.+.||+|+||.||++.+. +...+|+|.+.... .....++..|+++++.+ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 555678999999999999999999853 12469999887543 33446688899999999 799999999999
Q ss_pred eeCCeeeEEEEeccCCchHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 009979 252 AEGAHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN 319 (521)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~N 319 (521)
......++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 999999999999999999999976432 123588999999999999999999998 99999999999
Q ss_pred eEeCCCCCceEeecccceecCCCCcce-eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 009979 320 ILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPG 397 (521)
Q Consensus 320 ILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~ 397 (521)
||++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~--- 247 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--- 247 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC---
Confidence 999999999999999998653322111 122234578999999998899999999999999999998 888885332
Q ss_pred cccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 398 EVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
..+..+. ...... . .. ...++ ..+.+++.+||..+|++||++.++++.|+..
T Consensus 248 ---~~~~~~~-~~~~~~---~--~~-~~~~~---~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 248 ---VEELFKL-LKEGHR---M--DK-PSNCT---NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred ---HHHHHHH-HHcCCC---C--CC-CCcCC---HHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 1222222 111110 0 01 11123 3444588899999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=312.50 Aligned_cols=253 Identities=26% Similarity=0.496 Sum_probs=203.1
Q ss_pred CCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
..+|++.+.||+|+||.||+|.+.++..+|+|.+..... ....+..|+++++.++|||++++++++......++||||+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 346888999999999999999987788899998864432 3457888999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~ 344 (521)
++++|.+++... ...+++..++.++.+++.||+|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999998764 24678999999999999999999998 999999999999999999999999999986543322
Q ss_pred ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
.......++..|+|||++.++.++.++||||||+++|||++ |..||..... .+.+...... .....+.
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~---~~~~~~~-- 224 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------SEVVETINAG---FRLYKPR-- 224 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHHhCC---CCCCCCC--
Confidence 11222335678999999998899999999999999999998 9999964321 1222222111 0111121
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
..+ ..+.+++.+||+.+|++||++.+++++|.
T Consensus 225 --~~~---~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 --LAS---QSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCC---HHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 122 34556888999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=318.99 Aligned_cols=257 Identities=23% Similarity=0.266 Sum_probs=208.2
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcC-CcEEEEEEeccCChhh---HHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQA---EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~---~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
.+..+.|++.+.||.|.-|+||++...+ +..+|+|++.+..... ......|-+||+.++||.++.||+.|+.+...
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 3445678889999999999999999764 5789999997654333 34566799999999999999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
|+|||||+||+|..++++. +...+++..++.++.+++.||+|||-. |||+|||||+||||.++|++.|+||.++.
T Consensus 153 cl~meyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred EEEEecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccc
Confidence 9999999999999999877 568899999999999999999999998 99999999999999999999999999974
Q ss_pred ecCC---------------------------------C-C---------------------cceeecccccccccccccc
Q 009979 338 LLGA---------------------------------E-R---------------------SYVTTRVMGTFGYVAPEYA 362 (521)
Q Consensus 338 ~~~~---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~ 362 (521)
.... . . ......++||-.|+|||++
T Consensus 228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 4210 0 0 0112246899999999999
Q ss_pred cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhcc
Q 009979 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCV 442 (521)
Q Consensus 363 ~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl 442 (521)
.+...+.++|+|+|||+|||||.|..||.+.... .. +...+. .+..+... +.....+.+||.+.|
T Consensus 308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~--~T----l~NIv~-------~~l~Fp~~--~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK--ET----LRNIVG-------QPLKFPEE--PEVSSAAKDLIRKLL 372 (459)
T ss_pred ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch--hh----HHHHhc-------CCCcCCCC--CcchhHHHHHHHHHh
Confidence 9999999999999999999999999999865432 11 122221 12233332 244455666999999
Q ss_pred CCCCCCCCC----HHHHHHH
Q 009979 443 DPNAHKRPK----MGHVIHM 458 (521)
Q Consensus 443 ~~dP~~RPt----~~evl~~ 458 (521)
.+||++|-. +.||-++
T Consensus 373 vKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred ccChhhhhccccchHHhhcC
Confidence 999999998 7777543
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=316.43 Aligned_cols=251 Identities=29% Similarity=0.455 Sum_probs=204.5
Q ss_pred cCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
..++|++.+.||.|+||.||+|... ++.||+|.+..... ..+.+..|+.+++.++|+||+++++++.+....++||||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 4568889999999999999999875 78899999976544 567788899999999999999999999988899999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999997652 24689999999999999999999998 99999999999999999999999999998763221
Q ss_pred cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
....++..|+|||++.+..++.++||||||+++||+++ |..||..... .+ +......... ...
T Consensus 157 ----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~-~~~~~~~~~~-----~~~ 220 (256)
T cd05039 157 ----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KD-VVPHVEKGYR-----MEA 220 (256)
T ss_pred ----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH------HH-HHHHHhcCCC-----CCC
Confidence 12345678999999988899999999999999999998 9999863321 11 1111111100 011
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
. ...+ ..+.+++.+||..+|++||++.+++.+|+.
T Consensus 221 ~-~~~~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 P-EGCP---PEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred c-cCCC---HHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1 1123 344558889999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=323.02 Aligned_cols=261 Identities=26% Similarity=0.456 Sum_probs=205.7
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc--------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCCeeeEEEEE
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE--------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYC 251 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~ 251 (521)
++..++|.+.+.||+|+||.||+|.+. ++..||+|.+.... ......+..|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 456678999999999999999999742 23468999886543 33446788999999999 899999999999
Q ss_pred eeCCeeeEEEEeccCCchHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 009979 252 AEGAHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN 319 (521)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~N 319 (521)
......++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence 999999999999999999999976422 124578889999999999999999998 99999999999
Q ss_pred eEeCCCCCceEeecccceecCCCCcce-eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 009979 320 ILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPG 397 (521)
Q Consensus 320 ILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~ 397 (521)
||+++++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--- 244 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--- 244 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC---
Confidence 999999999999999998764332221 223346778999999988899999999999999999998 788885332
Q ss_pred cccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 398 EVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
..+........... . ....++.. +..++.+||+.+|.+||++.++++.|+.
T Consensus 245 ---~~~~~~~~~~~~~~------~-~~~~~~~~---~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 245 ---VEELFKLLKEGHRM------D-KPANCTNE---LYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred ---HHHHHHHHHcCCcC------C-CCCCCCHH---HHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 22333322211110 0 11123334 4458889999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=307.48 Aligned_cols=252 Identities=22% Similarity=0.336 Sum_probs=202.7
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--------hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeC
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--------GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEG 254 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~ 254 (521)
.+.|...+.||.|..++|.++..+ ++.++|+|++.... ....+.-..|+.+|+++ .||+|+++.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 346777889999999999999854 68899999985321 11224456799999998 599999999999999
Q ss_pred CeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecc
Q 009979 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (521)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFG 334 (521)
...++|+|.|+.|.|+++|... -.++++...+|+.|+..|++|||.. +|+||||||+|||+|++.++||+|||
T Consensus 96 sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence 9999999999999999999876 5799999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCcceeeccccccccccccccc------CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH
Q 009979 335 LAKLLGAERSYVTTRVMGTFGYVAPEYAS------TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408 (521)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 408 (521)
+++.+... ......||||+|+|||.+. ...|+...|+|++||+||.|+.|..||-... -.- +.++
T Consensus 169 Fa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk------Qml-MLR~ 239 (411)
T KOG0599|consen 169 FACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK------QML-MLRM 239 (411)
T ss_pred eeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH------HHH-HHHH
Confidence 99987544 3456789999999999874 3458889999999999999999999994221 111 1222
Q ss_pred hhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 409 VTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 409 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
+.++.. .+......+......+|+.+||+.||.+|-|++|++.+
T Consensus 240 ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 240 IMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 222221 12222233344445558889999999999999999743
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=316.10 Aligned_cols=250 Identities=25% Similarity=0.392 Sum_probs=197.9
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
++|++.+.||+|+||.||+|.+. +++.||+|.+... .......+..|++++++++||||+++++++......++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36788899999999999999854 6788999988654 333456788999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++++|..+ ..+++..+..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHh--------hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 999998654 2467888899999999999999998 9999999999999999999999999999865332
Q ss_pred cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcc-cHHHHHHHHhhccccccCCCccc
Q 009979 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV-NLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
......||..|+|||++.+..++.++|||||||++|+|++|+.||......... ...+..+.... .. .+.+
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~-----~~~~ 220 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-ED-----PPVL 220 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-cC-----CCCC
Confidence 223457899999999999989999999999999999999999999653322111 11111111111 10 1111
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.. .....++.+++.+||+.+|++||++.+++++
T Consensus 221 ~~---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 PV---GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CC---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11 1122345568889999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=337.06 Aligned_cols=252 Identities=24% Similarity=0.337 Sum_probs=195.8
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|+..+.||+|+||.||++... +++.||+|++.... ......+..|+.++..++||||+++++++.+....|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999965 58889999986432 233466788999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 999999999999764 4689999999999999999999998 999999999999999999999999999875422
Q ss_pred CCc----------------------------------ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 009979 342 ERS----------------------------------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 387 (521)
Q Consensus 342 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~ 387 (521)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0012357999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHH
Q 009979 388 NPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK---MGHVIHM 458 (521)
Q Consensus 388 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt---~~evl~~ 458 (521)
.||....+ .+.......... ...+.+. .+.+...+ +++.+|+ .||.+|++ +.+++.+
T Consensus 234 ~Pf~~~~~------~~~~~~i~~~~~-~~~~p~~---~~~s~~~~---~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 234 PPFCSETP------QETYRKVMNWKE-TLVFPPE---VPISEKAK---DLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCCH------HHHHHHHHcCCC-ceecCCC---CCCCHHHH---HHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 99975432 222222221110 0001111 11233333 4666766 49999985 5666543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=324.69 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=199.5
Q ss_pred CCccccceEccCCcEEEEEEEEcC-Cc--EEEEEEeccC-ChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLED-NT--NVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV 260 (521)
++|++.+.||+|+||.||+|...+ +. .+++|.+... .....+.+..|++++.++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 478899999999999999998653 33 4688877643 233456788999999999 799999999999998999999
Q ss_pred EEeccCCchHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCc
Q 009979 261 YEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~v 328 (521)
|||+++++|.++++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999975421 123588999999999999999999998 99999999999999999999
Q ss_pred eEeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHH
Q 009979 329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKT 407 (521)
Q Consensus 329 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 407 (521)
||+|||++..... .........+..|+|||++.+..++.++|||||||++|||++ |..||...... +....
T Consensus 159 kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~------~~~~~ 230 (297)
T cd05089 159 KIADFGLSRGEEV--YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA------ELYEK 230 (297)
T ss_pred EECCcCCCccccc--eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH
Confidence 9999999864321 111111223557999999998899999999999999999998 99999644321 11222
Q ss_pred HhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 408 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
.... ..+... ..++. .+.+++.+||+.+|.+||++.++++.|+...
T Consensus 231 ~~~~------~~~~~~-~~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 231 LPQG------YRMEKP-RNCDD---EVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred HhcC------CCCCCC-CCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 001111 11233 3455888999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=328.14 Aligned_cols=240 Identities=26% Similarity=0.290 Sum_probs=187.5
Q ss_pred ceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHH-HHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVE-VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E-i~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
+.||+|+||+||+|++. +++.||+|.+..... .....+..| ..+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 567899999865321 222333444 3457889999999999999999999999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
|+|.+++... ..+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~ 152 (325)
T cd05602 81 GELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT 152 (325)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence 9999999764 4677888889999999999999998 99999999999999999999999999997542222 22
Q ss_pred eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCc
Q 009979 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 426 (521)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......... . .+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~---~----~~~~-~ 218 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNKP---L----QLKP-N 218 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH------HHHHHHHHhCC---c----CCCC-C
Confidence 3456799999999999999999999999999999999999999964332 22222222111 0 1111 1
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 009979 427 CSRALKRALLVALRCVDPNAHKRPKMGHVI 456 (521)
Q Consensus 427 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl 456 (521)
.+. .+.+++.+||+.||.+||++.+.+
T Consensus 219 ~~~---~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 219 ITN---SARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCH---HHHHHHHHHcccCHHHCCCCCCCH
Confidence 223 344577899999999999987443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=315.81 Aligned_cols=255 Identities=28% Similarity=0.477 Sum_probs=202.2
Q ss_pred CCCccccceEccCCcEEEEEEEEc-C---CcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-D---NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
.++|++.+.||+|+||.||+|.+. + +..+|+|.+.... ....+.+..|+.+++.++||||+++++++..+...++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357888999999999999999864 2 3368999886543 2334678899999999999999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++..+
T Consensus 83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 99999999999999765 24688999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcceee--cccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 340 GAERSYVTT--RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 340 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
........+ ...++..|+|||++.+..++.++|+|||||++||+++ |..||...... +..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~------~~~~~~~~~~~--- 227 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ------DVIKAIEEGYR--- 227 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH------HHHHHHhCCCc---
Confidence 443322221 2233568999999998899999999999999999887 99999644321 11122111100
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
.+. ....+. .+.+++.+||+.+|.+||++.++++.|+.
T Consensus 228 --~~~--~~~~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 228 --LPA--PMDCPA---ALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred --CCC--CCCCCH---HHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 010 111233 34558889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=320.81 Aligned_cols=256 Identities=25% Similarity=0.441 Sum_probs=201.0
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCc----EEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNT----NVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
..++|++.+.||+|+||+||+|.+. ++. .||+|.+.... .....++..|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 3457889999999999999999854 343 48999886543 33456788999999999999999999999764 56
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
+++|||+++|+|.++++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 84 ~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 84 QLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence 8999999999999999764 34689999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCcce-eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 338 LLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 338 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~ 230 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPD----LLEKGERL 230 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHCCCcC
Confidence 764332211 122345678999999998899999999999999999998 99998643321 1111 11111100
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
+ . ...++ ..+.+++.+||+.||++||++.++++.|+..
T Consensus 231 ----~-~-~~~~~---~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 231 ----P-Q-PPICT---IDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred ----C-C-CccCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 0 0 11122 3445588899999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=316.87 Aligned_cols=246 Identities=28% Similarity=0.454 Sum_probs=194.9
Q ss_pred eEccCCcEEEEEEEEc---CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCC
Q 009979 193 VIGEGGYGIVYHGVLE---DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267 (521)
Q Consensus 193 ~LG~G~fG~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 267 (521)
+||+|+||.||+|.+. ++..+|+|++.... ....+++..|+.+++.+.||||+++++++.. ...++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999753 56789999886443 2345778899999999999999999998864 5678999999999
Q ss_pred chHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCccee
Q 009979 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347 (521)
Q Consensus 268 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 347 (521)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||.|||+++++.+||+|||+++.+........
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 999999754 4688999999999999999999998 999999999999999999999999999987654332211
Q ss_pred --ecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCC
Q 009979 348 --TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (521)
Q Consensus 348 --~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 424 (521)
....++..|+|||.+....++.++|||||||++|||++ |..||..... .+.... ...... +...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~-i~~~~~-----~~~~- 220 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG------NEVTQM-IESGER-----MECP- 220 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHH-HHCCCC-----CCCC-
Confidence 22334678999999988889999999999999999998 9999964322 122222 221111 1111
Q ss_pred CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 425 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
..++.. +.+++.+||+.||++||++.+|.+.|+..
T Consensus 221 ~~~~~~---l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 221 QRCPPE---MYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCHH---HHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 113333 44588899999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=325.58 Aligned_cols=258 Identities=24% Similarity=0.413 Sum_probs=200.0
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCc--EEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeee
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNT--NVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~ 258 (521)
..++|++.+.||+|+||.||+|.+. ++. .+|+|.+.... ......+..|++++.++ +|+||+++++++..+...+
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 3457889999999999999999964 344 35777765432 33446788899999999 8999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC
Q 009979 259 LVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW 326 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~ 326 (521)
+||||+++++|.++++.... ....+++..++.++.|++.||+|||+. +++||||||+|||++.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCC
Confidence 99999999999999975421 124688999999999999999999998 999999999999999999
Q ss_pred CceEeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHH
Q 009979 327 NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWL 405 (521)
Q Consensus 327 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~ 405 (521)
.+||+|||++...... .......++..|+|||++.+..++.++|||||||++|||+| |..||..... .+..
T Consensus 162 ~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~ 233 (303)
T cd05088 162 VAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELY 233 (303)
T ss_pred cEEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh------HHHH
Confidence 9999999998642111 11112234668999999988889999999999999999998 9999964332 1222
Q ss_pred HHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 406 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
+.... .. ..... ...+ ..+.+++.+||+.+|++||++.+++.+|+..
T Consensus 234 ~~~~~-~~-----~~~~~-~~~~---~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 234 EKLPQ-GY-----RLEKP-LNCD---DEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHHhc-CC-----cCCCC-CCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22111 10 00001 1122 2355688899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=334.61 Aligned_cols=263 Identities=19% Similarity=0.250 Sum_probs=199.3
Q ss_pred cCCCccccceEccCCcEEEEEEEEc---CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE---DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
...+|.+.+.||+|+||.||+|... .+..||+|.+... ..+.+|+++++.++||||+++++++......++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3457999999999999999999753 3567899987543 2356799999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
||++. ++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 165 ~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 165 MPKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred ehhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99995 5899988433 5789999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc----
Q 009979 341 AERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE---- 415 (521)
Q Consensus 341 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 415 (521)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.+........
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 43221 2234679999999999999999999999999999999999999997654332211111111111100000
Q ss_pred -------------cCCCcccCCCcc---HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 416 -------------GVLDPRLQEKPC---SRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 416 -------------~~~d~~l~~~~~---~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
....+....... .....++.+++.+||..||++||++.+++.+-
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 000000000000 01122455688899999999999999998653
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=318.43 Aligned_cols=255 Identities=24% Similarity=0.395 Sum_probs=196.1
Q ss_pred ccccceEccCCcEEEEEEEEcCCc---EEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC------Ce
Q 009979 188 FADENVIGEGGYGIVYHGVLEDNT---NVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------AH 256 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~~~~---~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------~~ 256 (521)
|.+.+.||+|+||.||+|.+.++. .+|+|.+... .....+.+..|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 356788999999999999975432 5899987653 234456788899999999999999999987432 24
Q ss_pred eeEEEEeccCCchHHhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDV--GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFG 334 (521)
.++||||+.+|+|.+++.... .....+++...+.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999874322 1234588999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCccee-ecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhcc
Q 009979 335 LAKLLGAERSYVT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (521)
Q Consensus 335 la~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (521)
+++.+........ ....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... .+.... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~-~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN------SEIYDY-LRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH-HHcC
Confidence 9987643322111 22345778999999999999999999999999999999 8899864321 122222 2221
Q ss_pred ccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 413 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
... .. ...++. .+.+++.+||+.||++|||+.++++.|+.
T Consensus 231 ~~~-----~~-~~~~~~---~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRL-----KQ-PPDCLD---GLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCC-----CC-CCCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 110 00 111223 34558889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=319.67 Aligned_cols=252 Identities=23% Similarity=0.293 Sum_probs=198.8
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
.|+..+.||+|+||.||++.+. +++.||+|.+..... .....+..|+.+++.++|+|++.+++.+.+....++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999965 588999998865422 223456789999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+.+++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999999986542 34688999999999999999999998 9999999999999999999999999999865332
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
.. .....||..|+|||++.+..++.++|||||||++|||++|+.||........ .+.......... ..+
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~---~~~~~~~~~~~~------~~~ 224 (285)
T cd05630 156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK---REEVERLVKEVQ------EEY 224 (285)
T ss_pred cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch---HHHHHhhhhhhh------hhc
Confidence 21 2234789999999999999999999999999999999999999975432111 111111111100 011
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRPK-----MGHVIHM 458 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~ 458 (521)
.. ..+. .+.+++.+||+.||++||+ +.|++++
T Consensus 225 ~~-~~~~---~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 225 SE-KFSP---DARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred Cc-cCCH---HHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 11 1222 3445888999999999999 8888754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=325.23 Aligned_cols=259 Identities=25% Similarity=0.406 Sum_probs=204.4
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeC
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEG 254 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~ 254 (521)
+..++|.+.+.||+|+||.||++... .+..||+|.+.... ....+.+..|+++++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 44567999999999999999999742 24468999886543 33346788999999999 799999999999999
Q ss_pred CeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecc
Q 009979 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (521)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFG 334 (521)
...++||||+.+|+|.++++... ...+++..++.++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999999997642 23489999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhcc
Q 009979 335 LAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (521)
Q Consensus 335 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (521)
+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... +.+.......
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~------~~~~~~~~~~ 260 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD------SKFYKLIKEG 260 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch------HHHHHHHHcC
Confidence 99865433221 1222346788999999999999999999999999999998 99998644321 1111222111
Q ss_pred ccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 413 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
. .+.. ....+ .++.+++.+||+.+|++||++.++++.|+.
T Consensus 261 ~-----~~~~-~~~~~---~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 261 Y-----RMAQ-PEHAP---AEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred C-----cCCC-CCCCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 1 0000 11112 345568889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=330.05 Aligned_cols=192 Identities=22% Similarity=0.348 Sum_probs=165.3
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
...+|++.+.||+|+||.||+|... ++..||+|..... ....|+.++++++||||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4457999999999999999999975 4677899975332 23458999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+. ++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 138 HYS-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred ccC-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 995 5899988754 35789999999999999999999998 9999999999999999999999999999753222
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCC
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPV 390 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf 390 (521)
.......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223456999999999999999999999999999999999965554
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=330.19 Aligned_cols=198 Identities=29% Similarity=0.367 Sum_probs=168.8
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC------
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------ 255 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~------ 255 (521)
.++|++.+.||+|+||.||++... ++..||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 358999999999999999999864 5889999998643 2334466788999999999999999999986443
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..|+||||+++ +|.+.++. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999975 67776642 477888999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~ 394 (521)
++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 170 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 170 ARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred ccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 9864322 22334578999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=331.35 Aligned_cols=240 Identities=27% Similarity=0.333 Sum_probs=189.1
Q ss_pred ceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHH-HHhcCCCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVE-AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
+.||+|+||+||+|... +++.||+|.+.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999965 68899999986532 122344455554 57789999999999999999999999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~ 152 (325)
T cd05604 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDT 152 (325)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCC
Confidence 9999988754 5789999999999999999999998 9999999999999999999999999999753222 222
Q ss_pred eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCc
Q 009979 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 426 (521)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... ..+.+ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~------~~~~~~~~~~~~---~~~~~----~- 218 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD------VAEMYDNILHKP---LVLRP----G- 218 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC------HHHHHHHHHcCC---ccCCC----C-
Confidence 345679999999999999999999999999999999999999996443 122222222211 11111 1
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 009979 427 CSRALKRALLVALRCVDPNAHKRPKMGHVI 456 (521)
Q Consensus 427 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl 456 (521)
.+ ..+.+++.+|++.||.+||++.+.+
T Consensus 219 ~~---~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 219 AS---LTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CC---HHHHHHHHHHhccCHHhcCCCCCCH
Confidence 22 3344588899999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=312.62 Aligned_cols=266 Identities=23% Similarity=0.327 Sum_probs=202.9
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh--hHHHHHHHHHHHhcCCCCC-eeeEEEEEeeCC------
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ--AEKEFKVEVEAIGRVRHKN-LVRLLGYCAEGA------ 255 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~hpn-iv~l~~~~~~~~------ 255 (521)
..|...++||+|+||+||+|+.. +|+.||+|++.-...+ ......+|+-+|+.++|+| |+++++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 35777888999999999999954 6889999999654332 3355678999999999999 999999998877
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..++|+||++. +|..++.........++...+..++.|++.||+|||++ +|+||||||.||||++.|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 78999999976 99999987643224577789999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh--cc
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT--NR 412 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~ 412 (521)
|+.+...... .+..++|.+|.|||++.+. .|+...||||+||+++||++++.-|.+... ...+..+++.+-. ..
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLLGTPNEK 243 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHcCCCCcc
Confidence 9976533222 3456789999999999876 799999999999999999999988865443 1122222221110 01
Q ss_pred ccccC---CCcc--cCCCc----cHH----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 413 NAEGV---LDPR--LQEKP----CSR----ALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 413 ~~~~~---~d~~--l~~~~----~~~----~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+.++ .+-. +.... ... ...+..+++.+|++.+|.+|.++..++.+
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11111 1111 11111 111 11256778899999999999999999876
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=328.47 Aligned_cols=241 Identities=22% Similarity=0.310 Sum_probs=192.7
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCeeeEEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV~ 261 (521)
+|+..+.||+|+||.||+|... ++..||+|++.+.. ....+.+..|+.+++.+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999965 58889999986532 233456777899998886 577888999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 999999999998764 4689999999999999999999998 999999999999999999999999999985432
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+...... . .
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~------~~~~~~i~~~~-~------~ 219 (323)
T cd05615 154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE------DELFQSIMEHN-V------S 219 (323)
T ss_pred CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-C------C
Confidence 21 123345799999999999999999999999999999999999999974432 12222222211 0 1
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCH
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKM 452 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~ 452 (521)
+... . ...+.+++.+||+.+|.+|++.
T Consensus 220 ~p~~-~---~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 YPKS-L---SKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCcc-C---CHHHHHHHHHHcccCHhhCCCC
Confidence 1111 2 2344568889999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=320.88 Aligned_cols=249 Identities=26% Similarity=0.388 Sum_probs=202.5
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
.+|++.+.||+|+||.||+|... ++..||+|.+..........+..|+.+++.+.|+||+++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 58899999999999999999864 68899999987666555677889999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~ 344 (521)
++++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999998643 578899999999999999999998 999999999999999999999999999886543222
Q ss_pred ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCC
Q 009979 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (521)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 424 (521)
. .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+. ........... +.+..
T Consensus 172 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~------~~~~~~~~~~~------~~~~~ 238 (296)
T cd06654 172 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGT------PELQN 238 (296)
T ss_pred c-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH------HhHHHHhcCCC------CCCCC
Confidence 1 23346899999999999888999999999999999999999999644321 11111111110 01110
Q ss_pred CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 425 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.......+.+++.+||+.+|++||++.+++.
T Consensus 239 --~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 239 --PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred --ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 1112234556888999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=326.57 Aligned_cols=261 Identities=22% Similarity=0.353 Sum_probs=197.8
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
++|.+.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+++++.++||||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57899999999999999999965 577899999864432 2334677899999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 888888654 34578899999999999999999998 99999999999999999999999999998653322
Q ss_pred cceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc----------
Q 009979 344 SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR---------- 412 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------- 412 (521)
. ......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||......... ..+.......
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL---HLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCCHHHHhhhcc
Confidence 2 1233467999999998854 56899999999999999999999999755432111 1111111000
Q ss_pred --ccccCCCcccCCCc----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 413 --NAEGVLDPRLQEKP----CSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 413 --~~~~~~d~~l~~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.......+...... .......+.+++.+||+.||.+|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000001110000 0112234556888999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=322.22 Aligned_cols=259 Identities=23% Similarity=0.346 Sum_probs=200.2
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
++|++.+.||+|+||.||++.+. ++..+|+|.+... .......+..|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36889999999999999999965 5777888887654 233346688899999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++++|.++++.. ..+++..+..++.|++.||.|||+.. +++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 9999999999765 56889999999999999999999732 8999999999999999999999999998765322
Q ss_pred cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc---------
Q 009979 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA--------- 414 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------- 414 (521)
......|+..|+|||.+.+..++.++|+|||||++|||++|+.||...+... ...++.........
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccC
Confidence 1234578999999999988889999999999999999999999996433111 11111000000000
Q ss_pred ------------------ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 415 ------------------EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 415 ------------------~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
..-..+.+.... ....+.+++.+||..||++||++.+++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGA---FSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcc---cCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000001111111 223455688899999999999999998553
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=315.76 Aligned_cols=240 Identities=23% Similarity=0.398 Sum_probs=188.9
Q ss_pred ceEccCCcEEEEEEEEcC-------------CcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 192 NVIGEGGYGIVYHGVLED-------------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
+.||+|+||.||+|+..+ ...|++|.+..........+..|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2248888876655555567888999999999999999999999988999
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCC-------ceEe
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN-------PKLS 331 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~-------vkL~ 331 (521)
+||||+++|+|..++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +|++
T Consensus 81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999988754 34689999999999999999999998 9999999999999987654 8999
Q ss_pred ecccceecCCCCcceeeccccccccccccccc-CCCCCCcccchhHHHHHHHHH-hCCCCCCCCCCCCcccHHHHHHHHh
Q 009979 332 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVI-SGRNPVDYSRPPGEVNLVEWLKTMV 409 (521)
Q Consensus 332 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwS~Gvvl~ell-tG~~Pf~~~~~~~~~~~~~~~~~~~ 409 (521)
|||++...... ....|+..|+|||.+. +..++.++|||||||++|||+ +|..||...... + .....
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~-~~~~~ 222 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA------E-KERFY 222 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh------H-HHHHH
Confidence 99998754322 2345788999999886 567899999999999999998 588888643211 1 11111
Q ss_pred hccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 410 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
... . .. ..+.. ..+.+++.+||+.||++||++.+|++.|+
T Consensus 223 ~~~-~-~~------~~~~~---~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQ-C-ML------VTPSC---KELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcC-c-cC------CCCCh---HHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 110 0 00 11122 34556888999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=317.48 Aligned_cols=252 Identities=28% Similarity=0.455 Sum_probs=200.5
Q ss_pred ccccceEccCCcEEEEEEEEcC-CcEEEEEEeccCChhhHH--HHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 188 FADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEK--EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
|++.+.||+|+||+||++.... ++.||+|.+......... ....|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6778999999999999999764 557999999776544332 3456999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~ 344 (521)
++++|.+++... ..+++..++.++.|++.||++||+. +++|+||||+||++++++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENN 152 (260)
T ss_dssp TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STT
T ss_pred cccccccccccc----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccc
Confidence 999999999833 5789999999999999999999998 99999999999999999999999999998642 222
Q ss_pred ceeeccccccccccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 345 YVTTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
.......++..|+|||++. +..++.++||||||+++|+|++|..||.... ..+....+........... ...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~----~~~ 225 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN---SDDQLEIIEKILKRPLPSS----SQQ 225 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS---HHHHHHHHHHHHHTHHHHH----TTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc---chhhhhhhhhccccccccc----ccc
Confidence 3344567899999999998 8889999999999999999999999997541 1122222222111100000 000
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.......+.+++.+||+.||++||++.++++
T Consensus 226 ---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 ---SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ---cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000145666888999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=312.81 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=205.4
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
.++|++.+.||+|+||.||+|... +++.+++|.+........+.+..|+++++.++||||+++++++.+....+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 457899999999999999999964 5778999998776656668899999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+.+++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 9999999998764 25688999999999999999999998 99999999999999999999999999998654321
Q ss_pred cceeecccccccccccccccCC---CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 344 SYVTTRVMGTFGYVAPEYASTG---MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
.......++..|+|||.+.+. .++.++|+|||||++|||+||+.||....+. +........ ....+
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~------~~~~~~~~~----~~~~~ 224 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM------RALFLISKS----NFPPP 224 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhc----cCCCc
Confidence 122345688999999998776 8899999999999999999999999644321 111111111 01111
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.+. ........+.+++.+||..+|.+||++.+|+.
T Consensus 225 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111 12233345667889999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=315.46 Aligned_cols=247 Identities=28% Similarity=0.470 Sum_probs=193.9
Q ss_pred eEccCCcEEEEEEEEc---CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCCc
Q 009979 193 VIGEGGYGIVYHGVLE---DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGN 268 (521)
Q Consensus 193 ~LG~G~fG~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~ 268 (521)
.||+|+||.||+|.+. .+..||+|.+..... ...+.+..|+.++++++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999864 345689998865533 334678999999999999999999999864 56799999999999
Q ss_pred hHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcceee
Q 009979 269 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT 348 (521)
Q Consensus 269 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 348 (521)
|.+++... ...+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++............
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99999754 35789999999999999999999998 9999999999999999999999999999865443322221
Q ss_pred --cccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCC
Q 009979 349 --RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425 (521)
Q Consensus 349 --~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 425 (521)
...++..|+|||.+.+..++.++|||||||++||+++ |..||..... .+.... +..... +.. ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~-~~~~~~-----~~~-~~ 221 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG------PEVMSF-IEQGKR-----LDC-PA 221 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHH-HHCCCC-----CCC-CC
Confidence 1233578999999988889999999999999999996 9999964432 122211 111110 011 11
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 426 PCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 426 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.++..+. +++.+||..+|++||++.+|.+.|+..
T Consensus 222 ~~~~~l~---~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 222 ECPPEMY---ALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCHHHH---HHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 2344444 488899999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=312.10 Aligned_cols=250 Identities=28% Similarity=0.422 Sum_probs=199.3
Q ss_pred cCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEe-eCCeeeEEEE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA-EGAHRMLVYE 262 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~-~~~~~~lV~e 262 (521)
..++|.+.+.||+|+||.||++... +..||+|.+.... ..+.+..|+.+++.++|+|++++++++. .+...++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 3457888999999999999999875 7789999886433 3467889999999999999999999764 4567899999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+++++|.++++... ...+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 81 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred CCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 999999999997652 34588999999999999999999998 9999999999999999999999999999864322
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
. ....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+...... .... +.
T Consensus 156 ~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~~-~~~~-----~~ 219 (256)
T cd05082 156 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRVE-KGYK-----MD 219 (256)
T ss_pred C----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHh-cCCC-----CC
Confidence 1 22345678999999998899999999999999999998 999986332 222222211 1110 11
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
.. ..++. .+.+++.+||+.+|++|||+.++++.|+.
T Consensus 220 ~~-~~~~~---~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 220 AP-DGCPP---VVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CC-CCCCH---HHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11 12333 34458889999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=313.74 Aligned_cols=257 Identities=27% Similarity=0.448 Sum_probs=201.8
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
++.+++.+.....||+|+||.||+|.+. ++..||+|.+........+.+.+|+++++.++|+||+++++++..+...++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 4566777777889999999999999954 577899999877666667789999999999999999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-CCCceEeecccc
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPL--TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLA 336 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l--~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~-~~~vkL~DFGla 336 (521)
||||+++++|.+++.... ..+ ++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 999999999999997642 234 7888889999999999999998 9999999999999976 678999999999
Q ss_pred eecCCCCcceeecccccccccccccccCCC--CCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
........ ......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||........ ...+.....
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~----~~~~~~~~~--- 228 (268)
T cd06624 157 KRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA----AMFKVGMFK--- 228 (268)
T ss_pred eecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh----hHhhhhhhc---
Confidence 86543222 222345899999999986543 78999999999999999999999964322111 001100000
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
..+.+. .....++.+++.+||+.+|++|||+.+++.+
T Consensus 229 ---~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 ---IHPEIP----ESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ---cCCCCC----cccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 011111 1122334558889999999999999999853
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=314.71 Aligned_cols=253 Identities=26% Similarity=0.362 Sum_probs=201.9
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
.++|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++++......++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 457888999999999999999864 5888999998766555556788899999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++++|.+++... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 88 CGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 9999999998754 4689999999999999999999998 99999999999999999999999999998654322
Q ss_pred cceeeccccccccccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 344 SYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
.......|+..|+|||++. ...++.++|||||||++|||++|..||....+... +...... ....+
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~~~~~----~~~~~ 229 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLMTKS----NFQPP 229 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHhhhcc----CCCCC
Confidence 2223457899999999874 45688999999999999999999999864432111 1111111 11111
Q ss_pred ccCC-CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 421 RLQE-KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 421 ~l~~-~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.... ...+. .+.+++.+||+.+|++||++.+++++
T Consensus 230 ~~~~~~~~~~---~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 230 KLKDKMKWSN---SFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cccccCCCCH---HHHHHHHHHccCCchhCcCHHHHhcC
Confidence 1111 01222 34558889999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=318.19 Aligned_cols=251 Identities=25% Similarity=0.295 Sum_probs=197.6
Q ss_pred ccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
|+..+.||+|+||+||+|.+. +++.||+|.+..... .....+..|+++++.++|+||+.+.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667889999999999999965 688899999865432 2234577899999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999999886542 34689999999999999999999998 99999999999999999999999999997653322
Q ss_pred cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
. .....|+..|+|||++.+..++.++|+|||||++|||++|..||....... ..+.+........ . .+.
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~---~~~~~~~~~~~~~--~----~~~ 225 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV---KREEVDRRVLETE--E----VYS 225 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhhhccc--c----ccC
Confidence 1 234578999999999998999999999999999999999999997443211 1111111111110 0 111
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRPK-----MGHVIHM 458 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~ 458 (521)
.. .+ ..+.+++.+||+.||++||+ +.+++.+
T Consensus 226 ~~-~~---~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 226 AK-FS---EEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cc-CC---HHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11 22 23445888999999999999 6666643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=311.59 Aligned_cols=254 Identities=26% Similarity=0.365 Sum_probs=191.8
Q ss_pred ceEccCCcEEEEEEEEcC---CcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCC
Q 009979 192 NVIGEGGYGIVYHGVLED---NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 267 (521)
+.||+|+||.||+|.+.+ +..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 35689998865443 33457888999999999999999999999988999999999999
Q ss_pred chHHhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 268 NLEQWLHGDVG-PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 268 ~L~~~l~~~~~-~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
+|.++++.... .....++..+..++.|++.||+|||+. +++||||||+||+++.++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999976432 123566778889999999999999998 99999999999999999999999999997543322211
Q ss_pred -eecccccccccccccccCC-------CCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 347 -TTRVMGTFGYVAPEYASTG-------MLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 347 -~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
.....|+..|+|||++.+. .++.++||||||+++|||++ |+.||....... .....+. ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~------~~~~~~~-~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ------VLTYTVR-EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH------HHHHHhh-cccCCC
Confidence 2235678899999988542 35789999999999999996 999996543211 1111111 111122
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
.++.+.. ..+.. +.+++.+|| .+|++|||+.+|+..|+
T Consensus 231 ~~~~~~~-~~~~~---~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKL-PLSDR---WYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCC-CCChH---HHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222221 12333 344777998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=329.86 Aligned_cols=263 Identities=26% Similarity=0.396 Sum_probs=202.1
Q ss_pred hhcCCCccccceEccCCcEEEEEEEE------cCCcEEEEEEeccCCh-hhHHHHHHHHHHHhcC-CCCCeeeEEEEEee
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE 253 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~ 253 (521)
+++.++|++.+.||+|+||.||+|.+ .+++.||||.+..... .....+..|+.++.++ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 45667899999999999999999974 2467899999875432 3345688899999999 68999999998865
Q ss_pred C-CeeeEEEEeccCCchHHhhhcCCCC-----------------------------------------------------
Q 009979 254 G-AHRMLVYEYIDNGNLEQWLHGDVGP----------------------------------------------------- 279 (521)
Q Consensus 254 ~-~~~~lV~e~~~~g~L~~~l~~~~~~----------------------------------------------------- 279 (521)
. ...++||||+++|+|.++++.....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 4 4678999999999999998753210
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcc-eee
Q 009979 280 ----------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTT 348 (521)
Q Consensus 280 ----------~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~ 348 (521)
...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++......... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 12467888899999999999999998 9999999999999999999999999999865332221 112
Q ss_pred cccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCcc
Q 009979 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPC 427 (521)
Q Consensus 349 ~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 427 (521)
...++..|+|||.+.+..++.++||||||+++|||++ |..||...... ..+.......... ... ...
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~~~-----~~~-~~~ 307 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLKEGTRM-----RAP-DYT 307 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------HHHHHHHhccCCC-----CCC-CCC
Confidence 2345678999999988899999999999999999997 99998644321 1111112111110 011 111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 428 SRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 428 ~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
+ ..+.+++.+||+.||++||++.+|++.|+..
T Consensus 308 ~---~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 308 T---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred C---HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2 2355688899999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=314.71 Aligned_cols=258 Identities=27% Similarity=0.458 Sum_probs=204.1
Q ss_pred CCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
.++|++.+.||+|+||.||+|..+ +...|++|.+...... ..+.+..|++++++++|+||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 457889999999999999999864 2456899988654443 457789999999999999999999999998899
Q ss_pred eEEEEeccCCchHHhhhcCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEee
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGP-----HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~D 332 (521)
++||||+++|+|.++++..... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++|+|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999999765321 12689999999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhc
Q 009979 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTN 411 (521)
Q Consensus 333 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (521)
||++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..+.... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~------~~~~~~~-~ 233 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE------EVLNRLQ-A 233 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH------HHHHHHH-c
Confidence 99987543333333334456788999999988889999999999999999999 88898643221 1111111 1
Q ss_pred cccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 412 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
..... . ....++.. +.+++.+||+.+|++||++.+++..|.
T Consensus 234 ~~~~~----~-~~~~~~~~---l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLEL----P-VPEGCPSR---LYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCC----C-CCCCCCHH---HHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11100 0 11123333 445888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=325.30 Aligned_cols=262 Identities=26% Similarity=0.449 Sum_probs=204.2
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc--------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCCeeeEEEEE
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE--------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYC 251 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~ 251 (521)
.+..++|.+.+.||+|+||.||+|... ....+|+|.+.... ......+..|+++++.+ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 455678999999999999999999742 23468999886543 33456788899999999 699999999999
Q ss_pred eeCCeeeEEEEeccCCchHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 009979 252 AEGAHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN 319 (521)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~N 319 (521)
......++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+. +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 998899999999999999999976421 124688999999999999999999998 99999999999
Q ss_pred eEeCCCCCceEeecccceecCCCCcce-eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 009979 320 ILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPG 397 (521)
Q Consensus 320 ILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~ 397 (521)
||+++++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-- 242 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV-- 242 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--
Confidence 999999999999999998664322211 122234568999999998899999999999999999999 8899854321
Q ss_pred cccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 398 EVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.+.+.... .... . .. ...++. ++.+++.+||+.||++||++.++++.|+..
T Consensus 243 ----~~~~~~~~-~~~~---~--~~-~~~~~~---~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 243 ----EELFKLLR-EGHR---M--DK-PSNCTH---ELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred ----HHHHHHHH-cCCC---C--CC-CCCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 12222221 1110 0 01 111233 344588899999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=353.34 Aligned_cols=262 Identities=23% Similarity=0.380 Sum_probs=201.9
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEee-
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE- 253 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~- 253 (521)
+...+...++|.+.+.||+|+||+||+|.+. ++..||+|.+... .......|..|+.+++.++|||||+++++|.+
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 3445566779999999999999999999975 4667889987643 22334678889999999999999999998854
Q ss_pred -CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeeecCCCCCCeEeCC----
Q 009979 254 -GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE----PKVVHRDIKSSNILLDK---- 324 (521)
Q Consensus 254 -~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~----~~iiHrDik~~NILl~~---- 324 (521)
...+||||||+++|+|.++|.........+++..++.|+.||+.||+|||+... .+|+||||||+||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 356899999999999999998654445679999999999999999999998521 25999999999999964
Q ss_pred -------------CCCceEeecccceecCCCCcceeecccccccccccccccC--CCCCCcccchhHHHHHHHHHhCCCC
Q 009979 325 -------------QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNP 389 (521)
Q Consensus 325 -------------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~elltG~~P 389 (521)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||||+||+.|
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 3348999999998764322 2234579999999998854 4589999999999999999999999
Q ss_pred CCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 390 VDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 390 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
|.... .....+...... +.+.....+ ..+.+|+.+||+.+|.+||++.+++.
T Consensus 243 F~~~~-----~~~qli~~lk~~--------p~lpi~~~S---~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 243 FHKAN-----NFSQLISELKRG--------PDLPIKGKS---KELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcCC-----cHHHHHHHHhcC--------CCCCcCCCC---HHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 96432 122222221111 111111122 34555888999999999999999983
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=309.86 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=201.6
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
+|++.+.||+|+||.||++... ++..||+|.+... .....+.+..|+.+++.++|+||+++++++..+...++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999965 5888999988543 2334567888999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~ 344 (521)
++++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999999987542 34678999999999999999999998 999999999999999999999999999987643322
Q ss_pred ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCC
Q 009979 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (521)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 424 (521)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||..... ......... ... .+ +..
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~~-~~~----~~-~~~ 222 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVCQ-GSY----KP-LPS 222 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHhc-CCC----CC-CCc
Confidence 22345689999999999988899999999999999999999999964321 111222211 111 11 111
Q ss_pred CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 425 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
..+ ..+.+++.+||+.||++||++.+++..
T Consensus 223 -~~~---~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 -HYS---YELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -ccC---HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 122 335568889999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=313.72 Aligned_cols=254 Identities=29% Similarity=0.501 Sum_probs=199.9
Q ss_pred CCccccceEccCCcEEEEEEEEcC-C---cEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLED-N---TNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
..|++.+.||+|+||.||+|.+.. + ..||+|.+... .......|..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357889999999999999999653 3 35999988654 233456899999999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+++++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999999765 34688999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCcce--eeccc--ccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 341 AERSYV--TTRVM--GTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 341 ~~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
...... ..... ++..|+|||++.+..++.++|||||||++||+++ |..||..... .+..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~------~~~~~~i~~~~~-- 229 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN------QDVINAIEQDYR-- 229 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH------HHHHHHHHcCCc--
Confidence 322211 11111 2457999999999999999999999999999887 9999964321 111222111100
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
. + ....++.. +.+++.+||+.+|.+||++.+|+..|+.
T Consensus 230 --~-~--~~~~~~~~---~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 230 --L-P--PPMDCPTA---LHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred --C-C--CcccCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0 0 01112333 4458889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=311.93 Aligned_cols=250 Identities=27% Similarity=0.425 Sum_probs=203.4
Q ss_pred CCCccccceEccCCcEEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
.++|++.+.||+|+||.||+|...+ +..|++|.+..... .+++..|+++++.++|+||+++++++......+++|||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3578999999999999999999764 78899998865433 67899999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++++|.+++... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 80 CGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred CCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 9999999999754 35789999999999999999999998 99999999999999999999999999998764332
Q ss_pred cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....+.... . ..... ..+.+.
T Consensus 154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~------~-~~~~~-----~~~~~~ 220 (256)
T cd06612 154 A-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------F-MIPNK-----PPPTLS 220 (256)
T ss_pred c-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh------h-hhccC-----CCCCCC
Confidence 1 223355889999999999989999999999999999999999999754322110 0 00000 011111
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
. .......+.+++.+||+.||++||++.+++.
T Consensus 221 ~--~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 D--PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred c--hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1 1112234566888999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=314.50 Aligned_cols=253 Identities=22% Similarity=0.321 Sum_probs=202.0
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
..+.|++.++||+|+||.||+|... ++..|++|.+........+.+..|+++++.++||||+++++++..+...++|||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 4467999999999999999999975 478899999877666667788899999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+++++|..++.+. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 90 FCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 99999999887654 34689999999999999999999998 9999999999999999999999999998764322
Q ss_pred Ccceeeccccccccccccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 343 RSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
........+++.|+|||++. ...++.++|||||||++|||++|..||....+ .+.........
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~----- 231 (292)
T cd06644 164 -LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSE----- 231 (292)
T ss_pred -ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhcCC-----
Confidence 12223456889999999884 34578899999999999999999999964332 12222221111
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.+.... ......++.+++.+||+.||++||++.++++
T Consensus 232 -~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 232 -PPTLSQ--PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -CccCCC--CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111110 1112234555888999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=317.96 Aligned_cols=258 Identities=26% Similarity=0.386 Sum_probs=206.5
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
..++|++.+.||+|+||+||++... +++.||+|++.... ....+.+..|+++++.++||||+++++++......++||
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 3467889999999999999999965 57889999876543 334577889999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++++|.+++... ..+++..+..++.+++.||.|||+.. +++||||||+||++++++.++|+|||++.....
T Consensus 83 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 83 EFMDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred ecCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 999999999998764 46899999999999999999999632 899999999999999999999999999875422
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCC-----cccHHHHHHHHhhcccccc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG-----EVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 416 (521)
. ......|+..|+|||++.+..++.++|||||||++|+|+||+.||....... .....+++.......
T Consensus 157 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 229 (284)
T cd06620 157 S---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---- 229 (284)
T ss_pred h---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----
Confidence 1 1234578999999999988899999999999999999999999998554321 112223333332211
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
.+.+... .....+.+++.+||+.||.+||++.|++++.
T Consensus 230 --~~~~~~~---~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 --PPRLPSS---DFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --CCCCCch---hcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1111111 1233456688899999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=311.49 Aligned_cols=247 Identities=27% Similarity=0.428 Sum_probs=197.5
Q ss_pred ceEccCCcEEEEEEEEcCCcEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCCchH
Q 009979 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLE 270 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L~ 270 (521)
++||+|+||.||++.+.+++.||+|.+...... ....+..|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877899999988765443 4567899999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCccee-ec
Q 009979 271 QWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT-TR 349 (521)
Q Consensus 271 ~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~-~~ 349 (521)
+++... ...+++..++.++.+++.||+|||++ +++||||||+|||++.++.+||+|||++........... ..
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 999764 24678899999999999999999998 999999999999999999999999999986542221111 12
Q ss_pred ccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccH
Q 009979 350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCS 428 (521)
Q Consensus 350 ~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 428 (521)
..++..|+|||.+.++.++.++|+|||||++|||+| |..||...... ... ....... .. .. ..
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~------~~~-~~~~~~~--~~---~~----~~ 218 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ------QTR-ERIESGY--RM---PA----PQ 218 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH------HHH-HHHhcCC--CC---CC----Cc
Confidence 234667999999988899999999999999999999 88888644321 111 1111110 00 00 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 429 RALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 429 ~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
.....+.+++.+||..+|++||++.|+++.|+
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 12234556888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=316.43 Aligned_cols=264 Identities=25% Similarity=0.391 Sum_probs=203.9
Q ss_pred chhhhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEe--
Q 009979 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCA-- 252 (521)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~-- 252 (521)
.++.+....++|++.+.||+|+||.||+|... +++.+|+|.+.... .....+..|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 35556667889999999999999999999865 57889999875432 2345678899999999 6999999999874
Q ss_pred ---eCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCce
Q 009979 253 ---EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK 329 (521)
Q Consensus 253 ---~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vk 329 (521)
.+...++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence 34568999999999999998875433346788999999999999999999998 999999999999999999999
Q ss_pred EeecccceecCCCCcceeeccccccccccccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHH
Q 009979 330 LSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEW 404 (521)
Q Consensus 330 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~ 404 (521)
|+|||+++...... .......|++.|+|||++. +..++.++|||||||++|||++|+.||....+. +.
T Consensus 165 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~------~~ 237 (286)
T cd06638 165 LVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM------RA 237 (286)
T ss_pred EccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh------HH
Confidence 99999998764322 1223356899999999875 345788999999999999999999999654321 11
Q ss_pred HHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 405 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
+...... ......++ ...+. .+..++.+||+.||++||++.|+++.+
T Consensus 238 ~~~~~~~-~~~~~~~~----~~~~~---~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 238 LFKIPRN-PPPTLHQP----ELWSN---EFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred Hhhcccc-CCCcccCC----CCcCH---HHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1111100 00011111 11222 355588899999999999999998754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=309.04 Aligned_cols=250 Identities=31% Similarity=0.513 Sum_probs=202.2
Q ss_pred ceEccCCcEEEEEEEEcC----CcEEEEEEeccCChhh-HHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 192 NVIGEGGYGIVYHGVLED----NTNVAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
+.||+|+||.||+|.... +..|++|.+....... .+.+..|+++++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999753 7789999987654433 67889999999999999999999999999999999999999
Q ss_pred CchHHhhhcCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 267 GNLEQWLHGDVGP-----HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 267 g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
++|.+++...... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875221 36789999999999999999999998 999999999999999999999999999987654
Q ss_pred CCc-ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 342 ERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 342 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
... .......++..|+|||.+....++.++|||||||++|||++ |..||..... .+....... .. ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~-~~--~~-- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------EEVLEYLRK-GY--RL-- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHc-CC--CC--
Confidence 321 11234567889999999988899999999999999999999 6999975521 222222221 11 00
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
.. .... ..++.+++.+||+.+|++||++.++++.|+
T Consensus 227 -~~-~~~~---~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -PK-PEYC---PDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -CC-CccC---ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01 1112 334556888999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=333.91 Aligned_cols=245 Identities=30% Similarity=0.488 Sum_probs=203.0
Q ss_pred ceEccCCcEEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCCchH
Q 009979 192 NVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLE 270 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L~ 270 (521)
-+||+|.||+||.|++.+ ..++|||.+........+-+..||.+-++|+|.|||+++|.|.+++..-|.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 379999999999999654 5568999998777777788999999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC-CCCCceEeecccceecCCCCccee
Q 009979 271 QWLHGDVGPHSPL--TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVT 347 (521)
Q Consensus 271 ~~l~~~~~~~~~l--~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~-~~~~vkL~DFGla~~~~~~~~~~~ 347 (521)
++|+... +++ .+.+.-.+..||++||.|||++ .|||||||-+||||+ -.|.+||+|||.++.+..-+. .+
T Consensus 661 sLLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~T 733 (1226)
T KOG4279|consen 661 SLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CT 733 (1226)
T ss_pred HHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc-cc
Confidence 9999874 455 7788889999999999999999 999999999999995 689999999999998865444 35
Q ss_pred ecccccccccccccccCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCC
Q 009979 348 TRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425 (521)
Q Consensus 348 ~~~~gt~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 425 (521)
.++.||..|||||++..+ .|+.++|||||||++.||.||++||.....+.. .|..- ++.. .-+.
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkV----GmyK--vHP~ 799 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKV----GMYK--VHPP 799 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhh----ccee--cCCC
Confidence 567899999999999665 489999999999999999999999975433211 01110 1110 1112
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 426 PCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 426 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.+.+...++..+|++|+.+||.+||++++++.
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 23455566777999999999999999999873
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=310.58 Aligned_cols=247 Identities=27% Similarity=0.470 Sum_probs=195.5
Q ss_pred ceEccCCcEEEEEEEEcC----CcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 192 NVIGEGGYGIVYHGVLED----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
++||+|+||.||+|.+.. +..+|+|.+..... ...+.+..|+++++.+.|+||+++++++.. ...++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 469999999999998532 25799999876544 345678899999999999999999998764 567999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
|+|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999865 3689999999999999999999998 99999999999999999999999999998764433222
Q ss_pred ee--cccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 347 TT--RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 347 ~~--~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
.. ...++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+.......... . ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~------~~~~~~~~~~~~---~----~~ 219 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG------AEVIAMLESGER---L----PR 219 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH------HHHHHHHHcCCc---C----CC
Confidence 11 1223568999999998999999999999999999998 9999964432 111121111110 0 01
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
...++. .+.+++.+||..+|++||++.++++.|+..
T Consensus 220 ~~~~~~---~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 220 PEECPQ---EIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 112333 345588899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=317.50 Aligned_cols=239 Identities=23% Similarity=0.405 Sum_probs=187.8
Q ss_pred eEccCCcEEEEEEEEcC-------------------------CcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeE
Q 009979 193 VIGEGGYGIVYHGVLED-------------------------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247 (521)
Q Consensus 193 ~LG~G~fG~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l 247 (521)
.||+|+||.||+|.+.. ...|++|.+..........+..|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 13488898866555555678889999999999999999
Q ss_pred EEEEeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC-
Q 009979 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW- 326 (521)
Q Consensus 248 ~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~- 326 (521)
+++|.+....++||||+++|+|..++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 99999999999999999999999998764 35688999999999999999999998 999999999999997644
Q ss_pred ------CceEeecccceecCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHH-hCCCCCCCCCCCCc
Q 009979 327 ------NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVI-SGRNPVDYSRPPGE 398 (521)
Q Consensus 327 ------~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~ell-tG~~Pf~~~~~~~~ 398 (521)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||....+...
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3799999998643221 22357888999998865 56899999999999999995 69999975433211
Q ss_pred ccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 399 VNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
...... . ..+... .. ..+.+++.+||+.+|++||++.+|++.|.
T Consensus 231 ---~~~~~~----~-------~~~~~~-~~---~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ---ERFYEK----K-------HRLPEP-SC---KELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHHHHh----c-------cCCCCC-CC---hHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111110 0 011111 11 24556888999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=305.59 Aligned_cols=253 Identities=22% Similarity=0.324 Sum_probs=201.6
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
..+.|++-++||+|.|+.||++... +|+++|+|.+.-. .....+++.+|+.+-+.|+|||||+|.+.+.+....|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3467888999999999999999854 6889999987432 333568899999999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC---CCCCceEeecccce
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD---KQWNPKLSDFGLAK 337 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~---~~~~vkL~DFGla~ 337 (521)
+|+|+|++|..-+-.+ .-+++..+-..+.||++||.|+|.+ +|||||+||+|+|+- ..--+||+|||+|.
T Consensus 89 Fe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 9999999997665443 3577888889999999999999999 999999999999994 34459999999999
Q ss_pred ecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
.++ .........|||.|||||++...+|+..+|||+.||+||-|+.|++||.+.+. ..+.+.++ .. -
T Consensus 162 ~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---~rlye~I~---~g-----~ 228 (355)
T KOG0033|consen 162 EVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYEQIK---AG-----A 228 (355)
T ss_pred EeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---HHHHHHHh---cc-----c
Confidence 886 23334557899999999999999999999999999999999999999975332 12222222 11 1
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.| +.....+....++.+|+.+||..||.+|-|+.|.|.+
T Consensus 229 yd--~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 229 YD--YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred cC--CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 11 1111122223334458889999999999999998743
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=313.03 Aligned_cols=250 Identities=22% Similarity=0.325 Sum_probs=198.3
Q ss_pred ccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
|++.+.||+|+||.||+|... ++..+++|.+........+.+..|+++++.++||||+++++++..+...++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 577889999999999999976 4677888888665555667788999999999999999999999999999999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
++|..++... ..++++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++....... ..
T Consensus 87 ~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~ 159 (282)
T cd06643 87 GAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 159 (282)
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence 9999988654 35789999999999999999999998 99999999999999999999999999997653221 12
Q ss_pred eeccccccccccccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 347 TTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
.....|+..|+|||++. +..++.++|||||||++|||++|+.||.... ..+.......... ....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~------~~~~~~~~~~~~~-~~~~--- 229 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN------PMRVLLKIAKSEP-PTLA--- 229 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC------HHHHHHHHhhcCC-CCCC---
Confidence 23356899999999873 4557889999999999999999999986432 1122222211111 0111
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.....+. .+.+++.+||+.||.+||++.+++..
T Consensus 230 -~~~~~~~---~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 -QPSRWSS---EFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -CccccCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111223 34558889999999999999998743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=318.63 Aligned_cols=260 Identities=26% Similarity=0.364 Sum_probs=192.1
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh--hHHHHHHHHHHHhcC---CCCCeeeEEEEEee-----CC
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ--AEKEFKVEVEAIGRV---RHKNLVRLLGYCAE-----GA 255 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l---~hpniv~l~~~~~~-----~~ 255 (521)
+|++.+.||+|+||+||+|.+. +++.||+|.+...... ....+..|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788999999999999999965 5888999988653221 223455677777655 79999999998864 24
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..++||||+.+ +|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 57899999975 8999887652 34589999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhc---c
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN---R 412 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~ 412 (521)
++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||....... .+..... .... .
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~-~~~~~~~~ 229 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFD-LIGLPPED 229 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHH-HhCCCChh
Confidence 98764322 2234568999999999998899999999999999999999999996443211 1111111 1000 0
Q ss_pred cc-------ccCCCcccCC---CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 413 NA-------EGVLDPRLQE---KPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 413 ~~-------~~~~d~~l~~---~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.. .....+.... ...+.....+.+++.+||+.||++|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 0000000000 000112234556888999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=314.68 Aligned_cols=252 Identities=27% Similarity=0.397 Sum_probs=197.9
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeC------C
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEG------A 255 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~------~ 255 (521)
+.+.|++.+.||+|+||.||+|... +++.||+|.+.... .....+..|+.+++.+ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567889999999999999999965 57889999886543 3446788899999998 699999999998753 4
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..++||||+.+++|.+++.... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 5789999999999999997642 35688999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCcceeeccccccccccccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (521)
+....... .......|+..|+|||++. +..++.++|||||||++|||++|+.||....+. ... .....
T Consensus 158 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~-~~~~~ 230 (272)
T cd06637 158 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RAL-FLIPR 230 (272)
T ss_pred ceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHH-HHHhc
Confidence 98653322 1233467899999999885 346888999999999999999999999643321 111 11111
Q ss_pred ccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 411 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
. ..+......++. .+.+++.+||..||.+||++.++++
T Consensus 231 -~-----~~~~~~~~~~~~---~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 -N-----PAPRLKSKKWSK---KFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -C-----CCCCCCCCCcCH---HHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 111111112233 3455888999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=320.47 Aligned_cols=260 Identities=26% Similarity=0.419 Sum_probs=204.2
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 255 (521)
+..++|++.+.||+|+||.||+|... ++..||+|.+.... .....++..|+.+++.++||||+++++++.++.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 34568999999999999999999863 36779999886543 334567889999999999999999999999999
Q ss_pred eeeEEEEeccCCchHHhhhcCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVG------------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKS 317 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~ 317 (521)
..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p 158 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLAT 158 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence 99999999999999999974321 123578889999999999999999998 999999999
Q ss_pred CCeEeCCCCCceEeecccceecCCCCcce-eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCC
Q 009979 318 SNILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRP 395 (521)
Q Consensus 318 ~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~ 395 (521)
+|||+++++.+||+|||++.......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998653322211 122334678999999998899999999999999999998 8888853321
Q ss_pred CCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
.+...... ..... + .. ...+ .++.+++.+||+.+|++||++.|+++.|+.
T Consensus 239 ------~~~~~~~~-~~~~~----~-~~-~~~~---~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ------EEVIYYVR-DGNVL----S-CP-DNCP---LELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HHHHHHHh-cCCCC----C-CC-CCCC---HHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 22222211 11110 0 01 1122 345568889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=315.51 Aligned_cols=260 Identities=24% Similarity=0.440 Sum_probs=201.1
Q ss_pred CCccccceEccCCcEEEEEEEE-----cCCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC--Cee
Q 009979 186 NGFADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHR 257 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~ 257 (521)
.-|++.+.||+|+||.||++.+ .++..||+|.+.... ......+..|+++++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3578899999999999999984 247789999986543 34456789999999999999999999998775 567
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 8999999999999999764 24689999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCcc--eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCC---------CCcccHHHHHH
Q 009979 338 LLGAERSY--VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP---------PGEVNLVEWLK 406 (521)
Q Consensus 338 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~---------~~~~~~~~~~~ 406 (521)
.+...... ......|+..|+|||++.+..++.++|||||||++|||+|++.|+..... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 76433221 11234567789999999888899999999999999999998776532110 11111111111
Q ss_pred HHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 407 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
. ....... + . ...+ ...+.+++.+||+.||++||++.++++.|+.
T Consensus 238 ~-~~~~~~~----~-~-~~~~---~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 238 V-LEEGKRL----P-R-PPNC---PEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred H-HHcCccC----C-C-CCCC---CHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 1 1111100 0 0 1112 2345668889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=322.99 Aligned_cols=264 Identities=26% Similarity=0.438 Sum_probs=206.5
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEcC--------CcEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCCeeeEEEE
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLED--------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGY 250 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~ 250 (521)
+++...+|++.+.||+|+||.||+|.+.. ...||+|.+.... ....+++..|+++++++ +||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 45566689999999999999999997421 2368999876543 23456788999999999 79999999999
Q ss_pred EeeCCeeeEEEEeccCCchHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 009979 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318 (521)
Q Consensus 251 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~ 318 (521)
|......++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence 9999999999999999999999976421 234588899999999999999999998 9999999999
Q ss_pred CeEeCCCCCceEeecccceecCCCCcce-eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCC
Q 009979 319 NILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPP 396 (521)
Q Consensus 319 NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~ 396 (521)
|||++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-- 241 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-- 241 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC--
Confidence 9999999999999999998764332221 122334568999999999999999999999999999998 888985432
Q ss_pred CcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 397 GEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
..+...... ...... . ...++ ..+.+++.+||+.+|++||++.+++..|+...
T Consensus 242 ----~~~~~~~~~-~~~~~~-----~-~~~~~---~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 242 ----VEELFKLLK-EGHRMD-----K-PANCT---HELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred ----HHHHHHHHH-cCCCCC-----C-CCCCC---HHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 222222222 111100 0 11123 34555888999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=318.80 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=202.6
Q ss_pred CCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 186 NGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
.+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+..|+.+++.++|+||+++++++..+...++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5899999999999999999996 468999999997665555677889999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~ 344 (521)
++++|.+++.+. .+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998643 578899999999999999999998 999999999999999999999999999987643322
Q ss_pred ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCC
Q 009979 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (521)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 424 (521)
. .....|++.|+|||.+.+..++.++|+|||||++|+|++|..||....+..... ...... .+....
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~------~~~~~~ 237 (297)
T cd06656 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG------TPELQN 237 (297)
T ss_pred C-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCC------CCCCCC
Confidence 1 234568999999999999889999999999999999999999996543321110 000000 000000
Q ss_pred CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 425 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.......+.+++.+||+.||++||++.++++
T Consensus 238 --~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 238 --PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred --ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112233445888999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=315.27 Aligned_cols=250 Identities=25% Similarity=0.436 Sum_probs=193.5
Q ss_pred ceEccCCcEEEEEEEEcC-Cc--EEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 192 NVIGEGGYGIVYHGVLED-NT--NVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
+.||+|+||.||+|.+.+ +. .+++|.+.... ......+..|++++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999753 33 46888776432 34456788999999999 799999999999999999999999999
Q ss_pred CchHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecc
Q 009979 267 GNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (521)
Q Consensus 267 g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFG 334 (521)
|+|.++++.... ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999976421 123578999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccc
Q 009979 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (521)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (521)
++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||..... .+..........
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------~~~~~~~~~~~~ 229 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEKLPQGYR 229 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH------HHHHHHHhCCCC
Confidence 98632111 11111234567999999988899999999999999999997 9999964321 122222211100
Q ss_pred cccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 414 ~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.+ .. ...+ ..+.+++.+||+.||.+||++.+++..|+..
T Consensus 230 ----~~--~~-~~~~---~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 230 ----LE--KP-LNCD---DEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ----CC--CC-CcCC---HHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00 11 1122 3455688899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=313.41 Aligned_cols=263 Identities=28% Similarity=0.438 Sum_probs=197.6
Q ss_pred ccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhc--CCCCCeeeEEEEEeeCC----eeeEEE
Q 009979 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR--VRHKNLVRLLGYCAEGA----HRMLVY 261 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~hpniv~l~~~~~~~~----~~~lV~ 261 (521)
..+.++||+|.||.||+|.+. ++.||||++.. +..+.|..|-++.+. ++|+||++|+++-.... .++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 455778999999999999985 68999999843 344667777777764 58999999999876555 789999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL------EPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~------~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
+|.+.|+|.+||..+ .++|....+|+..+++||+|||+.. +|+|+|||||++||||..+++.-|+|||+
T Consensus 288 ~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999875 7899999999999999999999653 77899999999999999999999999999
Q ss_pred ceecCCCCcce-eecccccccccccccccCCC-CC-----CcccchhHHHHHHHHHhCCCCCCCCCC-----------CC
Q 009979 336 AKLLGAERSYV-TTRVMGTFGYVAPEYASTGM-LN-----ERSDVYSFGILIMEVISGRNPVDYSRP-----------PG 397 (521)
Q Consensus 336 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-~~-----~~sDvwS~Gvvl~elltG~~Pf~~~~~-----------~~ 397 (521)
|..+....... ....+||.+|||||++.+.. +. .+.||||+|.|||||++...-+..... ..
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 99886543322 23478999999999997643 22 368999999999999996544431111 11
Q ss_pred cccHHHHHHHH-hhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 009979 398 EVNLVEWLKTM-VTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 464 (521)
Q Consensus 398 ~~~~~~~~~~~-~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 464 (521)
...+ +.++.. +..+....+. ...........+. +.+..||+.||+.|.|+.=+-+.+.....
T Consensus 443 hPt~-e~mq~~VV~kK~RP~~p-~~W~~h~~~~~l~---et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 443 HPTL-EEMQELVVRKKQRPKIP-DAWRKHAGMAVLC---ETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CCCH-HHHHHHHHhhccCCCCh-hhhhcCccHHHHH---HHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 1122 223333 3322222222 2222233344444 47779999999999999888777765543
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=310.52 Aligned_cols=254 Identities=23% Similarity=0.358 Sum_probs=191.2
Q ss_pred ceEccCCcEEEEEEEEcCCc---EEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCC
Q 009979 192 NVIGEGGYGIVYHGVLEDNT---NVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~~~---~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 267 (521)
+.||+|+||.||+|...++. .+++|.+.... ....+.+.+|+.+++.++||||++++++|......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999854333 45667665433 334578899999999999999999999999999999999999999
Q ss_pred chHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC-cce
Q 009979 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER-SYV 346 (521)
Q Consensus 268 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~-~~~ 346 (521)
+|.+++++........++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999986543345667778889999999999999998 99999999999999999999999999986432111 111
Q ss_pred eecccccccccccccccC-------CCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCC
Q 009979 347 TTRVMGTFGYVAPEYAST-------GMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (521)
.....|+..|+|||++.. ..++.++|||||||++|||++ |..||..... .+.+...... ....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~-~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKD-QQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhh-cccccC
Confidence 234568899999998743 345789999999999999997 5678753321 2222222222 222334
Q ss_pred CcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 419 d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
++.+... ... ++.+++..|| .+|++||++.+|++.|.
T Consensus 231 ~~~~~~~-~~~---~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELP-YSE---RWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCC-CcH---HHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 4444322 222 3444777899 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.26 Aligned_cols=259 Identities=21% Similarity=0.311 Sum_probs=199.5
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|++.++||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47899999999999999999975 58899999986532 223467889999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecc
Q 009979 262 EYIDNGNLEQWLHGDVG-------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFG 334 (521)
||++||+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 123456778899999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCc-----------------ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCC
Q 009979 335 LAKLLGAERS-----------------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG 397 (521)
Q Consensus 335 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~ 397 (521)
+++....... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 01123579999999999999999999999999999999999999996532210
Q ss_pred cccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhhc
Q 009979 398 EVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP-KMGHVIHMLEA 461 (521)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RP-t~~evl~~L~~ 461 (521)
. . ... ...++.- ..+.......+.+++.+||+.||++|| ++.++++.|+.
T Consensus 239 i---~--~~~--------~i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 I---S--YRD--------VILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred h---h--hhh--------hccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 0 000 0011100 000111122344588899999999996 56666666654
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=318.62 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=202.8
Q ss_pred CCCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 185 TNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
..+|++.+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+++++.++||||+++++++......++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 34799999999999999999985 46889999998766555567888999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++++|..++... .+++..+..++.+++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 98 LAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred cCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9999999988643 588999999999999999999998 99999999999999999999999999988654332
Q ss_pred cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
. ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||....+. +.+....... ..... .
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~------~~~~~~~~~~-~~~~~----~ 237 (296)
T cd06655 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLIATNG-TPELQ----N 237 (296)
T ss_pred c-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcC-CcccC----C
Confidence 2 123356899999999999888999999999999999999999999654321 1111111111 00000 0
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
....+. .+.+++.+||..||++||++.+++.
T Consensus 238 ~~~~~~---~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 238 PEKLSP---IFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cccCCH---HHHHHHHHHhhcChhhCCCHHHHhh
Confidence 111222 3445888999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=309.74 Aligned_cols=248 Identities=26% Similarity=0.417 Sum_probs=198.9
Q ss_pred ceEccCCcEEEEEEEEcC--Cc--EEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 192 NVIGEGGYGIVYHGVLED--NT--NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~--~~--~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
+.||+|+||.||+|.+.+ ++ .||+|.+..... ...+.+..|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 22 589999877655 566789999999999999999999999988 888999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
++|.+++..... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999987532 5789999999999999999999998 99999999999999999999999999998764422211
Q ss_pred --eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 347 --TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 347 --~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+..+....... ....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~~~~~~~--~~~~---- 222 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG------SQILKKIDKEGE--RLER---- 222 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcCC--cCCC----
Confidence 123457889999999999999999999999999999999 9999964322 222222221111 0000
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
.... ...+.+++.+||+.+|++||++.++++.|.
T Consensus 223 ~~~~---~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 PEAC---PQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CccC---CHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1112 234556888999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=311.67 Aligned_cols=250 Identities=28% Similarity=0.469 Sum_probs=198.6
Q ss_pred CccccceEccCCcEEEEEEEEcCCcEEEEEEeccCCh------hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
+|+..+.||+|+||.||+|...+++.+|+|.+..... .....+.+|+++++.++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999987888999998864321 2235688899999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+++++|.+++... .++++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999999764 4678999999999999999999998 99999999999999999999999999997653
Q ss_pred CCC-----cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 341 AER-----SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 341 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
... ........|+..|+|||++.+..++.++|||||||++|+|++|..||...+.. .. ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~-~~~~~~~~--- 224 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-----AA-MFYIGAHR--- 224 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH-----HH-HHHhhhcc---
Confidence 211 11123356899999999999988999999999999999999999999643211 11 11111100
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
. ..+.+.. ..+. .+.+++.+||+.+|.+||++.+++.
T Consensus 225 ~-~~~~~~~-~~~~---~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 G-LMPRLPD-SFSA---AAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C-CCCCCCC-CCCH---HHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 1111111 1233 3455888999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=320.73 Aligned_cols=197 Identities=22% Similarity=0.372 Sum_probs=161.5
Q ss_pred cceEccCCcEEEEEEEEc---CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEee--CCeeeEEEEecc
Q 009979 191 ENVIGEGGYGIVYHGVLE---DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVYEYID 265 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~~lV~e~~~ 265 (521)
.++||+|+||+||+|... ++..||+|.+.... ....+.+|+++++.++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 45789999886542 23456789999999999999999998854 456789999986
Q ss_pred CCchHHhhhcCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe----CCCCCceEeecccc
Q 009979 266 NGNLEQWLHGDVG-----PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL----DKQWNPKLSDFGLA 336 (521)
Q Consensus 266 ~g~L~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl----~~~~~vkL~DFGla 336 (521)
++|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 488888753311 123588999999999999999999998 99999999999999 45678999999999
Q ss_pred eecCCCCc--ceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 009979 337 KLLGAERS--YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS 393 (521)
Q Consensus 337 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~ 393 (521)
+....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87643221 12234678999999998876 45899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=327.57 Aligned_cols=197 Identities=28% Similarity=0.362 Sum_probs=168.5
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC------C
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------A 255 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------~ 255 (521)
.++|++.+.||+|+||.||++... .++.||+|++... .......+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 468999999999999999999864 5888999998653 233346677899999999999999999988643 3
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..++||||+++ +|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence 56999999975 77777643 478888999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~ 393 (521)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 166 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 166 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred cccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9865332 2233457899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=320.59 Aligned_cols=263 Identities=22% Similarity=0.330 Sum_probs=198.2
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
.++|.+.+.||+|+||.||+|... ++..||+|.+.... ......+..|+.+++.++||||+++++++..+...++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 357899999999999999999865 57889999886432 2233567789999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|++ ++|.+++... ...+++..++.++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 85 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 85 YLD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred ccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 997 5999988764 34688999999999999999999998 9999999999999999999999999999765332
Q ss_pred CcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh-----------
Q 009979 343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT----------- 410 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----------- 410 (521)
.. ......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||....... ....+.....
T Consensus 158 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 158 TK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred CC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhh
Confidence 21 1223457899999998765 458889999999999999999999997543211 1111111110
Q ss_pred -ccccccCCCcccCCC----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 411 -NRNAEGVLDPRLQEK----PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 411 -~~~~~~~~d~~l~~~----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.......-.+..... ........+.+++.+||+.||.+|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000000111000 001122344568889999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=311.94 Aligned_cols=248 Identities=26% Similarity=0.402 Sum_probs=202.0
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
++|++.+.||.|+||.||+|.+. +++.||+|.+.... ......+..|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888999999999999999965 58889999886543 33446788999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++++|.++++.. ++++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998753 788999999999999999999998 99999999999999999999999999998775432
Q ss_pred cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
.......|++.|+|||++.+..++.++|||||||++|+|+||+.||....+. +....... . ..+.+.
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~------~~~~~~~~-~-----~~~~~~ 219 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM------RVLFLIPK-N-----NPPSLE 219 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH------HHHHHhhh-c-----CCCCCc
Confidence 1223456889999999999888999999999999999999999999644321 11111111 1 111111
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
....+ ..+.+++.+||..+|++||+++++++
T Consensus 220 ~~~~~---~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 GNKFS---KPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccccC---HHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11122 23455888999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=305.94 Aligned_cols=250 Identities=21% Similarity=0.338 Sum_probs=200.1
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEee-CCeeeEEEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-GAHRMLVYE 262 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-~~~~~lV~e 262 (521)
+|++.+.||+|+||.||++... +++.||+|++.... ....+.+..|+++++.++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999965 57789999986432 2344678889999999999999999998764 446789999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+++++|.+++.... ...+++..++.++.+++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999997642 35689999999999999999999998 9999999999999999999999999999876432
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
. .......|++.|+|||++.+..++.++||||||+++|+|++|+.||...+ ............ + +.+
T Consensus 156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~~~~-----~-~~~ 222 (257)
T cd08223 156 C-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRIIEGK-----L-PPM 222 (257)
T ss_pred C-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhcC-----C-CCC
Confidence 2 22334568999999999999999999999999999999999999996332 222222222211 1 011
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.......+.+++.+||+.||++||++.+++++
T Consensus 223 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 ----PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11223445568889999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=327.99 Aligned_cols=198 Identities=29% Similarity=0.362 Sum_probs=168.9
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC------C
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------A 255 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------~ 255 (521)
.++|.+.+.||+|+||.||+|... .++.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 458999999999999999999965 57889999986532 23346678899999999999999999987543 3
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..|+||||+++ +|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 57999999965 77777743 477888999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~ 394 (521)
++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 173 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 173 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred ccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 9865332 22334578999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=312.39 Aligned_cols=254 Identities=27% Similarity=0.415 Sum_probs=201.0
Q ss_pred CccccceEccCCcEEEEEEEEcC--CcEEEEEEeccC----------ChhhHHHHHHHHHHHhc-CCCCCeeeEEEEEee
Q 009979 187 GFADENVIGEGGYGIVYHGVLED--NTNVAVKNLLNN----------RGQAEKEFKVEVEAIGR-VRHKNLVRLLGYCAE 253 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~Ei~~l~~-l~hpniv~l~~~~~~ 253 (521)
.|++.+.||+|+||.||+|.+.. ++.+|+|.+... ......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999764 678999987532 22233556778888875 799999999999999
Q ss_pred CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEeCCCCCceEee
Q 009979 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (521)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~iiHrDik~~NILl~~~~~vkL~D 332 (521)
+...++||||+++++|.+++.........+++..++.++.|++.||.|||+ . +++|+||+|+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999886543334678999999999999999999996 4 899999999999999999999999
Q ss_pred cccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc
Q 009979 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (521)
Q Consensus 333 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (521)
||++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ......... .
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~~~~-~ 228 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATKIVE-A 228 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHHHhh-c
Confidence 99998764433 23445689999999999988899999999999999999999999964321 111222111 1
Q ss_pred ccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 413 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
. ..+. .....+ ..+.+++.+||+.||++||++.|+..+++
T Consensus 229 ~----~~~~-~~~~~~---~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 V----YEPL-PEGMYS---EDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred c----CCcC-CcccCC---HHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1 1111 111122 33455888999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=308.82 Aligned_cols=248 Identities=25% Similarity=0.446 Sum_probs=197.8
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh---------hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ---------AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 256 (521)
+|.+...||+|+||.||+|... +++.||+|.+...... ..+.+..|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999864 5788999988643221 22568889999999999999999999999999
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 99999999999999999764 4688899999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCc-----ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhc
Q 009979 337 KLLGAERS-----YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN 411 (521)
Q Consensus 337 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (521)
+....... .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||..... ...+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~- 226 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ------LQAIFKIGE- 226 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH------HHHHHHHhc-
Confidence 87642211 111234588999999999988899999999999999999999999964321 111111111
Q ss_pred cccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 412 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
...+.+... .+ ..+.+++.+||+.||.+||++.++++
T Consensus 227 -----~~~~~~~~~-~~---~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 -----NASPEIPSN-IS---SEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----cCCCcCCcc-cC---HHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111112111 22 34455888999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=304.13 Aligned_cols=251 Identities=23% Similarity=0.384 Sum_probs=203.6
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
+|+..+.||+|+||.||.+... ++..+++|.+.... ......+.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788999999999999999854 58889999876432 33446788999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997652 35688999999999999999999998 99999999999999999999999999998764433
Q ss_pred cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
. ......|++.|+|||++.+..++.++||||||+++|||++|..||..... .+........ .. .+ .
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~-~~----~~--~ 221 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIVQG-NY----TP--V 221 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcC-CC----CC--C
Confidence 2 23445689999999999888899999999999999999999999964322 2222222211 11 11 0
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
....+ ..+.+++.+||..+|.+||++.++++++
T Consensus 222 ~~~~~---~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 VSVYS---SELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccccC---HHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11123 3345588899999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=311.15 Aligned_cols=248 Identities=24% Similarity=0.379 Sum_probs=202.1
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
.|+..+.||.|+||.||+|.+. ++..||+|.+.... ......+..|+++++.+.|+||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 5777889999999999999965 57889999886543 344577889999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~ 344 (521)
++++|.+++.. .++++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999999864 3578889999999999999999998 999999999999999999999999999987644322
Q ss_pred ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCC
Q 009979 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (521)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 424 (521)
......++..|+|||++.+..++.++|+|||||++|||+||..||....+.. ..... .. ....
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~------~~~~~-~~---------~~~~ 219 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR------VLFLI-PK---------NNPP 219 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh------Hhhhh-hc---------CCCC
Confidence 2233568899999999998889999999999999999999999996543211 11111 00 0011
Q ss_pred CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 425 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
.........+.+++.+||+.+|++||++.+++..-
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 11223344566688899999999999999997653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=311.98 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=203.0
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
.++|++.+.||.|+||.||+|.+. ++..||+|.+........+.+..|++++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 457999999999999999999965 5888999998766666667889999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++++|.+++... ...+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 9999999998764 34689999999999999999999998 99999999999999999999999999987653322
Q ss_pred cceeeccccccccccccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCC
Q 009979 344 SYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (521)
. ......|++.|+|||.+. +..++.++||||||+++|||++|+.||..... .+.+...... .
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~-~----- 224 (280)
T cd06611 158 Q-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP------MRVLLKILKS-E----- 224 (280)
T ss_pred c-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH------HHHHHHHhcC-C-----
Confidence 2 223456899999999874 34577899999999999999999999964432 1111111111 0
Q ss_pred CcccC-CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 419 DPRLQ-EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 419 d~~l~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+.+. ....+. .+.+++.+||+.+|.+||++.++++.
T Consensus 225 ~~~~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 225 PPTLDQPSKWSS---SFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCCcCCcccCCH---HHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11111 111233 34458889999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=313.91 Aligned_cols=262 Identities=22% Similarity=0.315 Sum_probs=196.3
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
+|++.+.||+|+||.||+|... ++..||+|++.... ......+..|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999965 68899999886432 22346788899999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
++ ++|.+++.... ....+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 58998886542 235789999999999999999999998 99999999999999999999999999998654322
Q ss_pred cceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh------------
Q 009979 344 SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT------------ 410 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~------------ 410 (521)
.......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||....... .....+.....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhh
Confidence 11233467899999998765 457899999999999999999999997443211 11111100000
Q ss_pred ---ccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 411 ---NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 411 ---~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
...........+.. .......++.+++.+||+.||.+|||+.+|+.
T Consensus 233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PDYKNTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHhhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000000 00011233456888999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=313.69 Aligned_cols=264 Identities=27% Similarity=0.390 Sum_probs=203.8
Q ss_pred cchhhhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEee
Q 009979 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE 253 (521)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~ 253 (521)
+.+..+....++|.+.+.||+|+||.||++... +++.+|+|.+.... .....+..|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 335555667889999999999999999999964 68889999886432 2345677899999999 79999999999875
Q ss_pred C-----CeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCc
Q 009979 254 G-----AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328 (521)
Q Consensus 254 ~-----~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~v 328 (521)
. ...++||||+++++|.++++........+++..++.++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 4 357999999999999999875433456789999999999999999999998 99999999999999999999
Q ss_pred eEeecccceecCCCCcceeecccccccccccccccCC-----CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHH
Q 009979 329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-----MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVE 403 (521)
Q Consensus 329 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~ 403 (521)
||+|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|+.||....+. +
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------~ 240 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------K 240 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------H
Confidence 9999999986543221 12234688999999987543 3688999999999999999999999644321 1
Q ss_pred HHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 404 WLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 404 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+..... .....+.++ ......+.+++.+||+.+|++||++.+++++
T Consensus 241 ~~~~~~~-~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 241 TLFKIPR-NPPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHHHhc-CCCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111111 111111111 1122345568889999999999999999854
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=329.80 Aligned_cols=252 Identities=26% Similarity=0.420 Sum_probs=207.6
Q ss_pred CCCccccceEccCCcEEEEEEEEcC--Cc--EEEEEEeccCChh-hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLED--NT--NVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
.+.....++||+|.||.|++|.|.. |+ .||||.+...... ...+|.+|+.+|.+|+|+|+++|||+..+ ....|
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 3455668899999999999999863 43 4799999776544 66899999999999999999999999988 77899
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
|||+++.|+|.+.|++. ....|.......++.|||.|+.||.++ ++|||||..+|+|+-....|||+|||+.+-+
T Consensus 188 V~ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred HhhhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceecc
Confidence 99999999999999983 467888899999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCcce-eec-ccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 340 GAERSYV-TTR-VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 340 ~~~~~~~-~~~-~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
+....+. ++. ..-.+.|+|||.+....++.+||||+|||+||||+| |..||.+- +-.++++..-...+
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~------~g~qIL~~iD~~er--- 333 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC------RGIQILKNIDAGER--- 333 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC------CHHHHHHhcccccc---
Confidence 7654433 221 233668999999999999999999999999999999 88999643 33444444332111
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.-+.++|++.+.. +++.||..+|++|||+..|.+.
T Consensus 334 ----LpRPk~csedIY~---imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 334 ----LPRPKYCSEDIYQ---IMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ----CCCCCCChHHHHH---HHHHhccCCccccccHHHHHHh
Confidence 1134557666555 8889999999999999999733
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=310.31 Aligned_cols=238 Identities=25% Similarity=0.444 Sum_probs=189.3
Q ss_pred ceEccCCcEEEEEEEEcCCc-----------EEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 192 NVIGEGGYGIVYHGVLEDNT-----------NVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999976433 4777876544333 6788899999999999999999999988 778999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC-------CceEeec
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-------NPKLSDF 333 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~-------~vkL~DF 333 (521)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 99999999999998752 3688999999999999999999998 999999999999999887 7999999
Q ss_pred ccceecCCCCcceeecccccccccccccccCC--CCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhh
Q 009979 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVT 410 (521)
Q Consensus 334 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (521)
|++..... .....++..|+|||++.+. .++.++|||||||++|||++ |..||........ ......
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~------~~~~~~ 221 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK------ERFYQD 221 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH------HHHHhc
Confidence 99986533 2234567889999999776 78999999999999999999 5778865432111 111110
Q ss_pred ccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 411 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
.. ... .+.. ..+.+++.+||+.+|.+||++.++++.|+
T Consensus 222 -~~-------~~~-~~~~---~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 -QH-------RLP-MPDC---AELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -CC-------CCC-CCCc---hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 000 1111 45566888999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=309.22 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=189.3
Q ss_pred ceEccCCcEEEEEEEEcC---CcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCC
Q 009979 192 NVIGEGGYGIVYHGVLED---NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 267 (521)
+.||+|+||.||+|...+ ...+|+|.+.... ......+.+|+++++.++|+||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997543 3467888765433 233466888999999999999999999999999999999999999
Q ss_pred chHHhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 268 NLEQWLHGDVGP-HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 268 ~L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
+|.+++...... ....++...+.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999765322 23456788899999999999999998 99999999999999999999999999987543322111
Q ss_pred -eeccccccccccccccc-------CCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 347 -TTRVMGTFGYVAPEYAS-------TGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 347 -~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
.....++..|+|||++. ...++.++|||||||++|||++ |..||....+ .+.+........ ..+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~~-~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD------EQVLKQVVREQD-IKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHHHHhhccC-ccC
Confidence 12334677899999864 3457889999999999999999 7888864322 112222222211 112
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
.++.+.. ..+.. +.+++..|| .||++||++.+|++.|.
T Consensus 231 ~~~~~~~-~~~~~---~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDL-KYSDR---WYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcccc-cCCHH---HHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2222221 12333 334677888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=310.50 Aligned_cols=262 Identities=25% Similarity=0.440 Sum_probs=203.9
Q ss_pred CCccccceEccCCcEEEEEEEEc-----CCcEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCCeeeEEEEEee--CCee
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHR 257 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~ 257 (521)
+.|++.+.||+|+||.||+|.+. ++..||+|.+...... ....+..|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46778899999999999999854 3678999998765443 46789999999999999999999999877 5578
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999999765 23689999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCccee--ecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcc--------cHHHHHHH
Q 009979 338 LLGAERSYVT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV--------NLVEWLKT 407 (521)
Q Consensus 338 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~--------~~~~~~~~ 407 (521)
.......... ....++..|+|||.+.+..++.++||||||+++|||+||+.|+......... .....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 7653322111 1234566799999998889999999999999999999999998643221100 01111111
Q ss_pred HhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 408 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
....... . + ....++ .++.+++.+||+.+|++||++.+|+++|+..
T Consensus 238 ~~~~~~~---~-~--~~~~~~---~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGER---L-P--RPPSCP---DEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCc---C-C--CCccCC---HHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111110 0 0 011122 3455688899999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=307.64 Aligned_cols=249 Identities=29% Similarity=0.471 Sum_probs=191.1
Q ss_pred ceEccCCcEEEEEEEEcC----CcEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEe-eCCeeeEEEEecc
Q 009979 192 NVIGEGGYGIVYHGVLED----NTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA-EGAHRMLVYEYID 265 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~-~~~~~~lV~e~~~ 265 (521)
+.||+|+||.||+|.+.+ ...||+|.+... .....+.+..|+.+++.++||||+++++++. .+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998532 346899988543 2344567888999999999999999999875 4456789999999
Q ss_pred CCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcc
Q 009979 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (521)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~ 345 (521)
+|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999765 23467778889999999999999998 9999999999999999999999999999865332211
Q ss_pred e---eecccccccccccccccCCCCCCcccchhHHHHHHHHHhC-CCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 346 V---TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG-RNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 346 ~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
. .....++..|+|||++.+..++.++|||||||++|||++| ..||.... ..+.......... +.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~~~~~~~------~~ 222 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD------SFDITVYLLQGRR------LL 222 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHhcCCC------CC
Confidence 1 1233467789999999888999999999999999999995 55664322 2222222221110 00
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.....+. .+.+++.+||+.+|++||++.+|+..|+..
T Consensus 223 -~~~~~~~---~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 223 -QPEYCPD---PLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred -CCCcCCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0111223 355588899999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=314.44 Aligned_cols=240 Identities=23% Similarity=0.409 Sum_probs=188.4
Q ss_pred ceEccCCcEEEEEEEEcC--------CcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 192 NVIGEGGYGIVYHGVLED--------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
+.||+|+||.||+|.... ...||+|.+........+.+..|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999998642 234788887655555557788899999999999999999999998999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCC--------ceEeeccc
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN--------PKLSDFGL 335 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~--------vkL~DFGl 335 (521)
+++|+|.++++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999865 23688999999999999999999998 9999999999999987765 59999998
Q ss_pred ceecCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCC-CCCCCCCCCCcccHHHHHHHHhhccc
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGR-NPVDYSRPPGEVNLVEWLKTMVTNRN 413 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (521)
+..... .....++..|+|||++.+ ..++.++|||||||++|||++|. .||....+. .... .....
T Consensus 155 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~------~~~~-~~~~~- 221 (258)
T cd05078 155 SITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ------KKLQ-FYEDR- 221 (258)
T ss_pred ccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH------HHHH-HHHcc-
Confidence 875432 123467889999999976 45899999999999999999985 565432211 1111 11100
Q ss_pred cccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 414 ~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
..+.. ... .++.+++.+||+.||++|||+.++++.|+
T Consensus 222 ------~~~~~-~~~---~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ------HQLPA-PKW---TELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------ccCCC-CCc---HHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01111 111 34556888999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=317.76 Aligned_cols=246 Identities=22% Similarity=0.345 Sum_probs=208.8
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhH--HHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAE--KEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
-|.+.+.||+|.|..|-+|++- +|..||||++.+.+.+.. ..+..|++.|+-++|||||+||++......+|||+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 5778899999999999999843 799999999987765543 5677899999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe-CCCCCceEeecccceecCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL-DKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl-~~~~~vkL~DFGla~~~~~~ 342 (521)
=++|+|++||-+. ...+.+..+.+++.||+.|+.|+|+. .+|||||||+||.+ .+-|-|||.|||++-.+.+.
T Consensus 99 GD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 99 GDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred cCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999776 46789999999999999999999998 89999999999877 57788999999999877554
Q ss_pred CcceeecccccccccccccccCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
. ..+..||...|-|||++.+..|+ ++.||||||||||.|++|+.||+.....+- +. .++|-.
T Consensus 173 ~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET------LT---------mImDCK 235 (864)
T KOG4717|consen 173 K--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET------LT---------MIMDCK 235 (864)
T ss_pred c--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh------hh---------hhhccc
Confidence 3 35678999999999999988876 478999999999999999999975543221 11 233433
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
+.. +....+++.+||.+||..||++|.+.++|+.
T Consensus 236 Ytv--PshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 236 YTV--PSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccC--chhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 332 4556677888999999999999999999973
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=312.65 Aligned_cols=253 Identities=25% Similarity=0.439 Sum_probs=199.1
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
++|++.+.||+|+||.||++.+. ++..||+|.+... .......+.+|++++++++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999976 6889999988654 233346788999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++++|..+++... ....+++..+..++.+++.||.|||+.. +|+||||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999987642 2347899999999999999999999632 8999999999999999999999999999765322
Q ss_pred cceeecccccccccccccccCC------CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 344 SYVTTRVMGTFGYVAPEYASTG------MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
......|++.|+|||.+.+. .++.++|+|||||++|||++|+.||...... .....+...... .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~-~---- 226 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQLSAIVDG-D---- 226 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHHHHHhhc-C----
Confidence 22334688899999988544 3588999999999999999999999643221 111111111111 0
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.+.+. ......+.+++.+||+.+|++||++.+++.
T Consensus 227 -~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 -PPTLP----SGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -CCCCC----cccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 11111 123344556888999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=310.33 Aligned_cols=247 Identities=30% Similarity=0.458 Sum_probs=197.6
Q ss_pred CCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEecc
Q 009979 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (521)
++|++.+.||+|+||.||++.. ++..||+|.+.... ....+..|+.+++.++|||++++++++... ..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688899999999999999986 57789999886532 345788899999999999999999998764 4799999999
Q ss_pred CCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcc
Q 009979 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (521)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~ 345 (521)
+++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 82 KGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred CCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999999997652 34688999999999999999999998 9999999999999999999999999999864321
Q ss_pred eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCC
Q 009979 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (521)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 424 (521)
......+..|+|||++.+..++.++|+|||||++|||++ |+.||..... .+.... ..... ..++
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~-~~~~~---~~~~---- 218 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL------KEVKEC-VEKGY---RMEP---- 218 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH------HHHHHH-HhCCC---CCCC----
Confidence 122334678999999998899999999999999999998 9999964432 121111 11111 0111
Q ss_pred CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 425 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
.......+.+++.+||+.+|++||++.+++..|+.
T Consensus 219 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 --PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11122344558889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=313.13 Aligned_cols=261 Identities=23% Similarity=0.354 Sum_probs=199.7
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+..|+++++.++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999976 58889999886543 2233567889999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|++++.|..++... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 99998888876543 4689999999999999999999998 9999999999999999999999999999876443
Q ss_pred CcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhc----------
Q 009979 343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN---------- 411 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---------- 411 (521)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||........ ...+......
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ---LYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChHHhhhcc
Confidence 22 1223457889999998865 5688999999999999999999999975432211 1111111000
Q ss_pred -cc-cccCCCcccCCCc-----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 412 -RN-AEGVLDPRLQEKP-----CSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 412 -~~-~~~~~d~~l~~~~-----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.. ......+...... .......+.+++.+||+.+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 0000001100000 0112345667899999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=304.71 Aligned_cols=251 Identities=29% Similarity=0.518 Sum_probs=200.8
Q ss_pred ccccceEccCCcEEEEEEEEcC-----CcEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 188 FADENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
|++.+.||.|+||.||++.+.+ +..||+|.+...... ..+.+..|+.+++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999753 377999998665443 5678899999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999976521 2289999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
..........+++.|+|||.+.+..++.++||||||+++|+|++ |+.||... +..+.......... .
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~------~~~~~~~~~~~~~~-~----- 223 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM------SNEEVLEYLKKGYR-L----- 223 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHHhcCCC-C-----
Confidence 43332222347889999999988889999999999999999998 78888642 22222222221111 0
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
.. ....+ .++.+++.+||+.||++|||+.++++.|
T Consensus 224 ~~-~~~~~---~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PK-PENCP---PEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CC-CCcCC---HHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01 11123 3455588899999999999999998765
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=313.90 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=199.3
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
.|+..+.||+|+||.||+|.+. ++..||+|.+.... ....+.+..|+++++.++||||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4677888999999999999865 57789999886443 334567889999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~ 344 (521)
++++|.+++.. ..+++..++.++.|++.|+.|||+. +++|+||+|+||++++++.+||+|||++..+.....
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999998864 3688999999999999999999998 999999999999999999999999999986543221
Q ss_pred ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCC
Q 009979 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (521)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 424 (521)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....+. ..... .... ..+.+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------~~~~~-~~~~-----~~~~~~- 222 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM------RVLFL-IPKN-----SPPTLE- 222 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh------hHHhh-hhcC-----CCCCCC-
Confidence 122346889999999999989999999999999999999999998643321 11111 1110 111111
Q ss_pred CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 425 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
......+.+++.+||+.+|++||++.+++.+
T Consensus 223 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 ---GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1223345568889999999999999999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=324.97 Aligned_cols=245 Identities=29% Similarity=0.415 Sum_probs=200.0
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh---hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ---AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
.|..++.||.|+||.||-|++. +...||||++.-...+ .-.++..|+..|++++|||++.+.|+|..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 5788899999999999999965 5777999999654333 34678899999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
||-| +-.|++.-. ..++-+..+..|+.+.+.||+|||++ +.||||||..|||+++.|.|||+|||.|....+.
T Consensus 107 YClG-SAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 107 YCLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHhc-cHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 9955 777766433 35788899999999999999999999 9999999999999999999999999999875443
Q ss_pred Ccceeeccccccccccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 343 RSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
..++|||+|||||++. .+.|+-++||||||++..||.-.++|+-.. |....+.....+ -.
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM------NAMSALYHIAQN------es 242 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQN------ES 242 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc------hHHHHHHHHHhc------CC
Confidence 4568999999999874 578999999999999999999999997422 222222222222 23
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
|.++....+..+.. ++..||++-|.+|||..+++.+
T Consensus 243 PtLqs~eWS~~F~~---Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 PTLQSNEWSDYFRN---FVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCCchhHHHHHH---HHHHHHhhCcccCCcHHHHhhc
Confidence 45555555666555 6669999999999999888643
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=308.76 Aligned_cols=262 Identities=24% Similarity=0.332 Sum_probs=202.7
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC--CeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~lV~ 261 (521)
++|...+.||.|++|.||++.+. +++.+|+|.+..... .....+.+|+++++.++||||++++++|.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999975 578899998865433 3456788999999999999999999988653 4689999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998865433456788999999999999999999998 999999999999999999999999999875432
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...... .....+....... .....+.+..
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~ 232 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELLSYIVN-MPNPELKDEP 232 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCChHHHHHHHhc-CCchhhccCC
Confidence 21 12345788999999999999999999999999999999999999765331 1112222222111 1111111110
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.... .....+.+++.+||+.+|.+|||+.|+++.
T Consensus 233 ~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 233 GNGI---KWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CCCC---chHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0001 123345668889999999999999999853
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=325.64 Aligned_cols=240 Identities=23% Similarity=0.266 Sum_probs=185.5
Q ss_pred EccCCcEEEEEEEEc-CCcEEEEEEeccCChh---hHHHHHHHHHHHhcC---CCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ---AEKEFKVEVEAIGRV---RHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 194 LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l---~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
||+|+||+||+|... ++..||+|.+...... ....+..|..++... .||||+++++++.+....|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999965 5889999998643221 223344566666655 699999999999999999999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 9999998754 5689999999999999999999998 99999999999999999999999999997542222 22
Q ss_pred eecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCC
Q 009979 347 TTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 425 (521)
....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ..+..+..... . ..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~------~~~~~~~i~~~-~------~~~~~~ 219 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED------TQQMYRNIAFG-K------VRFPKN 219 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC------HHHHHHHHHcC-C------CCCCCc
Confidence 3446799999999998654 58999999999999999999999996432 12222222211 1 111111
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCC----CHHHHHH
Q 009979 426 PCSRALKRALLVALRCVDPNAHKRP----KMGHVIH 457 (521)
Q Consensus 426 ~~~~~~~~~~~li~~cl~~dP~~RP----t~~evl~ 457 (521)
..+.. +.+++.+||+.||++|| ++.++++
T Consensus 220 ~~~~~---~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 VLSDE---GRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred cCCHH---HHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 12333 34578899999999998 5666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=311.65 Aligned_cols=250 Identities=28% Similarity=0.481 Sum_probs=194.9
Q ss_pred ceEccCCcEEEEEEEEcC-------CcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 192 NVIGEGGYGIVYHGVLED-------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
+.||+|+||.||+|...+ +..+|+|.+.... ......+.+|+++++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998643 2468999876543 23456788899999999999999999999998899999999
Q ss_pred ccCCchHHhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC-----CceEeeccc
Q 009979 264 IDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-----NPKLSDFGL 335 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~-----~vkL~DFGl 335 (521)
+++++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975421 124578899999999999999999998 999999999999999877 899999999
Q ss_pred ceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccc
Q 009979 336 AKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (521)
Q Consensus 336 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (521)
++........ ......++..|+|||++.++.++.++|||||||++|||+| |+.||..... .+..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~------~~~~~~~~~~~~ 231 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN------QEVLQHVTAGGR 231 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH------HHHHHHHhcCCc
Confidence 9865332211 1122345788999999999999999999999999999998 9999963321 121221111110
Q ss_pred cccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 414 ~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
. .. .......+.+++.+||..+|.+||++.+|++.|+
T Consensus 232 ---~---~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 232 ---L---QK----PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---c---CC----cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 00 1112234556888999999999999999999986
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=312.22 Aligned_cols=255 Identities=27% Similarity=0.453 Sum_probs=202.0
Q ss_pred CCCccccceEccCCcEEEEEEEEcC-Cc----EEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLED-NT----NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
..+|++.+.||+|+||.||+|.+.+ +. .+|+|.+..... .....+..|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 4578889999999999999998643 32 589998765543 344678899999999999999999999987 7789
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999999765 34589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCccee-ecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 339 LGAERSYVT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 339 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
......... ....++..|+|||.+....++.++|+||||+++||+++ |+.||..... .+....... .. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~-~~--~ 229 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA------VEIPDLLEK-GE--R 229 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHHhC-CC--C
Confidence 653322211 12234678999999988899999999999999999999 9999965432 122222211 11 0
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.-. ...++ .++.+++.+||..||++||++.++++.|...
T Consensus 230 ~~~----~~~~~---~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 230 LPQ----PPICT---IDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred CCC----CCCCC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 000 11122 2345588899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=303.99 Aligned_cols=250 Identities=21% Similarity=0.365 Sum_probs=201.9
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
+|++.+.||+|+||.||++... +++.||+|.+... .....+++..|+.+++.++||||+++++++......++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788999999999999999854 6888999998643 233446788999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+.+++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999987642 24678899999999999999999998 99999999999999999999999999998764332
Q ss_pred cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
. ......|++.|+|||++.+..++.++|+|||||++++|++|+.||.... ..+.+........ . ..
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~~~~-----~-~~- 221 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKIIRGSY-----P-PV- 221 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHhcCCC-----C-CC-
Confidence 2 1233468899999999998899999999999999999999999996432 2222222222110 0 01
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.......+.+++.+||+.+|.+||++.+|+++
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 ---SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ---cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11122345558889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=305.27 Aligned_cols=256 Identities=27% Similarity=0.426 Sum_probs=203.8
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
++|++.+.||.|+||+||+|... ++..+|+|.+.... ......+..|+++++.++|+||+++++.+..+...++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999964 57789999886543 23457789999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++++|.++++.... ...+++..++.++.|++.||+|||+. +++||||+|+||++++++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999976421 24689999999999999999999998 99999999999999999999999999998765432
Q ss_pred cc---eeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 344 SY---VTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 344 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
.. ......|+..|+|||++... .++.++|+|||||++|||++|+.||....+.. .+....... .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~------~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQND------P 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCC------C
Confidence 22 12345689999999998776 78999999999999999999999996543321 111111111 1
Q ss_pred cccCCCc-cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 420 PRLQEKP-CSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 420 ~~l~~~~-~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
+.+.... .......+.+++.+||+.||++||++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111110 1122344556888999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=316.71 Aligned_cols=199 Identities=20% Similarity=0.236 Sum_probs=166.2
Q ss_pred ccceEccC--CcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 190 DENVIGEG--GYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 190 ~~~~LG~G--~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
+.++||+| +||+||++... ++..||+|++.... ....+.+..|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78999999864 68899999986542 334467888999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~ 344 (521)
++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.++++|||..........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999996542 24588999999999999999999998 999999999999999999999999987544321111
Q ss_pred c------eeecccccccccccccccC--CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 009979 345 Y------VTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVDYS 393 (521)
Q Consensus 345 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~elltG~~Pf~~~ 393 (521)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 0 0112356788999999875 46899999999999999999999999743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=304.25 Aligned_cols=247 Identities=25% Similarity=0.405 Sum_probs=199.1
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-----GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
+|+..+.||+|+||.||+|... ++..|++|.+.... .+..+.+..|+.+++.++|+||+++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999976 78899999886533 23456788999999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999999764 4688999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCcceeecccccccccccccccCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
... ......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||....+ .............
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~----- 220 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKEL----- 220 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccC-----
Confidence 332 234456899999999987766 89999999999999999999999964331 1111111110111
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
+.+. ......+.+++.+||+.+|.+||++.+++.
T Consensus 221 ~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 PPIP----DHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCcC----CCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1111 111233445888999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=303.01 Aligned_cols=253 Identities=24% Similarity=0.412 Sum_probs=206.4
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
++|++.+.||+|+||.||+|... ++..|++|++..... .....+..|++.+..++|+|++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999976 488999999876544 4457889999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
+++++|.+++... ..+++..++.++.|++.||+|||+ . +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999765 578999999999999999999999 8 9999999999999999999999999999876443
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
... .....++..|+|||.+.+..++.++|+||||+++|+|+||+.||........... .+...... .+.+
T Consensus 154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~---~~~~~~~~------~~~~ 223 (264)
T cd06623 154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL---MQAICDGP------PPSL 223 (264)
T ss_pred CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH---HHHHhcCC------CCCC
Confidence 322 2345688999999999999999999999999999999999999975543222222 22222111 1111
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.....+ ..+.+++.+||..+|++||++.+++++
T Consensus 224 ~~~~~~---~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEEFS---PEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CcccCC---HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111122 345558889999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=316.59 Aligned_cols=252 Identities=25% Similarity=0.286 Sum_probs=201.0
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh---hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ---AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|+..+.||+|+||.||+|... ++..||+|.+...... ..+.+..|+++++.++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999975 4889999998765332 4467888999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+.+++|.+++... ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999998754 235789999999999999999999998 999999999999999999999999999876432
Q ss_pred CCcc----------------------------eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 009979 342 ERSY----------------------------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393 (521)
Q Consensus 342 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~ 393 (521)
.... ......||..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2110 112346889999999999889999999999999999999999999644
Q ss_pred CCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 009979 394 RPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK----MGHVIH 457 (521)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt----~~evl~ 457 (521)
+.. ..+....... ..+.. .......+.+++.+||+.||++||+ +.+++.
T Consensus 236 ~~~------~~~~~~~~~~-------~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRD------ETFSNILKKE-------VTFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chH------HHHHHHhcCC-------ccCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 321 1112211111 01111 1113345556888999999999999 666664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=315.54 Aligned_cols=197 Identities=22% Similarity=0.371 Sum_probs=160.9
Q ss_pred cceEccCCcEEEEEEEEc---CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEee--CCeeeEEEEecc
Q 009979 191 ENVIGEGGYGIVYHGVLE---DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVYEYID 265 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~~lV~e~~~ 265 (521)
..+||+|+||.||+|... ++..||+|.+.... ....+.+|+++++.++||||+++++++.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999965 34679999886542 23457789999999999999999998853 457789999986
Q ss_pred CCchHHhhhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe----CCCCCceEeecccc
Q 009979 266 NGNLEQWLHGDV-----GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL----DKQWNPKLSDFGLA 336 (521)
Q Consensus 266 ~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl----~~~~~vkL~DFGla 336 (521)
+ +|.+++.... .....+++..++.++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 8888775321 1234688999999999999999999998 99999999999999 56678999999999
Q ss_pred eecCCCCc--ceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 009979 337 KLLGAERS--YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS 393 (521)
Q Consensus 337 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~ 393 (521)
+....... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 87643322 11234578999999998876 45899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=321.44 Aligned_cols=258 Identities=22% Similarity=0.323 Sum_probs=193.3
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC------C
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------A 255 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------~ 255 (521)
.++|.+.+.||+|+||.||+|... ++..||||++..... .....+.+|+++++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 468999999999999999999964 678899999865322 2335677899999999999999999987543 3
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..|++|+++ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcc
Confidence 468999998 7799988753 3689999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc--
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR-- 412 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-- 412 (521)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+.......
T Consensus 165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 237 (343)
T cd07878 165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI---DQLKRIMEVVGTPSP 237 (343)
T ss_pred ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHhCCCCH
Confidence 9865332 234578999999999876 57899999999999999999999999654321 1111110000000
Q ss_pred ---------ccccCCC--cccCCCc----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 413 ---------NAEGVLD--PRLQEKP----CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 413 ---------~~~~~~d--~~l~~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.....+. +...... .......+.+++.+||+.||.+|||+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 0000000 00011234568889999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=304.93 Aligned_cols=252 Identities=25% Similarity=0.387 Sum_probs=201.7
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEee--CCeeeEEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLVY 261 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~~lV~ 261 (521)
+|++.+.||.|+||.||++... ++..||+|.+.... ....+.+..|+++++.++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999854 67889999886432 3334678889999999999999999998754 45678999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-----EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH-----~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
||+++++|.+++........++++..++.++.|++.||+||| +. +++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999765444568999999999999999999999 66 9999999999999999999999999999
Q ss_pred eecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
......... .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... .+.. ........
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~-~~~~~~~~-- 227 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ------LQLA-SKIKEGKF-- 227 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH------HHHH-HHHhcCCC--
Confidence 976543321 2345689999999999988899999999999999999999999975431 1111 12221111
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
+.+. ......+.+++.+||+.+|++||++.+|+++
T Consensus 228 ---~~~~----~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 ---RRIP----YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---CCCc----cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1111 1223445568889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=309.45 Aligned_cols=258 Identities=27% Similarity=0.405 Sum_probs=200.5
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEee--
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE-- 253 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~-- 253 (521)
+.++..+.+.|++.+.||.|+||.||+|.+. +++.+|+|.+.... .....+..|+.+++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 4555556778999999999999999999964 57889999875543 3345688899999998 69999999999853
Q ss_pred ----CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCce
Q 009979 254 ----GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK 329 (521)
Q Consensus 254 ----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vk 329 (521)
....++||||+.+|+|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.++
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 457799999999999999987643 34678888999999999999999998 999999999999999999999
Q ss_pred EeecccceecCCCCcceeeccccccccccccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHH
Q 009979 330 LSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEW 404 (521)
Q Consensus 330 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~ 404 (521)
|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|||++|..||....+....
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----- 235 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----- 235 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----
Confidence 999999876532211 123456899999999875 356888999999999999999999999644321111
Q ss_pred HHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 405 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
..... ...+.+....++ ..+.+++.+||+.||.+||++.|++.
T Consensus 236 -~~~~~------~~~~~~~~~~~~---~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 -FLIPR------NPPPKLKSKKWS---KKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -hhHhh------CCCCCCcccccC---HHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00000 011111111223 34555888999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=306.19 Aligned_cols=252 Identities=23% Similarity=0.446 Sum_probs=199.5
Q ss_pred CccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCC------hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 187 GFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR------GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
+|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+..|+++++.++|+||+++++++.+....++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999985 468899999886432 1234678899999999999999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC-CceEeeccccee
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKL 338 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~-~vkL~DFGla~~ 338 (521)
||||+++++|.+++... .++++..+..++.|++.||+|||+. +++|+||+|+||+++.++ .+||+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 99999999999999764 4688999999999999999999998 999999999999998776 599999999987
Q ss_pred cCCCCc---ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 339 LGAERS---YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 339 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
+..... .......|+..|+|||.+.+..++.++||||||+++|+|++|..||....... ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~---- 226 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---HLALIFKIASA---- 226 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---hHHHHHHHhcc----
Confidence 643211 11223568899999999988889999999999999999999999996443221 11111111110
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
...+.+ .......+.+++.+||+.+|.+||++.+++.
T Consensus 227 -~~~~~~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 -TTAPSI----PEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -CCCCCC----chhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 001111 1223345556888999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=313.57 Aligned_cols=261 Identities=24% Similarity=0.380 Sum_probs=198.5
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
++|++.+.||+|+||.||+|.+. +++.||+|.+..... ...+.+..|+++++.++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999975 588899998765332 234668889999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+++++|..+.... ..+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 99998888876543 3589999999999999999999998 9999999999999999999999999999876443
Q ss_pred CcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh-----------
Q 009979 343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT----------- 410 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----------- 410 (521)
. .......++..|+|||++.+ ..++.++||||||+++|||++|+.||...... .....+.....
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI---DQLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH---HHHHHHHHHhCCCchhhHHHhc
Confidence 3 22234568899999998865 45788999999999999999999998643211 11000000000
Q ss_pred cc-ccccCCCcccCCC-----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 411 NR-NAEGVLDPRLQEK-----PCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 411 ~~-~~~~~~d~~l~~~-----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.. .......+..... ..+.....+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 0000001111000 01122344666888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=304.59 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=200.5
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh--hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ--AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
+|...+.||+|+||.||+|... ++..|++|.+...... ..+.+..|+++++.++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999865 6888999998765443 567889999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++++|.+++... ..+++..++.++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 9999999998764 4578899999999999999999998 99999999999999999999999999998764433
Q ss_pred cceee---cccccccccccccccCCC---CCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 344 SYVTT---RVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 344 ~~~~~---~~~gt~~y~aPE~~~~~~---~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
..... ...++..|+|||++.+.. ++.++||||||+++||+++|+.||..... .......... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-----~~~~~~~~~~-~----- 222 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-----EFQIMFHVGA-G----- 222 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-----hHHHHHHHhc-C-----
Confidence 22211 356789999999998766 88999999999999999999999964321 1111111111 1
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
..+.+... ......+.+++.+||+.+|.+||++.+++.
T Consensus 223 ~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 HKPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111 111233445888999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=334.22 Aligned_cols=270 Identities=19% Similarity=0.287 Sum_probs=190.7
Q ss_pred hcCCCccccceEccCCcEEEEEEEEcC--CcEEEEEE--------------ec---cCChhhHHHHHHHHHHHhcCCCCC
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLED--NTNVAVKN--------------LL---NNRGQAEKEFKVEVEAIGRVRHKN 243 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~--~~~vavK~--------------~~---~~~~~~~~~~~~Ei~~l~~l~hpn 243 (521)
...++|++.+.||+|+||+||+|.++. +..+++|. +. .........+.+|+.+|+.++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345689999999999999999987532 11122221 10 112223456889999999999999
Q ss_pred eeeEEEEEeeCCeeeEEEEeccCCchHHhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe
Q 009979 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDV-GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL 322 (521)
Q Consensus 244 iv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl 322 (521)
|+++++++...+..|+|++++. ++|.+++.... ..........+..++.|++.||+|||++ +|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9999999999999999999985 57877765432 1122334566788999999999999998 99999999999999
Q ss_pred CCCCCceEeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCC-CCCCCCCCCcccH
Q 009979 323 DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRN-PVDYSRPPGEVNL 401 (521)
Q Consensus 323 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~-Pf~~~~~~~~~~~ 401 (521)
+.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|.. ||..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999998875544433445679999999999999999999999999999999999875 4443322211222
Q ss_pred HHHHHHHhhccccccCCCc-----------cc--CCCccHH------HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 402 VEWLKTMVTNRNAEGVLDP-----------RL--QEKPCSR------ALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 402 ~~~~~~~~~~~~~~~~~d~-----------~l--~~~~~~~------~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+.+...... ..++.++ .+ ....... ...++.+++.+||+.||++|||+.|++.+
T Consensus 381 ~~~~~~~~~~--~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSLSVC--DEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhcccC--hhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 2211110000 0000000 00 0000001 11234557889999999999999999864
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=306.77 Aligned_cols=254 Identities=26% Similarity=0.403 Sum_probs=204.5
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
++|+..+.||+|+||.||++.+. +++.+|+|.+.... ......+.+|+++++.++||||+++++++......++||||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999976 58889999886653 34456788999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
+++++|.+++.... ..+++..+..++.|++.||+|||+ . +++|+||||+||++++++.+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999997652 578899999999999999999999 7 9999999999999999999999999998765322
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
.. ....|+..|+|||++.+..++.++||||||+++|+|++|+.||...... .....+.++...... .+.+
T Consensus 155 ~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~------~~~~ 224 (265)
T cd06605 155 LA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEP------PPRL 224 (265)
T ss_pred Hh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCC------CCCC
Confidence 11 1267899999999999999999999999999999999999999654321 122233333332211 1111
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.... ....+.+++.+||..||++|||+.+++.+
T Consensus 225 ~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 PSGK---FSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred Chhh---cCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1111 23345568889999999999999999743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=312.54 Aligned_cols=262 Identities=24% Similarity=0.341 Sum_probs=200.7
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
++|++.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+..|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999975 57889999886432 2334678899999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|++++.+..+.... ..+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99987777665443 4589999999999999999999998 9999999999999999999999999999876544
Q ss_pred CcceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh-----------
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT----------- 410 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----------- 410 (521)
.........++..|+|||++.+. .++.++||||||+++|+|++|+.||...... +..........
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI---DQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHhhhcc
Confidence 33233446788999999999887 8899999999999999999999999644321 11111111110
Q ss_pred -ccccc--cCCCcccCC----CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 411 -NRNAE--GVLDPRLQE----KPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 411 -~~~~~--~~~d~~l~~----~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
..... ...+..... .........+.+++.+||+.+|++||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 000000000 000011345667899999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=323.37 Aligned_cols=198 Identities=24% Similarity=0.350 Sum_probs=171.2
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCC-C-----CCeeeEEEEEeeCCeee
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-H-----KNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h-----pniv~l~~~~~~~~~~~ 258 (521)
-+|++.+.||+|.||.|-+|.+. +++.||||++++.. ....+-..|+.+|..|+ | -|+|+++++|...++.|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 38899999999999999999954 68999999887654 33455566999999997 4 38999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC--CCCceEeecccc
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK--QWNPKLSDFGLA 336 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~--~~~vkL~DFGla 336 (521)
||+|++.. +|+++|+.+. ...++...++.++.||+.||.+||+. +|||+||||+||||.+ ...|||+|||.|
T Consensus 265 iVfELL~~-NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 265 IVFELLST-NLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeehhhhh-hHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence 99999955 9999999883 56799999999999999999999998 9999999999999954 346999999999
Q ss_pred eecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~ 394 (521)
+....... ...-+..|.|||++.+..|+.+.||||||||++||++|.+-|.+..
T Consensus 339 c~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 339 CFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 97533221 3455788999999999999999999999999999999988886554
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=305.97 Aligned_cols=254 Identities=23% Similarity=0.385 Sum_probs=197.5
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh----------hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG----------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 255 (521)
+|...+.||+|+||.||+|... +++.||+|.+..... ...+.+..|+.+++.++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999854 588899998753211 11246788999999999999999999999999
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..++||||+++++|.++++.. ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999765 4688999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCcc-eeecccccccccccccccCCC--CCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc
Q 009979 336 AKLLGAERSY-VTTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (521)
Q Consensus 336 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (521)
++........ ......|+..|+|||.+.... ++.++|+||||+++||+++|..||..... . +.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~-~~~~~~~~~~ 228 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----I-AAMFKLGNKR 228 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----H-HHHHHhhccc
Confidence 9865322111 123456889999999987654 88999999999999999999999953321 1 1111111111
Q ss_pred ccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 413 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
....++... .......+.+++.+||+.+|.+||++.+|+++
T Consensus 229 -~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 -SAPPIPPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -cCCcCCccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 011111111 11223445558889999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=303.76 Aligned_cols=249 Identities=24% Similarity=0.385 Sum_probs=194.0
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHhcCCCCCeeeEEEEEee--CCee
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-----GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHR 257 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~ 257 (521)
.+|+..+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888999999999999999864 58899999885432 1234568889999999999999999998865 3567
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
+++|||+++++|.+++... ..+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 8999999999999999764 4578899999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCC--cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 338 LLGAER--SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 338 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
...... ........++..|+|||++.+..++.++|||||||++|||++|+.||..... .+.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~--- 225 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQP--- 225 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCC---
Confidence 653211 1112234688999999999988899999999999999999999999964321 11112111111
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
..+.+.. ..... +..++ +||..+|++||++.+|+.
T Consensus 226 --~~~~~~~-~~~~~---~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 --TNPQLPS-HISEH---ARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --CCCCCch-hcCHH---HHHHH-HHhcCChhhCcCHHHHhc
Confidence 1122211 11222 23344 788899999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=310.12 Aligned_cols=255 Identities=23% Similarity=0.331 Sum_probs=200.8
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|++.+.||+|+||.||++... .++.|++|.+..... .....+..|+++++.++||||+++++.+..+...++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999965 477899998865432 23456788999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 999999999999764 4688999999999999999999998 999999999999999999999999999874211
Q ss_pred C--------------CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 009979 342 E--------------RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407 (521)
Q Consensus 342 ~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 407 (521)
. .........|+..|+|||++.+..++.++|+|||||++|||++|..||.... ..+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~------~~~~~~~ 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT------PEELFGQ 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHH
Confidence 0 0011123467889999999988889999999999999999999999996432 1222222
Q ss_pred HhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 408 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
..... ...+... ...+.. +.+++.+||+.||++||++.++.+.|+.
T Consensus 228 ~~~~~----~~~~~~~-~~~~~~---~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISDD----IEWPEGD-EALPAD---AQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhcc----cCCCCcc-ccCCHH---HHHHHHHHhccChhhccCccCHHHHHhC
Confidence 22211 1111111 112333 4458889999999999997777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=316.98 Aligned_cols=255 Identities=27% Similarity=0.470 Sum_probs=199.1
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCc----EEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNT----NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
.++|+..+.||+|+||.||+|.+. ++. .||+|.+..... ....++..|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 457888899999999999999864 343 478888765433 2335788999999999999999999998764 467
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+++||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 999999999999998765 34688999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 339 LGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 339 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
....... ......++..|+|||++.+..++.++|||||||++|||++ |+.||..... .. ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~----~~~~~~~~~~-- 229 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---RE----IPDLLEKGER-- 229 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HH----HHHHHHCCCC--
Confidence 6433221 1223345778999999998999999999999999999998 9999864321 11 1122221110
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
... ...++ ..+.+++.+||..+|++||++.++++.|...
T Consensus 230 ~~~----~~~~~---~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 230 LPQ----PPICT---IDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred CCC----CCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000 11122 2455688899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=305.93 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=195.0
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh-hhHHHHHHHHHH-HhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEA-IGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~-l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
++|++.+.||+|+||.||+|.+. ++..||+|.+..... .....+..|+.+ ++.++||||+++++++..+...++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999975 588999999865432 233445556654 667789999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|++ |+|.+++.........+++..++.++.|++.||+|||++. +++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 5898888765444567999999999999999999999743 8999999999999999999999999999865322
Q ss_pred CcceeecccccccccccccccC----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCC
Q 009979 343 RSYVTTRVMGTFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (521)
. ..+...|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||..... ..+.+...... .
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~------~ 224 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-----PFQQLKQVVEE------P 224 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-----CHHHHHHHHhc------C
Confidence 1 1233568999999998754 4578899999999999999999999963221 11122222211 1
Q ss_pred CcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 419 d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.+.+.....+ ..+.+++.+||..+|.+||++.++++
T Consensus 225 ~~~~~~~~~~---~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 SPQLPAEKFS---PEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCCccccC---HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112111123 34555888999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=308.28 Aligned_cols=249 Identities=25% Similarity=0.361 Sum_probs=207.3
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEecc
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (521)
-|.+..+||+|.||.||+|.++ .|+.+|||++... ....++..|+.+|++++.|++|++||.+.....++||||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4778899999999999999965 6888999988543 456788889999999999999999999888889999999999
Q ss_pred CCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcc
Q 009979 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (521)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~ 345 (521)
.|++.+.++.+ +.++++..+..++...++||+|||.. .-||||||..|||++.+|++||+|||.+-.+.+. ..
T Consensus 112 AGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MA 184 (502)
T KOG0574|consen 112 AGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MA 184 (502)
T ss_pred CCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-HH
Confidence 99999999876 57999999999999999999999998 8899999999999999999999999999876432 33
Q ss_pred eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCC
Q 009979 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425 (521)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 425 (521)
...++.|||.|||||++..-.|+.++||||||++..||.-|++||.+-.|-...- | +..--.|.++.
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-------M-----IPT~PPPTF~K- 251 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-------M-----IPTKPPPTFKK- 251 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-------e-----ccCCCCCCCCC-
Confidence 4456889999999999999999999999999999999999999997654321110 0 01112223322
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 426 PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 426 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
...-..++-+++..||-++|++|-|+.+++++
T Consensus 252 -PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 -PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred -hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 22233455568889999999999999888754
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=307.96 Aligned_cols=262 Identities=23% Similarity=0.338 Sum_probs=200.8
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
+|++.+.||+|+||.||+|.+. +++.||+|++.... ......+..|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999965 68899999987543 23346788999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+ +++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999998765 25789999999999999999999998 99999999999999999999999999998765433
Q ss_pred cceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc----------
Q 009979 344 SYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR---------- 412 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------- 412 (521)
........|+..|+|||.+.+. .++.++|||||||++|||+||..||...... .....+.......
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccC
Confidence 2223345689999999988654 4689999999999999999998887543221 1111111110000
Q ss_pred --ccccCCCcccCCCc----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 413 --NAEGVLDPRLQEKP----CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 413 --~~~~~~d~~l~~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
....+..+.-.... .+.....+.+++.+||+.||++||++++++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000000 01122556678889999999999999999854
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=291.00 Aligned_cols=254 Identities=26% Similarity=0.410 Sum_probs=200.0
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCeeeEE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV 260 (521)
..+..+....||.|..|.||++++. .|.-.|||.+... ..+..+.+...+.++..-+ +|+||+.+|+|..+...++.
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 3456677888999999999999976 4788999999764 3344466777787776664 99999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
||.|. ..++.+++.. ..++++..+-++...++.||.||.+++ +|+|||+||+|||+|+.|++||||||++-.+-
T Consensus 170 MelMs-~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 170 MELMS-TCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred HHHHH-HHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceee
Confidence 99995 3777777765 467999999999999999999999875 99999999999999999999999999998765
Q ss_pred CCCcceeeccccccccccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 341 AERSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
+... .++..|.+.|||||.+. ...|+-++||||||+.|+||.||+.||...... ++.+.....+ .
T Consensus 244 dSkA--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-----Fe~ltkvln~-e---- 311 (391)
T KOG0983|consen 244 DSKA--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-----FEVLTKVLNE-E---- 311 (391)
T ss_pred cccc--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-----HHHHHHHHhc-C----
Confidence 4433 35567999999999884 446899999999999999999999999754322 2333333321 1
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.|.+.... .....+.+++..||.+|+.+||.+.+++++
T Consensus 312 -PP~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 -PPLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -CCCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 13333221 123344557779999999999999998743
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=315.46 Aligned_cols=248 Identities=26% Similarity=0.364 Sum_probs=198.8
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEecc
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (521)
.|.....||+|+||.||++... ++..||||.+........+.+..|+.+++.++|+||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444577999999999999864 588899999876555566778899999999999999999999999999999999999
Q ss_pred CCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcc
Q 009979 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (521)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~ 345 (521)
+++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 103 ~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 103 GGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence 9999998854 3578899999999999999999998 999999999999999999999999999976533222
Q ss_pred eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCC-
Q 009979 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE- 424 (521)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~- 424 (521)
......|+..|+|||++.+..++.++||||||+++|||++|+.||....+. +.+..... .+.+.+..
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~------~~~~~~~~~ 241 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL------QAMRRIRD------NLPPRVKDS 241 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh------cCCCccccc
Confidence 223356899999999998888999999999999999999999999643321 11111111 11111111
Q ss_pred CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 425 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
...+.. +..++.+||..||++|||+.++++.
T Consensus 242 ~~~~~~---~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 HKVSSV---LRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccCHH---HHHHHHHHccCChhHCcCHHHHhhC
Confidence 112233 4447779999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=310.41 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=202.5
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
.++|.+.+.||+|+||.||++... ++..||+|.+........+.+..|+.+++.++||||+++++++......++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 358889999999999999999854 6788999998655555567788999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++++|.+++.+. .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 9999999998653 578889999999999999999998 99999999999999999999999999987654332
Q ss_pred cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
. ......|++.|+|||.+.+..++.++|+|||||++|++++|+.||....+.... ....... .+.+.
T Consensus 170 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~------~~~~~~~------~~~~~ 236 (293)
T cd06647 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNG------TPELQ 236 (293)
T ss_pred c-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe------eehhcCC------CCCCC
Confidence 2 223346889999999998888999999999999999999999999754332111 0000000 00111
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
. .......+.+++.+||+.+|++||++.+++.+
T Consensus 237 ~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 N--PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred C--ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 11122345568889999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=310.89 Aligned_cols=245 Identities=25% Similarity=0.336 Sum_probs=199.8
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|++.+.||+|+||.||++.+. +++.||+|.+.... ....+.+..|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999965 57889999886532 233466888999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 999999999999765 5788999999999999999999998 999999999999999999999999999987643
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... .+..+.... .. ..
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~------~~ 216 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQIYEKILE-GK------VR 216 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhc-CC------cc
Confidence 3 2345689999999999888899999999999999999999999964431 111122211 11 01
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~ 458 (521)
+... .+ ..+.+++.+||+.||.+|+ ++.+++..
T Consensus 217 ~~~~-~~---~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 217 FPSF-FS---PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred CCcc-CC---HHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 1111 12 3344578899999999999 77777644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=308.03 Aligned_cols=262 Identities=22% Similarity=0.323 Sum_probs=195.9
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
++|++.+.||+|+||.||+|... +++.||+|.+..... .....+..|+++++.++|+||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57899999999999999999965 678899999865432 2234567899999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+.+ +|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 975 999988765 24688999999999999999999998 99999999999999999999999999987543221
Q ss_pred cceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccc---------
Q 009979 344 SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN--------- 413 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------- 413 (521)
. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||...... ..........+....
T Consensus 158 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred c-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhh
Confidence 1 1122356889999998865 55899999999999999999999999644311 011111111100000
Q ss_pred ---cccCCCcccCCCc------cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 414 ---AEGVLDPRLQEKP------CSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 414 ---~~~~~d~~l~~~~------~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
......+...... .......+.+++.+||+.+|++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000000000 0001144566888999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=300.62 Aligned_cols=249 Identities=23% Similarity=0.404 Sum_probs=199.3
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
+|+..+.||+|+||.||++... +++.+|+|.+.... ......+..|+++++.++|||++++++.+..+...++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788999999999999999864 67889999886542 23456788999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC-CceEeecccceecCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKLLGAE 342 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~-~vkL~DFGla~~~~~~ 342 (521)
+++++|.+++.... ...+++..++.++.+++.||+|||++ +++|+||||+||++++++ .+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997652 34689999999999999999999998 999999999999998554 5799999999876433
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. ......... .... +
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~~-~~~~-----~ 221 (256)
T cd08220 156 S--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMSG-TFAP-----I 221 (256)
T ss_pred c--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHhc-CCCC-----C
Confidence 2 123356899999999999888999999999999999999999999644321 111111111 1001 1
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
. ...+. .+.+++.+||+.+|.+|||+.+++.+
T Consensus 222 ~-~~~~~---~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 S-DRYSP---DLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred C-CCcCH---HHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1 11223 34458889999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=326.10 Aligned_cols=253 Identities=23% Similarity=0.365 Sum_probs=206.2
Q ss_pred CCccccceEccCCcEEEEEEEEcCCcE-EEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 186 NGFADENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~-vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
+-|.++..||.|+||.||+|..++... .|.|.+........++|..||++|..+.||+||+|++.|..++.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 457788899999999999999765333 4678777777777889999999999999999999999999899999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~ 344 (521)
.||-....+-.- ...+++..+..+++|++.||.|||++ +|||||||..|||++-+|.++|+|||.+-.... ..
T Consensus 112 ~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TR 184 (1187)
T ss_pred CCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HH
Confidence 999998887665 57899999999999999999999999 999999999999999999999999999865322 22
Q ss_pred ceeeccccccccccccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 345 YVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
.....+.|||+|||||+.. ..+|+.++||||||++|.||..+.+|-. +.+....+.+...... ..+
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh------elnpMRVllKiaKSeP-PTL-- 255 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH------ELNPMRVLLKIAKSEP-PTL-- 255 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc------ccchHHHHHHHhhcCC-Ccc--
Confidence 2345688999999999763 4679999999999999999999998853 4555554444433221 122
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
+++...+..+.+ ++.+||.+||..||++++++++-
T Consensus 256 --lqPS~Ws~~F~D---fLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 256 --LQPSHWSRSFSD---FLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred --cCcchhhhHHHH---HHHHHHhcCCccCCCHHHHhhCc
Confidence 223334444444 77799999999999999998543
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=310.64 Aligned_cols=261 Identities=22% Similarity=0.331 Sum_probs=195.5
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
+|++.+.||+|+||.||+|.+. +|..||+|.+..... .....+..|+++++.++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999975 588999998864322 2235677899999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
++ ++|.+++... ...+++..++.++.|+++||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 4888887654 35689999999999999999999998 99999999999999999999999999998654322
Q ss_pred cceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccc------ccc
Q 009979 344 SYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN------AEG 416 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~------~~~ 416 (521)
. ......+++.|+|||++.+. .++.++|||||||++|||+||..||...... ....+.+........ ...
T Consensus 154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHhhh
Confidence 2 12334678999999988664 4789999999999999999999986433221 111111111110000 000
Q ss_pred CCC----cccCCC-----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 417 VLD----PRLQEK-----PCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 417 ~~d----~~l~~~-----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
..+ +..... ..+.....+.+++.+||+.||.+|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 000000 01112345556888999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=303.98 Aligned_cols=250 Identities=23% Similarity=0.336 Sum_probs=194.9
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC--Cee
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-----GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHR 257 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~ 257 (521)
++|++.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999965 58899999875321 22346788899999999999999999988763 467
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 8999999999999998754 4578888999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCc--ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 338 LLGAERS--YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 338 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
....... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||..... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~--- 225 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQP--- 225 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch------HHHHHHHhcCC---
Confidence 6532111 112335689999999999888899999999999999999999999963321 11111111110
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
..+.. .......+.+++.+||. +|++||++++|+++
T Consensus 226 --~~~~~----~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 --TNPVL----PPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred --CCCCC----chhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 11111 12223345557778884 99999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=305.00 Aligned_cols=247 Identities=26% Similarity=0.432 Sum_probs=198.2
Q ss_pred CccccceEccCCcEEEEEEEE-cCCcEEEEEEeccC-ChhhHHHHHHHHHHHhcCC---CCCeeeEEEEEeeCCeeeEEE
Q 009979 187 GFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~---hpniv~l~~~~~~~~~~~lV~ 261 (521)
.|+..+.||+|+||.||+|.+ .++..||+|.+... ......++..|+++++.++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999996 46888999988654 2334567888999999996 999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++++|.++++.. .+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999998643 688999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
... ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||....... .... .. ....+
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~~-~~-----~~~~~ 220 (277)
T cd06917 154 NSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMML-IP-----KSKPP 220 (277)
T ss_pred Ccc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhhc-cc-----cCCCC
Confidence 332 2234568999999998865 457899999999999999999999997443211 1110 00 01112
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.+.... ....+.+++.+||+.||++||++.+++.
T Consensus 221 ~~~~~~---~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLEDNG---YSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCccc---CCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 222211 2334556888999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=304.92 Aligned_cols=255 Identities=31% Similarity=0.411 Sum_probs=200.1
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCC------
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGA------ 255 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~------ 255 (521)
+.++|++.+.||+|+||.||+|... +++.+++|.+..... ..+.+..|+.+++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999975 577899998865443 346788999999999 6999999999997644
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..++||||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 48999999999999999876543346789999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (521)
+....... .......|+..|+|||++.. ..++.++|||||||++|+|++|+.||...... ........
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~ 232 (275)
T cd06608 160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RALFKIPR 232 (275)
T ss_pred ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HHHHHhhc
Confidence 98654322 22234568999999998753 34778999999999999999999999643211 11111111
Q ss_pred ccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 411 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
. . .+.+.. .......+.+++.+||..||++|||+.++++
T Consensus 233 ~-~-----~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 N-P-----PPTLKS--PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred c-C-----CCCCCc--hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 0 111111 1112234556888999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=313.51 Aligned_cols=248 Identities=25% Similarity=0.340 Sum_probs=198.2
Q ss_pred ccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
|.....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..+...++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 444567999999999999864 6889999998655545556788999999999999999999999999999999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
++|.+++.. ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....... ..
T Consensus 103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~ 173 (297)
T cd06659 103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PK 173 (297)
T ss_pred CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cc
Confidence 999998754 3578999999999999999999998 99999999999999999999999999997653322 12
Q ss_pred eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCc
Q 009979 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 426 (521)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....+ .+.+..... ...... .....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~-~~~~~~----~~~~~ 242 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP------VQAMKRLRD-SPPPKL----KNAHK 242 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhc-cCCCCc----cccCC
Confidence 2345689999999999988899999999999999999999999964332 111121111 100000 00111
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 427 CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 427 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+. .+.+++.+||+.+|++||++.+++++
T Consensus 243 ~~~---~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISP---VLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCH---HHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 222 34458889999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=322.79 Aligned_cols=245 Identities=23% Similarity=0.408 Sum_probs=198.4
Q ss_pred cccceEccCCcEEEEEEEEc-CCcEEEEEEe--cc--CChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe--eeEEE
Q 009979 189 ADENVIGEGGYGIVYHGVLE-DNTNVAVKNL--LN--NRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH--RMLVY 261 (521)
Q Consensus 189 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~--~~--~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~--~~lV~ 261 (521)
++..+||+|+|-+||+|.+. +|.+||=-.+ .+ ......+.|..|+.+|+.|+||||+++++++.+... .-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 55678999999999999964 4666652222 11 123334789999999999999999999999877665 67899
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC-CCCCceEeecccceecC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~-~~~~vkL~DFGla~~~~ 340 (521)
|+|..|+|..|+++. ..+..+....|+.||++||.|||++ .|+|||||||.+||+|+ ..|.|||+|+|||..+.
T Consensus 123 EL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 999999999999876 5788899999999999999999997 89999999999999997 56899999999999874
Q ss_pred CCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
... ...+.|||.|||||+.. ..|++.+||||||++|+||.|+..||. +..+..++.+++..... ..
T Consensus 198 ~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs-----EC~n~AQIYKKV~SGiK-----P~ 263 (632)
T KOG0584|consen 198 KSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS-----ECTNPAQIYKKVTSGIK-----PA 263 (632)
T ss_pred ccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh-----hhCCHHHHHHHHHcCCC-----HH
Confidence 432 33478999999999886 889999999999999999999999995 56677777777776432 22
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.+..-. ..+. .++|.+|+.. .++|||+.|+|.
T Consensus 264 sl~kV~-dPev---r~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 264 ALSKVK-DPEV---REFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HhhccC-CHHH---HHHHHHHhcC-chhccCHHHHhh
Confidence 222211 1223 3378899999 999999999984
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=309.03 Aligned_cols=262 Identities=17% Similarity=0.222 Sum_probs=186.2
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcCC----cEEEEEEeccCChhhH-----------HHHHHHHHHHhcCCCCCeee
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLEDN----TNVAVKNLLNNRGQAE-----------KEFKVEVEAIGRVRHKNLVR 246 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~Ei~~l~~l~hpniv~ 246 (521)
++..++|.+.+.||+|+||.||+|.+.++ ..+|+|.......... .....+...+..+.|+|+++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 34557899999999999999999997543 3456664322211110 11122344556778999999
Q ss_pred EEEEEeeCC----eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe
Q 009979 247 LLGYCAEGA----HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL 322 (521)
Q Consensus 247 l~~~~~~~~----~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl 322 (521)
+++++.... ..+++||++.. ++.+.+... ...++..+..++.|++.||+|||+. +|+||||||+|||+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill 159 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV 159 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 999765543 34678888743 677666543 3456788899999999999999998 99999999999999
Q ss_pred CCCCCceEeecccceecCCCCc------ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCC
Q 009979 323 DKQWNPKLSDFGLAKLLGAERS------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP 396 (521)
Q Consensus 323 ~~~~~vkL~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~ 396 (521)
+.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 9999999999999987643221 1112346999999999999999999999999999999999999999755322
Q ss_pred CcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 397 GEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
.. .....+.... ..+..+......++.. +.+++..||..+|++||++.++++.++
T Consensus 240 ~~--~~~~~~~~~~----~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 240 GN--LIHAAKCDFI----KRLHEGKIKIKNANKF---IYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hH--HHHHhHHHHH----HHhhhhhhccCCCCHH---HHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11 1111110000 0111111222223433 455788999999999999999998763
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=312.75 Aligned_cols=205 Identities=24% Similarity=0.366 Sum_probs=171.3
Q ss_pred CccccceEccCCcEEEEEEEEc---CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC--Ceee
Q 009979 187 GFADENVIGEGGYGIVYHGVLE---DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRM 258 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~ 258 (521)
+|.+.+.||+|+||.||+|... ++..||+|.+.... ......+..|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999965 37889999987643 33346678899999999999999999999888 7899
Q ss_pred EEEEeccCCchHHhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC----CCCceEeec
Q 009979 259 LVYEYIDNGNLEQWLHGDVGP-HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK----QWNPKLSDF 333 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~----~~~vkL~DF 333 (521)
+||||+++ +|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 777777543322 23789999999999999999999998 9999999999999999 899999999
Q ss_pred ccceecCCCCc--ceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCC
Q 009979 334 GLAKLLGAERS--YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRP 395 (521)
Q Consensus 334 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~ 395 (521)
|++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99987643322 11233567899999998765 4588999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=304.88 Aligned_cols=247 Identities=25% Similarity=0.419 Sum_probs=198.9
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
-|...+.||+|+||.||+|... ++..||+|.+.... ......+.+|+++++.++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4677889999999999999864 57889999875433 233467889999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~ 344 (521)
++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999999864 3578999999999999999999998 999999999999999999999999999987643221
Q ss_pred ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCC
Q 009979 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (521)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 424 (521)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||....+ ....... .... .+.+.
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~-~~~~-----~~~~~- 222 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP------MKVLFLI-PKNN-----PPTLE- 222 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch------HHHHHHH-hcCC-----CCCCC-
Confidence 22335688999999999888899999999999999999999999964321 1111111 1111 11111
Q ss_pred CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 425 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
......+.+++.+||+.+|.+||++.+++.+
T Consensus 223 ---~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 ---GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1122334558889999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=313.71 Aligned_cols=253 Identities=23% Similarity=0.362 Sum_probs=200.4
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEecc--CChhhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCee
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLN--NRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~ 257 (521)
+.+....|+++++||.||.+.||++...+.+.||+|++.. .+.+...-|..|+.+|.+|+ |.+||+|++|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3456678999999999999999999988888899988753 34555678999999999996 99999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
||||||=+ -||..+|++.. .....-.++.+..|++.|+.++|++ +|||.||||.|+|+-+ |.+||+|||.|.
T Consensus 436 YmvmE~Gd-~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~ 507 (677)
T KOG0596|consen 436 YMVMECGD-IDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIAN 507 (677)
T ss_pred EEEeeccc-ccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhc
Confidence 99999854 59999998873 2333237888999999999999999 9999999999999865 579999999999
Q ss_pred ecCCCCcc-eeecccccccccccccccCCC-----------CCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 009979 338 LLGAERSY-VTTRVMGTFGYVAPEYASTGM-----------LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL 405 (521)
Q Consensus 338 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~ 405 (521)
.+..+... .....+||+.||+||.+.... .+.+|||||+||+||+|+.|+.||... .+....+
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n~~aKl 582 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----INQIAKL 582 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HHHHHHH
Confidence 87654433 345678999999999874322 567899999999999999999999521 1121111
Q ss_pred HHHhhccccccCCCcc----cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 406 KTMVTNRNAEGVLDPR----LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 406 ~~~~~~~~~~~~~d~~----l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
. .+.||. +...+.. .+++++++.||+.||.+||+..++|++
T Consensus 583 ~---------aI~~P~~~Iefp~~~~~---~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 583 H---------AITDPNHEIEFPDIPEN---DELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred H---------hhcCCCccccccCCCCc---hHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1 233442 1111122 227779999999999999999999854
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=301.78 Aligned_cols=262 Identities=26% Similarity=0.393 Sum_probs=200.8
Q ss_pred CCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhc--CCCCCeeeEEEEEeeC----CeeeE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR--VRHKNLVRLLGYCAEG----AHRML 259 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~hpniv~l~~~~~~~----~~~~l 259 (521)
.+..+.+.||+|.||+||+|.|. |..||||++... .++...+|.++.+. |+|+||+.|++.-..+ .+++|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 36678899999999999999996 888999998543 23445567777765 5999999999875433 36799
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCeEeCCCCCceEeecc
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-----LEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-----~~~~iiHrDik~~NILl~~~~~vkL~DFG 334 (521)
|.+|.+.|+|+|||... .++.+..+++++.+|.||++||-. .+|.|.|||||+.|||+.+++..-|+|+|
T Consensus 287 vTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred eeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 99999999999999865 789999999999999999999954 37899999999999999999999999999
Q ss_pred cceecCCCCcc---eeecccccccccccccccCCC----C--CCcccchhHHHHHHHHHhC----------CCCCCCCCC
Q 009979 335 LAKLLGAERSY---VTTRVMGTFGYVAPEYASTGM----L--NERSDVYSFGILIMEVISG----------RNPVDYSRP 395 (521)
Q Consensus 335 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~--~~~sDvwS~Gvvl~elltG----------~~Pf~~~~~ 395 (521)
+|-........ ..+..+||-+|||||++.... + -..+||||||.|+||+... +.||.+--+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 99876443221 124468999999999985432 1 1368999999999999762 367765433
Q ss_pred CCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
.+ . .++.+++.+.-+.....++++.. ..+.+..+..+|..||..||.-|-|+--|-+.|..
T Consensus 442 ~D-P-s~eeMrkVVCv~~~RP~ipnrW~---s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~ 502 (513)
T KOG2052|consen 442 SD-P-SFEEMRKVVCVQKLRPNIPNRWK---SDPALRVMAKLMKECWYANPAARLTALRIKKTLAK 502 (513)
T ss_pred CC-C-CHHHHhcceeecccCCCCCcccc---cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence 21 1 23334444443333333333333 45667777789999999999999999888776654
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=304.40 Aligned_cols=247 Identities=23% Similarity=0.299 Sum_probs=201.0
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
+|++.+.||.|+||.||+|... ++..||+|.+.+.. ....+.+..|++++++++||||+++++++.++...++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788999999999999999975 58899999986543 2345788899999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+.+++|.+++... .++++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999998764 4788999999999999999999998 9999999999999999999999999999876433
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... ...++...... ... ..
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~--~~~----~~ 221 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQET--ADV----LY 221 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhcc--ccc----cC
Confidence 2 223456889999999998888999999999999999999999999755432 11111111111 001 11
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCCCH--HHHH
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRPKM--GHVI 456 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~--~evl 456 (521)
. ......+.+++.+||+.||.+||++ .+++
T Consensus 222 ~----~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 222 P----ATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred c----ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1 1122445568889999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=306.96 Aligned_cols=261 Identities=23% Similarity=0.290 Sum_probs=198.4
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh-----hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ-----AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
+|++.+.||+|+||.||+|... +++.||+|.+...... ....+..|+++++.++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999965 5889999999754332 335567899999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+ +++|.+++.... ..+++..++.++.|+++||.|||++ +++|+||||+|||++.++.+||+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 889999997652 3689999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc-------
Q 009979 341 AERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR------- 412 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------- 412 (521)
..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|..||...... .............
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHHHHHHHHcCCCchhhhhh
Confidence 43221 223456889999998854 56789999999999999999998877643321 1111111100000
Q ss_pred --ccccCCCcccCCC-----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 413 --NAEGVLDPRLQEK-----PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 413 --~~~~~~d~~l~~~-----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
............. ........+.+++.+||+.||++||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000 011223456678999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=293.92 Aligned_cols=250 Identities=27% Similarity=0.444 Sum_probs=203.7
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEecc
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (521)
.|+..+.||+|+||.||++... ++..+++|++..........+..|+++++.++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677899999999999999975 688899999977655566789999999999999999999999999999999999999
Q ss_pred CCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcc
Q 009979 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (521)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~ 345 (521)
+++|.+++... ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999998765 25789999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCC
Q 009979 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425 (521)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 425 (521)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||..... .+....... ..... +...
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~~-----~~~~ 220 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP------MKALFKIAT-NGPPG-----LRNP 220 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch------HHHHHHHHh-cCCCC-----cCcc
Confidence 3345789999999999888899999999999999999999999964321 111111111 11111 1110
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 426 PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 426 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
......+.+++.+||+.||++|||+.+++.+
T Consensus 221 --~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 --EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred --cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0012345558889999999999999999753
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=301.38 Aligned_cols=256 Identities=22% Similarity=0.402 Sum_probs=196.9
Q ss_pred ccccceEccCCcEEEEEEEEc----CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC------
Q 009979 188 FADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------ 255 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~------ 255 (521)
|.+.+.||+|+||.||+|.+. ++..||||.+.... ....+++..|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999853 36789999886542 334567888999999999999999999886532
Q ss_pred eeeEEEEeccCCchHHhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeec
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDV--GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DF 333 (521)
..++++||+.+|+|.+++.... .....+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2378899999999998875332 1223578899999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhc
Q 009979 334 GLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTN 411 (521)
Q Consensus 334 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (521)
|+++........ ......+++.|++||.+....++.++|||||||++|||++ |+.||..... .+........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN------SEIYNYLIKG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH------HHHHHHHHcC
Confidence 999865432211 1223345678999999998899999999999999999999 8899864322 1111111111
Q ss_pred cccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 412 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.. . ... ......+.+++.+||+.+|++||++.++++.|+..
T Consensus 232 ~~---~---~~~----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NR---L---KQP----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred Cc---C---CCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 0 000 11223556688899999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=307.28 Aligned_cols=249 Identities=28% Similarity=0.395 Sum_probs=197.0
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
....|...+.||+|+||.||+|... +++.||+|.+.... ......+..|+++++.++||||++++++|.+....++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 3457889999999999999999965 58899999885432 2334578889999999999999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
||||+. |+|.+++... ...+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||++...
T Consensus 93 v~e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 93 VMEYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred EHHhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceec
Confidence 999997 5777777543 24689999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCcceeeccccccccccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
... ....|++.|+|||++. ...++.++||||||+++|||+||+.||..... .......... .
T Consensus 166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~------~~~~~~~~~~-~--- 230 (307)
T cd06607 166 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQN-D--- 230 (307)
T ss_pred CCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH------HHHHHHHhcC-C---
Confidence 322 2346788999999874 46688999999999999999999999964321 1111111111 0
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
.+.+... .....+.+++.+||+.+|++||++.+++.+.
T Consensus 231 --~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 231 --SPTLSSN---DWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred --CCCCCch---hhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 1111111 1223455688899999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=305.54 Aligned_cols=260 Identities=20% Similarity=0.266 Sum_probs=194.7
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
.++|.+.+.||+|+||.||+|... ++..||+|.+...... ....+.+|+++++.++|+||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 468999999999999999999864 5889999998654322 23467789999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+. ++|.+++... ...+.+..+..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 996 6887777544 24577888899999999999999998 9999999999999999999999999999764322
Q ss_pred CcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhc----------
Q 009979 343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN---------- 411 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---------- 411 (521)
.. ......+++.|+|||.+.+ ..++.++|||||||++|||++|..||+..... .+.+...+..
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 157 SQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-----FEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred CC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-----HHHHHHHHHHcCCCChhhhh
Confidence 21 1223457899999999865 45788999999999999999999999754321 1111111100
Q ss_pred ------cccccCCCcccCCC-----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 412 ------RNAEGVLDPRLQEK-----PCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 412 ------~~~~~~~d~~l~~~-----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.............. ........+.+++.+|++.||++|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000000 00001234455888999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=300.37 Aligned_cols=244 Identities=25% Similarity=0.283 Sum_probs=199.0
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHH---HHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEK---EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~---~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
+-.++|.++++||+|.||.|.+++.+ +++.||+|++++...-..+ .-..|-++|+..+||.+..|...|+..+.+|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 45578999999999999999999955 6888999999876443333 3456899999999999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+||||..||.|+-.|... ..+++.....+..+|+.||.|||+. +||+||||.+|.|+|++|++||+|||+++.
T Consensus 245 FVMeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred EEEEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchh
Confidence 999999999999888765 5788899999999999999999998 999999999999999999999999999985
Q ss_pred cCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCC
Q 009979 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (521)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (521)
- ......+..+||||.|+|||++....|+.+.|+|.+|||||||++|+.||...+.. .+++.+.. .
T Consensus 318 ~-I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---kLFeLIl~--e-------- 383 (516)
T KOG0690|consen 318 E-IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---KLFELILM--E-------- 383 (516)
T ss_pred c-ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---HHHHHHHh--h--------
Confidence 3 23344567799999999999999999999999999999999999999999755432 22222111 0
Q ss_pred CcccCCCccHHHHHHHHHHHHhccCCCCCCCCC
Q 009979 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPK 451 (521)
Q Consensus 419 d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt 451 (521)
|-++..... .+ +..|+...|.+||.+|.-
T Consensus 384 d~kFPr~ls-~e---AktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 384 DLKFPRTLS-PE---AKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred hccCCccCC-HH---HHHHHHHHhhcChHhhcC
Confidence 112222222 22 333666888999999963
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=303.62 Aligned_cols=247 Identities=27% Similarity=0.385 Sum_probs=199.4
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEecc
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (521)
.|...+.||+|+||.||++... ++..+++|++........+.+.+|+.+++.++||||+++++++......++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4555679999999999999964 688899998865555555678899999999999999999999999999999999999
Q ss_pred CCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcc
Q 009979 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (521)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~ 345 (521)
+++|.+++.. ..+++..++.++.|++.||+|||++ +++||||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 9999999875 3578899999999999999999998 999999999999999999999999998876533222
Q ss_pred eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCC
Q 009979 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425 (521)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 425 (521)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||....+ .+........ . .+.....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~~~-~-----~~~~~~~ 238 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIRDN-L-----PPKLKNL 238 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHhc-C-----CCCCccc
Confidence 22335689999999999888899999999999999999999999964332 2222222211 1 1111111
Q ss_pred -ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 426 -PCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 426 -~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
..+ ..+.+++.+||+.+|++||++.++++
T Consensus 239 ~~~~---~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 HKVS---PRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccCC---HHHHHHHHHHcccChhhCcCHHHHcc
Confidence 122 34555888999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=304.85 Aligned_cols=260 Identities=26% Similarity=0.343 Sum_probs=198.5
Q ss_pred ccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC--CeeeEEEE
Q 009979 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLVYE 262 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~lV~e 262 (521)
|++.+.||+|+||.||+|... +++.+|+|.+.... ......+..|+++++.++|+|++++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999976 47889999997653 33346688899999999999999999999887 78999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+++ +|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 899888654 25789999999999999999999998 9999999999999999999999999999877544
Q ss_pred CcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc---cC-
Q 009979 343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE---GV- 417 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~- 417 (521)
.....+...++..|+|||.+.+ ..++.++||||||+++|||+||+.||....... ....+.......... ..
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccc
Confidence 3222334467889999997754 468899999999999999999999997544221 111111111100000 00
Q ss_pred -------CCcccC--C---CccHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 418 -------LDPRLQ--E---KPCSR-ALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 418 -------~d~~l~--~---~~~~~-~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
..+... . ..... ....+++++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000 0 00000 1345677999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=303.47 Aligned_cols=261 Identities=22% Similarity=0.330 Sum_probs=195.6
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
+|+..+.||.|+||.||+|... +++.||||++.... ......+..|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999865 58889999886432 22335788899999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+. ++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 58999887642 35789999999999999999999998 99999999999999999999999999998654322
Q ss_pred cceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc----------
Q 009979 344 SYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR---------- 412 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------- 412 (521)
.. .....+++.|+|||++.+. .++.++|||||||++|||+||+.||...... ....+.....-...
T Consensus 155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 155 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhHH
Confidence 11 2234578899999988654 4688999999999999999999999643211 11111111100000
Q ss_pred -----ccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 413 -----NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 413 -----~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.........+.. ..+.....+.+++.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 232 PDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 00011233456888999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=300.07 Aligned_cols=253 Identities=27% Similarity=0.392 Sum_probs=204.1
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
..+.|+..+.||+|+||.||+|.+. ++..|++|.+..... ..+.+..|+++++.++|+|++++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888999999999999999976 688899999876544 45678889999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999998752 4789999999999999999999998 9999999999999999999999999998765432
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
.. ......++..|+|||++.+..++.++|+|||||++|+|++|+.||....+. ........ ...... .
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~~----~ 237 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFLITT-KGIPPL----K 237 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-cCCCCC----c
Confidence 21 223345789999999998888999999999999999999999999643221 11111111 111010 0
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.....+ ..+.+++.+||+.+|.+||++.+++.+
T Consensus 238 ~~~~~~---~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 238 NPEKWS---PEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred chhhCC---HHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111123 344558889999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=303.86 Aligned_cols=261 Identities=21% Similarity=0.296 Sum_probs=196.5
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh--hHHHHHHHHHHHhcCCCCCeeeEEEEEeeC--CeeeEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ--AEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLV 260 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~lV 260 (521)
++|++.+.||+|+||.||+|.+. +++.+|+|.+...... ....+.+|+.+++.++||||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47888999999999999999976 5788999998654322 234567899999999999999999998877 789999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+.+ +|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+|||+++++.+||+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999975 999988764 23689999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCcceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh---------
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT--------- 410 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------- 410 (521)
.... ......+++.|+|||.+.+. .++.++|+||||+++|||++|..||....... ..+.+.....
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 158 SPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID---QLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred CCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchHHHHH
Confidence 4321 12334578999999988654 46899999999999999999999997543211 1111111000
Q ss_pred --------ccccccCCCcccCCCccHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 411 --------NRNAEGVLDPRLQEKPCSR-ALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 411 --------~~~~~~~~d~~l~~~~~~~-~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
...........+....... ....+.+++.+||+.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000000011110000 1334556888999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=298.17 Aligned_cols=250 Identities=23% Similarity=0.406 Sum_probs=199.6
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
+|++.+.||+|+||.||+|... ++..+|+|.+.... ....+.+..|+++++.++|+||+++++++......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999975 57889999886532 22345778899999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCC-ceEeecccceecCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN-PKLSDFGLAKLLGAE 342 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~-vkL~DFGla~~~~~~ 342 (521)
+++++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||++++++. +||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999997642 34678999999999999999999998 9999999999999988764 699999999876433
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
.. ......|++.|+|||++.+..++.++|+||||+++|||++|..||.... ..++....... .+.+.
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~-----~~~~~- 222 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQG-----YFAPI- 222 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhcc-----cCCCC-
Confidence 22 2233468999999999988889999999999999999999999996332 22222222211 11111
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+.....+.+++.+||+.+|++|||+.+++..
T Consensus 223 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 ----SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11112345558889999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=292.54 Aligned_cols=250 Identities=26% Similarity=0.407 Sum_probs=203.1
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC--CeeeEEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRMLVY 261 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~lV~ 261 (521)
+|...+.||+|++|.||+|... +++.|++|.+..... ...+.+..|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999976 688899998865542 4567889999999999999999999999988 8899999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999999765 3789999999999999999999998 999999999999999999999999999988754
Q ss_pred CCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 342 ERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 342 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|..||.... +.............. +
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~-----~ 223 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEP-----P 223 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCC-----c
Confidence 4321 1234568999999999988889999999999999999999999997544 111111111110110 1
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.+. ......+.+++.+|++.||++||++.+++.
T Consensus 224 ~~~----~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 EIP----EHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCC----cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111 111344555888999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=311.21 Aligned_cols=262 Identities=26% Similarity=0.310 Sum_probs=196.4
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC------C
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------A 255 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------~ 255 (521)
.++|+..+.||+|+||.||+|... ++..||+|.+... .......+..|+.+++.++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 468999999999999999999965 6889999988643 233345677899999999999999999988643 3
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..|+||||+.+ +|.+++.. .++...+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred cEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 56999999964 88888753 278889999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccc------------HHH
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVN------------LVE 403 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~------------~~~ 403 (521)
++...... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+...... ...
T Consensus 165 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 165 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred ceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 98764322 2234568899999999999999999999999999999999999996543211000 000
Q ss_pred HH----HHHhhccc------cccCCC----cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 404 WL----KTMVTNRN------AEGVLD----PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 404 ~~----~~~~~~~~------~~~~~d----~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+ ........ ...... +.............+.+++.+||+.||++|||+.|++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 00000000 000000 000011011223445678999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=305.03 Aligned_cols=256 Identities=29% Similarity=0.391 Sum_probs=194.5
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCeeeEEEEe
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
+|...+.||+|+||.||++.+. +++.||+|.+.... ......+..|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 5667789999999999999965 57889999986543 334567888999999996 99999999999988899999999
Q ss_pred ccCCchHHhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 264 IDNGNLEQWLHGD-VGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 264 ~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
+.. +|.++.... ......+++..+..++.+++.||+|||+.. +++||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 665543211 011357899999999999999999999632 8999999999999999999999999999765332
Q ss_pred CcceeecccccccccccccccCC---CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTG---MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
. ......|++.|+|||++.+. .++.++|||||||++|||++|+.||.... ...+.+...... ..
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~------~~ 228 (288)
T cd06616 162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG------DP 228 (288)
T ss_pred C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC------CC
Confidence 2 22334689999999998765 68999999999999999999999996432 222222222111 11
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
+.+...........+.+++.+||+.||++||++.+|+..
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122211111233345568889999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=307.67 Aligned_cols=255 Identities=24% Similarity=0.295 Sum_probs=204.5
Q ss_pred chhhhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEe
Q 009979 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252 (521)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~ 252 (521)
.++...+..+.|..-++||+||||+||-++.. +|+.||+|++.+.+ ...+....+|-.+|.+++.+.||.+-..|+
T Consensus 176 ~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe 255 (591)
T KOG0986|consen 176 WLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE 255 (591)
T ss_pred HHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec
Confidence 34445566788999999999999999999854 68899999886543 223345677999999999999999999999
Q ss_pred eCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEee
Q 009979 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (521)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~D 332 (521)
..+.+++||..|+||||.-.|-... ...+++..+..++.+|+.||++||.. .||+||+||+|||+|++|+++|+|
T Consensus 256 Tkd~LClVLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISD 330 (591)
T KOG0986|consen 256 TKDALCLVLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISD 330 (591)
T ss_pred CCCceEEEEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeec
Confidence 9999999999999999988775542 35789999999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc
Q 009979 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (521)
Q Consensus 333 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (521)
+|+|..+...... +..+||.+|||||++.++.|+...|+|||||+||||+.|+.||...... ...+.+.+++...
T Consensus 331 LGLAvei~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK---vk~eEvdrr~~~~ 405 (591)
T KOG0986|consen 331 LGLAVEIPEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK---VKREEVDRRTLED 405 (591)
T ss_pred cceEEecCCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh---hhHHHHHHHHhcc
Confidence 9999988655433 3348999999999999999999999999999999999999999644322 2222344443322
Q ss_pred ccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCC
Q 009979 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK 451 (521)
Q Consensus 413 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt 451 (521)
.. .++.. .+++. ..++...|+.||.+|.-
T Consensus 406 ~~------ey~~k-FS~ea---kslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 406 PE------EYSDK-FSEEA---KSLCEGLLTKDPEKRLG 434 (591)
T ss_pred hh------hcccc-cCHHH---HHHHHHHHccCHHHhcc
Confidence 11 12211 23333 34666888999999964
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=293.89 Aligned_cols=252 Identities=24% Similarity=0.391 Sum_probs=206.0
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
+|.+.+.||.|+||.||++.+. ++..|++|.+..... .....+..|+++++.++|+|++++++.+..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999975 588899999875533 4556788999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++++|.+++.........+++..++.++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999987543347899999999999999999999998 99999999999999999999999999998764433
Q ss_pred cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.... ..+........ .. . .+.
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~~-~~----~-~~~ 224 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKILKG-QY----P-PIP 224 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHHhcC-CC----C-CCC
Confidence 23344578999999999988889999999999999999999999996443 12222222221 11 1 111
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
. ..+ ..+.+++.+||..+|++||++.+++..
T Consensus 225 ~-~~~---~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 225 S-QYS---SELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred C-CCC---HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 123 334558889999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=300.09 Aligned_cols=245 Identities=22% Similarity=0.272 Sum_probs=187.3
Q ss_pred eEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHH---HhcCCCCCeeeEEEEEeeCCeeeEEEEecc
Q 009979 193 VIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEA---IGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (521)
Q Consensus 193 ~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~---l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (521)
.||+|+||.||++... +++.+|+|.+.+... .....+..|..+ +...+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999965 588999998865322 112233444433 344579999999999999899999999999
Q ss_pred CCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcc
Q 009979 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (521)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~ 345 (521)
+++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 99999998754 4689999999999999999999998 99999999999999999999999999997653322
Q ss_pred eeeccccccccccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCC
Q 009979 346 VTTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (521)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 424 (521)
.....||..|+|||.+. +..++.++|||||||++|||++|..||......... .+...... .+..+..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~------~~~~~~~ 220 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLT------VNVELPD 220 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHhhc------CCcCCcc
Confidence 22346899999999886 456899999999999999999999999754332211 11111111 1111111
Q ss_pred CccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhhc
Q 009979 425 KPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHMLEA 461 (521)
Q Consensus 425 ~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~~ 461 (521)
....++.+++.+||+.||.+|| ++++++++.-.
T Consensus 221 ----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~ 258 (279)
T cd05633 221 ----SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF 258 (279)
T ss_pred ----ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccc
Confidence 1223445588899999999999 59999876533
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=316.07 Aligned_cols=262 Identities=22% Similarity=0.330 Sum_probs=195.3
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC-----Cee
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHR 257 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----~~~ 257 (521)
.++|++.+.||+|+||.||+|... +++.||+|.+... .......+..|+.+++.++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 358999999999999999999864 6889999998643 223345678899999999999999999987644 357
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+.+ +|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 999999965 88887754 3689999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCcc--eeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccc-
Q 009979 338 LLGAERSY--VTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN- 413 (521)
Q Consensus 338 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~- 413 (521)
........ ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.. .....+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCCH
Confidence 75432221 1133568999999998654 56899999999999999999999999654311 11111111110000
Q ss_pred --cccCCCc----------ccCCC----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 414 --AEGVLDP----------RLQEK----PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 414 --~~~~~d~----------~l~~~----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
...+.+. ..... ..+....++.+++.+||+.+|++|||+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 00000 011223456679999999999999999999865
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=295.68 Aligned_cols=242 Identities=24% Similarity=0.307 Sum_probs=195.8
Q ss_pred EccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCCch
Q 009979 194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL 269 (521)
Q Consensus 194 LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L 269 (521)
||.|+||.||+|... +++.||+|.+..... ...+.+..|+++++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 488899999865432 3446789999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcceeec
Q 009979 270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR 349 (521)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 349 (521)
.+++.+. ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 9999765 4588999999999999999999998 99999999999999999999999999998764432 2233
Q ss_pred ccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHH
Q 009979 350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429 (521)
Q Consensus 350 ~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 429 (521)
..|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... +..+.......... ....... .
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~-----~~~~~~~-~-- 219 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----DPMEIYNDILKGNG-----KLEFPNY-I-- 219 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----CHHHHHHHHhccCC-----CCCCCcc-c--
Confidence 5689999999999888899999999999999999999999975542 12232333221110 1111111 1
Q ss_pred HHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 009979 430 ALKRALLVALRCVDPNAHKRPK-----MGHVIH 457 (521)
Q Consensus 430 ~~~~~~~li~~cl~~dP~~RPt-----~~evl~ 457 (521)
...+..++.+||+.||++||+ +.|+++
T Consensus 220 -~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 -DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred -CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 334556888999999999999 777764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=305.59 Aligned_cols=261 Identities=22% Similarity=0.277 Sum_probs=194.5
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCe-----
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAH----- 256 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~----- 256 (521)
++|++.+.||+|+||.||+|.+. +++.||+|.+..... .....+..|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999965 588999998754322 23356788999999995 6999999999877665
Q ss_pred eeEEEEeccCCchHHhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-CCCceEeecc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGP-HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFG 334 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~-~~~vkL~DFG 334 (521)
.|+||||+++ +|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 899888654322 45789999999999999999999998 9999999999999998 8899999999
Q ss_pred cceecCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhc--
Q 009979 335 LAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN-- 411 (521)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-- 411 (521)
+++.+..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...... +....+...
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~------~~~~~~~~~~~ 229 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL------QQLLHIFKLLG 229 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHHHhC
Confidence 9986533211 1122356889999998754 56799999999999999999999999643321 111111110
Q ss_pred -cc---cccC---C----CcccCCC----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 412 -RN---AEGV---L----DPRLQEK----PCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 412 -~~---~~~~---~----d~~l~~~----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.. .... . -+..... ..+.....+.+++.+||+.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0000 0 0000000 00112344566889999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=307.70 Aligned_cols=264 Identities=25% Similarity=0.338 Sum_probs=196.8
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC--Ceee
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRM 258 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~ 258 (521)
..++|++.+.||+|+||.||+|.+. ++..||+|.+..... .....+..|+.++++++|+||+++++++.+. ...+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3458999999999999999999975 588999999864322 2233466799999999999999999998755 4679
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+||||+.+ +|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++..
T Consensus 85 lv~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeee
Confidence 99999965 898888764 25789999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccc--c-
Q 009979 339 LGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN--A- 414 (521)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~- 414 (521)
...... ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....+. .....+........ .
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 158 YGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI---EQLDLIIQLLGTPNESIW 233 (309)
T ss_pred cCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCChhhc
Confidence 654321 1223346888999998865 56899999999999999999999999754321 11111111110000 0
Q ss_pred ccC------CCcccCCCc-------cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 415 EGV------LDPRLQEKP-------CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 415 ~~~------~d~~l~~~~-------~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
..+ -...+...+ .......+.+++.+||+.||++|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 000000000 00123445668899999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=299.74 Aligned_cols=258 Identities=21% Similarity=0.282 Sum_probs=193.1
Q ss_pred ccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeC--CeeeEEEE
Q 009979 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEG--AHRMLVYE 262 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~--~~~~lV~e 262 (521)
|++.+.||+|+||.||+|... ++..||+|.+..... ........|+.+++++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999964 588899998865422 22233456888899885 99999999999887 88999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|++ ++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 5888888654 24789999999999999999999998 9999999999999999 99999999999876433
Q ss_pred Ccceeeccccccccccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh-----------
Q 009979 343 RSYVTTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT----------- 410 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----------- 410 (521)
... ....++..|+|||++. ++.++.++|||||||++|||++|..||...+.. ...........
T Consensus 153 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 153 PPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred CCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---HHHHHHHHHcCCCCHHHHHhhc
Confidence 222 2346789999999764 456789999999999999999999999654321 11111111110
Q ss_pred ccccccCCCcccCCC----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 411 NRNAEGVLDPRLQEK----PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 411 ~~~~~~~~d~~l~~~----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.........+..... ........+.+++.+||+.+|++||++.+++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000000000 011234566779999999999999999999853
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=321.14 Aligned_cols=250 Identities=28% Similarity=0.472 Sum_probs=203.6
Q ss_pred ccccceEccCCcEEEEEEEEc-CC----cEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 188 FADENVIGEGGYGIVYHGVLE-DN----TNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~-~~----~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
....++||.|+||+||+|.|- .+ -+||+|++..... ....++..|+-.|.++.|||+++|+|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 355789999999999999853 33 3589998876544 34578999999999999999999999998866 78999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
+||++|+|.++++.. ..++..+..+.|..|||+|+.|||++ .++||||..+|||+..-.++||.|||+++.+..
T Consensus 777 q~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999999886 46788899999999999999999999 999999999999999999999999999998865
Q ss_pred CCccee-ecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 342 ERSYVT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 342 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
+..... ....-.+.|||-|.+....|+.++|||||||++||++| |..||+.....+ +...+..++
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-------I~dlle~ge------ 917 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-------IPDLLEKGE------ 917 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-------hhHHHhccc------
Confidence 443332 33334678999999999999999999999999999999 999997654332 222232222
Q ss_pred ccc-CCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 420 PRL-QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 420 ~~l-~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
++ ++..|+ .++..++.+||..|+..||+++++...+..
T Consensus 918 -RLsqPpiCt---iDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 918 -RLSQPPICT---IDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred -cCCCCCCcc---HHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 12 222233 344558889999999999999999876654
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=299.51 Aligned_cols=260 Identities=24% Similarity=0.348 Sum_probs=195.7
Q ss_pred ccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
|++.+.||.|++|.||+|.+. ++..||+|++..... .....+..|+++++.++|||++++++++.++...++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999965 689999998865432 23356788999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~ 344 (521)
+ ++|.+++.... ...+++..++.++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 69999987652 24689999999999999999999998 999999999999999999999999999986543221
Q ss_pred ceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc-----------
Q 009979 345 YVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR----------- 412 (521)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~----------- 412 (521)
. .....+++.|+|||++.+. .++.++||||||+++|+|++|+.||....... ......+......
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhch
Confidence 1 1223568899999987654 57899999999999999999999996543211 1111111000000
Q ss_pred c----cccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 413 N----AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 413 ~----~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
. .......... .........+.+++.+||+.||++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 232 DYKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 0000000000 001112234566889999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=304.53 Aligned_cols=260 Identities=22% Similarity=0.307 Sum_probs=193.6
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC-------
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------- 255 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~------- 255 (521)
++|++.+.||+|+||.||+|... +++.||+|.+..... .....+..|+++++.++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 47999999999999999999965 588999998864322 22345567999999999999999999987654
Q ss_pred -eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecc
Q 009979 256 -HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (521)
Q Consensus 256 -~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFG 334 (521)
..++||||+.+ +|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 34999999964 888888654 34689999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCcc---eeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh
Q 009979 335 LAKLLGAERSY---VTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410 (521)
Q Consensus 335 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (521)
++..+...... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||........ ...+..+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~---~~~~~~~~~ 241 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ---LTLISQLCG 241 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhC
Confidence 99866432211 12234578899999988654 478899999999999999999999975443211 111111111
Q ss_pred ccc---cc------------------cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 411 NRN---AE------------------GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 411 ~~~---~~------------------~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
... .. ......+.... ....+.+++.+||..||.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYV---KDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhccccc---CCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000 00 00000000000 11334568999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=304.95 Aligned_cols=265 Identities=25% Similarity=0.335 Sum_probs=198.4
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC----
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA---- 255 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~---- 255 (521)
...++|++.+.||+|+||.||+|.+. +++.||+|.+.... ......+..|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45578999999999999999999975 57889999986432 223356778999999999999999999987654
Q ss_pred ------eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCce
Q 009979 256 ------HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK 329 (521)
Q Consensus 256 ------~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vk 329 (521)
..++||||+++ +|.+++... ...+++..++.++.|++.||+|||+. +|+|+||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999976 777777654 34789999999999999999999998 999999999999999999999
Q ss_pred EeecccceecCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH
Q 009979 330 LSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408 (521)
Q Consensus 330 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 408 (521)
|+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ....+.+...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~---~~~~~~~~~~ 233 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE---LAQLELISRL 233 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHH
Confidence 99999998764433222223356888999998754 4578999999999999999999999964332 2222222222
Q ss_pred hhccccc---cC--------CCcccC--C---CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 409 VTNRNAE---GV--------LDPRLQ--E---KPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 409 ~~~~~~~---~~--------~d~~l~--~---~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
....... .+ .++... . .........+.+++.+||+.||.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111000 00 000000 0 001112344566888999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=302.62 Aligned_cols=248 Identities=28% Similarity=0.405 Sum_probs=196.1
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
+.|...+.||+|+||.||++... ++..||+|.+.... ......+..|+++++.++|||++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 35788899999999999999964 58889999886432 223456888999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+.+ +|.+++... ..++++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCCC-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 99974 888877544 35689999999999999999999998 999999999999999999999999999875432
Q ss_pred CCcceeecccccccccccccc---cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCC
Q 009979 342 ERSYVTTRVMGTFGYVAPEYA---STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (521)
. ....|++.|+|||++ ..+.++.++|||||||++|||++|+.||.... .............
T Consensus 178 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~------~~~~~~~~~~~~~----- 241 (317)
T cd06635 178 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNES----- 241 (317)
T ss_pred c-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHhccC-----
Confidence 2 234688999999987 34678999999999999999999999986432 1111111111110
Q ss_pred CcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 419 d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
+.......+ ..+.+++.+||+.+|.+||++.++++.+.
T Consensus 242 -~~~~~~~~~---~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 242 -PTLQSNEWS---DYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred -CCCCCcccc---HHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 111111122 33455888999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=300.47 Aligned_cols=261 Identities=23% Similarity=0.362 Sum_probs=197.6
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
+|++.+.||+|++|.||+|... ++..||+|.+..... .....+..|+++++.++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788999999999999999975 588899999865432 23456778999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~ 344 (521)
++ +|.+++.... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 75 8998886542 235689999999999999999999998 999999999999999999999999999976533211
Q ss_pred ceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc---------cc
Q 009979 345 YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR---------NA 414 (521)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------~~ 414 (521)
......++..|++||.+.+ ..++.++|||||||++|+|++|+.||........ ...+....... ..
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ---LLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCChhhHHHHhcC
Confidence 1233457899999998765 4578999999999999999999999975543211 11111110000 00
Q ss_pred ccCCCcccCC-------CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 415 EGVLDPRLQE-------KPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 415 ~~~~d~~l~~-------~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.... ..+.. ...+.....+.+++.+||+.||.+||++.++++
T Consensus 232 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYK-PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhc-ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 00000 000112334556888999999999999999974
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=294.26 Aligned_cols=250 Identities=23% Similarity=0.313 Sum_probs=203.3
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
+|++.+.||+|+||.||++... ++..+|+|.+.... ......+..|+++++.++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999855 67889999986532 23345677899999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++++|.+++.........+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999877443446789999999999999999999998 9999999999999999999999999999876543
Q ss_pred cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
......|++.|+|||.+.+..++.++|+||||+++|||++|+.||...+. .+. ........... +
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~-~~~~~~~~~~~-----~- 221 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM------QDL-RYKVQRGKYPP-----I- 221 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHH-HHHHhcCCCCC-----C-
Confidence 22234688999999999998999999999999999999999999964432 111 11111111111 1
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
......++.+++.+||+.+|++||++.++++.
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 ---PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ---chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 12333456668889999999999999999854
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=303.07 Aligned_cols=246 Identities=26% Similarity=0.379 Sum_probs=196.8
Q ss_pred ccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
|....+||+|+||.||++... ++..||+|++..........+..|+.+++.++|+||+++++++..++..++||||+++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 334567999999999999864 6889999998655555567788999999999999999999999999999999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
++|.+++.. ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........ .
T Consensus 102 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~ 172 (292)
T cd06657 102 GALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 172 (292)
T ss_pred CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-c
Confidence 999998754 3578899999999999999999998 999999999999999999999999999876543221 2
Q ss_pred eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCC-C
Q 009979 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE-K 425 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~ 425 (521)
.....|++.|+|||++.+..++.++|+||||+++|+|++|..||...... .....+... +.+.+.. .
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~~---------~~~~~~~~~ 240 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDN---------LPPKLKNLH 240 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhh---------CCcccCCcc
Confidence 23356899999999998888999999999999999999999999643221 111111111 1111111 1
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 426 PCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 426 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
..+. .+.+++.+||+.+|.+||++.+++.
T Consensus 241 ~~~~---~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 241 KVSP---SLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cCCH---HHHHHHHHHHhCCcccCcCHHHHhc
Confidence 1222 3445788999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=297.54 Aligned_cols=244 Identities=25% Similarity=0.303 Sum_probs=190.9
Q ss_pred EccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCCch
Q 009979 194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL 269 (521)
Q Consensus 194 LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L 269 (521)
||+|+||+||+|... ++..||+|.+.... ......+..|+++++.++||||+++++++......|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 58889999886432 22334567899999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcceeec
Q 009979 270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR 349 (521)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 349 (521)
.+++.... ...+++..++.++.|++.||.|||+. +++||||+|+||++++++.+||+|||++....... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 153 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG 153 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence 99997652 24689999999999999999999998 99999999999999999999999999998654321 2233
Q ss_pred ccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHH
Q 009979 350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429 (521)
Q Consensus 350 ~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 429 (521)
..++..|+|||++.+..++.++|||||||++|+|++|+.||........ .+.+....... ...+.. ..+
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~------~~~~~~-~~~- 222 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE---KEELKRRTLEM------AVEYPD-KFS- 222 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc---HHHHHhccccc------cccCCc-cCC-
Confidence 4678899999999888899999999999999999999999975443111 11111111100 001111 122
Q ss_pred HHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 009979 430 ALKRALLVALRCVDPNAHKRP-----KMGHVIH 457 (521)
Q Consensus 430 ~~~~~~~li~~cl~~dP~~RP-----t~~evl~ 457 (521)
..+.+++.+||+.||.+|| ++.+++.
T Consensus 223 --~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 223 --PEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred --HHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 2344588899999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=295.42 Aligned_cols=249 Identities=22% Similarity=0.343 Sum_probs=194.8
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC-----ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC--Cee
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-----RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHR 257 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~ 257 (521)
++|.+.+.||+|+||.||+|... ++..||+|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999964 5889999987432 223346788999999999999999999998664 457
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+++++|.+++... ..+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 8999999999999998754 4578899999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCC--cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 338 LLGAER--SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 338 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
...... ........|+..|+|||++.+..++.++|+|||||++|+|++|+.||..... .+.+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~--- 225 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA------MAAIFKIATQP--- 225 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH------HHHHHHHHcCC---
Confidence 653211 1112335689999999999888899999999999999999999999964321 11111111111
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
..+.+ +......+.+++.+||. +|..||++.+++.
T Consensus 226 --~~~~~----p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 --TKPML----PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --CCCCC----CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11111 11222344557889999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=302.70 Aligned_cols=261 Identities=22% Similarity=0.345 Sum_probs=194.4
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
++|++.+.||+|+||+||+|... +++.||+|++..... ...+.+..|+++++.++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 47889999999999999999965 688899998864322 234668889999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-CCCceEeecccceecCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~-~~~vkL~DFGla~~~~~ 341 (521)
|++ ++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 58888876542 23467888889999999999999998 9999999999999985 55799999999986543
Q ss_pred CCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCC--
Q 009979 342 ERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL-- 418 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 418 (521)
... ..+...|++.|+|||++.+ ..++.++|||||||++|+|+||+.||......+.. ...+ ...... .....
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~--~~~~-~~~~~~-~~~~~~~ 230 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL--FKIF-RILGTP-NEETWPG 230 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH-HHhCCC-Chhhccc
Confidence 221 1233467899999998865 45789999999999999999999999754322111 1100 000000 00000
Q ss_pred ----------CcccCCC----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 419 ----------DPRLQEK----PCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 419 ----------d~~l~~~----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
-+..... ..+.....+.+++.+|++.+|++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 00112234556888999999999999999985
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=298.60 Aligned_cols=252 Identities=23% Similarity=0.299 Sum_probs=196.3
Q ss_pred CccccceEccCCcEEEEEEEE----cCCcEEEEEEeccCCh----hhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCee
Q 009979 187 GFADENVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNRG----QAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~ 257 (521)
+|++.+.||+|+||.||++.. .++..||+|.+..... ...+.+..|+++++.+ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999986 3678899999865322 2346678899999999 599999999999998999
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 9999999999999999764 4688899999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCcceeecccccccccccccccC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
..............|+..|+|||.+.+ ..++.++||||||+++|+|++|..||...... ....++.+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~--- 228 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE--- 228 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccC---
Confidence 764433333334568999999999865 34788999999999999999999999643221 12222222222111
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~ 458 (521)
+.+.. ..+. .+.+++.+||+.||++|| ++.+++.+
T Consensus 229 ----~~~~~-~~~~---~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 ----PPYPQ-EMSA---LAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ----CCCCc-cCCH---HHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 11111 1222 344588899999999997 66666543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=297.24 Aligned_cols=245 Identities=24% Similarity=0.366 Sum_probs=195.6
Q ss_pred EccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCCch
Q 009979 194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL 269 (521)
Q Consensus 194 LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L 269 (521)
||.|+||.||++.+. +++.+++|.+..... ...+.+..|+++++.++||||+++++.+..+...|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 488999999865433 3456788899999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc-----
Q 009979 270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS----- 344 (521)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~----- 344 (521)
.+++... ..+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9999764 3789999999999999999999998 999999999999999999999999999876433211
Q ss_pred --ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 345 --YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 345 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
.......++..|+|||.+....++.++||||||+++|+|++|..||..... .+........ . .. .
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~-~----~~--~ 220 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP------EEIFQNILNG-K----IE--W 220 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcC-C----cC--C
Confidence 122345688899999999888899999999999999999999999964432 1222222211 0 00 0
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
. ..+ .....+..++.+||+.+|.+|||+..+.+.|+
T Consensus 221 ~-~~~-~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 P-EDV-EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred C-ccc-cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 001 01344556888999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=333.50 Aligned_cols=268 Identities=24% Similarity=0.289 Sum_probs=215.0
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEee
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~ 253 (521)
+++++...++|.+.++||+|+||.|.+++.+ +++.||+|++.+. +......|..|-.+|..-+.+-|+.++-.|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 6778889999999999999999999999975 5777899998763 33445779999999999999999999999999
Q ss_pred CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeec
Q 009979 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (521)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DF 333 (521)
+.++|||||||+||||..++.+. .+++++.+..++..++.||.-||+. |+|||||||+|||||..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 99999999999999999999876 3799999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCcceeeccccccccccccccc----C-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH
Q 009979 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYAS----T-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408 (521)
Q Consensus 334 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 408 (521)
|.+-.+..+........+|||.|++||++. + +.|+..+|+||+||++|||+.|..||. ..++++-..+.
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY------adslveTY~KI 293 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY------ADSLVETYGKI 293 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch------HHHHHHHHHHH
Confidence 999988776666667789999999999884 3 679999999999999999999999995 23344433333
Q ss_pred hhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHHhhccCCCc
Q 009979 409 VTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK---MGHVIHMLEAEEFPF 466 (521)
Q Consensus 409 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt---~~evl~~L~~~~~~~ 466 (521)
+.-.+.-.+-+ ....+...+. ||.+.+ -+|+.|.. +.++-.+.-.....|
T Consensus 294 m~hk~~l~FP~----~~~VSeeakd---LI~~ll-~~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 294 MNHKESLSFPD----ETDVSEEAKD---LIEALL-CDREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred hchhhhcCCCc----ccccCHHHHH---HHHHHh-cChhhhcccccHHHHHhCccccCCCh
Confidence 33221111110 0112333333 554444 46778877 888876554444444
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=298.79 Aligned_cols=256 Identities=25% Similarity=0.309 Sum_probs=200.3
Q ss_pred CccccceEccCCcEEEEEEEEc----CCcEEEEEEeccCC----hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCee
Q 009979 187 GFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~ 257 (521)
+|++.+.||+|+||.||++... ++..||+|.+.... ....+.+..|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3778899999999999999842 46789999886432 22335678899999999 599999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 9999999999999998754 4688899999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCcceeecccccccccccccccCCC--CCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
..............|+..|+|||.+.+.. .+.++||||||+++|||++|..||...... ....+..+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~--- 228 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKSK--- 228 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHccC---
Confidence 76443333233456899999999987655 788999999999999999999999643221 11122222222110
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
+.... ..+. .+.+++.+||+.||++|||+.++.+.|+..
T Consensus 229 ----~~~~~-~~~~---~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 ----PPFPK-TMSA---EARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ----CCCCc-ccCH---HHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 11111 1222 344588899999999999999888877653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=306.67 Aligned_cols=265 Identities=25% Similarity=0.356 Sum_probs=195.0
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeC--Ceee
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEG--AHRM 258 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~--~~~~ 258 (521)
.++|++.+.||+|+||.||+|.+. ++..+|+|++... .......+..|+.+++++ +||||++++++|... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 357899999999999999999975 5788999988543 223335677899999999 999999999998643 4679
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+||||++ ++|.+++... .+.+..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 86 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 9999997 5999988653 678889999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCc----ceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHH-----------
Q 009979 339 LGAERS----YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLV----------- 402 (521)
Q Consensus 339 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~----------- 402 (521)
...... .......||..|+|||++.+ ..++.++||||||+++|+|+||+.||....+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 643322 12234568999999998754 56889999999999999999999999654322110000
Q ss_pred -HHHHHHhhccccccCCCcccC--CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 403 -EWLKTMVTNRNAEGVLDPRLQ--EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 403 -~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
..+.................. ....+.....+.+++.+||+.||++|||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000000000000000 00001123445668889999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=299.34 Aligned_cols=256 Identities=26% Similarity=0.416 Sum_probs=196.1
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcC-CcEEEEEEeccCC-hhhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCeee
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~ 258 (521)
.+..++|++.+.||+|+||.||+|.+++ ++.||||.+.... ......+..|+.++.... |+||+++++++.+....+
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 3455788999999999999999999864 8889999986543 233455666777776665 999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+||||+. ++|.+++... ...+++..+..++.|++.||+|||+.. +|+||||+|+||++++++.+||+|||++..
T Consensus 91 ~v~e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 91 ICMELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred EEeeccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchh
Confidence 9999985 4788777654 247899999999999999999999731 899999999999999999999999999976
Q ss_pred cCCCCcceeecccccccccccccccCCC----CCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 339 LGAERSYVTTRVMGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
+..... .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..... ..+.+........
T Consensus 165 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~~- 236 (296)
T cd06618 165 LVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-----EFEVLTKILQEEP- 236 (296)
T ss_pred ccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-----HHHHHHHHhcCCC-
Confidence 533222 22345788999999986553 88899999999999999999999964221 1222222222111
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
+.+... .....++.+++.+||+.||++||++.+++.+
T Consensus 237 -----~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 -----PSLPPN--EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -----CCCCCC--CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111110 0122345568889999999999999999855
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=296.46 Aligned_cols=265 Identities=25% Similarity=0.321 Sum_probs=211.8
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCCeeeEEEE
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGY 250 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~ 250 (521)
+.++.+..++++....+-+|.||.||+|.|. +.+.|.+|.+++...+ ....+..|.-++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 6677888889999999999999999999654 3445778877765433 34678889999999999999999999
Q ss_pred EeeC-CeeeEEEEeccCCchHHhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC
Q 009979 251 CAEG-AHRMLVYEYIDNGNLEQWLHGDVG----PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ 325 (521)
Q Consensus 251 ~~~~-~~~~lV~e~~~~g~L~~~l~~~~~----~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~ 325 (521)
+.+. ...+.++.++.-|+|+.||...++ ..+.++..+...++.|++.|++|||.+ +|||.||..+|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 8654 567889999999999999983322 245677778889999999999999999 99999999999999999
Q ss_pred CCceEeecccceecCCCCcceeec-ccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHH
Q 009979 326 WNPKLSDFGLAKLLGAERSYVTTR-VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVE 403 (521)
Q Consensus 326 ~~vkL~DFGla~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~ 403 (521)
.+|||+|=.+++.+.+.+...... ......||+||.+.+..|+.++|||||||+||||+| |+.||..-+|. +
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf------E 506 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF------E 506 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH------H
Confidence 999999999999876655544333 334668999999999999999999999999999999 99999755543 2
Q ss_pred HHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 404 WLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 404 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
. ..++..+. . .-++..|++++- .++.-||...|++||+++|++.-|..
T Consensus 507 m-~~ylkdGy--R----laQP~NCPDeLf---~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 507 M-EHYLKDGY--R----LAQPFNCPDELF---TVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred H-HHHHhccc--e----ecCCCCCcHHHH---HHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1 11222111 0 112334666554 48889999999999999999988864
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=310.93 Aligned_cols=260 Identities=22% Similarity=0.312 Sum_probs=196.3
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC-----Cee
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHR 257 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----~~~ 257 (521)
++|.+.+.||+|+||+||+|... ++..||||.+... .......+..|+.+++.++|+||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 47899999999999999999964 5889999988653 223345677899999999999999999987644 347
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+. ++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 99999996 6899888754 5689999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc----
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR---- 412 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---- 412 (521)
...... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...... .....+.......
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV---HQLKLITELLGSPSEED 232 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCCCChHH
Confidence 764332 22234567899999998754 56899999999999999999999999654211 1111111111000
Q ss_pred -------c-------cccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 413 -------N-------AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 413 -------~-------~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
. .....++.+.. ..+.....+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0 00000000000 011223455678999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=301.95 Aligned_cols=260 Identities=22% Similarity=0.279 Sum_probs=191.2
Q ss_pred ceEccC--CcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 192 NVIGEG--GYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 192 ~~LG~G--~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
..||+| +||+||++.+. +++.||+|.+.... ....+.+..|+.+++.++||||++++++|..+...++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999964 68999999986432 23346788999999999999999999999999999999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999988653 24588999999999999999999998 99999999999999999999999998654321111000
Q ss_pred ------eecccccccccccccccCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH-----------
Q 009979 347 ------TTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT----------- 407 (521)
Q Consensus 347 ------~~~~~gt~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~----------- 407 (521)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||....... .....+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCcccccc
Confidence 0112346679999998763 47899999999999999999999997543110 00000000
Q ss_pred -----Hh----------------hccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 408 -----MV----------------TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 408 -----~~----------------~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.. .......+.+..+...........+.+++.+||+.||++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 0000001111111111122344566779999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=309.43 Aligned_cols=261 Identities=24% Similarity=0.352 Sum_probs=199.7
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC-----eee
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA-----HRM 258 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~-----~~~ 258 (521)
+|.+.+.||.|+||.||+|... ++..||+|++.... ....+.+..|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788899999999999999975 48899999987643 334567888999999999999999999988765 789
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+||||+. ++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 4899988754 3789999999999999999999998 999999999999999999999999999997
Q ss_pred cCCCCc--ceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhc----
Q 009979 339 LGAERS--YVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN---- 411 (521)
Q Consensus 339 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---- 411 (521)
...... .......++..|+|||++.+. .++.++|+||||+++|+|++|+.||........ ...+......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~ 229 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSEE 229 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCChh
Confidence 654321 122345689999999999877 899999999999999999999999975542111 1111110000
Q ss_pred -------cccccCCCc--ccCCCc----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 412 -------RNAEGVLDP--RLQEKP----CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 412 -------~~~~~~~d~--~l~~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
......+.. ...... .+.....+.+++.+||+.+|.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000000 000000 01123445668889999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=311.00 Aligned_cols=263 Identities=22% Similarity=0.372 Sum_probs=197.2
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEee----CCeee
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRM 258 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~----~~~~~ 258 (521)
++|++.+.||+|+||.||+|... ++..||+|++.... ......+..|+.+++.++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 58899999999999999999965 58899999986542 2334667789999999999999999998753 34679
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+||||+. ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++..
T Consensus 85 lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999995 5999988654 4589999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCc---ceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh----
Q 009979 339 LGAERS---YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT---- 410 (521)
Q Consensus 339 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---- 410 (521)
...... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||......... ..+..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~---~~~~~~~g~~~~ 233 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL---KLILSVLGSPSE 233 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH---HHHHHHhCCChh
Confidence 543221 11234578999999998755 56899999999999999999999999654321111 10000000
Q ss_pred -------ccccccCCC--cccCCCc----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 411 -------NRNAEGVLD--PRLQEKP----CSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 411 -------~~~~~~~~d--~~l~~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
........+ +...... .......+.+++.+||+.+|++||++.+++.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 000000000 0000000 112234566788999999999999999988643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=288.45 Aligned_cols=247 Identities=28% Similarity=0.473 Sum_probs=201.3
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
+|++.+.||+|+||.||++... +++.|++|.+..... .....+..|++++++++|+|++++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 578899999876543 4557789999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998764 5789999999999999999999998 99999999999999999999999999998775433
Q ss_pred cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
.. .....|+..|+|||...+..++.++||||||+++|+|++|+.||..... ........... .+.+.
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~------~~~~~ 220 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP------MAALFRIVQDD------HPPLP 220 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhccC------CCCCC
Confidence 22 2345689999999999888899999999999999999999999964331 11111111110 11111
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
. ..+. .+..++.+||..+|++||++.+++.
T Consensus 221 ~-~~~~---~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 E-GISP---ELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred C-CCCH---HHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1 1223 3445888999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=327.51 Aligned_cols=264 Identities=28% Similarity=0.479 Sum_probs=212.6
Q ss_pred hhhhcCCCccccceEccCCcEEEEEEEEc----C----CcEEEEEEeccCChh-hHHHHHHHHHHHhcC-CCCCeeeEEE
Q 009979 180 ELEVSTNGFADENVIGEGGYGIVYHGVLE----D----NTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRV-RHKNLVRLLG 249 (521)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~----~----~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l-~hpniv~l~~ 249 (521)
.+++..++..+.+.||+|.||.|++|... . ...||||.++..... ..+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 46777778888889999999999999843 1 346899998765443 457899999999999 5999999999
Q ss_pred EEeeCCeeeEEEEeccCCchHHhhhcCC---CC-------C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 009979 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDV---GP-------H--SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKS 317 (521)
Q Consensus 250 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~---~~-------~--~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~ 317 (521)
+|......++|+||+..|+|..+|+..+ .. . ..++....+.++.|||.|++||++. +++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999998875 11 1 2388999999999999999999998 999999999
Q ss_pred CCeEeCCCCCceEeecccceecCCCCcceeecccc--cccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCC
Q 009979 318 SNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG--TFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR 394 (521)
Q Consensus 318 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~ 394 (521)
+|||+.++..+||+|||+++.......+......| ...|||||.+....|+.++|||||||+|||++| |..||..-.
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999765555554343333 346999999999999999999999999999999 999995421
Q ss_pred CCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 395 PPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
. ...+.+ .+..+.. .-++..|..+ +..+|+.||+.+|++||++.++++.++.
T Consensus 527 ~--~~~l~~----~l~~G~r------~~~P~~c~~e---iY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 527 P--TEELLE----FLKEGNR------MEQPEHCSDE---IYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred c--HHHHHH----HHhcCCC------CCCCCCCCHH---HHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 1 112222 2222221 1122335444 4458999999999999999999999987
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=293.85 Aligned_cols=243 Identities=21% Similarity=0.301 Sum_probs=186.8
Q ss_pred eEccCCcEEEEEEEEc-CCcEEEEEEeccCChh---hHHHHHHH---HHHHhcCCCCCeeeEEEEEeeCCeeeEEEEecc
Q 009979 193 VIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ---AEKEFKVE---VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (521)
Q Consensus 193 ~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E---i~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (521)
.||+|+||.||+|... +++.||+|.+.+.... ....+..| +.+++...||||+++++++......++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 5789999988654221 11223333 344555689999999999999999999999999
Q ss_pred CCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcc
Q 009979 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (521)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~ 345 (521)
||+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 99999988654 4789999999999999999999998 99999999999999999999999999997653322
Q ss_pred eeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCC
Q 009979 346 VTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (521)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 424 (521)
.....|+..|+|||++.++ .++.++|||||||++|||++|+.||........... ...... .++.+..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~------~~~~~~~ 220 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLT------MAVELPD 220 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhhc------cCCCCCC
Confidence 2234689999999998754 689999999999999999999999975533221111 111110 1111211
Q ss_pred CccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 009979 425 KPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHML 459 (521)
Q Consensus 425 ~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L 459 (521)
. . ...+.+++.+||..+|.+|| ++.+++++-
T Consensus 221 ~-~---s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 221 S-F---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred c-C---CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 1 2 23455588899999999999 999998543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=291.97 Aligned_cols=244 Identities=23% Similarity=0.279 Sum_probs=187.7
Q ss_pred ceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh---hHHHHHHHHHHH-hcCCCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 192 NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ---AEKEFKVEVEAI-GRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~Ei~~l-~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
+.||+|+||.||+|... +++.||+|.+...... ....+..|..++ ...+|+|++++++++..+...++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 5789999998654322 223344454444 455899999999999999999999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 9999999764 4688999999999999999999998 999999999999999999999999999986432
Q ss_pred eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCc
Q 009979 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 426 (521)
.....|+..|+|||.+.+..++.++||||||+++|||++|..||..... .+......... . + .....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-~----~--~~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP------DAVFDNILSRR-I----N--WPEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcc-c----C--CCCcc
Confidence 2234688999999999888899999999999999999999999964322 12222221111 0 0 00000
Q ss_pred cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 427 CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 427 ~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
.......+.+++.+||+.||++||++.++.+.|.
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 1112234555888999999999998765555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=299.91 Aligned_cols=248 Identities=25% Similarity=0.363 Sum_probs=201.2
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCeeeEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV 260 (521)
++|.+.+.||+|+||.||+|... +++.||+|.+... .....+.+..|++++++++ |+||+++++++..+...++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47888999999999999999965 6889999988653 2233467888999999998 99999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+++++|.+++.+. ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 9999999999999765 4799999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCc-------------------ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccH
Q 009979 341 AERS-------------------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNL 401 (521)
Q Consensus 341 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~ 401 (521)
.... .......|+..|+|||.+.+..++.++|+||||++++++++|+.||.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------ 227 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------ 227 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------
Confidence 3321 122335678999999999888899999999999999999999999974431
Q ss_pred HHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCH----HHHHH
Q 009979 402 VEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM----GHVIH 457 (521)
Q Consensus 402 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~----~evl~ 457 (521)
...++...... . .+. ......+.+++.+||+.+|.+||++ .+++.
T Consensus 228 ~~~~~~~~~~~---~----~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 YLTFQKILKLE---Y----SFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHHHhcC---C----CCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11122222110 0 111 1113345568889999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=295.84 Aligned_cols=260 Identities=23% Similarity=0.318 Sum_probs=198.9
Q ss_pred ccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh--hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ--AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
|+..+.||+|++|.||+|... +++.+++|.+...... ....+..|+++++.++|+||+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999965 6888999988654332 4467888999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~ 344 (521)
++ +|.+++... ...+++..++.++.|++.||+|||+. +|+|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 898888764 25789999999999999999999998 99999999999999999999999999998775443
Q ss_pred ceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc---ccccCCC-
Q 009979 345 YVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR---NAEGVLD- 419 (521)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d- 419 (521)
.......++..|+|||.+.+. .++.++|+||||+++|+|+||+.||........ ........... ......+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhh
Confidence 112234578899999998776 789999999999999999999999964432111 11011100000 0000000
Q ss_pred --------cccC----CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 420 --------PRLQ----EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 420 --------~~l~----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
+... ....+.....+.+++.+||+.||.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 00012234566779999999999999999999853
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.53 Aligned_cols=262 Identities=18% Similarity=0.202 Sum_probs=192.5
Q ss_pred cccceEccCCcEEEEEEEEcCCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 189 ~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
.+.+.+|.|+++.||++.. +++.||+|++... .....+.+..|+++++.++|+||+++++++.+....+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445556666666666655 6889999998654 344557899999999999999999999999999999999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc--
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-- 344 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~-- 344 (521)
|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+..+.....
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 84 GSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 99999998652 34688899999999999999999998 999999999999999999999999999876532211
Q ss_pred ----ceeecccccccccccccccC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh--------
Q 009979 345 ----YVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT-------- 410 (521)
Q Consensus 345 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-------- 410 (521)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||....... ...+.......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCch
Confidence 11233457889999999865 358899999999999999999999997543211 11111100000
Q ss_pred ---cccccc----CCCcccC----CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 411 ---NRNAEG----VLDPRLQ----EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 411 ---~~~~~~----~~d~~l~----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
...... ..++... .........++.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 0011000 00111223456678999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=294.05 Aligned_cols=242 Identities=22% Similarity=0.306 Sum_probs=186.5
Q ss_pred CCccccceE--ccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVI--GEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~L--G~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|.+.+.+ |+|+||.||++... ++..+|+|.+........ |+.....+ +||||+++++++...+..++||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~ 88 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM 88 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence 456666665 99999999999964 578889998764322111 22222222 6999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC-CceEeecccceecC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKLLG 340 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~-~vkL~DFGla~~~~ 340 (521)
||+++++|.+++... ..+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||+++...
T Consensus 89 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 89 DYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 999999999999765 3789999999999999999999998 999999999999999888 99999999998754
Q ss_pred CCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
... ...|+..|+|||++.+..++.++||||||+++|||++|+.||..... ...+...+.... . .. . +
T Consensus 162 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~-~-~~---~--~ 228 (267)
T PHA03390 162 TPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQ-Q-KK---L--P 228 (267)
T ss_pred CCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhh-c-cc---C--C
Confidence 322 23589999999999998999999999999999999999999974432 222222222221 1 00 0 0
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPK-MGHVIH 457 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt-~~evl~ 457 (521)
. .......+.+++.+||+.+|.+||+ ++++++
T Consensus 229 -~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 229 -F----IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -c----ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 0112234455788999999999996 688873
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=292.35 Aligned_cols=256 Identities=25% Similarity=0.350 Sum_probs=194.3
Q ss_pred ccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh--hHHHHHHHHHHHhcC---CCCCeeeEEEEEeeCCe-----
Q 009979 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ--AEKEFKVEVEAIGRV---RHKNLVRLLGYCAEGAH----- 256 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l---~hpniv~l~~~~~~~~~----- 256 (521)
|++.+.||+|+||.||+|.+. +++.||+|.+...... ....+..|+.+++++ +|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999976 4889999998643222 234566687777665 59999999999987776
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.+++|||+.+ +|.+++.... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 8999887642 23689999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc----
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR---- 412 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---- 412 (521)
........ .....++..|+|||++.+..++.++|+|||||++|||++|+.||...... +.+.+.....
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~------~~~~~~~~~~~~~~ 226 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA------DQLDKIFDVIGLPS 226 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH------HHHHHHHHHcCCCC
Confidence 87643322 22345788999999999889999999999999999999999998744321 1111111100
Q ss_pred ccc---------cCCCcccCC---CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 413 NAE---------GVLDPRLQE---KPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 413 ~~~---------~~~d~~l~~---~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
... ......... ...+.....+.+++.+||+.||.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000 000000000 001223355667899999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=308.74 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=203.0
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhH--HHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAE--KEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
....|.+...||+|.|+.|.+|++. ++..||||.+.+...... ..+.+|+++|+.++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3457889999999999999999954 689999999977644332 4578899999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+.+|.+++++.+. +...+..+..++.|++.|++|||++ .|+|||||.+||||+.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999876 4566688999999999999999999 99999999999999999999999999999885
Q ss_pred CCCcceeecccccccccccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
. .....+.+|++.|.|||++.+..| ++.+|+||+|++||.|+.|.+||++..-.... ..++.
T Consensus 207 ~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr---------------~rvl~ 269 (596)
T KOG0586|consen 207 Y--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR---------------PRVLR 269 (596)
T ss_pred c--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc---------------chhee
Confidence 3 344567899999999999988765 57899999999999999999999855422111 01111
Q ss_pred cccCCC-ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 420 PRLQEK-PCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 420 ~~l~~~-~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.+++-. +-....+ +++.+++-.+|.+|+++.++..
T Consensus 270 gk~rIp~~ms~dce---~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 270 GKYRIPFYMSCDCE---DLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeecccceeechhH---HHHHHhhccCccccCCHHHhhh
Confidence 122211 1222233 3777899999999999998864
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=302.70 Aligned_cols=263 Identities=22% Similarity=0.305 Sum_probs=194.3
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC------
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------ 255 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~------ 255 (521)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999965 588899998864322 22345678999999999999999999875433
Q ss_pred --eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeec
Q 009979 256 --HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (521)
Q Consensus 256 --~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DF 333 (521)
..++||||+.+ +|..++... ...+++..+..++.|+++||+|||+. +++|+||||+|||+++++.+||+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 46899999965 787777654 35789999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCcc----------eeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHH
Q 009979 334 GLAKLLGAERSY----------VTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLV 402 (521)
Q Consensus 334 Gla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~ 402 (521)
|++......... ..+...|++.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~---~~~ 236 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI---DQL 236 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH---HHH
Confidence 999865332211 1123467889999998765 45899999999999999999999999654321 111
Q ss_pred HHHHHHhhc---------ccccc----CCCcccCCCc---cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 403 EWLKTMVTN---------RNAEG----VLDPRLQEKP---CSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 403 ~~~~~~~~~---------~~~~~----~~d~~l~~~~---~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
+.+...... ..... .......... .......+.+++.+||+.||.+|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111111100 00000 0000111000 0112245667999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=296.44 Aligned_cols=244 Identities=28% Similarity=0.411 Sum_probs=192.6
Q ss_pred ccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
|...+.||+|+||+||+|... ++..|++|.+..... .....+..|+++++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999964 588899998864322 2335678899999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+. |+|.+++... ..++++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 96 5888877654 35689999999999999999999998 999999999999999999999999999864322
Q ss_pred cceeeccccccccccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 344 SYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
.....|+..|+|||++. ...++.++|||||||++|||++|..||..... ...+....... . +
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~-~-----~ 238 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQND-S-----P 238 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcC-C-----C
Confidence 23456899999999874 46688899999999999999999999864322 12222221111 0 1
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.......+. .+.+++.+||+.+|.+||++.+++..
T Consensus 239 ~~~~~~~~~---~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 TLQSNEWTD---SFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCccccCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111223 34458889999999999999999844
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=297.78 Aligned_cols=249 Identities=26% Similarity=0.384 Sum_probs=195.2
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
.+.|...+.||+|+||.||+|... ++..+|+|.+... .......+..|+++++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 345778889999999999999965 5778999988542 223345677899999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+. |+|.+++... ..++++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 94 MEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 99996 5888877544 34688999999999999999999998 99999999999999999999999999998653
Q ss_pred CCCcceeeccccccccccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 341 AERSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
.. ....|++.|+|||.+. ...++.++|||||||++|+|++|..||..... .+....... ..
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~-~~---- 230 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ-NE---- 230 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH------HHHHHHHhh-cC----
Confidence 32 2346889999999874 45688899999999999999999999854321 111111111 11
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
.+..... .....+.+++.+||+.+|++||++.+++....
T Consensus 231 -~~~~~~~---~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 231 -SPALQSG---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred -CCCcCcc---cccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 0111111 22234555888999999999999999986643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=326.31 Aligned_cols=250 Identities=25% Similarity=0.379 Sum_probs=185.4
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEee----------
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE---------- 253 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~---------- 253 (521)
++|+..+.||+||||.||+++.+ ||+.||||++.-.. ......+.+|+.+|++|+|||||+++..+.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 47888999999999999999966 89999999996543 2333667889999999999999998851100
Q ss_pred --------------------------------------------------------------------------------
Q 009979 254 -------------------------------------------------------------------------------- 253 (521)
Q Consensus 254 -------------------------------------------------------------------------------- 253 (521)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ---------------------C--------CeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 009979 254 ---------------------G--------AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304 (521)
Q Consensus 254 ---------------------~--------~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~ 304 (521)
+ ..+||-||||+.-.|.++++.+. ..-.....++++.+|+.||+|+|+
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~---~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH---FNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc---cchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 12588999999988888887662 111467889999999999999999
Q ss_pred cCCCCeeecCCCCCCeEeCCCCCceEeecccceecC-----------------CCCcceeecccccccccccccccCC--
Q 009979 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-----------------AERSYVTTRVMGTFGYVAPEYASTG-- 365 (521)
Q Consensus 305 ~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~-- 365 (521)
. |||||||||.||++|++++|||+|||+|+... .......+..+||.-|+|||++.+.
T Consensus 716 ~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 Q---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred C---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 9 99999999999999999999999999998721 0112234667899999999999664
Q ss_pred -CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCC
Q 009979 366 -MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDP 444 (521)
Q Consensus 366 -~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~ 444 (521)
.|+.|+|+||+|||++||+. ||... ..-...+...- .+.+..- +.+....++. -..+|.++++.
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~Ts-----MERa~iL~~LR-~g~iP~~--~~f~~~~~~~----e~slI~~Ll~h 857 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTS-----MERASILTNLR-KGSIPEP--ADFFDPEHPE----EASLIRWLLSH 857 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCch-----HHHHHHHHhcc-cCCCCCC--cccccccchH----HHHHHHHHhcC
Confidence 49999999999999999985 56421 11111111111 1111111 1111111222 23388899999
Q ss_pred CCCCCCCHHHHH
Q 009979 445 NAHKRPKMGHVI 456 (521)
Q Consensus 445 dP~~RPt~~evl 456 (521)
||.+|||+.|+|
T Consensus 858 dP~kRPtA~eLL 869 (1351)
T KOG1035|consen 858 DPSKRPTATELL 869 (1351)
T ss_pred CCccCCCHHHHh
Confidence 999999999986
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=293.55 Aligned_cols=263 Identities=22% Similarity=0.306 Sum_probs=196.2
Q ss_pred ccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCeeeEEEEec
Q 009979 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
|++.+.||+|+||+||+|... ++..|++|++..... .......+|+..+++++ |+|++++++++..+...++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999975 477899998865432 22234456999999999 999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~ 344 (521)
+|+|.+++.... ...+++..++.++.|++.+|.|||++ +++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 779999887652 34789999999999999999999998 999999999999999999999999999987643322
Q ss_pred ceeeccccccccccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHH----------HHHHHHhhccc
Q 009979 345 YVTTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLV----------EWLKTMVTNRN 413 (521)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~----------~~~~~~~~~~~ 413 (521)
.....|+..|+|||++. +..++.++|+||||+++|||++|+.||............ .|.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 23356889999999874 456889999999999999999999999655321111000 00000000000
Q ss_pred cccCCCcccCCC---ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 414 AEGVLDPRLQEK---PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 414 ~~~~~d~~l~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
....+....... ..+.....+.+++.+||+.||++||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000000 001113456679999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.79 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=197.7
Q ss_pred CccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 187 GFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
+|.....||.|.||.||-|.. ++|.-.|+|.+.-... ...+.+.+|+.++..++|||+|+++|+-.+.+..+|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 566778999999999999995 4577789998864433 3346788899999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
|++|+|.+++... .-.++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|..+....
T Consensus 1316 C~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred hccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 9999999999754 4566677777888999999999999 99999999999999999999999999999875442
Q ss_pred c---ceeecccccccccccccccC---CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 344 S---YVTTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 344 ~---~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
. ......+||+.|||||++.+ .....++||||+|||+.||+||+.||...+. -..++-.+ ..+.
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-----e~aIMy~V-~~gh---- 1458 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-----EWAIMYHV-AAGH---- 1458 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-----hhHHHhHH-hccC----
Confidence 1 11235689999999999964 4467789999999999999999999974432 12222222 1111
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
-|.++. +...+-.+++.+||..||++|.++.|++++
T Consensus 1459 -~Pq~P~----~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 -KPQIPE----RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -CCCCch----hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 122222 233334457779999999999999888754
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=290.12 Aligned_cols=251 Identities=19% Similarity=0.302 Sum_probs=195.4
Q ss_pred CccccceEccCCcEEEEEEEEcC-CcEEEEEEeccC-----ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNN-----RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
+|.+.+.||+|+||.||++.+.. +..+++|.++.. .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999998653 344556655431 122334566799999999999999999999988899999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999876444456799999999999999999999998 9999999999999975 569999999998764
Q ss_pred CCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... .......... . ..+
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~-~-----~~~ 223 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVE-G-----PTP 223 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHc-C-----CCC
Confidence 322 22234568899999999988889999999999999999999999995322 2222222211 1 111
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+ .......+.+++.+||+.||++||++.++++.
T Consensus 224 ~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 SL----PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CC----cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11 11223345568889999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.33 Aligned_cols=263 Identities=21% Similarity=0.274 Sum_probs=194.9
Q ss_pred CCcc-ccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhh--------------HHHHHHHHHHHhcCCCCCeeeEEE
Q 009979 186 NGFA-DENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQA--------------EKEFKVEVEAIGRVRHKNLVRLLG 249 (521)
Q Consensus 186 ~~~~-~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~Ei~~l~~l~hpniv~l~~ 249 (521)
++|. +.+.||+|+||+||+|.+. +++.||+|++....... ...+..|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3554 4578999999999999965 68899999886432221 124678999999999999999999
Q ss_pred EEeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCce
Q 009979 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK 329 (521)
Q Consensus 250 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vk 329 (521)
++..+...++||||+. |+|.+++... ..+++.....++.|++.||.|||+. +++|+||+|+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999996 5999998654 4688999999999999999999998 999999999999999999999
Q ss_pred EeecccceecCCCC-------------cceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCC
Q 009979 330 LSDFGLAKLLGAER-------------SYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRP 395 (521)
Q Consensus 330 L~DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~ 395 (521)
|+|||++....... ........+++.|+|||.+.+. .++.++|||||||++|||++|..||...+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999998764110 1111223568899999988664 478999999999999999999999975542
Q ss_pred CCcccHHHHHHHHhhccccc---cC--------CCcccCCCc---cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 396 PGEVNLVEWLKTMVTNRNAE---GV--------LDPRLQEKP---CSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~---~~--------~d~~l~~~~---~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
. .....+.......... .. ......... .......+.+++.+||+.+|++||++.+++.+-
T Consensus 240 ~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 240 I---DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred H---HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 1 1111111111100000 00 000000000 011234466788999999999999999998533
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.53 Aligned_cols=262 Identities=23% Similarity=0.325 Sum_probs=193.3
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC----------
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG---------- 254 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~---------- 254 (521)
.+|.+.+.||.|+||.||+|... ++..||+|++........+.+..|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 58999999999999999999965 5889999998766656667788999999999999999999776543
Q ss_pred ----CeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC-CCCCce
Q 009979 255 ----AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNPK 329 (521)
Q Consensus 255 ----~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~-~~~~vk 329 (521)
...++||||++ ++|.+++.. ..+++..++.++.|++.||.|||+. +|+||||||+||+++ +++.+|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence 35789999997 599888854 3588999999999999999999998 999999999999997 456789
Q ss_pred EeecccceecCCCCcc--eeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 009979 330 LSDFGLAKLLGAERSY--VTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK 406 (521)
Q Consensus 330 L~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~ 406 (521)
|+|||+++........ ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||....+..... ..+.
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~--~~~~ 233 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ--LILE 233 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHH
Confidence 9999999865332111 1123467889999997644 568899999999999999999999996543211100 0000
Q ss_pred HHh----------hccccccCC-CcccCCCc----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 407 TMV----------TNRNAEGVL-DPRLQEKP----CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 407 ~~~----------~~~~~~~~~-d~~l~~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
... ......... .......+ ......++.+++.+||+.||++|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000 000000000 00000000 01122456678999999999999999999843
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=299.90 Aligned_cols=264 Identities=23% Similarity=0.344 Sum_probs=196.0
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEee-CCee
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-GAHR 257 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-~~~~ 257 (521)
...+++|++.+.||+|+||.||+|... ++..||+|++.... ....+.+..|+++++.++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 345678999999999999999999865 68899999886432 2234677889999999999999999999865 5578
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+ +++|.++++.. ++++..+..++.|++.||.|||+. +|+||||+|+|||+++++.+||+|||++.
T Consensus 86 ~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 8999998 56899888643 578888889999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHH---------HHHHH
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLV---------EWLKT 407 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~---------~~~~~ 407 (521)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||............ ++...
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54321 223467889999998765 57899999999999999999999999654321111000 00000
Q ss_pred HhhccccccCCCcccC-CCcc----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 408 MVTNRNAEGVLDPRLQ-EKPC----SRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 408 ~~~~~~~~~~~d~~l~-~~~~----~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.........+..-... ..+. +.....+.+++.+||+.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000000 0001 1122456668889999999999999998744
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=311.42 Aligned_cols=202 Identities=28% Similarity=0.427 Sum_probs=173.3
Q ss_pred cccceEccCCcEEEEEEEE-cCCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC------eeeEE
Q 009979 189 ADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------HRMLV 260 (521)
Q Consensus 189 ~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~------~~~lV 260 (521)
...+.||+||||.||+|++ .+|..||||.+.+.. ....+...+|+++|++++|+|||+++++-.+.. ...+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 4467899999999999994 479999999987643 233456778999999999999999998765443 45799
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe--CCCCC--ceEeecccc
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL--DKQWN--PKLSDFGLA 336 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl--~~~~~--vkL~DFGla 336 (521)
||||.||||...|++.. +...+++...+.++.+++.||.|||++ +|+||||||.||++ .++|+ -||+|||.|
T Consensus 96 mEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999998753 456799999999999999999999998 99999999999999 33343 699999999
Q ss_pred eecCCCCcceeeccccccccccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCC
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRNPVDYSRPP 396 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~ 396 (521)
+.+.++. ..+.++||..|++||+.. .+.|+..+|.|||||++|+..||..||.....+
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 9886554 567789999999999998 588999999999999999999999999866544
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=304.19 Aligned_cols=264 Identities=22% Similarity=0.294 Sum_probs=196.8
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~ 254 (521)
..++....++|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 444556678999999999999999999985 468899999986532 22345677899999999999999999988643
Q ss_pred ------CeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCc
Q 009979 255 ------AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328 (521)
Q Consensus 255 ------~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~v 328 (521)
...+++++++ +++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 3467888887 7799988764 3588999999999999999999998 99999999999999999999
Q ss_pred eEeecccceecCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 009979 329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407 (521)
Q Consensus 329 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 407 (521)
||+|||+++..... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ....+..
T Consensus 160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~ 232 (345)
T cd07877 160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILR 232 (345)
T ss_pred EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHH
Confidence 99999999864322 233568899999998765 568899999999999999999999996443211 1111100
Q ss_pred Hhh-----------cc-------ccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 408 MVT-----------NR-------NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 408 ~~~-----------~~-------~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
... .. .........+... .......+.+++.+|++.||.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhh-cCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 00 0000000000000 00112345668889999999999999998854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=291.76 Aligned_cols=258 Identities=24% Similarity=0.377 Sum_probs=197.8
Q ss_pred ccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+..|+.+++.++|+|++++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999976 48899999987653 333467788999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~ 344 (521)
+ ++|.+++.... ..+++..++.++.+++.||+|||+. +|+||||+|+||++++++.+||+|||++........
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 59999997652 4689999999999999999999998 999999999999999999999999999987643322
Q ss_pred ceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh-----------cc
Q 009979 345 YVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT-----------NR 412 (521)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-----------~~ 412 (521)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ....+..... ..
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHHHhCCCcHHHHHhhccc
Confidence 12234567889999998766 88999999999999999999999996543211 1111111100 00
Q ss_pred c-cccCCCcccCC----CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 413 N-AEGVLDPRLQE----KPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 413 ~-~~~~~d~~l~~----~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
. ..... +.... ...+.....+.+++.+||+.||++||++.+++.
T Consensus 230 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTF-PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccc-cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 00000 00000 001112345677999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=281.83 Aligned_cols=254 Identities=23% Similarity=0.359 Sum_probs=200.4
Q ss_pred cceEccCCcEEEEEEE-EcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCeeeEEEEeccCCc
Q 009979 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYIDNGN 268 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~~~g~ 268 (521)
.+.||+|+|+.|--++ ..++.+||||++.+..+.....+.+|++++.+.+ |+||++|++||+++...|||||-|.||.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 4679999999999988 5689999999999988888889999999999996 9999999999999999999999999999
Q ss_pred hHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCC---ceEeecccceecCCCC--
Q 009979 269 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKLLGAER-- 343 (521)
Q Consensus 269 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~---vkL~DFGla~~~~~~~-- 343 (521)
|.+.|++. ..+++..+..++.+|+.||.|||.+ ||.||||||+|||-....+ ||||||.+..-+....
T Consensus 163 lLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 163 LLSHIQKR----KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred HHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 99999876 6799999999999999999999999 9999999999999976554 8999998875432211
Q ss_pred ----cceeecccccccccccccc-----cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCC------CcccHH--HHHH
Q 009979 344 ----SYVTTRVMGTFGYVAPEYA-----STGMLNERSDVYSFGILIMEVISGRNPVDYSRPP------GEVNLV--EWLK 406 (521)
Q Consensus 344 ----~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~------~~~~~~--~~~~ 406 (521)
.....+.+|+..|||||+. ....|+.+.|.||||||||-||+|..||.+.-.. ++..-. +.+-
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 1123456799999999976 3356999999999999999999999999765321 122111 1111
Q ss_pred HHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 407 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.-+.++.. .+..........+.-+++...+..|+.+|.++.+++.
T Consensus 316 esIQEGkY------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 316 ESIQEGKY------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHhccCC------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11111111 1223333344444555777888899999999988875
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=297.89 Aligned_cols=258 Identities=22% Similarity=0.325 Sum_probs=193.1
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC-----
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA----- 255 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~----- 255 (521)
..++|++.+.||+|+||.||+|... ++..||||++.... ......+..|+++++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4568999999999999999999854 68899999885432 223356788999999999999999999987553
Q ss_pred -eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecc
Q 009979 256 -HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (521)
Q Consensus 256 -~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFG 334 (521)
..++||||+ +++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999998 6799988764 3688999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH-------
Q 009979 335 LAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK------- 406 (521)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~------- 406 (521)
++...... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||....... ...+..+
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~ 237 (343)
T cd07880 164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCH
Confidence 99865322 223467899999998865 458899999999999999999999997443210 0000000
Q ss_pred ---HHhhccc-------cccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 407 ---TMVTNRN-------AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 407 ---~~~~~~~-------~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
..+.... ........+. .........+.+++.+|++.||++|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 0000000000 000111224556888999999999999999884
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=287.13 Aligned_cols=258 Identities=28% Similarity=0.374 Sum_probs=199.1
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh-hhHHHHHHHHHHH-hcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAI-GRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l-~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
.++.+.+..||.|+||+|++-.++ .|+..|||++..... ...+.+..|.+.. +.-++||||+++|.+..++.++|.|
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 445566788999999999998865 688999999976544 3345677777654 4557999999999999999999999
Q ss_pred EeccCCchHHhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 262 EYIDNGNLEQWLHGD-VGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 262 e~~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|+|+- +|..+...- .-....+++...-.|...++.||.||.... +||||||||+|||+|..|.+||||||.+-.+.
T Consensus 143 ELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 99965 776654321 012467889999999999999999998764 99999999999999999999999999997663
Q ss_pred CCCcceeeccccccccccccccc--CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCC
Q 009979 341 AERSYVTTRVMGTFGYVAPEYAS--TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (521)
. +...+.-.|...|||||.+. +..|+-+|||||||++|||+.||+.||... .+.++.+...+........
T Consensus 220 ~--SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w-----~svfeql~~Vv~gdpp~l~- 291 (361)
T KOG1006|consen 220 D--SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW-----DSVFEQLCQVVIGDPPILL- 291 (361)
T ss_pred H--HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH-----HHHHHHHHHHHcCCCCeec-
Confidence 2 33345567899999999884 445899999999999999999999999633 2455655555543321111
Q ss_pred CcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 419 d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
....+......+..++.-|+.+|-..||++.++.+
T Consensus 292 ----~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 292 ----FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ----CcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 11223344455666888999999999999998863
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.18 Aligned_cols=257 Identities=22% Similarity=0.364 Sum_probs=191.1
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC------
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------ 255 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~------ 255 (521)
.++|...+.||+|+||.||+|... +++.||+|++.... ......+..|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 458999999999999999999964 68899999886532 222356788999999999999999999986542
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..++||||+.. +|..++. ..+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46899999964 7777652 3578899999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHh-----
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV----- 409 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~----- 409 (521)
++..... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ....+....
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 236 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGP 236 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence 9864322 223467889999998866 468899999999999999999999997543211 111000000
Q ss_pred ------hccccccCCC--cccCCCc----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 410 ------TNRNAEGVLD--PRLQEKP----CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 410 ------~~~~~~~~~d--~~l~~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.......... +...... .+.....+.+++.+||+.||++||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 0000000 01122345678899999999999999999853
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=293.45 Aligned_cols=245 Identities=22% Similarity=0.296 Sum_probs=199.0
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcC-CcEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCe
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAH 256 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~ 256 (521)
.+...+|.++.+||+|+||.|.+|..+. ..-||||+++++. .+..+.-+.|-++|+.. +-|.++++..+|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 4455689999999999999999998664 4568999998753 23334455688888766 57899999999999999
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
+|+||||+.||+|--.+++- +.+.+..+..++.+||-||-+||++ +||+||||.+|||+|.+|++||+|||++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence 99999999999999888765 5677888899999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
+.-- -....+.+++|||.|+|||++...+|+..+|+|||||+||||+.|+.||+..+. ..+++.+...
T Consensus 498 KEni-~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE---~elF~aI~eh-------- 565 (683)
T KOG0696|consen 498 KENI-FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQAIMEH-------- 565 (683)
T ss_pred cccc-cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHc--------
Confidence 8532 223345678999999999999999999999999999999999999999986543 2333322211
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCC
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK 451 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt 451 (521)
.........+++..++...+.+.|.+|.-
T Consensus 566 ------nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 566 ------NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ------cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 11123344566777888999999999964
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=295.89 Aligned_cols=261 Identities=23% Similarity=0.298 Sum_probs=189.7
Q ss_pred CccccceEccCCcEEEEEEEEc-C--CcEEEEEEeccC--ChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeC----Ce
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-D--NTNVAVKNLLNN--RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEG----AH 256 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~----~~ 256 (521)
+|++.+.||+|+||.||++... . +..||+|++... .....+.+..|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999965 3 678999988643 222345677899999999 599999999875432 45
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.++++||+. ++|.+++... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 688999985 5999988654 5689999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCcc---eeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccH---------HH
Q 009979 337 KLLGAERSY---VTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNL---------VE 403 (521)
Q Consensus 337 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~---------~~ 403 (521)
+.+...... ......||..|+|||++.+ ..++.++|||||||++|+|++|..||........... .+
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 875432211 1233578999999998755 5689999999999999999999999975432100000 00
Q ss_pred HHHHHhhcc------ccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 009979 404 WLKTMVTNR------NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVI 456 (521)
Q Consensus 404 ~~~~~~~~~------~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl 456 (521)
.+....... .....-...+.. ..+.....+.+++.+||+.||++|||+.+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000000000 000000000000 0011123455688899999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.71 Aligned_cols=146 Identities=28% Similarity=0.411 Sum_probs=131.5
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
.++|.+.+.||+|+||.||+|.+. ++..||||++.... ......+..|+.+++.++||||+++++++......|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 357899999999999999999976 58899999986532 22346788899999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
|||+.+++|.++++.. ..+++..++.|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999764 4688899999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=278.24 Aligned_cols=252 Identities=21% Similarity=0.272 Sum_probs=196.2
Q ss_pred CCccc-cceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEee----CCeee
Q 009979 186 NGFAD-ENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE----GAHRM 258 (521)
Q Consensus 186 ~~~~~-~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~----~~~~~ 258 (521)
++|.+ .++||-|-.|.|..+..+ +++++|+|++... ...++|+++--.. .|||||.++++|.+ ...+.
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 44543 368999999999999865 6888999988643 2344577765444 59999999999864 34567
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---CCCceEeeccc
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFGL 335 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~---~~~vkL~DFGl 335 (521)
+|||.|+||.|++.+.+.. ...+++..+..|+.||+.|+.|||+. +|.||||||+|+|... +..+||+|||+
T Consensus 136 iVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence 9999999999999998773 46799999999999999999999999 9999999999999953 45689999999
Q ss_pred ceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
|+.... .....+.+-||+|+|||++....|+...|+||+||++|-||+|.+||...... .+.--+++.+..+..
T Consensus 211 AK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~gqy- 284 (400)
T KOG0604|consen 211 AKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTGQY- 284 (400)
T ss_pred ccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhccCc-
Confidence 997432 33445668899999999999999999999999999999999999999644321 111112222222211
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+.....+...+...++|..+|..+|.+|.|+.+++.+
T Consensus 285 -----~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 -----EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -----cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 23333345556666678999999999999999998743
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.17 Aligned_cols=257 Identities=23% Similarity=0.329 Sum_probs=194.4
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe-----
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH----- 256 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~----- 256 (521)
.++|++.+.||+|+||.||+|... ++..||+|++.... ......+..|+.+++.++||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 568999999999999999999975 57889999886432 2233567789999999999999999988765554
Q ss_pred -eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 257 -RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 257 -~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
.++|+||+ +++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 6699998864 3689999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh----
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT---- 410 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---- 410 (521)
+...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ...+.....
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~---~~~i~~~~~~~~~ 237 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ---LKRIMNLVGTPDE 237 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHhcCCCCH
Confidence 9865332 233467899999998865 4688999999999999999999999964432111 111111000
Q ss_pred -------cccc-------ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 411 -------NRNA-------EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 411 -------~~~~-------~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.... .....+.+.. ........+.+++.+||+.||++|||+.+|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000 0000000000 001123456678899999999999999999743
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=282.80 Aligned_cols=236 Identities=27% Similarity=0.322 Sum_probs=191.4
Q ss_pred EccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCCch
Q 009979 194 IGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNL 269 (521)
Q Consensus 194 LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L 269 (521)
||+|+||.||++... +++.+|+|.+..... .....+..|+++++.++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 488999998865432 2456788899999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcceeec
Q 009979 270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR 349 (521)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 349 (521)
.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 9999765 3689999999999999999999998 99999999999999999999999999998764332 22344
Q ss_pred ccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHH
Q 009979 350 VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429 (521)
Q Consensus 350 ~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 429 (521)
..|+..|+|||...+...+.++|+||||+++|+|++|..||..... .+........ ...+... .
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~-------~~~~~~~-~-- 216 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILKD-------PLRFPEF-L-- 216 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcC-------CCCCCCC-C--
Confidence 5688999999999888899999999999999999999999964432 1112222210 0011111 1
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHH
Q 009979 430 ALKRALLVALRCVDPNAHKRPKMGH 454 (521)
Q Consensus 430 ~~~~~~~li~~cl~~dP~~RPt~~e 454 (521)
...+.+++.+||..||++||++.+
T Consensus 217 -~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 -SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -CHHHHHHHHHHhcCCHhhCCCccc
Confidence 234455888999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=300.66 Aligned_cols=219 Identities=23% Similarity=0.342 Sum_probs=185.6
Q ss_pred CcccchhhhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEE
Q 009979 173 GHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLL 248 (521)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~ 248 (521)
.+|..++.-.....-|..++.||-|+||+|.++... +...||+|.+.+.+ ......++.|-.||..-..+-||+|+
T Consensus 616 SnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy 695 (1034)
T KOG0608|consen 616 SNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY 695 (1034)
T ss_pred hhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence 344555555666777999999999999999999844 46668999986643 23345678899999999999999999
Q ss_pred EEEeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCc
Q 009979 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328 (521)
Q Consensus 249 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~v 328 (521)
-.|++.+.+|+||+|++||++-.+|-+. +-+.+..++.++.++..|+++.|.. |+|||||||+|||||.+|++
T Consensus 696 ySFQDkdnLYFVMdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHI 768 (1034)
T KOG0608|consen 696 YSFQDKDNLYFVMDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHI 768 (1034)
T ss_pred EEeccCCceEEEEeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCce
Confidence 9999999999999999999999998765 6789999999999999999999998 99999999999999999999
Q ss_pred eEeecccceec---------CCCC--------------------------------cceeecccccccccccccccCCCC
Q 009979 329 KLSDFGLAKLL---------GAER--------------------------------SYVTTRVMGTFGYVAPEYASTGML 367 (521)
Q Consensus 329 kL~DFGla~~~---------~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~ 367 (521)
||+||||+.-+ .... .......+||+.|+|||++....|
T Consensus 769 KLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~ 848 (1034)
T KOG0608|consen 769 KLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY 848 (1034)
T ss_pred eeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc
Confidence 99999998432 1000 001123679999999999999999
Q ss_pred CCcccchhHHHHHHHHHhCCCCCCCCCCCCc
Q 009979 368 NERSDVYSFGILIMEVISGRNPVDYSRPPGE 398 (521)
Q Consensus 368 ~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~ 398 (521)
+..+|+||.|||||||+.|+.||....+.+-
T Consensus 849 ~q~cdwws~gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 849 TQLCDWWSVGVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred cccchhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence 9999999999999999999999988776543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=295.30 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=204.7
Q ss_pred cceEccCCcEEEEEEEE-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCC
Q 009979 191 ENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 267 (521)
.++||.|.||+||-|++ ++|+.||||++.+-+ ...+..+++|+.+|+++.||.||.|.-.|+..+..+.|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 57899999999999995 479999999996543 33457899999999999999999999999999999999999955
Q ss_pred chHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC---CCceEeecccceecCCCCc
Q 009979 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ---WNPKLSDFGLAKLLGAERS 344 (521)
Q Consensus 268 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~---~~vkL~DFGla~~~~~~~~ 344 (521)
++.+.+-.. ..+.+++.....++.||+.||.|||.+ +|+|+||||+|||+... -++||||||+|+.++..
T Consensus 648 DMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-- 720 (888)
T KOG4236|consen 648 DMLEMILSS--EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-- 720 (888)
T ss_pred hHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence 665555433 257899999999999999999999999 99999999999999644 46999999999998543
Q ss_pred ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCC
Q 009979 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (521)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 424 (521)
.....++|||.|+|||++.++.|+..-|+||.||++|--++|..||... .+..+.++... + .+..
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd-----EdIndQIQNAa-------F---MyPp 785 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED-----EDINDQIQNAA-------F---MYPP 785 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc-----cchhHHhhccc-------c---ccCC
Confidence 3345689999999999999999999999999999999999999999522 22223222211 1 2345
Q ss_pred CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 425 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
.+..+....+++||...|+..-++|-+...-+.+..-.+
T Consensus 786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence 567777778888999999999999999888775544333
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=301.05 Aligned_cols=260 Identities=27% Similarity=0.402 Sum_probs=209.4
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEee--
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE-- 253 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~-- 253 (521)
+..+...++.|++.++||.|.+|.||+++. ++++..|+|++... .+..+++..|.++|+.. .|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 444555678899999999999999999994 46888899977544 33456788899999888 59999999999853
Q ss_pred ---CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceE
Q 009979 254 ---GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKL 330 (521)
Q Consensus 254 ---~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL 330 (521)
++.++||||||.+|+.-++++... ...+.|..+..|++.++.||.+||.+ .++|||||-.|||+++++.|||
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence 467899999999999999998875 67899999999999999999999998 9999999999999999999999
Q ss_pred eecccceecCCCCcceeecccccccccccccccC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 009979 331 SDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL 405 (521)
Q Consensus 331 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~ 405 (521)
+|||++..+..... ...+..|||.|||||++.. ..|+..+|+||||++..||--|.+|+.+..|-
T Consensus 165 vDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------- 234 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------- 234 (953)
T ss_pred eeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---------
Confidence 99999988754333 3445789999999999853 34778999999999999999999999866542
Q ss_pred HHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 406 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
+.+.. +..--.|++. ....-.+++.++|..||.+|..+||++.+++++
T Consensus 235 raLF~---IpRNPPPkLk--rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 235 RALFL---IPRNPPPKLK--RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhhcc---CCCCCCcccc--chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11110 0011112222 133445667779999999999999999998754
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=258.89 Aligned_cols=226 Identities=26% Similarity=0.364 Sum_probs=185.0
Q ss_pred cchhhhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEe
Q 009979 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCA 252 (521)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~ 252 (521)
...+.+++..+.......||+|+||.|=+-++. +|+-.|+|.+...- .+..+.+..|+.+..+. .+|.+|.|+|...
T Consensus 36 I~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 36 IGDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred EecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 334456777788888899999999999877754 68889999996542 33446677788876554 7999999999998
Q ss_pred eCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEee
Q 009979 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (521)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~D 332 (521)
.....+|.||.|+. +|..+.++-......+++...-+|+..++.||.|||++. .+||||+||+||||+.+|+||+||
T Consensus 116 regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCD 192 (282)
T KOG0984|consen 116 REGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICD 192 (282)
T ss_pred ccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcc
Confidence 88999999999975 998888776666789999999999999999999999975 899999999999999999999999
Q ss_pred cccceecCCCCcceeeccccccccccccccc----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH
Q 009979 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYAS----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408 (521)
Q Consensus 333 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 408 (521)
||.+-++.++- ..+-..|.-.|||||.+. ...|+-+|||||||+++.||.+++.||+... ..++.++..
T Consensus 193 FGIsG~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~-----tpF~qLkqv 265 (282)
T KOG0984|consen 193 FGISGYLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG-----TPFQQLKQV 265 (282)
T ss_pred cccceeehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC-----CHHHHHHHH
Confidence 99998874332 223346888999999874 3479999999999999999999999997543 345556655
Q ss_pred hhc
Q 009979 409 VTN 411 (521)
Q Consensus 409 ~~~ 411 (521)
+..
T Consensus 266 Vee 268 (282)
T KOG0984|consen 266 VEE 268 (282)
T ss_pred hcC
Confidence 543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=281.67 Aligned_cols=270 Identities=19% Similarity=0.264 Sum_probs=206.6
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCC--C----CeeeEEEE
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH--K----NLVRLLGY 250 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--p----niv~l~~~ 250 (521)
+...+...++|.+...+|+|.||.|-.+.+. .+..||+|+++.-. ...+.-+.|+++|.++.+ | -+|.+.+|
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 4455566889999999999999999999965 46789999876533 233455669999999942 2 37888899
Q ss_pred EeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC------
Q 009979 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK------ 324 (521)
Q Consensus 251 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~------ 324 (521)
|.-.++.|||+|.+ |-+++++|..+ ...+++...+..|+.|++++++|||+. +++|.||||+|||+..
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEE
Confidence 99999999999998 66999999886 457889999999999999999999999 9999999999999921
Q ss_pred --------------CCCceEeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCC
Q 009979 325 --------------QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPV 390 (521)
Q Consensus 325 --------------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf 390 (521)
+..+||+|||.|+.-.... ..++.|..|.|||++.+-.++.++||||+||||+||.||..-|
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 3458999999999754333 4466799999999999999999999999999999999999999
Q ss_pred CCCCCCCcccHHHHHHH-----Hhhcc---------cc-----------ccCCCccc----CCCccHHHHHHHHHHHHhc
Q 009979 391 DYSRPPGEVNLVEWLKT-----MVTNR---------NA-----------EGVLDPRL----QEKPCSRALKRALLVALRC 441 (521)
Q Consensus 391 ~~~~~~~~~~~~~~~~~-----~~~~~---------~~-----------~~~~d~~l----~~~~~~~~~~~~~~li~~c 441 (521)
...+..++..+.+.+-. |+... .+ ..+.++.. .......+-.++++|+.++
T Consensus 310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 87764433333322110 11000 00 00111100 0111234556788999999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 009979 442 VDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 442 l~~dP~~RPt~~evl~~ 458 (521)
|..||.+|+|+.|++.+
T Consensus 390 L~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 390 LEFDPARRITLREALSH 406 (415)
T ss_pred HccCccccccHHHHhcC
Confidence 99999999999999743
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=253.19 Aligned_cols=262 Identities=23% Similarity=0.334 Sum_probs=194.8
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
.|...++||+|.||+||+|+.. ++.-||+|.+.-+.. .......+|+-+++.++|.|||+++++...+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4666789999999999999954 577899999864332 2235567799999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
|+. +|..+.... ++.++.+....++.|+++||.++|++ +++|||+||.|.||+.+|.+||+|||+++.++...
T Consensus 83 cdq-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 965 999988765 57889999999999999999999999 99999999999999999999999999999886654
Q ss_pred cceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHH--hhccccc---c
Q 009979 344 SYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTM--VTNRNAE---G 416 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~---~ 416 (521)
.+.. ..+-|.+|.+|.++.+. .|+...|+||.||++.|+.. |++-|.+.+- ...+..+++.. ..+.... .
T Consensus 156 rcys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv--ddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 156 RCYS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred Eeee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH--HHHHHHHHHHhCCCccccCCcccc
Confidence 4433 34569999999988764 58999999999999999988 5555643321 11222222211 1111111 1
Q ss_pred CCCcccCCC-c----cHH----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 417 VLDPRLQEK-P----CSR----ALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 417 ~~d~~l~~~-~----~~~----~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
+-|-..-+. + ..+ .-..=.+++.+.+.-+|.+|.++++.+++
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111111110 0 011 11122346667778899999999887753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=296.67 Aligned_cols=241 Identities=24% Similarity=0.305 Sum_probs=191.4
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeEEE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~ 261 (521)
.++.|.+...+|.|+|+.|-.+... +++..++|++.+... +...|+.++... +||||+++.+++.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3567888889999999999999854 678899999876522 233467555555 7999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe-CCCCCceEeecccceecC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL-DKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl-~~~~~vkL~DFGla~~~~ 340 (521)
|++.|+-|.+.+.... ... ..+..|+.+++.|+.|||++ ||+||||||+|||+ +..++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~~----~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP----EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhcc----hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 9999998888776552 222 67778999999999999998 99999999999999 699999999999999775
Q ss_pred CCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
.. ...-+-|..|.|||++....|++++||||||++||+||+|+.||...... .+... .+.. +
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei~~-~i~~--------~ 529 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEIHT-RIQM--------P 529 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HHHHH-hhcC--------C
Confidence 44 22235588999999999999999999999999999999999999755433 22222 2211 1
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+. ...+...++ |+..||+.||.+||+|.++..+
T Consensus 530 ~~s-~~vS~~AKd---Ll~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 530 KFS-ECVSDEAKD---LLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ccc-cccCHHHHH---HHHHhccCChhhCcChhhhccC
Confidence 122 123344444 7779999999999999999743
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=272.58 Aligned_cols=204 Identities=23% Similarity=0.356 Sum_probs=168.5
Q ss_pred CCccccceEccCCcEEEEEEEEc-C----CcEEEEEEeccCChh--hHHHHHHHHHHHhcCCCCCeeeEEEEEee-CCee
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-D----NTNVAVKNLLNNRGQ--AEKEFKVEVEAIGRVRHKNLVRLLGYCAE-GAHR 257 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~----~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-~~~~ 257 (521)
..|+....||+|.||.||+|.-. + +..+|+|+++..+.. .....-+|+.+++.++|||++.|..++.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 36888999999999999999632 2 236899998765322 12344569999999999999999999877 7789
Q ss_pred eEEEEeccCCchHHhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC----CCceEee
Q 009979 258 MLVYEYIDNGNLEQWLHGDVG-PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ----WNPKLSD 332 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~----~~vkL~D 332 (521)
+|++||.+. +|...++-.+. ....++...+..|+.||+.|+.|||++ -|+||||||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999987 99998864332 235788999999999999999999999 89999999999999766 8999999
Q ss_pred cccceecCCCCcc--eeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Q 009979 333 FGLAKLLGAERSY--VTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYS 393 (521)
Q Consensus 333 FGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~ 393 (521)
||+++.+...-.. ....++-|.+|.|||++.+. .|+.+.|||+.||++.||+|-.+-|...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9999988543222 23456789999999988764 6999999999999999999988877654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=275.91 Aligned_cols=219 Identities=21% Similarity=0.179 Sum_probs=174.6
Q ss_pred CCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCCchHHhhhc
Q 009979 197 GGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG 275 (521)
Q Consensus 197 G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~ 275 (521)
|.||.||++.+. +++.||+|.+.... .+..|...+....||||+++++++.+....++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999965 68889999986542 233455556666799999999999999999999999999999999876
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcceeeccccccc
Q 009979 276 DVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355 (521)
Q Consensus 276 ~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~ 355 (521)
. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+...... .....++..
T Consensus 79 ~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~ 147 (237)
T cd05576 79 F----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM 147 (237)
T ss_pred h----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence 4 3589999999999999999999998 9999999999999999999999999988755332 223356778
Q ss_pred ccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHH
Q 009979 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRAL 435 (521)
Q Consensus 356 y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 435 (521)
|+|||.+.+..++.++||||+|+++|||++|+.||........ ......+.. ..+ ..+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----------------~~~~~~~~~-~~~---~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----------------THTTLNIPE-WVS---EEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----------------cccccCCcc-cCC---HHHH
Confidence 9999999888899999999999999999999988753211100 000001111 122 2344
Q ss_pred HHHHhccCCCCCCCCCH
Q 009979 436 LVALRCVDPNAHKRPKM 452 (521)
Q Consensus 436 ~li~~cl~~dP~~RPt~ 452 (521)
+++.+||+.||++||++
T Consensus 207 ~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 207 SLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHccCCHHHhcCC
Confidence 58889999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=293.35 Aligned_cols=260 Identities=23% Similarity=0.272 Sum_probs=212.0
Q ss_pred CCCccccceEccCCcEEEEEEEEcCCc-EEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLEDNT-NVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
..+++....||-||||.|=++..++.. .+|+|.+++. .....+.+..|-++|...+.|.||++|..|.+....||+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 345667788999999999999876433 3788887654 334446677899999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
||-|-||.|...|++. +.+...++..++..+++|++|||++ +||+|||||+|+++|.+|-+||.|||+|+.++
T Consensus 499 mEaClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 499 MEACLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HHhhcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 9999999999999876 6788889999999999999999999 99999999999999999999999999999875
Q ss_pred CCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
.. ..+.++||||.|+|||++.++..+.++|.|+||+++|||++|.+||...++-.-.+++-.--.++.
T Consensus 572 ~g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~---------- 639 (732)
T KOG0614|consen 572 SG--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE---------- 639 (732)
T ss_pred cC--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh----------
Confidence 43 345678999999999999999999999999999999999999999986665332222211011110
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhhccCCCchh
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPK-----MGHVIHMLEAEEFPFRD 468 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~L~~~~~~~~~ 468 (521)
.+....+.+.+++++.+..+|.+|.- +.+|-++-.-..+.|..
T Consensus 640 -----~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweg 687 (732)
T KOG0614|consen 640 -----FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEG 687 (732)
T ss_pred -----cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhh
Confidence 01233445666888999999999986 67887777766666644
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=279.92 Aligned_cols=256 Identities=23% Similarity=0.386 Sum_probs=193.4
Q ss_pred CCCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCChh-------hHHHHHHHHHHHhcCCCCCeeeEEEEEe-eCC
Q 009979 185 TNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQ-------AEKEFKVEVEAIGRVRHKNLVRLLGYCA-EGA 255 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~Ei~~l~~l~hpniv~l~~~~~-~~~ 255 (521)
.++|-.++.||+|||++||+|.+ ...+.||||+-.-++.. ..+...+|..+-+.|.||.||+++++|. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 45788899999999999999984 34667888875433221 1234557999999999999999999986 445
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC---CCCCceEee
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD---KQWNPKLSD 332 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~---~~~~vkL~D 332 (521)
.+|-|+|||+|.+|.-||+.. ..++++.+..|+.||+.||.||.+. +++|||-||||.|||+- ..|.+||+|
T Consensus 542 sFCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 678899999999999999875 6789999999999999999999985 88999999999999994 467899999
Q ss_pred cccceecCCCCcc------eeecccccccccccccccC----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHH
Q 009979 333 FGLAKLLGAERSY------VTTRVMGTFGYVAPEYAST----GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLV 402 (521)
Q Consensus 333 FGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~ 402 (521)
||+++.+.++... .+....||.+|++||.+.- ...+.|+||||.||++|..+.|+.||...... .
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-----Q 691 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-----Q 691 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-----H
Confidence 9999998654433 2334679999999997743 34788999999999999999999999744321 1
Q ss_pred HHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 009979 403 EWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVI 456 (521)
Q Consensus 403 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl 456 (521)
+++. ...+....+-.+..+ +....++..+|.+||+.--++|....++.
T Consensus 692 dILq----eNTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 692 DILQ----ENTILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred HHHh----hhchhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1111 111111111122222 22222333488899999999998877654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=302.82 Aligned_cols=262 Identities=19% Similarity=0.251 Sum_probs=171.2
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc-C----CcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEE------E
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE-D----NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY------C 251 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~------~ 251 (521)
...++|.+.+.||+|+||.||+|++. + +..||+|++...... +....| .++...+.++..++.. +
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 36789999999999999999999975 3 578999987543211 111111 1222222222222211 2
Q ss_pred eeCCeeeEEEEeccCCchHHhhhcCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 009979 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGP----------------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDI 315 (521)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDi 315 (521)
..+...++||||+.+++|.+++...... ........+..++.|++.||+|||+. +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 4556789999999999999998754210 01112344667999999999999998 9999999
Q ss_pred CCCCeEeCC-CCCceEeecccceecCCCCcceeecccccccccccccccCC----------------------CCCCccc
Q 009979 316 KSSNILLDK-QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG----------------------MLNERSD 372 (521)
Q Consensus 316 k~~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD 372 (521)
||+|||+++ ++.+||+|||+++.+............||+.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999985 67899999999987654444445567899999999965321 2445679
Q ss_pred chhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccc----cccCCCcccCCC----c--cHHHHHHHHHHHHhcc
Q 009979 373 VYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN----AEGVLDPRLQEK----P--CSRALKRALLVALRCV 442 (521)
Q Consensus 373 vwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~----~~~~~d~~l~~~----~--~~~~~~~~~~li~~cl 442 (521)
||||||+||||+++..|++.. .....+....... ....+.+..... . .........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 999999999999987765321 1111111100000 000011110000 0 0000112335888999
Q ss_pred CCCCCCCCCHHHHHHH
Q 009979 443 DPNAHKRPKMGHVIHM 458 (521)
Q Consensus 443 ~~dP~~RPt~~evl~~ 458 (521)
+.||++|||+.+++++
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999864
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=264.49 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=199.5
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCe
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAH 256 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~ 256 (521)
.+..++|.+.++||+|+|..|.+++++ +.+-||+|++++. ..+..+.+..|-.+..+- +||.+|.+..+|+.+..
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 345678999999999999999999965 4667899988653 444556677788777766 69999999999999999
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
+++|.||++||+|--.+++. ..++++.+..+..+|..||.|||+. |||+||||.+|+|+|..|++||+|+|++
T Consensus 326 lffvieyv~ggdlmfhmqrq----rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmc 398 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMC 398 (593)
T ss_pred EEEEEEEecCcceeeehhhh----hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchh
Confidence 99999999999998777654 5799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCC-CcccHHHHHHHHhhccccc
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP-GEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 415 (521)
+.-- .....+.+++|||.|+|||++.+..|+...|+|++||+|+||+.|+.||+.-... .+.|..+++-..+.+..+
T Consensus 399 ke~l-~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi- 476 (593)
T KOG0695|consen 399 KEGL-GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI- 476 (593)
T ss_pred hcCC-CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-
Confidence 8632 3344566789999999999999999999999999999999999999999853222 122333444333332211
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCC
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP 450 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RP 450 (521)
++.. ....++..+++.-|++||.+|.
T Consensus 477 -----ripr----slsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 -----RIPR----SLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -----cccc----eeehhhHHHHHHhhcCCcHHhc
Confidence 1111 1122333466678889999985
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=291.14 Aligned_cols=263 Identities=22% Similarity=0.357 Sum_probs=180.8
Q ss_pred hcCCCccccceEccCCcEEEEEEEE-----------------cCCcEEEEEEeccCChhhHHH--------------HHH
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVL-----------------EDNTNVAVKNLLNNRGQAEKE--------------FKV 231 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~ 231 (521)
...++|.+.++||+|+||+||+|.+ ..++.||||++........++ ...
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4678999999999999999999964 234679999986543322222 334
Q ss_pred HHHHHhcCCCCCe-----eeEEEEEee--------CCeeeEEEEeccCCchHHhhhcCCC--------------------
Q 009979 232 EVEAIGRVRHKNL-----VRLLGYCAE--------GAHRMLVYEYIDNGNLEQWLHGDVG-------------------- 278 (521)
Q Consensus 232 Ei~~l~~l~hpni-----v~l~~~~~~--------~~~~~lV~e~~~~g~L~~~l~~~~~-------------------- 278 (521)
|+.++.+++|.++ ++++++|.. ....+|||||+++++|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777776654 677777753 3467999999999999999975321
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcceeecccccccccc
Q 009979 279 PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358 (521)
Q Consensus 279 ~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~a 358 (521)
....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...............+|+.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 112356778899999999999999998 99999999999999999999999999997654332222223345899999
Q ss_pred cccccCCC--------------------C--CCcccchhHHHHHHHHHhCCC-CCCCCCCCC------cccHHHHHHHHh
Q 009979 359 PEYASTGM--------------------L--NERSDVYSFGILIMEVISGRN-PVDYSRPPG------EVNLVEWLKTMV 409 (521)
Q Consensus 359 PE~~~~~~--------------------~--~~~sDvwS~Gvvl~elltG~~-Pf~~~~~~~------~~~~~~~~~~~~ 409 (521)
||.+.... + ..+.||||+||++|+|++|.. ||....... ...+..| +..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~--r~~ 456 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW--RMY 456 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH--Hhh
Confidence 99875322 1 234799999999999999875 765321110 0011111 111
Q ss_pred hccccccCCCcccCCCccHHHHHHHHHHHHhccCCCC---CCCCCHHHHHHH
Q 009979 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNA---HKRPKMGHVIHM 458 (521)
Q Consensus 410 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP---~~RPt~~evl~~ 458 (521)
.... .+-.. ...... ...+++.+++..+| .+|+|+.|++++
T Consensus 457 ~~~~----~~~~~-~d~~s~---~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 KGQK----YDFSL-LDRNKE---AGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cccC----CCccc-ccccCh---HHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 1110 11110 011233 33447778888755 789999999854
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=262.11 Aligned_cols=238 Identities=26% Similarity=0.393 Sum_probs=192.0
Q ss_pred CcEEEEEEEEc-CCcEEEEEEeccCChhh-HHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCCchHHhhhc
Q 009979 198 GYGIVYHGVLE-DNTNVAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG 275 (521)
Q Consensus 198 ~fG~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~ 275 (521)
+||.||+|.+. ++..+|+|.+....... .+.+..|++.++.++|+|++++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48899999987655444 67899999999999999999999999998999999999999999999876
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcceeeccccccc
Q 009979 276 DVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355 (521)
Q Consensus 276 ~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~ 355 (521)
. ..+++..++.++.+++.++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 5 2388999999999999999999998 99999999999999999999999999998765432 3344568899
Q ss_pred ccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHH
Q 009979 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRAL 435 (521)
Q Consensus 356 y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 435 (521)
|++||.+.+..++.++||||||+++++|++|..||.... ........ ..... .... .........+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-----~~~~~~~~-~~~~~----~~~~---~~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-----QLLELFKK-IGKPK----PPFP---PPEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----cHHHHHHH-HhccC----CCCc---cccccCCHHHH
Confidence 999999988889999999999999999999999996431 11111111 11110 0000 00000223455
Q ss_pred HHHHhccCCCCCCCCCHHHHHH
Q 009979 436 LVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 436 ~li~~cl~~dP~~RPt~~evl~ 457 (521)
+++.+||..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 6888999999999999999985
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=266.28 Aligned_cols=267 Identities=22% Similarity=0.357 Sum_probs=194.3
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEee--------C
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--------G 254 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--------~ 254 (521)
..|+...+||+|.||+||+|+.+ .++.||+|++... +..-...-.+|+++|..++|+|++.++++|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 46777889999999999999965 5777898876432 22222445669999999999999999988753 2
Q ss_pred CeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecc
Q 009979 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (521)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFG 334 (521)
..+|+||++|+. +|..+|... ...++...+.++..++..||.|+|.. .|+|||+|+.|+||+.+|.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 347999999987 999988654 46788899999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCcc---eeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh
Q 009979 335 LAKLLGAERSY---VTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410 (521)
Q Consensus 335 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (521)
+++.+...... ..+..+-|.+|.+||.+.+ ..|+++.|||..||++.||.||.+-+..........++..+-.-..
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 99876432221 1234556999999998765 5799999999999999999999988875543222222211110000
Q ss_pred cccccc--------CC--Cccc--CCCccHHHHH------HHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 411 NRNAEG--------VL--DPRL--QEKPCSRALK------RALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 411 ~~~~~~--------~~--d~~l--~~~~~~~~~~------~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
..-+.. .+ +|.. +.......++ ..++|+..++..||.+|+++.+++.+-
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 000000 00 0000 0000111222 566788899999999999999987543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=290.66 Aligned_cols=247 Identities=27% Similarity=0.398 Sum_probs=188.6
Q ss_pred CccccceEccCCcE-EEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 187 GFADENVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 187 ~~~~~~~LG~G~fG-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
-|...+++|.|..| .||+|.+. ++.||||++... ..+...+|+..|+.- .|||||++++.-.+.+..||..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 45667789999998 68999995 889999998643 233456799999988 5999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---C--CCceEeecccceec
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---Q--WNPKLSDFGLAKLL 339 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~---~--~~vkL~DFGla~~~ 339 (521)
.- +|.+++...............+.++.|++.||++||+. +||||||||.||||+. + ..++|+|||+++.+
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 65 99999987411112222245677888999999999998 9999999999999965 2 46899999999998
Q ss_pred CCCCccee--ecccccccccccccccCCCCCCcccchhHHHHHHHHHhC-CCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 340 GAERSYVT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG-RNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 340 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
........ ....||.+|+|||.+....-+.++||||||||+|+.++| ..||.+.-.. +.| .+....
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~N-------Il~~~~--- 730 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QAN-------ILTGNY--- 730 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhh-------hhcCcc---
Confidence 76554433 346799999999999988888899999999999999995 9999754211 001 011100
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
-+. .+...... .+.+||.+|++++|..||++.+|+.
T Consensus 731 ~L~-~L~~~~d~----eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 731 TLV-HLEPLPDC----EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred cee-eeccCchH----HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 000 11111111 5566899999999999999999973
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=260.20 Aligned_cols=277 Identities=21% Similarity=0.263 Sum_probs=202.2
Q ss_pred CCcccchhhhhhcC-CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCC-----C---
Q 009979 172 WGHWYTLRELEVST-NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-----H--- 241 (521)
Q Consensus 172 ~~~~~~~~~~~~~~-~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----h--- 241 (521)
.|.|..++-.++.. .+|.+.++||.|.|++||+|++. +.+.||+|+.+.. ....+.-..||++|++++ |
T Consensus 63 kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~ 141 (590)
T KOG1290|consen 63 KGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGK 141 (590)
T ss_pred cCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 34555566666665 89999999999999999999965 4667888877543 334455667999999884 3
Q ss_pred CCeeeEEEEEe----eCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 009979 242 KNLVRLLGYCA----EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKS 317 (521)
Q Consensus 242 pniv~l~~~~~----~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~ 317 (521)
.+||+|++.|. ++.++|||+|++ |-+|..+|... ...-++...+.+|+.|++.||.|||..| +|||.||||
T Consensus 142 ~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKP 216 (590)
T KOG1290|consen 142 KCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKP 216 (590)
T ss_pred ceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCc
Confidence 46999999986 456899999998 66999999876 3567888999999999999999999987 999999999
Q ss_pred CCeEeCCC------------------------------------------------------------------------
Q 009979 318 SNILLDKQ------------------------------------------------------------------------ 325 (521)
Q Consensus 318 ~NILl~~~------------------------------------------------------------------------ 325 (521)
+|||+..+
T Consensus 217 ENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~ 296 (590)
T KOG1290|consen 217 ENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEE 296 (590)
T ss_pred ceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 99999211
Q ss_pred --------------------------------------------------------------------------------
Q 009979 326 -------------------------------------------------------------------------------- 325 (521)
Q Consensus 326 -------------------------------------------------------------------------------- 325 (521)
T Consensus 297 ~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~ 376 (590)
T KOG1290|consen 297 EPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIAS 376 (590)
T ss_pred cccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccc
Confidence
Q ss_pred --------------CCceEeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 009979 326 --------------WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391 (521)
Q Consensus 326 --------------~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~ 391 (521)
-.+||+|||-|+..... .+.-.-|..|.|||++.+..|+..+|||||+|++|||.||-.-|+
T Consensus 377 n~~v~p~~~~~~~di~vKIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFe 452 (590)
T KOG1290|consen 377 NPLVNPDIPLPECDIRVKIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFE 452 (590)
T ss_pred ccccCCCCCCCccceeEEEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeec
Confidence 01455666665543211 122234778999999999999999999999999999999999998
Q ss_pred CCCCCC----cccHH---HHHHHHh-----hccccccCCCc--------ccCCC-----------ccHHHHHHHHHHHHh
Q 009979 392 YSRPPG----EVNLV---EWLKTMV-----TNRNAEGVLDP--------RLQEK-----------PCSRALKRALLVALR 440 (521)
Q Consensus 392 ~~~~~~----~~~~~---~~~~~~~-----~~~~~~~~~d~--------~l~~~-----------~~~~~~~~~~~li~~ 440 (521)
.....+ +..+. +.+..+. ......++++. +++.. ...+..+++.+++.-
T Consensus 453 PhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~P 532 (590)
T KOG1290|consen 453 PHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSP 532 (590)
T ss_pred CCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHH
Confidence 654322 11111 1111111 01111112211 12221 234566778889999
Q ss_pred ccCCCCCCCCCHHHHHHH
Q 009979 441 CVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 441 cl~~dP~~RPt~~evl~~ 458 (521)
||+.+|++|||+.+.+++
T Consensus 533 mLef~PeKR~tA~~cl~h 550 (590)
T KOG1290|consen 533 MLEFDPEKRPTAAQCLKH 550 (590)
T ss_pred HHhcCccccccHHHHhcC
Confidence 999999999999999854
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-33 Score=260.32 Aligned_cols=270 Identities=21% Similarity=0.291 Sum_probs=203.5
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC-----Ceee
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHRM 258 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----~~~~ 258 (521)
+.+..+-||.|+||.||.+.+. +|+.||.|++.+- .....+.+-+|+++|..++|.|++..+++.+-. .++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3455778999999999999854 7999999998653 333446778899999999999999998876543 2457
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+|.|+|.. +|...+-.. ..++.+.+.-+++||++||+|||+. +|+||||||.|.|++.+..+||||||+++.
T Consensus 134 V~TELmQS-DLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSP----QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHh-hhhheeccC----CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence 88898854 887777543 6788888889999999999999998 999999999999999999999999999998
Q ss_pred cCCCCcceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH--------HHh
Q 009979 339 LGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK--------TMV 409 (521)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~--------~~~ 409 (521)
........++..+-|-+|.|||++.+. .|+.+.||||.||++.||+..+.-|....+.....++..+. +..
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 877766677777789999999998775 59999999999999999999999998766544333332111 111
Q ss_pred hccccccC-----CCcccCCC----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 009979 410 TNRNAEGV-----LDPRLQEK----PCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 464 (521)
Q Consensus 410 ~~~~~~~~-----~d~~l~~~----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 464 (521)
.++...-+ ..|.+..- .....-.+.+.+...++..||.+|.+..+.+..+.-.+-
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 11111111 11221110 011223345557778899999999999988876654443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=240.24 Aligned_cols=254 Identities=22% Similarity=0.378 Sum_probs=195.4
Q ss_pred CCCccccceEccCCcEEEEEEE-EcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCC--eeeEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGA--HRMLV 260 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~--~~~lV 260 (521)
.++|++.+++|+|.|++||.|. ..++.+++||.++.- ..+.+.+|+++|..|. ||||++++++..+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4689999999999999999998 446888999998653 3467889999999997 999999999987654 45799
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-CCCceEeecccceec
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAKLL 339 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~-~~~vkL~DFGla~~~ 339 (521)
+||+++.+...+. ..++...+..++.+++.||.|+|+. ||+|||+||.|++||. ...++|+|+|+|..+
T Consensus 114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999998887765 4577788899999999999999999 9999999999999985 566999999999988
Q ss_pred CCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH--------Hhh
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT--------MVT 410 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~--------~~~ 410 (521)
.+...+.. .+.+..|--||++.. ..|+..-|+|||||+|..|+..+.||-... .+...++.+.+- .+.
T Consensus 184 Hp~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~-dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 184 HPGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH-DNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC-CCHHHHHHHHHHhChHHHHHHHH
Confidence 77665543 356788999998854 568888999999999999999999985332 222333332221 111
Q ss_pred ccccccCCCcccCC-------Ccc--------HH-HHHHHHHHHHhccCCCCCCCCCHHHHH
Q 009979 411 NRNAEGVLDPRLQE-------KPC--------SR-ALKRALLVALRCVDPNAHKRPKMGHVI 456 (521)
Q Consensus 411 ~~~~~~~~d~~l~~-------~~~--------~~-~~~~~~~li~~cl~~dP~~RPt~~evl 456 (521)
.-. --+||.+.. .+. .. ...++++++.+.|..|-++|+|+.|..
T Consensus 261 KY~--i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 261 KYQ--IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred HHc--cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 111 113332211 111 11 124567788899999999999999976
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=236.89 Aligned_cols=210 Identities=32% Similarity=0.579 Sum_probs=182.1
Q ss_pred EccCCcEEEEEEEEcC-CcEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCCchHH
Q 009979 194 IGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQ 271 (521)
Q Consensus 194 LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L~~ 271 (521)
||+|++|.||++...+ +..+++|.+...... ..+.+.+|++.++.++|++++++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 889999998765432 34678899999999999999999999999899999999999899999
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-CCCceEeecccceecCCCCcceeecc
Q 009979 272 WLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAKLLGAERSYVTTRV 350 (521)
Q Consensus 272 ~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~ 350 (521)
++.... ..+++..++.++.+++.++++||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 987642 4688999999999999999999998 9999999999999999 89999999999987644321 12335
Q ss_pred cccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHH
Q 009979 351 MGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429 (521)
Q Consensus 351 ~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 429 (521)
.+...|++||.+... .++.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999999877 888999999999999999
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 430 ALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 430 ~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
..+.+++.+|++.||++||++.++++.
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 234458889999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=265.97 Aligned_cols=277 Identities=21% Similarity=0.212 Sum_probs=209.8
Q ss_pred CcccchhhhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCC------CCee
Q 009979 173 GHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH------KNLV 245 (521)
Q Consensus 173 ~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h------pniv 245 (521)
..||.++-.++-..+|.+....|+|-|++|.+|.+. -|+.||||++.++.... +.=..|+++|++|+. -|++
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHH
Confidence 557888888999999999999999999999999965 47799999998764433 333459999999963 4899
Q ss_pred eEEEEEeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC
Q 009979 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ 325 (521)
Q Consensus 246 ~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~ 325 (521)
+|+..|...+++|||+|-+ ..+|.+.|++.. ..-.|....+..++.|+..||..|..+ +|+|.||||+|||+++.
T Consensus 498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHhhhcceeEEEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccC
Confidence 9999999999999999988 459999998763 345677889999999999999999988 99999999999999875
Q ss_pred C-CceEeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHH
Q 009979 326 W-NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEW 404 (521)
Q Consensus 326 ~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~ 404 (521)
. .+||||||.|....... .+-..-+..|.|||++.+..|+...|+||.||+||||.||+.-|.+........+...
T Consensus 573 k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred cceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 4 58999999998654322 1222335569999999999999999999999999999999999976554322222221
Q ss_pred HH-----HHhhcccc-ccCCCccc----------------------C---------------CCccHHHHHHHHHHHHhc
Q 009979 405 LK-----TMVTNRNA-EGVLDPRL----------------------Q---------------EKPCSRALKRALLVALRC 441 (521)
Q Consensus 405 ~~-----~~~~~~~~-~~~~d~~l----------------------~---------------~~~~~~~~~~~~~li~~c 441 (521)
++ +|+..+.+ ..-+|..+ . +...+..+..+.+|+..|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 11 11110000 00011100 0 011233455677788899
Q ss_pred cCCCCCCCCCHHHHHHH
Q 009979 442 VDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 442 l~~dP~~RPt~~evl~~ 458 (521)
|..||++|-|..+.|.+
T Consensus 730 l~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 730 LILDPEKRITVNQALKH 746 (752)
T ss_pred hccChhhcCCHHHHhcC
Confidence 99999999999998753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=273.46 Aligned_cols=252 Identities=27% Similarity=0.387 Sum_probs=206.7
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
+.++|+..+.+|.|.||.||++++. .+...|+|.++-...+...-+..|+-+++..+|||||.++|.+......+++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 5668999999999999999999965 688899999988877878888899999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
||.+|+|++..+-. .++++.++...+.+..+||+|||+. +=+|||||-.|||+++.|.+|++|||.+-.+...
T Consensus 93 ycgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred ecCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh
Confidence 99999999988765 7899999999999999999999998 8899999999999999999999999999776432
Q ss_pred Ccceeecccccccccccccc---cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 343 RSYVTTRVMGTFGYVAPEYA---STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
-.....+.||++|||||+. ..+.|+.++|||++|+...|+---+.|.-+. ...+.+..|..+ ....
T Consensus 166 -i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl------hpmr~l~LmTkS----~~qp 234 (829)
T KOG0576|consen 166 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL------HPMRALFLMTKS----GFQP 234 (829)
T ss_pred -hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc------chHHHHHHhhcc----CCCC
Confidence 2334567899999999976 5678999999999999999997777664322 122222333222 2333
Q ss_pred cccCCC-ccHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 009979 420 PRLQEK-PCSRALKRALLVALRCVDPNAHKRPKMGHVI 456 (521)
Q Consensus 420 ~~l~~~-~~~~~~~~~~~li~~cl~~dP~~RPt~~evl 456 (521)
|.++.+ -....+.+ +++-|+.++|++||++.-+|
T Consensus 235 p~lkDk~kws~~fh~---fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 235 PTLKDKTKWSEFFHN---FVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CcccCCccchHHHHH---HHHHHhcCCCccCCChhhhe
Confidence 444432 23445555 77799999999999987654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=264.62 Aligned_cols=196 Identities=24% Similarity=0.403 Sum_probs=168.4
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhH--------HHHHHHHHHHhcCC---CCCeeeEEEEEee
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAE--------KEFKVEVEAIGRVR---HKNLVRLLGYCAE 253 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~--------~~~~~Ei~~l~~l~---hpniv~l~~~~~~ 253 (521)
.+|+..+.||+|+||.|++|.++ +...|+||.+.+.+.-.. -.+..||.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35899999999999999999976 456788998876532211 12456999999997 9999999999999
Q ss_pred CCeeeEEEEec-cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEee
Q 009979 254 GAHRMLVYEYI-DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (521)
Q Consensus 254 ~~~~~lV~e~~-~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~D 332 (521)
++++||+||-. +|-+|++++... ..+++..+..|+.|++.|+++||+. +|||||||-+|+.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999975 345899998754 6799999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCcceeecccccccccccccccCCCC-CCcccchhHHHHHHHHHhCCCCCC
Q 009979 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVD 391 (521)
Q Consensus 333 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltG~~Pf~ 391 (521)
||.+.+.... ....++||..|.|||++.+..| +..-|||++|++||.++....||.
T Consensus 714 fgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999875332 2345789999999999988765 556899999999999999999984
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-29 Score=238.33 Aligned_cols=199 Identities=31% Similarity=0.476 Sum_probs=174.0
Q ss_pred ccccceEccCCcEEEEEEEEcC-CcEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEecc
Q 009979 188 FADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYID 265 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~ 265 (521)
|.+.+.||.|++|.||++...+ +..+|+|.+...... ..+.+..|++.++.++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999764 788999999765544 56788999999999999999999999999899999999999
Q ss_pred CCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcc
Q 009979 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (521)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~ 345 (521)
+++|.+++.... ..+++...+.++.+++.++.+||+. +++|+||++.||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999998652 1278899999999999999999998 9999999999999999999999999999887544211
Q ss_pred eeecccccccccccccc-cCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 009979 346 VTTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRNPVDY 392 (521)
Q Consensus 346 ~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~ 392 (521)
......++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 23345678899999998 677788899999999999999999999953
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=236.77 Aligned_cols=256 Identities=25% Similarity=0.290 Sum_probs=191.5
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC------Ce
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------AH 256 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------~~ 256 (521)
.+|.-...+|.|.- .|..+.+. .+++||+|++... .....+.-.+|+.++..++|+||++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 36777788899888 55555532 5889999988543 223345667799999999999999999998543 35
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.|+|||||+. +|.+.++. .++-++...|+.|++.|+.|||+. +|+||||||+||++..++.+||.|||++
T Consensus 96 ~y~v~e~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 7999999965 99998873 366678899999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH--------
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM-------- 408 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~-------- 408 (521)
+.-+. ...++..+.|..|.|||++.+..|.+.+||||.||++.||++|+.-|.+.+ .+.+|.+-.
T Consensus 166 r~e~~--~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 166 RTEDT--DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPDP 238 (369)
T ss_pred cccCc--ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCCH
Confidence 86432 246677888999999999988889999999999999999999999886432 222222211
Q ss_pred -------------hhc------ccccc-CCCcccCCC--ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 409 -------------VTN------RNAEG-VLDPRLQEK--PCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 409 -------------~~~------~~~~~-~~d~~l~~~--~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
+.+ ....+ +-|..+... ........+.+++.+||-.||++|-++.++|.+-
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 110 00011 111111110 0111223344578899999999999999998654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=223.35 Aligned_cols=252 Identities=21% Similarity=0.357 Sum_probs=183.1
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCCeeeEEEE-EeeCCeeeEEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGY-CAEGAHRMLVYE 262 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~-~~~~~~~~lV~e 262 (521)
+.|.+.+.||+|.||.+-++.++ +++.+++|.+.. .....++|.+|...--.| .|.||+.-+++ |+..+.++++||
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 57999999999999999999976 477788887754 344567899998887777 48999988875 566677789999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC--CCCCceEeecccceecC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD--KQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~--~~~~vkL~DFGla~~~~ 340 (521)
|++.|+|.+-+.. ..+.+....+++.|++.|+.|+|++ ++||||||.+||||- +...|||||||+.+..+
T Consensus 103 ~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999886654 3577788889999999999999999 999999999999992 33469999999998653
Q ss_pred CCCcceeecccccccccccccccCC-----CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTG-----MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
.. .....-+..|.+||..... ...+.+|+|.||+++|.++||..||+.. ........+|.+ +..+.
T Consensus 175 ~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~--w~~rk-- 245 (378)
T KOG1345|consen 175 TT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQ--WLKRK-- 245 (378)
T ss_pred ce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHH--Hhccc--
Confidence 32 2233446779999976432 2466899999999999999999999833 222222333322 11111
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
.+.+... ......+++.+.++-+..++++|-...++-++.
T Consensus 246 ---~~~~P~~-F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 246 ---NPALPKK-FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred ---CccCchh-hcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 1111111 111223344466688999999996655555443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=272.37 Aligned_cols=196 Identities=18% Similarity=0.253 Sum_probs=140.2
Q ss_pred cCCC-CCeeeEEEEE-------eeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 009979 238 RVRH-KNLVRLLGYC-------AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309 (521)
Q Consensus 238 ~l~h-pniv~l~~~~-------~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ 309 (521)
.++| +||++++++| .+....+++|||+ +++|.++|+.. ...+++..++.++.||+.||+|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4455 5888888877 2334567788987 56999999754 35689999999999999999999998 9
Q ss_pred eeecCCCCCCeEeCC-------------------CCCceEeecccceecCCCC---------------cceeeccccccc
Q 009979 310 VVHRDIKSSNILLDK-------------------QWNPKLSDFGLAKLLGAER---------------SYVTTRVMGTFG 355 (521)
Q Consensus 310 iiHrDik~~NILl~~-------------------~~~vkL~DFGla~~~~~~~---------------~~~~~~~~gt~~ 355 (521)
|+||||||+||||+. ++.+|++|||+++...... .......+||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 4456677777765421100 000112468999
Q ss_pred ccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHH
Q 009979 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRAL 435 (521)
Q Consensus 356 y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 435 (521)
|||||++.+..++.++|||||||+||||++|..|+.... .....+.. ..+.+.. .....+..
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~--------~~~~~~~-----~~~~~~~~ 242 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRH--------RVLPPQI-----LLNWPKEA 242 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHH--------hhcChhh-----hhcCHHHH
Confidence 999999999999999999999999999999988864211 11111110 1111111 01122344
Q ss_pred HHHHhccCCCCCCCCCHHHHHHH
Q 009979 436 LVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 436 ~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.++.+||+++|.+||++.|++++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhc
Confidence 57889999999999999999753
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=233.09 Aligned_cols=198 Identities=26% Similarity=0.402 Sum_probs=164.0
Q ss_pred cCCCccccceEccCCcEEEEEEEEc----CCcEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCeee
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~ 258 (521)
-.+.|...++||+|.|++||++.+. ....||+|.+... .....+..|+++|..+. +.||+++.+++..+++..
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 3457889999999999999999843 3567999988543 34466889999999995 999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-CCCceEeecccce
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAK 337 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~-~~~vkL~DFGla~ 337 (521)
+||||++.-+..+++.. ++...+..+++.+..||.++|.+ |||||||||.|+|.+. .+.-.|+|||+|.
T Consensus 112 ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHH
Confidence 99999999888888754 45788899999999999999999 9999999999999975 4568999999997
Q ss_pred ecCC---------------------------------CCcc----------eeecccccccccccccccC-CCCCCcccc
Q 009979 338 LLGA---------------------------------ERSY----------VTTRVMGTFGYVAPEYAST-GMLNERSDV 373 (521)
Q Consensus 338 ~~~~---------------------------------~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~sDv 373 (521)
.... ...+ ......||++|.|||++.. ...+.++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 2100 0000 0112469999999998854 567889999
Q ss_pred hhHHHHHHHHHhCCCCCCCC
Q 009979 374 YSFGILIMEVISGRNPVDYS 393 (521)
Q Consensus 374 wS~Gvvl~elltG~~Pf~~~ 393 (521)
||.||++.-+++++.||-..
T Consensus 262 ws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred eeccceeehhhccccccccC
Confidence 99999999999999999654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-26 Score=228.05 Aligned_cols=258 Identities=18% Similarity=0.246 Sum_probs=194.6
Q ss_pred CccccceEccCCcEEEEEEEEcCC--cEEEEEEeccCChhhHHHHHHHHHHHhcCCC----CCeeeEEEEE-eeCCeeeE
Q 009979 187 GFADENVIGEGGYGIVYHGVLEDN--TNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH----KNLVRLLGYC-AEGAHRML 259 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h----pniv~l~~~~-~~~~~~~l 259 (521)
+|.+.+.||+|+||.||++..... ..+|+|............+..|+.++..+.. .++..+++.. ..+...+|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997653 4788887765433333377889999988873 6899999998 47778899
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC-----CCceEeecc
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-----WNPKLSDFG 334 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~-----~~vkL~DFG 334 (521)
||+.+ |.+|.++..... ...++..+...|+.|++.+|++||+. |++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99998 779999876653 57899999999999999999999998 99999999999999754 459999999
Q ss_pred cce--ecCCCCc-----c-e-eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 009979 335 LAK--LLGAERS-----Y-V-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL 405 (521)
Q Consensus 335 la~--~~~~~~~-----~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~ 405 (521)
+++ .+..... . . .....||..|+++..+.+...+.+.|+||+++++.|++.|..||............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~--- 249 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF--- 249 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH---
Confidence 998 4322111 1 1 12356999999999999999999999999999999999999999655433222111
Q ss_pred HHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 406 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
....... .... -....+..+..+.. .+-..+...+|....+...|...
T Consensus 250 ~~~~~~~----~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 250 EKDPRKL----LTDR--FGDLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHhhhh----cccc--ccCCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHHH
Confidence 1111111 1110 11123444554333 44458999999999998887543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=210.34 Aligned_cols=166 Identities=24% Similarity=0.243 Sum_probs=125.5
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
|+|.++++.. ...+++..++.++.|++.||+|||+. + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 6899999764 35799999999999999999999998 5 999999999999999 99998764322
Q ss_pred eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCc
Q 009979 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP 426 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 426 (521)
..||+.|+|||++.+..++.++|||||||++|||+||+.||...... ......+....... ++.... .
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~------~~~~~~-~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPAD------DPRDRS-N 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccC------Cccccc-c
Confidence 26899999999999999999999999999999999999999643221 11111111111110 000000 0
Q ss_pred cHHHH--HHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 427 CSRAL--KRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 427 ~~~~~--~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
..... ..+.+++.+||+.||.+||++.++++++..
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 11111 246779999999999999999999988764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=225.42 Aligned_cols=163 Identities=20% Similarity=0.234 Sum_probs=128.1
Q ss_pred cCCCccccceEccCCcEEEEEEEEc--CCcEEEEEEeccC-----ChhhHHHHHHHHHHHhcCCCCCeee-EEEEEeeCC
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE--DNTNVAVKNLLNN-----RGQAEKEFKVEVEAIGRVRHKNLVR-LLGYCAEGA 255 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~hpniv~-l~~~~~~~~ 255 (521)
..++|.+.+.||+|+||+||+|.+. +++.||||++... .......|.+|+++|+.++|+|++. ++++ .
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 4458999999999999999999864 4677899987533 1223466899999999999999985 4432 4
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCeEeCCCCCceEeecc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDI-KSSNILLDKQWNPKLSDFG 334 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDi-k~~NILl~~~~~vkL~DFG 334 (521)
..||||||++|++|... .. .. ...++.++++||.|||+. +|+|||| ||+|||++.++.+||+|||
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CcEEEEEccCCCCHHHh-Cc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 57999999999999732 11 11 145778999999999998 9999999 9999999999999999999
Q ss_pred cceecCCCCcc-------eeecccccccccccccccC
Q 009979 335 LAKLLGAERSY-------VTTRVMGTFGYVAPEYAST 364 (521)
Q Consensus 335 la~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 364 (521)
+++.+...... ..+..++++.|+|||++..
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99976432211 1135678999999999854
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=205.29 Aligned_cols=259 Identities=19% Similarity=0.226 Sum_probs=201.4
Q ss_pred hcCCCccccceEccCCcEEEEEEE-EcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCC-CCeeeEEEEEeeCCeeeEE
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH-KNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-pniv~l~~~~~~~~~~~lV 260 (521)
+..++|.+.++||.|+||.+|.|. ..+|.+||||.-.+... ...+..|.++.+.|++ ..|..+..+..+..+..+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 345689999999999999999999 55799999997654332 2457779999999975 7888888889999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---CCCceEeecccce
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFGLAK 337 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~---~~~vkL~DFGla~ 337 (521)
|+++ |.+|+++++-. ...++.++.+.++-|++.-++|+|.. ++|||||||+|+|+.- ...+.|+|||+|+
T Consensus 90 MdLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 9998 77999998765 46788999999999999999999999 9999999999999964 3458999999999
Q ss_pred ecCCCCcc------eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhc
Q 009979 338 LLGAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN 411 (521)
Q Consensus 338 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (521)
.+.+.... ......||..|.+--.+.+...+.+.|+-|+|.+|.++..|..||++..........+.+...-.+
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s 242 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS 242 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence 87543221 123567999999998888888899999999999999999999999977665544444433222111
Q ss_pred cccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 412 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
. .....|...+.++...+..|-..-.++-|....+-+..
T Consensus 243 ~---------~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF 281 (341)
T KOG1163|consen 243 T---------PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF 281 (341)
T ss_pred C---------CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence 1 11122444455555567788888888888876655443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-25 Score=209.08 Aligned_cols=202 Identities=21% Similarity=0.311 Sum_probs=171.9
Q ss_pred CccccceEccCCcEEEEEEE-EcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCeeeEEEEec
Q 009979 187 GFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
.|.+.++||+|.||+.+.|. .-+++.||||.-. .....-.+..|.+..+.|. .++|...+-+..++.+..||||++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP--rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP--RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecc--ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 68899999999999999998 4479999999542 2334456778888888885 799999999999999999999998
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC-----CCceEeecccceec
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-----WNPKLSDFGLAKLL 339 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~-----~~vkL~DFGla~~~ 339 (521)
|-+|+|+..-+ ...++.+++..++.|++.-++|+|++ .+|+|||||+|+||... ..+.|+|||+|+.+
T Consensus 107 -GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 107 -GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred -CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 77999988765 56899999999999999999999999 99999999999999643 34899999999987
Q ss_pred CCCCcc------eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCC
Q 009979 340 GAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG 397 (521)
Q Consensus 340 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~ 397 (521)
.+.... ......||..||+--.+.+...+.+.|+-|||-|++++|.|.+||.+...+.
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 543221 1245679999999999999999999999999999999999999998765443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-23 Score=206.32 Aligned_cols=261 Identities=28% Similarity=0.397 Sum_probs=197.4
Q ss_pred ccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChh---hHHHHHHHHHHHhcCCCC-CeeeEEEEEeeCCeeeEEEEe
Q 009979 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ---AEKEFKVEVEAIGRVRHK-NLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~hp-niv~l~~~~~~~~~~~lV~e~ 263 (521)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667889999999999999986 77899988665333 367889999999999988 799999999777778999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC-CceEeecccceecCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKLLGAE 342 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~-~vkL~DFGla~~~~~~ 342 (521)
+.++++.+++...... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++.+...
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777654211 3688899999999999999999998 999999999999999988 6999999999866443
Q ss_pred Ccc-----eeecccccccccccccccC---CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 343 RSY-----VTTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 343 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
... ......||..|+|||.+.+ ..+....|+||+|++++++++|..||...... .........+.....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~ 232 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPT 232 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCC
Confidence 322 2356789999999999987 68889999999999999999999997644321 011111111111110
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
. .................+.+++.+|+..+|..|.+..+....
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000011110001122344557789999999999999877654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-25 Score=204.55 Aligned_cols=251 Identities=20% Similarity=0.325 Sum_probs=188.3
Q ss_pred CccccceEccCCcEEEEEEEEcCCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
+..+..+|.+...|+.|+|+|. |..+++|++... .....++|..|.-.|+.+.||||+.++|.|....++.++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 4455678999999999999997 455667766432 3334478999999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~ 344 (521)
+.|+|+..|++.. .-..+..++.++++++|+|++|||+. ++-|.---|.+..++||++.+++|.= +-.+. +
T Consensus 270 p~gslynvlhe~t--~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kf-----s 340 (448)
T KOG0195|consen 270 PFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----S 340 (448)
T ss_pred cchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-cccee-----e
Confidence 9999999999873 34556678899999999999999986 55555557899999999999988751 21221 1
Q ss_pred ceeecccccccccccccccCCCCC---CcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 345 YVTTRVMGTFGYVAPEYASTGMLN---ERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
+......-.|.||+||.++..+-+ +++|+|||.++||||.|...||.+..+- +.-.+... +-+.+.
T Consensus 341 fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm------ecgmkial-----eglrv~ 409 (448)
T KOG0195|consen 341 FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM------ECGMKIAL-----EGLRVH 409 (448)
T ss_pred eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch------hhhhhhhh-----cccccc
Confidence 122223347899999999776543 4789999999999999999999765432 21111111 112222
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
+ .+.....+-.|+.-|+..||.+||.+..|+-.||..
T Consensus 410 i----ppgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 410 I----PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred C----CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 2 223333344488899999999999999999888753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-24 Score=229.48 Aligned_cols=253 Identities=21% Similarity=0.251 Sum_probs=185.8
Q ss_pred cccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhH----HHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 189 ADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAE----KEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 189 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~----~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
.....+|.|++|.|+..... ....++.|..... ..... ..+..|+.+-..+.|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45778999999988877633 3333444433210 11111 12556777788899999988888777766666669
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
|||++ +|+.++... ..++...+..++.|+..|++|+|+. ||.|||+|++|++++.+|.+||+|||.+..+..
T Consensus 401 E~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 999998764 4688889999999999999999999 999999999999999999999999999987754
Q ss_pred CCc---ceeecccccccccccccccCCCCCC-cccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 342 ERS---YVTTRVMGTFGYVAPEYASTGMLNE-RSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 342 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
... ......+|+..|+|||++.+..|.+ ..||||.|+++..|++|+.||.......... ....... ..
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~---~~ 544 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSD---QR 544 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcccc---cc
Confidence 333 4456788999999999999988887 5799999999999999999998665432211 0000000 00
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
....-..........+...++.++|+.||.+|-|+++|++
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000011112233334455888999999999999999974
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.7e-23 Score=192.79 Aligned_cols=173 Identities=13% Similarity=0.151 Sum_probs=134.0
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHH---------HHHHHHHHHhcCCCCCeeeEEEEEe
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEK---------EFKVEVEAIGRVRHKNLVRLLGYCA 252 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~Ei~~l~~l~hpniv~l~~~~~ 252 (521)
.+-.++|...++||.|+||.||++.. ++..+|+|.+......... .+.+|++.+.++.|++|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 34567999999999999999999766 5778999999654333222 2678999999999999999998865
Q ss_pred eC--------CeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC
Q 009979 253 EG--------AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK 324 (521)
Q Consensus 253 ~~--------~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~ 324 (521)
.. ...+|||||++|.+|.++.. ++. ....+++.+|..||+. |++|||+||+||+++.
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence 33 34789999999999988732 222 2355889999999999 9999999999999998
Q ss_pred CCCceEeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHH
Q 009979 325 QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 384 (521)
Q Consensus 325 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ell 384 (521)
++ ++|+|||........... . .+.....|+.++|+|+||+++..+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~--d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK--D-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhH--H-----------HHHHHhHhcccccccceeEeehHHH
Confidence 88 999999988754221111 0 0334445668999999999877654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-22 Score=186.52 Aligned_cols=139 Identities=17% Similarity=0.169 Sum_probs=108.1
Q ss_pred cceEccCCcEEEEEEEEcCCcEEEEEEeccCChhh--------------------------HHHHHHHHHHHhcCCCCCe
Q 009979 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQA--------------------------EKEFKVEVEAIGRVRHKNL 244 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~Ei~~l~~l~hpni 244 (521)
...||+|+||.||+|...+|+.||||++....... ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999998789999999986542110 1122359999999987776
Q ss_pred eeEEEEEeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCCCCCCeEeC
Q 009979 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL-HEGLEPKVVHRDIKSSNILLD 323 (521)
Q Consensus 245 v~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~L-H~~~~~~iiHrDik~~NILl~ 323 (521)
.....+... ..+|||||++++++...+... ..++...+..++.|++.+|.|| |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 443332222 238999999987776543222 4678899999999999999999 687 999999999999998
Q ss_pred CCCCceEeecccceec
Q 009979 324 KQWNPKLSDFGLAKLL 339 (521)
Q Consensus 324 ~~~~vkL~DFGla~~~ 339 (521)
++.++|+|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-23 Score=224.26 Aligned_cols=249 Identities=22% Similarity=0.233 Sum_probs=183.9
Q ss_pred CccccceEccCCcEEEEEEEEcCCcEEEEEEeccCC-hhhHHHHHHHHHH--HhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR-GQAEKEFKVEVEA--IGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~--l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
.|...+.||.+.|=.|.+|+++.|. |+||++.+.. .-..+.|.++++- ...+++||.+++.-+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777889999999999999988776 9999987655 3334555544433 4456899999998887777888999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec--CC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GA 341 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~--~~ 341 (521)
+.+ +|+|.|..+ .-+...+.+.|+.|++.||..+|.. ||+|||||.+||||+.-+-+.|+||...+.. ..
T Consensus 103 vkh-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 977 999988765 4566777888999999999999999 9999999999999999989999999887643 22
Q ss_pred CCc----ceeecccccccccccccccC----------C-CCCCcccchhHHHHHHHHHh-CCCCCCCCC-----CCCccc
Q 009979 342 ERS----YVTTRVMGTFGYVAPEYAST----------G-MLNERSDVYSFGILIMEVIS-GRNPVDYSR-----PPGEVN 400 (521)
Q Consensus 342 ~~~----~~~~~~~gt~~y~aPE~~~~----------~-~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~-----~~~~~~ 400 (521)
++. +...+...-.+|+|||.+.. . .++++.||||+||+++||++ |++||.... ..+..+
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~ 254 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADD 254 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccC
Confidence 221 11222233458999997633 1 26788999999999999999 788885221 000111
Q ss_pred HHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 009979 401 LVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 465 (521)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 465 (521)
....+ +++-|+ .+..+++.|++.||.+|-++.+.|+.-.+..+|
T Consensus 255 ~e~~L---------e~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP 298 (1431)
T KOG1240|consen 255 PEQLL---------EKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFP 298 (1431)
T ss_pred HHHHH---------HhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhhhccccH
Confidence 10000 011111 234478899999999999999999887666654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.7e-21 Score=178.80 Aligned_cols=140 Identities=21% Similarity=0.198 Sum_probs=111.1
Q ss_pred cceEccCCcEEEEEEEEcCCcEEEEEEeccCChh--------------------------hHHHHHHHHHHHhcCCCCCe
Q 009979 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ--------------------------AEKEFKVEVEAIGRVRHKNL 244 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~Ei~~l~~l~hpni 244 (521)
...||+|+||.||+|...+|+.||||.+...... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999778999999998754211 01234578999999999987
Q ss_pred eeEEEEEeeCCeeeEEEEeccCCchHHh-hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEe
Q 009979 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQW-LHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILL 322 (521)
Q Consensus 245 v~l~~~~~~~~~~~lV~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~iiHrDik~~NILl 322 (521)
.....+.... .+|||||++|+++... +.. ..++......++.|++.++.+||+ . +|+||||||+|||+
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 5544443332 4899999998755433 332 356778889999999999999999 7 99999999999999
Q ss_pred CCCCCceEeecccceecCC
Q 009979 323 DKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 323 ~~~~~vkL~DFGla~~~~~ 341 (521)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 78999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.1e-21 Score=176.17 Aligned_cols=186 Identities=17% Similarity=0.125 Sum_probs=138.7
Q ss_pred cccceEccCCcEEEEEEEEcCCcEEEEEEeccCChh----hHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCeeeEEEEe
Q 009979 189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ----AEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 189 ~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
.....|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|+++. |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999998766 5777887776544321 1235788999999995 5889999886 345999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCeEeCCCCCceEeecccceecCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDI-KSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDi-k~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
+.|.+|.+.+.. . ...++.|++.+|+++|++ ||+|||| ||+|||++.++.++|+|||++......
T Consensus 80 I~G~~L~~~~~~-----~------~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR-----G------DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh-----h------hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999888764321 0 134677899999999999 9999999 799999999999999999999865432
Q ss_pred Ccc----e--------eecccccccccccccccCC-CCC-CcccchhHHHHHHHHHhCCCCCCCC
Q 009979 343 RSY----V--------TTRVMGTFGYVAPEYASTG-MLN-ERSDVYSFGILIMEVISGRNPVDYS 393 (521)
Q Consensus 343 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwS~Gvvl~elltG~~Pf~~~ 393 (521)
... . ......++.|++|+...-- ..+ ...++++-|+.+|.++|++.|.-..
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 210 0 1123467888888754221 222 4568999999999999999886433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-22 Score=207.75 Aligned_cols=225 Identities=24% Similarity=0.270 Sum_probs=174.5
Q ss_pred eEccCCcEEEEEEE----EcCCcEEEEEEeccCChhh--HHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCeeeEEEEecc
Q 009979 193 VIGEGGYGIVYHGV----LEDNTNVAVKNLLNNRGQA--EKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYID 265 (521)
Q Consensus 193 ~LG~G~fG~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~~ 265 (521)
++|+|.||.|+++. .+.+.-+|+|.+.+..... ......|..++...+ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999876 2346778888876542111 114455888888887 9999999999999999999999999
Q ss_pred CCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcc
Q 009979 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345 (521)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~ 345 (521)
||+|...+.+. ..+++.....+...++.+++++|+. +++|||+|++||+++.+|++|+.|||+++..-....
T Consensus 81 gg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKE----VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhccccC----CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 99999987665 4677777788888999999999999 999999999999999999999999999987533322
Q ss_pred eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCC
Q 009979 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425 (521)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 425 (521)
.|||..|||||+++ .....+|.||||++++||+||..||.. +..+..... ++ .
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~----~~-------~ 205 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKA----EL-------E 205 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhh----cc-------C
Confidence 18999999999998 677889999999999999999999964 112221110 01 1
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCH
Q 009979 426 PCSRALKRALLVALRCVDPNAHKRPKM 452 (521)
Q Consensus 426 ~~~~~~~~~~~li~~cl~~dP~~RPt~ 452 (521)
........+..++..++..+|..|--.
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 122223333446667788888888755
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=193.44 Aligned_cols=214 Identities=27% Similarity=0.496 Sum_probs=162.8
Q ss_pred HhcCCCCCeeeEEEEEeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-eecC
Q 009979 236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV-VHRD 314 (521)
Q Consensus 236 l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~i-iHrD 314 (521)
|+.+.|.|+.+|+|.+.++...++|.+||..|+|.+.+... ...+++.....++.+++.||+|||.. +| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 46789999999999999999999999999999999999874 46789999999999999999999986 44 9999
Q ss_pred CCCCCeEeCCCCCceEeecccceecCCCCc-ceeecccccccccccccccCC-------CCCCcccchhHHHHHHHHHhC
Q 009979 315 IKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTG-------MLNERSDVYSFGILIMEVISG 386 (521)
Q Consensus 315 ik~~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwS~Gvvl~elltG 386 (521)
+++.|+++|..+.+||+|||+......... .......-..-|.|||.+.+. ..+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 999999999999999999999987642100 111112235579999988653 146779999999999999999
Q ss_pred CCCCCCCCCCCcc-cHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 387 RNPVDYSRPPGEV-NLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 387 ~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
..||+........ .++..++. .....+.|.+.... +....++.++.+||..+|.+||++.+|-..++..
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred cCccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 9999865332222 22222222 12233444433221 2223577789999999999999999997776643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.5e-20 Score=172.15 Aligned_cols=136 Identities=15% Similarity=0.250 Sum_probs=106.0
Q ss_pred cccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcC-----CCCCeeeEEEEEeeCC---eee-E
Q 009979 189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-----RHKNLVRLLGYCAEGA---HRM-L 259 (521)
Q Consensus 189 ~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-----~hpniv~l~~~~~~~~---~~~-l 259 (521)
...+.||+|+||.||. +......+||++........+.+.+|+.+++.+ .||||++++|++.++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3467899999999996 433333479988765455567899999999999 5799999999998863 333 7
Q ss_pred EEEe--ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeecCCCCCCeEeCC----CCCceEee
Q 009979 260 VYEY--IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL-TYLHEGLEPKVVHRDIKSSNILLDK----QWNPKLSD 332 (521)
Q Consensus 260 V~e~--~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al-~~LH~~~~~~iiHrDik~~NILl~~----~~~vkL~D 332 (521)
|||| +.+|+|.+++.+. .+++. ..++.+++.++ +|||++ +|+||||||+|||++. ++.++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 5579999999653 24444 35567777777 999999 9999999999999974 34799999
Q ss_pred cccc
Q 009979 333 FGLA 336 (521)
Q Consensus 333 FGla 336 (521)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5434
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-20 Score=181.51 Aligned_cols=234 Identities=23% Similarity=0.350 Sum_probs=148.0
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhcCCC----------CCeeeEEEEE-
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRH----------KNLVRLLGYC- 251 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h----------pniv~l~~~~- 251 (521)
.+...+.||.|+|+.||.+++. +++.+|+|....... ...+.+++|.-....+.+ -.++-.++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3456789999999999999986 488999998854332 233556666655544322 1222222221
Q ss_pred --------eeCC--------eeeEEEEeccCCchHHhhh---cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 009979 252 --------AEGA--------HRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312 (521)
Q Consensus 252 --------~~~~--------~~~lV~e~~~~g~L~~~l~---~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiH 312 (521)
.... +.+++|+-+. +||.+++. ........+....++.+..|+++.+++||+. |++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 1111 2367888874 58888753 2211123445566777889999999999999 9999
Q ss_pred cCCCCCCeEeCCCCCceEeecccceecCCCCcceeecccccccccccccccC--------CCCCCcccchhHHHHHHHHH
Q 009979 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST--------GMLNERSDVYSFGILIMEVI 384 (521)
Q Consensus 313 rDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwS~Gvvl~ell 384 (521)
+||||+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|++|+++|.|.
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999988765332111 344678999997633 25788999999999999999
Q ss_pred hCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCC
Q 009979 385 SGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKR 449 (521)
Q Consensus 385 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~R 449 (521)
+|+.||+...+...... .+ ..|......+..||..+|+.||.+|
T Consensus 245 C~~lPf~~~~~~~~~~~-------------------~f--~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW-------------------DF--SRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG-------------------GG--TTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc-------------------cc--hhcCCcCHHHHHHHHHHccCCcccC
Confidence 99999985543222111 11 1233444445558889999999987
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.7e-20 Score=201.99 Aligned_cols=201 Identities=21% Similarity=0.221 Sum_probs=162.7
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCC---CCCeeeEEEEEeeC
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR---HKNLVRLLGYCAEG 254 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---hpniv~l~~~~~~~ 254 (521)
..+.++..+.|.+.+.||+|+||.||+|...+++.||+|+-+.... -+|..-.+++.+|+ -+.|..+...+.-.
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 4455677888999999999999999999988899999998765433 23333445555555 23445555555555
Q ss_pred CeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC-------CCCC
Q 009979 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-------KQWN 327 (521)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~-------~~~~ 327 (521)
+..+||+||.+-|+|.++++.. ..+++...+.+..|++..++.||.. +|||+||||+|+||. +.--
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred CcceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccc
Confidence 6678999999999999999844 6789999999999999999999998 999999999999993 2344
Q ss_pred ceEeecccceecCCCC-cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCC
Q 009979 328 PKLSDFGLAKLLGAER-SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRN 388 (521)
Q Consensus 328 vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~ 388 (521)
++|+|||.+..+.--. .......++|-.+-.+|...+..++..+|.|.|..+++-||.|+.
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 8999999997653222 234566789999999999999999999999999999999999863
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.4e-19 Score=170.23 Aligned_cols=141 Identities=19% Similarity=0.156 Sum_probs=111.0
Q ss_pred CccccceEccCCcEEEEEEE--EcCCcEEEEEEeccCChh------------------------hHHHHHHHHHHHhcCC
Q 009979 187 GFADENVIGEGGYGIVYHGV--LEDNTNVAVKNLLNNRGQ------------------------AEKEFKVEVEAIGRVR 240 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~l~ 240 (521)
-|.+.+.||+|+||.||+|. ..+|+.||+|.+...... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47889999999999999998 457999999998643210 1123567999999997
Q ss_pred CC--CeeeEEEEEeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeecCCCC
Q 009979 241 HK--NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-VVHRDIKS 317 (521)
Q Consensus 241 hp--niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~-iiHrDik~ 317 (521)
+. .+.+++++ ...++||||+++++|..++... ..+.......++.|++.++.+||+. + ++||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 53 34455543 2348999999998887654322 2455566788999999999999998 9 99999999
Q ss_pred CCeEeCCCCCceEeecccceec
Q 009979 318 SNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 318 ~NILl~~~~~vkL~DFGla~~~ 339 (521)
+||+++ ++.++|+|||.+...
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhcc
Confidence 999999 889999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=164.19 Aligned_cols=134 Identities=21% Similarity=0.336 Sum_probs=113.3
Q ss_pred ceEccCCcEEEEEEEEcCCcEEEEEEeccCChh--------hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ--------AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
+.||+|++|.||+|.+ ++..+++|+....... ....+..|++++..+.|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 5778999986543211 124577899999999999988877777777788999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
++|++|.+++.... . .+..++.+++.+|.+||+. +++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986431 1 7788999999999999998 999999999999999 78899999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-19 Score=194.58 Aligned_cols=210 Identities=23% Similarity=0.322 Sum_probs=144.5
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
..+|..++.|..|+||.||.++++ ..+++|+| +.+++... ++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lil----Rn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLIL----RN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhh----hc---cccccCCccee------------------
Confidence 357888999999999999999876 46778884 43322111 00 22222233332
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC-
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE- 342 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~- 342 (521)
||-...++.. ++++... +.+++|||+. +|+|||+||+|.+|+.-|++|+.|||+++.....
T Consensus 136 ---gDc~tllk~~----g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ---GDCATLLKNI----GPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ---chhhhhcccC----CCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 4555555433 3444333 6789999998 9999999999999999999999999998753211
Q ss_pred -------------CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHh
Q 009979 343 -------------RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409 (521)
Q Consensus 343 -------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 409 (521)
.......++||+.|.|||++....|+..+|+|++|+++||++-|..||....+++ .+..++
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee------lfg~vi 271 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVI 271 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH------HHhhhh
Confidence 1122345799999999999999999999999999999999999999998765542 223333
Q ss_pred hccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCH
Q 009979 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM 452 (521)
Q Consensus 410 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~ 452 (521)
.... ...+. ....+. ++.+++.++|+.+|..|--.
T Consensus 272 sd~i--~wpE~---dea~p~---Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 272 SDDI--EWPEE---DEALPP---EAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred hhhc--ccccc---CcCCCH---HHHHHHHHHHHhChHhhccc
Confidence 2211 11111 111222 33447778999999999643
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=168.18 Aligned_cols=196 Identities=22% Similarity=0.292 Sum_probs=135.1
Q ss_pred CCCCeeeEEEEEee---------------------------CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHH
Q 009979 240 RHKNLVRLLGYCAE---------------------------GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292 (521)
Q Consensus 240 ~hpniv~l~~~~~~---------------------------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~ 292 (521)
+|||||++.++|.+ +..+|+||...+. +|.+++..+ ..+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-----~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-----HRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-----CCchHHHHHHH
Confidence 59999999987643 2356999998865 999999765 45566777888
Q ss_pred HHHHHHHHHHHhcCCCCeeecCCCCCCeEe--CCCC--CceEeecccceecCC---CCcce--eeccccccccccccccc
Q 009979 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILL--DKQW--NPKLSDFGLAKLLGA---ERSYV--TTRVMGTFGYVAPEYAS 363 (521)
Q Consensus 293 ~~ia~al~~LH~~~~~~iiHrDik~~NILl--~~~~--~vkL~DFGla~~~~~---~~~~~--~~~~~gt~~y~aPE~~~ 363 (521)
.|+++|+.|||.+ ||.|||+|++|||| |+++ .+.|+|||++---.. .-.+. ....-|...-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 99999999999999 3333 478999999854221 01111 12345788899999885
Q ss_pred CCC------CCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHH
Q 009979 364 TGM------LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLV 437 (521)
Q Consensus 364 ~~~------~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l 437 (521)
..+ --.|+|.|+.|.+.||+++...||.... ....+...+. +---|.+... ++.... ++
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~~r~Yq----------e~qLPalp~~-vpp~~r---ql 489 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLDTRTYQ----------ESQLPALPSR-VPPVAR---QL 489 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc-hheechhhhh----------hhhCCCCccc-CChHHH---HH
Confidence 432 2358999999999999999999996421 1111111111 1111122221 333333 37
Q ss_pred HHhccCCCCCCCCCHHHHHHHh
Q 009979 438 ALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 438 i~~cl~~dP~~RPt~~evl~~L 459 (521)
+...|+.||++|++..-....|
T Consensus 490 V~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHhcCCccccCCccHHHhHH
Confidence 7788999999999965444333
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-19 Score=182.68 Aligned_cols=174 Identities=21% Similarity=0.415 Sum_probs=130.7
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
++||.|++|...+|.+||.... .....++.....++.|++.|++| + +.+|||+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 5789999999999999997543 24566778889999999999999 5 899999999999999999999999999
Q ss_pred ceecCCCC-----cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHh
Q 009979 336 AKLLGAER-----SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMV 409 (521)
Q Consensus 336 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 409 (521)
........ ....+...||..||+||.+.+..|+.++|||+||++|+||++ -..+|+ ....+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------------r~~t~- 469 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------------RIATL- 469 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------------HHHhh-
Confidence 98765433 223466789999999999999999999999999999999998 333321 01110
Q ss_pred hccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 009979 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHV 455 (521)
Q Consensus 410 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~ev 455 (521)
.......++|.+..+. +.+ ..++.+++.+.|.+||++.++
T Consensus 470 -~d~r~g~ip~~~~~d~-p~e----~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 470 -TDIRDGIIPPEFLQDY-PEE----YTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred -hhhhcCCCChHHhhcC-cHH----HHHHHHhcCCCcccCchHHHH
Confidence 1111233333322221 111 226678999999999955443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.4e-18 Score=182.93 Aligned_cols=137 Identities=20% Similarity=0.317 Sum_probs=112.2
Q ss_pred CCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCC--------hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--------GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 256 (521)
...|...+.||+|+||+||+|.+.+. .+++|+..... ....+.+..|+++++.++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34556789999999999999987544 44544432211 1123568889999999999999988888877777
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.++||||+++++|.+++. ....++.+++.+|.|||+. +++||||||+|||+ +++.++|+|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 899999999999999875 3467888999999999998 99999999999999 6778999999999
Q ss_pred ee
Q 009979 337 KL 338 (521)
Q Consensus 337 ~~ 338 (521)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 75
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.6e-18 Score=159.70 Aligned_cols=130 Identities=22% Similarity=0.360 Sum_probs=106.5
Q ss_pred eEccCCcEEEEEEEEcCCcEEEEEEeccCCh--------hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 193 ~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
.||+|+||.||+|.+ ++..+++|....... .....+..|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999996 578899998654321 11256778999999999887655555555666779999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+|++|.+++.... . .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999875431 0 7788999999999998 999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.5e-18 Score=158.69 Aligned_cols=139 Identities=19% Similarity=0.150 Sum_probs=109.3
Q ss_pred CCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChh----------------------hHHHHHHHHHHHhcCCCC-
Q 009979 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ----------------------AEKEFKVEVEAIGRVRHK- 242 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~Ei~~l~~l~hp- 242 (521)
..|.+.+.||+|+||.||++...+++.||||++...... ....+..|+.++..+.|+
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 347888999999999999999878999999987543210 112356789999998877
Q ss_pred -CeeeEEEEEeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeE
Q 009979 243 -NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321 (521)
Q Consensus 243 -niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NIL 321 (521)
.++..++. ...++||||++|++|..+... .....++.+++.++.++|+. +++||||||+||+
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nil 157 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNIL 157 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEE
Confidence 44454442 345899999999998765321 23456888999999999998 9999999999999
Q ss_pred eCCCCCceEeecccceecCC
Q 009979 322 LDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 322 l~~~~~vkL~DFGla~~~~~ 341 (521)
+++++.++|+|||++.....
T Consensus 158 l~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EcCCCcEEEEECCccccCCC
Confidence 99999999999999975533
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.6e-17 Score=142.54 Aligned_cols=135 Identities=19% Similarity=0.174 Sum_probs=114.0
Q ss_pred ccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCC--CCeeeEEEEEeeCCeeeEEEEeccCC
Q 009979 190 DENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH--KNLVRLLGYCAEGAHRMLVYEYIDNG 267 (521)
Q Consensus 190 ~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--pniv~l~~~~~~~~~~~lV~e~~~~g 267 (521)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+.+++.++| .+++++++++...+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999854 7899998765433 5678889999999976 58999999888878899999999987
Q ss_pred chHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 268 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
.+..+ +......++.+++.++++||.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76653 4456677889999999999986445799999999999999989999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.1e-16 Score=145.71 Aligned_cols=136 Identities=23% Similarity=0.231 Sum_probs=98.0
Q ss_pred cceEccCCcEEEEEEEEcCCcEEEEEEeccCChhh--HHH----------------------HHHHHHHHhcCCCC--Ce
Q 009979 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQA--EKE----------------------FKVEVEAIGRVRHK--NL 244 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~Ei~~l~~l~hp--ni 244 (521)
.+.||+|+||+||+|...+++.||||.+....... ... ...|.+.+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998789999999886532211 111 13466666666443 24
Q ss_pred eeEEEEEeeCCeeeEEEEeccCCchHH-hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEe
Q 009979 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQ-WLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILL 322 (521)
Q Consensus 245 v~l~~~~~~~~~~~lV~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~iiHrDik~~NILl 322 (521)
.+.+++ ...++||||++++.+.. .+... ... ..+..++.+++.++.++|. . +|+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 444443 23589999999854322 11111 001 5577889999999999998 7 99999999999999
Q ss_pred CCCCCceEeecccceecC
Q 009979 323 DKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 323 ~~~~~vkL~DFGla~~~~ 340 (521)
+ ++.++|+|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-15 Score=147.39 Aligned_cols=136 Identities=21% Similarity=0.264 Sum_probs=105.7
Q ss_pred cceEc-cCCcEEEEEEEEcCCcEEEEEEeccCC-------------hhhHHHHHHHHHHHhcCCCCCe--eeEEEEEeeC
Q 009979 191 ENVIG-EGGYGIVYHGVLEDNTNVAVKNLLNNR-------------GQAEKEFKVEVEAIGRVRHKNL--VRLLGYCAEG 254 (521)
Q Consensus 191 ~~~LG-~G~fG~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~Ei~~l~~l~hpni--v~l~~~~~~~ 254 (521)
...|| .||.|+||.+... +..+++|.+.... ......+.+|++++..+.|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 8999999999875 7789999874311 1123457789999999998875 6777765433
Q ss_pred Ce----eeEEEEeccC-CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCce
Q 009979 255 AH----RMLVYEYIDN-GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK 329 (521)
Q Consensus 255 ~~----~~lV~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vk 329 (521)
.. .++||||++| .+|.+++... .++.. .+.+++.+|.+||+. ||+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 22 2599999997 6899888643 34443 356889999999999 999999999999999988999
Q ss_pred Eeecccceec
Q 009979 330 LSDFGLAKLL 339 (521)
Q Consensus 330 L~DFGla~~~ 339 (521)
|+|||.+...
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.6e-17 Score=179.20 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=186.0
Q ss_pred CccccceEccCCcEEEEEEEEcC--CcEEEEEEeccCC--hhhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCeeeEEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLED--NTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV~ 261 (521)
.|.+.+.||+|.|+.|-...... ...+|+|.+.... .........|..+-+.+. |+|++.+++...+....++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 56667789999999999887533 3345666554332 222234445777777776 999999999999999999999
Q ss_pred EeccCCchHHhh-hcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeecCCCCCCeEeCCCC-CceEeeccccee
Q 009979 262 EYIDNGNLEQWL-HGDVGPHSPLTWEIRMNIILGTAKGLTYLH-EGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKL 338 (521)
Q Consensus 262 e~~~~g~L~~~l-~~~~~~~~~l~~~~~~~i~~~ia~al~~LH-~~~~~~iiHrDik~~NILl~~~~-~vkL~DFGla~~ 338 (521)
+|.+|+++.+.+ +.. ....+...+-.++.|+..++.|+| .. ++.||||||+|.+++..+ .+|++|||+|..
T Consensus 101 ~~s~g~~~f~~i~~~~---~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPD---STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred CcccccccccccccCC---ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988 433 124555667788899999999999 77 999999999999999999 999999999998
Q ss_pred cCC--CCcceeecccc-cccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 339 LGA--ERSYVTTRVMG-TFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 339 ~~~--~~~~~~~~~~g-t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
+.. .........+| ++.|+|||...+ ....+..|+||.|+++.-+++|..|++........ ...|....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~------ 247 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK------ 247 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc------
Confidence 765 33444456778 999999999887 46677899999999999999999999866543311 11111100
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVI 456 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl 456 (521)
..+...+..........+..+++..+|..|.+.+++-
T Consensus 248 -----~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 248 -----GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred -----cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 0001111222223344467788889999999988764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=8.7e-14 Score=145.73 Aligned_cols=142 Identities=22% Similarity=0.212 Sum_probs=99.5
Q ss_pred cceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhH----------------------------------------HHHH
Q 009979 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAE----------------------------------------KEFK 230 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 230 (521)
.+.||.|++|.||+|++.+|+.||||+......... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999865321100 0234
Q ss_pred HHHHHHhcC----CCCCeeeEEEEEe-eCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 009979 231 VEVEAIGRV----RHKNLVRLLGYCA-EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK-GLTYLHE 304 (521)
Q Consensus 231 ~Ei~~l~~l----~hpniv~l~~~~~-~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~-al~~LH~ 304 (521)
.|++.+.++ +|.+-+.+-.++. .....+|||||++|++|.++..... .... ...++..++. .+.++|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHHHHHHh
Confidence 455555544 2333333333332 2345689999999999988765321 1122 2345555555 4788898
Q ss_pred cCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 305 ~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
. |++|+|++|.||++++++.++|+|||++..+..
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7 999999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1e-13 Score=133.02 Aligned_cols=204 Identities=20% Similarity=0.318 Sum_probs=142.5
Q ss_pred HHhcCCCCCeeeEEEEEeeCC-----eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 009979 235 AIGRVRHKNLVRLLGYCAEGA-----HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309 (521)
Q Consensus 235 ~l~~l~hpniv~l~~~~~~~~-----~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ 309 (521)
-|-++.|-|||+++.|+.+.. ...++.|||..|+|.++|++.......+......+++.||..||.|||+. .|.
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 344567999999998876543 45789999999999999998766677888888999999999999999984 999
Q ss_pred eeecCCCCCCeEeCCCCCceEeecccceecCC----CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh
Q 009979 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA----ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS 385 (521)
Q Consensus 310 iiHrDik~~NILl~~~~~vkL~DFGla~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt 385 (521)
|+|+.+..+-|++..+|-+|+.- +.-..... ..........|-++|.+||+=.....+.++|||+||+...||-.
T Consensus 199 iihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999888888742 11111100 00111122346789999998877778889999999999999988
Q ss_pred CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 386 GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 386 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
+..--.... ......+.+...+. .+...++. .++.+|++..|+.||+|.+++.+.
T Consensus 278 lEiq~tnse--S~~~~ee~ia~~i~------~len~lqr-----------~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 278 LEIQSTNSE--SKVEVEENIANVII------GLENGLQR-----------GSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred heeccCCCc--ceeehhhhhhhhee------eccCcccc-----------CcCcccccCCCCCCcchhhhhcCc
Confidence 764321111 11111111111110 11111111 167799999999999999886443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.6e-13 Score=142.28 Aligned_cols=246 Identities=22% Similarity=0.266 Sum_probs=178.3
Q ss_pred CCccccceEcc--CCcEEEEEEEE---cCCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCee
Q 009979 186 NGFADENVIGE--GGYGIVYHGVL---EDNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 186 ~~~~~~~~LG~--G~fG~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~ 257 (521)
..|.+.+.+|. |.+|.||.+.. .++..+|+|+-+.... .....=.+|+...+.++ |+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 35677888999 99999999986 3577789887432221 22222334666666664 99999988899999999
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeeecCCCCCCeEeCCC-CCceEee
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK----GLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSD 332 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~----al~~LH~~~~~~iiHrDik~~NILl~~~-~~vkL~D 332 (521)
++-+|+|. .+|.++.+.. ...++....+.++.+... ||.++|+. +++|-|+||.||++..+ ...+++|
T Consensus 194 fiqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 99999985 6888888765 334677778888888888 99999998 99999999999999988 8899999
Q ss_pred cccceecCCCCcce----eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH
Q 009979 333 FGLAKLLGAERSYV----TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408 (521)
Q Consensus 333 FGla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 408 (521)
||+...+....... ..+..|...|++||.. .+.++..+|+|++|.+..+..++..+....... .|
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W---- 335 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS------SW---- 335 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC------Cc----
Confidence 99999886544211 1233688899999987 456788999999999999998877654322100 00
Q ss_pred hhccccccCCCcc-cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 009979 409 VTNRNAEGVLDPR-LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVI 456 (521)
Q Consensus 409 ~~~~~~~~~~d~~-l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl 456 (521)
.-++.. ++...|.....++...+..+++.+|..|++.+.+.
T Consensus 336 -------~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 336 -------SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred -------cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 001111 12222322333333377789999999999987764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.3e-12 Score=119.18 Aligned_cols=131 Identities=21% Similarity=0.159 Sum_probs=95.7
Q ss_pred cceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCee-eEEEEEeeCCeeeEEEEeccCCch
Q 009979 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV-RLLGYCAEGAHRMLVYEYIDNGNL 269 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv-~l~~~~~~~~~~~lV~e~~~~g~L 269 (521)
.+.|+.|.++.||++... +..|++|....... ....+..|+++++.+.+.+++ +++.+.. ...++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 356899999999999875 77899998754432 223467799999988655544 4554433 345899999999877
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL--EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~--~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
... . . ....++.+++++|+.||... ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~---~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE---D------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc---c------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 643 0 0 11235568999999999872 11259999999999999 66899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.6e-12 Score=136.38 Aligned_cols=144 Identities=16% Similarity=0.141 Sum_probs=94.1
Q ss_pred CccccceEccCCcEEEEEEEEcC-CcEEEEEEeccCChhh----------------------------------HH----
Q 009979 187 GFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQA----------------------------------EK---- 227 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~---- 227 (521)
.|.. +.||.|++|.||+|++++ |+.||||++.+..... .+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4555 689999999999999887 9999999986542110 01
Q ss_pred --HHHHHHHHHhcC----CCCCeeeEEEEEee-CCeeeEEEEeccCCchHHh--hhcCCCCCCCCCHHHHHHHHHHHHHH
Q 009979 228 --EFKVEVEAIGRV----RHKNLVRLLGYCAE-GAHRMLVYEYIDNGNLEQW--LHGDVGPHSPLTWEIRMNIILGTAKG 298 (521)
Q Consensus 228 --~~~~Ei~~l~~l----~hpniv~l~~~~~~-~~~~~lV~e~~~~g~L~~~--l~~~~~~~~~l~~~~~~~i~~~ia~a 298 (521)
+|..|+.-+.++ .+.+.+.+-.++.+ ....+|||||++|+.+.++ +.........+....+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q---- 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ---- 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH----
Confidence 133344444433 24444544444443 3456899999999999874 2221100112222223333333
Q ss_pred HHHHHhcCCCCeeecCCCCCCeEeCCCC----CceEeecccceecCC
Q 009979 299 LTYLHEGLEPKVVHRDIKSSNILLDKQW----NPKLSDFGLAKLLGA 341 (521)
Q Consensus 299 l~~LH~~~~~~iiHrDik~~NILl~~~~----~vkL~DFGla~~~~~ 341 (521)
+... |++|+|+||.||+++.++ .++++|||++..+..
T Consensus 276 ---if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ---VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ---HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3445 999999999999999887 899999999987744
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.3e-11 Score=125.51 Aligned_cols=166 Identities=20% Similarity=0.224 Sum_probs=126.7
Q ss_pred EcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHH
Q 009979 207 LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWE 286 (521)
Q Consensus 207 ~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~ 286 (521)
..++.+|.|...............+-++-|+.++||||+++++.+...+..|||+|.+. -|..++.+. ...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHH
Confidence 34677888887766655444567778899999999999999999999999999999985 677777654 356
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcceeecccccccccccccccCCC
Q 009979 287 IRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366 (521)
Q Consensus 287 ~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 366 (521)
.....+.||+.||.|||+.+ +++|++|.-+.|+++..|..||++|-++........ ......---.|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 67778889999999999655 999999999999999999999999988865432221 011111122456666543222
Q ss_pred CCCcccchhHHHHHHHHHhC
Q 009979 367 LNERSDVYSFGILIMEVISG 386 (521)
Q Consensus 367 ~~~~sDvwS~Gvvl~elltG 386 (521)
-..|.|-|||+++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 345999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.28 E-value=7.2e-11 Score=109.44 Aligned_cols=137 Identities=18% Similarity=0.182 Sum_probs=98.1
Q ss_pred cceEccCCcEEEEEEEEcC-------CcEEEEEEeccCC----------------------hhhHHHHH----HHHHHHh
Q 009979 191 ENVIGEGGYGIVYHGVLED-------NTNVAVKNLLNNR----------------------GQAEKEFK----VEVEAIG 237 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~Ei~~l~ 237 (521)
...||.|--+.||.|...+ +..+|||+.+... ....+.+. .|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998543 4789999774210 01122333 7999999
Q ss_pred cCCC--CCeeeEEEEEeeCCeeeEEEEeccCCchHH-hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeec
Q 009979 238 RVRH--KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQ-WLHGDVGPHSPLTWEIRMNIILGTAKGLTYL-HEGLEPKVVHR 313 (521)
Q Consensus 238 ~l~h--pniv~l~~~~~~~~~~~lV~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~~ia~al~~L-H~~~~~~iiHr 313 (521)
++.. -++.+++++ ...+|||||+.+..+.. .++. ..++......+..+++.+|..| |.. +++|+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 8853 466666665 34589999997643322 2221 2344455667788999999999 787 99999
Q ss_pred CCCCCCeEeCCCCCceEeecccceecC
Q 009979 314 DIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 314 Dik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
||++.|||+++ +.++|+|||.+-...
T Consensus 150 DLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 99999999974 679999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.4e-12 Score=131.62 Aligned_cols=256 Identities=19% Similarity=0.197 Sum_probs=176.9
Q ss_pred ccchhh-hhhcCCCccccceEccCCcEEEEEEEEc--CCcEEEEEEeccCChhhHHHH--HHHHHHHhcC-CCCCeeeEE
Q 009979 175 WYTLRE-LEVSTNGFADENVIGEGGYGIVYHGVLE--DNTNVAVKNLLNNRGQAEKEF--KVEVEAIGRV-RHKNLVRLL 248 (521)
Q Consensus 175 ~~~~~~-~~~~~~~~~~~~~LG~G~fG~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~--~~Ei~~l~~l-~hpniv~l~ 248 (521)
++...+ ......+|.....||.|.|+.|+....+ ++..|++|.+.+.......++ ..|+.+...+ .|.++++.+
T Consensus 253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~ 332 (524)
T KOG0601|consen 253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN 332 (524)
T ss_pred eecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence 333444 3445568899999999999999998743 577899998877654443332 2366666655 488888877
Q ss_pred EEEeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC-CC
Q 009979 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-WN 327 (521)
Q Consensus 249 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~-~~ 327 (521)
..+....+.|+--|||+++++...+.. ...+.+...+.+..|++.++.++|+. .++|+|+||+||++..+ +.
T Consensus 333 ~~W~~~r~~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~ 405 (524)
T KOG0601|consen 333 SSWSQLRQGYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFF 405 (524)
T ss_pred CCccccccccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhh
Confidence 777666777899999999988776632 35677778889999999999999988 99999999999999876 78
Q ss_pred ceEeecccceecCCCCcceeecccccccc-cccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 009979 328 PKLSDFGLAKLLGAERSYVTTRVMGTFGY-VAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK 406 (521)
Q Consensus 328 vkL~DFGla~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~ 406 (521)
-++.|||+...+.. .......++..| .+++......+..+.|++|||.-+.|.+++..--. . . .+|..
T Consensus 406 ~~~~~~~~~t~~~~---~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-~----~---~~~~~ 474 (524)
T KOG0601|consen 406 SKLGDFGCWTRLAF---SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-S----G---VQSLT 474 (524)
T ss_pred hhccccccccccce---ecccccccccccccchhhccccccccccccccccccccccccCcccCc-c----c---cccee
Confidence 89999999874321 111222233344 36666677889999999999999999998763211 1 0 11110
Q ss_pred HHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 407 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
+....+... +.....+..+...+...++..||.+.++..+.+
T Consensus 475 ----------i~~~~~p~~--~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 475 ----------IRSGDTPNL--PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ----------eecccccCC--CchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 001111111 111133444667888999999999888765443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.7e-11 Score=112.11 Aligned_cols=142 Identities=19% Similarity=0.242 Sum_probs=109.7
Q ss_pred ceEccCCcEEEEEEEEcCCcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCC--CCeeeEEEEEeeCC---eeeEEEEecc
Q 009979 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRH--KNLVRLLGYCAEGA---HRMLVYEYID 265 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h--pniv~l~~~~~~~~---~~~lV~e~~~ 265 (521)
+.|+.|.++.||++...+|..+++|....... .....+..|+++++.+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987668899998754332 134578889999999975 44677888776543 5689999999
Q ss_pred CCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 009979 266 NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL--------------------------------------- 306 (521)
Q Consensus 266 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~--------------------------------------- 306 (521)
|.++.+.+.. ..++......++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888775431 24666777788888888888888521
Q ss_pred --------------CCCeeecCCCCCCeEeCC--CCCceEeeccccee
Q 009979 307 --------------EPKVVHRDIKSSNILLDK--QWNPKLSDFGLAKL 338 (521)
Q Consensus 307 --------------~~~iiHrDik~~NILl~~--~~~vkL~DFGla~~ 338 (521)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 56689999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.6e-10 Score=103.70 Aligned_cols=130 Identities=23% Similarity=0.370 Sum_probs=98.4
Q ss_pred eEccCCcEEEEEEEEcCCcEEEEEEeccCCh---h-----hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG---Q-----AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 193 ~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~---~-----~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
.+++|+-..+|.+.+. +..+++|.-.+... . ......+|++++.+++--.|.-..=+..+.....|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999875 44466665433211 1 1244567999999887555554444556667778999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+|..|.+++... ...++..+-.-+.-||.. +|+|+||.++||++...+ +.++|||++..
T Consensus 82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 998999888754 145566777778899998 999999999999998765 99999999974
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.5e-12 Score=139.88 Aligned_cols=251 Identities=21% Similarity=0.234 Sum_probs=169.5
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
+...+.|.+.+-+-.|.|+.++.+.-. .+.-.++|..... .....+....+-.++-..++|.++...--+.-....
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 456677888888999999999988733 2433444433221 111112222233333334456666655555556678
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
+||++|..+++|...|+.. ...+.+.....+..+..+++|||.. .+.|||++|.|+|+..+++.++.|||...
T Consensus 880 ~L~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred chhhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccc
Confidence 9999999999999999876 3556666677777889999999987 79999999999999999999999998433
Q ss_pred ecCCC------------------------------CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCC
Q 009979 338 LLGAE------------------------------RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 387 (521)
Q Consensus 338 ~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~ 387 (521)
..+.. .........||+.|.+||...+......+|+|++|++++|.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 22100 001123467999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHH
Q 009979 388 NPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMG 453 (521)
Q Consensus 388 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~ 453 (521)
.||....+.... ..+.... +--+. .......++..++.+.+..+|.+|-.+.
T Consensus 1033 pp~na~tpq~~f------~ni~~~~----~~~p~----g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQIF------ENILNRD----IPWPE----GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCcchhhhh------hccccCC----CCCCC----CccccChhhhhhhhhhhccCchhccCcc
Confidence 999866553221 1111100 00000 0111222333466688889999998765
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.9e-10 Score=101.65 Aligned_cols=143 Identities=20% Similarity=0.289 Sum_probs=106.1
Q ss_pred ccceEccCCcEEEEEEEEcCCcEEEEEEeccCC--------hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 190 DENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--------GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 190 ~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
....|-+|+-+.|+++.+. |+.+.||.-.... .-......+|+++|.++.--.|.-..=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678999999999999985 7777777543221 112356778999999987555555444566666678999
Q ss_pred EeccC-CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC---CceEeecccce
Q 009979 262 EYIDN-GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW---NPKLSDFGLAK 337 (521)
Q Consensus 262 e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~---~vkL~DFGla~ 337 (521)
||++| .++.+++..... ..........++..+-+.+.-||.. +|+|+||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99977 478888876532 2222233367888899999999999 999999999999995443 35899999987
Q ss_pred e
Q 009979 338 L 338 (521)
Q Consensus 338 ~ 338 (521)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1e-08 Score=102.25 Aligned_cols=269 Identities=14% Similarity=0.161 Sum_probs=162.0
Q ss_pred cccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCCeeeEEEE------EeeC-CeeeEE
Q 009979 189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGY------CAEG-AHRMLV 260 (521)
Q Consensus 189 ~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~------~~~~-~~~~lV 260 (521)
.....||+|+-+.+|-.-.- +. .+.|+..........+ -+..|... .||-+-.=+.| .-++ ....+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchh-hc-hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 34567999999999964321 22 3457665543332222 22334333 45543321221 1122 235688
Q ss_pred EEeccCCc-hHHhhh--cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 261 YEYIDNGN-LEQWLH--GDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 261 ~e~~~~g~-L~~~l~--~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
|..+.+.. +..++. ..+.......|...++.+..++.+.+.||++ |.+-+|+.++|+|+.+++.|.|.|-....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 88887742 333332 2223456788999999999999999999999 99999999999999999999999866554
Q ss_pred ecCCCCcceeeccccccccccccccc-----CCCCCCcccchhHHHHHHHHHhC-CCCCCCCC------CCCcccHHHHH
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISG-RNPVDYSR------PPGEVNLVEWL 405 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltG-~~Pf~~~~------~~~~~~~~~~~ 405 (521)
....+. ....-+|...|++||... +..-+..+|.|.||+++++|+.| +.||.+-. ++.+..+.. .
T Consensus 166 i~~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~-g 242 (637)
T COG4248 166 INANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH-G 242 (637)
T ss_pred eccCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc-c
Confidence 432222 223457899999999654 44566789999999999999996 99997532 111111110 0
Q ss_pred HHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCC--CCCCCCCHHHHHHHhhccCCCchhh
Q 009979 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDP--NAHKRPKMGHVIHMLEAEEFPFRDE 469 (521)
Q Consensus 406 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~--dP~~RPt~~evl~~L~~~~~~~~~~ 469 (521)
.-........... +.-...+..-....+..+..+|+.. ++.-|||++.++..|......+..+
T Consensus 243 ~f~ya~~~~~g~~-p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C 307 (637)
T COG4248 243 RFAYASDQRRGLK-PPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKC 307 (637)
T ss_pred eeeechhccCCCC-CCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhh
Confidence 0000001111111 1111112222222233355578754 4779999999988887655444433
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.05 E-value=5.9e-09 Score=106.45 Aligned_cols=169 Identities=18% Similarity=0.270 Sum_probs=130.2
Q ss_pred cEEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEe----eCCeeeEEEEeccC-CchHHh
Q 009979 199 YGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA----EGAHRMLVYEYIDN-GNLEQW 272 (521)
Q Consensus 199 fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~----~~~~~~lV~e~~~~-g~L~~~ 272 (521)
-.+.|++.. .+|..|++|++.-.+.+.......-++.++++.|+|+|+|.++|. .+..+++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 347899984 479999999995544444433445688899999999999999886 34567899999986 578776
Q ss_pred hhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 273 LHGDV-----------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 273 l~~~~-----------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
..... ......++...|.++.|+..||.++|+. |+..+-|.+.+||++.+..++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54321 1234677899999999999999999999 999999999999999998999998888776543
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCC
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRN 388 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~ 388 (521)
+. . |.+. --.+-|.=-||.+++-|.||..
T Consensus 446 d~-------------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DP-------------T--EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC-------------C--cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 32 0 1111 1235689999999999999853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.6e-09 Score=97.74 Aligned_cols=126 Identities=27% Similarity=0.313 Sum_probs=82.0
Q ss_pred EEEEEEEcCCcEEEEEEeccCC--------------------------hhhHHHHHHHHHHHhcCCCC--CeeeEEEEEe
Q 009979 201 IVYHGVLEDNTNVAVKNLLNNR--------------------------GQAEKEFKVEVEAIGRVRHK--NLVRLLGYCA 252 (521)
Q Consensus 201 ~Vy~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~Ei~~l~~l~hp--niv~l~~~~~ 252 (521)
.||.|...++..+|+|...... .........|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998889999999874210 00123466799999999765 566776553
Q ss_pred eCCeeeEEEEecc--CCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeeecCCCCCCeEeCCCCCce
Q 009979 253 EGAHRMLVYEYID--NGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY-LHEGLEPKVVHRDIKSSNILLDKQWNPK 329 (521)
Q Consensus 253 ~~~~~~lV~e~~~--~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~-LH~~~~~~iiHrDik~~NILl~~~~~vk 329 (521)
..+|||||++ |..+..+.... ++......++.+++..+.. +|.. |++|+|+.+.|||++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 2379999998 65554433322 1123345566677775555 5777 99999999999999988 999
Q ss_pred EeecccceecC
Q 009979 330 LSDFGLAKLLG 340 (521)
Q Consensus 330 L~DFGla~~~~ 340 (521)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.2e-08 Score=99.91 Aligned_cols=140 Identities=16% Similarity=0.097 Sum_probs=98.3
Q ss_pred eEccCCcEEEEEEEEcCCcEEEEEEeccCChh-----------hHHHHHHHHHHHhcCCCCC--eeeEEEEEee-----C
Q 009979 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ-----------AEKEFKVEVEAIGRVRHKN--LVRLLGYCAE-----G 254 (521)
Q Consensus 193 ~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~hpn--iv~l~~~~~~-----~ 254 (521)
.+-+.....|++..+ +|+.|.||........ ....+.+|...+..+...+ .+.++++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344333445667766 5778999976432211 1113677888888874333 3344555432 2
Q ss_pred CeeeEEEEeccCC-chHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-------CC
Q 009979 255 AHRMLVYEYIDNG-NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-------QW 326 (521)
Q Consensus 255 ~~~~lV~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~-------~~ 326 (521)
...+||||++++- +|.+++.... ..+........++.+++..+.-||+. ||+|+|++++|||++. +.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 3468999999875 7999886431 13455677788999999999999999 9999999999999975 46
Q ss_pred CceEeeccccee
Q 009979 327 NPKLSDFGLAKL 338 (521)
Q Consensus 327 ~vkL~DFGla~~ 338 (521)
.+.|+||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 799999998863
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.1e-08 Score=94.36 Aligned_cols=136 Identities=23% Similarity=0.196 Sum_probs=93.7
Q ss_pred CccccceEccCCcEEEEEEEEcCCcEEEEEEeccC----------Ch------------hhHHHHHHHHHHHhcCCCC--
Q 009979 187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN----------RG------------QAEKEFKVEVEAIGRVRHK-- 242 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~----------~~------------~~~~~~~~Ei~~l~~l~hp-- 242 (521)
-..+...||.|--+.||.|....|.++|||.=.-. +. -......+|.++|.+|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 35667899999999999999988999999954211 00 0112345799999999755
Q ss_pred CeeeEEEEEeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe
Q 009979 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL 322 (521)
Q Consensus 243 niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl 322 (521)
.+.+.+++ +...+||||++|-.|...- ++.+..-.++..|+.-+.-+-.. ||||+|+.+-||++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILV 235 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEE
Confidence 67777665 3347999999986665432 11122222333333333333344 99999999999999
Q ss_pred CCCCCceEeeccccee
Q 009979 323 DKQWNPKLSDFGLAKL 338 (521)
Q Consensus 323 ~~~~~vkL~DFGla~~ 338 (521)
+++|.+.++||--+..
T Consensus 236 ~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TEDGDIVVIDWPQAVP 251 (304)
T ss_pred ecCCCEEEEeCccccc
Confidence 9999999999976553
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=2e-07 Score=86.75 Aligned_cols=138 Identities=14% Similarity=0.160 Sum_probs=102.9
Q ss_pred EccCCcEEEEEEEEcCCcEEEEEEeccCC------hhhHHHHHHHHHHHhcCCC--CCeeeEEEEEe-e--C--CeeeEE
Q 009979 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNR------GQAEKEFKVEVEAIGRVRH--KNLVRLLGYCA-E--G--AHRMLV 260 (521)
Q Consensus 194 LG~G~fG~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~h--pniv~l~~~~~-~--~--~~~~lV 260 (521)
-|+||.+-|++..+. |..+-+|.-.+.. .-....|.+|+..|..+.. -.+.++. ++. . + -..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 367999999998875 5578888765221 2245678999999998853 2244444 332 1 1 235799
Q ss_pred EEeccC-CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCC--ceEeecccce
Q 009979 261 YEYIDN-GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN--PKLSDFGLAK 337 (521)
Q Consensus 261 ~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~--vkL~DFGla~ 337 (521)
+|-++| -+|.+++... ...+.+...+..++.+++..+.-||+. |+.|+|+.+.|||++.++. ++++||--++
T Consensus 104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998764 5899988654 234567777889999999999999999 9999999999999986667 9999998665
Q ss_pred e
Q 009979 338 L 338 (521)
Q Consensus 338 ~ 338 (521)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.4e-07 Score=88.95 Aligned_cols=106 Identities=22% Similarity=0.244 Sum_probs=81.9
Q ss_pred HHHHHHHHHHhcCCC--CCeeeEEEEEeeC----CeeeEEEEeccCC-chHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 009979 227 KEFKVEVEAIGRVRH--KNLVRLLGYCAEG----AHRMLVYEYIDNG-NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299 (521)
Q Consensus 227 ~~~~~Ei~~l~~l~h--pniv~l~~~~~~~----~~~~lV~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al 299 (521)
....+|...+..+.. -...+.+++.... ...+||+|++++. +|.+++.... ..+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence 456667777777743 3345556665542 2458999999874 7999987642 255567788999999999
Q ss_pred HHHHhcCCCCeeecCCCCCCeEeCCCC---CceEeecccceec
Q 009979 300 TYLHEGLEPKVVHRDIKSSNILLDKQW---NPKLSDFGLAKLL 339 (521)
Q Consensus 300 ~~LH~~~~~~iiHrDik~~NILl~~~~---~vkL~DFGla~~~ 339 (521)
+-||+. ||+|+|+++.|||++.++ .+.|+||+-++..
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 999999999999998877 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.5e-08 Score=107.08 Aligned_cols=149 Identities=20% Similarity=0.280 Sum_probs=97.5
Q ss_pred HHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCccee--------ecccccccccccccccCC
Q 009979 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT--------TRVMGTFGYVAPEYASTG 365 (521)
Q Consensus 294 ~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~~ 365 (521)
+++.|+.|+|.. +++||+.|.|++|.++.++.+||+.|+++........+.. --..-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 555899999976 4999999999999999999999999998865433211111 012235689999999998
Q ss_pred CCCCcccchhHHHHHHHHHhCCCC-CCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCC
Q 009979 366 MLNERSDVYSFGILIMEVISGRNP-VDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDP 444 (521)
Q Consensus 366 ~~~~~sDvwS~Gvvl~elltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~ 444 (521)
..+.++|+||+||++|.+..|..+ +............. ..+..-..........++.+-+.+++..
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-------------~~~~~~~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-------------NLLNAGAFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-------------cccccccccccccCcHHHHHHHHHHhcC
Confidence 899999999999999999955544 33222111111000 0000000000112222333455688899
Q ss_pred CCCCCCCHHHHHH
Q 009979 445 NAHKRPKMGHVIH 457 (521)
Q Consensus 445 dP~~RPt~~evl~ 457 (521)
++..||++.++..
T Consensus 252 ~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 252 DSAVRPTLDLLLS 264 (700)
T ss_pred CcccCcchhhhhc
Confidence 9999998777653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.7e-06 Score=82.74 Aligned_cols=140 Identities=19% Similarity=0.177 Sum_probs=86.2
Q ss_pred ceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCC--eeeEEEEEeeCCeeeEEEEeccCCc-
Q 009979 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLLGYCAEGAHRMLVYEYIDNGN- 268 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn--iv~l~~~~~~~~~~~lV~e~~~~g~- 268 (521)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+..-+ +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 25567888765422 3355788999998886433 4677888877777889999999863
Q ss_pred hHHh---------------------hhcCCCCCCCCCHHHHHHHHHH----------HHH-HHHHHHhc-CCCCeeecCC
Q 009979 269 LEQW---------------------LHGDVGPHSPLTWEIRMNIILG----------TAK-GLTYLHEG-LEPKVVHRDI 315 (521)
Q Consensus 269 L~~~---------------------l~~~~~~~~~l~~~~~~~i~~~----------ia~-al~~LH~~-~~~~iiHrDi 315 (521)
+... ||........+.... ..+..+ +.. ...+|... ..+.++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 1111 122100111111000 000000 001 12222211 1346789999
Q ss_pred CCCCeEeCCCCCceEeeccccee
Q 009979 316 KSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 316 k~~NILl~~~~~vkL~DFGla~~ 338 (521)
.|.||++++++ +.++||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999888 99999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=7.3e-07 Score=94.50 Aligned_cols=142 Identities=20% Similarity=0.221 Sum_probs=91.4
Q ss_pred ceEccCCcEEEEEEEEcCCcEEEEEEeccCChhh------------------------------HH----------HHHH
Q 009979 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQA------------------------------EK----------EFKV 231 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~----------~~~~ 231 (521)
+-|+.++-|.||+|++++|+.||||+....-... .+ ++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5789999999999999999999999885431110 01 1333
Q ss_pred HHHHHhcC----CCCCeeeEEEEEee-CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 009979 232 EVEAIGRV----RHKNLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306 (521)
Q Consensus 232 Ei~~l~~l----~hpniv~l~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~ 306 (521)
|..-+.++ +...-+++=.++++ .....|+|||++|-.+.+...-.. ...+.+.....+.++. +..+=..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f--~~q~~~d- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAF--LRQLLRD- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHH--HHHHHhc-
Confidence 44444444 22223333344443 355689999999988888742221 1233233222222221 2222223
Q ss_pred CCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 307 ~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
|++|.|..|.||+++.+|.+.+.|||+...+..
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999987643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.45 E-value=4e-06 Score=78.48 Aligned_cols=139 Identities=14% Similarity=0.181 Sum_probs=91.7
Q ss_pred hcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHH---------HHHHHHHhcCC---CCCeeeEEEE
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEF---------KVEVEAIGRVR---HKNLVRLLGY 250 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~Ei~~l~~l~---hpniv~l~~~ 250 (521)
+..++|...+++-......|.+-.. +|..+++|..........+.| .+++..+..++ .-....++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 4566788888888888777877776 478899997755432222222 23333333332 3333333333
Q ss_pred Eee-----CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC
Q 009979 251 CAE-----GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ 325 (521)
Q Consensus 251 ~~~-----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~ 325 (521)
+.. ....+|||||++|..|.++.. ++.. +...++.++.-||+. |+.|+|..|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e~----~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDED----LAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCHH----HHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence 221 234468999999987776432 2222 334567789999999 99999999999999965
Q ss_pred CCceEeeccccee
Q 009979 326 WNPKLSDFGLAKL 338 (521)
Q Consensus 326 ~~vkL~DFGla~~ 338 (521)
+ ++++||+..+.
T Consensus 172 ~-i~iID~~~k~~ 183 (229)
T PF06176_consen 172 G-IRIIDTQGKRM 183 (229)
T ss_pred c-EEEEECccccc
Confidence 4 99999987753
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.40 E-value=3e-06 Score=80.87 Aligned_cols=145 Identities=22% Similarity=0.251 Sum_probs=85.7
Q ss_pred cceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCC--CeeeEEEEEee---CCeeeEEEEecc
Q 009979 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK--NLVRLLGYCAE---GAHRMLVYEYID 265 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hp--niv~l~~~~~~---~~~~~lV~e~~~ 265 (521)
.+.|+.|..+.||+....+ ..+++|..... .....+..|..+++.+... .+.+++.++.. ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4578999999999999876 68999986544 4557788899998888533 35566664433 234689999999
Q ss_pred CCchHH----------------hh---hcCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 009979 266 NGNLEQ----------------WL---HGDVGPHSPLTWEI---------RMNI------------ILGTAK-GLTYLHE 304 (521)
Q Consensus 266 ~g~L~~----------------~l---~~~~~~~~~l~~~~---------~~~i------------~~~ia~-al~~LH~ 304 (521)
|..+.. .+ +............. .... ...+.. .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 987777 11 22211111111111 0000 011222 2333332
Q ss_pred c----CCCCeeecCCCCCCeEeC-CCCCceEeeccccee
Q 009979 305 G----LEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKL 338 (521)
Q Consensus 305 ~----~~~~iiHrDik~~NILl~-~~~~vkL~DFGla~~ 338 (521)
. ....++|+|+.+.|||++ +++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1 234799999999999999 556667999998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=7.2e-08 Score=100.94 Aligned_cols=187 Identities=18% Similarity=0.121 Sum_probs=134.5
Q ss_pred CCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCC-eeeEEEEEeeCCeeeEEEEec
Q 009979 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn-iv~l~~~~~~~~~~~lV~e~~ 264 (521)
.-+..-+.+++|+++.+++.+....+....+.+... .....++++|.+++||| .++.++-+..+...+++|+++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 345556678999999999987533333344544332 44566899999999999 777777777788889999999
Q ss_pred cCC-chHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 265 DNG-NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 265 ~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
.++ +-...... ....+.......+...-.++++|||+. .=+|+| ||+..+ +..|..||+....+....
T Consensus 317 s~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 317 STGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred cCCccccccCCh---hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc
Confidence 876 22211110 012233344555666677899999986 458998 777766 678999999998765432
Q ss_pred cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCC
Q 009979 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPV 390 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf 390 (521)
......+|+.|+|||+...+.+..+-|+|++|+=..++--|-.|-
T Consensus 386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 345567999999999999999999999999998666666666553
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.29 E-value=9.3e-06 Score=76.90 Aligned_cols=136 Identities=21% Similarity=0.225 Sum_probs=92.2
Q ss_pred ceEccCCcEEEEEEEEcCCcEEEEEEeccCChhh------------------------HHHHHHHHHHHhcCC--CCCee
Q 009979 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQA------------------------EKEFKVEVEAIGRVR--HKNLV 245 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~------------------------~~~~~~Ei~~l~~l~--hpniv 245 (521)
..|+.|--..||+|...++..+|+|+........ ......|+.-|+++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 4677888899999998789999999885432110 112345777777663 44555
Q ss_pred eEEEEEeeCCeeeEEEEeccCC-chHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC
Q 009979 246 RLLGYCAEGAHRMLVYEYIDNG-NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK 324 (521)
Q Consensus 246 ~l~~~~~~~~~~~lV~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~ 324 (521)
+.+++..+ .|||||+... .-.-.|.. -++.......+..++++.+.-|-..+ ++||+||+.-|||+.
T Consensus 134 ~Pi~~~~n----VLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~- 201 (268)
T COG1718 134 EPIAFRNN----VLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH- 201 (268)
T ss_pred CceeecCC----eEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-
Confidence 66655443 7999999542 11111111 12233356666777777777776522 999999999999999
Q ss_pred CCCceEeecccceec
Q 009979 325 QWNPKLSDFGLAKLL 339 (521)
Q Consensus 325 ~~~vkL~DFGla~~~ 339 (521)
++.+.|+|||-|...
T Consensus 202 ~~~p~iID~~QaV~~ 216 (268)
T COG1718 202 DGEPYIIDVSQAVTI 216 (268)
T ss_pred CCeEEEEECcccccc
Confidence 789999999988754
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.1e-05 Score=78.06 Aligned_cols=142 Identities=16% Similarity=0.141 Sum_probs=85.7
Q ss_pred eEccCCc-EEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCeeeEEEEeccCCchH
Q 009979 193 VIGEGGY-GIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYIDNGNLE 270 (521)
Q Consensus 193 ~LG~G~f-G~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~~~g~L~ 270 (521)
.|..|.+ ..||+.... +..+.+|...... ...+..|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3555665 689998764 4678888764432 345677888888874 445667888777666679999999987665
Q ss_pred Hhh-------------------hcCCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHhc----
Q 009979 271 QWL-------------------HGDVGPHSPLTWE--IRMNIIL--------------------GTAKGLTYLHEG---- 305 (521)
Q Consensus 271 ~~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------~ia~al~~LH~~---- 305 (521)
... |.......++... ....... .+...+..|-..
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 431 2111001111100 0000000 011112222111
Q ss_pred CCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 306 ~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
..+.++|+|+.+.|||+++++.+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 134699999999999999987788999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.1e-05 Score=72.24 Aligned_cols=128 Identities=23% Similarity=0.324 Sum_probs=92.2
Q ss_pred cceEccCCcEEEEEEEEcCCcEEEEEEeccCC----------------hhhHHHHHHHHHHHhcCC------CCCeeeEE
Q 009979 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR----------------GQAEKEFKVEVEAIGRVR------HKNLVRLL 248 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~Ei~~l~~l~------hpniv~l~ 248 (521)
...||+|+.=.||.- .++...+||+..... ....++..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 457999999999954 455667899887655 122355666776666655 88999999
Q ss_pred EEEeeCCeeeEEEEeccC------CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe
Q 009979 249 GYCAEGAHRMLVYEYIDN------GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL 322 (521)
Q Consensus 249 ~~~~~~~~~~lV~e~~~~------g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl 322 (521)
|+.+.+.-..+|+|.+.+ -+|.+++... .++. ..... +-+-..||-++ .|+.+|++|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~~~~~---L~~f~~~l~~~---~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-ELRQA---LDEFKRYLLDH---HIVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-HHHHH---HHHHHHHHHHc---CCeecCCCcccEEE
Confidence 999999888999998754 3688888543 3444 33333 33456777777 89999999999999
Q ss_pred CCC--C--CceEee
Q 009979 323 DKQ--W--NPKLSD 332 (521)
Q Consensus 323 ~~~--~--~vkL~D 332 (521)
..+ + .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 432 2 477887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.16 E-value=9.1e-06 Score=75.33 Aligned_cols=104 Identities=22% Similarity=0.253 Sum_probs=82.2
Q ss_pred HHHHHHhcCCC-CCeeeEEEEEeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 009979 231 VEVEAIGRVRH-KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309 (521)
Q Consensus 231 ~Ei~~l~~l~h-pniv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ 309 (521)
.|.-+|+.+++ +++++++|+|-. ++|.||...+++..... ........+|..+.+|+.++++.+++|+......
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~-~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYR-PLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccc-ccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 48888888876 699999999954 78999998776543200 0011235689999999999999999999854446
Q ss_pred eeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 310 iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
+.-.|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.5e-05 Score=71.51 Aligned_cols=129 Identities=19% Similarity=0.302 Sum_probs=90.2
Q ss_pred ccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCee-eEEEEEeeCCeeeEEEEeccC
Q 009979 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV-RLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv-~l~~~~~~~~~~~lV~e~~~~ 266 (521)
....+.|++|++|.||+|.+. |..+|+|+-..+ .....+..|+++|..+.--++- +++.|..+ ++.|||++|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G 96 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDG 96 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcC
Confidence 345678999999999999996 568899975433 3446788899999998866654 45544333 566999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC--CCeEeCCCCCceEeeccccee
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKS--SNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~--~NILl~~~~~vkL~DFGla~~ 338 (521)
-.|.++-... +.+. +..++++-.-|-.. ||-|..|.- .||++.++ .+.|+||.-|+.
T Consensus 97 ~~L~~~~~~~-------~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIGG-------DRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDR-DVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhcc-------cHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence 8887765421 1222 33455554444444 999999875 45555554 899999998874
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.9e-05 Score=88.41 Aligned_cols=148 Identities=13% Similarity=0.225 Sum_probs=91.8
Q ss_pred cceEccCCcEEEEEEEEcCC---cEEEEEEeccCC-hhhHHHHHHHHHHHhcCC-CCCe--eeEEEEEeeC---CeeeEE
Q 009979 191 ENVIGEGGYGIVYHGVLEDN---TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVR-HKNL--VRLLGYCAEG---AHRMLV 260 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-hpni--v~l~~~~~~~---~~~~lV 260 (521)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |.++ .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999887543 367777654322 123356889999999995 6654 7888888764 357899
Q ss_pred EEeccCCchHH--------------------h---hhcCCCC-------CCCCCH--HHHHHHH---------------H
Q 009979 261 YEYIDNGNLEQ--------------------W---LHGDVGP-------HSPLTW--EIRMNII---------------L 293 (521)
Q Consensus 261 ~e~~~~g~L~~--------------------~---l~~~~~~-------~~~l~~--~~~~~i~---------------~ 293 (521)
|||++|..+.+ . ||..... ..+..+ .....+. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998754321 1 1221100 001111 1111110 1
Q ss_pred HHHHHHHHHHhcCC--------CCeeecCCCCCCeEeCC-CCC-ceEeeccccee
Q 009979 294 GTAKGLTYLHEGLE--------PKVVHRDIKSSNILLDK-QWN-PKLSDFGLAKL 338 (521)
Q Consensus 294 ~ia~al~~LH~~~~--------~~iiHrDik~~NILl~~-~~~-vkL~DFGla~~ 338 (521)
.+...+.+|..+.. +.+||+|+++.|||++. ++. +-|.||.++..
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 12334566654321 35999999999999975 333 57999999875
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.3e-05 Score=84.82 Aligned_cols=140 Identities=20% Similarity=0.247 Sum_probs=86.9
Q ss_pred cceEccCCcEEEEEEEEcCCcEEEEEEeccCChhh-------------------------------HH------HHHHHH
Q 009979 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQA-------------------------------EK------EFKVEV 233 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~Ei 233 (521)
.+.||.-..|.||+|+.++|+.||||+-.+.-... .+ +|..|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 36799999999999999999999999775431110 01 122333
Q ss_pred HHHh----cCCCCC---eeeEEEEEee-CCeeeEEEEeccCCchHHh--hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 009979 234 EAIG----RVRHKN---LVRLLGYCAE-GAHRMLVYEYIDNGNLEQW--LHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303 (521)
Q Consensus 234 ~~l~----~l~hpn---iv~l~~~~~~-~~~~~lV~e~~~~g~L~~~--l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH 303 (521)
+-.. .+.|-+ -|.+=.++++ .....|+||||+|..+.+. |.+. .++...+..-+.+.. ++.+=
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~-----gi~~~~i~~~l~~~~--~~qIf 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR-----GISPHDILNKLVEAY--LEQIF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc-----CCCHHHHHHHHHHHH--HHHHH
Confidence 3322 234555 1222233333 2456899999999866554 3332 344443333333222 11122
Q ss_pred hcCCCCeeecCCCCCCeEeCC----CCCceEeecccceecC
Q 009979 304 EGLEPKVVHRDIKSSNILLDK----QWNPKLSDFGLAKLLG 340 (521)
Q Consensus 304 ~~~~~~iiHrDik~~NILl~~----~~~vkL~DFGla~~~~ 340 (521)
.. |++|.|=.|.||+++. ++.+.+-|||+...+.
T Consensus 319 ~~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 319 KT---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred hc---CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 22 8999999999999983 6779999999998653
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00011 Score=73.31 Aligned_cols=78 Identities=10% Similarity=0.050 Sum_probs=57.1
Q ss_pred cccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCC---CCeeeEEEEEeeC---CeeeEEEE
Q 009979 189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH---KNLVRLLGYCAEG---AHRMLVYE 262 (521)
Q Consensus 189 ~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h---pniv~l~~~~~~~---~~~~lV~e 262 (521)
.-.+.||.|..+.||+....++ .+++|..+. ......+..|.+.|+.+.- ..+.+++++|..+ +..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3456799999999999876555 466676432 1133578889999988853 4678888887543 55799999
Q ss_pred eccCCch
Q 009979 263 YIDNGNL 269 (521)
Q Consensus 263 ~~~~g~L 269 (521)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00012 Score=67.76 Aligned_cols=125 Identities=26% Similarity=0.390 Sum_probs=89.1
Q ss_pred CCccccceEccCCc-EEEEEEEEcCCcEEEEEEeccC----------C-h----------hhHHHHHHHHHHHhcCC---
Q 009979 186 NGFADENVIGEGGY-GIVYHGVLEDNTNVAVKNLLNN----------R-G----------QAEKEFKVEVEAIGRVR--- 240 (521)
Q Consensus 186 ~~~~~~~~LG~G~f-G~Vy~~~~~~~~~vavK~~~~~----------~-~----------~~~~~~~~Ei~~l~~l~--- 240 (521)
.+++..+.||.|.- |.||++... |..||+|....- . . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 57888999999999 999999985 779999983210 0 0 11245778888888775
Q ss_pred CCCe--eeEEEEEeeC------------------CeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHH
Q 009979 241 HKNL--VRLLGYCAEG------------------AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300 (521)
Q Consensus 241 hpni--v~l~~~~~~~------------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~ 300 (521)
+.++ |+.+||..-. ....||.||++... .++... +.++.+-+.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~~----~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIRD----IPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchhH----HHHHHHHHH
Confidence 4566 8999987322 11357888876522 222233 335666788
Q ss_pred HHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 301 ~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.+|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 89988 9999999999985 3489999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.92 E-value=8.6e-05 Score=71.51 Aligned_cols=73 Identities=14% Similarity=0.221 Sum_probs=45.9
Q ss_pred ceEccCCcE-EEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCC---CeeeEEEEEeeC---CeeeEEEEec
Q 009979 192 NVIGEGGYG-IVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK---NLVRLLGYCAEG---AHRMLVYEYI 264 (521)
Q Consensus 192 ~~LG~G~fG-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hp---niv~l~~~~~~~---~~~~lV~e~~ 264 (521)
+.|+.||.. .||+. +..+++|.... ......+..|+++++.+... .+.++++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777766 59975 23577776433 22345788899999887532 344455444332 2347899999
Q ss_pred cCCchH
Q 009979 265 DNGNLE 270 (521)
Q Consensus 265 ~~g~L~ 270 (521)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 986653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00022 Score=68.58 Aligned_cols=142 Identities=18% Similarity=0.182 Sum_probs=80.9
Q ss_pred ceEccCCcEEEEEEEEcC--CcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCC-eeeEEEEEeeCCeeeEEEEeccCCc
Q 009979 192 NVIGEGGYGIVYHGVLED--NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLVYEYIDNGN 268 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn-iv~l~~~~~~~~~~~lV~e~~~~g~ 268 (521)
+.|..|-...+|+....+ +..|++|....... ..-+...|+.+++.+...+ .+++++.+. -.+||||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567778888999998654 57888886643322 1123346888888885333 444544433 248999999865
Q ss_pred hHHh-----------------hhcCCCCC-------CCC-CHHHHHHHHH----------------------HHHHHHHH
Q 009979 269 LEQW-----------------LHGDVGPH-------SPL-TWEIRMNIIL----------------------GTAKGLTY 301 (521)
Q Consensus 269 L~~~-----------------l~~~~~~~-------~~l-~~~~~~~i~~----------------------~ia~al~~ 301 (521)
+... +|...... ... .+..+..+.. .+...+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 5211 12211111 011 1122111111 11111111
Q ss_pred H----Hhc-CCCCeeecCCCCCCeEeCC-CCCceEeeccccee
Q 009979 302 L----HEG-LEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAKL 338 (521)
Q Consensus 302 L----H~~-~~~~iiHrDik~~NILl~~-~~~vkL~DFGla~~ 338 (521)
| -.. ....++|+|+.+.|||+++ ++.+.|+||..|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1 111 2346999999999999997 57899999987763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00011 Score=71.62 Aligned_cols=139 Identities=14% Similarity=0.084 Sum_probs=78.9
Q ss_pred EccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCe-eeEEEEEeeCCeeeEEEEeccCCchHHh
Q 009979 194 IGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYIDNGNLEQW 272 (521)
Q Consensus 194 LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpni-v~l~~~~~~~~~~~lV~e~~~~g~L~~~ 272 (521)
+..|-.+.+|+... ++..+++|..........-....|.++++.+..-++ .+++..+. .++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677789998874 467788886543322211235678888888864333 34444432 3799999998654321
Q ss_pred -----------------hhcCCCCCCCCCHHH-HHHHHHHH---------HHHHHHHHhc-----CCCCeeecCCCCCCe
Q 009979 273 -----------------LHGDVGPHSPLTWEI-RMNIILGT---------AKGLTYLHEG-----LEPKVVHRDIKSSNI 320 (521)
Q Consensus 273 -----------------l~~~~~~~~~l~~~~-~~~i~~~i---------a~al~~LH~~-----~~~~iiHrDik~~NI 320 (521)
||.......+++... ...+..++ ...+..+-.. ..+.++|+|+.+.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 232211112222221 11111111 1112222111 123589999999999
Q ss_pred EeCCCCCceEeeccccee
Q 009979 321 LLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 321 Ll~~~~~vkL~DFGla~~ 338 (521)
++++++ +.|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 89999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.72 E-value=9.5e-05 Score=83.04 Aligned_cols=198 Identities=20% Similarity=0.251 Sum_probs=136.7
Q ss_pred HHHHHHHHHHhcCCCCCeeeEEEEEeeCCee----eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 009979 227 KEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR----MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302 (521)
Q Consensus 227 ~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~----~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~L 302 (521)
.....|++.+.++.|+|++.++.|-.+.... .+..++|..-++.+.+..- ...+..+.+.+..++..||+|+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v----~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV----GSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc----cccCHHHHHHHHHHHhhhHHHH
Confidence 3345578888899999999999987665433 2445778777888777654 5788889989999999999999
Q ss_pred HhcCCCCeeecCCCCC---CeEeCCCCCceEe--ecccceecCCCCcceeecccccccccccccccCCCCCC--cccchh
Q 009979 303 HEGLEPKVVHRDIKSS---NILLDKQWNPKLS--DFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE--RSDVYS 375 (521)
Q Consensus 303 H~~~~~~iiHrDik~~---NILl~~~~~vkL~--DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDvwS 375 (521)
|+. ...|.-+..+ +...+..+.+.++ ||+.++.+....... ...-+..|.++|......+.. ..|+|.
T Consensus 303 h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 303 HSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred HHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHH
Confidence 998 6666655555 5555666777777 999888765433222 223456788888776665554 479999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 009979 376 FGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHV 455 (521)
Q Consensus 376 ~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~ev 455 (521)
+|..+..+..|..+-...... ..+++ ..+.. .+.+...+|+..++++|+.+.++
T Consensus 378 lgll~~~~~~~~~i~~~~~~~------------------~~~l~-----~~~~~---~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSAVP------------------VSLLD-----VLSTS---ELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHHhhhhhcCcccccccch------------------hhhhc-----cccch---hhhhhhhhhcchhhhhccchhhh
Confidence 999999999876553211100 01111 11111 23446669999999999999999
Q ss_pred HHHh
Q 009979 456 IHML 459 (521)
Q Consensus 456 l~~L 459 (521)
+.+.
T Consensus 432 l~~~ 435 (1351)
T KOG1035|consen 432 LTHP 435 (1351)
T ss_pred hhch
Confidence 8654
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00061 Score=70.35 Aligned_cols=75 Identities=19% Similarity=0.236 Sum_probs=53.7
Q ss_pred cceEccCCcEEEEEEEEcCC-cEEEEEEeccC-----C--hhhHHHHHHHHHHHhcCC---CCCeeeEEEEEeeCCeeeE
Q 009979 191 ENVIGEGGYGIVYHGVLEDN-TNVAVKNLLNN-----R--GQAEKEFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~Ei~~l~~l~---hpniv~l~~~~~~~~~~~l 259 (521)
.+.||.|.+..||++...+| +.++||.-... . ....+.+..|.+.|+.+. ..++.+++.+. ....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 35799999999999998776 48999975321 1 123456677888888763 34677777763 355689
Q ss_pred EEEeccCC
Q 009979 260 VYEYIDNG 267 (521)
Q Consensus 260 V~e~~~~g 267 (521)
||||+++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99999863
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00034 Score=69.75 Aligned_cols=144 Identities=16% Similarity=0.159 Sum_probs=85.2
Q ss_pred cceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCC--CeeeEEEE------EeeCCeeeEEEE
Q 009979 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK--NLVRLLGY------CAEGAHRMLVYE 262 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hp--niv~l~~~------~~~~~~~~lV~e 262 (521)
.+.|..|....+|+.... +..+++|.... .....+..|++++..+.+. .+.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 556777888899998764 44688887654 2345566788888777432 24454431 123345689999
Q ss_pred eccCCchHH--------------hhhcCCC----C---CCCCCHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 009979 263 YIDNGNLEQ--------------WLHGDVG----P---HSPLTWEIRM----------NIILGTAKGLTYLHE----GLE 307 (521)
Q Consensus 263 ~~~~g~L~~--------------~l~~~~~----~---~~~l~~~~~~----------~i~~~ia~al~~LH~----~~~ 307 (521)
|++|..+.. .+|.... . .....|.... .....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998865421 0121100 0 0111111110 011112334455443 123
Q ss_pred CCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 308 ~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
.+++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999887778999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0016 Score=65.44 Aligned_cols=146 Identities=16% Similarity=0.199 Sum_probs=83.5
Q ss_pred ccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCC--eeeEEEE------EeeCCeeeEEE
Q 009979 190 DENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLLGY------CAEGAHRMLVY 261 (521)
Q Consensus 190 ~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn--iv~l~~~------~~~~~~~~lV~ 261 (521)
..+.++.|....+|+....++ .+++|...... ..+.+..|++++..|...+ +.+++.. ....+..+++|
T Consensus 26 ~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred eccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 356677777789999876544 67888764422 2344556777777764222 3444432 12235568999
Q ss_pred EeccCCchH-----------H---hhhcCCCC---CC-----CCCHHHHH------------HHHHHHHHHHHHHHh---
Q 009979 262 EYIDNGNLE-----------Q---WLHGDVGP---HS-----PLTWEIRM------------NIILGTAKGLTYLHE--- 304 (521)
Q Consensus 262 e~~~~g~L~-----------~---~l~~~~~~---~~-----~l~~~~~~------------~i~~~ia~al~~LH~--- 304 (521)
+|++|..+. . .+|..... .. .-.|.... .....+...++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 999885431 0 12221110 00 00111100 001123334555542
Q ss_pred -cCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 305 -GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 305 -~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
....+++|+|+.+.||++++++.+.|+||+.+..
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 1245899999999999999887778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00094 Score=66.82 Aligned_cols=142 Identities=25% Similarity=0.291 Sum_probs=82.9
Q ss_pred ceEccCCcEEEEEEEEcC-------CcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCC-eeeEEEEEeeCCeeeEEEEe
Q 009979 192 NVIGEGGYGIVYHGVLED-------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn-iv~l~~~~~~~~~~~lV~e~ 263 (521)
+.|..|--..||+....+ +..+++|...... ........|++++..+...+ ..++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456666677999988654 4788899865432 22345567888888775333 3455655542 468999
Q ss_pred ccCCchHHh-----------------hhcCCCCC-C----CCC--HHHHHH--------------------------HHH
Q 009979 264 IDNGNLEQW-----------------LHGDVGPH-S----PLT--WEIRMN--------------------------IIL 293 (521)
Q Consensus 264 ~~~g~L~~~-----------------l~~~~~~~-~----~l~--~~~~~~--------------------------i~~ 293 (521)
++|..+... +|...... . ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988665321 12221110 0 111 111111 011
Q ss_pred HHHHHHHHHHh------cCCCCeeecCCCCCCeEeCCC----CCceEeeccccee
Q 009979 294 GTAKGLTYLHE------GLEPKVVHRDIKSSNILLDKQ----WNPKLSDFGLAKL 338 (521)
Q Consensus 294 ~ia~al~~LH~------~~~~~iiHrDik~~NILl~~~----~~vkL~DFGla~~ 338 (521)
.+...+.+|-. .....++|+|+.+.|||++++ +.++++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 12222334432 134579999999999999875 8899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.43 E-value=1.8e-05 Score=90.43 Aligned_cols=161 Identities=14% Similarity=0.033 Sum_probs=119.5
Q ss_pred HHHHHHHHhcCCCCCeeeEEEEEe--eCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 009979 229 FKVEVEAIGRVRHKNLVRLLGYCA--EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306 (521)
Q Consensus 229 ~~~Ei~~l~~l~hpniv~l~~~~~--~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~ 306 (521)
...|...++...|+++.....-.. +....+.+++|+.+|++++.|-+......++........-.+...+..-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 344666677778999887665443 234568999999999999999776555555555544444334355555555442
Q ss_pred --CCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHH
Q 009979 307 --EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 384 (521)
Q Consensus 307 --~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ell 384 (521)
..-.+|+++|+-|.+|..+-++|++++|+.+....... ......+++.|+.|+..+.-.++.++|+|..|+-+|++.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s-f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS-FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHh-hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 22378999999999999999999999999994433322 234456788999999999999999999999999999998
Q ss_pred hCCCCC
Q 009979 385 SGRNPV 390 (521)
Q Consensus 385 tG~~Pf 390 (521)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887765
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0043 Score=62.56 Aligned_cols=144 Identities=13% Similarity=0.145 Sum_probs=77.9
Q ss_pred cceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCC--CeeeEEE------EEeeCCeeeEEEE
Q 009979 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK--NLVRLLG------YCAEGAHRMLVYE 262 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hp--niv~l~~------~~~~~~~~~lV~e 262 (521)
.+.|+.|....+|+....++ .+++|+... ...+.+..|+.++..|... .+.+.+. +....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 34577788789999887655 688897652 1223444455666555311 1333332 1223456789999
Q ss_pred eccCCchH-----------Hh---hhcCCCC-------CCCCCH-HHHHH------------HHHH-HHHHHHHHHhc--
Q 009979 263 YIDNGNLE-----------QW---LHGDVGP-------HSPLTW-EIRMN------------IILG-TAKGLTYLHEG-- 305 (521)
Q Consensus 263 ~~~~g~L~-----------~~---l~~~~~~-------~~~l~~-~~~~~------------i~~~-ia~al~~LH~~-- 305 (521)
|++|..+. .. +|..... ...+.+ ..... .+.+ +...++.+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 99886431 11 1221100 001111 11111 1111 11122333211
Q ss_pred --CCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 306 --LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 306 --~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
...++||+|+.+.|||++++...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 244899999999999999765568999998863
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00024 Score=69.75 Aligned_cols=143 Identities=17% Similarity=0.114 Sum_probs=92.9
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEec----------cCC------hhh------HHHHHHHHHH
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLL----------NNR------GQA------EKEFKVEVEA 235 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~----------~~~------~~~------~~~~~~Ei~~ 235 (521)
++.+.....-+.+.+.||-|--+.||.+.+.+|++.++|.-. .++ ... .-....|...
T Consensus 84 lktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfaf 163 (465)
T KOG2268|consen 84 LKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAF 163 (465)
T ss_pred HHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHH
Confidence 333333333467889999999999999999889999988431 111 000 0123358888
Q ss_pred HhcCC-CC-CeeeEEEEEeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 009979 236 IGRVR-HK-NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313 (521)
Q Consensus 236 l~~l~-hp-niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHr 313 (521)
|+.|. |. -+.+.+++. ..++|||++.|-.|.+.-+- .....+.. .+..-+--|-.+ |+||+
T Consensus 164 mkaL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly~---~lm~~Iv~la~~---GlIHg 226 (465)
T KOG2268|consen 164 MKALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVRHV-------EDPPTLYD---DLMGLIVRLANH---GLIHG 226 (465)
T ss_pred HHHHHHcCCCCCCccccc----ceeeHHHhhcccceeeeeec-------CChHHHHH---HHHHHHHHHHHc---Cceec
Confidence 88875 32 234444443 34899999998777664321 12222222 222234445555 99999
Q ss_pred CCCCCCeEeCCCCCceEeecccce
Q 009979 314 DIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 314 Dik~~NILl~~~~~vkL~DFGla~ 337 (521)
|..--||++++++.++++||--..
T Consensus 227 DFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 227 DFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred ccchheeEEecCCCEEEeechHhh
Confidence 999999999999999999996543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0047 Score=61.18 Aligned_cols=76 Identities=14% Similarity=0.223 Sum_probs=48.4
Q ss_pred ccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCC---CCCeeeEEEEEeeCCeeeEEEEec
Q 009979 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
.+..+.|+.|....+|+.. .+++.+.||.-. ......|..|++-|+.|. --.+.+++++....+..+|||||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3445678989999999987 568889999765 233456777888887773 456778898887777779999999
Q ss_pred cCC
Q 009979 265 DNG 267 (521)
Q Consensus 265 ~~g 267 (521)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 875
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0073 Score=60.36 Aligned_cols=138 Identities=20% Similarity=0.232 Sum_probs=83.9
Q ss_pred cceEccCCcEEEEEEEEcCCcEEEEEEecc--CChhhHHHHHHHHHHHhcCCC--CCeeeEEEEEeeCC--eeeEEEEec
Q 009979 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLN--NRGQAEKEFKVEVEAIGRVRH--KNLVRLLGYCAEGA--HRMLVYEYI 264 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h--pniv~l~~~~~~~~--~~~lV~e~~ 264 (521)
.+.+..|..-.+|..... ++++++. ... ..........+|+++|+.+.- .-+...+++|.++. ..+.||+|+
T Consensus 30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 344433433355555443 6777777 221 222334566778888887742 34456677777766 669999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHH-HHHHHHHHHHH----------------------------------------
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNII-LGTAKGLTYLH---------------------------------------- 303 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~-~~ia~al~~LH---------------------------------------- 303 (521)
+|..+.+.+... ... .+++ ..++..|+-||
T Consensus 108 eGe~~~~~~~~~-----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 108 EGEVVWSALPPE-----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred cceeccCcCCcc-----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 985333322111 000 1111 24444444444
Q ss_pred ----------hcC-----CCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 304 ----------EGL-----EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 304 ----------~~~-----~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
.+. .+.++|+|+.+.||+++..+-+=+.||+++.+-
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 221 346999999999999998888999999999864
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0072 Score=60.64 Aligned_cols=140 Identities=16% Similarity=0.177 Sum_probs=91.7
Q ss_pred cccceEccCCcEEEEEEEEcCCcEEEEEEeccCC----------------------hhhH----HHHHHHHHHHhcCCCC
Q 009979 189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR----------------------GQAE----KEFKVEVEAIGRVRHK 242 (521)
Q Consensus 189 ~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~----~~~~~Ei~~l~~l~hp 242 (521)
.+...|..|--..||.|...+|..+|||+++... .... -....|++-|++|+.-
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4456789999999999998899999999874320 0001 1223477777777544
Q ss_pred CeeeEEEEEeeCCeeeEEEEeccCCch-HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeE
Q 009979 243 NLVRLLGYCAEGAHRMLVYEYIDNGNL-EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321 (521)
Q Consensus 243 niv~l~~~~~~~~~~~lV~e~~~~g~L-~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NIL 321 (521)
.|.-.--+.. ....|||+|+..... .-.|+ .-.++...+..+-.+++.-+.-|-..| .+||.||.--|+|
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~L 297 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLL 297 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhhe
Confidence 4332111111 123799999953111 11122 235566667777778888888777666 8999999999999
Q ss_pred eCCCCCceEeeccccee
Q 009979 322 LDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 322 l~~~~~vkL~DFGla~~ 338 (521)
+-+ |.+.|+|-+-+-.
T Consensus 298 yhd-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 298 YHD-GKLYIIDVSQSVE 313 (520)
T ss_pred EEC-CEEEEEEcccccc
Confidence 865 5799999877654
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.01 Score=58.57 Aligned_cols=31 Identities=32% Similarity=0.496 Sum_probs=26.1
Q ss_pred CCeeecCCCCCCeEeCCCCC-ceEeeccccee
Q 009979 308 PKVVHRDIKSSNILLDKQWN-PKLSDFGLAKL 338 (521)
Q Consensus 308 ~~iiHrDik~~NILl~~~~~-vkL~DFGla~~ 338 (521)
+.++|+|+.+.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999998875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.023 Score=58.00 Aligned_cols=142 Identities=19% Similarity=0.205 Sum_probs=80.8
Q ss_pred ceEccCCcEEEEEEEEcC-----CcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCe-eeEEEEEeeCCeeeEEEEecc
Q 009979 192 NVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYID 265 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpni-v~l~~~~~~~~~~~lV~e~~~ 265 (521)
..|-.|-.-.+|++...+ +..|++|.......... +-..|..+++.+..-++ .++++.+..+ .|++|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 355557778999987542 35788887755432222 23568888888854333 3556665432 5899998
Q ss_pred CCchHHh-----------------hhcCCCCCC--CCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 009979 266 NGNLEQW-----------------LHGDVGPHS--PLTWEIRMNIILGT-----------------AKGLTYL----HE- 304 (521)
Q Consensus 266 ~g~L~~~-----------------l~~~~~~~~--~l~~~~~~~i~~~i-----------------a~al~~L----H~- 304 (521)
+.+|... +|....... ...+.....+..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7665321 222211111 11223322332111 1112222 21
Q ss_pred cCCCCeeecCCCCCCeEeCC-CCCceEeeccccee
Q 009979 305 GLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAKL 338 (521)
Q Consensus 305 ~~~~~iiHrDik~~NILl~~-~~~vkL~DFGla~~ 338 (521)
.....++|+|+++.|||+++ ++.+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 12346899999999999986 46799999988864
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.02 Score=57.37 Aligned_cols=30 Identities=27% Similarity=0.362 Sum_probs=26.2
Q ss_pred CCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 308 ~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 48999999999999988 6789999997653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.024 Score=56.93 Aligned_cols=32 Identities=22% Similarity=0.321 Sum_probs=28.6
Q ss_pred CCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 307 ~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
..+++|+|+.+.|||+++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34799999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.033 Score=56.62 Aligned_cols=72 Identities=18% Similarity=0.267 Sum_probs=47.1
Q ss_pred eEccCCcEEEEEEEEcCC-cEEEEEEeccC-------ChhhHHHHHHHHHHHhcCC--CC-CeeeEEEEEeeCCeeeEEE
Q 009979 193 VIGEGGYGIVYHGVLEDN-TNVAVKNLLNN-------RGQAEKEFKVEVEAIGRVR--HK-NLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 193 ~LG~G~fG~Vy~~~~~~~-~~vavK~~~~~-------~~~~~~~~~~Ei~~l~~l~--hp-niv~l~~~~~~~~~~~lV~ 261 (521)
.||.|....||++...++ +.|+||.-... -.-..+....|.+.|+... .| .+.+++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997654 57999976321 1122344556778887663 34 45555543 444557999
Q ss_pred EeccC
Q 009979 262 EYIDN 266 (521)
Q Consensus 262 e~~~~ 266 (521)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.028 Score=56.75 Aligned_cols=142 Identities=20% Similarity=0.256 Sum_probs=82.4
Q ss_pred eEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCC---CC---eeeEEE----EEeeCCeeeEEEE
Q 009979 193 VIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH---KN---LVRLLG----YCAEGAHRMLVYE 262 (521)
Q Consensus 193 ~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h---pn---iv~l~~----~~~~~~~~~lV~e 262 (521)
.|.+ .-..||+....++.. ++|..... ....++..|+..|..|.- += +..+-| ....+...+-|++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 446799998876665 88877554 455677778888887731 11 222212 1222236678999
Q ss_pred eccCCchHH-h--------------hhc----C----CCCCCCCCHHH-------------HHHHHHHHHHHHHHHHhcC
Q 009979 263 YIDNGNLEQ-W--------------LHG----D----VGPHSPLTWEI-------------RMNIILGTAKGLTYLHEGL 306 (521)
Q Consensus 263 ~~~~g~L~~-~--------------l~~----~----~~~~~~l~~~~-------------~~~i~~~ia~al~~LH~~~ 306 (521)
|++|..+.. . ||. . ........|.. ......++...+..+.+..
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999876662 1 111 1 00111223330 0112223334444444322
Q ss_pred ----CCC---eeecCCCCCCeEeCCCCC-ceEeeccccee
Q 009979 307 ----EPK---VVHRDIKSSNILLDKQWN-PKLSDFGLAKL 338 (521)
Q Consensus 307 ----~~~---iiHrDik~~NILl~~~~~-vkL~DFGla~~ 338 (521)
... +||+|+.+.||+++.+.. +-++|||.+..
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 223 999999999999998885 89999998863
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.086 Score=54.57 Aligned_cols=73 Identities=15% Similarity=0.256 Sum_probs=50.0
Q ss_pred cceEccCCcEEEEEEEEcCCcEEEEEEeccCC---h----hhHHHHHHHHHHHhcCC---CCCeeeEEEEEeeCCeeeEE
Q 009979 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR---G----QAEKEFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~---~----~~~~~~~~Ei~~l~~l~---hpniv~l~~~~~~~~~~~lV 260 (521)
.+.||.|....||+.... +..++||.-.... . .....-..|++.|+.+. ..++.+++.++.+ ..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence 567899999999998874 5568999764211 1 12333344566666553 3578889988874 35889
Q ss_pred EEeccC
Q 009979 261 YEYIDN 266 (521)
Q Consensus 261 ~e~~~~ 266 (521)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.03 Score=56.78 Aligned_cols=142 Identities=20% Similarity=0.281 Sum_probs=77.8
Q ss_pred ceEccCCcEEEEEEEEcC----CcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCe-eeEEEEEeeCCeeeEEEEeccC
Q 009979 192 NVIGEGGYGIVYHGVLED----NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpni-v~l~~~~~~~~~~~lV~e~~~~ 266 (521)
+.|..|=-..+|+....+ +..|++|........ .-+-.+|..+++.+..-++ .++++++.. + +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcC
Confidence 345446667889887543 237888876543321 2223568888888865444 355666532 2 58999877
Q ss_pred CchHH-----------------hhhcCCCCCC--CCCHHHHHHHHHHH----------------------HHHHHHHHh-
Q 009979 267 GNLEQ-----------------WLHGDVGPHS--PLTWEIRMNIILGT----------------------AKGLTYLHE- 304 (521)
Q Consensus 267 g~L~~-----------------~l~~~~~~~~--~l~~~~~~~i~~~i----------------------a~al~~LH~- 304 (521)
..|.. .+|....... +-.+.....+..++ ..-+..+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 55421 1122211111 11223222222111 111222211
Q ss_pred ----cCCCCeeecCCCCCCeEeCC-CCCceEeeccccee
Q 009979 305 ----GLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAKL 338 (521)
Q Consensus 305 ----~~~~~iiHrDik~~NILl~~-~~~vkL~DFGla~~ 338 (521)
....-++|.|+.+.|||+++ ++.++++||..|-.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11224799999999999974 57899999998854
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.02 Score=53.56 Aligned_cols=150 Identities=17% Similarity=0.130 Sum_probs=90.7
Q ss_pred CCcEEEEEEEEcCCcEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCCchHHhhhc
Q 009979 197 GGYGIVYHGVLEDNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG 275 (521)
Q Consensus 197 G~fG~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~ 275 (521)
|+..+.-.+..+-| ...+|++..-.-. ...-|..+..+++++. .|+++..= +.-.+.++.|+|..-.
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~------- 140 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK------- 140 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-------
Confidence 44455555554333 3566776543333 3455677888888774 46666621 3334568999985311
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcceeeccccccc
Q 009979 276 DVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355 (521)
Q Consensus 276 ~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~ 355 (521)
-. -..++..=..+|.-.|+. ..+.+|+|..|+||+-|..|.+||.|-+..-. . +.-
T Consensus 141 ------i~----~~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~----~---------~V~ 196 (308)
T PF07387_consen 141 ------IN----FSNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE----N---------QVN 196 (308)
T ss_pred ------cc----hhHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh----h---------eee
Confidence 11 122222224678888964 55899999999999999999999999764421 0 112
Q ss_pred ccccccccCCCCCCcccchhHHHHHHHHHh
Q 009979 356 YVAPEYASTGMLNERSDVYSFGILIMEVIS 385 (521)
Q Consensus 356 y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt 385 (521)
|.--| ....+.++.+-+|=.-++++..
T Consensus 197 ~vN~~---Y~~lT~~aE~~~fv~s~l~~v~ 223 (308)
T PF07387_consen 197 MVNIE---YESLTQEAEVKVFVKSCLKLVE 223 (308)
T ss_pred EEeee---ccccChHHHHHHHHHHHHHHHH
Confidence 22212 2335667777777666666665
|
The function of this family is unknown. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.039 Score=52.02 Aligned_cols=30 Identities=37% Similarity=0.527 Sum_probs=21.8
Q ss_pred CeeecCCCCCCeEe-CCCCCceEeeccccee
Q 009979 309 KVVHRDIKSSNILL-DKQWNPKLSDFGLAKL 338 (521)
Q Consensus 309 ~iiHrDik~~NILl-~~~~~vkL~DFGla~~ 338 (521)
.++|.|+.+.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58899999999999 8899999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.02 Score=57.53 Aligned_cols=74 Identities=22% Similarity=0.206 Sum_probs=58.1
Q ss_pred CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeec
Q 009979 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (521)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DF 333 (521)
....|++|++- |++|... ....+.+...++.+.+..++-+... .+.-|||+.-.||||+ +|+|-|+||
T Consensus 298 ~~y~yl~~kdh-gt~is~i--------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDf 365 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII--------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDF 365 (488)
T ss_pred ceEEEEEEecC-Cceeeee--------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEe
Confidence 34557888874 4455431 2345788899999988888888765 4899999999999999 999999999
Q ss_pred ccceec
Q 009979 334 GLAKLL 339 (521)
Q Consensus 334 Gla~~~ 339 (521)
-+++.-
T Consensus 366 klsRl~ 371 (488)
T COG5072 366 KLSRLS 371 (488)
T ss_pred eeeecc
Confidence 999953
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.16 Score=51.46 Aligned_cols=70 Identities=17% Similarity=0.089 Sum_probs=42.8
Q ss_pred CcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCC--CeeeEE---E--EEeeCCeeeEEEEeccCCc
Q 009979 198 GYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK--NLVRLL---G--YCAEGAHRMLVYEYIDNGN 268 (521)
Q Consensus 198 ~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hp--niv~l~---~--~~~~~~~~~lV~e~~~~g~ 268 (521)
.-..||+....++..+++|...... ....++..|++.+..|.-. .++... | +...++..+.|+++++|..
T Consensus 37 ~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 37 YENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 3458999988778889999764332 2345666777777766321 122211 1 2223456778999998753
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.11 Score=60.73 Aligned_cols=143 Identities=18% Similarity=0.271 Sum_probs=79.4
Q ss_pred ceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcC-------CCCCeeeEE-----EEEee-CC--e
Q 009979 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-------RHKNLVRLL-----GYCAE-GA--H 256 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-------~hpniv~l~-----~~~~~-~~--~ 256 (521)
+.|+ |.+-.+|+....++..+++|+..... ....+..|.++|..| ..|.+++-. ..... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4564 45678899887778889999886542 233444455566544 234444322 11111 22 4
Q ss_pred eeEEEEeccCCchHHh-----------------hhc----CC--CCCCCCCHHH-----------------HHHHHHHHH
Q 009979 257 RMLVYEYIDNGNLEQW-----------------LHG----DV--GPHSPLTWEI-----------------RMNIILGTA 296 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~-----------------l~~----~~--~~~~~l~~~~-----------------~~~i~~~ia 296 (521)
.+-+++|++|..|.+. ++. .. .....+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5678999998766541 111 00 0011122221 112222222
Q ss_pred HHHH-----HHHhcCCCCeeecCCCCCCeEeCCCC--Cce-Eeeccccee
Q 009979 297 KGLT-----YLHEGLEPKVVHRDIKSSNILLDKQW--NPK-LSDFGLAKL 338 (521)
Q Consensus 297 ~al~-----~LH~~~~~~iiHrDik~~NILl~~~~--~vk-L~DFGla~~ 338 (521)
..++ .|.+ ...++||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2221 1222 244799999999999998775 565 999998864
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.22 Score=47.17 Aligned_cols=76 Identities=17% Similarity=0.249 Sum_probs=51.5
Q ss_pred cceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcC---CCCCeeeEEEEEeeCCeeeEEEEeccCC
Q 009979 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV---RHKNLVRLLGYCAEGAHRMLVYEYIDNG 267 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l---~hpniv~l~~~~~~~~~~~lV~e~~~~g 267 (521)
.+.+.-|.--..|...+ +...+.||.= .......|..|+.-|..| +--++.+++.+.....+.|+||||++.|
T Consensus 21 r~~v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 21 REEVSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred ccccCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 34455555555665554 4667888852 333445677777666655 4466888888888999999999999876
Q ss_pred chH
Q 009979 268 NLE 270 (521)
Q Consensus 268 ~L~ 270 (521)
.+.
T Consensus 97 ~~d 99 (286)
T COG3001 97 PLD 99 (286)
T ss_pred CCC
Confidence 554
|
|
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=95.43 E-value=0.01 Score=50.20 Aligned_cols=34 Identities=9% Similarity=0.150 Sum_probs=15.9
Q ss_pred cchhHHHHHHHHHHHHHHHHHH-HHHhhhcccccc
Q 009979 19 GLRLWVVLGICVGAGIVLVLFL-ISLWFTSKRNSN 52 (521)
Q Consensus 19 g~~~~~~i~i~~g~~~v~~l~~-l~~~~~~rr~~~ 52 (521)
+|.--.+++|++||++-+++++ |++||.+||++|
T Consensus 60 ~fs~~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk 94 (122)
T PF01102_consen 60 RFSEPAIIGIIFGVMAGVIGIILLISYCIRRLRKK 94 (122)
T ss_dssp SSS-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred CccccceeehhHHHHHHHHHHHHHHHHHHHHHhcc
Confidence 4444566777777755333333 334444444333
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.22 Score=51.52 Aligned_cols=74 Identities=14% Similarity=0.292 Sum_probs=43.6
Q ss_pred ceEccCCcEEEEEEEEcCC--cE-----EEEEEeccCChhhHHHHHHHHHHHhcCCCCCe-eeEEEEEeeCCeeeEEEEe
Q 009979 192 NVIGEGGYGIVYHGVLEDN--TN-----VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpni-v~l~~~~~~~~~~~lV~e~ 263 (521)
+.|..|--..+|++...++ .. |.+... .......-+-..|+++++.+...++ .++++.+.. ++|+||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~-g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS-STYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEec-cCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 3555578889999975433 23 333322 1111111223458889998865544 455666543 699999
Q ss_pred ccCCchH
Q 009979 264 IDNGNLE 270 (521)
Q Consensus 264 ~~~g~L~ 270 (521)
++|..|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9986653
|
|
| >PF12273 RCR: Chitin synthesis regulation, resistance to Congo red; InterPro: IPR020999 RCR proteins are ER membrane proteins that regulate chitin deposition in fungal cell walls | Back alignment and domain information |
|---|
Probab=95.14 E-value=0.012 Score=51.09 Aligned_cols=13 Identities=31% Similarity=0.695 Sum_probs=8.8
Q ss_pred HHHHHHHHHHHHH
Q 009979 23 WVVLGICVGAGIV 35 (521)
Q Consensus 23 ~~~i~i~~g~~~v 35 (521)
|++++|+|++++|
T Consensus 2 W~l~~iii~~i~l 14 (130)
T PF12273_consen 2 WVLFAIIIVAILL 14 (130)
T ss_pred eeeHHHHHHHHHH
Confidence 7787777766443
|
Although chitin, a linear polymer of beta-1,4-linked N-acetylglucosamine, constitutes only 2% of the cell wall it plays a vital role in the overall protection of the cell wall against stress, noxious chemicals and osmotic pressure changes. Congo red is a cell wall-disrupting benzidine-type dye extensively used in many cell wall mutant studies that specifically targets chitin in yeast cells and inhibits growth. RCR proteins render the yeasts resistant to Congo red by diminishing the content of chitin in the cell wall []. RCR proteins are probably regulating chitin synthase III interact directly with ubiquitin ligase Rsp5, and the VPEY motif is necessary for this, via interaction with the WW domains of Rsp5 []. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.12 Score=53.33 Aligned_cols=74 Identities=16% Similarity=0.219 Sum_probs=49.4
Q ss_pred cceEccCCcEEEEEEEEcC-CcEEEEEEeccC--C----hhhHHHHHHHHHHHhcCC--CC-CeeeEEEEEeeCCeeeEE
Q 009979 191 ENVIGEGGYGIVYHGVLED-NTNVAVKNLLNN--R----GQAEKEFKVEVEAIGRVR--HK-NLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~--~----~~~~~~~~~Ei~~l~~l~--hp-niv~l~~~~~~~~~~~lV 260 (521)
.+.||.|.-..||++...+ ++.|+||.-..- . .-..+....|.+.|+... .| .+.+++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4678999999999999743 567999976421 1 223355666888887663 34 45556544 44455789
Q ss_pred EEeccC
Q 009979 261 YEYIDN 266 (521)
Q Consensus 261 ~e~~~~ 266 (521)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999854
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 521 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-63 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-61 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-51 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-51 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-38 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-26 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-22 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-18 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-17 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 9e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 520 bits (1342), Expect = 0.0
Identities = 131/323 (40%), Positives = 201/323 (62%), Gaps = 4/323 (1%)
Query: 159 VAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNL 218
V A PEV HLG ++LREL+V+++ F+++N++G GG+G VY G L D T VAVK L
Sbjct: 4 VPAEEDPEV-HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 62
Query: 219 LNNRGQA-EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDV 277
R Q E +F+ EVE I H+NL+RL G+C R+LVY Y+ NG++ L
Sbjct: 63 KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122
Query: 278 GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337
PL W R I LG+A+GL YLH+ +PK++HRD+K++NILLD+++ + DFGLAK
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG 397
L+ + ++VTT V GT G++APEY STG +E++DV+ +G++++E+I+G+ D +R
Sbjct: 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242
Query: 398 E--VNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHV 455
+ V L++W+K ++ + E ++D LQ +++ + VAL C + +RPKM V
Sbjct: 243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302
Query: 456 IHMLEAEEFPFRDERRAGREHGR 478
+ MLE + R E E R
Sbjct: 303 VRMLEGDGLAERWEEWQKEEMFR 325
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 490 bits (1263), Expect = e-173
Identities = 117/313 (37%), Positives = 184/313 (58%), Gaps = 4/313 (1%)
Query: 149 GSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLE 208
GS + ++ A++ + L +LE +TN F + +IG G +G VY GVL
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 209 DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGN 268
D VA+K Q +EF+ E+E + RH +LV L+G+C E +L+Y+Y++NGN
Sbjct: 62 DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121
Query: 269 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328
L++ L+G P ++WE R+ I +G A+GL YLH ++HRD+KS NILLD+ + P
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVP 178
Query: 329 KLSDFGLAKL-LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR 387
K++DFG++K ++++++T V GT GY+ PEY G L E+SDVYSFG+++ EV+ R
Sbjct: 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 388 NPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAH 447
+ + S P VNL EW N E ++DP L +K +L++ A++C+ ++
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 448 KRPKMGHVIHMLE 460
RP MG V+ LE
Sbjct: 299 DRPSMGDVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 406 bits (1046), Expect = e-140
Identities = 103/299 (34%), Positives = 171/299 (57%), Gaps = 21/299 (7%)
Query: 174 HWYTLRELEVSTNGFADE------NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR----G 223
H ++ EL+ TN F + N +GEGG+G+VY G + +NT VAVK L
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 224 QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPL 283
+ +++F E++ + + +H+NLV LLG+ ++G LVY Y+ NG+L L G PL
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPL 130
Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE- 342
+W +R I G A G+ +LH E +HRDIKS+NILLD+ + K+SDFGLA+
Sbjct: 131 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLV 402
++ +T+R++GT Y+APE G + +SD+YSFG++++E+I+G VD R L+
Sbjct: 188 QTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLL 244
Query: 403 EWLKTMVTN-RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+ + + + E +D ++ + S +++ VA +C+ +KRP + V +L+
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDAD-STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 4e-91
Identities = 74/308 (24%), Positives = 126/308 (40%), Gaps = 30/308 (9%)
Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAI 236
L + V G +G V+ L N VAVK + + + + + EV ++
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVK-IFPIQDKQSWQNEYEVYSL 72
Query: 237 GRVRHKNLVRLLGYCAEGAH----RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
++H+N+++ +G G L+ + + G+L +L + ++W +I
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHIA 127
Query: 293 LGTAKGLTYLHE-------GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345
A+GL YLHE G +P + HRDIKS N+LL ++DFGLA A +S
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 346 V-TTRVMGTFGYVAPEYASTGMLNE-----RSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
T +GT Y+APE + + R D+Y+ G+++ E+ S D +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 400 NLVEWLKTMVTNRNAEGV-----LDPRLQEKPCSRALKRALL-VALRCVDPNAHKRPKMG 453
E + + + + V P L++ A L C D +A R G
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 454 HVIHMLEA 461
V +
Sbjct: 308 CVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 1e-64
Identities = 69/322 (21%), Positives = 110/322 (34%), Gaps = 53/322 (16%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE--AIG 237
E + + +IG G YG VY G L D VAVK + F E +
Sbjct: 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIYRVP 62
Query: 238 RVRHKNLVRLLGYCAEG-----AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
+ H N+ R + +LV EY NG+L ++L W +
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLA 117
Query: 293 LGTAKGLTYLHE------GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG------ 340
+GL YLH +P + HRD+ S N+L+ +SDFGL+ L
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 341 -AERSYVTTRVMGTFGYVAPEYASTGM-------LNERSDVYSFGILIMEVISGRNPVDY 392
E +GT Y+APE + ++ D+Y+ G++ E+ +
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 393 SRPPGEVNL-----------VEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVAL-- 439
E + E ++ +V+ P+ E +L L
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIE 293
Query: 440 RCVDPNAHKRPKMGHVIHMLEA 461
C D +A R +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAE 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 6e-64
Identities = 82/314 (26%), Positives = 145/314 (46%), Gaps = 24/314 (7%)
Query: 151 HHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDN 210
HH ++ P +L + ++++ + IG G +G V+
Sbjct: 3 HHHH-HHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HG 60
Query: 211 TNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGN 268
++VAVK L+ + EF EV + R+RH N+V +G + + +V EY+ G+
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 269 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328
L + LH G L R+++ AKG+ YLH P +VHR++KS N+L+DK++
Sbjct: 121 LYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTV 178
Query: 329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRN 388
K+ DFGL++L A + GT ++APE NE+SDVYSFG+++ E+ + +
Sbjct: 179 KVCDFGLSRLK-ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237
Query: 389 PVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ-EKPCSRALKRALLVALRCVDPNAH 447
P + +N + + V + RL+ + + + ++ C
Sbjct: 238 P--WG----NLNPAQVVA-AVGFKCK------RLEIPRNLNPQVAA-IIE--GCWTNEPW 281
Query: 448 KRPKMGHVIHMLEA 461
KRP ++ +L
Sbjct: 282 KRPSFATIMDLLRP 295
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 1e-60
Identities = 79/292 (27%), Positives = 127/292 (43%), Gaps = 29/292 (9%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
+ E V+G G +G+V +VA+K + + K F VE+ + RV H
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNH 60
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
N+V+L G C LV EY + G+L LHG P T M+ L ++G+ Y
Sbjct: 61 PNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWN-PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
LH ++HRD+K N+LL K+ DFG A + T G+ ++APE
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPE 173
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
+E+ DV+S+GI++ EVI+ R P + E+ + +
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKP--FD----EIGGPAFRIMWAVHNGT------ 221
Query: 421 RLQE-KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA--EEFPFRDE 469
R K + ++ L+ RC + +RP M ++ ++ FP DE
Sbjct: 222 RPPLIKNLPKPIES-LMT--RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 5e-60
Identities = 71/284 (25%), Positives = 121/284 (42%), Gaps = 34/284 (11%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTN-VAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
V+G+G +G + + +K L+ + ++ F EV+ + + H N+++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
+ + EYI G L + S W R++ A G+ YLH
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLH---SMN 128
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR-------------VMGTFGY 356
++HRD+ S N L+ + N ++DFGLA+L+ E++ V+G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416
+APE + +E+ DV+SFGI++ E+I N P +TM N G
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP----------RTMDFGLNVRG 238
Query: 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
LD C + + +RC D + KRP + H LE
Sbjct: 239 FLDRYCPPN-CPPSFFP---ITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 6e-60
Identities = 73/300 (24%), Positives = 139/300 (46%), Gaps = 42/300 (14%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAE-------KEFK 230
R ++ N E IG+GG+G+V+ G ++D + VA+K+L+ + E +EF+
Sbjct: 12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
EV + + H N+V+L G +V E++ G+L L P+ W +++
Sbjct: 72 REVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLR 126
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-----NPKLSDFGLAKLLGAERSY 345
++L A G+ Y+ P +VHRD++S NI L K++DFGL++ + +
Sbjct: 127 LMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVH 181
Query: 346 VTTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILIMEVISGRNPVDYS-RPPGEVNLV 402
+ ++G F ++APE A E++D YSF +++ +++G P + G++ +
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP--FDEYSYGKIKFI 239
Query: 403 EWLKTMVTNRNAEGVLDPRLQ-EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
M+ R + C L+ ++ C + KRP +++ L
Sbjct: 240 N----MIREEGL------RPTIPEDCPPRLRN-VIE--LCWSGDPKKRPHFSYIVKELSE 286
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 4e-59
Identities = 75/295 (25%), Positives = 130/295 (44%), Gaps = 40/295 (13%)
Query: 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLL----NNRGQAEKEFKVEVEAI 236
LE+ E +IG GG+G VY VAVK + Q + + E +
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
++H N++ L G C + + LV E+ G L + L G + +I +N + A
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIA 115
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDK--------QWNPKLSDFGLAKLLGAERSYVTT 348
+G+ YLH+ ++HRD+KSSNIL+ + K++DFGLA+ R+ +
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMS 173
Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408
G + ++APE M ++ SDV+S+G+L+ E+++G P + ++ +
Sbjct: 174 AA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP--FR----GIDGLAVAY-G 225
Query: 409 VTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
V L P C + + C +P+ H RP +++ L
Sbjct: 226 VAMNKL------AL-PIPSTCPEPFAK---LMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-58
Identities = 58/291 (19%), Positives = 115/291 (39%), Gaps = 34/291 (11%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAI 236
+ + + E G ++ G ++ VK L + ++F E +
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRL 61
Query: 237 GRVRHKNLVRLLGYCAE--GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
H N++ +LG C H L+ ++ G+L LH G + + + L
Sbjct: 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALD 119
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF 354
A+G+ +LH LEP + + S ++++D+ ++S + S+ + M
Sbjct: 120 MARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVK------FSFQSPGRMYAP 172
Query: 355 GYVAPE---YASTGMLNERSDVYSFGILIMEVISGRNP-VDYSRPPGEVNLVEWLKTMVT 410
+VAPE +D++SF +L+ E+++ P D S E+ + V
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS--NMEIGM------KVA 224
Query: 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
L P + S + + L+ C++ + KRPK ++ +LE
Sbjct: 225 LEG----LRPTIPPG-ISPHVSK-LMK--ICMNEDPAKRPKFDMIVPILEK 267
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 1e-57
Identities = 76/293 (25%), Positives = 131/293 (44%), Gaps = 30/293 (10%)
Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVE 234
+ E+ IG G +G VY G + +VAVK L Q + FK EV
Sbjct: 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVG 72
Query: 235 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
+ + RH N++ +GY +V ++ + +L LH + + ++I
Sbjct: 73 VLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQ 128
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGT 353
TA+G+ YLH ++HRD+KS+NI L + K+ DFGLA S+ ++ G+
Sbjct: 129 TARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 354 FGYVAPE---YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410
++APE + + +SDVY+FGI++ E+++G+ P ++ MV
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IEMV- 238
Query: 411 NRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
G L P L + C + +KR + C+ +RP ++ +E
Sbjct: 239 ---GRGSLSPDLSKVRSNCPKRMKRLM---AECLKKKRDERPSFPRILAEIEE 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 9e-57
Identities = 66/301 (21%), Positives = 113/301 (37%), Gaps = 41/301 (13%)
Query: 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVE 234
L+E ++ +IG+G +G VYHG + VA++ + R K FK EV
Sbjct: 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVM 81
Query: 235 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
A + RH+N+V +G C H ++ L + L I
Sbjct: 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQE 138
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM--- 351
KG+ YLH ++H+D+KS N+ D ++DFGL + G ++ +
Sbjct: 139 IVKGMGYLH---AKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 352 -GTFGYVAPEYASTGML---------NERSDVYSFGILIMEVISGRNPVDYSR-PPGEVN 400
G ++APE ++ SDV++ G + E+ + P + P +
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP--FKTQPAEAI- 251
Query: 401 LVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+ P L + + + L L C +RP ++ MLE
Sbjct: 252 ------IWQMGTG----MKPNLSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDMLE 298
Query: 461 A 461
Sbjct: 299 K 299
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 8e-56
Identities = 71/298 (23%), Positives = 116/298 (38%), Gaps = 40/298 (13%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE--AIGRVRHKNLVRLL 248
+G+G YG V+ G NVAVK + EK + E E +RH+N++ +
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 249 GYCAEGAHR----MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
H L+ Y + G+L +L + L + I+L A GL +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 305 GLE-----PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL---GAERSYVTTRVMGTFGY 356
+ P + HRD+KS NIL+ K ++D GLA + + +GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 357 VAPE------YASTGMLNERSDVYSFGILIMEVISGRNP---VDYSRPP-----GEVNLV 402
+APE +R D+++FG+++ EV V+ +PP
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 403 EWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
E ++ +V + R P +L + L+ C N R + L
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK-LMK--ECWYQNPSARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-54
Identities = 66/296 (22%), Positives = 114/296 (38%), Gaps = 36/296 (12%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
IG+G YG V+ G VAVK + +A + E+ +RH+N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVK-VFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 251 CAEGAHR----MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-- 304
+G L+ +Y +NG+L +L + L + + + + GL +LH
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 305 ---GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---YVTTRVMGTFGYVA 358
+P + HRD+KS NIL+ K ++D GLA ++ + +GT Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 359 PE------YASTGMLNERSDVYSFGILIMEVISGRNPV----DYSRP----PGEVNLVEW 404
PE + +D+YSFG+++ EV +Y P E
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
++ +V + R C R + + + C N R V L
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGK---LMTECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 5e-52
Identities = 68/315 (21%), Positives = 119/315 (37%), Gaps = 47/315 (14%)
Query: 174 HWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEV 233
R + + + IG+G +G V+ G VAVK + E+ + E
Sbjct: 37 QRTIARTIVL-------QESIGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREA 85
Query: 234 E--AIGRVRHKNLVRLLGYC----AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEI 287
E +RH+N++ + LV +Y ++G+L +L+ +T E
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEG 140
Query: 288 RMNIILGTAKGLTYLHEGLE-----PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
+ + L TA GL +LH + P + HRD+KS NIL+ K ++D GLA +
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200
Query: 343 RS---YVTTRVMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGRNPVD-- 391
+GT Y+APE +R+D+Y+ G++ E+ +
Sbjct: 201 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260
Query: 392 ------YSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPN 445
Y VE ++ +V + + R Q R + + ++ C N
Sbjct: 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAK-IMR--ECWYAN 317
Query: 446 AHKRPKMGHVIHMLE 460
R + L
Sbjct: 318 GAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-39
Identities = 74/278 (26%), Positives = 120/278 (43%), Gaps = 32/278 (11%)
Query: 191 ENVIGEGGYGIVYHGVL-EDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
IG G +G V+ G L DNT VAVK+ + +F E + + H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
G C + +V E + G+ +L + L + + ++ A G+ YL
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLE---SK 232
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGM 366
+HRD+ + N L+ ++ K+SDFG+++ A+ Y + + APE + G
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 367 LNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425
+ SDV+SFGIL+ E S G +P Y P N +G RL
Sbjct: 292 YSSESDVWSFGILLWETFSLGASP--Y---PNLSN------QQTREFVEKGG---RL-PC 336
Query: 426 P--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
P C A+ R + +C +RP + L++
Sbjct: 337 PELCPDAVFR---LMEQCWAYEPGQRPSFSTIYQELQS 371
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 78/273 (28%), Positives = 128/273 (46%), Gaps = 28/273 (10%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
E +G+G +G V+ G T VA+K L + + F E + + ++RH+ LV+L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
+E +V EY+ G+L +L G+ G + L +++ A G+ Y+
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVER---MNY 301
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNER 370
VHRD++++NIL+ + K++DFGLA+L+ + APE A G +
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 371 SDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP--C 427
SDV+SFGIL+ E+ + GR P Y PG VN V ++ G R+ P C
Sbjct: 362 SDVWSFGILLTELTTKGRVP--Y---PGMVN------REVLDQVERGY---RM-PCPPEC 406
Query: 428 SRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+L + +C +RP ++ LE
Sbjct: 407 PESLHD---LMCQCWRKEPEERPTFEYLQAFLE 436
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 70/302 (23%), Positives = 126/302 (41%), Gaps = 38/302 (12%)
Query: 164 TPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG 223
P + LG+G W E+ +G G +G+V +G +VA+K +
Sbjct: 8 APSTAGLGYGSW------EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGS 60
Query: 224 QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPL 283
+E EF E + + + H+ LV+L G C + ++ EY+ NG L +L
Sbjct: 61 MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RF 117
Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
+ + + + + YL + +HRD+ + N L++ Q K+SDFGL++ +
Sbjct: 118 QTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV--LD 172
Query: 344 SYVTTRVMGTFGY--VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVN 400
T+ V F PE + +SD+++FG+L+ E+ S G+ P Y N
Sbjct: 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP--Y---ERFTN 227
Query: 401 LVEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458
+ A+G+ RL +P S + + C A +RP ++
Sbjct: 228 ------SETAEHIAQGL---RL-YRPHLASEKVYT---IMYSCWHEKADERPTFKILLSN 274
Query: 459 LE 460
+
Sbjct: 275 IL 276
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-37
Identities = 66/285 (23%), Positives = 121/285 (42%), Gaps = 26/285 (9%)
Query: 191 ENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
+ +G+G +G V VAVK L ++ +++F+ E++ + + +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 246 RLLGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+ G + LV EY+ +G L +L L + KG+ YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLG 144
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEY 361
+ VHRD+ + NIL++ + + K++DFGLAKLL ++ Y R G + APE
Sbjct: 145 ---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
S + + +SDV+SFG+++ E+ + S + ++ + + +L+
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLELLEE 259
Query: 421 --RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
RL P C + + C P+ RP + L+
Sbjct: 260 GQRL-PAPPACPAEVHE---LMKLCWAPSPQDRPSFSALGPQLDM 300
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-37
Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 194 IGEGGYGIVYHGVLED---NTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
+G GG VY ED N VA+K + + + K F+ EV ++ H+N+V +
Sbjct: 19 LGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
+ E LV EYI+ L +++ H PL+ + +N G+ + H+
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM-- 130
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
++VHRDIK NIL+D K+ DFG+AK L T V+GT Y +PE A
Sbjct: 131 -RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 368 NERSDVYSFGILIMEVISGRNP 389
+E +D+YS GI++ E++ G P
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPP 211
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-37
Identities = 73/278 (26%), Positives = 119/278 (42%), Gaps = 36/278 (12%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
IG G +G+V+ G + VA+K + +E++F E E + ++ H LV+L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
C E A LV E++++G L +L G E + + L +G+ YL E V
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLE---EACV 125
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGMLN 368
+HRD+ + N L+ + K+SDFG+ + + T+ F +PE S +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 369 ERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP--RLQEK 425
+SDV+SFG+L+ EV S G+ P Y +N + RL K
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIP--Y---EN-----------RSNSEVVEDISTGFRL-YK 226
Query: 426 P--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
P S + + + C RP ++ L
Sbjct: 227 PRLASTHVYQ---IMNHCWRERPEDRPAFSRLLRQLAE 261
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-37
Identities = 73/296 (24%), Positives = 120/296 (40%), Gaps = 42/296 (14%)
Query: 173 GHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVE 232
GH E+ +G G +G+V G + +VAVK + +E EF E
Sbjct: 1 GHM------ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQE 53
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
+ + ++ H LV+ G C++ +V EYI NG L +L G + + M
Sbjct: 54 AQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEM--C 110
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
+G+ +L + +HRD+ + N L+D+ K+SDFG+ + + + V
Sbjct: 111 YDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV--LDDQYVSSVGT 165
Query: 353 TFGY--VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMV 409
F APE + +SDV++FGIL+ EV S G+ P Y
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP--Y---DL-----------Y 209
Query: 410 TNRNAEGVLDP--RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
TN + RL +P S + + + C KRP ++ +E
Sbjct: 210 TNSEVVLKVSQGHRL-YRPHLASDTIYQ---IMYSCWHELPEKRPTFQQLLSSIEP 261
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 1e-36
Identities = 73/321 (22%), Positives = 128/321 (39%), Gaps = 42/321 (13%)
Query: 164 TPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNR 222
T + W E+ ++ +G G YG VY GV + + VAVK L
Sbjct: 204 TIYGVSPNYDKW------EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KED 256
Query: 223 GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP 282
+EF E + ++H NLV+LLG C ++ E++ GNL +L
Sbjct: 257 TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QE 314
Query: 283 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
++ + + + + + YL + +HR++ + N L+ + K++DFGL++L+
Sbjct: 315 VSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM--T 369
Query: 343 RSYVTTRVMGTFGY--VAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEV 399
T F APE + + +SDV++FG+L+ E+ + G +P Y PG
Sbjct: 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--Y---PGID 424
Query: 400 NLVEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIH 457
+ V + R+ E+P C + + C N RP +
Sbjct: 425 L------SQVYELLEKDY---RM-ERPEGCPEKVYE---LMRACWQWNPSDRPSFAEIHQ 471
Query: 458 MLE----AEEFPFRDERRAGR 474
E E+ G+
Sbjct: 472 AFETMFQESSISDEVEKELGK 492
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 4e-36
Identities = 78/273 (28%), Positives = 128/273 (46%), Gaps = 28/273 (10%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
E +G+G +G V+ G T VA+K L + + F E + + ++RH+ LV+L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
+E +V EY+ G+L +L G+ G + L +++ A G+ Y+
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNER 370
VHRD++++NIL+ + K++DFGLA+L+ + APE A G +
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 371 SDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP--C 427
SDV+SFGIL+ E+ + GR P Y PG VN V ++ G R+ P C
Sbjct: 445 SDVWSFGILLTELTTKGRVP--Y---PGMVN------REVLDQVERGY---RM-PCPPEC 489
Query: 428 SRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+L + +C +RP ++ LE
Sbjct: 490 PESLHD---LMCQCWRKEPEERPTFEYLQAFLE 519
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-36
Identities = 75/299 (25%), Positives = 126/299 (42%), Gaps = 54/299 (18%)
Query: 191 ENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNL 244
V+G G +G VY G+ VA+K L +A KE E + V + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
RLLG C + L+ + + G L ++ + + +N + AKG+ YL +
Sbjct: 80 CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED 135
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV-------MGTFGYV 357
++VHRD+ + N+L+ + K++DFGLAKLLGAE M
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM------ 186
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416
A E + +SDV+S+G+ + E+++ G P Y G +
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--Y---DG-----------IPASEISS 230
Query: 417 VLDP--RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDERR 471
+L+ RL +P C+ + + +C +A RPK +I + RD +R
Sbjct: 231 ILEKGERL-PQPPICTIDVYM---IMRKCWMIDADSRPKFRELIIEF--SKM-ARDPQR 282
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 73/288 (25%), Positives = 130/288 (45%), Gaps = 36/288 (12%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
E+ E +G G +G V+ +T VAVK + + + F E + +
Sbjct: 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTL 240
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
+H LV+L + ++ E++ G+L +L D G S ++ A+G+
Sbjct: 241 QHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGM 297
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--V 357
++ + +HRD++++NIL+ K++DFGLA+++ E + T R F
Sbjct: 298 AFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWT 352
Query: 358 APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416
APE + G +SDV+SFGIL+ME+++ GR P Y PG ++N
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIP--Y---PG-----------MSNPEVIR 396
Query: 417 VLDP--RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
L+ R+ +P C L + +RC +RP ++ +L+
Sbjct: 397 ALERGYRM-PRPENCPEELYN---IMMRCWKNRPEERPTFEYIQSVLD 440
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-36
Identities = 67/266 (25%), Positives = 107/266 (40%), Gaps = 31/266 (11%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
IG G + VY G+ E VA + FK E E + ++H N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 250 YCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
LV E + +G L+ +L + ++ + KGL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 306 LEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
P ++HRD+K NI + + K+ D GLA L A + V+GT ++APE
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204
Query: 365 GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424
+E DVY+FG+ ++E+ + P YS E + VT+ P +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYP--YS----ECQNAAQIYRRVTSGVK-----PASFD 252
Query: 425 KPCSRALKRALLVALRCVDPNAHKRP 450
K +K + C+ N +R
Sbjct: 253 KVAIPEVKEII---EGCIRQNKDERY 275
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-36
Identities = 76/282 (26%), Positives = 120/282 (42%), Gaps = 38/282 (13%)
Query: 191 ENVIGEGGYGIVYHGVL---EDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
+ +G G +G V GV + +VA+K L +E E + + ++ + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
L+G C A MLV E G L ++L G + ++ + G+ YL E
Sbjct: 75 LIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEE-- 128
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYAST 364
VHRD+ + N+LL + K+SDFGL+K LGA+ SY T R G + + APE +
Sbjct: 129 -KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 365 GMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP--R 421
+ RSDV+S+G+ + E +S G+ P Y + ++ R
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKP--Y---KK-----------MKGPEVMAFIEQGKR 231
Query: 422 LQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
+ E P C L + C RP V + A
Sbjct: 232 M-ECPPECPPELYA---LMSDCWIYKWEDRPDFLTVEQRMRA 269
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 9e-36
Identities = 74/282 (26%), Positives = 122/282 (43%), Gaps = 40/282 (14%)
Query: 191 ENVIGEGGYGIVYHGVL---EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLV 245
+ +G G +G V G + VAVK L N + E E + ++ + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
R++G C + MLV E + G L ++L + + + + ++ + G+ YL E
Sbjct: 82 RMIGICEAESW-MLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYL-E- 134
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEYAS 363
E VHRD+ + N+LL Q K+SDFGL+K L A+ +Y + G + + APE +
Sbjct: 135 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 364 TGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP-- 420
+ +SDV+SFG+L+ E S G+ P Y G + +L+
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP--Y---RG-----------MKGSEVTAMLEKGE 237
Query: 421 RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
R+ P C R + + C + RP V L
Sbjct: 238 RM-GCPAGCPREMYD---LMNLCWTYDVENRPGFAAVELRLR 275
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 79/326 (24%), Positives = 122/326 (37%), Gaps = 48/326 (14%)
Query: 143 YPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIV 202
Y A G V W ++ IG+G +G V
Sbjct: 156 YTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGW------ALNMKELKLLQTIGKGEFGDV 209
Query: 203 YHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR-MLVY 261
G VAVK + + F E + ++RH NLV+LLG E +V
Sbjct: 210 MLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266
Query: 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321
EY+ G+L +L S L + + L + + YL VHRD+ + N+L
Sbjct: 267 EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVL 321
Query: 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGMLNERSDVYSFGIL 379
+ + K+SDFGL + +T+ G APE + +SDV+SFGIL
Sbjct: 322 VSEDNVAKVSDFGLT------KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 375
Query: 380 IMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP--RLQEKP--CSRALKRA 434
+ E+ S GR P Y P + ++ ++ ++ + P C A+
Sbjct: 376 LWEIYSFGRVP--Y---PR-----------IPLKDVVPRVEKGYKM-DAPDGCPPAVYD- 417
Query: 435 LLVALRCVDPNAHKRPKMGHVIHMLE 460
V C +A RP + LE
Sbjct: 418 --VMKNCWHLDAATRPTFLQLREQLE 441
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 81/281 (28%), Positives = 132/281 (46%), Gaps = 34/281 (12%)
Query: 191 ENVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLV 245
E +IG G G V +G L + + VA+K L + ++ +F E +G+ H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
RL G G M+V EY++NG+L+ +L G T + ++ G G+ YL +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLSD- 169
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYAS 363
VHRD+ + N+L+D K+SDFGL+++L + T G APE +
Sbjct: 170 --LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 364 TGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422
+ SDV+SFG+++ EV++ G P Y N V + EG RL
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERP--Y---WNMTN------RDVISSVEEGY---RL 273
Query: 423 QEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
P C AL + + L C + +RP+ ++ +L+A
Sbjct: 274 -PAPMGCPHALHQ---LMLDCWHKDRAQRPRFSQIVSVLDA 310
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 4e-35
Identities = 82/396 (20%), Positives = 141/396 (35%), Gaps = 38/396 (9%)
Query: 77 PTIPNISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILVEDSPASGRNRIHIEIG 136
+ + ++ +++ D + + + P++ +
Sbjct: 227 TKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDT 286
Query: 137 KDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGE 196
+ PE A + E + N + +G
Sbjct: 287 LNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGC 346
Query: 197 GGYGIVYHGVLE---DNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252
G +G V GV +VA+K L +E E + + ++ + +VRL+G C
Sbjct: 347 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 406
Query: 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312
A MLV E G L ++L G + ++ + G+ YL E VH
Sbjct: 407 AEAL-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEE---KNFVH 459
Query: 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGMLNER 370
R++ + N+LL + K+SDFGL+K LGA+ SY T R G + APE + + R
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 519
Query: 371 SDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP--RLQEKP- 426
SDV+S+G+ + E +S G+ P Y + ++ R+ E P
Sbjct: 520 SDVWSYGVTMWEALSYGQKP--Y---KK-----------MKGPEVMAFIEQGKRM-ECPP 562
Query: 427 -CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
C L + C RP V + A
Sbjct: 563 ECPPELYA---LMSDCWIYKWEDRPDFLTVEQRMRA 595
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 4e-35
Identities = 74/278 (26%), Positives = 115/278 (41%), Gaps = 42/278 (15%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
IG+G +G V G VAVK + + F E + ++RH NLV+LLG
Sbjct: 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 251 CAEGAHR-MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
E +V EY+ G+L +L S L + + L + + YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NN 137
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGML 367
VHRD+ + N+L+ + K+SDFGL + +T+ G APE
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLT------KEASSTQDTGKLPVKWTAPEALREKKF 191
Query: 368 NERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP--RLQE 424
+ +SDV+SFGIL+ E+ S GR P Y P + ++ ++ ++ +
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVP--Y---PR-----------IPLKDVVPRVEKGYKM-D 234
Query: 425 KP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
P C A+ V C +A RP + LE
Sbjct: 235 APDGCPPAVYE---VMKNCWHLDAAMRPSFLQLREQLE 269
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 191 ENVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLV 245
+ V+G G +G V G L + +VA+K L + ++ +F E +G+ H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
RL G + M+V EY++NG+L+ +L T + ++ G A G+ YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLS-- 164
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYAS 363
+ VHRD+ + NIL++ K+SDFGL ++L + T G +PE +
Sbjct: 165 -DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 364 TGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422
SDV+S+GI++ EV+S G P Y N V EG RL
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP--Y---WEMSN------QDVIKAVDEGY---RL 269
Query: 423 QEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
P C AL + + L C + + RPK ++ +L+
Sbjct: 270 -PPPMDCPAALYQ---LMLDCWQKDRNNRPKFEQIVSILDK 306
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 5e-35
Identities = 65/285 (22%), Positives = 111/285 (38%), Gaps = 42/285 (14%)
Query: 191 ENVIGEGGYGIVYHGVL----EDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKN 243
+G+G +G+V G +VAVK L + ++ +A +F EV A+ + H+N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
L+RL G +V E G+L L G + A+G+ YL
Sbjct: 83 LIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLE 138
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEY 361
+ +HRD+ + N+LL + K+ DFGL + L + + + APE
Sbjct: 139 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
T + SD + FG+ + E+ + G+ P + G + +D
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEP--W---IG-----------LNGSQILHKIDK 239
Query: 421 ---RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
RL +P C + + V ++C RP + L
Sbjct: 240 EGERL-PRPEDCPQDIYN---VMVQCWAHKPEDRPTFVALRDFLL 280
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-35
Identities = 70/284 (24%), Positives = 123/284 (43%), Gaps = 43/284 (15%)
Query: 191 ENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNL 244
V+G G +G V+ GV V +K + + G Q+ + + AIG + H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
VRLLG C G+ LV +Y+ G+L + G P +N + AKG+ YL E
Sbjct: 78 VRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQL---LLNWGVQIAKGMYYLEE 133
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEY 361
+VHR++ + N+LL +++DFG+A LL + + ++A E
Sbjct: 134 ---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAKTPIKWMALES 188
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
G +SDV+S+G+ + E+++ G P Y G + +L+
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEP--Y---AG-----------LRLAEVPDLLEK 232
Query: 421 --RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
RL +P C+ + V ++C + + RP + +
Sbjct: 233 GERL-AQPQICTIDVYM---VMVKCWMIDENIRPTFKELANEFT 272
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-35
Identities = 78/277 (28%), Positives = 131/277 (47%), Gaps = 36/277 (12%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
+G G +G V+ G +T VAVK+L + F E + +++H+ LVRL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
+ ++ EY++NG+L +L G LT +++ A+G+ ++ E
Sbjct: 77 VTQE-PIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGMLN 368
+HRD++++NIL+ + K++DFGLA+L+ + Y T R F APE + G
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLI-EDNEY-TAREGAKFPIKWTAPEAINYGTFT 188
Query: 369 ERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP--RLQEK 425
+SDV+SFGIL+ E+++ GR P Y PG +TN L+ R+ +
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIP--Y---PG-----------MTNPEVIQNLERGYRM-VR 231
Query: 426 P--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
P C L + + C RP ++ +LE
Sbjct: 232 PDNCPEELYQ---LMRLCWKERPEDRPTFDYLRSVLE 265
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-35
Identities = 66/292 (22%), Positives = 123/292 (42%), Gaps = 39/292 (13%)
Query: 191 ENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNL 244
+GEG +G V + VAVK+L G + K E+E + + H+N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 245 VRLLGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
V+ G C E L+ E++ +G+L+++L + + + ++ + KG+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYL 142
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPE 360
+ VHRD+ + N+L++ + K+ DFGL K + ++ Y T + + APE
Sbjct: 143 GS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199
Query: 361 YASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR--------PPGEVNLVEWLKTMVTN 411
SDV+SFG+ + E+++ + G++ + + N
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR-----LVN 254
Query: 412 RNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
EG RL P C + + + +C + R ++I EA
Sbjct: 255 TLKEGK---RL-PCPPNCPDEVYQ---LMRKCWEFQPSNRTSFQNLIEGFEA 299
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-35
Identities = 71/296 (23%), Positives = 124/296 (41%), Gaps = 40/296 (13%)
Query: 191 ENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
++ +G G YG VY GV + + VAVK L +EF E + ++H NLV+LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
C ++ E++ GNL +L ++ + + + + + YL +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLE---KKN 131
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYASTGML 367
+HRD+ + N L+ + K++DFGL++L+ T F APE +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 368 NERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP--RLQE 424
+ +SDV++FG+L+ E+ + G +P Y PG + +L+ R+ E
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP--Y---PG-----------IDLSQVYELLEKDYRM-E 232
Query: 425 KP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE----AEEFPFRDERRAGR 474
+P C + + C N RP + E E+ G+
Sbjct: 233 RPEGCPEKVYE---LMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGK 285
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-35
Identities = 63/287 (21%), Positives = 122/287 (42%), Gaps = 29/287 (10%)
Query: 191 ENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
+G+G +G V + VAVK L ++ + ++F+ E+E + ++H N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 246 RLLGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+ G C R L+ EY+ G+L +L + + KG+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 131
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEY 361
+ +HRD+ + NIL++ + K+ DFGL K+L ++ + + G + APE
Sbjct: 132 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-----GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416
+ + SDV+SFG+++ E+ + P ++ R G + + +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248
Query: 417 VLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
RL +P C + + C + N ++RP + ++
Sbjct: 249 G---RL-PRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQ 288
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 73/300 (24%), Positives = 119/300 (39%), Gaps = 35/300 (11%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG 237
+ + + +GEGG+ V L D A+K +L + Q +E + E +
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 238 RVRHKNLVRLLGYCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLT-WEIRMNII 292
H N++RL+ YC L+ + G L + + LT +I + ++
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI-LWLL 140
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM- 351
LG +GL +H HRD+K +NILL + P L D G +
Sbjct: 141 LGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 352 -------GTFGYVAPE---YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNL 401
T Y APE S +++ER+DV+S G ++ ++ G P D G+
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--- 254
Query: 402 VEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
+ PR S AL LL ++ VDP+ +RP + ++ LEA
Sbjct: 255 ---SVALAVQNQLSIPQSPRH-----SSAL-WQLLNSMMTVDPH--QRPHIPLLLSQLEA 303
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 81/308 (26%), Positives = 137/308 (44%), Gaps = 43/308 (13%)
Query: 191 ENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNL 244
+ VIG G +G VY G+L + VA+K L + ++ +F E +G+ H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
+RL G ++ M++ EY++NG L+++L G + + ++ G A G+ YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLA- 164
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY--VAPEYA 362
VHRD+ + NIL++ K+SDFGL+++L + T G APE
Sbjct: 165 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 363 STGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP- 420
S SDV+SFGI++ EV++ G P Y ++N ++
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERP--Y---WE-----------LSNHEVMKAINDG 266
Query: 421 -RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE----AEEFPFRDERRAG 473
RL P C A+ + + ++C +RPK ++ +L+ A +
Sbjct: 267 FRL-PTPMDCPSAIYQ---LMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDP 322
Query: 474 REHGRSPH 481
R R P
Sbjct: 323 RVSIRLPS 330
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-34
Identities = 69/286 (24%), Positives = 118/286 (41%), Gaps = 29/286 (10%)
Query: 191 ENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNL 244
+GEG +G V + VAVK L + G Q +K E++ + + H+++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 245 VRLLGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
++ G C + LV EY+ G+L +L + L + +G+ YL
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYL 150
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPE 360
H +HRD+ + N+LLD K+ DFGLAK + Y R G + APE
Sbjct: 151 HA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 207
Query: 361 YASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419
SDV+SFG+ + E+++ + E+ + +T +L+
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ--GQMTVLRLTELLE 265
Query: 420 P--RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
RL +P C + + C + A RP ++I +L+
Sbjct: 266 RGERL-PRPDKCPAEVYH---LMKNCWETEASFRPTFENLIPILKT 307
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 78/323 (24%), Positives = 132/323 (40%), Gaps = 48/323 (14%)
Query: 161 AAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVA 214
A++ PE Y E EV+ +G+G +G+VY GV E T VA
Sbjct: 2 ASVNPEYFSAA--DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVA 59
Query: 215 VKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL 273
+K + E+ EF E + ++VRLLG ++G +++ E + G+L+ +L
Sbjct: 60 IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119
Query: 274 ------HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN 327
+ +P + + + A G+ YL+ K VHRD+ + N ++ + +
Sbjct: 120 RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 176
Query: 328 PKLSDFGLAKLLGAERSYVTTRVMGTFGYV-----APEYASTGMLNERSDVYSFGILIME 382
K+ DFG+ + + Y G G + +PE G+ SDV+SFG+++ E
Sbjct: 177 VKIGDFGMTRDIYETDYY----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 232
Query: 383 VIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVAL 439
+ + P Y G N E + V L +KP C L +
Sbjct: 233 IATLAEQP--Y---QGLSN--EQVLRFVMEGG-------LL-DKPDNCPDMLFE---LMR 274
Query: 440 RCVDPNAHKRPKMGHVIHMLEAE 462
C N RP +I ++ E
Sbjct: 275 MCWQYNPKMRPSFLEIISSIKEE 297
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 62/284 (21%), Positives = 120/284 (42%), Gaps = 23/284 (8%)
Query: 191 ENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
+G+G +G V + VAVK L ++ + ++F+ E+E + ++H N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 246 RLLGYCAEGAHR--MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+ G C R L+ EY+ G+L +L + + KG+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 162
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF--GYVAPEY 361
+ +HRD+ + NIL++ + K+ DFGL K+L ++ Y + G + APE
Sbjct: 163 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP- 420
+ + SDV+SFG+++ E+ + + + + + +L
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279
Query: 421 -RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
RL +P C + + C + N ++RP + ++
Sbjct: 280 GRL-PRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLALRVDQ 319
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 51/207 (24%), Positives = 83/207 (40%), Gaps = 19/207 (9%)
Query: 191 ENVIGEGGYGIVYHGVLEDNT---NVAVKNLLNNRGQAEKE----FKVEVEAIGRVRHKN 243
++G GG G VY ED VA+K L++ ++ + E GR++ +
Sbjct: 39 RRLVGRGGMGDVYEA--EDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+V + + + I+ +L L PL + I+ L H
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAH 151
Query: 304 E-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
G HRD+K NIL+ L DFG+A E+ +GT Y+APE
Sbjct: 152 AAGA----THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207
Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
S R+D+Y+ ++ E ++G P
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPP 234
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 61/311 (19%), Positives = 114/311 (36%), Gaps = 54/311 (17%)
Query: 191 ENVIGEGGYGIVYHGVL--------EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK 242
+G+G + ++ GV T V +K L + F + ++ HK
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
+LV G C G +LV E++ G+L+ +L + + W++ + A + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEV--AKQLAAAMHFL 129
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNP--------KLSDFGLAKLLGAERSYVTTRVMGTF 354
E ++H ++ + NILL ++ + KLSD G++ + + + R+
Sbjct: 130 E---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQERIPWV- 184
Query: 355 GYVAPEYASTG-MLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNR 412
PE LN +D +SFG + E+ S G P + ++
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP--L---SA-----------LDSQ 225
Query: 413 NAEGVLDP--RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDER 470
+ +L P + L + C+D RP +I L + F +
Sbjct: 226 RKLQFYEDRHQL-PAPKAAELAN---LINNCMDYEPDHRPSFRAIIRDLNSL---FTPDL 278
Query: 471 RAGREHGRSPH 481
H H
Sbjct: 279 VPRGSHHHHHH 289
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 72/284 (25%), Positives = 124/284 (43%), Gaps = 43/284 (15%)
Query: 191 ENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNL 244
V+G G +G VY G+ VA+K L +A KE E + V + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
RLLG C + L+ + + G L ++ + + +N + AKG+ YL +
Sbjct: 80 CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED 135
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT---FGYVAPEY 361
++VHRD+ + N+L+ + K++DFGLAKLLGAE G ++A E
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALES 190
Query: 362 ASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
+ +SDV+S+G+ + E+++ G P Y G + +L+
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKP--Y---DG-----------IPASEISSILEK 234
Query: 421 --RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
RL +P C+ + + ++C +A RPK +I
Sbjct: 235 GERL-PQPPICTIDVYM---IMVKCWMIDADSRPKFRELIIEFS 274
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 194 IGEGGYGIVYHGVLEDNT---NVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
+G GG V+ D +VAVK L L F+ E + + H +V +
Sbjct: 20 LGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 248 LGY-CAEGAHRMLVY---EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
AE L Y EY+D L +H P+T + + +I + L + H
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSH 133
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT--RVMGTFGYVAPEY 361
+ ++HRD+K +NI++ K+ DFG+A+ + + VT V+GT Y++PE
Sbjct: 134 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNP 389
A ++ RSDVYS G ++ EV++G P
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 70/289 (24%), Positives = 119/289 (41%), Gaps = 40/289 (13%)
Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKN 243
+G G +G VY G + VAVK L + ++ +F +E I + H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLT 300
+VR +G + R ++ E + G+L+ +L S L +++ A G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFG-- 355
YL E +HRDI + N LL K+ DFG+A+ + SY
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPVK 210
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414
++ PE G+ ++D +SFG+L+ E+ S G P Y P + N + + VT+
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--Y---PSKSN--QEVLEFVTSGG- 262
Query: 415 EGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
R+ + P C + R + +C RP ++ +E
Sbjct: 263 ------RM-DPPKNCPGPVYR---IMTQCWQHQPEDRPNFAIILERIEY 301
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-33
Identities = 71/289 (24%), Positives = 115/289 (39%), Gaps = 56/289 (19%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
V+G+G +G V D+ A+K + + + EV + + H+ +VR
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIK-KIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 252 AEGAHRM-------------LVYEYIDNGNLEQWLHGDVGPHSP--LTWEIRMNIILGTA 296
E + + + EY +NG L +H + W + I+
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-SENLNQQRDEYWRLFRQILEA-- 128
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV---------- 346
L+Y+H ++HRD+K NI +D+ N K+ DFGLAK + +
Sbjct: 129 --LSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 347 ----TTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNL 401
T+ + GT YVA E TG NE+ D+YS GI+ E+I +
Sbjct: 184 SDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--------FSTGMER 234
Query: 402 VEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP 450
V LK + R+ P + + K+ ++ L DPN KRP
Sbjct: 235 VNILKKL---RSVSIEFPPDF-DDNKMKVEKK-IIRLLIDHDPN--KRP 276
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 9e-33
Identities = 77/300 (25%), Positives = 125/300 (41%), Gaps = 56/300 (18%)
Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKN 243
+GE +G VY G L E VA+K L + G +EF+ E R++H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWL------------HGDVGPHSPLTWEIRMNI 291
+V LLG + +++ Y +G+L ++L D S L +++
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT--- 348
+ A G+ YL VVH+D+ + N+L+ + N K+SD GL + + A Y
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 349 ----RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVE 403
R M APE G + SD++S+G+++ EV S G P Y G N +
Sbjct: 191 LLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--Y---CGYSN--Q 237
Query: 404 WLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
+ M+ NR L P C + + + C + +RP+ + L A
Sbjct: 238 DVVEMIRNRQ-------VL-PCPDDCPAWVYA---LMIECWNEFPSRRPRFKDIHSRLRA 286
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 69/296 (23%), Positives = 122/296 (41%), Gaps = 50/296 (16%)
Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
+ +GEG +G V+ +D VAVK L A ++F+ E E + ++H+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWL-----------HGDVGPHSPLTWEIRMNIIL 293
VR G C EG ++V+EY+ +G+L ++L G+ PL + +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
A G+ YL VHRD+ + N L+ + K+ DFG+++ + + Y +G
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY----RVGG 218
Query: 354 FGYV-----APEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKT 407
+ PE SDV+SFG+++ E+ + G+ P + N
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--W---YQLSN--TEAID 271
Query: 408 MVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
+T L E+P C + + C +R + V L+A
Sbjct: 272 CITQGR-------EL-ERPRACPPEVYA---IMRGCWQREPQQRHSIKDVHARLQA 316
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 72/287 (25%), Positives = 127/287 (44%), Gaps = 44/287 (15%)
Query: 191 ENVIGEGGYGIVYHGVLED----NTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLV 245
+ VIG+G +G+VYHG D A+K+L + F E + + H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 246 RLLGYCAEGA-HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
L+G ++ Y+ +G+L Q++ P T + ++ L A+G+ YL E
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE 142
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV-----AP 359
K VHRD+ + N +LD+ + K++DFGLA+ + +R Y + + + A
Sbjct: 143 ---QKFVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQ-QHRHARLPVKWTAL 197
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418
E T +SDV+SFG+L+ E+++ G P Y + + L
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPP--Y---RH-----------IDPFDLTHFL 241
Query: 419 DP--RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
RL +P C +L + V +C + + RP ++ +E
Sbjct: 242 AQGRRL-PQPEYCPDSLYQ---VMQQCWEADPAVRPTFRVLVGEVEQ 284
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 78/335 (23%), Positives = 134/335 (40%), Gaps = 56/335 (16%)
Query: 150 SHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLED 209
SHH ++ + P S L ++ + N ++GEG +G V G L+
Sbjct: 4 SHHHHHH---SSGLVPRGSEE---LQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQ 57
Query: 210 ----NTNVAVKNL-LNNRGQAEK-EFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHRM 258
+ VAVK + L+N Q E EF E + H N++RLLG C E M
Sbjct: 58 EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM 117
Query: 259 LVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIK 316
++ ++ G+L +L + + + ++ A G+ YL +HRD+
Sbjct: 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLA 174
Query: 317 SSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV-------MGTFGYVAPEYASTGMLNE 369
+ N +L ++DFGL+K + + Y R+ + A E + +
Sbjct: 175 ARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI------AIESLADRVYTS 228
Query: 370 RSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP-- 426
+SDV++FG+ + E+ + G P Y PG V E + + + RL ++P
Sbjct: 229 KSDVWAFGVTMWEIATRGMTP--Y---PG-VQNHEMYD-YLLHGH-------RL-KQPED 273
Query: 427 CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
C L + C + RP + LE
Sbjct: 274 CLDELYE---IMYSCWRTDPLDRPTFSVLRLQLEK 305
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 73/295 (24%), Positives = 122/295 (41%), Gaps = 40/295 (13%)
Query: 191 ENVIGEGGYGIVYHGVL----EDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
++GEG +G VY GV + NVAVK + +++F E + + H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
+L+G E ++ E G L +L + L + L K + YL
Sbjct: 77 KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYLES- 131
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
VHRDI NIL+ KL DFGL++ + E Y + +++PE +
Sbjct: 132 --INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 189
Query: 366 MLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP--RL 422
SDV+ F + + E++S G+ P + + N++ GVL+ RL
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQP--F---FW-----------LENKDVIGVLEKGDRL 233
Query: 423 QEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDERRAGRE 475
KP C L + RC D + RP+ ++ L + ++ E+ E
Sbjct: 234 -PKPDLCPPVLYT---LMTRCWDYDPSDRPRFTELVCSL--SDV-YQMEKDIAME 281
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 83/288 (28%), Positives = 127/288 (44%), Gaps = 46/288 (15%)
Query: 191 ENVIGEGGYGIVYHGVLEDN----TNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLV 245
VIG G +G VYHG L DN + AVK+L E +F E + H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 246 RLLGYCAEGAH-RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
LLG C ++V Y+ +G+L ++ + T + + L AKG+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKYLAS 146
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG------YVA 358
K VHRD+ + N +LD+++ K++DFGLA+ + + Y V G ++A
Sbjct: 147 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWMA 200
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417
E T +SDV+SFG+L+ E+++ G P Y P V +
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--Y---PD-----------VNTFDITVY 244
Query: 418 LDP--RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
L RL +P C L V L+C P A RP ++ + A
Sbjct: 245 LLQGRRL-LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISA 288
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 60/268 (22%), Positives = 112/268 (41%), Gaps = 33/268 (12%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLL 248
IG G + VY L D VA+K + + + + E++ + ++ H N+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
E +V E D G+L + + + + L ++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---R 155
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE------YA 362
+V+HRDIK +N+ + KL D GL + ++ + + V GT Y++PE Y
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGY- 213
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422
N +SD++S G L+ E+ + ++P ++NL L + + P L
Sbjct: 214 -----NFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYS-LCKKIEQCDY-----PPL 258
Query: 423 QEKPCSRALKRALLVALRCVDPNAHKRP 450
S L++ + C++P+ KRP
Sbjct: 259 PSDHYSEELRQLV---NMCINPDPEKRP 283
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-32
Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLG 249
IG G YG D + K L + +AEK+ V EV + ++H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 250 YCAEGAHRML--VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE--G 305
+ + L V EY + G+L + L E + ++ L H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
V+HRD+K +N+ LD + N KL DFGLA++L + S+ T V GT Y++PE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRM 191
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
NE+SD++S G L+ E+ + P
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPP 215
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 9/200 (4%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEF-KVEVEAIGRVRHKNLVRLLG 249
IGEG +G ED +K + ++ E+E + EV + ++H N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
E +V +Y + G+L + ++ G + ++ + L ++H+ K
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHD---RK 145
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
++HRDIKS NI L K +L DFG+A++L + + GT Y++PE N
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNN 204
Query: 370 RSDVYSFGILIMEVISGRNP 389
+SD+++ G ++ E+ + ++
Sbjct: 205 KSDIWALGCVLYELCTLKHA 224
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 69/289 (23%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKN 243
+G G +G VY G + VAVK L + ++ +F +E I + H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLH---GDVGPHSPLTWEIRMNIILGTAKGLT 300
+VR +G + R ++ E + G+L+ +L S L +++ A G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFG-- 355
YL E +HRDI + N LL K+ DFG+A+ + Y
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRAGYYRKGGCAMLPVK 251
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414
++ PE G+ ++D +SFG+L+ E+ S G P Y P + N + + VT+
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--Y---PSKSN--QEVLEFVTSGG- 303
Query: 415 EGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
R+ + P C + R + +C RP ++ +E
Sbjct: 304 ------RM-DPPKNCPGPVYR---IMTQCWQHQPEDRPNFAIILERIEY 342
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-32
Identities = 70/299 (23%), Positives = 124/299 (41%), Gaps = 55/299 (18%)
Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
+ +GEG +G V+ +D VAVK L + A K+F+ E E + ++H+++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWL------------HGDVGPHSPLTWEIRMNII 292
V+ G C +G ++V+EY+ +G+L ++L L ++I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT---- 348
A G+ YL VHRD+ + N L+ K+ DFG+++ + + Y
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 349 ---RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEW 404
R M PE SDV+SFG+++ E+ + G+ P + N E
Sbjct: 197 LPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--W---FQLSN-TEV 244
Query: 405 LKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
++ +T L E+P C + + V L C +R + + +L A
Sbjct: 245 IE-CITQGR-------VL-ERPRVCPKEVYD---VMLGCWQREPQQRLNIKEIYKILHA 291
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 7e-32
Identities = 61/307 (19%), Positives = 121/307 (39%), Gaps = 45/307 (14%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDN----TNVAVKNL-LNNRGQAEKE-F 229
L ++ + F ++G+G +G V L+ VAVK L + ++ E F
Sbjct: 13 EKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEF 72
Query: 230 KVEVEAIGRVRHKNLVRLLGYCAEG------AHRMLVYEYIDNGNLEQWL--HGDVGPHS 281
E + H ++ +L+G M++ ++ +G+L +L
Sbjct: 73 LREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132
Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341
L + + ++ A G+ YL +HRD+ + N +L + ++DFGL++ +
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKI-Y 188
Query: 342 ERSYVTTRVMGTF--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGE 398
Y ++A E + + SDV++FG+ + E+++ G+ P Y G
Sbjct: 189 SGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP--Y---AGI 243
Query: 399 VN--LVEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGH 454
N + +L G RL ++P C + + +C + +RP
Sbjct: 244 ENAEIYNYLI--------GGN---RL-KQPPECMEEVYD---LMYQCWSADPKQRPSFTC 288
Query: 455 VIHMLEA 461
+ LE
Sbjct: 289 LRMELEN 295
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 64/295 (21%), Positives = 111/295 (37%), Gaps = 37/295 (12%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVL----EDNTNVAVKNL-LNNRGQAEKEFK 230
+ R+ E+ IGEG +G V+ G+ VA+K ++F
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 64
Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
E + + H ++V+L+G ++ E G L +L L +
Sbjct: 65 QEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASLIL 120
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
+ L YL + VHRDI + N+L+ KL DFGL++ + Y ++
Sbjct: 121 YAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMV 409
++APE + SDV+ FG+ + E++ G P + G V
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP--F---QG-----------V 221
Query: 410 TNRNAEGVLDP--RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
N + G ++ RL P C L + +C + +RP+ + L
Sbjct: 222 KNNDVIGRIENGERL-PMPPNCPPTLYS---LMTKCWAYDPSRRPRFTELKAQLS 272
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 1e-31
Identities = 63/280 (22%), Positives = 107/280 (38%), Gaps = 37/280 (13%)
Query: 191 ENVIGEGGYGIVYHGVL----EDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
IGEG +G V+ G+ VA+K ++F E + + H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
+L+G E ++ E G L +L L + + L YL
Sbjct: 455 KLIGVITENP-VWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLES- 509
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
+ VHRDI + N+L+ KL DFGL++ + Y ++ ++APE +
Sbjct: 510 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 366 MLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP--RL 422
SDV+ FG+ + E++ G P + G V N + G ++ RL
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKP--F---QG-----------VKNNDVIGRIENGERL 611
Query: 423 QEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
P C L + +C + +RP+ + L
Sbjct: 612 -PMPPNCPPTLYS---LMTKCWAYDPSRRPRFTELKAQLS 647
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 80/287 (27%), Positives = 127/287 (44%), Gaps = 44/287 (15%)
Query: 191 ENVIGEGGYGIVYHGVLEDN----TNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKNLV 245
VIG G +G VYHG L DN + AVK+L E +F E + H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 246 RLLGYCAEGAH-RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
LLG C ++V Y+ +G+L ++ + T + + L AKG+ +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKFLAS 210
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV-----AP 359
K VHRD+ + N +LD+++ K++DFGLA+ + ++ + + T + A
Sbjct: 211 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEFDSVH-NKTGAKLPVKWMAL 265
Query: 360 EYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418
E T +SDV+SFG+L+ E+++ G P Y P V + L
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--Y---PD-----------VNTFDITVYL 309
Query: 419 DP--RLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
RL +P C L V L+C P A RP ++ + A
Sbjct: 310 LQGRRL-LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISA 352
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
F + +IG GG+G V+ D +K + N +AE+E V+A+ ++ H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVH 68
Query: 247 LLGYCAEGAHRM----------------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
G + + E+ D G LEQW+ G L + +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALE 126
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV 350
+ KG+ Y+H K+++RD+K SNI L K+ DFGL L + TR
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL--KNDGKRTRS 181
Query: 351 MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
GT Y++PE S+ + D+Y+ G+++ E++ +
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 51/215 (23%), Positives = 91/215 (42%), Gaps = 29/215 (13%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
+G GG+G+V+ D+ N A+K + L NR A ++ EV+A+ ++ H +VR
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 251 CAEGAHRM------------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
E + + NL+ W++G + ++I L A+
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIFLQIAEA 130
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM------- 351
+ +LH ++HRD+K SNI K+ DFGL + + T
Sbjct: 131 VEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 352 ----GTFGYVAPEYASTGMLNERSDVYSFGILIME 382
GT Y++PE + + D++S G+++ E
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 72/262 (27%), Positives = 116/262 (44%), Gaps = 23/262 (8%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
V+G+G YGIVY G L + +A+K + + + E+ ++HKN+V+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
+E + E + G+L L GP + +GL YLH+ ++V
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGP-LKDNEQTIGFYTKQILEGLKYLHDN---QIV 144
Query: 312 HRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE--YASTGMLN 368
HRDIK N+L++ K+SDFG +K L T GT Y+APE
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYG 203
Query: 369 ERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCS 428
+ +D++S G I+E+ +G+ P + L E M + + P + E S
Sbjct: 204 KAADIWSLGCTIIEMATGKPP--FY------ELGEPQAAMF--KVGMFKVHPEIPES-MS 252
Query: 429 RALKRALLVALRCVDPNAHKRP 450
K + L+C +P+ KR
Sbjct: 253 AEAKAFI---LKCFEPDPDKRA 271
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 77/340 (22%), Positives = 140/340 (41%), Gaps = 59/340 (17%)
Query: 153 GSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVL----- 207
GS + P ++ + + E + +GEG +G V
Sbjct: 2 GSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDK 61
Query: 208 ---EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYE 262
++ VAVK L ++ + + + E+E + + +HKN++ LLG C + ++ E
Sbjct: 62 DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 121
Query: 263 YIDNGNLEQWL------------HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
Y GNL ++L + P +T++ ++ A+G+ YL K
Sbjct: 122 YASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKC 178
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRV-------MGTFGYVAPEYAS 363
+HRD+ + N+L+ + K++DFGLA+ + Y T M APE
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM------APEALF 232
Query: 364 TGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422
+ +SDV+SFG+L+ E+ + G +P Y PG E L ++ + R+
Sbjct: 233 DRVYTHQSDVWSFGVLMWEIFTLGGSP--Y---PGIPV--EELFKLLKEGH-------RM 278
Query: 423 QEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+KP C+ L + C +RP ++ L+
Sbjct: 279 -DKPANCTNELYM---MMRDCWHAVPSQRPTFKQLVEDLD 314
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-31
Identities = 43/206 (20%), Positives = 80/206 (38%), Gaps = 26/206 (12%)
Query: 193 VIGEGGYGIVYHG---VLEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLL 248
I GG G +Y + V +K L+++ + E + + V H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRP-VVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 249 GYCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+ +V EY+ +L++ L + +L L+YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLH 199
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
+V+ D+K NI+L ++ KL D G + + + GT G+ APE
Sbjct: 200 S---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAPEIVR 250
Query: 364 TGMLNERSDVYSFGILIMEVISGRNP 389
TG +D+Y+ G + +
Sbjct: 251 TGP-TVATDIYTVGRTLAALTLDLPT 275
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 76/329 (23%), Positives = 136/329 (41%), Gaps = 59/329 (17%)
Query: 164 TPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVL--------EDNTNVAV 215
TP ++ + + E + +GEG +G V ++ VAV
Sbjct: 59 TPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAV 118
Query: 216 KNLLNNRGQAEK-EFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNL---- 269
K L ++ + + + E+E + + +HKN++ LLG C + ++ EY GNL
Sbjct: 119 KMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 178
Query: 270 --------EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321
E + P +T++ ++ A+G+ YL K +HRD+ + N+L
Sbjct: 179 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL 235
Query: 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRV-------MGTFGYVAPEYASTGMLNERSDVY 374
+ + K++DFGLA+ + Y T M APE + +SDV+
Sbjct: 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVW 289
Query: 375 SFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP--CSRAL 431
SFG+L+ E+ + G +P Y PG E L ++ + R+ +KP C+ L
Sbjct: 290 SFGVLMWEIFTLGGSP--Y---PGIPV--EELFKLLKEGH-------RM-DKPANCTNEL 334
Query: 432 KRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+ C +RP ++ L+
Sbjct: 335 YM---MMRDCWHAVPSQRPTFKQLVEDLD 360
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 72/294 (24%), Positives = 129/294 (43%), Gaps = 51/294 (17%)
Query: 191 ENVIGEGGYGIVYHGVL---EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-RHKNLV 245
++VIGEG +G V + + A+K + + + +F E+E + ++ H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWL------------HGDVGPHSPLTWEIRMNIIL 293
LLG C + L EY +GNL +L S L+ + ++
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
A+G+ YL + + +HRD+ + NIL+ + + K++DFGL++ + + MG
Sbjct: 150 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGR 202
Query: 354 F--GYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVN--LVEWLKTM 408
++A E + + SDV+S+G+L+ E++S G P Y G L E L
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--Y---CGMTCAELYEKLP-- 255
Query: 409 VTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+G RL EKP C + + +C ++RP ++ L
Sbjct: 256 ------QGY---RL-EKPLNCDDEVYD---LMRQCWREKPYERPSFAQILVSLN 296
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 82/307 (26%), Positives = 130/307 (42%), Gaps = 64/307 (20%)
Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRVRHKN 243
+GEG +G V T VAVK L N +E + E + +V H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--------------------HGDVGPHSPL 283
+++L G C++ +L+ EY G+L +L D L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
T ++ ++G+ YL E K+VHRD+ + NIL+ + K+SDFGL++ + E
Sbjct: 148 TMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 344 SYVTT-------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRP 395
SYV + M A E + +SDV+SFG+L+ E+++ G NP Y
Sbjct: 205 SYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--Y--- 253
Query: 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMG 453
PG E L ++ + R+ E+P CS + R + L+C KRP
Sbjct: 254 PGIPP--ERLFNLLKTGH-------RM-ERPDNCSEEMYR---LMLQCWKQEPDKRPVFA 300
Query: 454 HVIHMLE 460
+ LE
Sbjct: 301 DISKDLE 307
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 77/316 (24%), Positives = 120/316 (37%), Gaps = 57/316 (18%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-E 228
Y + E + +G G +G V VAVK L +E
Sbjct: 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 229 FKVEVEAIGRV-RHKNLVRLLGYC-AEGAHRMLVYEYIDNGNLEQWL------------H 274
E++ + + H N+V LLG C G M++ E+ GNL +L
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 275 GDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334
+ LT E + AKG+ +L K +HRD+ + NILL ++ K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFG 193
Query: 335 LAKLLGAERSYVTT-------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-G 386
LA+ + + YV + M APE + +SDV+SFG+L+ E+ S G
Sbjct: 194 LARDIYKDPDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLG 247
Query: 387 RNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDP 444
+P Y + LK EG R+ P + + + L C
Sbjct: 248 ASP--YPGVKIDEEFCRRLK--------EGT---RM-RAPDYTTPEMYQ---TMLDCWHG 290
Query: 445 NAHKRPKMGHVIHMLE 460
+RP ++ L
Sbjct: 291 EPSQRPTFSELVEHLG 306
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 72/302 (23%), Positives = 117/302 (38%), Gaps = 58/302 (19%)
Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-RHK 242
+G G +G V + VAVK L + E+ E++ + + H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--------------HGDVGPHSPLTWEIR 288
N+V LLG C G +++ EY G+L +L L E
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT 348
++ AKG+ +L +HRD+ + NILL K+ DFGLA+ + + +YV
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 349 -------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVN 400
+ M APE + SDV+S+GI + E+ S G +P Y PG
Sbjct: 205 GNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP--Y---PGMPV 253
Query: 401 LVEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458
++ K M+ R+ P + + C D + KRP ++ +
Sbjct: 254 DSKFYK-MIKEGF-------RM-LSPEHAPAEMYD---IMKTCWDADPLKRPTFKQIVQL 301
Query: 459 LE 460
+E
Sbjct: 302 IE 303
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-29
Identities = 63/278 (22%), Positives = 112/278 (40%), Gaps = 26/278 (9%)
Query: 181 LEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGR 238
+EV + +G G YG+V + +AVK + Q +K ++++ R
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 239 -VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
V V G + E +D +L+++ + + +I I + K
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L +LH + V+HRD+K SN+L++ K+ DFG++ L G Y+
Sbjct: 121 ALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYM 176
Query: 358 APE----YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413
APE + + +SD++S GI ++E+ R P D P + LK +V
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-----LKQVVEE-- 229
Query: 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK 451
P+L S + +C+ N+ +RP
Sbjct: 230 ----PSPQLPADKFSAEFVD--FTS-QCLKKNSKERPT 260
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNL----LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
+G+G +G VY + +A+K L L G + + EVE +RH N++R
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
L GY + L+ EY G + + L S + I A L+Y H
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHS-- 127
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
+V+HRDIK N+LL K++DFG + + R GT Y+ PE M
Sbjct: 128 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-DL--CGTLDYLPPEMIEGRM 183
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
+E+ D++S G+L E + G+ P
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 12/204 (5%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
IGEG GIV VAVK + + Q + EV + +H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYLHEG 305
+ G ++ E++ G L D+ L E ++ + + L YLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT-----DIVSQVRLN-EEQIATVCEAVLQALAYLHA- 159
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
V+HRDIKS +ILL KLSDFG + + + V GT ++APE S
Sbjct: 160 --QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRS 216
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
+ D++S GI+++E++ G P
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 68/298 (22%), Positives = 121/298 (40%), Gaps = 54/298 (18%)
Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-RHK 242
+G G +G V + VAVK L + EK E++ + + +H+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL----------HGDVGPHSPLTWEIRMNII 292
N+V LLG C G +++ EY G+L +L +S + ++
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT---- 348
A+G+ +L +HRD+ + N+LL K+ DFGLA+ + + +Y+
Sbjct: 171 SQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 349 ---RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEW 404
+ M APE + +SDV+S+GIL+ E+ S G NP Y PG + ++
Sbjct: 228 LPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP--Y---PGILVNSKF 276
Query: 405 LKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
K +V + ++ +P + + + C RP + L+
Sbjct: 277 YK-LVKDGY-------QM-AQPAFAPKNIYS---IMQACWALEPTHRPTFQQICSFLQ 322
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 74/307 (24%), Positives = 128/307 (41%), Gaps = 63/307 (20%)
Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-RHK 242
V+G G +G V + + VAVK L +E+ E++ + ++ H+
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL-------------------HGDVGPHSPL 283
N+V LLG C L++EY G+L +L + + L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 284 TWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
T+E + AKG+ +L VHRD+ + N+L+ K+ DFGLA+ + ++
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 344 SYVTT-------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRP 395
+YV + M APE G+ +SDV+S+GIL+ E+ S G NP Y
Sbjct: 227 NYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP--Y--- 275
Query: 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMG 453
PG + K ++ N ++ ++P + + + C ++ KRP
Sbjct: 276 PGIPVDANFYK-LIQNGF-------KM-DQPFYATEEIYI---IMQSCWAFDSRKRPSFP 323
Query: 454 HVIHMLE 460
++ L
Sbjct: 324 NLTSFLG 330
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-29
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
+ IG+G G VY + + VA++ + + ++ E+ + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYLHEG 305
L G +V EY+ G+L DV + + E ++ + + L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLT-----DVVTETCMD-EGQIAAVCRECLQALEFLHSN 135
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
+V+HRDIKS NILL + KL+DFG + E+S +T V GT ++APE +
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 191
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
+ D++S GI+ +E+I G P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 77/319 (24%), Positives = 121/319 (37%), Gaps = 60/319 (18%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEK-EFK 230
L LE N IGEG +G V+ E T VAVK L + +F+
Sbjct: 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 98
Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL----------------- 273
E + + N+V+LLG CA G L++EY+ G+L ++L
Sbjct: 99 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 274 ---HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKL 330
PL+ ++ I A G+ YL E K VHRD+ + N L+ + K+
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 215
Query: 331 SDFGLAKLLGAERSYVTTRVMGTFGYV-----APEYASTGMLNERSDVYSFGILIMEVIS 385
+DFGL++ + + Y + PE SDV+++G+++ E+ S
Sbjct: 216 ADFGLSRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
Query: 386 -GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCV 442
G P Y G + E + V + N L P C L + C
Sbjct: 272 YGLQP--Y---YGMAH--EEVIYYVRDGN-------IL-ACPENCPLELYN---LMRLCW 313
Query: 443 DPNAHKRPKMGHVIHMLEA 461
RP + +L+
Sbjct: 314 SKLPADRPSFCSIHRILQR 332
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 74/302 (24%), Positives = 129/302 (42%), Gaps = 59/302 (19%)
Query: 191 ENVIGEGGYGIVYHGVL--------EDNTNVAVKNLLNNRGQAEK-EFKVEVEAIGRV-R 240
+GEG +G V T VAVK L ++ + + + E+E + + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 241 HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL------------HGDVGPHSPLTWEIR 288
HKN++ LLG C + ++ EY GNL ++L + P L+ +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT 348
++ A+G+ YL K +HRD+ + N+L+ + K++DFGLA+ + Y T
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 349 -------RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVN 400
+ M APE + +SDV+SFG+L+ E+ + G +P Y PG
Sbjct: 251 TNGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--Y---PGVPV 299
Query: 401 LVEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458
E L ++ + R+ +KP C+ L + C +RP ++
Sbjct: 300 --EELFKLLKEGH-------RM-DKPSNCTNELYM---MMRDCWHAVPSQRPTFKQLVED 346
Query: 459 LE 460
L+
Sbjct: 347 LD 348
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 11/213 (5%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
+ E+ + F + +G G G+V+ +A K + L + + E++ +
Sbjct: 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
+V G + E++D G+L+Q L + +I + +
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVI 141
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
KGLTYL E + K++HRD+K SNIL++ + KL DFG++ L S + V GT Y
Sbjct: 142 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSY 196
Query: 357 VAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
++PE + +SD++S G+ ++E+ GR P
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 35/293 (11%), Positives = 65/293 (22%), Gaps = 51/293 (17%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLL---NNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
+ G +V+ +E + A+K N + A R+ ++
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 249 GYCAEGA--------------------------HRMLVYEYI--DNGNLEQWLHGDVGPH 280
+ +L+ D L L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 281 SPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340
+ + L +VH N+ + L D +G
Sbjct: 189 GDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 341 AERSYVTTRVMGTFGYVAPEY--ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE 398
Y E+ AST + + G+ I V P P +
Sbjct: 246 T----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 399 VNLVEWLKTMVTNRNAEGVLDPRLQEKPCS-RALKRALLVALRCVDPNAHKRP 450
W + + + + P + L L D +R
Sbjct: 302 ---GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLN----FDRR--RRL 345
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-28
Identities = 58/287 (20%), Positives = 109/287 (37%), Gaps = 61/287 (21%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRV-RHKNLVRLL 248
IG G +G V+ V D A+K G +++ + EV A + +H ++VR
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
AE H ++ EY + G+L + + S +++L +GL Y+H
Sbjct: 78 SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SM 134
Query: 309 KVVHRDIKSSNILLDKQWNP-------------------KLSDFGLAKLLGAERSYVTTR 349
+VH DIK SNI + + P K+ D G + + +
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE--- 191
Query: 350 VMGTFGYVAPEYASTGMLNER------SDVYSFGILIMEVISGRNPVDYSRPPGEVNLVE 403
G ++A E +L E +D+++ + ++ P + +
Sbjct: 192 --GDSRFLANE-----VLQENYTHLPKADIFALALTVVCAAGAE------PLPRNGD--Q 236
Query: 404 WLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP 450
W + +G L PR+ + S+ L+ + + P+ +RP
Sbjct: 237 WHEIR------QGRL-PRIPQV-LSQEFTE--LLKV-MIHPDPERRP 272
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 245
F IG+G +G V+ G+ VA+K + + E E + E+ + + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
+ G + ++ EY+ G+ D+ PL I+ KGL YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSAL-----DLLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
K +HRDIK++N+LL + KL+DFG+A L + T +GT ++APE
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQS 194
Query: 366 MLNERSDVYSFGILIMEVISGRNP 389
+ ++D++S GI +E+ G P
Sbjct: 195 AYDSKADIWSLGITAIELARGEPP 218
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 76/283 (26%), Positives = 115/283 (40%), Gaps = 28/283 (9%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
+ + + D IG G YG V V +AVK + + +K+ ++++ +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 237 GR-VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
R +V+ G + E + + + + + EI I L T
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
K L +L E K++HRDIK SNILLD+ N KL DFG++ L S TR G
Sbjct: 135 VKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRP 190
Query: 356 YVAPE----YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN 411
Y+APE AS + RSDV+S GI + E+ +GR P + T V
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD------QLTQVVK 244
Query: 412 RNAEGVLDPRLQEKPC---SRALKRALLVALRCVDPNAHKRPK 451
+ P+L S + V C+ + KRPK
Sbjct: 245 GDP-----PQLSNSEEREFSPSFIN--FVN-LCLTKDESKRPK 279
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 25/214 (11%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNL--VRL 247
IG GG V+ + E A+K NL Q ++ E+ + +++ + +RL
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
Y + +V E N +L WL + R + + + +H+
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH-- 146
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPE------ 360
+VH D+K +N L+ KL DFG+A + S V +GT Y+ PE
Sbjct: 147 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 361 -----YASTGMLNERSDVYSFGILIMEVISGRNP 389
S ++ +SDV+S G ++ + G+ P
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 49/222 (22%), Positives = 91/222 (40%), Gaps = 30/222 (13%)
Query: 174 HWYTLRELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVE 232
HW T + +G G +G V+ + AVK + + E E
Sbjct: 58 HWMTHQPR------------VGRGSFGEVHRMKDKQTGFQCAVKKV-----RLEVFRVEE 100
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
+ A + +V L G EG + E ++ G+L Q + L + + +
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK----QMGCLPEDRALYYL 156
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTTR-- 349
+GL YLH +++H D+K+ N+LL + L DFG A L + +
Sbjct: 157 GQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213
Query: 350 --VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
+ GT ++APE + + D++S +++ +++G +P
Sbjct: 214 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 25/214 (11%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNL--VRL 247
IG GG V+ + E A+K NL Q ++ E+ + +++ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
Y + +V E N +L WL + R + + + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH-- 127
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPE------ 360
+VH D+K +N L+ KL DFG+A + S V +GT Y+ PE
Sbjct: 128 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 361 -----YASTGMLNERSDVYSFGILIMEVISGRNP 389
S ++ +SDV+S G ++ + G+ P
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 16/204 (7%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
+G+GG+ + + A K +LL Q EK +E+ + H+++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 81
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT-WEIRMNIILGTAKGLTYLHEGLE 307
G+ + +V E +L + LT E R + G YLH
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEAR-YYLRQIVLGCQYLHRN-- 134
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
+V+HRD+K N+ L++ K+ DFGLA + + + GT Y+APE S
Sbjct: 135 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH 192
Query: 368 NERSDVYSFGILIMEVISGRNPVD 391
+ DV+S G ++ ++ G+ P +
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
F +GEG YG VY + E VA+K + +E E+ + + ++V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVK 88
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
G + +V EY G++ + + LT + I+ T KGL YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM- 144
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM 366
+ +HRDIK+ NILL+ + + KL+DFG+A L + T + GT ++APE
Sbjct: 145 --RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIG 201
Query: 367 LNERSDVYSFGILIMEVISGRNP 389
N +D++S GI +E+ G+ P
Sbjct: 202 YNCVADIWSLGITAIEMAEGKPP 224
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
+G+G + VY + VA+K + G ++ + EV+ +++H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELY 77
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT-WEIRMNIILGTAKGLTYLHEGLE 307
Y + + LV E NG + ++L V P + E R + + G+ YLH
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP---FSENEAR-HFMHQIITGMLYLHS--- 130
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
++HRD+ SN+LL + N K++DFGLA L T + GT Y++PE A+
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAH 189
Query: 368 NERSDVYSFGILIMEVISGRNP 389
SDV+S G + ++ GR P
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPP 211
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 68/267 (25%), Positives = 98/267 (36%), Gaps = 42/267 (15%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKV-EVEAIGRV-RHKNLVRLL 248
+G G YG V+ ED AVK RG ++ K+ EV + +V +H VRL
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
EG L E +L+Q + L + T L +LH
Sbjct: 124 QAWEEGGILYLQTELCG-PSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS---Q 176
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-----YAS 363
+VH D+K +NI L + KL DFGL LG + G Y+APE Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQE-GDPRYMAPELLQGSY-- 232
Query: 364 TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423
+DV+S G+ I+EV W + +G L P
Sbjct: 233 ----GTAADVFSLGLTILEVACNMELPHGGEG--------WQQLR------QGYLPPEFT 274
Query: 424 EKPCSRALKRALLVALRCVDPNAHKRP 450
S L+ L + ++P+ R
Sbjct: 275 AG-LSSELRSVL---VMMLEPDPKLRA 297
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 53/356 (14%), Positives = 94/356 (26%), Gaps = 72/356 (20%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLL---NNRGQAEKEFKVEVEAIGR---------- 238
V+G+ E + V A K+ K EV +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 239 ------------VRHKNLVRLLGYCAEGAHRMLVYEYI-------DNGNLEQWLHGDVGP 279
V+ +++ + ++ + + + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338
H L R+ + L + L LH G +VH ++ +I+LD++ L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 339 LGAERSYVTTRVMGTFGYVAPE-----YASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393
GA R A ++ D ++ G+ I + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320
Query: 394 RPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP-CSRALKRALLVALRCVDPNAHKRPKM 452
A G + + + + RALL R
Sbjct: 321 -------------------AALGGSEWIFRSCKNIPQPV-RALLEGFLRYPKE--DRL-- 356
Query: 453 GHVIHMLEAEEFPFRDERRAGREHGRSPHNGIKGRLMEKGVSESGDSSGYESGVQT 508
L+A E P ++ R + E G SG S E+G
Sbjct: 357 ----LPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGAAE 408
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 27/223 (12%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLL 248
V+ EGG+ VY + A+K LL+N + + EV + ++ H N+V+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 249 GYCAEGAHRM-------LVYEYIDNGNLEQWLHGDVGPHSPLT-WEIRMNIILGTAKGLT 300
+ G L+ + G L ++L + PL+ + I T + +
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVL-KIFYQTCRAVQ 150
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM--------- 351
++H +P ++HRD+K N+LL Q KL DFG A + Y +
Sbjct: 151 HMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 352 --GTFGYVAPE---YASTGMLNERSDVYSFGILIMEVISGRNP 389
T Y PE S + E+ D+++ G ++ + ++P
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 16/202 (7%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL----LNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
+G+G +G VY ++ +A+K L L G E + + E+E +RH N++R+
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLRHPNILRM 79
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
Y + L+ E+ G L + L H + + A L Y HE
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKELQ----KHGRFDEQRSATFMEELADALHYCHE--- 132
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
KV+HRDIK N+L+ + K++DFG + + R + GT Y+ PE
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRTMCGTLDYLPPEMIEGKTH 189
Query: 368 NERSDVYSFGILIMEVISGRNP 389
+E+ D++ G+L E + G P
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPP 211
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 58/290 (20%), Positives = 109/290 (37%), Gaps = 44/290 (15%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
++G+G V+ G + A+K N ++ + + + E E + ++ HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLFA 74
Query: 250 Y--CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
H++L+ E+ G+L L + L + ++ G+ +L E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 308 PKVVHRDIKSSNILL----DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
+VHR+IK NI+ D Q KL+DFG A+ L + + GT Y+ P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHPDMYE 188
Query: 364 TGML--------NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415
+L D++S G+ +G P P E + ++T + +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP--RRNKEVMYKIITGKPSG 246
Query: 416 GVLDPRLQEK----------------PCSRALKRALLVALRCVDPNAHKR 449
+ + E + L +L + D K
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE--KC 294
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 43/209 (20%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
+ +G+G +G VY E A K + + +++ VE+E + H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYLHEG 305
LLG ++ E+ G ++ + + E ++ ++ + L +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT----EPQIQVVCRQMLEALNFLHSK 136
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
+++HRD+K+ N+L+ + + +L+DFG++ + +GT ++APE
Sbjct: 137 ---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCE 192
Query: 366 ML-----NERSDVYSFGILIMEVISGRNP 389
+ + ++D++S GI ++E+ P
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 67/279 (24%), Positives = 112/279 (40%), Gaps = 34/279 (12%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLL-NNRGQAEKEFKVEVEAIGRVRHKNLVR 246
F ++V+G G G + + + DN +VAVK +L A++E ++ E+ H N++R
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDE---HPNVIR 82
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
+ + + E L++++ + ++ T GL +LH
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHS-- 136
Query: 307 EPKVVHRDIKSSNILL-----DKQWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAP 359
+VHRD+K NIL+ + +SDFGL K L R + R V GT G++AP
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 360 EY---ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416
E D++S G + VIS + P G+ +
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH-----PFGKSLQRQANI-----LLGAC 245
Query: 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHV 455
LD EK + L+ + + + KRP HV
Sbjct: 246 SLDCLHPEKHEDVIARE--LIE-KMIAMDPQKRPSAKHV 281
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 16/202 (7%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
+G+GG+ + + A K +LL Q EK +E+ + H+++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 107
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT-WEIRMNIILGTAKGLTYLHEGLE 307
G+ + +V E +L + LT E R + G YLH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEAR-YYLRQIVLGCQYLHR--- 159
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
+V+HRD+K N+ L++ K+ DFGLA + + + GT Y+APE S
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH 218
Query: 368 NERSDVYSFGILIMEVISGRNP 389
+ DV+S G ++ ++ G+ P
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPP 240
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 5e-26
Identities = 60/218 (27%), Positives = 93/218 (42%), Gaps = 23/218 (10%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLL-- 248
+G GG+G V + + VA+K +E + +E++ + ++ H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 249 ----GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT-WEIR--MNIILGTAKGLTY 301
A +L EY + G+L ++L+ L IR ++ I L Y
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDIS---SALRY 136
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
LHE +++HRD+K NI+L K+ D G AK L + T V GT Y+A
Sbjct: 137 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV-GTLQYLA 191
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP 396
PE D +SFG L E I+G P + P
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 229
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 49/214 (22%), Positives = 86/214 (40%), Gaps = 25/214 (11%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNL--VRL 247
IG GG V+ + E A+K NL Q ++ E+ + +++ + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
Y + +V E N +L WL + R + + + +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH-- 174
Query: 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPE------ 360
+VH D+K +N L+ KL DFG+A + S V +G Y+ PE
Sbjct: 175 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 361 -----YASTGMLNERSDVYSFGILIMEVISGRNP 389
S ++ +SDV+S G ++ + G+ P
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 59/290 (20%), Positives = 108/290 (37%), Gaps = 44/290 (15%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
++G+G V+ G + A+K N ++ + + + E E + ++ HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLFA 74
Query: 250 YCAEGAHRM--LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
E R L+ E+ G+L L + L + ++ G+ +L E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 308 PKVVHRDIKSSNILL----DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
+VHR+IK NI+ D Q KL+DFG A+ L + + GT Y+ P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHPDMYE 188
Query: 364 TGML--------NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415
+L D++S G+ +G P P E + ++T + +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP--RRNKEVMYKIITGKPSG 246
Query: 416 GVLDPRLQEK----------------PCSRALKRALLVALRCVDPNAHKR 449
+ + E + L +L + D K
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE--KC 294
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 53/229 (23%), Positives = 95/229 (41%), Gaps = 16/229 (6%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAI 236
+ + N + +G G G V+ + +AVK + + + K ++++ +
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 237 GR-VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
+ +V+ G + E + + P+ I + +
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKR----MQGPIPERILGKMTVAI 133
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
K L YL E + V+HRD+K SNILLD++ KL DFG++ L R G
Sbjct: 134 VKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAA 189
Query: 356 YVAPE-----YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399
Y+APE + + R+DV+S GI ++E+ +G+ P + EV
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV 238
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 6e-26
Identities = 44/320 (13%), Positives = 92/320 (28%), Gaps = 39/320 (12%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN------VAVKNLLNNRGQAEKEFKVE 232
E ++ + +++GEG + VY D + +K + EF +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ---KPANPWEFYIG 114
Query: 233 VEAIGRVR---HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL-HGDVGPHSPLTWEIR 288
+ + R++ ++ +LV E G L + P + +
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-----------KLSDFGLAK 337
++ + + +H+ +++H DIK N +L + L D G +
Sbjct: 175 ISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 338 LLGAERSYVTTRVM-GTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNPVD 391
+ T G+ E ML+ + D + + ++ G
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVE-----MLSNKPWNYQIDYFGVAATVYCMLFGTYM-K 285
Query: 392 YSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK 451
GE + + L C LL H K
Sbjct: 286 VKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNK 345
Query: 452 MGHVIHMLEAEEFPFRDERR 471
+ + + L + R+
Sbjct: 346 IRALRNRLIVLLLECKRSRK 365
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 46/220 (20%), Positives = 89/220 (40%), Gaps = 29/220 (13%)
Query: 193 VIGEGGYGIVYHGVLEDNTNVAVK-----------------NLLNNRGQAEKEFKVEVEA 235
+ +G + + +DN A+K N + +FK E++
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL----HGDVGPHSPLTWEIRMNI 291
I ++++ + G ++YEY++N ++ ++ D + ++ I
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM 351
I +Y+H + HRD+K SNIL+DK KLSDFG ++ +
Sbjct: 157 IKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEY--MVDKKIKG-SR 211
Query: 352 GTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNP 389
GT+ ++ PE+ S + D++S GI + + P
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 72/277 (25%), Positives = 122/277 (44%), Gaps = 37/277 (13%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLV 245
F ++G G YG VY G ++ A+K +++ G E+E K E+ + + H+N+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 246 RLLG-YCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
G + + M LV E+ G++ + G + L E I +GL
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGL 142
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
++LH+ KV+HRDIK N+LL + KL DFG++ L T +GT ++AP
Sbjct: 143 SHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAP 198
Query: 360 E-----YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP-GEVNLVEWLKTMVTNRN 413
E + +SD++S GI +E+ G PP +++ + L + N
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEG-------APPLCDMHPMRALFLIPRNP- 250
Query: 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP 450
PRL+ K S+ + + L + +RP
Sbjct: 251 -----APRLKSKKWSKKFQSFIESCL-VKNH--SQRP 279
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 54/268 (20%), Positives = 91/268 (33%), Gaps = 80/268 (29%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
F +G GG+G+V+ D+ N A+K + L NR A ++ EV+A+ ++ H +V
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 246 RLLGYCAEGAHRMLVYE------------------------------------------- 262
R E E
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 263 ---------YI-----DNGNLEQWLHGDVGPHSP---LTWEIRMNIILGTAKGLTYLHEG 305
YI NL+ W++ + I + I + +LH
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAE----AVEFLH-- 181
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT-----------TRVMGTF 354
++HRD+K SNI K+ DFGL + + T T +GT
Sbjct: 182 -SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIME 382
Y++PE + + D++S G+++ E
Sbjct: 241 LYMSPEQIHGNNYSHKVDIFSLGLILFE 268
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 37/241 (15%), Positives = 71/241 (29%), Gaps = 52/241 (21%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLL---NNRGQAEKEFKVEVEAIGRVR-------- 240
V+G+ E + V A K+ K EV + +R
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 241 -----------------HKNLVRLLGYCAEGAHRMLVYEY----IDNGNLEQWLHGDVGP 279
K ++R+ + + Y + + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339
H L R+ + L + L LH +VH ++ +I+LD++ L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 340 GAERSYVTTRVMGTFGYVAPEYAST-----------GMLNERSDVYSFGILIMEVISGRN 388
GA + G+ PE + ++ D ++ G++I +
Sbjct: 257 GARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 389 P 389
P
Sbjct: 312 P 312
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 52/223 (23%), Positives = 86/223 (38%), Gaps = 34/223 (15%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLG 249
E ++G G G V VAVK +L + +E++ + H N++R
Sbjct: 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYC 76
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRM-NIILGTAKGLTYLHEGL 306
+ E N NL+ + + L E +++ A G+ +LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-- 133
Query: 307 EPKVVHRDIKSSNILLDKQWNP-------------KLSDFGLAKLLGAERSYVTTRVM-- 351
K++HRD+K NIL+ +SDFGL K L + +S T +
Sbjct: 134 -LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 352 -GTFGYVAPE-------YASTGMLNERSDVYSFGILIMEVISG 386
GT G+ APE + L D++S G + ++S
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 68/286 (23%), Positives = 125/286 (43%), Gaps = 45/286 (15%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 245
+ + VIG G +V VA+K + + Q + E++A+ + H N+V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNL----EQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLT 300
LV + + G++ + + L E + IL +GL
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILREVLEGLE 135
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF-G---Y 356
YLH+ +HRD+K+ NILL + + +++DFG++ L +V TF G +
Sbjct: 136 YLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 357 VAPE-------YASTGMLNERSDVYSFGILIMEVISGRNPVDYSR-PPGEVNLVEWLKTM 408
+APE Y + ++D++SFGI +E+ +G P Y + PP +V M
Sbjct: 193 MAPEVMEQVRGY------DFKADIWSFGITAIELATGAAP--YHKYPPMKV-------LM 237
Query: 409 VTNRNA----EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP 450
+T +N E + + K ++ ++ +++L C+ + KRP
Sbjct: 238 LTLQNDPPSLETGVQDKEMLKKYGKSFRK--MISL-CLQKDPEKRP 280
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 42/225 (18%), Positives = 72/225 (32%), Gaps = 18/225 (8%)
Query: 178 LRELEVSTNGFADENVIGEG--GYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVE 232
+ + VIG+G V V V+ NL + + E
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNII 292
+ H N+V +V ++ G+ + + + I+
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC--THFMDGMNELAIAYIL 134
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG 352
G K L Y+H VHR +K+S+IL+ LS + +
Sbjct: 135 QGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 353 TFGYV------APEYASTGML--NERSDVYSFGILIMEVISGRNP 389
V +PE + + +SD+YS GI E+ +G P
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 63/260 (24%), Positives = 106/260 (40%), Gaps = 42/260 (16%)
Query: 149 GSHHGSGDQTVAAAITPEVSHLGWG-----HWYTLRELEVSTNGFADENVIGEGGYGIVY 203
GS S + P T + E++ + + VIG G +G+V+
Sbjct: 1 GSFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIA---YTNCKVIGNGSFGVVF 57
Query: 204 HGVLEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLVRLLGYCAEGAHRM---- 258
L ++ VA+K +L +K FK E++ + V+H N+V L + +
Sbjct: 58 QAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112
Query: 259 --LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIK 316
LV EY+ + + + + + + L Y+H + HRDIK
Sbjct: 113 LNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIK 168
Query: 317 SSNILLDKQWNP-KLSDFGLAKLLGAER---SYVTTRVMGTFGYVAPEYASTGMLNERS- 371
N+LLD KL DFG AK+L A SY+ +R Y APE + +
Sbjct: 169 PQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPEL----IFGATNY 219
Query: 372 ----DVYSFGILIMEVISGR 387
D++S G ++ E++ G+
Sbjct: 220 TTNIDIWSTGCVMAELMQGQ 239
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 73/272 (26%), Positives = 116/272 (42%), Gaps = 38/272 (13%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAE---KEFKVEVEAIGRVRHKN 243
F+D IG G +G VY + ++ VA+K + + Q+ ++ EV + ++RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL-GTAKGLTYL 302
++ G LV EY G+ L P E+ + + G +GL YL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ----EVEIAAVTHGALQGLAYL 170
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-- 360
H ++HRD+K+ NILL + KL DFG A ++ S+V GT ++APE
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVI 222
Query: 361 -YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP-GEVNLVEWLKTMVTNRNAEGVL 418
G + + DV+S GI +E+ +PP +N + L + N +
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAER-------KPPLFNMNAMSALYHIAQNES----- 270
Query: 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRP 450
P LQ S + + L P RP
Sbjct: 271 -PALQSGHWSEYFRNFVDSCL-QKIPQ--DRP 298
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 9e-23
Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 35/217 (16%)
Query: 188 FADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGRVRHKNLV 245
+ D VIG G +G+VY L + VA+K +L +K FK E++ + ++ H N+V
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 110
Query: 246 RLLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
RL + + LV +Y+ + + L + + L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAER---SYVTTRVMGTFG 355
Y+H + HRDIK N+LLD KL DFG AK L SY+ +R
Sbjct: 170 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----- 221
Query: 356 YVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
Y APE + DV+S G ++ E++ G+
Sbjct: 222 YRAPEL----IFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 1e-22
Identities = 56/216 (25%), Positives = 86/216 (39%), Gaps = 44/216 (20%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------R 238
IGEG YG+V+ +N + A K+F + +
Sbjct: 9 GKIGEGSYGVVFKC----------RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQ 58
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
++H NLV LL LV+EY D+ + L D ++ +I T +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVK-SITWQTLQA 114
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
+ + H+ +HRD+K NIL+ K KL DFG A+LL Y V T Y +
Sbjct: 115 VNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRS 170
Query: 359 PE-------YASTGMLNERSDVYSFGILIMEVISGR 387
PE Y + DV++ G + E++SG
Sbjct: 171 PELLVGDTQY-GPPV-----DVWAIGCVFAELLSGV 200
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 50/220 (22%), Positives = 89/220 (40%), Gaps = 29/220 (13%)
Query: 185 TNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN 243
+ F E + G+G +G V G +VA+K ++ + +E + ++ + + H N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPN 80
Query: 244 LVRLLGY-CAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
+V+L Y G +V EY+ + L + + +
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFGLAKLLGAER---SYVTTRVMG 352
+ + LH V HRDIK N+L+++ KL DFG AK L +Y+ +R
Sbjct: 140 RSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-- 196
Query: 353 TFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
Y APE + + D++S G + E++ G
Sbjct: 197 ---YRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 1e-21
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 32/212 (15%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNLV 245
IGEG YG V+ E + VA+K + R + E E+ + ++HKN+V
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
RL LV+E+ D +L+++ G P + + +L KGL + H
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGFCHSR 120
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE---- 360
V+HRD+K N+L+++ KL++FGLA+ G R Y + V+ T Y P+
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVV-TLWYRPPDVLFG 175
Query: 361 ---YASTGMLNERSDVYSFGILIMEVISGRNP 389
Y ST + D++S G + E+ + P
Sbjct: 176 AKLY-STSI-----DMWSAGCIFAELANAGRP 201
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 46/219 (21%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE------AIGR------- 238
+G G Y VY G N A KE K++ E AI R
Sbjct: 11 EKLGNGTYATVYKG----------LNKTTGVYVALKEVKLDSEEGTPSTAI-REISLMKE 59
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTA 296
++H+N+VRL LV+E++DN +L++++ L +
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFG 355
+GL + HE K++HRD+K N+L++K+ KL DFGLA+ G ++ ++ V+ T
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF-SSEVV-TLW 173
Query: 356 YVAPE-------YASTGMLNERSDVYSFGILIMEVISGR 387
Y AP+ Y ST + D++S G ++ E+I+G+
Sbjct: 174 YRAPDVLMGSRTY-STSI-----DIWSCGCILAEMITGK 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 93.3 bits (233), Expect = 2e-21
Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 35/211 (16%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNL 244
IGEG YG+VY ++N A+K + R + E E E+ + ++H N+
Sbjct: 8 EKIGEGTYGVVYKA--QNNYGETFALKKI---RLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
V+L +LV+E++D +L++ L G +T + + +L G+ Y H+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYCHD 118
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE--- 360
+V+HRD+K N+L++++ K++DFGLA+ G R Y T ++ T Y AP+
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIV-TLWYRAPDVLM 173
Query: 361 ----YASTGMLNERSDVYSFGILIMEVISGR 387
Y ST + D++S G + E+++G
Sbjct: 174 GSKKY-STTI-----DIWSVGCIFAEMVNGT 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 50/182 (27%), Positives = 79/182 (43%), Gaps = 31/182 (17%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------R 238
++GEG YG+V +N R A K+F + +
Sbjct: 31 GLVGEGSYGMVMKC----------RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
+RH+NLV LL C + LV+E++D+ + L ++ P+ L +++ + G
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPN-GLDYQVVQKYLFQIING 136
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
+ + H ++HRDIK NIL+ + KL DFG A+ L A V T Y A
Sbjct: 137 IGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRA 192
Query: 359 PE 360
PE
Sbjct: 193 PE 194
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 35/211 (16%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNL 244
+GEG YG+VY +D+ VA+K + R AE E E+ + + H N+
Sbjct: 27 EKVGEGTYGVVYKA--KDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
V L+ LV+E+++ +L++ L + +I + +L +G+ + H+
Sbjct: 82 VSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQ 137
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE--- 360
+++HRD+K N+L++ KL+DFGLA+ G RSY T V+ T Y AP+
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-THEVV-TLWYRAPDVLM 192
Query: 361 ----YASTGMLNERSDVYSFGILIMEVISGR 387
Y ST + D++S G + E+I+G+
Sbjct: 193 GSKKY-STSV-----DIWSIGCIFAEMITGK 217
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 40/218 (18%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEAI---------GRVR 240
IGEG YG V+ N VA+K + R Q +E + + I
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEE-GMPLSTIREVAVLRHLETFE 72
Query: 241 HKNLVRLL----GYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
H N+VRL + ++ LV+E++D +L +L D P + E +++
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMMFQL 129
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFG 355
+GL +LH +VVHRD+K NIL+ KL+DFGLA++ + + T+ V+ T
Sbjct: 130 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVV-TLW 184
Query: 356 YVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
Y APE Y +T + D++S G + E+ +
Sbjct: 185 YRAPEVLLQSSY-ATPV-----DLWSVGCIFAEMFRRK 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 4e-21
Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 40/219 (18%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEV-----------EAIGRV 239
IG G YG VY VA+K++ R + +
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGGGGGGGLPISTVREVALLRRLEAF 71
Query: 240 RHKNLVRLLGYCAEGAHR-----MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
H N+VRL+ CA LV+E++D +L +L D P L E +++
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQ 128
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF 354
+GL +LH +VHRD+K NIL+ KL+DFGLA++ + + T V+ T
Sbjct: 129 FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TPVVV-TL 183
Query: 355 GYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
Y APE Y +T + D++S G + E+ +
Sbjct: 184 WYRAPEVLLQSTY-ATPV-----DMWSVGCIFAEMFRRK 216
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 26/214 (12%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
++GEG YG V + E AVK L E K E++ + R+RHKN+++L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 248 LG--YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT-WEIR---MNIILGTAKGLTY 301
+ Y E +V EY G E D P + +I GL Y
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEML---DSVPEKRFPVCQAHGYFCQLID----GLEY 124
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER--SYVTTRVMGTFGYVAP 359
LH +VH+DIK N+LL K+S G+A+ L T G+ + P
Sbjct: 125 LH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQPP 180
Query: 360 EYASTGMLNE--RSDVYSFGILIMEVISGRNPVD 391
E A+ + D++S G+ + + +G P +
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 6e-21
Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 16/205 (7%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
+G G YG V + A+K + + + EV + + H N+++L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
+ + + LV E G L + II G+TYLH+
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH-- 155
Query: 308 PKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
+VHRD+K N+LL +K K+ DFGL+ + E +GT Y+APE
Sbjct: 156 -NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--ENQKKMKERLGTAYYIAPE-VLR 211
Query: 365 GMLNERSDVYSFGILIMEVISGRNP 389
+E+ DV+S G+++ +++G P
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPP 236
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 29/210 (13%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKV----EVEAIGRVRHKNLV 245
+ +GEG + VY N VA+K + L +R +A+ E++ + + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
LL ++ LV+++++ +LE + LT +L T +GL YLH+
Sbjct: 76 GLLDAFGHKSNISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH 131
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPE---- 360
++HRD+K +N+LLD+ KL+DFGLAK G+ R+Y T +V+ T Y APE
Sbjct: 132 ---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVV-TRWYRAPELLFG 186
Query: 361 ---YASTGMLNERSDVYSFGILIMEVISGR 387
Y G+ D+++ G ++ E++
Sbjct: 187 ARMY-GVGV-----DMWAVGCILAELLLRV 210
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
+ V+G+G +G V AVK + + E EV+ + ++ H N++
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES-LLREVQLLKQLDHPNIM 89
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
+L + + + LV E G L + + II G+TY+H+
Sbjct: 90 KLYEFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 306 LEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
K+VHRD+K N+LL K N ++ DFGL+ A + +GT Y+APE
Sbjct: 146 ---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAPE-V 199
Query: 363 STGMLNERSDVYSFGILIMEVISGRNP 389
G +E+ DV+S G+++ ++SG P
Sbjct: 200 LHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-20
Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 27/216 (12%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVK-------------NLLNNRGQAEKEFKVEVEAI 236
+G G YG V ++ A+K + N + +E E+ +
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
+ H N+++L + + LV E+ + G L + + NI+
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQIL 156
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
G+ YLH+ +VHRDIK NILL + N K+ DFGL+ + Y +GT
Sbjct: 157 SGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYKLRDRLGT 211
Query: 354 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
Y+APE NE+ DV+S G+++ ++ G P
Sbjct: 212 AYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 6e-20
Identities = 64/285 (22%), Positives = 115/285 (40%), Gaps = 26/285 (9%)
Query: 110 DPLPEPEPILV-EDSPASGRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVS 168
P P+L+ D R E GK R + ++ E+
Sbjct: 92 KPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIK 151
Query: 169 HLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAE 226
H Y + E +G G +G+V+ E T A K ++ +
Sbjct: 152 HDHVLDHYDIHE------------ELGTGAFGVVHRVT-ERATGNNFAAKFVMTPHESDK 198
Query: 227 KEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWE 286
+ + E++ + +RH LV L + +++YE++ G L + + H+ ++ +
Sbjct: 199 ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV---ADEHNKMSED 255
Query: 287 IRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP--KLSDFGLAKLLGAERS 344
+ + KGL ++HE VH D+K NI+ + + KL DFGL L ++S
Sbjct: 256 EAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312
Query: 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
GT + APE A + +D++S G+L ++SG +P
Sbjct: 313 VKV--TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 6e-20
Identities = 49/222 (22%), Positives = 90/222 (40%), Gaps = 52/222 (23%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIG-------------R 238
+GEG YG VY + + N A K ++E E G
Sbjct: 40 TKLGEGTYGEVYKA----------IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKE 89
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
++H+N++ L L++EY +N +L++++ + ++ + + + G
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD----KNPDVSMRVIKSFLYQLING 144
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNP-----KLSDFGLAKLLGAE-RSYVTTRVMG 352
+ + H + +HRD+K N+LL K+ DFGLA+ G R + T ++
Sbjct: 145 VNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-THEII- 199
Query: 353 TFGYVAPE-------YASTGMLNERSDVYSFGILIMEVISGR 387
T Y PE Y ST + D++S + E++
Sbjct: 200 TLWYRPPEILLGSRHY-STSV-----DIWSIACIWAEMLMKT 235
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 8e-20
Identities = 62/221 (28%), Positives = 93/221 (42%), Gaps = 49/221 (22%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV--EVEAIGRVRHKNLVRLLGY 250
+GEG YG V V VAVK +++ + + + E+ + H+N+V+ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 251 CAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTAKG 298
EG + L EY G L + M ++ G
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQRFFHQLMAGVV-- 119
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL--LGAERSYVTTRVMGTFGY 356
YLH + HRDIK N+LLD++ N K+SDFGLA + + GT Y
Sbjct: 120 --YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPY 173
Query: 357 VAPEYASTGMLNER------SDVYSFGILIMEVISGRNPVD 391
VAPE +L R DV+S GI++ +++G P D
Sbjct: 174 VAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 47/196 (23%), Positives = 85/196 (43%), Gaps = 13/196 (6%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
VIG+G + +V + E AVK ++ G + ++ K E ++H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
LL + +V+E++D +L + + + + + + L Y H+
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN- 149
Query: 307 EPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
++HRD+K +LL + N KL FG+A LG RV GT ++APE
Sbjct: 150 --NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVK 206
Query: 364 TGMLNERSDVYSFGIL 379
+ DV+ G++
Sbjct: 207 REPYGKPVDVWGCGVI 222
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-19
Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 32/231 (13%)
Query: 175 WYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNV--AVKNLLNNRGQAEKEF--- 229
W L + + F D V+G GG+G V+ T A K L R + K +
Sbjct: 174 WKWLEAQPMGEDWFLDFRVLGRGGFGEVF-ACQMKATGKLYACKKLNKKRLKKRKGYQGA 232
Query: 230 KVEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIR 288
VE + + +V + +V L Y E + LV ++ G++ ++ + E R
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPR 290
Query: 289 MN-----IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
I+ G L +LH+ +++RD+K N+LLD N ++SD GLA L A +
Sbjct: 291 AIFYTAQIVSG----LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343
Query: 344 SYVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
+ GT G++APE +L D ++ G+ + E+I+ R P
Sbjct: 344 TKTKGYA-GTPGFMAPE-----LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 54/256 (21%), Positives = 98/256 (38%), Gaps = 20/256 (7%)
Query: 146 RAAGSHHGSGDQTVAAAITPEVSHLGWGHW-----YTLRELEVSTNGFAD----ENVIGE 196
R + HH G + P+++ + Y + +EV D +G
Sbjct: 2 RGSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGS 61
Query: 197 GGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255
G +G+V+ V K + + K E+ + ++ H L+ L +
Sbjct: 62 GAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121
Query: 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDI 315
+L+ E++ G L + + S M GL ++HE +VH DI
Sbjct: 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---GLKHMHEH---SIVHLDI 175
Query: 316 KSSNILLDKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDV 373
K NI+ + + K+ DFGLA L + T + APE + +D+
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKV--TTATAEFAAPEIVDREPVGFYTDM 233
Query: 374 YSFGILIMEVISGRNP 389
++ G+L ++SG +P
Sbjct: 234 WAIGVLGYVLLSGLSP 249
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 63/274 (22%), Positives = 111/274 (40%), Gaps = 57/274 (20%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGV 206
HH SG + + P + L +E E + + ++G GG+G VY G+
Sbjct: 5 HHHHHHSSGLVPRGSHMAPC-NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGI 63
Query: 207 -LEDNTNVAVK----NLLNNRGQAEKEFKV--EVEAIGRVRHK--NLVRLLGYCAEGAHR 257
+ DN VA+K + +++ G+ +V EV + +V ++RLL +
Sbjct: 64 RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123
Query: 258 MLVYEYIDN-GNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTAKGLTYLHE 304
+L+ E + +L ++ G + ++ + + + H
Sbjct: 124 VLILERPEPVQDLFDFITERG------------ALQEELARSFFWQVL----EAVRHCHN 167
Query: 305 GLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
V+HRDIK NIL+D + KL DFG LL + + T GT Y PE
Sbjct: 168 C---GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFD-GTRVYSPPE--- 218
Query: 364 TGMLNER------SDVYSFGILIMEVISGRNPVD 391
+ + V+S GIL+ +++ G P +
Sbjct: 219 --WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 54/256 (21%), Positives = 97/256 (37%), Gaps = 67/256 (26%)
Query: 181 LEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV-EVEAIGR 238
LE S+ ++ +G G +GIV +E A+K +L + +K E++ +
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKV 56
Query: 239 VRHKNLVRLLGYCAEGAHRM--------------------------------------LV 260
+ H N+++L+ Y ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320
EY+ + L + L + + + I + + ++H + HRDIK N+
Sbjct: 117 MEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNL 172
Query: 321 LLDKQWNP-KLSDFGLAKLLGAER---SYVTTRVMGTFGYVAPEYASTGMLNERS----- 371
L++ + N KL DFG AK L +Y+ +R Y APE ML
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPEL----MLGATEYTPSI 223
Query: 372 DVYSFGILIMEVISGR 387
D++S G + E+I G+
Sbjct: 224 DLWSIGCVFGELILGK 239
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 47/217 (21%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVE------AIGR------- 238
+ +GEG Y VY G K+ L + A KE ++E E AI R
Sbjct: 8 DKLGEGTYATVYKG----------KSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKD 56
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
++H N+V L LV+EY+D +L+Q+L + + + +G
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDD---CGNIINMHNVKLFLFQLLRG 112
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYV 357
L Y H KV+HRD+K N+L++++ KL+DFGLA+ ++Y V+ T Y
Sbjct: 113 LAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-DNEVV-TLWYR 167
Query: 358 APE-------YASTGMLNERSDVYSFGILIMEVISGR 387
P+ Y ST + D++ G + E+ +GR
Sbjct: 168 PPDILLGSTDY-STQI-----DMWGVGCIFYEMATGR 198
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 59/224 (26%), Positives = 86/224 (38%), Gaps = 46/224 (20%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKV--EVEAIGRVR----H 241
++G+GG+G V+ G L D VA+K N + EV + +V H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGD----VGPHSPLT--------WEIRM 289
++RLL + MLV E D + PL ++
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPA-------QDLFDYITEKGPLGEGPSRCFFGQV-- 148
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP-KLSDFGLAKLLGAERSYVTT 348
+ + H VVHRDIK NIL+D + KL DFG LL T
Sbjct: 149 ------VAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTD 197
Query: 349 RVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRNPVD 391
GT Y PE+ S + V+S GIL+ +++ G P +
Sbjct: 198 FD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 26/210 (12%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRL 247
++G+G +G V AVK N + + + EVE + ++ H N+++L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 248 LGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLE 307
+ + +V E G L + + II G+TY+H+
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH-- 140
Query: 308 PKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE---- 360
+VHRD+K NILL +K + K+ DFGL+ +++ +GT Y+APE
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYIAPEVLRG 197
Query: 361 -YASTGMLNERSDVYSFGILIMEVISGRNP 389
Y +E+ DV+S G+++ ++SG P
Sbjct: 198 TY------DEKCDVWSAGVILYILLSGTPP 221
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 63/222 (28%), Positives = 93/222 (41%), Gaps = 51/222 (22%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEK-EFKV--EVEAIGRVRHKNLVRLLG 249
+GEG YG V V VAVK + + +A + E+ + H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTAK 297
+ EG + L EY G L + M ++ G
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQRFFHQLMAG--- 117
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL--LGAERSYVTTRVMGTFG 355
+ YLH + HRDIK N+LLD++ N K+SDFGLA + + GT
Sbjct: 118 -VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLP 172
Query: 356 YVAPEYASTGMLNER------SDVYSFGILIMEVISGRNPVD 391
YVAPE +L R DV+S GI++ +++G P D
Sbjct: 173 YVAPE-----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 56/194 (28%), Positives = 86/194 (44%), Gaps = 26/194 (13%)
Query: 179 RELEVSTNGFADE----NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEV 233
++L ++ F D IG G Y + + N AVK + ++ ++ E+
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEI 66
Query: 234 EAIGR-VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM--N 290
E + R +H N++ L +G + +V E + G L + S E R
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL-RQKFFS----E-REASA 120
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILL-DKQWNP---KLSDFGLAKLLGAERSYV 346
++ K + YLH VVHRD+K SNIL D+ NP ++ DFG AK L AE +
Sbjct: 121 VLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 347 TTRVMGTFGYVAPE 360
T T +VAPE
Sbjct: 178 MTPC-YTANFVAPE 190
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 7e-19
Identities = 45/201 (22%), Positives = 83/201 (41%), Gaps = 32/201 (15%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
V+G G + V+ A+K + + + + E+ + +++H+N+V L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM---------NIILGTAKGLT 300
H LV + + G L + + +I +
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRI-------------LERGVYTEKDASLVIQQVLSAVK 120
Query: 301 YLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
YLHE +VHRD+K N+L ++ ++DFGL+K+ + ++T GT GYV
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTAC-GTPGYV 174
Query: 358 APEYASTGMLNERSDVYSFGI 378
APE + ++ D +S G+
Sbjct: 175 APEVLAQKPYSKAVDCWSIGV 195
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 9e-19
Identities = 50/188 (26%), Positives = 86/188 (45%), Gaps = 31/188 (16%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKV----EVEAIGRVRHKNLV 245
IG+G +G V+ + VA+K + + EKE F + E++ + ++H+N+V
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKILQLLKHENVV 79
Query: 246 RLLGYCAEGAHRM--------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
L+ C A LV+++ ++ +L L T ++
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLN 135
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-----AERSYVTTRVMG 352
GL Y+H K++HRD+K++N+L+ + KL+DFGLA+ Y T RV+
Sbjct: 136 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY-TNRVV- 190
Query: 353 TFGYVAPE 360
T Y PE
Sbjct: 191 TLWYRPPE 198
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 9e-19
Identities = 35/265 (13%), Positives = 70/265 (26%), Gaps = 57/265 (21%)
Query: 193 VIGEGGYGIVYHGVLEDNT---NVAVKNLLNNRGQAE---KEFKVEVEAIGRVRHKNLVR 246
G + + D VA+ + + +E + R+ + R
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-G 305
+L A ++V E+I G+L++ P + + A H G
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG------AIRAMQSLAAAADAAHRAG 149
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
V S + +S G L +
Sbjct: 150 ----VALSIDHPSRVR--------VSIDGDVVL-------------AYPATMPDA----- 179
Query: 366 MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425
N + D+ G + ++ R P+ + + A ++P ++
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-------APAERDTAGQPIEPADIDR 230
Query: 426 PCSRALKRALLVALRCVDPNAHKRP 450
+ VA R V + R
Sbjct: 231 DIPFQISA---VAARSVQGDGGIRS 252
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 45/191 (23%), Positives = 80/191 (41%), Gaps = 11/191 (5%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLVRLLGY 250
+G G +G V+ +K + +R Q E + E+E + + H N++++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
+ + +V E + G L + + L+ ++ L Y H V
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HV 145
Query: 311 VHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML 367
VH+D+K NIL K+ DFGLA+L ++ T GT Y+APE +
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-TNAA-GTALYMAPEVFK-RDV 202
Query: 368 NERSDVYSFGI 378
+ D++S G+
Sbjct: 203 TFKCDIWSAGV 213
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 24/181 (13%)
Query: 193 VIGEGGYGIVYHGVLEDNTN--VAVK----NLLNNRGQAEKE----FKVEVEAIGRVRHK 242
+G G G V E T VA++ E + + E+E + ++ H
Sbjct: 142 TLGSGACGEVKLAF-ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
++++ + + +V E ++ G L V + L + YL
Sbjct: 201 CIIKIKNFFDAEDY-YIVLELMEGGELFDK----VVGNKRLKEATCKLYFYQMLLAVQYL 255
Query: 303 HEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
HE ++HRD+K N+LL ++ K++DFG +K+LG E S + T GT Y+AP
Sbjct: 256 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC-GTPTYLAP 310
Query: 360 E 360
E
Sbjct: 311 E 311
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 57/241 (23%), Positives = 97/241 (40%), Gaps = 63/241 (26%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK------------------------NLLNNRGQAEKE 228
IG+G YG+V DNT A+K
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 229 FKVEVE-AIGR-VRHKNLVRLLGY----CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSP 282
+V E AI + + H N+V+L H +V+E ++ G + +V P
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVM-----EVPTLKP 133
Query: 283 LT----WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338
L+ ++I G + YLH K++HRDIK SN+L+ + + K++DFG++
Sbjct: 134 LSEDQARFYFQDLIKG----IEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNER--------SDVYSFGILIMEVISGRNPV 390
+ ++ V GT ++APE L+E DV++ G+ + + G+ P
Sbjct: 187 FKGSDALLSNTV-GTPAFMAPE-----SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240
Query: 391 D 391
Sbjct: 241 M 241
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 41/200 (20%), Positives = 88/200 (44%), Gaps = 12/200 (6%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
+G G +GIV+ V K + +G + K E+ + RH+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
++++E+I ++ + ++ + ++ + + L +LH +
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC---EALQFLHSH---NIG 124
Query: 312 HRDIKSSNILLDKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
H DI+ NI+ + + K+ +FG A+ L ++ + Y APE +++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPEVHQHDVVST 182
Query: 370 RSDVYSFGILIMEVISGRNP 389
+D++S G L+ ++SG NP
Sbjct: 183 ATDMWSLGTLVYVLLSGINP 202
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 3e-18
Identities = 43/190 (22%), Positives = 79/190 (41%), Gaps = 36/190 (18%)
Query: 194 IGEGGYGIVYHGVLEDNTN---VAVKNLLNNRGQAEKEFKVEVEAIGRV------RHKNL 244
+G G YG VY +D + A+K + + + + A + +H N+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI--------EGTGISMSACREIALLRELKHPNV 80
Query: 245 VRLLGYCAEGAHR--MLVYEYIDNGNLEQWLH-----GDVGPHSPLTWEIRMNIILGTAK 297
+ L A R L+++Y ++ +L + L + +++
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNP----KLSDFGLAKLLGAE-RSY--VTTRV 350
G+ YLH V+HRD+K +NIL+ + K++D G A+L + + + V
Sbjct: 140 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 351 MGTFGYVAPE 360
+ TF Y APE
Sbjct: 197 V-TFWYRAPE 205
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 52/224 (23%), Positives = 84/224 (37%), Gaps = 40/224 (17%)
Query: 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKE--FKVEVEA---------I 236
+ + I G YG V GV + VA+K + N +
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 237 GRVRHKNLVRLLG-YCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
H N++ L + M LV E + +L Q +H ++ +
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHD---QRIVISPQHIQYF 139
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---YVTT 348
+ GL LHE VVHRD+ NILL + + DF LA+ A+ + YVT
Sbjct: 140 MYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH 196
Query: 349 RVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
R Y APE ++ + D++S G ++ E+ + +
Sbjct: 197 RW-----YRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 5e-18
Identities = 51/198 (25%), Positives = 80/198 (40%), Gaps = 20/198 (10%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 245
+G G + IV A K +R +E + EV + +V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
L +L+ E + G L +L S + IL G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILD---GVNYLHTK 134
Query: 306 LEPKVVHRDIKSSNILLDKQWNP----KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
K+ H D+K NI+L + P KL DFGLA + + + GT +VAPE
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEI 189
Query: 362 ASTGMLNERSDVYSFGIL 379
+ L +D++S G++
Sbjct: 190 VNYEPLGLEADMWSIGVI 207
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 6e-18
Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 33/230 (14%)
Query: 175 WYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEF---K 230
W L V+ N F V+G+GG+G V + + A K L R + K
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL 232
Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRM 289
E + + +V + +V L Y E + LV ++ G+L+ ++ P E R
Sbjct: 233 NEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EARA 288
Query: 290 -----NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344
I G L LH ++V+RD+K NILLD + ++SD GLA + E
Sbjct: 289 VFYAAEICCG----LEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQ 340
Query: 345 YVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
+ RV GT GY+APE ++ D ++ G L+ E+I+G++P
Sbjct: 341 TIKGRV-GTVGYMAPE-----VVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 53/219 (24%), Positives = 87/219 (39%), Gaps = 47/219 (21%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV--EVEAIGRVRHKNLVRLLGY 250
IG+G + V + VA+K + + K+ EV + + H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 251 CAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTAKG 298
L+ EY G + +L HG RM I+
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHG------------RMKEKEARSKFRQIVSA---- 126
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
+ Y H+ ++VHRD+K+ N+LLD N K++DFG + + G Y A
Sbjct: 127 VQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAFC-GAPPYAA 181
Query: 359 PEYASTGMLNER------SDVYSFGILIMEVISGRNPVD 391
PE + + DV+S G+++ ++SG P D
Sbjct: 182 PE-----LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 7e-18
Identities = 50/199 (25%), Positives = 83/199 (41%), Gaps = 20/199 (10%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 245
+G G + IV A K L ++R +E + EV + +RH N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
L +L+ E + G L +L + + IL G+ YLH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILD---GVHYLHSK 127
Query: 306 LEPKVVHRDIKSSNILLDKQWNP----KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
++ H D+K NI+L + P KL DFG+A + A + + GT +VAPE
Sbjct: 128 ---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEI 182
Query: 362 ASTGMLNERSDVYSFGILI 380
+ L +D++S G++
Sbjct: 183 VNYEPLGLEADMWSIGVIT 201
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 8e-18
Identities = 62/317 (19%), Positives = 101/317 (31%), Gaps = 75/317 (23%)
Query: 68 SNYNSSSGNPTIP-NISKEIQEIRIDPDSNSNSNCKPHSAPNPDPLPEPEPILVEDSPAS 126
+++SS + + +EIR P+ N + DP +
Sbjct: 4 HHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLND 63
Query: 127 GRNRIHIEIGKDHRIAYPERAAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTN 186
+ + E G D+ A E Y ++
Sbjct: 64 AQPKG------------TENLYFQSMGPEDELPDWAAAKEFYQK-----YDPKD------ 100
Query: 187 GFADENVIGEGGYGIVYHGV-LEDNTNVAVK--------NLLNNRGQAEKEFKVEVEAIG 237
VIG G +V V AVK + + + E +
Sbjct: 101 ------VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 238 RVR-HKNLVRLLGYCAEGAHRMLVYEYIDNGNL-----------EQWLHGDVGPHSPLTW 285
+V H +++ L+ + LV++ + G L E+
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEK-------------- 200
Query: 286 EIR--MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
E R M +L + +++LH +VHRD+K NILLD +LSDFG + L
Sbjct: 201 ETRSIMRSLL---EAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE 254
Query: 344 SYVTTRVMGTFGYVAPE 360
GT GY+APE
Sbjct: 255 KL-RELC-GTPGYLAPE 269
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 9e-18
Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 30/225 (13%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEF---KVE-- 232
+ ++ N F+ +IG GG+G VY D + A+K L R + ++ E
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 233 -VEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
+ + +V + Y ++ + + ++ G+L L + E M
Sbjct: 242 MLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADMR 295
Query: 291 -----IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345
IILG L ++H VV+RD+K +NILLD+ + ++SD GLA ++ +
Sbjct: 296 FYAAEIILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 348
Query: 346 VTTRVMGTFGYVAPEYASTGMLNERS-DVYSFGILIMEVISGRNP 389
V GT GY+APE G+ + S D +S G ++ +++ G +P
Sbjct: 349 --ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 9e-18
Identities = 49/195 (25%), Positives = 70/195 (35%), Gaps = 24/195 (12%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
IG G +G V V A K + + FK E+E + + H N++RL
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
+ LV E G L + + I+ + Y H+ V
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVA 128
Query: 312 HRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-----YAS 363
HRD+K N L KL DFGLA + T+V GT YV+P+ Y
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-RTKV-GTPYYVSPQVLEGLY-- 184
Query: 364 TGMLNERSDVYSFGI 378
D +S G+
Sbjct: 185 ----GPECDEWSAGV 195
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 50/193 (25%), Positives = 78/193 (40%), Gaps = 26/193 (13%)
Query: 184 STNGFADE----NVIGEGGYGIVYHGVLEDNTN--VAVK-------NLLNNRGQAEKEFK 230
ST+GF + ++G G +V + T AVK + E
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCI-HKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 231 V--EVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEI 287
EV+ + +V H N+++L LV++ + G L +L L+ +
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKE 125
Query: 288 RMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT 347
I+ + + LH+ +VHRD+K NILLD N KL+DFG + L
Sbjct: 126 TRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-R 181
Query: 348 TRVMGTFGYVAPE 360
GT Y+APE
Sbjct: 182 EVC-GTPSYLAPE 193
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 53/247 (21%), Positives = 85/247 (34%), Gaps = 54/247 (21%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
IG+G YG+V + + A+K + + + K EV + ++ H N+ R
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 247 LLGYCAEGAHRMLVYEYIDNGNL--------------------EQWLHGDVGPHSPLTWE 286
L + + LV E G+L + + +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 287 IRMNIILGTAKGLT----------------YLHEGLEPKVVHRDIKSSNILL--DKQWNP 328
YLH + HRDIK N L +K +
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEI 209
Query: 329 KLSDFGLAKLLG----AERSYVTTRVMGTFGYVAPE--YASTGMLNERSDVYSFGILIME 382
KL DFGL+K E +TT+ GT +VAPE + + D +S G+L+
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 383 VISGRNP 389
++ G P
Sbjct: 269 LLMGAVP 275
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 52/217 (23%), Positives = 81/217 (37%), Gaps = 36/217 (16%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK--------NLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
+G G +G V+ V E N V VK + +E+ + RV H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDV----GPHSPLTWEIRMNIILGTAKGLT 300
+++L LV E +G D+ H L + I +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG-------LDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
YL ++HRDIK NI++ + + KL DFG A L T GT Y APE
Sbjct: 145 YLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL-ERGKLFYTFC-GTIEYCAPE 199
Query: 361 YASTGMLNERS------DVYSFGILIMEVISGRNPVD 391
+L +++S G+ + ++ NP
Sbjct: 200 -----VLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 51/198 (25%), Positives = 80/198 (40%), Gaps = 20/198 (10%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 245
+G G + IV A K +R +E + EV + +V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
L +L+ E + G L +L S + IL G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILD---GVNYLHTK 134
Query: 306 LEPKVVHRDIKSSNILLDKQWNP----KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
K+ H D+K NI+L + P KL DFGLA + + + GT +VAPE
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEI 189
Query: 362 ASTGMLNERSDVYSFGIL 379
+ L +D++S G++
Sbjct: 190 VNYEPLGLEADMWSIGVI 207
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 46/181 (25%), Positives = 78/181 (43%), Gaps = 24/181 (13%)
Query: 193 VIGEGGYGIVYHGVLEDNTN--VAVK----NLLNNRGQAEKE----FKVEVEAIGRVRHK 242
+G G G V E T VA+K E + + E+E + ++ H
Sbjct: 17 TLGSGACGEVKLAF-ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
++++ + + +V E ++ G L + G + L + YL
Sbjct: 76 CIIKIKNFFDAEDY-YIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYL 130
Query: 303 HEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
HE ++HRD+K N+LL ++ K++DFG +K+LG E S + T GT Y+AP
Sbjct: 131 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC-GTPTYLAP 185
Query: 360 E 360
E
Sbjct: 186 E 186
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 41/212 (19%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYC 251
+G G Y V+ + + +N V VK L + +K+ K E++ + +R N++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLADIV 100
Query: 252 AEGAHRMLVY--EYIDNGNLEQWLHGDVGPHSPLT-WEIR--MNIILGTAKGLTYLHEGL 306
+ R E+++N + +Q LT ++IR M IL K L Y H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEIL---KALDYCHSM- 149
Query: 307 EPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSY---VTTRVMGTFGYVAPEYA 362
++HRD+K N+++D + +L D+GLA+ + Y V +R + PE
Sbjct: 150 --GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPEL- 201
Query: 363 STGMLNERS-----DVYSFGILIMEVISGRNP 389
+++ + D++S G ++ +I + P
Sbjct: 202 ---LVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 42/217 (19%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLL 248
+ +GEG + I V + N AVK + E + E+ A+ H N+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLH 72
Query: 249 GYCAEGAHRMLVYEYIDNGNL-----------EQWLHGDVGPHSPLTWEIRMNIILGTAK 297
+ H LV E ++ G L E E I+
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKKKHFSET--------------EAS-YIMRKLVS 117
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILL-DKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTF 354
++++H+ VVHRD+K N+L D+ N K+ DFG A+L + + T T
Sbjct: 118 AVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTL 173
Query: 355 GYVAPEYASTGMLNERSDVYSFGIL--IMEVISGRNP 389
Y APE + +E D++S G++ M +SG+ P
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVILYTM--LSGQVP 208
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 49/215 (22%), Positives = 87/215 (40%), Gaps = 38/215 (17%)
Query: 193 VIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEF---KVEVEAIGRVRHKNLVRLL 248
++GEG + V + A+K L E + E + + R+ H V+L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN-------------IILGT 295
+ Y NG L +++ ++ I+
Sbjct: 97 FTFQDDEKLYFGLSYAKNGELLKYIR-------------KIGSFDETCTRFYTAEIVSA- 142
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM-GTF 354
L YLH ++HRD+K NILL++ + +++DFG AK+L E GT
Sbjct: 143 ---LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
YV+PE + + SD+++ G +I ++++G P
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 49/204 (24%), Positives = 83/204 (40%), Gaps = 28/204 (13%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKE-FKVEVEAIGRVRHKN 243
+G G + +V A K ++R +E + EV + ++H N
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR----MNIILGTAKGL 299
++ L +L+ E + G E L + LT E + IL G+
Sbjct: 76 VITLHEVYENKTDVILILELVAGG--E--LFDFLAEKESLT-EEEATEFLKQILN---GV 127
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNP----KLSDFGLAKLLGAERSYVTTRVMGTFG 355
YLH ++ H D+K NI+L + P K+ DFGLA + + + GT
Sbjct: 128 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPE 182
Query: 356 YVAPEYASTGMLNERSDVYSFGIL 379
+VAPE + L +D++S G++
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVI 206
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 4e-17
Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 26/197 (13%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLG 249
++G+G +G V AVK + + EVE + ++ H N+++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
+ + +V E G L + S + + G+TY+H+
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEII-KRKRFSEHDAARIIKQVFS---GITYMHKH---N 141
Query: 310 VVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE-----Y 361
+VHRD+K NILL +K + K+ DFGL+ R+ GT Y+APE Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-KDRI-GTAYYIAPEVLRGTY 199
Query: 362 ASTGMLNERSDVYSFGI 378
+E+ DV+S G+
Sbjct: 200 ------DEKCDVWSAGV 210
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 49/199 (24%), Positives = 90/199 (45%), Gaps = 19/199 (9%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE-FKVEVEAIGRVRHKNLV 245
+ ++G G +G V+ +A K ++ RG +KE K E+ + ++ H NL+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAK-IIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLT-WEIR--MNIILGTAKGLTYL 302
+L +LV EY+D G L + + LT + M I G+ ++
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRI---IDESYNLTELDTILFMKQICE---GIRHM 203
Query: 303 HEGLEPKVVHRDIKSSNILL-DKQWNP-KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
H+ ++H D+K NIL ++ K+ DFGLA+ GT ++APE
Sbjct: 204 HQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV--NFGTPEFLAPE 258
Query: 361 YASTGMLNERSDVYSFGIL 379
+ ++ +D++S G++
Sbjct: 259 VVNYDFVSFPTDMWSVGVI 277
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 44/178 (24%), Positives = 77/178 (43%), Gaps = 22/178 (12%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLL--NNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
+G+G + +V V + A + + ++ + E ++H N+VRL
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR----MNIILGTAKGLTYLHEG 305
+E H L+++ + G L + + +S E + IL + + H+
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIV-AREYYS----EADASHCIQQILE---AVLHCHQM 129
Query: 306 LEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
VVHR++K N+LL K KL+DFGLA + E+ GT GY++PE
Sbjct: 130 ---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPE 183
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 47/220 (21%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLL 248
E+V+GEG + V + L + AVK + G EVE + + + H+N++ L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 249 GYCAEGAHRMLVYEYIDNGNL-----------EQWLHGDVGPHSPLTWEIRMNIILGTAK 297
+ E LV+E + G++ E E ++ A
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL--------------EAS-VVVQDVAS 122
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLL--GAERSYVTTRVM- 351
L +LH + HRD+K NIL ++ K+ DF L + + S ++T +
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 352 ---GTFGYVAPE-----YASTGMLNERSDVYSFG-IL-IM 381
G+ Y+APE + ++R D++S G IL I+
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYIL 219
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 6e-17
Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 50/221 (22%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
+G G +G V G VAVK + + K K E++ + RH ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK-IKREIQNLKLFRHPHIIKLY 77
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTA 296
+ +V EY+ G L ++ HG R+ I+
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHG------------RVEEMEARRLFQQIL---- 121
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
+ Y H VVHRD+K N+LLD N K++DFGL+ ++ T+ G+ Y
Sbjct: 122 SAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNY 176
Query: 357 VAPEYASTGMLNER------SDVYSFGILIMEVISGRNPVD 391
APE +++ R D++S G+++ ++ G P D
Sbjct: 177 AAPE-----VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 55/222 (24%), Positives = 102/222 (45%), Gaps = 37/222 (16%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIG 237
E+ + +G G YG V + VA+K L + A++ ++ E+ +
Sbjct: 21 ELPKT-YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLK 78
Query: 238 RVRHKNLVRLLG-YCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
++H+N++ LL + + R LV ++ +L++ + + E +
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG------LKFSEEKIQYL 131
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRV 350
+ KGL Y+H VVHRD+K N+ +++ K+ DFGLA+ AE + YV TR
Sbjct: 132 VYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW 188
Query: 351 MGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
Y APE +L+ D++S G ++ E+++G+
Sbjct: 189 -----YRAPEV----ILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 7e-17
Identities = 49/195 (25%), Positives = 86/195 (44%), Gaps = 18/195 (9%)
Query: 193 VIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKEFKV--EVEAIGRVRHKNLVRLL 248
+G+G + +V V T A K + + A K+ E +++H N+VRL
Sbjct: 13 ELGKGAFSVVRRCV-HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
E + LV++ + G L + + +S + IL + + Y H
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFEDIV-AREFYSEADASHCIQQIL---ESIAYCHSN--- 124
Query: 309 KVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
+VHR++K N+LL + KL+DFGLA + ++ GT GY++PE
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW-HGFA-GTPGYLSPEVLKKD 182
Query: 366 MLNERSDVYSFG-IL 379
++ D+++ G IL
Sbjct: 183 PYSKPVDIWACGVIL 197
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 243
+ + IG G GIV NVA+K L N+ A++ ++ E+ + V HKN
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKN 85
Query: 244 LVRLLG-YCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
++ LL + + + +V E +D NL Q + L E ++
Sbjct: 86 IIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLC 138
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---YVTTRVMGTF 354
G+ +LH ++HRD+K SNI++ K+ DFGLA+ G YV TR
Sbjct: 139 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 191
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVISGR 387
Y APE E D++S G ++ E+I G
Sbjct: 192 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 49/190 (25%), Positives = 79/190 (41%), Gaps = 15/190 (7%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
+G G IVY A+K L + +K + E+ + R+ H N+++L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
LV E + G L + + + + + + YLHE +V
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIV 170
Query: 312 HRDIKSSNILL-DKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
HRD+K N+L + K++DFGL+K++ + T V GT GY APE
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--VCGTPGYCAPEILRGCAYG 228
Query: 369 ERSDVYSFGI 378
D++S GI
Sbjct: 229 PEVDMWSVGI 238
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 58/221 (26%), Positives = 89/221 (40%), Gaps = 52/221 (23%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV--EVEAIGRVRHKNLVRLLGY 250
IG G +G+ VAVK + RG A E V E+ +RH N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDE-NVQREIINHRSLRHPNIVRFKEV 84
Query: 251 CAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMN----------IILGTAKG 298
H ++ EY G L + + G R + ++ G
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAG------------RFSEDEARFFFQQLLS----G 128
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGY 356
++Y H ++ HRD+K N LLD P K+ DFG +K S + V GT Y
Sbjct: 129 VSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTV-GTPAY 183
Query: 357 VAPEYASTGMLNER------SDVYSFGILIMEVISGRNPVD 391
+APE +L + +DV+S G+ + ++ G P +
Sbjct: 184 IAPE-----VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 2e-16
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 37/217 (17%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 243
+ + IG G GIV + NVA+K L N+ A++ ++ E+ + V HKN
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKN 122
Query: 244 LVRLLG-YCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
++ LL + + LV E +D NL Q + L E ++
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLC 175
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---YVTTRVMGTF 354
G+ +LH ++HRD+K SNI++ K+ DFGLA+ G YV TR
Sbjct: 176 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 228
Query: 355 GYVAPEYASTGMLNER----SDVYSFGILIMEVISGR 387
Y APE +L D++S G ++ E++ +
Sbjct: 229 -YRAPEV----ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 41/174 (23%), Positives = 76/174 (43%), Gaps = 15/174 (8%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLG 249
+G+G + +V V A K + + + ++ + E +++H N+VRL
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
E + LV++ + G L + D+ + + I + + Y H
Sbjct: 96 SIQEESFHYLVFDLVTGGELFE----DIVAREFYSEADASHCIQQILESIAYCHSN---G 148
Query: 310 VVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
+VHR++K N+LL + KL+DFGLA + ++ GT GY++PE
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW-HGFA-GTPGYLSPE 200
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 243
+ D +G G YG V V VA+K L + A++ ++ E+ + +RH+N
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHEN 85
Query: 244 LVRLLG-YCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
++ LL + + LV ++ +L + + + L + ++ K
Sbjct: 86 VIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE-----KLGEDRIQFLVYQMLK 139
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGY 356
GL Y+H ++HRD+K N+ +++ K+ DFGLA+ +E + YV TR Y
Sbjct: 140 GLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----Y 191
Query: 357 VAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
APE +LN D++S G ++ E+I+G+
Sbjct: 192 RAPEV----ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 55/241 (22%), Positives = 88/241 (36%), Gaps = 39/241 (16%)
Query: 169 HLGWGHWYTLRELEVSTNGFAD-----ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR 222
H G + E D + V+G G G V A+K LL +
Sbjct: 7 HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK-LLYDS 65
Query: 223 GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM----LVYEYIDNGNL-----EQWL 273
+A +E +A G ++V +L H ++ E ++ G L E+
Sbjct: 66 PKARQEVDHHWQASG---GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER-- 120
Query: 274 HGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKL 330
T I+ + +LH + HRD+K N+L +K KL
Sbjct: 121 -----GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKL 172
Query: 331 SDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGIL--IMEVISGRN 388
+DFG AK + T T YVAPE ++ D++S G++ I+ + G
Sbjct: 173 TDFGFAKETTQNA--LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL--LCGFP 227
Query: 389 P 389
P
Sbjct: 228 P 228
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 8e-16
Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 36/214 (16%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
+G G +G V G VAVK + + K + E++ + RH ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK-IRREIQNLKLFRHPHIIKLY 82
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRM---NIILGTAKGLTYLH 303
+ + +V EY+ G L ++ +G + E R I+ G+ Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK-----ESRRLFQQIL----SGVDYCH 133
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
VVHRD+K N+LLD N K++DFGL+ ++ T+ G+ Y APE
Sbjct: 134 RH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE--- 185
Query: 364 TGMLNER------SDVYSFGILIMEVISGRNPVD 391
+++ R D++S G+++ ++ G P D
Sbjct: 186 --VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 50/229 (21%), Positives = 100/229 (43%), Gaps = 48/229 (20%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
+ D +G GG G+V+ V + + VA+K + L + + + E++ I R+ H N+V
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIV 71
Query: 246 RLL----------GYCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
++ + +V EY++ +L L PL E
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLE-----QGPLLEEHARLF 125
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKLLGAERS------ 344
+ +GL Y+H V+HRD+K +N+ ++ + K+ DFGLA+++ S
Sbjct: 126 MYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 345 -YVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
+ T+ Y +P +L+ + D+++ G + E+++G+
Sbjct: 183 EGLVTK-----WYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 41/194 (21%), Positives = 82/194 (42%), Gaps = 14/194 (7%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKV--EVEAIGRVRH-KNLVRLL 248
+G G + +V + A K L R + ++ E+ + + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
+ +L+ EY G + ++ ++ + +I +G+ YLH+
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEM--VSENDVIRLIKQILEGVYYLHQN--- 150
Query: 309 KVVHRDIKSSNILL-DKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
+VH D+K NILL K+ DFG+++ +G +MGT Y+APE +
Sbjct: 151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYLAPEILNYD 208
Query: 366 MLNERSDVYSFGIL 379
+ +D+++ GI+
Sbjct: 209 PITTATDMWNIGII 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 58/226 (25%), Positives = 106/226 (46%), Gaps = 40/226 (17%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN--NRGQAEKEFKVEVEAIGR 238
+V + + + IGEG YG+V + VA+K + ++ ++ + E++ + R
Sbjct: 24 DVGPR-YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLR 81
Query: 239 VRHKNLVRLLG-YCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL 293
RH+N++ + A +M +V + ++ +L + L L+ + +
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT-----QHLSNDHICYFLY 135
Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-------YV 346
+GL Y+H V+HRD+K SN+LL+ + K+ DFGLA++ + YV
Sbjct: 136 QILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 347 TTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
TR Y APE MLN + D++S G ++ E++S R
Sbjct: 193 ATR-----WYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 50/227 (22%), Positives = 94/227 (41%), Gaps = 46/227 (20%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
F ++++GEG YG+V VA+K + A + + E++ + +H+N+
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENI 71
Query: 245 VRLLG-YCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
+ + + ++ E + +L + + L+ + I T + +
Sbjct: 72 ITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ-----MLSDDHIQYFIYQTLRAV 125
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS--------------Y 345
LH V+HRD+K SN+L++ + K+ DFGLA+++ + +
Sbjct: 126 KVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 346 VTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
V TR Y APE ML DV+S G ++ E+ R
Sbjct: 183 VATR-----WYRAPEV----MLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 35/216 (16%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 243
+ + + +G G YG V + VAVK L + A++ ++ E+ + ++H+N
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHEN 89
Query: 244 LVRLLG-YCAEGAHRM-----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK 297
++ LL + + LV + +L + LT + +I +
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVK-----CQKLTDDHVQFLIYQILR 143
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGY 356
GL Y+H ++HRD+K SN+ +++ K+ DFGLA+ E + YV TR Y
Sbjct: 144 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----Y 195
Query: 357 VAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
APE MLN D++S G ++ E+++GR
Sbjct: 196 RAPEI----MLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 37/214 (17%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK----NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
+GEG +G V + VA+K LL + + E+ + +RH ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHIIKLY 75
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRM---NIILGTAKGLTYLH 303
++V EY G L ++ + E R II + Y H
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTED-----EGRRFFQQII----CAIEYCH 125
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
K+VHRD+K N+LLD N K++DFGL+ ++ T+ G+ Y APE
Sbjct: 126 RH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE--- 177
Query: 364 TGMLNER------SDVYSFGILIMEVISGRNPVD 391
++N + DV+S GI++ ++ GR P D
Sbjct: 178 --VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 33/231 (14%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNV-AVKNL----LNNRGQAEKEFKVE 232
L+E+ + + F VIG G + V ++ V A+K + + RG+ F+ E
Sbjct: 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC-FREE 111
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTW------ 285
+ + + + +L + + + + LV EY G+L L G P
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEMARFYLA 169
Query: 286 EIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY 345
EI M + +H VHRDIK NILLD+ + +L+DFG L A+ +
Sbjct: 170 EIVM--------AIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218
Query: 346 VTTRVMGTFGYVAPEYASTGMLNERSDVY-------SFGILIMEVISGRNP 389
+ +GT Y++PE + Y + G+ E+ G+ P
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 18/100 (18%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L YL +++HRD+K NILLD+ + ++DF +A +L E T + GT Y+
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTMAGTKPYM 181
Query: 358 APEYASTGMLNERS--------DVYSFGILIMEVISGRNP 389
APE M + R D +S G+ E++ GR P
Sbjct: 182 APE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 47/255 (18%), Positives = 93/255 (36%), Gaps = 63/255 (24%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 243
+ ++IG G YG V + VA+K +L + ++ + E+ + R+ H +
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDH 113
Query: 244 LVRLLG-YCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
+V++L + + +V E + LT ++ G
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-------------- 344
+ Y+H ++HRD+K +N L+++ + K+ DFGLA+ + +
Sbjct: 169 VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 345 -----------------YVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIME 382
+V TR Y APE +L + + DV+S G + E
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTR-----WYRAPEL----ILLQENYTEAIDVWSIGCIFAE 276
Query: 383 VISGRNPVDYSRPPG 397
+++
Sbjct: 277 LLNMIKENVAYHADR 291
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 56/278 (20%), Positives = 107/278 (38%), Gaps = 64/278 (23%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLN---NRGQAEKEFKVEVEAIGRVRHKN 243
+ +++IG G YG VY NVA+K + + ++ + E+ + R++
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDY 86
Query: 244 LVRLLG-YCAEGAHRM----LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
++RL + + +V E D+ +L++ + LT E I+ G
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPI----FLTEEHIKTILYNLLLG 141
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-------------- 344
++HE ++HRD+K +N LL++ + K+ DFGLA+ + +E+
Sbjct: 142 ENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 345 ------------YVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVISGR 387
+V TR Y APE +L + + D++S G + E+++
Sbjct: 199 PHNKNLKKQLTSHVVTR-----WYRAPEL----ILLQENYTKSIDIWSTGCIFAELLNML 249
Query: 388 NPVDYS----RP--PGEVNLVEWLKTMVTNRNAEGVLD 419
P PG + + D
Sbjct: 250 QSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRD 287
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 53/230 (23%), Positives = 90/230 (39%), Gaps = 36/230 (15%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNV-AVKNL----LNNRGQAEKEFKVE 232
+R+L + + VIG G +G V + V A+K L + R + F E
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-FWEE 119
Query: 233 VEAIGRVRHKNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
+ + +V+L Y + + +V EY+ G+L + ++
Sbjct: 120 RDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMS-------------NYDV 165
Query: 292 ILGTAK--------GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343
A+ L +H +HRD+K N+LLDK + KL+DFG + E
Sbjct: 166 PEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222
Query: 344 SYVTTRVMGTFGYVAPE----YASTGMLNERSDVYSFGILIMEVISGRNP 389
+GT Y++PE G D +S G+ + E++ G P
Sbjct: 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 36/221 (16%)
Query: 181 LEVSTNGFADE-----NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVE 234
L++ N D+ V+G G G V A+K +L + +A +E ++
Sbjct: 52 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWR 110
Query: 235 AIGRVRHKNLVRLLGYC----AEGAHRMLVYEYIDNGNL-----EQWLHGDVGPHSPLTW 285
A ++VR++ A ++V E +D G L ++ T
Sbjct: 111 ASQ---CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-------GDQAFTE 160
Query: 286 EIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL-DKQWNP--KLSDFGLAKLLGAE 342
I+ + + YLH + HRD+K N+L K+ N KL+DFG AK +
Sbjct: 161 REASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217
Query: 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFG-IL-IM 381
S T T YVAPE ++ D++S G I+ I+
Sbjct: 218 NSLTT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 256
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 53/228 (23%), Positives = 93/228 (40%), Gaps = 29/228 (12%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKE---FKVEV 233
++++ + F VIG G +G V L++ V A+K L E F+ E
Sbjct: 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREER 125
Query: 234 EAIGRVRHKNLVRLLGYCA--EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR--- 288
+ + K + L + A + + LV +Y G+L L E
Sbjct: 126 DVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP----EEMARF 179
Query: 289 --MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346
+++ + +H+ VHRDIK NIL+D + +L+DFG L + +
Sbjct: 180 YLAEMVIA----IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232
Query: 347 TTRVMGTFGYVAPE-----YASTGMLNERSDVYSFGILIMEVISGRNP 389
++ +GT Y++PE G D +S G+ + E++ G P
Sbjct: 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 58/212 (27%), Positives = 88/212 (41%), Gaps = 33/212 (15%)
Query: 193 VIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEF---KVEVEAIGRVRHKNLVRLL 248
++G+G +G V + A+K L A+ E E + RH L L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 249 GYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN-----IILGTAKGLTYL 302
Y + R+ V EY + G L L + E R I+ L YL
Sbjct: 215 -YSFQTHDRLCFVMEYANGGELFFHLS-----RERVFSEDRARFYGAEIVSA----LDYL 264
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
H VV+RD+K N++LDK + K++DFGL K G + GT Y+APE
Sbjct: 265 HSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPE-- 319
Query: 363 STGMLNERS-----DVYSFGILIMEVISGRNP 389
+L + D + G+++ E++ GR P
Sbjct: 320 ---VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 8e-13
Identities = 58/243 (23%), Positives = 100/243 (41%), Gaps = 68/243 (27%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR------ 240
+ +G+G YGIV+ + VAVK + + F+ +A R
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-------AFQNSTDAQRTFREIMILT 63
Query: 241 ----HKNLVRLLG-YCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
H+N+V LL A+ + LV++Y++ +L + + L + ++
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN-----ILEPVHKQYVVYQ 117
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---------- 344
K + YLH G ++HRD+K SNILL+ + + K++DFGL++ R
Sbjct: 118 LIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 345 ---------------YVTTRVMGTFGYVAPEYASTGMLNERS-----DVYSFGILIMEVI 384
YV TR Y APE +L D++S G ++ E++
Sbjct: 175 ENTENFDDDQPILTDYVATR-----WYRAPEI----LLGSTKYTKGIDMWSLGCILGEIL 225
Query: 385 SGR 387
G+
Sbjct: 226 CGK 228
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 8e-13
Identities = 59/212 (27%), Positives = 87/212 (41%), Gaps = 34/212 (16%)
Query: 193 VIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEF---KVEVEAIGRVRHKNLVRLL 248
++G+G +G V + A+K L A+ E E + RH L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 249 GYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN-----IILGTAKGLTYL 302
Y + R+ V EY + G L L + E R I+ L YL
Sbjct: 72 -YAFQTHDRLCFVMEYANGGELFFHLS-----RERVFTEERARFYGAEIVSA----LEYL 121
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
H VV+RDIK N++LDK + K++DFGL K G GT Y+APE
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPE-- 175
Query: 363 STGMLNERS-----DVYSFGILIMEVISGRNP 389
+L + D + G+++ E++ GR P
Sbjct: 176 ---VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 14/97 (14%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L +LH +++RD+K NILLD++ + KL+DFGL+K + GT Y+
Sbjct: 138 ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYM 193
Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
APE ++N R D +SFG+L+ E+++G P
Sbjct: 194 APE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 71/345 (20%), Positives = 111/345 (32%), Gaps = 95/345 (27%)
Query: 191 ENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAE-KEFKVE----------- 232
+G G +G V VAVK L +E + E
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 233 --VEAIGRV--------------RHKNLVRLL--------GYCAEGAHRMLVYEYIDNGN 268
V +G + NL L Y +GA +Y+
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146
Query: 269 LEQWLHGDVGPHS-----------------------------PLTWEIRMNIILGTAKGL 299
++ D S LT E + AKG+
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVA 358
+L K +HRD+ + NILL ++ K+ DFGLA+ + + YV ++A
Sbjct: 207 EFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263
Query: 359 PEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417
PE + +SDV+SFG+L+ E+ S G +P Y + LK EG
Sbjct: 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--YPGVKIDEEFCRRLK--------EGT 313
Query: 418 LDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
R+ P + + + L C +RP ++ L
Sbjct: 314 ---RM-RAPDYTTPEMYQ---TMLDCWHGEPSQRPTFSELVEHLG 351
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 3e-12
Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 14/97 (14%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L +LH+ +++RD+K NI+L+ Q + KL+DFGL K VT GT Y+
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYM 188
Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
APE +L D +S G L+ ++++G P
Sbjct: 189 APE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 34/97 (35%), Positives = 51/97 (52%), Gaps = 14/97 (14%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L YLH +V+RD+K NILLD Q + L+DFGL K E + T+ GT Y+
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYL 206
Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
APE +L+++ D + G ++ E++ G P
Sbjct: 207 APE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 14/97 (14%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L +LH+ +++RD+K N+LLD + + KL+DFG+ K G T GT Y+
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYI 191
Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
APE +L E D ++ G+L+ E++ G P
Sbjct: 192 APE-----ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 15/99 (15%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L +LH+ +++RDIK NILLD + L+DFGL+K A+ + GT Y+
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 358 APEYASTGMLNERS-------DVYSFGILIMEVISGRNP 389
AP+ ++ D +S G+L+ E+++G +P
Sbjct: 228 APD-----IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 193 VIGEGGYGIVYHGVLEDNTNV-AVKNLLNNRGQAEKEF---KVEVEAIGRVRHKNLVRLL 248
+G G +G V +++ N A+K L + K+ E + V LV+L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN----------IILGTAKG 298
+ ++ +V EY+ G E + H L R + I+L
Sbjct: 108 FSFKDNSNLYMVMEYVAGG--EMFSH--------LRRIGRFSEPHARFYAAQIVLT---- 153
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
YLH +++RD+K N+L+D+Q +++DFG AK + T + GT +A
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALA 206
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNP 389
PE + N+ D ++ G+LI E+ +G P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 8e-12
Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 14/97 (14%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L YLHE +++RD+K N+LLD + + KL+D+G+ K G T+ GT Y+
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYI 177
Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
APE +L D ++ G+L+ E+++GR+P
Sbjct: 178 APE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 14/97 (14%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
GL +LH +V+RD+K NILLDK + K++DFG+ K T GT Y+
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDYI 185
Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
APE +L + D +SFG+L+ E++ G++P
Sbjct: 186 APE-----ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 14/97 (14%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L YLHE +++RD+K N+LLD + + KL+D+G+ K G T+ GT Y+
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYI 220
Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
APE +L D ++ G+L+ E+++GR+P
Sbjct: 221 APE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 14/97 (14%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
GL +L +++RD+K N++LD + + K++DFG+ K T GT Y+
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYI 188
Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
APE ++ + D ++FG+L+ E+++G+ P
Sbjct: 189 APE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 14/97 (14%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
GL +L +++RD+K N++LD + + K++DFG+ K T GT Y+
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYI 509
Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
APE ++ + D ++FG+L+ E+++G+ P
Sbjct: 510 APE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 4e-11
Identities = 37/97 (38%), Positives = 55/97 (56%), Gaps = 17/97 (17%)
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYV 357
L YLH +++RD+K NILLDK + K++DFG AK + VT + GT Y+
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYI 170
Query: 358 APEYASTGMLNERS-----DVYSFGILIMEVISGRNP 389
APE +++ + D +SFGILI E+++G P
Sbjct: 171 APE-----VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.4 bits (153), Expect = 4e-11
Identities = 36/203 (17%), Positives = 61/203 (30%), Gaps = 57/203 (28%)
Query: 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVK--------NLLNNRGQAEKEFKVEVE 234
+ T IGEG +G V+ + D+T VA+K + + + +E E+
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 235 ---------AIGRVRHKNLVRLLG-YCAEGAH---------------------------- 256
R + + L +C +G++
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 257 -RMLVYEYIDNGN-LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRD 314
+V E+ G LEQ + +I+ L + HRD
Sbjct: 136 QLFIVLEFEFGGIDLEQM------RTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRD 187
Query: 315 IKSSNILLDKQWNPKLSDFGLAK 337
+ N+LL K KL K
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGK 210
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 50/225 (22%), Positives = 94/225 (41%), Gaps = 48/225 (21%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNN---RGQAEKEFKV-------EVEAIGRVRH 241
+G G + V+ + +NT+VA+K + + AE E K+ + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 242 KNLVRLLGY----CAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGT 295
++++LL + G H ++V+E + NL + + G +I ++LG
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLLG- 143
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP------KLSDFGLAKLLGAERS-YVTT 348
L Y+H ++H DIK N+L++ +P K++D G A + + T
Sbjct: 144 ---LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198
Query: 349 RVMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
R Y +PE + +D++S LI E+I+G
Sbjct: 199 RE-----YRSPEVLLGAPW------GCGADIWSTACLIFELITGD 232
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 54/232 (23%), Positives = 93/232 (40%), Gaps = 35/232 (15%)
Query: 173 GHWYTLRELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNN---RGQAEKE 228
Y ++ E + + +++IG+G +G V + VA+K + N QA+ E
Sbjct: 42 YD-YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE 100
Query: 229 FKV--EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLT 284
++ + +V L + H LV+E + NL L G LT
Sbjct: 101 VRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLT 159
Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP--KLSDFGLAKLLGAE 342
+ + L +L E ++H D+K NILL K+ DFG + LG
Sbjct: 160 RKFAQQMCTA----LLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 214
Query: 343 R-SYVTTRVMGTFGYVAPE------YASTGMLNERSDVYSFGILIMEVISGR 387
Y+ +R F Y +PE Y + D++S G +++E+ +G
Sbjct: 215 IYQYIQSR----F-YRSPEVLLGMPY------DLAIDMWSLGCILVEMHTGE 255
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 33/155 (21%), Positives = 65/155 (41%), Gaps = 24/155 (15%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
IG G +G + G L N VA+K + + Q E++ + + ++ +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS---GDGIPQVYYF 73
Query: 251 CAEGAHRMLVYEYIDNG-NLEQWLHGDVGPHSPLTWEIRMNIILGT--AKGLTYLHEGLE 307
G + +V E + G +LE D+ T+ ++ +++ + Y+H
Sbjct: 74 GPCGKYNAMVLELL--GPSLE-----DLFDLCDRTFSLKTVLMIAIQLISRMEYVHS--- 123
Query: 308 PKVVHRDIKSSNILLDKQWNPK-----LSDFGLAK 337
+++RD+K N L+ + N + DF LAK
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 41/176 (23%), Positives = 66/176 (37%), Gaps = 34/176 (19%)
Query: 181 LEVSTNGFADE-----NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVE 234
L++ N D+ V+G G G V A+K L + + + EVE
Sbjct: 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVE 62
Query: 235 AIGRV-RHKNLVRLLGYC----AEGAHRMLVYEYIDNGNL-----EQWLHGDVGPHSPLT 284
R + ++VR++ A ++V E +D G L ++ T
Sbjct: 63 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-------GDQAFT 115
Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAK 337
I+ + + YLH + HRD+K N+L KL+DFG AK
Sbjct: 116 EREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 39/156 (25%), Positives = 66/156 (42%), Gaps = 26/156 (16%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVKN--LLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
IGEG +G+++ G L +N VA+K ++ Q E++ G + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT---GIPNVYYF 74
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAK----GLTYLHEGL 306
EG H +LV + + +LE L S T + AK + +HE
Sbjct: 75 GQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKT-------VAMAAKQMLARVQSIHE-- 124
Query: 307 EPKVVHRDIKSSNILLDKQWNPK-----LSDFGLAK 337
+V+RDIK N L+ + + + DFG+ K
Sbjct: 125 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 36/212 (16%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNN---RGQAEKEFKV--EVEAIGRVRHKNLVR 246
VIG+G +G V + + +VA+K + N QA +E ++ + + N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWL--HGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
+L H + +E + NL + + + G PL + +I+ + L LH+
Sbjct: 164 MLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSIL----QCLDALHK 218
Query: 305 GLEPKVVHRDIKSSNILLDKQWNP--KLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPE- 360
+++H D+K NILL +Q K+ DFG + Y+ +R F Y APE
Sbjct: 219 ---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR----F-YRAPEV 270
Query: 361 -----YASTGMLNERSDVYSFGILIMEVISGR 387
Y D++S G ++ E+++G
Sbjct: 271 ILGARY------GMPIDMWSLGCILAELLTGY 296
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 37/169 (21%), Positives = 72/169 (42%), Gaps = 34/169 (20%)
Query: 194 IGEGGYGIVYHGVLEDNTNV------AVKNLLNNRGQAEKEFKV-----EVEAIGRVRHK 242
IG+GG+G +Y + + +V VK ++ G E K + E I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 243 NLVRLLG----------YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPL--TWEIRMN 290
++ LG ++R ++ + + +L++ ++ ++ +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQK-IYEANAKRFSRKTVLQLSLR 160
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK--LSDFGLAK 337
I+ L Y+HE + VH DIK+SN+LL+ + + L D+GLA
Sbjct: 161 IL----DILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 46/257 (17%), Positives = 89/257 (34%), Gaps = 74/257 (28%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK---NLLNNRGQAEKEFKVEVEAIGRVR-----HKNL 244
+G G + V+ ++ VA+K + + A E ++ +++ + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLL-KSVRNSDPNDPNREMV 103
Query: 245 VRLLGY----CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
V+LL G H +V+E + + +L +W+ + L II +GL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWII--KSNYQGLPLPCVKKIIQQVLQGLD 160
Query: 301 YLHEGLEPKVVHRDIKSSNILL-------------------------------------- 322
YLH + +++H DIK NILL
Sbjct: 161 YLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 323 -----------DKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNER 370
++ K++D G A + + + TR Y + E N
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTP 273
Query: 371 SDVYSFGILIMEVISGR 387
+D++S + E+ +G
Sbjct: 274 ADIWSTACMAFELATGD 290
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 39/167 (23%), Positives = 69/167 (41%), Gaps = 33/167 (19%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVA---VKNLLNNRGQAEKEFKVE-----VEAIGRVRHKNL 244
IG GG+G++Y A VK G E K + I + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 245 VRLLG-----YC-----AEGAHRMLVYEYIDNG-NLEQWLHGDVGPHSPLT-WEIRMNII 292
+ LG ++R +V E + G +L++ + G G T ++ + ++
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTVLQLGIRML 161
Query: 293 LGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK--LSDFGLAK 337
L Y+HE + VH DIK++N+LL + + L+D+GL+
Sbjct: 162 ----DVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 37/159 (23%), Positives = 63/159 (39%), Gaps = 34/159 (21%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNL------ 244
IG G +G +Y G + VA+K + Q E K+ +K +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI---------YKMMQGGVGI 67
Query: 245 VRLLGYCAEGAHRMLVYEYIDNG-NLEQWLHGDVGPHSPLTWEIRMNIILGT--AKGLTY 301
+ AEG + ++V E + G +LE D+ + ++ ++L + Y
Sbjct: 68 PTIRWCGAEGDYNVMVMELL--GPSLE-----DLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPK---LSDFGLAK 337
+H +HRD+K N L+ + DFGLAK
Sbjct: 121 IHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 27/170 (15%), Positives = 56/170 (32%), Gaps = 36/170 (21%)
Query: 194 IGEGGYGIVYHGV---------LEDNTNVAVKNLLNNRGQAEKEFKV--------EVEAI 236
GI+Y ++K L G+ E +V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 237 GRVRHKNLV---RLLGY-CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS---PLTWEIRM 289
++ L+ +G+ + +R LV + +L+ H ++
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQS-ALDVSPKHVLSERSVLQVAC 166
Query: 290 NIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK--LSDFGLAK 337
++ L +LHE + VH ++ + NI +D + + L+ +G A
Sbjct: 167 RLL----DALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 37/152 (24%), Positives = 63/152 (41%), Gaps = 20/152 (13%)
Query: 194 IGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
IG G +G +Y G ++ N VA+K N+ Q E K+ G + + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQG---GTGIPNVRWF 71
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT--AKGLTYLHEGLEP 308
EG + +LV + + +LE + S ++ ++L + ++H
Sbjct: 72 GVEGDYNVLVMDLLGP-SLEDLFNFCSRKLS-----LKTVLMLADQMINRVEFVHS---K 122
Query: 309 KVVHRDIKSSNILLDKQWNPK---LSDFGLAK 337
+HRDIK N L+ + DFGLAK
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 521 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.69 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.12 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.08 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.78 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.62 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.6 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.52 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.4 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.39 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.11 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.1 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.06 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.93 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.92 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.56 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.51 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.46 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.44 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.35 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.31 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.31 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.13 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 96.93 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.92 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.92 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 96.8 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 96.76 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.63 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 96.26 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.96 | |
| 2l34_A | 33 | TYRO protein tyrosine kinase-binding protein; immu | 95.5 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 95.3 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 94.52 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 94.11 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.09 | |
| 2k1a_A | 42 | Integrin alpha-IIB; single-PASS transmembrane segm | 93.24 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 90.63 | |
| 2klu_A | 70 | T-cell surface glycoprotein CD4; cell membrane, di | 89.49 | |
| 2knc_B | 79 | Integrin beta-3; transmembrane signaling, protein | 88.57 | |
| 1q55_A | 880 | EP-cadherin, C-cadherin; trans interaction, desmos | 87.94 | |
| 2k9j_B | 43 | Integrin beta-3; transmembrane complex, cell adhes | 87.91 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.67 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.57 | |
| 2klu_A | 70 | T-cell surface glycoprotein CD4; cell membrane, di | 85.25 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.89 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 80.46 | |
| 1q90_G | 37 | Cytochrome B6F complex subunit PETG; membrane prot | 80.43 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-57 Score=448.74 Aligned_cols=261 Identities=25% Similarity=0.471 Sum_probs=214.8
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 256 (521)
+..++|.+.+.||+|+||+||+|++. ++..||||++........++|.+|+++|++++|||||+++|+|.+++.
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 45568899999999999999999864 367899999987777777889999999999999999999999999999
Q ss_pred eeEEEEeccCCchHHhhhcCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCC
Q 009979 257 RMLVYEYIDNGNLEQWLHGDV---------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN 327 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~ 327 (521)
.|||||||++|+|.++|+... .....+++..++.|+.|++.||+|||++ +|+||||||+||||+++++
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCc
Confidence 999999999999999997642 2346799999999999999999999998 9999999999999999999
Q ss_pred ceEeecccceecCCCCccee-ecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHH
Q 009979 328 PKLSDFGLAKLLGAERSYVT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWL 405 (521)
Q Consensus 328 vkL~DFGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~ 405 (521)
+||+|||+|+.......... ....||+.|||||++.+..|+.++|||||||+||||+| |+.||.... ..+.+
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~------~~~~~ 240 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS------NNEVI 240 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC------HHHHH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC------HHHHH
Confidence 99999999987654433322 34579999999999999999999999999999999999 899996432 22333
Q ss_pred HHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 406 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
........ . .. +..++..+ .+|+.+||+.||++|||+.+|++.|+..
T Consensus 241 ~~i~~~~~-~-----~~-p~~~~~~~---~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 241 ECITQGRV-L-----QR-PRTCPQEV---YELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHHHTCC-C-----CC-CTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHcCCC-C-----CC-CccchHHH---HHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 33322211 0 11 12244444 4588899999999999999999999753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-56 Score=449.23 Aligned_cols=261 Identities=26% Similarity=0.459 Sum_probs=208.6
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 256 (521)
+..++|.+.++||+|+||+||+|++. +++.||||++........++|.+|+++|++++|||||+++|+|.++..
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 34567888999999999999999864 467899999987777777889999999999999999999999999999
Q ss_pred eeEEEEeccCCchHHhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVG-----------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ 325 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~ 325 (521)
.|||||||++|+|.++|+.... ...++++..++.|+.|++.||+|||+. +||||||||+||||+++
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG 194 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCC
Confidence 9999999999999999986532 235799999999999999999999998 99999999999999999
Q ss_pred CCceEeecccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHH
Q 009979 326 WNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVE 403 (521)
Q Consensus 326 ~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~ 403 (521)
+++||+|||+++........ ..+..+||+.|||||++.+..|+.++|||||||+||||+| |+.||.... ..+
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~------~~~ 268 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS------NTE 268 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC------HHH
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC------HHH
Confidence 99999999999976443322 2345689999999999999999999999999999999999 899996432 223
Q ss_pred HHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 404 WLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 404 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.+........ +.. +..++..+ .+|+.+||+.||++||||.||+++|+..
T Consensus 269 ~~~~i~~g~~------~~~-p~~~~~~~---~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 269 AIDCITQGRE------LER-PRACPPEV---YAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp HHHHHHHTCC------CCC-CTTCCHHH---HHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCC------CCC-cccccHHH---HHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 3333322211 111 12244444 4588899999999999999999999863
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-56 Score=444.58 Aligned_cols=264 Identities=28% Similarity=0.469 Sum_probs=208.8
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
|++..++|.+.++||+|+||+||+|+++ ..||||+++.. .....+.|.+|+++|++++|||||+++|+|.+ +..+
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 4778889999999999999999999874 35999998643 33445789999999999999999999999865 5689
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
||||||++|+|.++|+.. ...+++..++.|+.|+|.||+|||++ +||||||||+||||++++++||+|||+|+.
T Consensus 108 iVmEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 181 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATV 181 (307)
T ss_dssp EEEECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred EEEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCcee
Confidence 999999999999999865 35799999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCC-cceeecccccccccccccccC---CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 339 LGAER-SYVTTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 339 ~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
..... ....+..+||+.|||||++.+ +.|+.++|||||||+||||+||+.||..... ...+...+...
T Consensus 182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~------~~~~~~~~~~~-- 253 (307)
T 3omv_A 182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN------RDQIIFMVGRG-- 253 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHHHHHHTT--
T ss_pred cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh------HHHHHHHHhcC--
Confidence 64322 223456789999999999853 4689999999999999999999999964432 12222222221
Q ss_pred ccCCCcccC--CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCc
Q 009979 415 EGVLDPRLQ--EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPF 466 (521)
Q Consensus 415 ~~~~d~~l~--~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 466 (521)
...|.+. ...++..+. +|+.+||+.||++||||.||++.|+....++
T Consensus 254 --~~~p~~~~~~~~~~~~l~---~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 254 --YASPDLSKLYKNCPKAMK---RLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp --CCCCCSTTSCTTSCHHHH---HHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred --CCCCCcccccccchHHHH---HHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 1222221 122444444 4888999999999999999999998654443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-56 Score=444.40 Aligned_cols=261 Identities=26% Similarity=0.415 Sum_probs=211.9
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 255 (521)
+....+++.++||+|+||+||+|.+. +++.||||++.... ....++|.+|+.+|++++|||||+++|+|.++.
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 34456778899999999999999863 46789999996543 334578999999999999999999999999999
Q ss_pred eeeEEEEeccCCchHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD 323 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~ 323 (521)
..+||||||++|+|.++|+.... ....+++..++.|+.|||.||+|||++ +||||||||+||||+
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEEC
Confidence 99999999999999999975421 134689999999999999999999998 999999999999999
Q ss_pred CCCCceEeecccceecCCCCc-ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccH
Q 009979 324 KQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNL 401 (521)
Q Consensus 324 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~ 401 (521)
+++++||+|||+++....... ...+...||+.|||||++.++.|+.++|||||||+||||+| |+.||.... .
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~------~ 253 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS------N 253 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC------H
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC------H
Confidence 999999999999987644332 23445689999999999999999999999999999999999 899996443 2
Q ss_pred HHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 402 VEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 402 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.+.+... ..+... + .+..++.. +.+|+.+||+.||++||||.||++.|++.
T Consensus 254 ~~~~~~i-~~~~~~----~--~p~~~~~~---~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 254 QDVVEMI-RNRQVL----P--CPDDCPAW---VYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHH-HTTCCC----C--CCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHH-HcCCCC----C--CcccchHH---HHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2222222 222111 1 11224444 44588899999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-55 Score=443.56 Aligned_cols=249 Identities=26% Similarity=0.355 Sum_probs=208.6
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
+.|++.++||+|+||+||+|++. +|+.||||++........+.+.+|+++|+.++|||||+++++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46899999999999999999976 68999999997665555677889999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~ 344 (521)
+||+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+||||+.++++||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 224 (346)
T 4fih_A 154 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 224 (346)
T ss_dssp TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred CCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence 999999999753 589999999999999999999999 99999999999999999999999999999875433
Q ss_pred ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCC
Q 009979 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424 (521)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 424 (521)
...+..+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..+.+...... ..+.+..
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~~~------~~~~~~~ 292 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP------PLKAMKMIRDN------LPPRLKN 292 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHS------SCCCCSC
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcC------CCCCCCc
Confidence 23456789999999999999999999999999999999999999996432 22222222221 1111111
Q ss_pred CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 425 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
......++.+|+.+||+.||++|||+.|+++
T Consensus 293 --~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 293 --LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp --GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1112234455888999999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=445.53 Aligned_cols=252 Identities=21% Similarity=0.363 Sum_probs=203.9
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999975 68999999997543 334567899999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
|||+||+|.++|.... ...+++..++.|+.||+.||+|||++ +|+||||||+||||+.++++||+|||+|+.+..
T Consensus 103 Ey~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp ECCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred eCCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 9999999999997652 35688999999999999999999999 999999999999999999999999999997643
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
. ....+..+||+.|||||++.+..|+.++|||||||+||||+||+.||... +..+.+........ . .
T Consensus 178 ~-~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~------~~~~~~~~i~~~~~-----~-~ 244 (350)
T 4b9d_A 178 T-VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG------SMKNLVLKIISGSF-----P-P 244 (350)
T ss_dssp H-HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHTCC-----C-C
T ss_pred C-cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc------CHHHHHHHHHcCCC-----C-C
Confidence 2 22234578999999999999999999999999999999999999999643 23333333333211 1 1
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
+.. ..+.. +.+|+.+||+.||++|||+.|++++
T Consensus 245 ~~~-~~s~~---~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 245 VSL-HYSYD---LRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCT-TSCHH---HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCc-cCCHH---HHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 13333 4458889999999999999999863
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-55 Score=434.71 Aligned_cols=248 Identities=22% Similarity=0.306 Sum_probs=208.1
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|++.+.||+|+||+||+|++. +++.||||++.+.. ....+.+.+|+++|+.++|||||++++++.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 47999999999999999999975 68899999996542 234567899999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
|||+||+|.+++.+. ..+++..+..++.|++.||+|||++ +|+||||||+||||+.++++||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 999999999999865 5799999999999999999999999 999999999999999999999999999998754
Q ss_pred CC-cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 342 ER-SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 342 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
.. .......+||+.|||||++.+..|+.++|||||||+||||+||+.||...+ ..+.+....... .
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~~~~-------~ 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN------EGLIFAKIIKLE-------Y 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTC-------C
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHcCC-------C
Confidence 33 233456799999999999999999999999999999999999999996432 223333333221 1
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.+... .+. ++.+|+.+||+.||++|||+.|++.
T Consensus 252 ~~p~~-~s~---~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 252 DFPEK-FFP---KARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp CCCTT-CCH---HHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred CCCcc-cCH---HHHHHHHHHccCCHhHCcChHHHcC
Confidence 12221 223 3455888999999999999998743
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-54 Score=443.66 Aligned_cols=249 Identities=27% Similarity=0.361 Sum_probs=209.6
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
.+.|++.++||+|+||.||+|++. +|+.||||++........+.+.+|+++|+.++|||||+++++|.+++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 357999999999999999999976 5899999999766666667789999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
|+||+|.++++.. .+++..+..++.||+.||+|||++ +||||||||+||||+.+|++||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 9999999999754 589999999999999999999999 99999999999999999999999999999875433
Q ss_pred cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
...+..+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..+.+...... ..+.+.
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~~~------~~~~~~ 368 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP------PLKAMKMIRDN------LPPRLK 368 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHS------CCCCCS
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcC------CCCCCc
Confidence 23456789999999999999999999999999999999999999996432 22222222221 111111
Q ss_pred C-CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 424 E-KPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 424 ~-~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
. ...+.. +.+|+.+||+.||++|||+.|+++
T Consensus 369 ~~~~~s~~---~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 369 NLHKVSPS---LKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CTTSSCHH---HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHH---HHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 112333 445888999999999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=434.18 Aligned_cols=251 Identities=19% Similarity=0.228 Sum_probs=202.8
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
.+.|++.++||+|+||+||+|++. +|+.||||++..... ..+|+.+|+.++|||||++++++.++..+||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 456888999999999999999975 588999999965432 24599999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC-CceEeecccceecCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKLLGAE 342 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~-~vkL~DFGla~~~~~~ 342 (521)
|+||+|.++|+.. ..+++..+..++.|++.||+|||++ +||||||||+||||+.++ ++||+|||+|+.+...
T Consensus 132 ~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 9999999999865 5799999999999999999999998 999999999999999887 6999999999987543
Q ss_pred Ccc----eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCC
Q 009979 343 RSY----VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (521)
Q Consensus 343 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (521)
... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||........ .. .........
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~---~i~~~~~~~--- 275 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CL---KIASEPPPI--- 275 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HH---HHHHSCCGG---
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HH---HHHcCCCCc---
Confidence 221 12346899999999999999999999999999999999999999976543321 11 111111000
Q ss_pred CcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 419 d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
..+. ..++..+ .+++.+||+.||++|||+.|+++.|..
T Consensus 276 -~~~~-~~~s~~~---~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 276 -REIP-PSCAPLT---AQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp -GGSC-TTSCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -hhcC-ccCCHHH---HHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 0111 1233444 447889999999999999999988754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=439.46 Aligned_cols=268 Identities=25% Similarity=0.382 Sum_probs=217.1
Q ss_pred cchhhhhhcCCCccccceEccCCcEEEEEEEEcC------CcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCC-CCeeeE
Q 009979 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRH-KNLVRL 247 (521)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h-pniv~l 247 (521)
|...+|+++.++|++.+.||+|+||+||+|.+.. ++.||||.+..... ...+.|.+|+++|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3456788999999999999999999999998653 24699999976543 345679999999999965 999999
Q ss_pred EEEEeeC-CeeeEEEEeccCCchHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 009979 248 LGYCAEG-AHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRD 314 (521)
Q Consensus 248 ~~~~~~~-~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrD 314 (521)
+|+|.+. ..++||||||++|+|.++|+.... ....+++..++.++.|||.||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999764 568999999999999999976421 135689999999999999999999999 999999
Q ss_pred CCCCCeEeCCCCCceEeecccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCC
Q 009979 315 IKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDY 392 (521)
Q Consensus 315 ik~~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~ 392 (521)
|||+|||+++++++||+|||+|+.+...... ..+..+||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999977544333 3345789999999999999999999999999999999998 9999975
Q ss_pred CCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 393 SRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
.... +.+...+..+.. +... ..++.. +.+++.+||+.||++|||+.||+++|+.
T Consensus 291 ~~~~------~~~~~~i~~g~~-----~~~p-~~~~~~---~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 291 VKID------EEFCRRLKEGTR-----MRAP-DYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp CCCS------HHHHHHHHHTCC-----CCCC-TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHH------HHHHHHHHcCCC-----CCCC-ccCCHH---HHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 4322 122222222211 1111 224444 4458889999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-54 Score=423.27 Aligned_cols=246 Identities=24% Similarity=0.403 Sum_probs=196.7
Q ss_pred cccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEee----CCeeeEEE
Q 009979 189 ADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRMLVY 261 (521)
Q Consensus 189 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~----~~~~~lV~ 261 (521)
++.++||+|+||+||+|.+. ++..||+|++... .....+.|.+|+++|++++|||||+++++|.+ +..+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 66788999999999999976 5888999999654 23345679999999999999999999999865 34679999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC-CCCCceEeecccceecC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~-~~~~vkL~DFGla~~~~ 340 (521)
|||+||+|.+++++. ..+++..+..++.|++.||+|||++ .++|+||||||+||||+ .++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999865 5799999999999999999999998 12399999999999997 47999999999998643
Q ss_pred CCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
. ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||.... +.....+... ... ..+
T Consensus 184 ~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~-----~~~~~~~~i~-~~~----~~~ 249 (290)
T 3fpq_A 184 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRRVT-SGV----KPA 249 (290)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHHHT-TTC----CCG
T ss_pred C---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----cHHHHHHHHH-cCC----CCC
Confidence 2 23456789999999998865 69999999999999999999999996432 2222222222 111 111
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.+.. ..+. ++.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~-~~~~---~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 SFDK-VAIP---EVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGG-CCCH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCc-cCCH---HHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 1223 3445888999999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-54 Score=429.33 Aligned_cols=263 Identities=24% Similarity=0.348 Sum_probs=201.8
Q ss_pred CccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC----eeeEEEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA----HRMLVYE 262 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~----~~~lV~e 262 (521)
+|.+.++||+|+||+||+|++ +|+.||||++..... ....+..|+..+.+++|||||+++|+|.++. .+|||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 578889999999999999998 588999999864322 2223345666677899999999999998654 5799999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG-----LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~-----~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
||++|+|.++|+.. .+++..+++++.|++.||+|||++ ..++|+||||||+||||+.++++||+|||+|+
T Consensus 82 y~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999864 689999999999999999999975 24589999999999999999999999999999
Q ss_pred ecCCCCcce---eecccccccccccccccCC------CCCCcccchhHHHHHHHHHhCCCCCCCCCCC---------Ccc
Q 009979 338 LLGAERSYV---TTRVMGTFGYVAPEYASTG------MLNERSDVYSFGILIMEVISGRNPVDYSRPP---------GEV 399 (521)
Q Consensus 338 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~---------~~~ 399 (521)
......... ....+||+.|||||++.+. .++.++|||||||+||||+||..||...... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 875443222 2346899999999998764 4678999999999999999998877543221 111
Q ss_pred cHHHHHHHHhhccccccCCCcccCCC-ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 400 NLVEWLKTMVTNRNAEGVLDPRLQEK-PCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
.. +.+...+.. ..++|.+... ........+.+|+.+||+.||++||||.||++.|+.
T Consensus 237 ~~-~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 237 SV-EEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CH-HHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred hH-HHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 22 223333322 2233333322 123455566779999999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=417.40 Aligned_cols=246 Identities=22% Similarity=0.352 Sum_probs=190.8
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|++.+.||+|+||+||+|.+. +++.||||++.+.. ....+.+.+|+++|+.++|||||++++++.+++..||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 47999999999999999999964 68999999996542 233467899999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||| +|+|.+++.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 67999999865 5799999999999999999999999 999999999999999999999999999987643
Q ss_pred CCcceeecccccccccccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
. ......+||+.|||||++.+..| +.++|||||||++|||+||+.||... +..+.++..... ..
T Consensus 165 ~--~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~------~~~~~~~~i~~~-~~------ 229 (275)
T 3hyh_A 165 G--NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE------SIPVLFKNISNG-VY------ 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHT-CC------
T ss_pred C--CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHHcC-CC------
Confidence 2 23345789999999999988876 57999999999999999999999643 222333332221 11
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+.. ..+.. +.+++.+||+.||++|||+.|++++
T Consensus 230 ~~p~-~~s~~---~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 TLPK-FLSPG---AAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp CCCT-TSCHH---HHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CCCC-CCCHH---HHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111 12333 4458889999999999999999863
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-54 Score=425.23 Aligned_cols=248 Identities=24% Similarity=0.279 Sum_probs=197.0
Q ss_pred CCCccccceEccCCcEEEEEEEEc----CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
.++|++.+.||+|+||+||+|+.. +++.||||++.+... .....+.+|+++|++++|||||++++++.+++..|
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 357999999999999999999863 467899999865422 22346788999999999999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
||||||+||+|.+++.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+|+.
T Consensus 103 ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EEECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 999999999999999875 5799999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCC
Q 009979 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (521)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (521)
..... ......+||+.|||||++.+..|+.++|||||||+||||+||+.||...+ ..+.+.......
T Consensus 176 ~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~~------ 242 (304)
T 3ubd_A 176 SIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD------RKETMTMILKAK------ 242 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCC------
T ss_pred ccCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC------HHHHHHHHHcCC------
Confidence 53322 23345789999999999999999999999999999999999999996432 223333333211
Q ss_pred CcccCCCccHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 009979 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM-----GHVIH 457 (521)
Q Consensus 419 d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~-----~evl~ 457 (521)
..+.. ..+.. +.+|+.+||+.||++|||+ +|+++
T Consensus 243 -~~~p~-~~s~~---~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 243 -LGMPQ-FLSPE---AQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -CCCCT-TSCHH---HHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -CCCCC-cCCHH---HHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11111 13333 4458889999999999984 66664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-52 Score=412.53 Aligned_cols=249 Identities=22% Similarity=0.419 Sum_probs=189.0
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC---------
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA--------- 255 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~--------- 255 (521)
+|++.+.||+|+||+||+|++. +++.||||++.... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 5888999999999999999975 68899999986543 334467899999999999999999999987544
Q ss_pred ---eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEee
Q 009979 256 ---HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (521)
Q Consensus 256 ---~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~D 332 (521)
.+|||||||++|+|.+++.... ......+..++.++.|++.||+|||++ +|+||||||+||||+.++++||+|
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 3689999999999999998653 233456777899999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCcc-----------eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccH
Q 009979 333 FGLAKLLGAERSY-----------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNL 401 (521)
Q Consensus 333 FGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~ 401 (521)
||+|+.+...... ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||.. ..+.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~-----~~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST-----QMER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS-----HHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC-----ccHH
Confidence 9999876543221 1234689999999999999999999999999999999996 7742 1122
Q ss_pred HHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 402 VEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 402 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
...+..... .. .. .........+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~-~~----~p-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRTLTDVRN-LK----FP-----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHHT-TC----CC-----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhc-CC----CC-----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 222222111 10 11 112223334556889999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=398.03 Aligned_cols=284 Identities=40% Similarity=0.713 Sum_probs=249.8
Q ss_pred cchhhhhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC
Q 009979 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (521)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 255 (521)
+++.+++...++|++.+.||+|+||.||+|.+.++..||+|++........+.+.+|+++++.++||||+++++++.+..
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34556667889999999999999999999998889999999988776666788999999999999999999999999999
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..++||||+++|+|.+++.........+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999987654456799999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCC-cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 336 AKLLGAER-SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 336 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
++...... ........||+.|+|||++.+..++.++|||||||++|||+||+.||....+....+..+|..........
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 98754322 22234456999999999999899999999999999999999999999988777777888887777777777
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
...+++.+...........+.+++.+||+.||++|||+.++++.|+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 777887777666777888888899999999999999999999999753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=401.82 Aligned_cols=295 Identities=41% Similarity=0.765 Sum_probs=255.9
Q ss_pred CCCCcccchhhhhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChh-hHHHHHHHHHHHhcCCCCCeeeEE
Q 009979 170 LGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ-AEKEFKVEVEAIGRVRHKNLVRLL 248 (521)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~hpniv~l~ 248 (521)
.+....|++.++.+..++|.+.+.||+|+||.||+|.+.+++.||||++...... ....+..|+++++.++||||++++
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 3444567899999999999999999999999999999878999999998764322 234688999999999999999999
Q ss_pred EEEeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCc
Q 009979 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328 (521)
Q Consensus 249 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~v 328 (521)
+++.+....++||||+++|+|.++++........+++..++.++.|++.||+|||+.+.++|+||||||+|||++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 99999999999999999999999998876556779999999999999999999999877789999999999999999999
Q ss_pred eEeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC--CCCCcccHHHHHH
Q 009979 329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS--RPPGEVNLVEWLK 406 (521)
Q Consensus 329 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~--~~~~~~~~~~~~~ 406 (521)
||+|||+++..............||+.|+|||++.+..++.++|||||||++|||+||+.||... .........+|+.
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 99999999987655555556677999999999998889999999999999999999999999632 2234456667777
Q ss_pred HHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 009979 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 464 (521)
Q Consensus 407 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 464 (521)
..........+.+..+...........+.+++.+||+.||.+|||+.+|+++|+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 7777777777888877777778888899999999999999999999999999987543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=406.61 Aligned_cols=261 Identities=24% Similarity=0.364 Sum_probs=200.8
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEee------CCe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE------GAH 256 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~------~~~ 256 (521)
++|++.+.||+|+||+||+|++. +|+.||||++.+.. ....+.+.+|+++|+.++|||||++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 68999999996543 2334678899999999999999999999764 357
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
+|||||||+ |+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 899999995 6899999765 5799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCC---cceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc
Q 009979 337 KLLGAER---SYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (521)
Q Consensus 337 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (521)
+.+.... ....+..+||+.|+|||++.+. .++.++||||+||++|||++|+.||...+. ......+.......
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~---~~~l~~I~~~~g~p 282 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY---VHQLQLIMMVLGTP 282 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCCC
Confidence 8764321 2234567899999999998765 579999999999999999999999964431 11222111111110
Q ss_pred cccc--------------CCCcccCCCcc----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 413 NAEG--------------VLDPRLQEKPC----SRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 413 ~~~~--------------~~d~~l~~~~~----~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.... .+.+. ...+. +....++.+|+.+||..||++|||+.|++++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPR-QPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCC-CCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ChHHhhhhhhhhhhhhhhcCCCc-CCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00000 00000 1112355678899999999999999998753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=421.72 Aligned_cols=252 Identities=21% Similarity=0.343 Sum_probs=210.4
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
++|++.+.||+|+||+||+|.+. +|+.||+|++........+.+.+|+++|+.++|||||+++++|.+...+|||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 58999999999999999999975 68999999998776666778899999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC--CCCceEeecccceecCCC
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK--QWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~--~~~vkL~DFGla~~~~~~ 342 (521)
+||+|.++|... ...+++..+..++.||+.||+|||++ +|+||||||+|||++. .+.+||+|||+|+.+...
T Consensus 237 ~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 237 SGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred CCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999754 35799999999999999999999999 9999999999999975 489999999999987543
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
. .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.... ..+.+....... ..+
T Consensus 311 ~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~------~~~~~~~i~~~~-------~~~ 375 (573)
T 3uto_A 311 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN------DDETLRNVKSCD-------WNM 375 (573)
T ss_dssp S--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS------HHHHHHHHHTTC-------CCC
T ss_pred C--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHhCC-------CCC
Confidence 3 3345689999999999999999999999999999999999999996432 223233322211 011
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
...........+.+|+.+||+.||.+|||+.|++++
T Consensus 376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111222345568889999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=398.75 Aligned_cols=197 Identities=25% Similarity=0.402 Sum_probs=169.9
Q ss_pred CCCccccceEccCCcEEEEEEEEc----CCcEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~l 259 (521)
.++|++.++||+|+||+||+|+.+ .++.||+|++.... ....+.+|+++|+.+ +|||||++++++.+.++.||
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 468999999999999999999863 36789999986543 345678899999998 69999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC-CCceEeeccccee
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFGLAKL 338 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~-~~vkL~DFGla~~ 338 (521)
|||||++|+|.++++ .+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +++||+|||+|+.
T Consensus 98 vmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 98 AMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 999999999999983 478999999999999999999999 99999999999999876 7999999999986
Q ss_pred cCCCCc---------------------------ceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCC
Q 009979 339 LGAERS---------------------------YVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPV 390 (521)
Q Consensus 339 ~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf 390 (521)
...... ...+..+||+.|+|||++.+. .|+.++||||+||++|||+||+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 543211 112345799999999998775 5899999999999999999999999
Q ss_pred CCC
Q 009979 391 DYS 393 (521)
Q Consensus 391 ~~~ 393 (521)
...
T Consensus 248 ~~~ 250 (361)
T 4f9c_A 248 YKA 250 (361)
T ss_dssp SCC
T ss_pred CCC
Confidence 643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=415.81 Aligned_cols=254 Identities=22% Similarity=0.281 Sum_probs=203.7
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhH---HHHHHHHHHHhcCCCCCeeeEEEEEeeCC
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAE---KEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~---~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 255 (521)
+..++|++.++||+|+||+||+|+.. +|+.||||++.+... ... .....++.+++.++|||||+++++|.+..
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 34578999999999999999999976 588999999964321 112 22334577788889999999999999999
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
.+|||||||+||+|.++|.+. ..+++..+..++.||+.||+|||++ +||||||||+||||+.+|++||+|||+
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGl 338 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGL 338 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccce
Confidence 999999999999999999865 5799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
|+.+.... ....+||+.|||||++.. ..|+.++|||||||+||||++|+.||....... ..+..+......
T Consensus 339 A~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---~~~i~~~i~~~~-- 410 (689)
T 3v5w_A 339 ACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTLTMA-- 410 (689)
T ss_dssp CEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---HHHHHHHHHHCC--
T ss_pred eeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhhcCCC--
Confidence 99865432 345789999999999964 579999999999999999999999997544332 222222222211
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhh
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK-----MGHVIHMLE 460 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~L~ 460 (521)
..+... .+. ++.+|+.+||+.||.+|++ +.||+++--
T Consensus 411 -----~~~p~~-~S~---~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf 452 (689)
T 3v5w_A 411 -----VELPDS-FSP---ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452 (689)
T ss_dssp -----CCCCTT-SCH---HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred -----CCCCcc-CCH---HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence 111111 233 3445888999999999998 788875443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=371.13 Aligned_cols=256 Identities=26% Similarity=0.467 Sum_probs=211.9
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
..++|.+.+.||+|+||+||+|.+. ++..||+|++........+.+.+|+++++.++||||+++++++.++...++|||
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 4568899999999999999999975 588899999977777777889999999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+++|+|.++++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 88 YIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 99999999999875 35789999999999999999999999 9999999999999999999999999999876433
Q ss_pred Ccce-------------eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCc---ccHHHHHH
Q 009979 343 RSYV-------------TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE---VNLVEWLK 406 (521)
Q Consensus 343 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~---~~~~~~~~ 406 (521)
.... .....||+.|+|||++.+..++.++|||||||++|||++|..||....+... ........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 2211 1145799999999999999999999999999999999999999875433221 11111111
Q ss_pred HHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 407 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.. .. ..++.. +.+++.+||+.||++|||+.++++.|+..
T Consensus 242 ~~---------~~-----~~~~~~---l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 242 RY---------CP-----PNCPPS---FFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp HT---------CC-----TTCCTT---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc---------CC-----CCCCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 10 01 112222 44588899999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=365.89 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=207.8
Q ss_pred CCCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 185 TNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
.++|++.+.||+|+||+||+|.+ .+++.||+|++........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 45899999999999999999995 46889999999766656667889999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++|+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999764 588999999999999999999999 99999999999999999999999999998765433
Q ss_pred cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....+ ............. ....
T Consensus 171 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~~-~~~~---- 238 (297)
T 3fxz_A 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTP-ELQN---- 238 (297)
T ss_dssp C-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCSC-CCSC----
T ss_pred c-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC-CCCC----
Confidence 2 23456799999999999999999999999999999999999999964321 2222222221111 1100
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
....+. .+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~---~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 239 PEKLSA---IFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GGGSCH---HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCH---HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111233 34558889999999999999999753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=366.37 Aligned_cols=264 Identities=27% Similarity=0.466 Sum_probs=203.4
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 255 (521)
...+++..++|++.+.||+|+||+||+|.+ +++.||||++.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 444566778999999999999999999987 58889999987653 334467889999999999999999999999999
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeEeCCCCCceEeec
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK--VVHRDIKSSNILLDKQWNPKLSDF 333 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~--iiHrDik~~NILl~~~~~vkL~DF 333 (521)
..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence 9999999999999999998642 112489999999999999999999998 8 999999999999999999999999
Q ss_pred ccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccc
Q 009979 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (521)
Q Consensus 334 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (521)
|+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..........
T Consensus 184 g~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~------~~~~~~~~~~~~ 256 (309)
T 3p86_A 184 GLSRLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP------AQVVAAVGFKCK 256 (309)
T ss_dssp C------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHHHSCC
T ss_pred CCCcccccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcCC
Confidence 999865332 2223456799999999999999999999999999999999999999964422 222222211111
Q ss_pred cccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 414 ~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
...+.. ..+.. +.+++.+||+.||.+|||+.++++.|+..
T Consensus 257 -----~~~~~~-~~~~~---l~~li~~~l~~dP~~Rps~~~ll~~L~~~ 296 (309)
T 3p86_A 257 -----RLEIPR-NLNPQ---VAAIIEGCWTNEPWKRPSFATIMDLLRPL 296 (309)
T ss_dssp -----CCCCCT-TSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCc-cCCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011111 12333 44588899999999999999999999764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=357.86 Aligned_cols=259 Identities=25% Similarity=0.408 Sum_probs=214.8
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++..++|++.+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|+++++.++||||+++++++.+....++||
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 556778999999999999999999998888899999875433 3467889999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 83 EYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp ECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred EccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 999999999999765 34689999999999999999999999 999999999999999999999999999998755
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
..........||+.|+|||.+.+..++.++||||||+++|||+| |+.||..... .+......... ....
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~---~~~~- 226 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN------SEVVLKVSQGH---RLYR- 226 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHHTTC---CCCC-
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh------HHHHHHHHcCC---CCCC-
Confidence 54444444567788999999998899999999999999999999 9999964331 12222222111 1111
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
....+.. +.+++.+||+.||++|||+.++++.|+...
T Consensus 227 ---~~~~~~~---l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 227 ---PHLASDT---IYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp ---CTTSCHH---HHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred ---CCcChHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1112333 445888999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=361.52 Aligned_cols=258 Identities=26% Similarity=0.447 Sum_probs=213.2
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
.+..++|++.+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|++++++++||||+++++++.+....++||
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EeChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 455678999999999999999999998888999999876433 3467899999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp ECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EeCCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 999999999999765 35789999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
..........||+.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+......... ...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~------~~~~~~~~~~~~---~~~-- 227 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDISTGF---RLY-- 227 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTTC---CCC--
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC------HHHHHHHHhcCc---cCC--
Confidence 43333344567889999999998999999999999999999999 999996432 222222222211 111
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.....+.. +.+++.+||+.||++||++.+++++|+..
T Consensus 228 --~~~~~~~~---~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 228 --KPRLASTH---VYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp --CCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCcCCHH---HHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 11112333 44588899999999999999999999753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=377.21 Aligned_cols=262 Identities=25% Similarity=0.439 Sum_probs=211.3
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc--------CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcC-CCCCeeeEEEEE
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE--------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLGYC 251 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~hpniv~l~~~~ 251 (521)
++..++|.+.+.||+|+||.||+|.+. ++..||||.+..... ...+.+.+|+++|+.+ +||||++++++|
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 445678999999999999999999863 345699999876533 3456789999999999 899999999999
Q ss_pred eeCCeeeEEEEeccCCchHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 009979 252 AEGAHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN 319 (521)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~N 319 (521)
.+....|+||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N 233 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 233 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchhh
Confidence 999999999999999999999986532 124689999999999999999999999 99999999999
Q ss_pred eEeCCCCCceEeecccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 009979 320 ILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPG 397 (521)
Q Consensus 320 ILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~ 397 (521)
||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~- 312 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE- 312 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 99999999999999999976543322 2234567899999999999999999999999999999999 99999754321
Q ss_pred cccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 398 EVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.... . +..... +.. ...++.. +.+++.+||+.||++||++.|+++.|+..
T Consensus 313 --~~~~---~-~~~~~~-----~~~-~~~~~~~---l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 313 --ELFK---L-LKEGHR-----MDK-PANCTNE---LYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp --GHHH---H-HHTTCC-----CCC-CTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHH---H-HhcCCC-----CCC-CCCCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2221 1 111110 111 1123333 44588899999999999999999999863
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=362.55 Aligned_cols=259 Identities=22% Similarity=0.375 Sum_probs=210.5
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
+++..++|++.+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|+++++.++||||+++++++.+....++|
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 19 WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp TBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 3567789999999999999999999998888999999875433 346788999999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 98 TEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp ECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred EeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 9999999999999764 34689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
...........||+.|+|||++.+..++.++||||||+++|||+| |+.||..... .+......... .
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~------~~~~~~~~~~~------~ 239 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------SETAEHIAQGL------R 239 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHHTTC------C
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh------hHHHHHHhccc------C
Confidence 433333334557889999999998899999999999999999998 9999964331 22222222111 0
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.. .....+. .+.+++.+||+.||.+|||+.++++.|+..
T Consensus 240 ~~-~~~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 240 LY-RPHLASE---KVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp CC-CCTTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC-CCCcCCH---HHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 11 1111233 344588899999999999999999999753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=368.60 Aligned_cols=258 Identities=28% Similarity=0.476 Sum_probs=207.6
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc----CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
+..++|.+.+.||+|+||.||+|.+. .+..||||.+... .....+.+.+|+++++.++||||+++++++.++...
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 44568999999999999999999974 3445999999764 334457799999999999999999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+++|+|.++++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 126 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 9999999999999999765 35799999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCcc--eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 338 LLGAERSY--VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 338 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... .+..........
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------~~~~~~~~~~~~- 272 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN------RDVISSVEEGYR- 272 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH------HHHHHHHHTTCC-
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH------HHHHHHHHcCCC-
Confidence 87543222 2233456889999999998999999999999999999999 9999964321 222222222111
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
... ...++.. +.+++.+||+.||++||++.+|++.|+..
T Consensus 273 -----~~~-~~~~~~~---l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 273 -----LPA-PMGCPHA---LHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp -----CCC-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCC-CCCcCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011 1123333 44588899999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=372.16 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=205.9
Q ss_pred cCCCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
..++|++.+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|+++|+.++||||+++++++......|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 345899999999999999999997 47899999998654 333456788999999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++...
T Consensus 93 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 9999999999999765 4689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcceeecccccccccccccccCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
... .....+||+.|+|||++.+..+. .++|||||||++|||++|+.||.... ..+..........
T Consensus 166 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~------ 231 (328)
T 3fe3_A 166 VGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------LKELRERVLRGKY------ 231 (328)
T ss_dssp SSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCC------
T ss_pred CCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCC------
Confidence 332 23456899999999999887765 78999999999999999999996432 2232333322111
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+.. ..+. .+.+++.+||+.||.+|||+.|++++
T Consensus 232 -~~p~-~~s~---~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 -RIPF-YMST---DCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -CCCT-TSCH---HHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -CCCC-CCCH---HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111 1223 34458889999999999999999753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=370.08 Aligned_cols=270 Identities=26% Similarity=0.376 Sum_probs=209.6
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC----ee
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA----HR 257 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~----~~ 257 (521)
.+..++|++.+.||+|+||+||+|.+. ++.||||++..... ....+..|+.++++++||||+++++++.... ..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 456678999999999999999999985 78999999865432 3345566999999999999999999998754 46
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CCCeeecCCCCCCeEeCCCCCceE
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL-------EPKVVHRDIKSSNILLDKQWNPKL 330 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-------~~~iiHrDik~~NILl~~~~~vkL 330 (521)
++||||+++|+|.++++.. .+++..++.++.|++.||+|||+.+ .++|+||||||+|||++.++.+||
T Consensus 98 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 9999999999999999764 5899999999999999999999751 338999999999999999999999
Q ss_pred eecccceecCCCCcc-eeecccccccccccccccC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcc-----
Q 009979 331 SDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV----- 399 (521)
Q Consensus 331 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~----- 399 (521)
+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.........
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 999999877543322 2334679999999999876 35667889999999999999999999765432221
Q ss_pred -----cHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 400 -----NLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 400 -----~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
....+ ............+...+.. ......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 253 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 253 IGQHPSLEDM-QEVVVHKKKRPVLRDYWQK---HAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp HCSSCCHHHH-HHHHTTSCCCCCCCGGGGS---SHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hccCCchhhh-hhhhhcccCCCCccccccc---cchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11122 2222222111222222222 23344566688899999999999999999999853
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=360.95 Aligned_cols=261 Identities=26% Similarity=0.415 Sum_probs=205.5
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
..++|++.+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 4568999999999999999999965 6889999998543 23344678899999999999999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
||||+++++|.+++... .++++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 89 v~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 99999999999999765 4789999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
............||+.|+|||.+.+..++.++|||||||++|||+||+.||.... ..+........... . ..
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~------~~~~~~~~~~~~~~-~-~~ 233 (294)
T 4eqm_A 162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET------AVSIAIKHIQDSVP-N-VT 233 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC------HHHHHHHHHSSCCC-C-HH
T ss_pred ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHhhccCC-C-cc
Confidence 5444344455679999999999999999999999999999999999999996432 12222222221100 0 00
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhhccC
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRP-KMGHVIHMLEAEE 463 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RP-t~~evl~~L~~~~ 463 (521)
.... ...+. .+.+++.+||+.||.+|| ++.++.+.|+...
T Consensus 234 ~~~~-~~~~~---~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 234 TDVR-KDIPQ---SLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHSC-TTSCH---HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred hhcc-cCCCH---HHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 0011 11233 344588899999999998 8999999998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=369.25 Aligned_cols=252 Identities=23% Similarity=0.266 Sum_probs=207.0
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
..++|++.+.||+|+||.||+|... +++.||+|.+.+.. ......+..|+++++.++||||+++++++.+....|+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 3468999999999999999999976 58899999996542 2344678889999999999999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 83 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 99999999999999765 4689999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.........
T Consensus 156 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~~~~------- 221 (337)
T 1o6l_A 156 ISD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HERLFELILMEE------- 221 (337)
T ss_dssp CCT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCC-------
T ss_pred ccC-CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC------HHHHHHHHHcCC-------
Confidence 322 223445789999999999999999999999999999999999999996432 222222222211
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHMLE 460 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~ 460 (521)
..+.. ..+. .+.+++.+||+.||++|| ++.+++++--
T Consensus 222 ~~~p~-~~s~---~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 222 IRFPR-TLSP---EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp CCCCT-TSCH---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred CCCCC-CCCH---HHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence 01111 1233 344588899999999999 8999986543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=387.45 Aligned_cols=263 Identities=24% Similarity=0.431 Sum_probs=215.1
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
...+++..++|.+.+.||+|+||.||+|.++++..||||++.... ...+.|.+|+++|+.++||||+++++++. ....
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 455688889999999999999999999999888899999987644 34678999999999999999999999987 5678
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+++|+|.++++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLAR 332 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred EEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence 99999999999999997541 23678899999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
..............+|+.|+|||++....++.++|||||||+||||+| |+.||.... ..+..........
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~------~~~~~~~i~~~~~--- 403 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS------NPEVIRALERGYR--- 403 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHHHHHHHHHTCC---
T ss_pred EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCCC---
Confidence 764332222233456889999999998999999999999999999999 999996432 2222222222111
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
. + ....++.. +.+++.+||+.||++|||+.+|++.|+...
T Consensus 404 ~--~--~~~~~~~~---l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 404 M--P--RPENCPEE---LYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp C--C--CCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred C--C--CCCCCCHH---HHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 0 0 11223444 445888999999999999999999998754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=368.88 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=205.8
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh------hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ------AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
.+.|.+.+.||+|+||.||+|... ++..||+|.+...... ..+.+.+|+.+|+.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 357999999999999999999976 5889999999754322 347789999999999999999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC----CceEeec
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW----NPKLSDF 333 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~----~vkL~DF 333 (521)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999754 5799999999999999999999999 999999999999998776 7999999
Q ss_pred ccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccc
Q 009979 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (521)
Q Consensus 334 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (521)
|+++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+.+.......
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~------~~~~~~~i~~~~- 234 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT------KQETLANITAVS- 234 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS------HHHHHHHHHTTC-
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhcC-
Confidence 9999765432 2345679999999999999999999999999999999999999996432 222222222111
Q ss_pred cccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 414 ~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.-.++.. .......+.+++.+||..||++|||+.|++++
T Consensus 235 --~~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 235 --YDFDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp --CCCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --CCCCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0011111 11112344558889999999999999999854
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=364.45 Aligned_cols=253 Identities=27% Similarity=0.386 Sum_probs=201.9
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
.++|++.+.||+|+||+||+|.+. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 358999999999999999999976 688999999865432 334668899999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 86 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 99999999998754 5689999999999999999999998 9999999999999999999999999999875422
Q ss_pred C-cceeecccccccccccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 343 R-SYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 343 ~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
. ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ... ...... ....
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~----~~~~~~---~~~~- 229 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYS----DWKEKK---TYLN- 229 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHH----HHHTTC---TTST-
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHH----HHhccc---ccCC-
Confidence 2 222345689999999999977765 7789999999999999999999975543211 111 111110 0111
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
+.......+.+++.+||+.||++|||+.|++++
T Consensus 230 -----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 -----PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 111222344558889999999999999999753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=357.71 Aligned_cols=261 Identities=25% Similarity=0.377 Sum_probs=202.6
Q ss_pred cCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhc--CCCCCeeeEEEEEeeC----Cee
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR--VRHKNLVRLLGYCAEG----AHR 257 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~hpniv~l~~~~~~~----~~~ 257 (521)
..++|++.+.||+|+||+||+|.+ +++.||||++... ....+..|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 346899999999999999999998 5889999998543 33455566777666 7999999999987543 457
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCCeEeCCCCCce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH--------EGLEPKVVHRDIKSSNILLDKQWNPK 329 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH--------~~~~~~iiHrDik~~NILl~~~~~vk 329 (521)
++||||+++|+|.++++. ..+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence 899999999999999954 36899999999999999999999 77 999999999999999999999
Q ss_pred EeecccceecCCCCcce---eecccccccccccccccCC------CCCCcccchhHHHHHHHHHhC----------CCCC
Q 009979 330 LSDFGLAKLLGAERSYV---TTRVMGTFGYVAPEYASTG------MLNERSDVYSFGILIMEVISG----------RNPV 390 (521)
Q Consensus 330 L~DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDvwS~Gvvl~elltG----------~~Pf 390 (521)
|+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||+|| +.||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999998764433222 2334799999999999776 455799999999999999999 7888
Q ss_pred CCCCCCCcccHHHHHHHHhhccccccCCCcccCCC-ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 391 DYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK-PCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
....+... .. ..+........ ..+.+... ........+.+++.+||+.||++|||+.+|++.|+..
T Consensus 234 ~~~~~~~~-~~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDP-SF-EDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSC-CH-HHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCc-ch-hhhhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 65433222 12 22222222111 11111111 1233455667799999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=358.97 Aligned_cols=265 Identities=22% Similarity=0.402 Sum_probs=206.0
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc-----CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC--C
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--A 255 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~ 255 (521)
+..++|++.+.||+|+||+||+|++. +++.||||++........+.+.+|+++++.++||||+++++++... .
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 44568999999999999999999852 5788999999877766778899999999999999999999998653 4
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred ceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 589999999999999999875 24689999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCcc--eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCC---------CCcccHHHH
Q 009979 336 AKLLGAERSY--VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP---------PGEVNLVEW 404 (521)
Q Consensus 336 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~---------~~~~~~~~~ 404 (521)
++........ ......||..|+|||.+.+..++.++||||||+++|||+||..||..... .........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 9876443221 22334578889999999999999999999999999999999999863210 001111111
Q ss_pred HHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 405 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
+......... .. ....++.. +.+++.+||+.||++|||+.++++.|+..
T Consensus 241 ~~~~~~~~~~-----~~-~~~~~~~~---l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 241 LIELLKNNGR-----LP-RPDGCPDE---IYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHHTTCC-----CC-CCTTCCHH---HHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhccCc-----CC-CCcCcCHH---HHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1122211110 00 11123343 44588899999999999999999999764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=376.42 Aligned_cols=261 Identities=25% Similarity=0.411 Sum_probs=211.0
Q ss_pred hhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 180 ELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
.+.+..++|.+.+.||+|+||.||+|.+. +++.||||.+.... ....+.|.+|+++|+.++||||+++++++.+....
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 34667789999999999999999999986 68899999987543 23345688899999999999999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+++|+|.++++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 188 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSR 261 (377)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence 9999999999999999764 34689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCccee-ecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 338 LLGAERSYVT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 338 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
.......... ....+++.|+|||.+.++.++.++|||||||++|||+| |..||..... .+ +...+.....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~------~~-~~~~~~~~~~- 333 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN------QQ-TREFVEKGGR- 333 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH------HH-HHHHHHTTCC-
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHHcCCC-
Confidence 7543221111 12345788999999998999999999999999999999 9999964431 11 1222221110
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
. .. +..++.. +.+++.+||+.||++|||+.++++.|+..
T Consensus 334 -~---~~-~~~~~~~---l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 334 -L---PC-PELCPDA---VFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp -C---CC-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -C---CC-CCCCCHH---HHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 0 01 1223444 44588899999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=358.69 Aligned_cols=247 Identities=26% Similarity=0.352 Sum_probs=205.9
Q ss_pred ccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
|...+.||+|+||.||+|... +|+.||||++........+.+.+|+.+++.++||||+++++++......++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 677889999999999999976 6899999999776666677899999999999999999999999999999999999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 127 ~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~ 197 (321)
T 2c30_A 127 GALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-K 197 (321)
T ss_dssp CBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred CCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-c
Confidence 999999864 3689999999999999999999998 999999999999999999999999999987654322 2
Q ss_pred eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCC-C
Q 009979 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE-K 425 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~ 425 (521)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ ..+.+.. .
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~------~~~~~~~~~ 265 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS------PVQAMKRLRDS------PPPKLKNSH 265 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHS------SCCCCTTGG
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhcC------CCCCcCccc
Confidence 345679999999999999999999999999999999999999996432 12222222211 1111111 1
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 426 PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 426 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
..+. .+.+++.+||+.||++|||+.+++++
T Consensus 266 ~~~~---~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 266 KVSP---VLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp GSCH---HHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223 34458889999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=361.68 Aligned_cols=263 Identities=20% Similarity=0.307 Sum_probs=203.6
Q ss_pred cCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
..++|++.+.||+|+||+||+|.+.+++.||+|++..... .....+.+|+++++.++||||+++++++.++...++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 4568999999999999999999998899999999865432 23467889999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++ +|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 99 e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCSE-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCCC-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99975 888888765 35689999999999999999999999 999999999999999999999999999997643
Q ss_pred CCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC---
Q 009979 342 ERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV--- 417 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 417 (521)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+............
T Consensus 172 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 172 PVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGG
T ss_pred Ccc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhh
Confidence 322 2344578999999999876 5689999999999999999999999976543322 2222221111100000
Q ss_pred ---------CCcccCCCc----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 418 ---------LDPRLQEKP----CSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 418 ---------~d~~l~~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
....+...+ .+....++.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000000 0112234566888999999999999999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=391.53 Aligned_cols=264 Identities=23% Similarity=0.416 Sum_probs=217.1
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 256 (521)
+..+++..++|++.+.||+|+||.||+|.+.. +..||||.+.... ...+.|.+|+++|++++||||++++++|.+...
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 45567778899999999999999999999874 7889999987543 345789999999999999999999999999999
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.+|||||+++|+|.++++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred EEEEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccc
Confidence 999999999999999998652 35689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
+..............+|+.|+|||++.+..++.++|||||||+||||+| |..||...... ...+. +....
T Consensus 366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~-- 436 (495)
T 1opk_A 366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYEL----LEKDY-- 436 (495)
T ss_dssp ECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH----HHTTC--
T ss_pred eeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCC--
Confidence 9765433333334456789999999999999999999999999999999 99999754322 22221 11110
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
... ....++.. +.+++.+||+.||++|||+.+|++.|+...
T Consensus 437 ---~~~-~~~~~~~~---l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 ---RME-RPEGCPEK---VYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ---CCC-CCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ---CCC-CCCCCCHH---HHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 001 11223444 445888999999999999999999998754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=353.78 Aligned_cols=278 Identities=36% Similarity=0.660 Sum_probs=221.3
Q ss_pred cchhhhhhcCCCcccc------ceEccCCcEEEEEEEEcCCcEEEEEEeccCC----hhhHHHHHHHHHHHhcCCCCCee
Q 009979 176 YTLRELEVSTNGFADE------NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVRHKNLV 245 (521)
Q Consensus 176 ~~~~~~~~~~~~~~~~------~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~hpniv 245 (521)
|++.++...++.|... +.||+|+||.||+|.+ +++.||+|++.... ....+.+.+|+++++.++||||+
T Consensus 15 ~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 93 (307)
T 2nru_A 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93 (307)
T ss_dssp CCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeE
Confidence 4566666666666655 8999999999999987 58899999986532 33457789999999999999999
Q ss_pred eEEEEEeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC
Q 009979 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ 325 (521)
Q Consensus 246 ~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~ 325 (521)
++++++.+....++||||+++++|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~ 169 (307)
T 2nru_A 94 ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEA 169 (307)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT
T ss_pred EEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCC
Confidence 99999999999999999999999999997542 235789999999999999999999998 99999999999999999
Q ss_pred CCceEeecccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHH
Q 009979 326 WNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEW 404 (521)
Q Consensus 326 ~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~ 404 (521)
+.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||.......... .+
T Consensus 170 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~ 246 (307)
T 2nru_A 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL--DI 246 (307)
T ss_dssp CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT--HH
T ss_pred CcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH--HH
Confidence 99999999999876543222 2334679999999998865 58999999999999999999999998655433221 11
Q ss_pred HHHHhh-ccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 405 LKTMVT-NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 405 ~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
...... .......+++.+.. ........+.+++.+||+.||.+|||+.+++++|+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSCSC-CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHhhhhhhhhhhhccccccc-cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 122111 11122333443332 2445566777899999999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=373.19 Aligned_cols=258 Identities=27% Similarity=0.481 Sum_probs=197.5
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc----CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
+..++|.+.+.||+|+||.||+|++. ++..||||.+... .....+.|.+|+.++++++||||+++++++.+....
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 44568999999999999999999864 4677999998754 334457799999999999999999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+++|+|.++++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 122 ~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp EEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 9999999999999999865 35789999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCcce--eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 338 LLGAERSYV--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 338 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
......... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... ..+...........
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~------~~~~~~~i~~~~~~ 269 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS------NQDVIKAVDEGYRL 269 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC------HHHHHHHHHTTEEC
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCCCC
Confidence 765432221 222345788999999999999999999999999999998 999996432 12222222211110
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
+ ....++. .+.+++.+||+.||++||++.+|++.|+..
T Consensus 270 -----~--~~~~~~~---~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 270 -----P--PPMDCPA---ALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp -----C--CCTTCBH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----C--CCccccH---HHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 0 0111333 345588899999999999999999999865
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=372.39 Aligned_cols=251 Identities=20% Similarity=0.275 Sum_probs=190.5
Q ss_pred Ccccc-ceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHH-hcCCCCCeeeEEEEEee----CCeeeE
Q 009979 187 GFADE-NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAI-GRVRHKNLVRLLGYCAE----GAHRML 259 (521)
Q Consensus 187 ~~~~~-~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l-~~l~hpniv~l~~~~~~----~~~~~l 259 (521)
+|.+. +.||+|+||+||+|.+. +++.||||++... ..+.+|++++ +..+||||+++++++.. ....||
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 56655 78999999999999976 5888999998532 4566788887 45589999999999875 567899
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---CCCceEeecccc
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFGLA 336 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~---~~~vkL~DFGla 336 (521)
|||||++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||++
T Consensus 137 v~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999998652 34699999999999999999999998 9999999999999987 788999999999
Q ss_pred eecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcc-cHHHHHHHHhhccccc
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV-NLVEWLKTMVTNRNAE 415 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~ 415 (521)
+...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+. ....
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~- 284 (400)
T 1nxk_A 212 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQY- 284 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCC-
T ss_pred cccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCcc-
Confidence 8754322 234568999999999999999999999999999999999999999765433211 1111111 1110
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
....+. ....+. .+.+++.+||+.||++|||+.+++++-
T Consensus 285 ~~~~~~--~~~~s~---~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 285 EFPNPE--WSEVSE---EVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp CCCTTT--TTTSCH---HHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred cCCCcc--cccCCH---HHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 001111 111233 345588899999999999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=379.94 Aligned_cols=266 Identities=22% Similarity=0.281 Sum_probs=213.5
Q ss_pred chhhhhhcCCCccccceEccCCcEEEEEEEEcC-CcEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCCeeeEEEEEe
Q 009979 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252 (521)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~ 252 (521)
.++++++..++|++.++||+|+||+||+|++.+ ++.||+|++.+... .....+..|+.++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 366677888999999999999999999999864 77899999865322 12234888999999999999999999999
Q ss_pred eCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEee
Q 009979 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (521)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~D 332 (521)
+....|||||||++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||||+.++++||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 999999999999999999999864 35799999999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCcceeeccccccccccccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 009979 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407 (521)
Q Consensus 333 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 407 (521)
||+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+....
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~------~~~~~~~ 292 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGK 292 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC------hhHHHHh
Confidence 9999877655544455578999999999986 5679999999999999999999999996432 2222222
Q ss_pred HhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHhh
Q 009979 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHK--RPKMGHVIHMLE 460 (521)
Q Consensus 408 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~evl~~L~ 460 (521)
.+.... .+.-|... ...+.. +.+++.+||..+|++ ||++.|++++--
T Consensus 293 i~~~~~--~~~~p~~~-~~~s~~---~~dLi~~lL~~~~~r~~r~~~~eil~Hpf 341 (437)
T 4aw2_A 293 IMNHKE--RFQFPTQV-TDVSEN---AKDLIRRLICSREHRLGQNGIEDFKKHPF 341 (437)
T ss_dssp HHTHHH--HCCCCSSC-CCSCHH---HHHHHHTTSSCGGGCTTTTTTHHHHTSGG
T ss_pred hhhccc--cccCCccc-ccCCHH---HHHHHHHHhcccccccCCCCHHHHhCCCc
Confidence 222110 00011110 112333 445788999888888 999999986543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=375.69 Aligned_cols=266 Identities=21% Similarity=0.285 Sum_probs=213.8
Q ss_pred chhhhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEe
Q 009979 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252 (521)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~ 252 (521)
.++++++..++|++.++||+|+||.||+|++. +++.||+|++.+.. ....+.+..|+.+++.++||||++++++|.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 35667778889999999999999999999976 57889999986532 122345788999999999999999999999
Q ss_pred eCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEee
Q 009979 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (521)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~D 332 (521)
+....|||||||+||+|.++++.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEec
Confidence 999999999999999999999754 589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCcceeecccccccccccccccCCC----CCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH
Q 009979 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM----LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408 (521)
Q Consensus 333 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 408 (521)
||+++.............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ..+.....
T Consensus 212 FG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i 285 (410)
T 3v8s_A 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------LVGTYSKI 285 (410)
T ss_dssp CTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHH
T ss_pred cceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC------hhhHHHHH
Confidence 9999987655444445678999999999997655 8899999999999999999999996432 22223332
Q ss_pred hhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHhhccC
Q 009979 409 VTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHK--RPKMGHVIHMLEAEE 463 (521)
Q Consensus 409 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~evl~~L~~~~ 463 (521)
...... +.-|. ....+.. +.+|+.+||..+|.+ ||++.||+++---..
T Consensus 286 ~~~~~~--~~~p~--~~~~s~~---~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 286 MNHKNS--LTFPD--DNDISKE---AKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp HTHHHH--CCCCT--TCCCCHH---HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred Hhcccc--ccCCC--cccccHH---HHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 221110 00010 0112333 445888999999998 999999997654433
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=358.22 Aligned_cols=261 Identities=22% Similarity=0.381 Sum_probs=198.0
Q ss_pred hhhhhcCCCccccceEccCCcEEEEEEEEcC----CcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEee
Q 009979 179 RELEVSTNGFADENVIGEGGYGIVYHGVLED----NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253 (521)
Q Consensus 179 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~ 253 (521)
+++++..++|++.+.||+|+||.||+|.+.. +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 3446677899999999999999999999743 4469999886543 334567899999999999999999999985
Q ss_pred CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeec
Q 009979 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (521)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DF 333 (521)
++..++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 160 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF 160 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-
T ss_pred cCccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcc
Confidence 45689999999999999999865 34689999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhcc
Q 009979 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (521)
Q Consensus 334 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (521)
|+++..............+|+.|+|||.+.+..++.++|||||||++|||++ |..||...... .... ......
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~---~i~~~~ 234 (281)
T 1mp8_A 161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIG---RIENGE 234 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHH---HHHTTC
T ss_pred ccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHH---HHHcCC
Confidence 9998775544333444567889999999998999999999999999999997 99999754322 2221 111111
Q ss_pred ccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 413 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
. ..+. ..++.. +.+++.+||+.||++||++.++++.|+..
T Consensus 235 ~------~~~~-~~~~~~---l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 235 R------LPMP-PNCPPT---LYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp C------CCCC-TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C------CCCC-CCCCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 0111 123333 44588899999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=366.50 Aligned_cols=255 Identities=21% Similarity=0.332 Sum_probs=204.4
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-----GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
++|++.+.||+|+||+||+|.+. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 47899999999999999999975 68899999985422 2235778999999999999999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCC---ceEeecccc
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLA 336 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~---vkL~DFGla 336 (521)
|||||++|+|.+++.........+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999999988865433345689999999999999999999999 9999999999999976554 999999999
Q ss_pred eecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .+......... .
T Consensus 181 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~i~~~~-~-- 249 (351)
T 3c0i_A 181 IQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-------ERLFEGIIKGK-Y-- 249 (351)
T ss_dssp EECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-------HHHHHHHHHTC-C--
T ss_pred eEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-------HHHHHHHHcCC-C--
Confidence 8875432 22345679999999999999999999999999999999999999996431 11222222111 0
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
..++.. .......+.+++.+||+.||++|||+.+++++
T Consensus 250 ~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 250 KMNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CCCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 011100 01112345568889999999999999999853
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=352.59 Aligned_cols=258 Identities=26% Similarity=0.439 Sum_probs=212.4
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
.+..++|++.+.||+|+||.||+|.+.++..||+|.+..... ..+.+.+|+++++.++||||+++++++.+....++||
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 456678999999999999999999998888999999876543 3467899999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 83 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp CCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred eCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999999999865 35689999999999999999999999 999999999999999999999999999987644
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
..........||+.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+.......... ..
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~~~i~~~~~---~~-- 225 (267)
T 3t9t_A 157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDISTGFR---LY-- 225 (267)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTTCC---CC--
T ss_pred ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC------HHHHHHHHhcCCc---CC--
Confidence 33223334567889999999998899999999999999999999 899996432 2222222222110 01
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.....+.. +.+++.+||+.||++||++.++++.|+..
T Consensus 226 --~~~~~~~~---l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 226 --KPRLASTH---VYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp --CCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCccCcHH---HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11123333 44588899999999999999999999753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=356.43 Aligned_cols=274 Identities=21% Similarity=0.263 Sum_probs=213.9
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC--eeeE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA--HRML 259 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~--~~~l 259 (521)
..++|.+.+.||+|+||+||+|.+. +++.||||++.... ....+.+.+|+++++.++||||+++++++.... ..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 3457999999999999999999976 48899999987543 233567889999999999999999999998765 7799
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe----CCCCCceEeeccc
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL----DKQWNPKLSDFGL 335 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl----~~~~~vkL~DFGl 335 (521)
||||+++++|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 87 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 9999999999999986532 23489999999999999999999999 99999999999999 7888899999999
Q ss_pred ceecCCCCcceeeccccccccccccccc--------CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYAS--------TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 407 (521)
++....... .....||+.|+|||++. +..++.++|||||||++|||+||+.||........ ..+.+..
T Consensus 163 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~ 238 (319)
T 4euu_A 163 ARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYK 238 (319)
T ss_dssp CEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHH
T ss_pred ceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHH
Confidence 998654332 23457999999999885 57899999999999999999999999975433221 1222222
Q ss_pred Hhhcccc---cc---CCC------cc--cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 009979 408 MVTNRNA---EG---VLD------PR--LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 465 (521)
Q Consensus 408 ~~~~~~~---~~---~~d------~~--l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 465 (521)
....... .. ... +. ............+.+++.+||+.||++|||+.|+++..+....+
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 2221110 00 000 00 11122345555666789999999999999999999999876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=366.95 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=205.6
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
+..++|.+.+.||+|+||.||+|... +++.||+|++.+.. ......+.+|+++|+.++||||+++++++.+....|
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 44568999999999999999999976 47889999986532 233467888999999999999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+||||+.+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++.
T Consensus 92 lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAM 164 (384)
T ss_dssp EEECCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeee
Confidence 999999999999999864 5799999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCcceeecccccccccccccccC---CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 339 LGAERSYVTTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
+... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... ........
T Consensus 165 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~---~~~~~~~~--- 236 (384)
T 4fr4_A 165 LPRE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI---VHTFETTV--- 236 (384)
T ss_dssp CCTT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH---HHHHHHCC---
T ss_pred ccCC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH---HHHHhhcc---
Confidence 6433 23455789999999999863 4589999999999999999999999975543322222 22221110
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK-MGHVIHM 458 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt-~~evl~~ 458 (521)
..+. ...+. .+.+++.+||+.||.+||+ +.+++.+
T Consensus 237 ----~~~p-~~~s~---~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 237 ----VTYP-SAWSQ---EMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp ----CCCC-TTSCH---HHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred ----cCCC-CcCCH---HHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 0111 11233 4455888999999999998 7777653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=364.83 Aligned_cols=268 Identities=26% Similarity=0.386 Sum_probs=214.9
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEcC------CcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEE
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGY 250 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~ 250 (521)
+..+++..++|++.+.||+|+||.||+|.+.+ ++.||+|.+.... ....+.+.+|+++++.++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 44556778899999999999999999999752 3789999987643 3345779999999999999999999999
Q ss_pred EeeCCeeeEEEEeccCCchHHhhhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 009979 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGP--------------------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310 (521)
Q Consensus 251 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~al~~LH~~~~~~i 310 (521)
+.+....++||||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +|
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~i 195 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 195 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 99999999999999999999999864211 25789999999999999999999999 99
Q ss_pred eecCCCCCCeEeCCCCCceEeecccceecCCCCc-ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCC
Q 009979 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRN 388 (521)
Q Consensus 311 iHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~ 388 (521)
+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |..
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999987643322 22234568999999999998899999999999999999999 999
Q ss_pred CCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 009979 389 PVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 464 (521)
Q Consensus 389 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 464 (521)
||.... ..+...... ..... .+ ...++. .+.+++.+||+.||++||++.++++.|+....
T Consensus 276 p~~~~~------~~~~~~~~~-~~~~~-----~~-~~~~~~---~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 276 PYYGMA------HEEVIYYVR-DGNIL-----AC-PENCPL---ELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TTTTSC------HHHHHHHHH-TTCCC-----CC-CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCCCCC------hHHHHHHHh-CCCcC-----CC-CCCCCH---HHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 996432 122222222 21111 11 112333 34458889999999999999999999987543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=359.25 Aligned_cols=253 Identities=18% Similarity=0.274 Sum_probs=206.8
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
.++|.+.+.||+|+||.||+|.+. ++..||+|.+... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999976 5788999988654 33456788999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC--CCCceEeecccceecCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK--QWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~--~~~vkL~DFGla~~~~~ 341 (521)
+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 9999999999764 35789999999999999999999999 9999999999999987 78999999999998754
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+.+........ .
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~~~~-------~ 221 (321)
T 1tki_A 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET------NQQIIENIMNAEY-------T 221 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHTCC-------C
T ss_pred CC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC------HHHHHHHHHcCCC-------C
Confidence 32 2345679999999999999889999999999999999999999996432 2222232222110 0
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
+...........+.+++.+||+.||.+|||+.|++++-
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 00000111223455688899999999999999998743
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=381.77 Aligned_cols=263 Identities=27% Similarity=0.413 Sum_probs=208.6
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
...+++..++|++.+.||+|+||.||+|.+.++..||||++.... ...+.|.+|+++|++++||||+++++++.+ ...
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 445677888999999999999999999999888889999987644 335678999999999999999999999976 678
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+++|+|.++++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 328 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred EEEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccce
Confidence 99999999999999997531 24689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
..............+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+.+........
T Consensus 329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~------~~~~~~~i~~~~~--- 399 (452)
T 1fmk_A 329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------NREVLDQVERGYR--- 399 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHHHHHTTCC---
T ss_pred ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCCC---
Confidence 765433333334557889999999998999999999999999999999 999996432 2222222222111
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
... ...++.. +.+++.+||+.||++|||+.++++.|+...
T Consensus 400 ---~~~-~~~~~~~---l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 400 ---MPC-PPECPES---LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp ---CCC-CTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ---CCC-CCCCCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 001 1123444 445888999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=367.87 Aligned_cols=268 Identities=24% Similarity=0.358 Sum_probs=213.1
Q ss_pred chhhhhhcCCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCCeeeEE
Q 009979 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLL 248 (521)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~ 248 (521)
....+++..++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+++++++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 35667888899999999999999999999842 35689999997643 33446789999999999 799999999
Q ss_pred EEEeeCC-eeeEEEEeccCCchHHhhhcCCCC------------------------------------------------
Q 009979 249 GYCAEGA-HRMLVYEYIDNGNLEQWLHGDVGP------------------------------------------------ 279 (521)
Q Consensus 249 ~~~~~~~-~~~lV~e~~~~g~L~~~l~~~~~~------------------------------------------------ 279 (521)
+++.+.. ..++||||+++|+|.++++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998755 489999999999999999865321
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc-
Q 009979 280 --------------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS- 344 (521)
Q Consensus 280 --------------~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~- 344 (521)
...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 12289999999999999999999999 999999999999999999999999999987644322
Q ss_pred ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||....... .+...+..... ....
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~-----~~~~ 318 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTR-----MRAP 318 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCC-----CCCC
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCCC-----CCCC
Confidence 23345678999999999999999999999999999999998 999997544321 11112211111 0111
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
...+. .+.+++.+||+.||.+|||+.+++++|+..
T Consensus 319 -~~~~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 319 -DYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp -TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCH---HHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 11233 344588899999999999999999999753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=369.46 Aligned_cols=263 Identities=25% Similarity=0.421 Sum_probs=212.9
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEc--------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCCeeeEEEE
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLE--------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGY 250 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~ 250 (521)
+++..++|.+.+.||+|+||.||+|.+. .+..||+|++.... ......+.+|+++++.+ +||||++++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 3566779999999999999999999863 23579999987653 33447788999999999 89999999999
Q ss_pred EeeCCeeeEEEEeccCCchHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 009979 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318 (521)
Q Consensus 251 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~ 318 (521)
+.+....++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 220 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 220 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcc
Confidence 9999999999999999999999987532 124699999999999999999999999 9999999999
Q ss_pred CeEeCCCCCceEeecccceecCCCCc-ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCC
Q 009979 319 NILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPP 396 (521)
Q Consensus 319 NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~ 396 (521)
|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~-- 298 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-- 298 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC--
Confidence 99999999999999999987644322 22334567899999999999999999999999999999999 999996432
Q ss_pred CcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 397 GEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
..+.......... ... ...++.. +.+++.+||+.||++|||+.+|++.|+..
T Consensus 299 ----~~~~~~~~~~~~~------~~~-~~~~~~~---l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 299 ----VEELFKLLKEGHR------MDK-PSNCTNE---LYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp ----HHHHHHHHHTTCC------CCC-CSSCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHHHcCCC------CCC-CccCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2222222222111 111 1123333 44588899999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=364.60 Aligned_cols=254 Identities=22% Similarity=0.320 Sum_probs=190.1
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
+...++|++.+.||+|+||.||+|.+. +++.||||++.... ..+.+.+|+++++.++||||+++++++.+....++|
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 445568999999999999999999986 47789999987543 346688899999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---CCCceEeecccce
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFGLAK 337 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~---~~~vkL~DFGla~ 337 (521)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++
T Consensus 127 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 127 LELVTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp ECCCCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 9999999999999764 4689999999999999999999998 9999999999999975 8899999999998
Q ss_pred ecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+...... .. ..
T Consensus 200 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~i~~~-~~-~~ 270 (349)
T 2w4o_A 200 IVEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-----QFMFRRILNC-EY-YF 270 (349)
T ss_dssp ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-----HHHHHHHHTT-CC-CC
T ss_pred ccCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-----HHHHHHHHhC-CC-cc
Confidence 75432 2234567999999999999999999999999999999999999999644321 1112222221 11 11
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
..+. .......+.+++.+||+.||++|||+.+++++
T Consensus 271 ~~~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 271 ISPW-----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CTTT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCch-----hhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 11122344558889999999999999999863
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=368.04 Aligned_cols=267 Identities=17% Similarity=0.228 Sum_probs=206.1
Q ss_pred hcCCCccccceEccCCcEEEEEEEEcC------CcEEEEEEeccCChhhH-----------HHHHHHHHHHhcCCCCCee
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNRGQAE-----------KEFKVEVEAIGRVRHKNLV 245 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~Ei~~l~~l~hpniv 245 (521)
...++|.+.+.||+|+||.||+|.+.. ++.||||.+........ ..+..|+..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 456689999999999999999999764 36799999876543221 2233466677888999999
Q ss_pred eEEEEEeeC----CeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeE
Q 009979 246 RLLGYCAEG----AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321 (521)
Q Consensus 246 ~l~~~~~~~----~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NIL 321 (521)
++++++... ...+|||||+ +++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nil 184 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLL 184 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEE
Confidence 999998764 4579999999 99999999875 35799999999999999999999999 9999999999999
Q ss_pred eC--CCCCceEeecccceecCCCCcce------eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 009979 322 LD--KQWNPKLSDFGLAKLLGAERSYV------TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393 (521)
Q Consensus 322 l~--~~~~vkL~DFGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~ 393 (521)
++ .++.+||+|||+++.+....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 98 88999999999998764332211 13355999999999999999999999999999999999999999753
Q ss_pred CCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 394 RPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
... ........... ......++++.+....++..+. +++.+||+.||.+||++.+|++.|+..
T Consensus 265 ~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~---~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 265 LKD--PKYVRDSKIRY-RENIASLMDKCFPAANAPGEIA---KYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp TTC--HHHHHHHHHHH-HHCHHHHHHHHSCTTCCCHHHH---HHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccC--HHHHHHHHHHh-hhhHHHHHHHhcccccCHHHHH---HHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 322 11121111111 1112233333333333444444 477799999999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=368.97 Aligned_cols=252 Identities=20% Similarity=0.288 Sum_probs=200.7
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCee
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~ 257 (521)
+..++|++.+.||+|+||.||+|++. +++.||||++.+.. ....+.+..|+.+++.+ +||||+++++++.+....
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34568999999999999999999976 58899999997542 23346678899999988 699999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
|+||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++
T Consensus 100 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence 9999999999999999765 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... .
T Consensus 173 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~~i~~~~----~ 241 (353)
T 3txo_A 173 EGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN------EDDLFEAILNDE----V 241 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCC----C
T ss_pred ecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC------HHHHHHHHHcCC----C
Confidence 54322 223445789999999999999899999999999999999999999996432 222333333211 1
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHHh
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM------GHVIHML 459 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~------~evl~~L 459 (521)
.+.. ..+. .+.+++.+||+.||++||++ .+++++-
T Consensus 242 ---~~p~-~~~~---~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 242 ---VYPT-WLHE---DATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp ---CCCT-TSCH---HHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred ---CCCC-CCCH---HHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 1111 1223 34458889999999999998 7777543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=362.48 Aligned_cols=259 Identities=16% Similarity=0.177 Sum_probs=208.6
Q ss_pred CCCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeEEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e 262 (521)
.++|++.+.||+|+||.||+|.. .+++.||||.+..... .+.+..|+++++.+ +||||+++++++..+...++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999996 4688999998865432 34588899999999 99999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCC-----ceEeecccce
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN-----PKLSDFGLAK 337 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~-----vkL~DFGla~ 337 (521)
|+ +++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 89999999865 35799999999999999999999999 9999999999999998887 9999999999
Q ss_pred ecCCCCcc------eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhc
Q 009979 338 LLGAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN 411 (521)
Q Consensus 338 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (521)
.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 76443221 124568999999999999999999999999999999999999999866543332222222211110
Q ss_pred cccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 412 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
... ..+ ...++ .+.+++.+||+.||.+||++.+|++.|+..
T Consensus 239 ~~~-----~~~-~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 239 TPI-----EVL-CENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp SCH-----HHH-TTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCH-----HHH-hccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 000 000 01122 455688899999999999999999998753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=366.07 Aligned_cols=252 Identities=21% Similarity=0.286 Sum_probs=206.8
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
++|++.+.||+|+||.||+|... +++.||+|.+..........+.+|+++|+.++||||+++++++.+....++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 47999999999999999999976 58889999987766556678899999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC--CCCCceEeecccceecCCC
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD--KQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~--~~~~vkL~DFGla~~~~~~ 342 (521)
++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||+++.....
T Consensus 131 ~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 131 SGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999764 34789999999999999999999999 999999999999997 4577999999999987543
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+........ ..++..
T Consensus 205 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~------~~~~~~~i~~~~~---~~~~~~ 273 (387)
T 1kob_A 205 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED------DLETLQNVKRCDW---EFDEDA 273 (387)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS------HHHHHHHHHHCCC---CCCSST
T ss_pred cc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCC---CCCccc
Confidence 32 334579999999999999999999999999999999999999996432 1222222222110 011111
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
. ...+ ..+.+++.+||+.||++|||+.+++++
T Consensus 274 ~-~~~s---~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 274 F-SSVS---PEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp T-TTSC---HHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred c-ccCC---HHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1 1123 344558889999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=358.64 Aligned_cols=252 Identities=22% Similarity=0.312 Sum_probs=205.0
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh------hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ------AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
++|.+.+.||+|+||.||+|... ++..||+|.+...... ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46899999999999999999976 5889999998654322 3577899999999999999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC----CceEeecc
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW----NPKLSDFG 334 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~----~vkL~DFG 334 (521)
+||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999754 5789999999999999999999998 999999999999998877 79999999
Q ss_pred cceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..+.+.......
T Consensus 164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~~~~~~-- 233 (326)
T 2y0a_A 164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT------KQETLANVSAVN-- 233 (326)
T ss_dssp TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS------HHHHHHHHHHTC--
T ss_pred CCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC------HHHHHHHHHhcC--
Confidence 999764332 2344679999999999999999999999999999999999999996432 122222222110
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
..+...........+.+++.+||+.||++|||+.+++++-
T Consensus 234 -----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 234 -----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp -----CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred -----CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 0011000111123345588899999999999999998753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=377.99 Aligned_cols=256 Identities=28% Similarity=0.410 Sum_probs=208.7
Q ss_pred hhhhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC-ee
Q 009979 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA-HR 257 (521)
Q Consensus 179 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~-~~ 257 (521)
..+++..++|++.+.||+|+||.||+|.+. ++.||||.+.... ..+.|.+|+++|++++||||+++++++.+.. ..
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence 445677889999999999999999999985 7899999997643 4578999999999999999999999987665 78
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+++|+|.++++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 337 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 337 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence 99999999999999998752 24578999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
..... .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||....... .. ..... +.
T Consensus 338 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~---~~i~~-~~--- 403 (450)
T 1k9a_A 338 EASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV---PRVEK-GY--- 403 (450)
T ss_dssp ECC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HH---HHHHT-TC---
T ss_pred ccccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HHHHc-CC---
Confidence 64322 223367899999999999999999999999999999999 999997554322 11 11111 11
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
... .+..++..+ .+++.+||+.||++|||+.++++.|+..
T Consensus 404 --~~~-~p~~~~~~l---~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 404 --KMD-APDGCPPAV---YDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp --CCC-CCTTCCHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCC-CCCcCCHHH---HHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 011 112244444 4488899999999999999999999753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=361.30 Aligned_cols=248 Identities=25% Similarity=0.285 Sum_probs=192.9
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCee
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~ 257 (521)
++..++|++.++||+|+||+||+|.+. +++.||||++..... .....+..|+..+..+ +||||++++++|.++...
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 344468999999999999999999986 689999999865422 2233444455555544 899999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+ +++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 133 ~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~ 205 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLV 205 (311)
T ss_dssp EEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred EEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeee
Confidence 9999999 66999988765 35799999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
...... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+... .. ...... ..
T Consensus 206 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------~~---~~~~~~-----~~ 268 (311)
T 3p1a_A 206 ELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------EG---WQQLRQ-----GY 268 (311)
T ss_dssp ECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------HH---HHHHTT-----TC
T ss_pred ecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------cH---HHHHhc-----cC
Confidence 764332 2344579999999999876 7899999999999999999997765321 11 111111 11
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
..+.+. ......+.+++.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 269 LPPEFT----AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccc----cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111111 112234556888999999999999999985
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=365.88 Aligned_cols=252 Identities=19% Similarity=0.308 Sum_probs=204.1
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
.++|++.+.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+++++.++||||+++++++.+....|+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999975 58899999996543 234467889999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC---CCceEeeccccee
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ---WNPKLSDFGLAKL 338 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~---~~vkL~DFGla~~ 338 (521)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||+++.
T Consensus 108 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp CCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999998754 5689999999999999999999999 99999999999999765 4599999999987
Q ss_pred cCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCC
Q 009979 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (521)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (521)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..+........ ..
T Consensus 181 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~------~~~~~~~i~~~-~~---- 247 (362)
T 2bdw_A 181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED------QHRLYAQIKAG-AY---- 247 (362)
T ss_dssp CTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHT-CC----
T ss_pred ecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhC-CC----
Confidence 64332 2345679999999999999999999999999999999999999996432 12222222211 10
Q ss_pred CcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 419 d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
+ +...........+.+++.+||+.||++||++.+++++
T Consensus 248 ~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 248 D--YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp C--CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred C--CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0111111122344558889999999999999999854
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=347.86 Aligned_cols=256 Identities=28% Similarity=0.498 Sum_probs=195.6
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCCh----hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG----QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
++..++|++.+.||+|+||.||+|.+. ++.||+|.+..... ...+.+.+|+++++.++||||+++++++.++...
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 445678999999999999999999985 88999999865432 2346788999999999999999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC--------CCCce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK--------QWNPK 329 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~--------~~~vk 329 (521)
++||||+++++|.+++.. ..+++..++.++.|++.||+|||+....+|+||||||+|||++. ++.+|
T Consensus 82 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp EEEEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred EEEEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceE
Confidence 999999999999999864 46899999999999999999999981112999999999999986 77899
Q ss_pred EeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHh
Q 009979 330 LSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409 (521)
Q Consensus 330 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 409 (521)
|+|||+++...... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ........
T Consensus 157 l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~ 227 (271)
T 3dtc_A 157 ITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------LAVAYGVA 227 (271)
T ss_dssp ECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHH
T ss_pred EccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHhhh
Confidence 99999998654322 2245799999999999999999999999999999999999999964321 11112222
Q ss_pred hccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 410 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
.... ..... ..++.. +.+++.+||+.||.+|||+.+++++|+.
T Consensus 228 ~~~~-----~~~~~-~~~~~~---~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 228 MNKL-----ALPIP-STCPEP---FAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp TSCC-----CCCCC-TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred cCCC-----CCCCC-cccCHH---HHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111 11111 123333 4458889999999999999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=357.18 Aligned_cols=263 Identities=24% Similarity=0.433 Sum_probs=217.9
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 256 (521)
++++++..++|++.+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|+++++.++||||+++++++.+...
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45667788899999999999999999999864 7789999986543 345778899999999999999999999999999
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.++||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred EEEEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccc
Confidence 999999999999999998752 35689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
...............||+.|+|||++.+..++.++||||||+++|+|++ |..||...... ...+.+. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~~---~~---- 228 (288)
T 3kfa_A 159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLE---KD---- 228 (288)
T ss_dssp GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHH---TT----
T ss_pred eeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh---cc----
Confidence 8776554444455668899999999998999999999999999999999 99999754322 2222111 11
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
..... ...++. .+.+++.+||+.||.+||++.++++.|+..
T Consensus 229 --~~~~~-~~~~~~---~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 229 --YRMER-PEGCPE---KVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp --CCCCC-CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCC-CCCCCH---HHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 01111 112333 344588899999999999999999999764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=360.76 Aligned_cols=265 Identities=28% Similarity=0.440 Sum_probs=213.3
Q ss_pred hhhhhcCCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEE
Q 009979 179 RELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251 (521)
Q Consensus 179 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~ 251 (521)
..+++..++|.+.+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+++++.++||||+++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 345667789999999999999999999862 34789999987543 34457788999999999999999999999
Q ss_pred eeCCeeeEEEEeccCCchHHhhhcCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 009979 252 AEGAHRMLVYEYIDNGNLEQWLHGDVG--------------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311 (521)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ii 311 (521)
.+....++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iv 172 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLV 172 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCc
Confidence 999999999999999999999986532 123488999999999999999999999 999
Q ss_pred ecCCCCCCeEeCCCCCceEeecccceecCCCCcce-eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCC
Q 009979 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNP 389 (521)
Q Consensus 312 HrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~P 389 (521)
||||||+|||++.++.+||+|||+++......... .....||+.|+|||.+.+..++.++|||||||++|||+| |..|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998765433322 234567889999999999999999999999999999999 9999
Q ss_pred CCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 390 VDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 390 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
|...... ..... +.... .+... ..++. .+.+++.+||+.||++||++.++++.|+..
T Consensus 253 ~~~~~~~---~~~~~----~~~~~-----~~~~~-~~~~~---~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 253 YPGIPPE---RLFNL----LKTGH-----RMERP-DNCSE---EMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp STTCCGG---GHHHH----HHTTC-----CCCCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCHH---HHHHH----hhcCC-----cCCCC-ccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 9754432 22211 11111 01111 11333 344588899999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=352.81 Aligned_cols=261 Identities=26% Similarity=0.442 Sum_probs=213.1
Q ss_pred hhhhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 179 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
+++++..++|++.+.||+|+||.||+|.+.++..||+|.+.... ...+.+..|+++++.++||||+++++++.+ +..+
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 83 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence 46678888999999999999999999999888899999986543 335678999999999999999999999875 5589
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++..
T Consensus 84 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp EEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 9999999999999997531 13689999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... .+.........
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~~----- 227 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLERGY----- 227 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTC-----
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH------HHHHHHHhccc-----
Confidence 75543333344567889999999998899999999999999999999 9999964321 22222222111
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
... ....++.. +.+++.+||+.||++|||+.++++.|+..
T Consensus 228 -~~~-~~~~~~~~---l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 228 -RMV-RPDNCPEE---LYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp -CCC-CCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCC-CcccccHH---HHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 011 11123333 44588899999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=370.21 Aligned_cols=262 Identities=26% Similarity=0.412 Sum_probs=209.1
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~ 254 (521)
++..++|++.+.||+|+||.||+|.+. ++..||||++... .......+..|+.+++.++||||+++++++.+.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345568999999999999999999953 3567999998654 344456788999999999999999999999999
Q ss_pred CeeeEEEEeccCCchHHhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC---Cc
Q 009979 255 AHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW---NP 328 (521)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~---~v 328 (521)
...++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceE
Confidence 999999999999999999976532 235689999999999999999999999 999999999999998554 59
Q ss_pred eEeecccceecCCCC-cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 009979 329 KLSDFGLAKLLGAER-SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLK 406 (521)
Q Consensus 329 kL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~ 406 (521)
||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||+| |..||.... ..+...
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~------~~~~~~ 297 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS------NQEVLE 297 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHHHHH
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHH
Confidence 999999998653221 122334568999999999999999999999999999999998 999996432 222222
Q ss_pred HHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 407 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
....... . .. ...++.. +.+++.+||+.||++||++.+|++.|+..
T Consensus 298 ~i~~~~~----~--~~-~~~~~~~---l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 298 FVTSGGR----M--DP-PKNCPGP---VYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HHHTTCC----C--CC-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHcCCC----C--CC-CccCCHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2222111 0 01 1123333 44588899999999999999999999764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=369.37 Aligned_cols=258 Identities=23% Similarity=0.319 Sum_probs=203.2
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeee
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~ 258 (521)
..++|++.++||+|+||.||+|++. +++.||+|++.+.. ....+.+..|..++.++ +||||+++++++.+....|
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3457999999999999999999976 47789999997542 22335578899999887 8999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
|||||+++|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+||||+.++++||+|||+++.
T Consensus 130 lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 999999999999999865 4689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCc--ccHHHHHHHHhhcccccc
Q 009979 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE--VNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~ 416 (521)
.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+..+.+...+.....
T Consensus 203 ~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-- 279 (396)
T 4dc2_A 203 GLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-- 279 (396)
T ss_dssp CCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--
T ss_pred cccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--
Confidence 3222 2234557899999999999999999999999999999999999999975432111 1111222222222111
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHHh
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM------GHVIHML 459 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~------~evl~~L 459 (521)
.+... .+. .+.+++.+||+.||++||++ .+|+++-
T Consensus 280 ----~~p~~-~s~---~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hp 320 (396)
T 4dc2_A 280 ----RIPRS-LSV---KAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320 (396)
T ss_dssp ----CCCTT-SCH---HHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHST
T ss_pred ----CCCCc-CCH---HHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCc
Confidence 11111 223 34558889999999999985 5665443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=351.87 Aligned_cols=262 Identities=17% Similarity=0.207 Sum_probs=210.6
Q ss_pred hcCCCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeEE
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV 260 (521)
+..++|++.+.||+|+||.||+|.. .+++.||+|.+.... ..+.+.+|+.+++.+ +|+|++++++++.+....++|
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 4456899999999999999999996 468899999886432 334578899999999 799999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCC-----ceEeeccc
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN-----PKLSDFGL 335 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~-----vkL~DFGl 335 (521)
|||+ +++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 85 ~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999 89999999865 34699999999999999999999998 9999999999999987766 99999999
Q ss_pred ceecCCCCcc------eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHh
Q 009979 336 AKLLGAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409 (521)
Q Consensus 336 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 409 (521)
++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence 9976543221 2345679999999999999999999999999999999999999998765443333332222211
Q ss_pred hccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 410 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
...... .+. ..++. .+.+++.+||+.||++||++.+|++.|+..
T Consensus 238 ~~~~~~-----~~~-~~~~~---~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 238 QSTPLR-----ELC-AGFPE---EFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HHSCHH-----HHT-TTSCH---HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cCccHH-----HHH-hhCcH---HHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 111000 000 11233 445588899999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=372.52 Aligned_cols=253 Identities=20% Similarity=0.275 Sum_probs=203.7
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
.++|++.+.||+|+||+||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++.++...|+||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 347899999999999999999965 688899999876542 33467889999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC---CCCCceEeeccccee
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD---KQWNPKLSDFGLAKL 338 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~---~~~~vkL~DFGla~~ 338 (521)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++ +++.+||+|||+++.
T Consensus 90 E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 90 DLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp CCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999999865 5699999999999999999999999 999999999999998 567899999999987
Q ss_pred cCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCC
Q 009979 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (521)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (521)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+........ .. ...
T Consensus 163 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~-~~-~~~ 233 (444)
T 3soa_A 163 VEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED------QHRLYQQIKAG-AY-DFP 233 (444)
T ss_dssp CCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHT-CC-CCC
T ss_pred ecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHhC-CC-CCC
Confidence 64432 22345679999999999999999999999999999999999999996432 12222222221 11 111
Q ss_pred CcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 419 d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+.. ...+. .+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~--~~~s~---~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 234 SPEW--DTVTP---EAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TTTT--TTSCH---HHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccc--ccCCH---HHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1111 11233 34458889999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=350.55 Aligned_cols=254 Identities=28% Similarity=0.557 Sum_probs=203.4
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhh-------HHHHHHHHHHHhcCCCCCeeeEEEEEeeC
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQA-------EKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~Ei~~l~~l~hpniv~l~~~~~~~ 254 (521)
+..++|++.+.||+|+||.||+|.+. +++.||+|++....... .+.+.+|+++++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 34578999999999999999999975 68899999986543221 16788999999999999999999999766
Q ss_pred CeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeEeCCCCC-----
Q 009979 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK--VVHRDIKSSNILLDKQWN----- 327 (521)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~--iiHrDik~~NILl~~~~~----- 327 (521)
. ++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. + |+||||||+|||++.++.
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred C--eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCcee
Confidence 5 7999999999999988765 35799999999999999999999998 8 999999999999988776
Q ss_pred ceEeecccceecCCCCcceeecccccccccccccc--cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 009979 328 PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA--STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL 405 (521)
Q Consensus 328 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~ 405 (521)
+||+|||+++.... ......||+.|+|||++ ....++.++|||||||++|||++|+.||...... .....
T Consensus 168 ~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~ 239 (287)
T 4f0f_A 168 AKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG----KIKFI 239 (287)
T ss_dssp EEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC----HHHHH
T ss_pred EEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc----HHHHH
Confidence 99999999985432 23456799999999998 4556889999999999999999999999754432 11112
Q ss_pred HHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 406 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
....... ..+.+.. .++.. +.+++.+||+.||++|||+.++++.|+.
T Consensus 240 ~~~~~~~-----~~~~~~~-~~~~~---l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 240 NMIREEG-----LRPTIPE-DCPPR---LRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHSC-----CCCCCCT-TSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHhccC-----CCCCCCc-ccCHH---HHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 2222111 1111211 13333 4458889999999999999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=352.78 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=195.5
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh--------------------------hHHHHHHHHHHHh
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ--------------------------AEKEFKVEVEAIG 237 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~Ei~~l~ 237 (521)
.++|++.+.||+|+||.||+|.+. +++.||||++...... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999975 5788999998654311 1356888999999
Q ss_pred cCCCCCeeeEEEEEee--CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 009979 238 RVRHKNLVRLLGYCAE--GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDI 315 (521)
Q Consensus 238 ~l~hpniv~l~~~~~~--~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDi 315 (521)
.++||||+++++++.+ ....++||||+++++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999986 5688999999999999886543 4789999999999999999999999 9999999
Q ss_pred CCCCeEeCCCCCceEeecccceecCCCCcceeecccccccccccccccCCC---CCCcccchhHHHHHHHHHhCCCCCCC
Q 009979 316 KSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEVISGRNPVDY 392 (521)
Q Consensus 316 k~~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwS~Gvvl~elltG~~Pf~~ 392 (521)
||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654332 234567999999999997655 47789999999999999999999964
Q ss_pred CCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 393 SRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.. .......... .... .+. ....+.. +.+++.+||+.||++||++.|+++
T Consensus 243 ~~------~~~~~~~~~~-~~~~---~~~--~~~~~~~---l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ER------IMCLHSKIKS-QALE---FPD--QPDIAED---LKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SS------HHHHHHHHHH-CCCC---CCS--SSCCCHH---HHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cc------HHHHHHHHhc-ccCC---CCC--ccccCHH---HHHHHHHHhhcChhhCCCHHHHhc
Confidence 32 2222222221 1110 010 1112333 445888999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=350.54 Aligned_cols=261 Identities=21% Similarity=0.336 Sum_probs=199.4
Q ss_pred CCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChh--hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ--AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
++|++.+.||+|+||+||+|...+++.||+|++...... ..+.+.+|+++++.++||||+++++++.+....++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 578999999999999999999988999999998654332 236788999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 975 999998765 35789999999999999999999999 99999999999999999999999999998764322
Q ss_pred cceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc-------
Q 009979 344 SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE------- 415 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------- 415 (521)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+..........
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHHCCCChhhchhhhc
Confidence 22334578999999999865 4589999999999999999999999964321 11111111111110000
Q ss_pred -cCCCcccCCC-------ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 416 -GVLDPRLQEK-------PCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 416 -~~~d~~l~~~-------~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
...++.+... ........+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0111111100 00112234456888999999999999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=376.43 Aligned_cols=265 Identities=22% Similarity=0.249 Sum_probs=211.5
Q ss_pred chhhhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEe
Q 009979 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252 (521)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~ 252 (521)
.+++.++..++|++.+.||+|+||.||+|+.. +++.||+|++.+.. ....+.+..|+.++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 46677788899999999999999999999975 68899999986532 122345788999999999999999999999
Q ss_pred eCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEee
Q 009979 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (521)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~D 332 (521)
+....||||||+++|+|.+++.+. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++++||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999999764 24789999999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCcceeeccccccccccccccc-------CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 009979 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYAS-------TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL 405 (521)
Q Consensus 333 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~ 405 (521)
||+++.............+||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+..
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~ 279 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS------TAETY 279 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC------HHHHH
Confidence 9999987554443444568999999999986 4678999999999999999999999996432 22222
Q ss_pred HHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCC---CCHHHHHHHhh
Q 009979 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKR---PKMGHVIHMLE 460 (521)
Q Consensus 406 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~R---Pt~~evl~~L~ 460 (521)
........ ....+.+. ...+. ++.+++.+||. +|.+| |++.|++++--
T Consensus 280 ~~i~~~~~--~~~~p~~~-~~~s~---~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf 330 (412)
T 2vd5_A 280 GKIVHYKE--HLSLPLVD-EGVPE---EARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330 (412)
T ss_dssp HHHHTHHH--HCCCC-----CCCH---HHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred HHHHhccc--CcCCCccc-cCCCH---HHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence 22222110 00011111 11233 34458889999 99998 68999976543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=356.44 Aligned_cols=248 Identities=25% Similarity=0.328 Sum_probs=205.7
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
.++|++.+.||+|+||.||+|+.. +++.||+|.+.+.. ....+.+..|+.+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 457899999999999999999976 68899999986542 23346788899999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 9999999999999865 4689999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... .
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~-------~ 220 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKILNAE-------L 220 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHCC-------C
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCC-------C
Confidence 32 234689999999999999999999999999999999999999996432 222333333221 0
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHMLE 460 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~ 460 (521)
.+.. ..+. .+.+++.+||+.||++|| ++.+++++--
T Consensus 221 ~~p~-~~~~---~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~ 261 (318)
T 1fot_A 221 RFPP-FFNE---DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261 (318)
T ss_dssp CCCT-TSCH---HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred CCCC-CCCH---HHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence 1111 1233 344588899999999999 8899885543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=363.82 Aligned_cols=246 Identities=23% Similarity=0.347 Sum_probs=201.4
Q ss_pred CCCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
.++|.+.+.||+|+||.||+|.+ .+++.||+|++.... ......+.+|+.+++.++||||+++++++......++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35899999999999999999997 468899999986432 22235788999999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+ +|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 67999998765 4689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcceeecccccccccccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......... .+..
T Consensus 160 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~---------------~i~~ 222 (336)
T 3h4j_B 160 DGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK---------------KVNS 222 (336)
T ss_dssp TSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC---------------CCCS
T ss_pred CCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH---------------HHHc
Confidence 332 2344679999999999988776 789999999999999999999997543322110 0000
Q ss_pred ccc-CCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 420 PRL-QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 420 ~~l-~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
... .+...+. .+.+++.+||+.||.+|||+.|++++
T Consensus 223 ~~~~~p~~~s~---~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 223 CVYVMPDFLSP---GAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp SCCCCCTTSCH---HHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCCCcccCCH---HHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 000 0111233 34458889999999999999999753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=365.43 Aligned_cols=267 Identities=26% Similarity=0.408 Sum_probs=211.3
Q ss_pred hhhhcCCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCCeeeEEEEE
Q 009979 180 ELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYC 251 (521)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~ 251 (521)
++++..++|.+.+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.+++++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 35667789999999999999999999962 35579999987542 33447789999999999 899999999999
Q ss_pred eeCCeeeEEEEeccCCchHHhhhcCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 009979 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGP-------------------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVH 312 (521)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiH 312 (521)
......++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 9999999999999999999999865321 13489999999999999999999998 9999
Q ss_pred cCCCCCCeEeCCCCCceEeecccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCC
Q 009979 313 RDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPV 390 (521)
Q Consensus 313 rDik~~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf 390 (521)
|||||+|||++.++.+||+|||++......... ......||+.|+|||.+.+..++.++|||||||++|||+| |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999999876443322 2334568899999999999999999999999999999998 99999
Q ss_pred CCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 009979 391 DYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 464 (521)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 464 (521)
....... . +........ .+... ..++. .+.+++.+||+.||.+||++.+++++|+....
T Consensus 276 ~~~~~~~--~----~~~~~~~~~-----~~~~~-~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 276 PGIPVDA--N----FYKLIQNGF-----KMDQP-FYATE---EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp TTCCCSH--H----HHHHHHTTC-----CCCCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ccCCcHH--H----HHHHHhcCC-----CCCCC-CCCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 7553221 1 112222111 11111 11333 34458889999999999999999999987543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=361.17 Aligned_cols=256 Identities=24% Similarity=0.325 Sum_probs=203.3
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~l 259 (521)
.++|++.+.||+|+||.||+|++. +++.||+|++.+.. ....+.+..|+.++..+ +||||+++++++.+....|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 457899999999999999999976 57889999997542 33446688899999988 89999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 99999999999999764 4689999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcc--cHHHHHHHHhhccccccC
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV--NLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 417 (521)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+...+.....
T Consensus 161 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--- 236 (345)
T 3a8x_A 161 LRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--- 236 (345)
T ss_dssp CCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC---
T ss_pred cCC-CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC---
Confidence 322 22344568999999999999999999999999999999999999999753221111 111122222221111
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHH
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM------GHVIHM 458 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~------~evl~~ 458 (521)
.+.. ..+. .+.+++.+||+.||++||++ .+++.+
T Consensus 237 ---~~p~-~~s~---~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 237 ---RIPR-SLSV---KAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ---CCCT-TSCH---HHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ---CCCC-CCCH---HHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 1111 1223 34458889999999999995 566543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=359.14 Aligned_cols=265 Identities=25% Similarity=0.414 Sum_probs=213.3
Q ss_pred hhhhcCCCccccceEccCCcEEEEEEEE------cCCcEEEEEEeccCCh-hhHHHHHHHHHHHhcC-CCCCeeeEEEEE
Q 009979 180 ELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLGYC 251 (521)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~hpniv~l~~~~ 251 (521)
.+++..++|++.+.||+|+||.||+|.+ .++..||+|.+..... ...+.+.+|+++++++ +||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 3566778999999999999999999985 2467899999975533 3457789999999999 899999999999
Q ss_pred eeCCeeeEEEEeccCCchHHhhhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 009979 252 AEGAHRMLVYEYIDNGNLEQWLHGDVG--------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKS 317 (521)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~ 317 (521)
.++...++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp 173 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCcc
Confidence 999999999999999999999986532 123589999999999999999999999 999999999
Q ss_pred CCeEeCCCCCceEeecccceecCCCCcce-eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCC
Q 009979 318 SNILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRP 395 (521)
Q Consensus 318 ~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~ 395 (521)
+|||++.++.+||+|||+++......... .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 99999999999999999998775443322 234567889999999999999999999999999999999 9999975432
Q ss_pred CCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
. ... ........ .+. .....+. .+.+++.+||+.||.+|||+.+++++|+..
T Consensus 254 ~--~~~----~~~~~~~~-----~~~-~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 254 D--SKF----YKMIKEGF-----RML-SPEHAPA---EMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp S--HHH----HHHHHHTC-----CCC-CCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred h--hHH----HHHhccCC-----CCC-CcccCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 2 111 11111110 111 1112333 345588899999999999999999999753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=356.85 Aligned_cols=251 Identities=21% Similarity=0.394 Sum_probs=198.9
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC--------
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA-------- 255 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~-------- 255 (521)
++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+++|++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 36889999999999999999986 78999999996543 334578999999999999999999999986543
Q ss_pred -------------------------------------------------eeeEEEEeccCCchHHhhhcCCCCCCCCCHH
Q 009979 256 -------------------------------------------------HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWE 286 (521)
Q Consensus 256 -------------------------------------------------~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~ 286 (521)
..++|||||++|+|.+++.... .....++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~ 164 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHG 164 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhH
Confidence 3789999999999999998753 23456777
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc-----------ceeeccccccc
Q 009979 287 IRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS-----------YVTTRVMGTFG 355 (521)
Q Consensus 287 ~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~-----------~~~~~~~gt~~ 355 (521)
.++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 8899999999999999998 999999999999999999999999999998754321 12234579999
Q ss_pred ccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHH
Q 009979 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRAL 435 (521)
Q Consensus 356 y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 435 (521)
|+|||++.+..++.++|||||||++|||++|..|+. ........... . .+ ..........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~~~~~~~~-~--------~~-~~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVRIITDVRN-L--------KF-PLLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHHHHHHHHT-T--------CC-CHHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHHHHHHhhc-c--------CC-CcccccCChhHH
Confidence 999999999999999999999999999999877642 11111111111 0 00 111223334556
Q ss_pred HHHHhccCCCCCCCCCHHHHHHH
Q 009979 436 LVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 436 ~li~~cl~~dP~~RPt~~evl~~ 458 (521)
+++.+||+.||++|||+.|++++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 68899999999999999999853
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=359.19 Aligned_cols=268 Identities=25% Similarity=0.348 Sum_probs=209.0
Q ss_pred hhcCCCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEee----CCe
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE----GAH 256 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~----~~~ 256 (521)
.+..++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+++++.++||||+++++++.. ...
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 45567899999999999999999997 4688999999877666677889999999999999999999999862 347
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.++||||+++|+|.+++.........+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 7899999999999999986433456899999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCcc--------eeecccccccccccccccCCC---CCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 009979 337 KLLGAERSY--------VTTRVMGTFGYVAPEYASTGM---LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL 405 (521)
Q Consensus 337 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~ 405 (521)
......... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ ....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~-- 258 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL-- 258 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH--
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH--
Confidence 865321110 012345799999999987554 78999999999999999999999953211111 1111
Q ss_pred HHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCc
Q 009979 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPF 466 (521)
Q Consensus 406 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 466 (521)
..... ...+ .....+. .+.+++.+||+.||.+||++.++++.|+....+.
T Consensus 259 --~~~~~----~~~~--~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 259 --AVQNQ----LSIP--QSPRHSS---ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp --HHHCC------CC--CCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred --Hhhcc----CCCC--ccccCCH---HHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 11110 0000 0111233 4455888999999999999999999998765443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=366.75 Aligned_cols=251 Identities=23% Similarity=0.333 Sum_probs=203.5
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCe
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAH 256 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~ 256 (521)
.+..++|.+.+.||+|+||.||+|++. +++.||+|.+.+.. ......+..|..++..+ +||||+++++++.+...
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999976 58889999996542 23345677899999876 89999999999999999
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.|+||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 99999999999999999864 4689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
+..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.........
T Consensus 166 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~~~~---- 234 (345)
T 1xjd_A 166 KENMLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD------EEELFHSIRMDN---- 234 (345)
T ss_dssp BCCCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCC----
T ss_pred hhcccC-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC------HHHHHHHHHhCC----
Confidence 864322 222455789999999999999999999999999999999999999996432 222222222211
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMG-HVIH 457 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~-evl~ 457 (521)
+.+.. ..+. .+.+++.+||+.||++||++. ++++
T Consensus 235 ---~~~p~-~~s~---~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 ---PFYPR-WLEK---EAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ---CCCCT-TSCH---HHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCCc-ccCH---HHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 11111 1233 344588899999999999997 6653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=359.33 Aligned_cols=266 Identities=20% Similarity=0.387 Sum_probs=195.8
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEcCCc----EEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEE
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNT----NVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~----~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~ 251 (521)
++++.+..++|++.+.||+|+||.||+|.+.... .||||.+... .....+.+.+|+++++.++||||+++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 4556678889999999999999999999865332 7999998654 334457889999999999999999999999
Q ss_pred eeCCee------eEEEEeccCCchHHhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC
Q 009979 252 AEGAHR------MLVYEYIDNGNLEQWLHGDV--GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD 323 (521)
Q Consensus 252 ~~~~~~------~lV~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~ 323 (521)
...... ++||||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~ 171 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLA 171 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEc
Confidence 877655 89999999999999986532 1223689999999999999999999999 999999999999999
Q ss_pred CCCCceEeecccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccH
Q 009979 324 KQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNL 401 (521)
Q Consensus 324 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~ 401 (521)
+++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... ..
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~ 248 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EI 248 (323)
T ss_dssp TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GH
T ss_pred CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HH
Confidence 9999999999999876443222 2233457889999999999999999999999999999999 99999754322 11
Q ss_pred HHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 402 VEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 402 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
......... ... ....+. .+.+++.+||+.||++|||+.++++.|+..
T Consensus 249 ---~~~~~~~~~------~~~-~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 249 ---YNYLIGGNR------LKQ-PPECME---EVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp ---HHHHHTTCC------CCC-CTTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHhcCCC------CCC-CCccCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 122221111 001 111233 455588899999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=357.70 Aligned_cols=254 Identities=25% Similarity=0.319 Sum_probs=197.4
Q ss_pred cCCCccccceEccCCcEEEEEEEE----cCCcEEEEEEeccCC----hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC
Q 009979 184 STNGFADENVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 255 (521)
..++|++.+.||+|+||.||+|+. .+++.||+|++.+.. ......+..|+++|+.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 446899999999999999999997 468899999987642 223456788999999999999999999999999
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..|+||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 999999999999999999764 4688999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+........
T Consensus 168 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~~~-- 238 (327)
T 3a62_A 168 CKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN------RKKTIDKILKCKL-- 238 (327)
T ss_dssp C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHTCC--
T ss_pred ccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhCCC--
Confidence 98643222 22345679999999999999999999999999999999999999996432 2222233222110
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhhcc
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHMLEAE 462 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~~~ 462 (521)
.+.. ..+. .+.+++.+||+.||++|| ++.+++++---.
T Consensus 239 -----~~p~-~~~~---~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~ 281 (327)
T 3a62_A 239 -----NLPP-YLTQ---EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281 (327)
T ss_dssp -----CCCT-TSCH---HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGS
T ss_pred -----CCCC-CCCH---HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCccc
Confidence 1111 1233 344588899999999999 788887654433
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=361.54 Aligned_cols=257 Identities=26% Similarity=0.457 Sum_probs=199.9
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcE----EEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTN----VAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
..++|++.+.||+|+||+||+|.+. +++. ||+|.+.... ....+.+.+|+.++++++||||++++++|.++. .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 3457999999999999999999964 3443 5788775432 344578999999999999999999999998755 7
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+.+|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++
T Consensus 92 ~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence 8999999999999999875 35789999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 338 LLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 338 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... ..... +.....
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~----~~~~~~- 237 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSI----LEKGER- 237 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH----HHTTCC-
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH---HHHHH----HHcCCC-
Confidence 77543322 2234567889999999999999999999999999999999 99999754322 22221 111110
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
.. ....++. .+..++.+||+.||++||++.+++++|+...
T Consensus 238 ----~~-~~~~~~~---~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 238 ----LP-QPPICTI---DVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ----CC-CCTTBCH---HHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ----CC-CCccCCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00 1111333 4555888999999999999999999998643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=354.89 Aligned_cols=276 Identities=24% Similarity=0.423 Sum_probs=219.7
Q ss_pred cccchhhhhhcCCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeee
Q 009979 174 HWYTLRELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVR 246 (521)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~ 246 (521)
..+...++++..++|++.+.||+|+||.||+|.+. ++..||+|.+..... .....+.+|+++++.++||||++
T Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred cccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEee
Confidence 33556677888899999999999999999999864 367899999875433 34467889999999999999999
Q ss_pred EEEEEeeCCeeeEEEEeccCCchHHhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 009979 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDV------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNI 320 (521)
Q Consensus 247 l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NI 320 (521)
+++++.+....++||||+++|+|.+++.... .....+++..++.++.|++.||+|||++ +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NI 169 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNC 169 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGE
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceE
Confidence 9999999999999999999999999997531 1124678999999999999999999999 999999999999
Q ss_pred EeCCCCCceEeecccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCc
Q 009979 321 LLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGE 398 (521)
Q Consensus 321 Ll~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~ 398 (521)
|++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---- 245 (322)
T 1p4o_A 170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---- 245 (322)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC----
T ss_pred EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC----
Confidence 9999999999999999865433221 1233467899999999999999999999999999999999 899996432
Q ss_pred ccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCchh
Q 009979 399 VNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRD 468 (521)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 468 (521)
..+........ .. .+ . ...++.. +.+++.+||+.||.+|||+.++++.|+....+...
T Consensus 246 --~~~~~~~~~~~-~~---~~--~-~~~~~~~---l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~ 303 (322)
T 1p4o_A 246 --NEQVLRFVMEG-GL---LD--K-PDNCPDM---LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 303 (322)
T ss_dssp --HHHHHHHHHTT-CC---CC--C-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred --HHHHHHHHHcC-Cc---CC--C-CCCCCHH---HHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCc
Confidence 22222222221 11 00 1 1123333 44588899999999999999999999987665543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=386.53 Aligned_cols=263 Identities=27% Similarity=0.413 Sum_probs=213.6
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
...+++..++|++.+.||+|+||.||+|.+.++..||||++.... ...+.|.+|+++|++++||||+++++++.+ ...
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 345667788899999999999999999999888889999997644 335679999999999999999999999976 678
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
+|||||+++|+|.++++... ...+++..++.++.|++.||+|||++ +|+||||||+||||++++.+||+|||+++
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 411 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred eEeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence 99999999999999997531 24688999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
..............++..|+|||++.+..++.++|||||||+||||+| |+.||.... ..+.+........
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~------~~~~~~~i~~~~~--- 482 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------NREVLDQVERGYR--- 482 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC------HHHHHHHHHTTCC---
T ss_pred ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCCC---
Confidence 764332222233457889999999998999999999999999999999 999996432 2222222222111
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
... ...++.. +.+|+.+||+.||++|||+.+|+++|+...
T Consensus 483 ---~~~-~~~~~~~---l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 483 ---MPC-PPECPES---LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp ---CCC-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred ---CCC-CCCCCHH---HHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 001 1123444 445888999999999999999999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=349.64 Aligned_cols=263 Identities=27% Similarity=0.473 Sum_probs=197.1
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
.++..++|++.+.||+|+||+||+|.+. ..||+|++.... ....+.+.+|+++++.++||||+++++++. ....+
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~ 95 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA 95 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccE
Confidence 4677889999999999999999999864 359999986543 344577899999999999999999999764 45689
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 96 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp EEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred EEEEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccc
Confidence 999999999999999765 35789999999999999999999999 999999999999999999999999999986
Q ss_pred cCCC-Ccceeeccccccccccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 339 LGAE-RSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 339 ~~~~-~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
.... .........||+.|+|||.+. +..++.++||||||+++|||++|+.||...... +.+.........
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~ 243 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIEMVGRGSL 243 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------HHHHHHHHHTSC
T ss_pred cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------HHHHHHhccccc
Confidence 5432 122234467999999999886 667888999999999999999999999654321 112222222111
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
..... .+ ...++. .+.+++.+||+.||.+||++.++++.|+...
T Consensus 244 ~~~~~-~~-~~~~~~---~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 244 SPDLS-KV-RSNCPK---RMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCCTT-SS-CTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred Ccchh-hc-cccCCH---HHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 11111 01 112333 3445888999999999999999999998653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=364.33 Aligned_cols=253 Identities=20% Similarity=0.304 Sum_probs=194.8
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
..++|.+.+.||+|+||+||++... +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 4568999999999999999999976 688999999865432 33668899999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCC--ceEeecccceecC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN--PKLSDFGLAKLLG 340 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~--vkL~DFGla~~~~ 340 (521)
|+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++...
T Consensus 97 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 97 YASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred eCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 99999999999764 4689999999999999999999998 9999999999999987765 9999999998532
Q ss_pred CCCcceeecccccccccccccccCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLNER-SDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
.. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... .....+........
T Consensus 170 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~~------ 239 (361)
T 3uc3_A 170 LH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSVKY------ 239 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTTCC------
T ss_pred cc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcCCC------
Confidence 22 22344579999999999988777665 899999999999999999997654332 22222333222110
Q ss_pred cccCC-CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 420 PRLQE-KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 420 ~~l~~-~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+.. ...+. .+.+++.+||+.||++|||+.|++++
T Consensus 240 -~~~~~~~~s~---~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 -SIPDDIRISP---ECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -CCCTTSCCCH---HHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -CCCCcCCCCH---HHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0111 01223 34458889999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=347.84 Aligned_cols=263 Identities=21% Similarity=0.314 Sum_probs=200.6
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
++|++.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|++++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999976 58889999996543 2334678899999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+++ +|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9975 666666554 35799999999999999999999999 9999999999999999999999999999876433
Q ss_pred CcceeecccccccccccccccCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccccc-----
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG----- 416 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----- 416 (521)
. .......||+.|+|||++.+.. ++.++|||||||++|||++|..||..... .......+...........
T Consensus 155 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 155 V-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp C-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred c-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhhc
Confidence 2 2234467899999999987765 89999999999999999999888643221 1111121211111100000
Q ss_pred -CCC----cc-----cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 417 -VLD----PR-----LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 417 -~~d----~~-----l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
..+ +. ......+.....+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 00 0000011122344568889999999999999999853
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=362.62 Aligned_cols=249 Identities=21% Similarity=0.294 Sum_probs=199.0
Q ss_pred cccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccCC
Q 009979 189 ADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNG 267 (521)
Q Consensus 189 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~g 267 (521)
...+.||+|+||.||+|... ++..||+|++........+.+.+|+++|++++||||+++++++.+....+|||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 34678999999999999975 68899999998776666788999999999999999999999999999999999999999
Q ss_pred chHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe--CCCCCceEeecccceecCCCCcc
Q 009979 268 NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL--DKQWNPKLSDFGLAKLLGAERSY 345 (521)
Q Consensus 268 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl--~~~~~vkL~DFGla~~~~~~~~~ 345 (521)
+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 172 ~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~- 244 (373)
T 2x4f_A 172 ELFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244 (373)
T ss_dssp EEHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence 999998754 34689999999999999999999999 99999999999999 6678899999999998754332
Q ss_pred eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCC
Q 009979 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425 (521)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 425 (521)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+........ ...+..
T Consensus 245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~------~~~~~~~i~~~~~--~~~~~~---- 311 (373)
T 2x4f_A 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN------DAETLNNILACRW--DLEDEE---- 311 (373)
T ss_dssp -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHTCC--CSCSGG----
T ss_pred -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhccC--CCChhh----
Confidence 234579999999999999999999999999999999999999996432 2222233222111 111111
Q ss_pred ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 426 PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 426 ~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.......+.+++.+||+.||.+|||+.|++++
T Consensus 312 -~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 312 -FQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp -GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -hccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11122345558889999999999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=359.64 Aligned_cols=207 Identities=24% Similarity=0.314 Sum_probs=182.0
Q ss_pred cchhhhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCC-----CCCeeeEEE
Q 009979 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-----HKNLVRLLG 249 (521)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----hpniv~l~~ 249 (521)
+++++..+..++|.+.++||+|+||+||+|.+. +++.||||++... ......+..|+++++.++ ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 346666777889999999999999999999974 6888999998643 334566778999999986 999999999
Q ss_pred EEeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-----
Q 009979 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK----- 324 (521)
Q Consensus 250 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~----- 324 (521)
++......++||||+ +++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccc
Confidence 999999999999999 889999998762 34689999999999999999999998 9999999999999975
Q ss_pred --------------------CCCceEeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHH
Q 009979 325 --------------------QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVI 384 (521)
Q Consensus 325 --------------------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ell 384 (521)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 788999999999875432 23467999999999999999999999999999999999
Q ss_pred hCCCCCCCC
Q 009979 385 SGRNPVDYS 393 (521)
Q Consensus 385 tG~~Pf~~~ 393 (521)
+|+.||...
T Consensus 254 ~g~~pf~~~ 262 (360)
T 3llt_A 254 TGSLLFRTH 262 (360)
T ss_dssp HSSCSCCCS
T ss_pred HCCCCCCCC
Confidence 999999754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=362.72 Aligned_cols=249 Identities=21% Similarity=0.251 Sum_probs=206.5
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
..++|++.+.||+|+||.||+|++. +++.||+|++.+.. ....+.+.+|+++++.++||||+++++++.+....|+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3458999999999999999999976 58899999986542 2334678889999999999999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 119 v~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceec
Confidence 99999999999999865 4689999999999999999999999 9999999999999999999999999999976
Q ss_pred CCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... .
T Consensus 192 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~~~~-~----- 255 (350)
T 1rdq_E 192 KGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVSGK-V----- 255 (350)
T ss_dssp SSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCC-C-----
T ss_pred cCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC------HHHHHHHHHcCC-C-----
Confidence 432 234679999999999999999999999999999999999999996432 223333333221 0
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhh
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPK-----MGHVIHMLE 460 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~L~ 460 (521)
.+.. ..+. .+.+++.+||+.||.+||+ +.+|+++--
T Consensus 256 -~~p~-~~~~---~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 256 -RFPS-HFSS---DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp -CCCT-TCCH---HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred -CCCC-CCCH---HHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence 1111 1233 3445888999999999998 888875543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=351.72 Aligned_cols=255 Identities=22% Similarity=0.351 Sum_probs=204.4
Q ss_pred hcCCCccccceEccCCcEEEEEEEEcC-C-------cEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLED-N-------TNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~ 254 (521)
+..++|.+.+.||+|+||.||+|.+.. + ..||+|.+........+.+.+|+++++.++||||+++++++.++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 445689999999999999999998653 3 46999999776666678899999999999999999999999999
Q ss_pred CeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCC-------
Q 009979 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN------- 327 (521)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~------- 327 (521)
...++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence 9999999999999999999875 24589999999999999999999999 9999999999999988887
Q ss_pred -ceEeecccceecCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 009979 328 -PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL 405 (521)
Q Consensus 328 -vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~ 405 (521)
+||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|||++|..|+.... ......
T Consensus 159 ~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~~~~ 228 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-----DSQRKL 228 (289)
T ss_dssp EEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS-----CHHHHH
T ss_pred eeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc-----chHHHH
Confidence 999999999754322 23468999999999987 779999999999999999999655443221 111111
Q ss_pred HHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 009979 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 465 (521)
Q Consensus 406 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 465 (521)
....... .+... .+. .+.+++.+||+.||++|||+.++++.|+....+
T Consensus 229 ~~~~~~~----~~~~~-----~~~---~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 229 QFYEDRH----QLPAP-----KAA---ELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HHHHTTC----CCCCC-----SSC---TTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred HHhhccC----CCCCC-----CCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 1111111 11111 122 244588899999999999999999999976654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=358.27 Aligned_cols=255 Identities=20% Similarity=0.338 Sum_probs=199.2
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCC--CCeeeEEEEEeeCCee
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRH--KNLVRLLGYCAEGAHR 257 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h--pniv~l~~~~~~~~~~ 257 (521)
.+..++|++.+.||+|+||.||+|...+++.||||++... .....+.+.+|+.+|+.++| |||+++++++.++...
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 4567789999999999999999999888999999998654 33345778999999999986 9999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++|||+ .+++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++
T Consensus 85 ~lv~e~-~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIAN 155 (343)
T ss_dssp EEEECC-CSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred EEEEeC-CCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccc
Confidence 999995 578999999875 5789999999999999999999999 999999999999997 5789999999998
Q ss_pred ecCCCCcc-eeecccccccccccccccC-----------CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 009979 338 LLGAERSY-VTTRVMGTFGYVAPEYAST-----------GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL 405 (521)
Q Consensus 338 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~ 405 (521)
........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... +....+
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~ 230 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKL 230 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHH
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-----hHHHHH
Confidence 76443222 2345679999999999864 678999999999999999999999996332 222222
Q ss_pred HHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 406 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
........ ...+.. ..+. .+.+++.+||+.||.+|||+.+++++.
T Consensus 231 ~~~~~~~~-----~~~~~~-~~~~---~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 231 HAIIDPNH-----EIEFPD-IPEK---DLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp HHHHCTTS-----CCCCCC-CSCH---HHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHhcCCc-----ccCCcc-cCCH---HHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 22222111 111111 1223 344588899999999999999998653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=360.25 Aligned_cols=269 Identities=18% Similarity=0.231 Sum_probs=201.5
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc----CCcEEEEEEeccCChhh-----------HHHHHHHHHHHhcCCCCCeeeE
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNRGQA-----------EKEFKVEVEAIGRVRHKNLVRL 247 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~Ei~~l~~l~hpniv~l 247 (521)
+..++|.+.+.||+|+||.||+|.+. ++..||+|++....... ...+..|+..++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 34578999999999999999999975 56789999987653221 1346678899999999999999
Q ss_pred EEEEee----CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC
Q 009979 248 LGYCAE----GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD 323 (521)
Q Consensus 248 ~~~~~~----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~ 323 (521)
++++.. ....++||||+ +++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLG 185 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEc
Confidence 999987 67889999999 99999999765 3789999999999999999999999 999999999999998
Q ss_pred CCC--CceEeecccceecCCCCcc------eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCC
Q 009979 324 KQW--NPKLSDFGLAKLLGAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395 (521)
Q Consensus 324 ~~~--~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~ 395 (521)
.++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 777 9999999999876432211 11345799999999999999999999999999999999999999964221
Q ss_pred CCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 009979 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 465 (521)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 465 (521)
. . ............. ....+.........+. .+.+++.+||+.||++||++.+|++.|+....+
T Consensus 266 ~-~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 266 D-P-VAVQTAKTNLLDE-LPQSVLKWAPSGSSCC---EIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP 329 (345)
T ss_dssp C-H-HHHHHHHHHHHHT-TTHHHHHHSCTTSCCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred c-c-HHHHHHHHhhccc-ccHHHHhhccccccHH---HHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence 1 1 1111111111110 0000000011112333 345588899999999999999999999986654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=355.72 Aligned_cols=263 Identities=25% Similarity=0.445 Sum_probs=210.8
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEc--------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCCeeeEEEE
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLE--------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGY 250 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~ 250 (521)
+++..++|.+.+.||+|+||.||+|.+. ++..||+|.+.... ....+.+..|+++++.+ +||||++++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 4566789999999999999999999863 46679999987543 33456788999999999 89999999999
Q ss_pred EeeCCeeeEEEEeccCCchHHhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 009979 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGP------------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318 (521)
Q Consensus 251 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~ 318 (521)
+.+....++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 186 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccc
Confidence 99999999999999999999999865321 23589999999999999999999999 9999999999
Q ss_pred CeEeCCCCCceEeecccceecCCCCcce-eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCC
Q 009979 319 NILLDKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPP 396 (521)
Q Consensus 319 NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~ 396 (521)
|||++.++.+||+|||+++......... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-- 264 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-- 264 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC--
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC--
Confidence 9999999999999999998765433222 234567889999999988899999999999999999999 999996432
Q ss_pred CcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 397 GEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
..+.......... .... ..++.. +.+++.+||+.||.+||++.++++.|+..
T Consensus 265 ----~~~~~~~~~~~~~------~~~~-~~~~~~---l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 265 ----VEELFKLLKEGHR------MDKP-ANCTNE---LYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp ----HHHHHHHHHHTCC------CCCC-TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHHhcCCC------CCCC-ccCCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2222222221110 0111 123333 44588899999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=343.19 Aligned_cols=254 Identities=19% Similarity=0.316 Sum_probs=205.8
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC--Cee
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHR 257 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~ 257 (521)
.+..++|.+.+.||+|+||.||+|.+. ++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 345568999999999999999999985 8889999987543 34456799999999999999999999999877 778
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeEeCCCCCceEeeccc
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK--VVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~--iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. + |+||||||+|||++.++.++|+|||+
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADV 159 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred EeeecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccc
Confidence 99999999999999998752 34689999999999999999999998 7 99999999999999999999999998
Q ss_pred ceecCCCCcceeecccccccccccccccCCCCCC---cccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE---RSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (521)
+.... .....||+.|+|||.+.+..++. ++|||||||++|||++|+.||.... ..+.........
T Consensus 160 ~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~ 227 (271)
T 3kmu_A 160 KFSFQ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS------NMEIGMKVALEG 227 (271)
T ss_dssp CCTTS------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC------HHHHHHHHHHSC
T ss_pred eeeec------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC------hHHHHHHHHhcC
Confidence 76432 22346899999999998766555 7999999999999999999996432 222222222221
Q ss_pred ccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 413 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
. .+.+.. ..+.. +.+++.+||+.||++|||+.++++.|+..
T Consensus 228 ~-----~~~~~~-~~~~~---~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 228 L-----RPTIPP-GISPH---VSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp C-----CCCCCT-TCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-----CCCCCC-CCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1 111111 13333 44588899999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=348.73 Aligned_cols=261 Identities=23% Similarity=0.356 Sum_probs=198.5
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
.++|++.+.||+|+||.||+|... ++..||+|++... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 357999999999999999999974 6889999998653 234456788999999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+++++|.+++.........+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999975332346789999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... +.......... ... +
T Consensus 188 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~-~~~-----~ 256 (310)
T 2wqm_A 188 SKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQ-CDY-----P 256 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHHHT-TCS-----C
T ss_pred CCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHhhc-ccC-----C
Confidence 332 223345789999999999999999999999999999999999999964321 22222222221 111 1
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.......+.. +.+++.+||+.||++||++.+|++.|+..
T Consensus 257 ~~~~~~~~~~---l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 257 PLPSDHYSEE---LRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp CCCTTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccccCHH---HHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111223333 44588899999999999999999999764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=350.73 Aligned_cols=263 Identities=24% Similarity=0.405 Sum_probs=205.8
Q ss_pred cCCCccccceEccCCcEEEEEEEE-----cCCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC--C
Q 009979 184 STNGFADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--A 255 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~ 255 (521)
..+.|++.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|+++++.++||||+++++++.+. .
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 345689999999999999999984 357889999987543 33447789999999999999999999999876 5
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred eEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccc
Confidence 689999999999999999665 35689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcc--eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC--------CCCCcccHHHHH
Q 009979 336 AKLLGAERSY--VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS--------RPPGEVNLVEWL 405 (521)
Q Consensus 336 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~--------~~~~~~~~~~~~ 405 (521)
+......... ......||..|+|||.+.+..++.++||||||+++|||+||..|+... .+.........+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 9987544332 233456889999999999999999999999999999999999986422 011111112222
Q ss_pred HHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 406 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
......... .... ...+. .+.+++.+||+.||.+|||+.++++.|+.
T Consensus 253 ~~~~~~~~~-----~~~~-~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 253 VNTLKEGKR-----LPCP-PNCPD---EVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHHHTTCC-----CCCC-TTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhccCC-----CCCC-CCCCH---HHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 222221110 0111 11233 34558889999999999999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=356.70 Aligned_cols=252 Identities=21% Similarity=0.288 Sum_probs=204.3
Q ss_pred hcCCCccccceEccCCcEEEEEEEEcC-CcEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCee
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~ 257 (521)
+..++|++.+.||+|+||.||+|.... ++.||+|++.+.. ....+.+..|..++..+ +||||+++++++.+....
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 345689999999999999999999864 7789999986542 23346678899999988 799999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
|+||||++||+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++
T Consensus 97 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 9999999999999999864 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.........
T Consensus 170 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~~i~~~~----- 237 (353)
T 2i0e_A 170 ENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED------EDELFQSIMEHN----- 237 (353)
T ss_dssp CCCCT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCC-----
T ss_pred ccccC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC------HHHHHHHHHhCC-----
Confidence 64322 223445789999999999999999999999999999999999999996432 223333333211
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHh
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK-----MGHVIHML 459 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~L 459 (521)
..+.. ..+ ..+.+++.+||+.||.+||+ +.+++++-
T Consensus 238 --~~~p~-~~s---~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 238 --VAYPK-SMS---KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp --CCCCT-TSC---HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred --CCCCC-CCC---HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence 01111 122 34455888999999999995 57776543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=350.14 Aligned_cols=258 Identities=24% Similarity=0.424 Sum_probs=204.0
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcC----CcEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLED----NTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 256 (521)
.+..++|.+.+.||+|+||.||+|.+.+ +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 4456789999999999999999998643 235999998765 33455778999999999999999999999875 45
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.++||||+++++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 160 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLS 160 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred CEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCC
Confidence 68999999999999999765 35689999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... .....+.. ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~~~~---~~~-- 232 (281)
T 3cc6_A 161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGVLEK---GDR-- 232 (281)
T ss_dssp GCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHHHHH---TCC--
T ss_pred cccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHHHhc---CCC--
Confidence 8765444333444567889999999998999999999999999999998 99999754322 22221111 110
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
. . ....++.. +.+++.+||+.||++||++.++++.|+..
T Consensus 233 -~---~-~~~~~~~~---l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 233 -L---P-KPDLCPPV---LYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp -C---C-CCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -C---C-CCCCCCHH---HHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 0 0 11113333 44588899999999999999999999753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=361.79 Aligned_cols=206 Identities=19% Similarity=0.231 Sum_probs=179.1
Q ss_pred cCCCccccceEccC--CcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 184 STNGFADENVIGEG--GYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 184 ~~~~~~~~~~LG~G--~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
..++|++.+.||+| +||.||+|.+. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.++...+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34589999999999 99999999976 68899999996543 334567888999999999999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+|||||++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999998652 35689999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCc------ceeecccccccccccccccC--CCCCCcccchhHHHHHHHHHhCCCCCCCCC
Q 009979 339 LGAERS------YVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVDYSR 394 (521)
Q Consensus 339 ~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~ 394 (521)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 422111 11223478999999999987 679999999999999999999999997644
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=357.40 Aligned_cols=249 Identities=23% Similarity=0.345 Sum_probs=179.9
Q ss_pred cceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCeeeEEEEeccCCc
Q 009979 191 ENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYIDNGN 268 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~~~g~ 268 (521)
.+.||+|+||.||+|.+. +++.||||++... ....+..|+.+++.+. ||||+++++++.++...|+||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999976 5889999998643 3466778999999997 9999999999999999999999999999
Q ss_pred hHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC---CceEeecccceecCCCCcc
Q 009979 269 LEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW---NPKLSDFGLAKLLGAERSY 345 (521)
Q Consensus 269 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~---~vkL~DFGla~~~~~~~~~ 345 (521)
|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++...... .
T Consensus 93 L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~ 164 (325)
T 3kn6_A 93 LFERIKKK----KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-Q 164 (325)
T ss_dssp HHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-C
Confidence 99999875 5799999999999999999999999 999999999999997665 79999999998764432 2
Q ss_pred eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCc-ccHHHHHHHHhhccccccCCCcccCC
Q 009979 346 VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE-VNLVEWLKTMVTNRNAEGVLDPRLQE 424 (521)
Q Consensus 346 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~ 424 (521)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....+.+..... ... .+..
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~-~~~------~~~~ 237 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK-GDF------SFEG 237 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT-TCC------CCCS
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc-CCC------CCCc
Confidence 23456789999999999999999999999999999999999999976543221 222232332222 111 1111
Q ss_pred CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 425 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.........+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 111122344556888999999999999999863
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=350.13 Aligned_cols=266 Identities=26% Similarity=0.398 Sum_probs=202.2
Q ss_pred hcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcC--CCCCeeeEEEEEeeC----Ce
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV--RHKNLVRLLGYCAEG----AH 256 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l--~hpniv~l~~~~~~~----~~ 256 (521)
...++|++.+.||+|+||.||+|.+. ++.||||++... ....+..|.+++..+ +||||+++++++... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34468999999999999999999985 889999998543 233445566666554 899999999999887 67
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCCeEeCCCCCceEe
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL-----EPKVVHRDIKSSNILLDKQWNPKLS 331 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-----~~~iiHrDik~~NILl~~~~~vkL~ 331 (521)
.++||||+++|+|.++++.. .+++..++.++.|++.||+|||+.. .++|+||||||+|||++.++.+||+
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred eEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 89999999999999999754 6899999999999999999999751 3489999999999999999999999
Q ss_pred ecccceecCCCCcce---eecccccccccccccccCCCCCCc------ccchhHHHHHHHHHhC----------CCCCCC
Q 009979 332 DFGLAKLLGAERSYV---TTRVMGTFGYVAPEYASTGMLNER------SDVYSFGILIMEVISG----------RNPVDY 392 (521)
Q Consensus 332 DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------sDvwS~Gvvl~elltG----------~~Pf~~ 392 (521)
|||+++.+....... .....||+.|+|||++.+..++.+ +|||||||++|||+|| ..||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999998764432221 124579999999999988777765 9999999999999999 666654
Q ss_pred CCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 393 SRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
..+... . ....................+. .......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 265 ~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 265 LVPSDP-S-YEDMREIVCIKKLRPSFPNRWS---SDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp TSCSSC-C-HHHHHHHHTTSCCCCCCCGGGG---GSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCC-c-hhhhHHHHhhhccCccccccch---hhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 433221 1 1222222222211111111111 124455566788999999999999999999999853
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=348.99 Aligned_cols=258 Identities=21% Similarity=0.282 Sum_probs=198.2
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
.++|.+.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 358999999999999999999976 688899999865432 2346788999999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999865 4689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
...........||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..+....... ...+
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~----~~~~ 254 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQA----IPRP 254 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSC----CCCG
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccC----CCCc
Confidence 4433334456799999999999999999999999999999999999999964321 1122222211 1111
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhhccC
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRP-KMGHVIHMLEAEE 463 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RP-t~~evl~~L~~~~ 463 (521)
.......+.. +.+++.+||+.||++|| ++.++++.|+...
T Consensus 255 ~~~~~~~~~~---l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 255 STVRPGIPVA---FDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp GGTSTTCCTH---HHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred cccCCCCCHH---HHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 1111123333 44488899999999999 9999999998654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=354.53 Aligned_cols=254 Identities=25% Similarity=0.392 Sum_probs=194.0
Q ss_pred cCCCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe---
Q 009979 184 STNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH--- 256 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~--- 256 (521)
..++|++.+.||+|+||.||+|.+ .+++.||||++.... ......+.+|+++++.++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 346899999999999999999997 468899999997643 2334678899999999999999999999876543
Q ss_pred -eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 257 -RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 257 -~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
.|+||||+++++|.++++.. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred ccEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 39999999999999999865 4689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCc--ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccc
Q 009979 336 AKLLGAERS--YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (521)
Q Consensus 336 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (521)
++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.........
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~------~~~~~~~~~~~~- 235 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVRED- 235 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCC-
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHhcCC-
Confidence 987644322 22234679999999999999999999999999999999999999996432 122222222211
Q ss_pred cccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 414 ~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
...+.......+. .+.+++.+||+.||++||++.+++.
T Consensus 236 ---~~~~~~~~~~~~~---~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 236 ---PIPPSARHEGLSA---DLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp ---CCCHHHHSTTCCH---HHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred ---CCCcccccCCCCH---HHHHHHHHHHhcCHhhChhhHHHHH
Confidence 1111111111233 3445888999999999997666553
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=353.22 Aligned_cols=260 Identities=28% Similarity=0.476 Sum_probs=202.9
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcC-----CcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLED-----NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 255 (521)
++..++|++.+.||+|+||.||+|.+.. +..||+|.+.... ......+.+|+++++.++||||+++++++.+..
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 4566789999999999999999998653 2359999987543 334467889999999999999999999999999
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred CcEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCc
Confidence 999999999999999999765 35789999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcc--eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhcc
Q 009979 336 AKLLGAERSY--VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (521)
Q Consensus 336 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (521)
++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.... ..+.........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~------~~~~~~~~~~~~ 267 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS------NHEVMKAINDGF 267 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTTC
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC------HHHHHHHHHCCC
Confidence 9876443221 1223456889999999999999999999999999999999 999996432 122222222111
Q ss_pred ccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 413 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
.. .. ...++.. +.+++.+||+.||++||++.++++.|+...
T Consensus 268 ~~------~~-~~~~~~~---l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 268 RL------PT-PMDCPSA---IYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp CC------CC-CTTCBHH---HHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cC------CC-cccCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 10 01 1123333 445888999999999999999999998643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=343.37 Aligned_cols=249 Identities=23% Similarity=0.288 Sum_probs=203.3
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
++|++.+.||+|+||.||+|.+. ++..||+|++........+.+.+|+++++.++||||+++++++.+....++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 46899999999999999999976 46789999997766666788999999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe---CCCCCceEeecccceecCC
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl---~~~~~vkL~DFGla~~~~~ 341 (521)
++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++.....
T Consensus 89 ~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 89 TGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999998765 4689999999999999999999999 99999999999999 7889999999999987654
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
.. ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||.... ..+.......... ..+
T Consensus 162 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~----~~~- 227 (277)
T 3f3z_A 162 GK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT------DSEVMLKIREGTF----TFP- 227 (277)
T ss_dssp TS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCC----CCC-
T ss_pred cc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhCCC----CCC-
Confidence 33 23445799999999998654 8999999999999999999999996432 1122222221110 000
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
..........+.+++.+||+.||++||++.++++
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 228 --EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp --HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000012234555888999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=357.82 Aligned_cols=257 Identities=25% Similarity=0.440 Sum_probs=201.7
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcE----EEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTN----VAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
..++|++.+.||+|+||+||+|.+. ++.. ||+|.+.... ......+..|+.+++.++||||+++++++.+ ...
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 89 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSL 89 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSE
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Ccc
Confidence 4568999999999999999999965 3443 7778775432 2333567789999999999999999999864 568
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++
T Consensus 90 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred EEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccc
Confidence 8999999999999999765 34688899999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCc-ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 338 LLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 338 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||....... ..+ .+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~-- 234 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPD----LLEKGE-- 234 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHH----HHHTTC--
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHH----HHHcCC--
Confidence 7654332 22344668889999999999999999999999999999999 999997554321 111 111111
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
....+ ..++. .+.+++.+||+.||.+||++.++++.|+...
T Consensus 235 ~~~~~----~~~~~---~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 235 RLAQP----QICTI---DVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp BCCCC----TTBCT---TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CCCCC----CcCcH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00111 11222 2344888999999999999999999998764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=356.79 Aligned_cols=258 Identities=24% Similarity=0.294 Sum_probs=198.6
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC-----ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-----RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
.++|++.+.||+|+||.||+|.+. ++..||+|.+... .....+.+..|+++++.++||||+++++++.+....+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 358999999999999999999975 5788999998643 2344578899999999999999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCCC------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 009979 259 LVYEYIDNGNLEQWLHGDVGP------------------------------------HSPLTWEIRMNIILGTAKGLTYL 302 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~al~~L 302 (521)
+||||+++|+|.+++...... ...+++..++.++.|++.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998531100 12235777889999999999999
Q ss_pred HhcCCCCeeecCCCCCCeEeCCCC--CceEeecccceecCCCC---cceeecccccccccccccccC--CCCCCcccchh
Q 009979 303 HEGLEPKVVHRDIKSSNILLDKQW--NPKLSDFGLAKLLGAER---SYVTTRVMGTFGYVAPEYAST--GMLNERSDVYS 375 (521)
Q Consensus 303 H~~~~~~iiHrDik~~NILl~~~~--~vkL~DFGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS 375 (521)
|+. +|+||||||+|||++.++ .+||+|||+++.+.... ........||+.|+|||++.+ ..++.++||||
T Consensus 185 H~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 999 999999999999998766 89999999998764321 222345679999999999865 67899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 009979 376 FGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHV 455 (521)
Q Consensus 376 ~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~ev 455 (521)
|||++|||++|+.||.... ..+.......... ....+ ........+.+++.+||+.||.+||++.++
T Consensus 262 lG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVN------DADTISQVLNKKL--CFENP-----NYNVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCC--CTTSG-----GGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHHHHCCCCCCCCC------hHHHHHHHHhccc--ccCCc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 9999999999999996432 2222333322211 01111 111122345558889999999999999999
Q ss_pred HHH
Q 009979 456 IHM 458 (521)
Q Consensus 456 l~~ 458 (521)
+++
T Consensus 329 l~h 331 (345)
T 3hko_A 329 LQH 331 (345)
T ss_dssp HHS
T ss_pred hcC
Confidence 864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=346.91 Aligned_cols=248 Identities=27% Similarity=0.425 Sum_probs=200.8
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
..++|++.+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4568999999999999999999976 46789999986532 2234678899999999999999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 99999999999999765 4689999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+.........
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~------- 223 (279)
T 3fdn_A 160 PSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------YQETYKRISRVE------- 223 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHTC-------
T ss_pred Ccc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc------HHHHHHHHHhCC-------
Confidence 322 2344679999999999999999999999999999999999999996432 222222222111
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
..+. ...+.. +.+++.+||+.||++|||+.|++++
T Consensus 224 ~~~~-~~~~~~---~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 FTFP-DFVTEG---ARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCCC-TTSCHH---HHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCC-CcCCHH---HHHHHHHHhccChhhCCCHHHHhhC
Confidence 0111 112333 4458889999999999999999864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=359.40 Aligned_cols=257 Identities=14% Similarity=0.179 Sum_probs=208.1
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEE------EcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCC---CCCeeeEE
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGV------LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR---HKNLVRLL 248 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---hpniv~l~ 248 (521)
..++++..++|.+.+.||+|+||+||+|. ..+++.||+|++.... ..++..|+++++.++ |+||++++
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 34566778899999999999999999994 4468889999986543 456777888888887 99999999
Q ss_pred EEEeeCCeeeEEEEeccCCchHHhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---
Q 009979 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVG-PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK--- 324 (521)
Q Consensus 249 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~--- 324 (521)
+++...+..+|||||+++|+|.++++.... ....+++..++.++.|++.||+|||+. +|+||||||+||||+.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGT
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEeccccc
Confidence 999999999999999999999999975321 245799999999999999999999998 9999999999999998
Q ss_pred --------CCCceEeecccceecCC-CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCC
Q 009979 325 --------QWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395 (521)
Q Consensus 325 --------~~~vkL~DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~ 395 (521)
++.+||+|||+++.+.. ......+..+||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 89999999999987542 223334567899999999999999999999999999999999999999954322
Q ss_pred CCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHhhc
Q 009979 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKR-PKMGHVIHMLEA 461 (521)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~R-Pt~~evl~~L~~ 461 (521)
.. ..+...+...+..+...+ ++..|++.+|.+| |++.++.+.|+.
T Consensus 291 ~~------------------~~~~~~~~~~~~~~~~~~---~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 291 GE------------------CKPEGLFRRLPHLDMWNE---FFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp TE------------------EEECSCCTTCSSHHHHHH---HHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred Cc------------------eeechhccccCcHHHHHH---HHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 10 111122223334455555 6679999999999 678888777764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=345.90 Aligned_cols=258 Identities=27% Similarity=0.441 Sum_probs=207.6
Q ss_pred hhcCCCccccc-eEccCCcEEEEEEEEc---CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe
Q 009979 182 EVSTNGFADEN-VIGEGGYGIVYHGVLE---DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (521)
Q Consensus 182 ~~~~~~~~~~~-~LG~G~fG~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 256 (521)
.+..++|.+.+ .||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+++++.++||||+++++++ ....
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA 83 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence 44556777776 9999999999999853 57789999997643 34457789999999999999999999999 4566
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLS 157 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred cEEEEEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccce
Confidence 89999999999999999754 35789999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcce--eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccc
Q 009979 337 KLLGAERSYV--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (521)
Q Consensus 337 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (521)
+......... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +..... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~i-~~~~ 230 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------EVMAFI-EQGK 230 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH------HHHHHH-HTTC
T ss_pred eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH------HHHHHH-hcCC
Confidence 9875433322 223457899999999988899999999999999999999 99999754321 111111 1111
Q ss_pred cccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 414 ~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
. +.+. ..++.. +.+++.+||+.||++||++.++++.|+..
T Consensus 231 ~-----~~~~-~~~~~~---l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 231 R-----MECP-PECPPE---LYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp C-----CCCC-TTCCHH---HHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred c-----CCCC-CCcCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 1111 123333 44588899999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=375.78 Aligned_cols=256 Identities=21% Similarity=0.253 Sum_probs=198.4
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
+..++|++.+.||+|+||.||+|... +++.||||++... .......+..|+.+++.++||||+++++++.+....+
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 44568999999999999999999975 5889999998653 2233456778999999999999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+ . +|+||||||+||||+.++.+||+|||+++
T Consensus 225 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCK 297 (446)
T ss_dssp EEECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred EEEeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCce
Confidence 999999999999999765 478999999999999999999998 7 99999999999999999999999999998
Q ss_pred ecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+..........
T Consensus 298 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~~~~~---- 366 (446)
T 4ejn_A 298 EGIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HEKLFELILMEEI---- 366 (446)
T ss_dssp TTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCC----
T ss_pred eccCC-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC------HHHHHHHHHhCCC----
Confidence 64322 223445789999999999999999999999999999999999999996432 1222222222110
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhhccC
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHMLEAEE 463 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~~~~ 463 (521)
.+.. ..+. .+.+++.+||+.||.+|| ++.|++++---..
T Consensus 367 ---~~p~-~~~~---~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 367 ---RFPR-TLGP---EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp ---CCCT-TSCH---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred ---CCCc-cCCH---HHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 1111 1223 344588899999999999 9999986544333
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=357.34 Aligned_cols=266 Identities=23% Similarity=0.362 Sum_probs=210.5
Q ss_pred cCCCccccceEccCCcEEEEEEEE-----cCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEe--eCCe
Q 009979 184 STNGFADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA--EGAH 256 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~--~~~~ 256 (521)
..++|++.+.||+|+||.||+|.+ .++..||||++........+.+.+|+++++.++||||+++++++. +...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 346899999999999999999985 357889999998777777788999999999999999999999886 4566
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred EEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence 89999999999999999764 24689999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCcc--eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCC--------CcccHHHHHH
Q 009979 337 KLLGAERSY--VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP--------GEVNLVEWLK 406 (521)
Q Consensus 337 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~--------~~~~~~~~~~ 406 (521)
+........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ........+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 987543322 223456888999999999999999999999999999999999998532110 0011111111
Q ss_pred HHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 009979 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 464 (521)
Q Consensus 407 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 464 (521)
....... .... ...++.. +.+++.+||+.||++|||+.+++++|+....
T Consensus 255 ~~~~~~~-----~~~~-~~~~~~~---l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 255 ELLEEGQ-----RLPA-PPACPAE---VHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHTTC-----CCCC-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHhhccc-----CCCC-CCcccHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111111 0011 1123333 4458889999999999999999999987643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=377.09 Aligned_cols=260 Identities=23% Similarity=0.281 Sum_probs=210.5
Q ss_pred hhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC
Q 009979 180 ELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (521)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 255 (521)
...+..++|.+.+.||+|+||.||+|... +++.||+|++.+.. ......+..|+++|+.++||||+++++++.+..
T Consensus 178 ~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 257 (576)
T ss_dssp TSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence 33466778999999999999999999975 68899999986532 223466888999999999999999999999999
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..|+||||++||+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+||||+.++++||+|||+
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGl 332 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGL 332 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEeccc
Confidence 9999999999999999997652 34589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
++...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+....... ..
T Consensus 333 a~~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--~~~i~~~i~~-~~-- 405 (576)
T 2acx_A 333 AVHVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVKE-VP-- 405 (576)
T ss_dssp CEECCTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--HHHHHHHHHH-CC--
T ss_pred ceecccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--HHHHHHHhhc-cc--
Confidence 98764432 23446899999999999999999999999999999999999999976543221 1222222111 11
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHML 459 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L 459 (521)
..+.. ..+. .+.+++.+||+.||.+|| ++.||+++-
T Consensus 406 ----~~~p~-~~s~---~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 406 ----EEYSE-RFSP---QARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp ----CCCCT-TSCH---HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred ----ccCCc-cCCH---HHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 11111 1223 345588899999999999 788887553
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=350.90 Aligned_cols=262 Identities=24% Similarity=0.336 Sum_probs=198.7
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
++|++.+.||+|+||+||+|.+. +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+....++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57999999999999999999976 488999999865433 234678889999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 99999999988754 5689999999999999999999999 9999999999999999999999999999876533
Q ss_pred CcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh-----------
Q 009979 343 RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT----------- 410 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----------- 410 (521)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+.....
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV---DQLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCHHHHHHHH
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhcccccccccccc
Confidence 22 2344578999999999875 67899999999999999999999999654321 11111111110
Q ss_pred -ccccc--cCCCcccCCC---ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 411 -NRNAE--GVLDPRLQEK---PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 411 -~~~~~--~~~d~~l~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
..... ...++..... ..+.....+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 0111100000 001122345568889999999999999999854
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=359.57 Aligned_cols=263 Identities=23% Similarity=0.303 Sum_probs=209.0
Q ss_pred cCCCccccceEccCCcEEEEEEEE----cCCcEEEEEEeccCC----hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeC
Q 009979 184 STNGFADENVIGEGGYGIVYHGVL----EDNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEG 254 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~ 254 (521)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+..|+++++.+ +||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 446899999999999999999997 368899999986432 22345577799999999 699999999999999
Q ss_pred CeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecc
Q 009979 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (521)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFG 334 (521)
...++||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred ceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCC
Confidence 9999999999999999999865 4689999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCcceeecccccccccccccccC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc
Q 009979 335 LAKLLGAERSYVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (521)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (521)
+++.+...........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .............
T Consensus 205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~ 282 (355)
T 1vzo_A 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE 282 (355)
T ss_dssp EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHCC
T ss_pred CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHHHhccC
Confidence 998765444444455789999999999975 457899999999999999999999997544322 2222223222211
Q ss_pred ccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhhccCCCc
Q 009979 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHMLEAEEFPF 466 (521)
Q Consensus 413 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~L~~~~~~~ 466 (521)
+.+.. ..+. .+.+++.+||+.||++|| ++.+++++.--....+
T Consensus 283 -------~~~~~-~~~~---~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 283 -------PPYPQ-EMSA---LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp -------CCCCT-TSCH---HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred -------CCCCc-ccCH---HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 11111 1223 344588899999999999 9999987765544443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=350.49 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=204.9
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh------hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ------AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
++|++.+.||+|+||.||+|.+. ++..||+|.+...... ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 46899999999999999999976 5889999998654322 3577999999999999999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC----CceEeecc
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW----NPKLSDFG 334 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~----~vkL~DFG 334 (521)
+||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 92 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999764 5689999999999999999999999 999999999999999887 79999999
Q ss_pred cceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..+.+.......
T Consensus 165 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~i~~~~-- 234 (321)
T 2a2a_A 165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT------KQETLANITSVS-- 234 (321)
T ss_dssp TCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS------HHHHHHHHHTTC--
T ss_pred cceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhcc--
Confidence 998765432 2344579999999999999999999999999999999999999996432 122222222110
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
...++.+.. ..+ ..+.+++.+||+.||++|||+.+++++
T Consensus 235 -~~~~~~~~~-~~~---~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 -YDFDEEFFS-HTS---ELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp -CCCCHHHHT-TCC---HHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred -cccChhhhc-ccC---HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001111101 122 334558889999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=370.28 Aligned_cols=248 Identities=22% Similarity=0.384 Sum_probs=205.0
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
..++|.+.+.||+|+||.||+|.+. +|+.||||++..... .....+.+|+.+++.++||||+++++++......++
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3468999999999999999999976 689999999865422 234678899999999999999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++..
T Consensus 94 v~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 94 VMEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EEECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 99999999999999754 5799999999999999999999998 9999999999999999999999999999976
Q ss_pred CCCCcceeecccccccccccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCC
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (521)
.... .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .......... . .
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~~-~----~ 233 (476)
T 2y94_A 167 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV------PTLFKKICDG-I----F 233 (476)
T ss_dssp CTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS------HHHHHHHHTT-C----C
T ss_pred cccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcC-C----c
Confidence 4432 2345689999999999988765 6899999999999999999999974432 1222222221 1 0
Q ss_pred CcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 419 d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.. +...+. .+.+++.+||+.||.+|||+.++++
T Consensus 234 --~~-p~~~s~---~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 --YT-PQYLNP---SVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --CC-CTTCCH---HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CC-CccCCH---HHHHHHHHHcCCCchhCcCHHHHHh
Confidence 01 111223 3455888999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=340.96 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=182.1
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|.+.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+++++.++||||+++++++.+....++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 47999999999999999999974 688999999864322 22467889999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999865 35789999999999999999999999 999999999999999999999999999987643
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ..... .+..
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~-------~~~~ 230 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------NKVVL-------ADYE 230 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCS-------SCCC
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------HHHhh-------cccC
Confidence 222 223457899999999999999999999999999999999999999754432111 10000 0111
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
+. ...+. .+.+++.+||+.||++||++.++++
T Consensus 231 ~~-~~~~~---~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 231 MP-SFLSI---EAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CC-TTSCH---HHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred Cc-cccCH---HHHHHHHHHcccCHhhCCCHHHHhc
Confidence 11 11233 3445888999999999999999974
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=343.62 Aligned_cols=260 Identities=20% Similarity=0.248 Sum_probs=203.3
Q ss_pred CCCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEE-eeCCeeeEEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC-AEGAHRMLVYE 262 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~-~~~~~~~lV~e 262 (521)
.++|++.+.||+|+||.||+|.+ .+++.||||++..... ...+..|+++++.++|++++..++++ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 46899999999999999999996 4688899998654322 23578899999999988777666655 66778899999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe---CCCCCceEeecccceec
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl---~~~~~vkL~DFGla~~~ 339 (521)
|+ +++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 86 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred cc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99 88999999854 34699999999999999999999999 99999999999999 78999999999999976
Q ss_pred CCCCcc------eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccc
Q 009979 340 GAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (521)
Q Consensus 340 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (521)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 543321 22356799999999999999999999999999999999999999987655444444333222211110
Q ss_pred cccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 414 ~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.. .+. ...+ ..+.+++.+||+.||++|||+.++++.|+..
T Consensus 239 ~~-----~~~-~~~~---~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 239 IE-----VLC-KGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HH-----HHT-TTSC---HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hh-----hhh-ccCC---HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 00 000 1122 3455588899999999999999999999753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=360.52 Aligned_cols=266 Identities=24% Similarity=0.405 Sum_probs=212.0
Q ss_pred hhhhcCCCccccceEccCCcEEEEEEEEcC-C-----cEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCCeeeEEEEE
Q 009979 180 ELEVSTNGFADENVIGEGGYGIVYHGVLED-N-----TNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYC 251 (521)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~ 251 (521)
.+++..++|.+.+.||+|+||.||+|.+.. + ..||+|.+.... ....+.+.+|+++++.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 456778899999999999999999999753 2 379999987643 33456789999999999 899999999999
Q ss_pred eeCCeeeEEEEeccCCchHHhhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeE
Q 009979 252 AEGAHRMLVYEYIDNGNLEQWLHGDVG----------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321 (521)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NIL 321 (521)
.+....++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence 999999999999999999999975311 134689999999999999999999999 9999999999999
Q ss_pred eCCCCCceEeecccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 009979 322 LDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEV 399 (521)
Q Consensus 322 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~ 399 (521)
++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+| |..||.......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-- 274 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-- 274 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--
Confidence 999999999999999876433322 2234567889999999999999999999999999999999 999997543221
Q ss_pred cHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 400 NLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
. +........ ... ....++. .+.+++.+||+.||.+|||+.++++.|+...
T Consensus 275 ~----~~~~~~~~~-----~~~-~~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 275 K----FYKLVKDGY-----QMA-QPAFAPK---NIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp H----HHHHHHHTC-----CCC-CCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H----HHHHHhcCC-----CCC-CCCCCCH---HHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 1 111121111 000 1111233 3455888999999999999999999998643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=341.17 Aligned_cols=252 Identities=19% Similarity=0.311 Sum_probs=203.8
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
.++|++.+.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999975 58899999986543 334467889999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCC---ceEeeccccee
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKL 338 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~---vkL~DFGla~~ 338 (521)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999988765 4689999999999999999999999 9999999999999976655 99999999987
Q ss_pred cCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCC
Q 009979 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (521)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (521)
...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ..+......... . ...
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~~~~~~~~-~-~~~ 227 (284)
T 3kk8_A 158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED------QHRLYAQIKAGA-Y-DYP 227 (284)
T ss_dssp CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTC-C-CCC
T ss_pred cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc------hhHHHHHHHhcc-c-cCC
Confidence 644322 234679999999999999999999999999999999999999996432 112222222111 0 011
Q ss_pred CcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 419 d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+. ....+.. +.+++.+||+.||++|||+.|++++
T Consensus 228 ~~~--~~~~~~~---~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 228 SPE--WDTVTPE---AKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TTT--TTTSCHH---HHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred chh--hcccCHH---HHHHHHHHcccChhhCCCHHHHhcC
Confidence 111 1112333 4458889999999999999999853
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=360.39 Aligned_cols=253 Identities=20% Similarity=0.331 Sum_probs=198.6
Q ss_pred cCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCC--CCCeeeEEEEEeeCCeeeE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVR--HKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--hpniv~l~~~~~~~~~~~l 259 (521)
..++|.+.+.||+|+||.||+|...+++.||||++... .....+.+.+|+++|+.++ ||||+++++++......||
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 34569999999999999999999888999999998654 3344578899999999996 5999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
||| +.+++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++.+
T Consensus 134 v~E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEE-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEe-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 999 5688999999875 4788999999999999999999998 999999999999996 578999999999876
Q ss_pred CCCCcc-eeecccccccccccccccC-----------CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 009979 340 GAERSY-VTTRVMGTFGYVAPEYAST-----------GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407 (521)
Q Consensus 340 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 407 (521)
...... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... +....+..
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~~~ 279 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHA 279 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CHHHHHHH
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-----HHHHHHHH
Confidence 433222 2345679999999999865 468899999999999999999999996432 22222333
Q ss_pred HhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 408 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
...... ...+... .+. .+.+++.+||+.||++||++.|++++.
T Consensus 280 ~~~~~~-----~~~~~~~-~~~---~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 280 IIDPNH-----EIEFPDI-PEK---DLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp HHCTTS-----CCCCCCC-SCH---HHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HhCccc-----cCCCCcc-chH---HHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 322111 1111111 223 345588899999999999999998653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=358.94 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=199.0
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
++|++.+.||+|+||.||+|.+. +++.||+|.+.+.... ...|++++.++ +||||+++++++.++...|+||||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 47899999999999999999976 5888999999765432 34588888887 799999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC-C---CceEeecccceec
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-W---NPKLSDFGLAKLL 339 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~-~---~vkL~DFGla~~~ 339 (521)
+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||+.+. + .+||+|||+++..
T Consensus 98 ~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 98 MKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999765 5689999999999999999999999 99999999999998433 3 4999999999976
Q ss_pred CCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+...... ...
T Consensus 171 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~~~~i~~~-~~~---- 241 (342)
T 2qr7_A 171 RAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD---TPEEILARIGSG-KFS---- 241 (342)
T ss_dssp BCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS---CHHHHHHHHHHC-CCC----
T ss_pred cCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC---CHHHHHHHHccC-Ccc----
Confidence 44332 234567999999999998888999999999999999999999999754322 222333332221 110
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
+...........+.+++.+||+.||++||++.+++++
T Consensus 242 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 --LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp --CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred --cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111111122334458889999999999999998753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=356.26 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=190.7
Q ss_pred hhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCCeeeEEEEEe-----
Q 009979 180 ELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCA----- 252 (521)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~----- 252 (521)
.+++...+|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.+++++. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 34556678999999999999999999975 68899999997777677788999999999996 999999999984
Q ss_pred ---eCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeEeCCCCC
Q 009979 253 ---EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK--VVHRDIKSSNILLDKQWN 327 (521)
Q Consensus 253 ---~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~--iiHrDik~~NILl~~~~~ 327 (521)
.....++||||+. |+|.+++.... ....+++..++.++.|++.||+|||+. + |+||||||+|||++.++.
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSC
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCC
Confidence 3445789999996 69999886532 135699999999999999999999998 7 999999999999999999
Q ss_pred ceEeecccceecCCCCcce-----------eecccccccccccccc---cCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 009979 328 PKLSDFGLAKLLGAERSYV-----------TTRVMGTFGYVAPEYA---STGMLNERSDVYSFGILIMEVISGRNPVDYS 393 (521)
Q Consensus 328 vkL~DFGla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~ 393 (521)
+||+|||+++......... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 9999999998764432211 1135689999999998 5677899999999999999999999999643
Q ss_pred CCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 394 RPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
... ...... .... .....+.. +.+++.+||+.||.+||++.++++.|+..
T Consensus 257 ~~~------~~~~~~---------~~~~-~~~~~~~~---~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 257 AKL------RIVNGK---------YSIP-PHDTQYTV---FHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp ------------------------CCCC-TTCCSSGG---GHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hHH------HhhcCc---------ccCC-cccccchH---HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 221 111100 0000 01112222 44588899999999999999999999764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=351.65 Aligned_cols=256 Identities=29% Similarity=0.485 Sum_probs=197.7
Q ss_pred cCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
..++|++.+.||+|+||.||+|.+. ++.||+|.+... ...+.+..|++++++++||||+++++++.+ ..++||||
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 3457899999999999999999985 788999998643 345778999999999999999999998874 47999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCC-ceEeecccceecCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN-PKLSDFGLAKLLGAE 342 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~-vkL~DFGla~~~~~~ 342 (521)
+++|+|.++++... ....+++..++.++.|++.||+|||+....+|+||||||+|||++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 99999999998652 2335788999999999999999999932128999999999999998887 799999999865322
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... .. .+.+
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~-~~-----~~~~ 225 (307)
T 2eva_A 160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMWAVHN-GT-----RPPL 225 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHHHHHT-TC-----CCCC
T ss_pred ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHHHHhc-CC-----CCCc
Confidence 23446999999999999999999999999999999999999999754321 1111111111 11 1111
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
.. ..+.. +.+++.+||+.||++|||+.++++.|+...
T Consensus 226 ~~-~~~~~---l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 226 IK-NLPKP---IESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp BT-TCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred cc-ccCHH---HHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 11 12333 445888999999999999999999998754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=352.03 Aligned_cols=260 Identities=21% Similarity=0.296 Sum_probs=198.2
Q ss_pred CCcccc-ceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeEEEE
Q 009979 186 NGFADE-NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 186 ~~~~~~-~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e 262 (521)
+.|.+. +.||+|+||.||+|... +++.||||++..........+.+|++++.++ +||||+++++++.++...++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 467774 78999999999999954 6889999999776666667889999999985 79999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCC---ceEeecccceec
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFGLAKLL 339 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~---vkL~DFGla~~~ 339 (521)
|+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++...
T Consensus 92 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 92 KMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred cCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999865 4689999999999999999999999 9999999999999988776 999999999865
Q ss_pred CCCCc------ceeecccccccccccccccC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcc--------c
Q 009979 340 GAERS------YVTTRVMGTFGYVAPEYAST-----GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV--------N 400 (521)
Q Consensus 340 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~--------~ 400 (521)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 32211 11223569999999999865 56899999999999999999999999765432210 0
Q ss_pred HHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 401 LVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
....+...+..... .+...........+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~i~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGKY------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccCc------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01111111111110 00000001112345568889999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=342.21 Aligned_cols=260 Identities=19% Similarity=0.243 Sum_probs=206.4
Q ss_pred CCCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEE-eeCCeeeEEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC-AEGAHRMLVYE 262 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~-~~~~~~~lV~e 262 (521)
.++|++.+.||+|+||.||+|.+ .+++.||+|.+..... .+.+..|+.+++.++|++++..+.++ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999997 4688999998865432 34688899999999988866665554 66778899999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe---CCCCCceEeecccceec
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl---~~~~~vkL~DFGla~~~ 339 (521)
|+ +++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 88999999754 35799999999999999999999999 99999999999999 48889999999999976
Q ss_pred CCCCcc------eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccc
Q 009979 340 GAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (521)
Q Consensus 340 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (521)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 543321 12456799999999999999999999999999999999999999987654444443333322111110
Q ss_pred cccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 414 ~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
. +.+. ...+ ..+.+++.+||+.||++||++.+|++.|+..
T Consensus 239 ~-----~~~~-~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 239 I-----EVLC-KGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp H-----HHHT-TTSC---HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred h-----HHHH-hhCC---HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 0 0000 1122 3355588899999999999999999999753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=349.52 Aligned_cols=267 Identities=24% Similarity=0.371 Sum_probs=212.3
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEE------cCCcEEEEEEeccCCh-hhHHHHHHHHHHHhcC-CCCCeeeEEE
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLG 249 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~hpniv~l~~ 249 (521)
...+++..++|++.+.||+|+||.||+|.+ .+++.||+|.+..... ...+.+.+|+++++.+ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 456677788999999999999999999985 2457899999876433 3446788999999999 7999999999
Q ss_pred EEeeCC-eeeEEEEeccCCchHHhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 009979 250 YCAEGA-HRMLVYEYIDNGNLEQWLHGDVGP------------HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIK 316 (521)
Q Consensus 250 ~~~~~~-~~~lV~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik 316 (521)
++...+ ..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +|+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCc
Confidence 987754 589999999999999999875321 12388999999999999999999999 99999999
Q ss_pred CCCeEeCCCCCceEeecccceecCCCCc-ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCC
Q 009979 317 SSNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSR 394 (521)
Q Consensus 317 ~~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~ 394 (521)
|+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |..||....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999987644332 22344668999999999999999999999999999999998 999997543
Q ss_pred CCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 395 PPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
... . +...+..... .... ...+. .+.+++.+||+.||.+|||+.+++++|+..
T Consensus 256 ~~~--~----~~~~~~~~~~-----~~~~-~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 256 IDE--E----FCRRLKEGTR-----MRAP-DYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CSH--H----HHHHHHHTCC-----CCCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhH--H----HHHHhccCcc-----CCCC-CCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 221 1 1111111110 0111 11233 344588899999999999999999999754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=360.88 Aligned_cols=247 Identities=26% Similarity=0.296 Sum_probs=193.7
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHH-HhcCCCCCeeeEEEEEeeCCeee
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEA-IGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~-l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
..++|++.+.||+|+||.||+|++. ++..||+|++.+... .....+..|..+ ++.++||||+++++++.+....|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 4468999999999999999999976 478899999965432 233455667766 57789999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+||||++||+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++.
T Consensus 116 lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 999999999999999765 4688999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCC
Q 009979 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (521)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (521)
.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+..........
T Consensus 189 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~------~~~~~~~~i~~~~~----- 256 (373)
T 2r5t_A 189 NIEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR------NTAEMYDNILNKPL----- 256 (373)
T ss_dssp GBCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS------BHHHHHHHHHHSCC-----
T ss_pred cccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC------CHHHHHHHHHhccc-----
Confidence 4322 22345578999999999999999999999999999999999999999643 22333333332210
Q ss_pred CcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 009979 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHV 455 (521)
Q Consensus 419 d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~ev 455 (521)
.+.. ..+.. +.+++.+||+.||.+||++.+.
T Consensus 257 --~~~~-~~~~~---~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 257 --QLKP-NITNS---ARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp --CCCS-SSCHH---HHHHHHHHTCSSGGGSTTTTTT
T ss_pred --CCCC-CCCHH---HHHHHHHHcccCHHhCCCCCCC
Confidence 1111 12333 4458889999999999998533
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=343.97 Aligned_cols=252 Identities=21% Similarity=0.356 Sum_probs=197.3
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
++|.+.+.||+|+||.||+|... ++..||+|++.... ....+.+..|+++++.++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 47899999999999999999975 58899999987643 23457889999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe---CCCCCceEeecccceecC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl---~~~~~vkL~DFGla~~~~ 340 (521)
+++|+|.+++.........+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999865432346799999999999999999999999 99999999999999 456789999999998754
Q ss_pred CCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
... ......||+.|+|||++. ..++.++|||||||++|||++|+.||.... ..+.......... ..
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~------~~~~~~~~~~~~~-----~~ 244 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS------LEEVQQKATYKEP-----NY 244 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCC-----CC
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC------HHHHHhhhccCCc-----cc
Confidence 322 234567999999999885 568899999999999999999999996432 1222222111110 00
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.....+.+. .+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~---~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 AVECRPLTP---QAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC--CCCCH---HHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccccCcCCH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111233 3445888999999999999999984
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=350.73 Aligned_cols=261 Identities=20% Similarity=0.299 Sum_probs=203.1
Q ss_pred hhhhhhcCCCcccc-ceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCC-CCCeeeEEEEEe
Q 009979 178 LRELEVSTNGFADE-NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVR-HKNLVRLLGYCA 252 (521)
Q Consensus 178 ~~~~~~~~~~~~~~-~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~ 252 (521)
+...+...++|.+. +.||+|+||.||+|... +++.||+|++.... ......+..|+.+++.+. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33444455677777 89999999999999976 58899999987543 233577889999999995 699999999999
Q ss_pred eCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---CCCce
Q 009979 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPK 329 (521)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~---~~~vk 329 (521)
+....++||||+++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+|
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence 999999999999999999998654 246789999999999999999999999 9999999999999987 78999
Q ss_pred EeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHh
Q 009979 330 LSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409 (521)
Q Consensus 330 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 409 (521)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......
T Consensus 175 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~ 246 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN------QETYLNIS 246 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH
T ss_pred EeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHHH
Confidence 99999999764332 23446799999999999999999999999999999999999999964321 11111111
Q ss_pred hccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 410 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
... . ....+.. ...+. .+.+++.+||+.||++|||+.+++++
T Consensus 247 ~~~-~-~~~~~~~--~~~~~---~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 247 QVN-V-DYSEETF--SSVSQ---LATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HTC-C-CCCTTTT--TTSCH---HHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred hcc-c-ccCchhh--cccCH---HHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 110 0 0001111 11233 34458889999999999999999854
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=351.97 Aligned_cols=265 Identities=22% Similarity=0.370 Sum_probs=189.1
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
.++|++.+.||+|+||.||+|.+. +++.||+|.+..... ...+.+.+|+++++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457999999999999999999965 588999999865432 334678899999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 263 YIDNGNLEQWLHGDV--GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|++ |+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999886532 1234689999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc-----
Q 009979 341 AERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA----- 414 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----- 414 (521)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.........
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND---EEQLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCTTTCGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCChhHhhh
Confidence 3322 2334578999999999876 4689999999999999999999999974432 1111111111110000
Q ss_pred -c--cCCCcccCCC---c---------cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 415 -E--GVLDPRLQEK---P---------CSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 415 -~--~~~d~~l~~~---~---------~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
. ....+.+... . .......+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 0000000000 0 0011234556888999999999999999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=355.55 Aligned_cols=274 Identities=25% Similarity=0.379 Sum_probs=200.9
Q ss_pred hcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHH--HhcCCCCCeeeEEEEEee-----CC
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEA--IGRVRHKNLVRLLGYCAE-----GA 255 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~--l~~l~hpniv~l~~~~~~-----~~ 255 (521)
+..++|++.+.||+|+||.||+|.+ +++.||||++.... ...+..|.++ +..++||||+++++++.. ..
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 4567899999999999999999987 58899999986432 2334444444 455899999999986532 23
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeeecCCCCCCeEeCCCCCce
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL------EPKVVHRDIKSSNILLDKQWNPK 329 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~------~~~iiHrDik~~NILl~~~~~vk 329 (521)
..++||||+++|+|.+++... ..++..++.++.|++.||+|||+.. .++|+||||||+|||++.++.+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred eEEEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 568999999999999999765 4588999999999999999999762 33899999999999999999999
Q ss_pred EeecccceecCCCC-------cceeecccccccccccccccC-------CCCCCcccchhHHHHHHHHHhCCCCCCCCCC
Q 009979 330 LSDFGLAKLLGAER-------SYVTTRVMGTFGYVAPEYAST-------GMLNERSDVYSFGILIMEVISGRNPVDYSRP 395 (521)
Q Consensus 330 L~DFGla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~ 395 (521)
|+|||+++.+.... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998764322 112234579999999999876 4567789999999999999999877654332
Q ss_pred CCccc-----------HHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 009979 396 PGEVN-----------LVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 464 (521)
Q Consensus 396 ~~~~~-----------~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 464 (521)
..... ..+..............+...... .......+.+++.+||+.||++|||+.|+++.|+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE--NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCC--CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccccc--ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 21110 111112222211111111111111 22344556678899999999999999999999987655
Q ss_pred Cch
Q 009979 465 PFR 467 (521)
Q Consensus 465 ~~~ 467 (521)
.+.
T Consensus 319 ~~~ 321 (336)
T 3g2f_A 319 IWE 321 (336)
T ss_dssp CCC
T ss_pred HHH
Confidence 443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=350.06 Aligned_cols=263 Identities=26% Similarity=0.382 Sum_probs=208.0
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhc--CCCCCeeeEEEEEeeCC----
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGR--VRHKNLVRLLGYCAEGA---- 255 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~hpniv~l~~~~~~~~---- 255 (521)
+...++|.+.+.||+|+||.||+|.+ +++.||||.+... ....+..|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 44456899999999999999999998 4889999998543 34567788888887 78999999999998776
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCCeEeCCCCC
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH--------EGLEPKVVHRDIKSSNILLDKQWN 327 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH--------~~~~~~iiHrDik~~NILl~~~~~ 327 (521)
..++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+|||++.++.
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSC
T ss_pred eeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCC
Confidence 789999999999999999754 5899999999999999999999 76 9999999999999999999
Q ss_pred ceEeecccceecCCCCcc---eeecccccccccccccccCCC------CCCcccchhHHHHHHHHHhC----------CC
Q 009979 328 PKLSDFGLAKLLGAERSY---VTTRVMGTFGYVAPEYASTGM------LNERSDVYSFGILIMEVISG----------RN 388 (521)
Q Consensus 328 vkL~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwS~Gvvl~elltG----------~~ 388 (521)
+||+|||+++........ ......||+.|+|||++.+.. ++.++|||||||++|||+|| ..
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 999999999876544322 224457999999999987652 34689999999999999999 78
Q ss_pred CCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCC-ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 389 PVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK-PCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 389 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
||....+.. .....+... +... ...+.+... ........+.+++.+||+.||++|||+.+|+++|+..
T Consensus 266 p~~~~~~~~-~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 266 PYYDLVPSD-PSVEEMRKV-VCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTTTTSCSS-CCHHHHHHH-HTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CccccCcCc-ccHHHHHHH-HHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 886544322 222222222 2221 122222211 1234555667799999999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=373.00 Aligned_cols=260 Identities=22% Similarity=0.282 Sum_probs=210.2
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
.+..++|.+.+.||+|+||.||+|++. +++.||+|++.+... .....+..|+++++.++||||+++++++.+....
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 345578999999999999999999975 589999999965422 2346788899999999999999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
|+||||++||+|.+++.........+++..++.++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceee
Confidence 999999999999999987644456799999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+.........
T Consensus 338 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~~~----- 409 (543)
T 3c4z_A 338 ELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLEQA----- 409 (543)
T ss_dssp ECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHHCC-----
T ss_pred eccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhhcc-----
Confidence 7654322 2344689999999999999999999999999999999999999997653221 2222233322211
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM-----GHVIHM 458 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~-----~evl~~ 458 (521)
..+. ...+.. +.+++.+||+.||++||++ .+|+.+
T Consensus 410 --~~~p-~~~s~~---~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 410 --VTYP-DKFSPA---SKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp --CCCC-TTSCHH---HHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred --cCCC-cccCHH---HHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 0111 112333 4458889999999999975 666643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=351.98 Aligned_cols=247 Identities=27% Similarity=0.414 Sum_probs=201.1
Q ss_pred CCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
+.|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++.++...++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588999999999999999996 468889999986543 233467889999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+. |+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 5888888654 35789999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcceeeccccccccccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCC
Q 009979 342 ERSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (521)
. ....||+.|+|||++. ...++.++|||||||++|||++|+.||.... ....+.......
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~------~~~~~~~~~~~~------ 269 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNE------ 269 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSC------
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcC------
Confidence 2 3457999999999884 5779999999999999999999999996432 222233332221
Q ss_pred CcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 419 d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
.+.+.....+..+. +++.+||+.||++|||+.+++++.
T Consensus 270 ~~~~~~~~~~~~l~---~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 270 SPALQSGHWSEYFR---NFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp CCCCCCTTSCHHHH---HHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CCCCCCCCCCHHHH---HHHHHHcccChhhCcCHHHHhhCh
Confidence 11222222344444 477899999999999999998543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=351.81 Aligned_cols=264 Identities=25% Similarity=0.339 Sum_probs=197.6
Q ss_pred hcCCCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccCC-----hhhHHHHHHHHHHHhcCC---CCCeeeEEEEEee
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR-----GQAEKEFKVEVEAIGRVR---HKNLVRLLGYCAE 253 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~---hpniv~l~~~~~~ 253 (521)
+..++|++.+.||+|+||+||+|.+ .+++.||+|++.... ......+.+|+++++.++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467899999999999999999996 468899999986432 112345667777777664 9999999999987
Q ss_pred CC-----eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCc
Q 009979 254 GA-----HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328 (521)
Q Consensus 254 ~~-----~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~v 328 (521)
.. ..++||||+. ++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 55 5789999997 59999998763 34589999999999999999999999 99999999999999999999
Q ss_pred eEeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH
Q 009979 329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408 (521)
Q Consensus 329 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 408 (521)
||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...
T Consensus 160 kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~ 234 (308)
T 3g33_A 160 KLADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLGKIFDL 234 (308)
T ss_dssp EECSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH---HHHHHHHHHH
T ss_pred EEeeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHH
Confidence 99999999865432 223456799999999999999999999999999999999999999964331 1111111111
Q ss_pred hhccccccC------CCcccCC---C----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 409 VTNRNAEGV------LDPRLQE---K----PCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 409 ~~~~~~~~~------~d~~l~~---~----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
......... ....+.. . ..+.....+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 111000000 0000000 0 00112234556888999999999999999984
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=346.90 Aligned_cols=258 Identities=25% Similarity=0.404 Sum_probs=203.7
Q ss_pred ccccceEccCCcEEEEEEEEc-----CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC--CeeeE
Q 009979 188 FADENVIGEGGYGIVYHGVLE-----DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG--AHRML 259 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~--~~~~l 259 (521)
|++.+.||+|+||+||++.+. +++.||||++..... ...+.+.+|+++++.++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999998753 578899999976533 3456789999999999999999999999874 67899
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
||||+++|+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999764 489999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCcc--eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCC--------CcccHHHHHHHHh
Q 009979 340 GAERSY--VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPP--------GEVNLVEWLKTMV 409 (521)
Q Consensus 340 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~--------~~~~~~~~~~~~~ 409 (521)
...... ......||..|+|||++.+..++.++|||||||++|||+||+.||...... ........+....
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 544322 223456888999999999989999999999999999999999998632110 0000011111222
Q ss_pred hccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 410 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.... .... ...++. .+.+++.+||+.||++|||+.++++.|+..
T Consensus 265 ~~~~-----~~~~-~~~~~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 265 ERGE-----RLPR-PDKCPA---EVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HTTC-----CCCC-CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hccc-----CCCC-CccccH---HHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111 0011 112333 455588899999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=362.94 Aligned_cols=200 Identities=26% Similarity=0.425 Sum_probs=163.3
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCC--eee
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGA--HRM 258 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~--~~~ 258 (521)
.++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|+.+++.+. ||||+++++++...+ ..|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 458999999999999999999975 6889999998643 3344566788999999997 999999999997544 689
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+|||||+ ++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 88 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 9999997 5999999763 688999999999999999999999 999999999999999999999999999987
Q ss_pred cCCC--------------------CcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 009979 339 LGAE--------------------RSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYS 393 (521)
Q Consensus 339 ~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~ 393 (521)
+... .....+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 5321 1122345689999999999876 67999999999999999999999999754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=345.75 Aligned_cols=260 Identities=28% Similarity=0.428 Sum_probs=205.4
Q ss_pred hhhhcCCCccccc-eEccCCcEEEEEEEEc---CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEee
Q 009979 180 ELEVSTNGFADEN-VIGEGGYGIVYHGVLE---DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAE 253 (521)
Q Consensus 180 ~~~~~~~~~~~~~-~LG~G~fG~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~ 253 (521)
++.+..++|.+.+ .||+|+||.||+|.+. ++..||||.+..... ...+.+.+|+++++.++||||+++++++ .
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 3445567888888 9999999999999653 367899999875432 2357799999999999999999999999 5
Q ss_pred CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeec
Q 009979 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (521)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DF 333 (521)
....++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccC
Confidence 56789999999999999999875 4689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCccee--ecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhh
Q 009979 334 GLAKLLGAERSYVT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVT 410 (521)
Q Consensus 334 Gla~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (521)
|++........... ....||+.|+|||.+.+..++.++||||||+++|||++ |+.||..... .+... .+.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~-~~~ 234 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------SEVTA-MLE 234 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHH-HHH
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH------HHHHH-HHH
Confidence 99988754433222 23456789999999988889999999999999999999 9999974432 11112 222
Q ss_pred ccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 411 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
.... +.+. ..++.. +.+++.+||+.||++||++.++++.|+..-
T Consensus 235 ~~~~-----~~~~-~~~~~~---l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 235 KGER-----MGCP-AGCPRE---MYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp TTCC-----CCCC-TTCCHH---HHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cCCC-----CCCC-CCCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 1111 123333 445888999999999999999999998653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=349.73 Aligned_cols=266 Identities=22% Similarity=0.400 Sum_probs=200.8
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEc----CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEE
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~ 251 (521)
+.++.+..++|.+.+.||+|+||.||+|.+. ++..||+|.+... .....+.+..|+.+++.++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 5556677889999999999999999999864 2347999998654 233456789999999999999999999999
Q ss_pred eeCC-----eeeEEEEeccCCchHHhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC
Q 009979 252 AEGA-----HRMLVYEYIDNGNLEQWLHGDV--GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK 324 (521)
Q Consensus 252 ~~~~-----~~~lV~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~ 324 (521)
.+.. ..++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+. +|+||||||+|||++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcC
Confidence 7755 3499999999999999985432 2346799999999999999999999998 9999999999999999
Q ss_pred CCCceEeecccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHH
Q 009979 325 QWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLV 402 (521)
Q Consensus 325 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~ 402 (521)
++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ...
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~ 259 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMY 259 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHH
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHH
Confidence 999999999999876433221 2233567889999999999999999999999999999999 89999654322 111
Q ss_pred HHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 403 EWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 403 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
........ +... ..++. .+.+++.+||+.||.+||++.+++++|+..
T Consensus 260 ---~~~~~~~~------~~~~-~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 260 ---DYLLHGHR------LKQP-EDCLD---ELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp ---HHHHTTCC------CCCB-TTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHcCCC------CCCC-ccccH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111110 1111 11233 445588899999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=340.29 Aligned_cols=251 Identities=27% Similarity=0.389 Sum_probs=202.4
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.++...++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 47889999999999999999976 68899999986443 34457789999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 87 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 87 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999998754 5689999999999999999999998 99999999999999999999999999998754322
Q ss_pred c-ceeecccccccccccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 344 S-YVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 344 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
. .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ .. ....... ....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~----~~~~~~~---~~~~-- 229 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EY----SDWKEKK---TYLN-- 229 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HH----HHHHTTC---TTST--
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HH----HHhhhcc---cccC--
Confidence 1 22344679999999999987665 7799999999999999999999975443211 11 1111110 0010
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
........+.+++.+||+.||++|||+.++++
T Consensus 230 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 ----PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 01112233455888999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=343.45 Aligned_cols=255 Identities=29% Similarity=0.455 Sum_probs=200.2
Q ss_pred CCccccceEccCCcEEEEEEEEcC----CcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEe-eCCeeeE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLED----NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCA-EGAHRML 259 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~-~~~~~~l 259 (521)
.+|++.+.||+|+||.||+|.+.+ ...||+|.+.... ....+.+.+|+.++++++||||+++++++. .+...++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 468889999999999999998643 2258999887543 344577899999999999999999999864 4567899
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999764 35689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCc---ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 340 GAERS---YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 340 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
..... .......||+.|+|||.+.+..++.++||||||+++|||++ |..||....... .. .......
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~---~~~~~~~--- 249 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---IT---VYLLQGR--- 249 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HH---HHHHTTC---
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HH---HHHhcCC---
Confidence 44322 12234567889999999999999999999999999999999 555665433221 11 1111111
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
. ......++.. +.+++.+||+.||++||++.++++.|+..
T Consensus 250 ~----~~~~~~~~~~---l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 250 R----LLQPEYCPDP---LYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp C----CCCCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----CCCCccCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 1111223333 44588899999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=343.20 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=200.6
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh------hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46889999999999999999986 588999999865432 23578999999999999999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC----CceEeecc
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW----NPKLSDFG 334 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~----~vkL~DFG 334 (521)
+||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999764 4689999999999999999999998 999999999999998877 89999999
Q ss_pred cceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ..+.+.......
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~-- 227 (283)
T 3bhy_A 158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET------KQETLTNISAVN-- 227 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTTC--
T ss_pred cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc------hHHHHHHhHhcc--
Confidence 998764332 2234579999999999999999999999999999999999999996432 122222221110
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
...++.. .......+.+++.+||+.||++||++.++++
T Consensus 228 -~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 -YDFDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -CCCCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -cCCcchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0001100 1111234555888999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=364.75 Aligned_cols=256 Identities=24% Similarity=0.301 Sum_probs=194.5
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC------C
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------A 255 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------~ 255 (521)
.++|++.+.||+|+||+||+|.+. +++.||||++... .....+.+.+|+.+|+.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999965 5888999999754 334456788999999999999999999999654 3
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..||||||+++ +|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 56999999976 67776643 488999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh-----
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT----- 410 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----- 410 (521)
++..... ...+..+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+. .+.+..++.
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~------~~~~~~i~~~lg~p 282 (464)
T 3ttj_A 211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY------IDQWNKVIEQLGTP 282 (464)
T ss_dssp C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCSC
T ss_pred eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHhcCCC
Confidence 9876432 234557899999999999999999999999999999999999999965431 111111111
Q ss_pred -----------------cccc-c-----cCCCccc-CCC--ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 411 -----------------NRNA-E-----GVLDPRL-QEK--PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 411 -----------------~~~~-~-----~~~d~~l-~~~--~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.... . ......+ ... ........+.+|+.+||+.||++|||+.|++++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0 0000000 000 001124457779999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=353.91 Aligned_cols=242 Identities=21% Similarity=0.360 Sum_probs=200.3
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--------hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 256 (521)
++|++.+.||+|+||.||+|.+. +++.||||.+..... .....+..|+++++.++||||+++++++.+...
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 47999999999999999999965 688899999876432 123456779999999999999999999999999
Q ss_pred eeEEEEeccCC-chHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 257 RMLVYEYIDNG-NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 257 ~~lV~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
.++||||+.+| +|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 99999999777 999999865 4699999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .
T Consensus 177 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------------~ 237 (335)
T 3dls_A 177 AAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------------V 237 (335)
T ss_dssp CEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------T
T ss_pred ceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------H
Confidence 997654332 334679999999999988776 78999999999999999999999632110 0
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
..... .....+.. +.+++.+||+.||++|||+.++++.-
T Consensus 238 ~~~~~---~~~~~~~~---l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 238 EAAIH---PPYLVSKE---LMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp TTCCC---CSSCCCHH---HHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred hhccC---CCcccCHH---HHHHHHHHccCChhhCcCHHHHhcCc
Confidence 01111 11113333 44588899999999999999998753
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=358.25 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=193.5
Q ss_pred CccccceEccCCcEEEEEEEEc--CC--cEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEee-CCeeeEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLE--DN--TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-GAHRMLV 260 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-~~~~~lV 260 (521)
.|.+.+.||+|+||.||+|.+. ++ ..||+|.+.... ....+.+.+|+.++++++||||+++++++.+ +...++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4778899999999999999864 22 358999886533 3445789999999999999999999998754 4578999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+++|+|.++++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999765 35688999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCcc---eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 341 AERSY---VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 341 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
..... ......||+.|+|||++.+..++.++|||||||++|||+| |..||....... .... ..... .
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~---~~~~~---~ 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY---LLQGR---R 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH---HHTTC---C
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH---HHcCC---C
Confidence 33211 1234567889999999999999999999999999999999 677886543321 2211 11111 1
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
. ..+..++.. +.+++.+||+.||++||++.++++.|+...
T Consensus 315 ~----~~p~~~~~~---l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 315 L----LQPEYCPDP---LYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp C----CCCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C----CCCCCCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 111224444 445888999999999999999999998653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=343.82 Aligned_cols=250 Identities=20% Similarity=0.323 Sum_probs=201.1
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
++|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 47899999999999999999975 68899999998665555577889999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe---CCCCCceEeecccceecCC
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl---~~~~~vkL~DFGla~~~~~ 341 (521)
++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++....
T Consensus 89 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 89 SGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999998764 4689999999999999999999999 99999999999999 7889999999999976432
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... . . ....
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~i~~~~-~-~-~~~~ 229 (304)
T 2jam_A 162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET------ESKLFEKIKEGY-Y-E-FESP 229 (304)
T ss_dssp B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHCC-C-C-CCTT
T ss_pred C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHcCC-C-C-CCcc
Confidence 2 2234579999999999999999999999999999999999999996432 112222222211 0 0 0111
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.. ...+. .+.+++.+||+.||++||++.+++++
T Consensus 230 ~~-~~~~~---~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 230 FW-DDISE---SAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TT-TTSCH---HHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cc-ccCCH---HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11 11233 34558889999999999999999853
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=381.92 Aligned_cols=258 Identities=27% Similarity=0.438 Sum_probs=202.6
Q ss_pred hhcCCCccccc-eEccCCcEEEEEEEEc---CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe
Q 009979 182 EVSTNGFADEN-VIGEGGYGIVYHGVLE---DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (521)
Q Consensus 182 ~~~~~~~~~~~-~LG~G~fG~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 256 (521)
.+..+++.+.+ .||+|+||.||+|.+. ++..||||++.... ....+.+.+|+++|+.++||||++++++|.. ..
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 409 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence 44555666666 8999999999999864 45679999997643 3356789999999999999999999999976 56
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.+|||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred eEEEEEeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 89999999999999999765 45799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCccee--ecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccc
Q 009979 337 KLLGAERSYVT--TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (521)
Q Consensus 337 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (521)
+.......... ....+|+.|+|||++.+..++.++|||||||+||||+| |+.||...... +.... +..+.
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------~~~~~-i~~~~ 556 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------EVMAF-IEQGK 556 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH------HHHHH-HHTTC
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH------HHHHH-HHcCC
Confidence 87643332222 22345789999999999999999999999999999998 99999754321 11222 22111
Q ss_pred cccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 414 ~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
. ... ...++.. +.+++.+||+.||++||++.+|++.|+..
T Consensus 557 ~-----~~~-p~~~~~~---l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 557 R-----MEC-PPECPPE---LYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp C-----CCC-CTTCCHH---HHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred C-----CCC-CCcCCHH---HHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0 011 1123444 44588899999999999999999999863
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=352.45 Aligned_cols=257 Identities=27% Similarity=0.466 Sum_probs=198.8
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcE----EEEEEeccC-ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTN----VAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
..++|++.+.||+|+||.||+|.+. +++. ||+|.+... .....+.+.+|+.+++.++||||+++++++..+. .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 4568999999999999999999965 3443 577776543 3345578899999999999999999999998765 7
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+.+|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 92 ~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred eEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 8999999999999999875 35789999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCc-ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 338 LLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 338 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
....... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||...... ..... +....
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~----~~~~~-- 236 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSI----LEKGE-- 236 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH----HHTTC--
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHH----HHcCC--
Confidence 7643322 22233457889999999999999999999999999999999 99999754322 22211 11111
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
... ....++.. +.+++.+||+.||.+||++.++++.|+...
T Consensus 237 ---~~~-~~~~~~~~---l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 237 ---RLP-QPPICTID---VYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ---CCC-CCTTBCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCC-CCccCCHH---HHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 000 11123333 445888999999999999999999998654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=351.56 Aligned_cols=261 Identities=22% Similarity=0.351 Sum_probs=194.0
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhh-HHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQA-EKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
++|.+.+.||+|+||+||+|... +++.||+|++....... ...+.+|+++++.++||||+++++++.+....++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999976 68899999986543221 12445699999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
++ |+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 5999998875 35689999999999999999999999 99999999999999999999999999998654322
Q ss_pred cceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc---cCC-
Q 009979 344 SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE---GVL- 418 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~- 418 (521)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.......... ...
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV---EEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChHhchhhhc
Confidence 22334578999999999876 5689999999999999999999999975432 12222222221111000 000
Q ss_pred --------CcccCCCc----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 419 --------DPRLQEKP----CSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 419 --------d~~l~~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.+...... .+.....+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000 0111234556888999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=362.52 Aligned_cols=194 Identities=24% Similarity=0.368 Sum_probs=155.7
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC-----Ce
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AH 256 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----~~ 256 (521)
.++|++.+.||+|+||+||+|.+. +++.||||++... .....+.+.+|+++|+.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 358999999999999999999965 6889999998653 333456788999999999999999999999443 56
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.|+||||+ +++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 56999999764 5799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCc--------------------------ceeecccccccccccccc-cCCCCCCcccchhHHHHHHHHHhC
Q 009979 337 KLLGAERS--------------------------YVTTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISG 386 (521)
Q Consensus 337 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwS~Gvvl~elltG 386 (521)
+....... ...+..+||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 87642211 123456789999999976 567799999999999999999993
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=358.00 Aligned_cols=261 Identities=16% Similarity=0.186 Sum_probs=203.8
Q ss_pred CCCccccceEccCCcEEEEEEEEcC---------CcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeee---------
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLED---------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR--------- 246 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~--------- 246 (521)
.++|.+.+.||+|+||.||+|.+.. ++.||+|.+... +.+.+|+++++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999763 788999998654 45778999999999999887
Q ss_pred ------EEEEEee-CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 009979 247 ------LLGYCAE-GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN 319 (521)
Q Consensus 247 ------l~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~N 319 (521)
+++++.. +...++||||+ +++|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 6777776 67889999999 999999998652 35799999999999999999999999 99999999999
Q ss_pred eEeCCCC--CceEeecccceecCCCCcc------eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 009979 320 ILLDKQW--NPKLSDFGLAKLLGAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391 (521)
Q Consensus 320 ILl~~~~--~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~ 391 (521)
||++.++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999988 8999999999876433221 1234579999999999999999999999999999999999999997
Q ss_pred CCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 392 YSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
...... ............ ....+.+........+.. +.+++.+||+.||++||++.++++.|+..
T Consensus 270 ~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~---l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 270 NCLPNT-EDIMKQKQKFVD--KPGPFVGPCGHWIRPSET---LQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp GGTTCH-HHHHHHHHHHHH--SCCCEECTTSCEECCCHH---HHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cCCcCH-HHHHHHHHhccC--ChhhhhhhccccCCCcHH---HHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 554221 112222221111 111111111111112333 44588899999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=343.33 Aligned_cols=256 Identities=24% Similarity=0.335 Sum_probs=203.5
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEee--CCeeeEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLV 260 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~~lV 260 (521)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+..|+++++.++||||+++++++.+ ....++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 57899999999999999999976 68889999987543 3345678899999999999999999998854 5678999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eeecCCCCCCeEeCCCCCceEeeccc
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK-----VVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~-----iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
|||+++++|.+++.........+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999976533345699999999999999999999998 7 99999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+....... ....
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~i~~-~~~~ 234 (279)
T 2w5a_A 163 ARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS------QKELAGKIRE-GKFR 234 (279)
T ss_dssp HHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHH-TCCC
T ss_pred heeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC------HHHHHHHHhh-cccc
Confidence 987643322 2234578999999999999899999999999999999999999996442 1122222221 1111
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
.+.. ..+.. +.+++.+||+.||++||++.++++.+..
T Consensus 235 -----~~~~-~~~~~---l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 235 -----RIPY-RYSDE---LNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -----CCCT-TSCHH---HHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----cCCc-ccCHH---HHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1111 12333 4458889999999999999999977653
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=357.85 Aligned_cols=271 Identities=21% Similarity=0.257 Sum_probs=211.2
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC--eeeE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA--HRML 259 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~--~~~l 259 (521)
..++|.+.+.||+|+||+||+|.+. +++.||||++.... ....+.+.+|+++++.++||||+++++++.... ..++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 3568999999999999999999976 48899999987543 233567788999999999999999999998765 6799
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe----CCCCCceEeeccc
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL----DKQWNPKLSDFGL 335 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl----~~~~~vkL~DFGl 335 (521)
||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 87 v~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 9999999999999976522 23489999999999999999999999 99999999999999 7778899999999
Q ss_pred ceecCCCCcceeecccccccccccccccC--------CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST--------GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 407 (521)
++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .+.+..
T Consensus 163 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~ 238 (396)
T 4eut_A 163 ARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYK 238 (396)
T ss_dssp CEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHH
T ss_pred ceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHH
Confidence 99765432 2334679999999998864 56788999999999999999999999754432221 222333
Q ss_pred Hhhccccc------cCCC--------cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 408 MVTNRNAE------GVLD--------PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 408 ~~~~~~~~------~~~d--------~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
........ .... ..............+..++.+||+.||++||++.++++.++..
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 33221100 0000 0011112344555666799999999999999999999888654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=348.22 Aligned_cols=264 Identities=22% Similarity=0.395 Sum_probs=208.6
Q ss_pred cCCCccccceEccCCcEEEEEEEE-----cCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC--e
Q 009979 184 STNGFADENVIGEGGYGIVYHGVL-----EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA--H 256 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~--~ 256 (521)
..++|++.+.||+|+||.||+|.+ .+++.||+|++........+.+.+|+++++.++||||+++++++.... .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 345789999999999999999984 357889999998776666788999999999999999999999987654 6
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcch
Confidence 79999999999999999875 34689999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCcce--eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC---------CCCcccHHHHH
Q 009979 337 KLLGAERSYV--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR---------PPGEVNLVEWL 405 (521)
Q Consensus 337 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~---------~~~~~~~~~~~ 405 (521)
+......... .....+|..|+|||.+.+..++.++|||||||++|||+||..||.... ..........+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 9875443322 223457888999999998889999999999999999999999985321 00001111111
Q ss_pred HHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 406 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
...+..... ... ...++.. +.+++.+||+.||++||++.++++.|+..
T Consensus 273 ~~~~~~~~~-----~~~-~~~~~~~---l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 273 IELLKNNGR-----LPR-PDGCPDE---IYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHHTTCC-----CCC-CTTCCHH---HHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhhcCCC-----CCC-CCcccHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 122211110 001 1123333 44588899999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=352.83 Aligned_cols=203 Identities=26% Similarity=0.421 Sum_probs=177.8
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
++..++|++.+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 345678999999999999999999976 6888999998765 33445778999999999999999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
||||+++++|.+++... ..+++..+..++.|++.||+|||+.. +|+||||||+|||++.++.+||+|||++...
T Consensus 109 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp EECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 99999999999999865 46899999999999999999999831 7999999999999999999999999999765
Q ss_pred CCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~ 393 (521)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 183 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 183 IDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp HHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 321 233457999999999999999999999999999999999999999643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=340.48 Aligned_cols=255 Identities=26% Similarity=0.400 Sum_probs=200.8
Q ss_pred CccccceEccCCcEEEEEEEEcC-Cc---EEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee-eEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLED-NT---NVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR-MLV 260 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~~-~~---~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~-~lV 260 (521)
.|...+.||+|+||+||+|.+.+ +. .||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.... ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667999999999999998643 22 699999875433 4457788999999999999999999999876655 899
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+.+|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999874 35789999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCc---ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 341 AERS---YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 341 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
.... .......||+.|+|||.+.+..++.++|||||||++|+|++|..|+..... .......+. ....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~---~~~~---- 246 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHFLA---QGRR---- 246 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHHHH---TTCC----
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHHhh---cCCC----
Confidence 3321 122345688999999999999999999999999999999996665432221 112222111 1110
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.. ....++.. +.+++.+||+.||.+|||+.++++.|+..
T Consensus 247 --~~-~~~~~~~~---l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 247 --LP-QPEYCPDS---LYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp --CC-CCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CC-CCccchHH---HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 11123333 44588899999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=362.14 Aligned_cols=253 Identities=22% Similarity=0.368 Sum_probs=191.8
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--------hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 255 (521)
.++|.+.+.||+|+||+||+|.+. +++.||||++..... .....+.+|+++|++++||||+++++++.. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 568999999999999999999975 578999999865321 112347889999999999999999999854 5
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC---CCceEee
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ---WNPKLSD 332 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~---~~vkL~D 332 (521)
..++||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred ceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 679999999999999998764 5789999999999999999999998 99999999999999654 4599999
Q ss_pred cccceecCCCCcceeeccccccccccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHh
Q 009979 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409 (521)
Q Consensus 333 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 409 (521)
||+++..... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..+.+.+
T Consensus 286 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~~i---- 357 (419)
T 3i6u_A 286 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQI---- 357 (419)
T ss_dssp SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHHHHH----
T ss_pred cccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHHHHH----
Confidence 9999876432 2334568999999999985 367888999999999999999999999754332 1222211
Q ss_pred hccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 410 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
...... ..+.. .......+.+++.+||+.||++||++.|++++-
T Consensus 358 ~~~~~~--~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 358 TSGKYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp HTTCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred hcCCCC--CCchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 111100 00000 111233455688899999999999999998653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=348.64 Aligned_cols=257 Identities=25% Similarity=0.420 Sum_probs=202.3
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcE--EEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTN--VAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~l 259 (521)
.++|++.+.||+|+||.||+|.+. ++.. +|+|.+.... ....+.+..|+++++++ +||||+++++++.+....++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 357899999999999999999965 4554 4899886532 33446788999999999 89999999999999999999
Q ss_pred EEEeccCCchHHhhhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCC
Q 009979 260 VYEYIDNGNLEQWLHGDV------------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN 327 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~ 327 (521)
||||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999998653 2235799999999999999999999998 9999999999999999999
Q ss_pred ceEeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 009979 328 PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLK 406 (521)
Q Consensus 328 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~ 406 (521)
+||+|||+++..... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.... ..+...
T Consensus 181 ~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~------~~~~~~ 252 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYE 252 (327)
T ss_dssp EEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHH
T ss_pred EEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc------HHHHHH
Confidence 999999999853221 12233457889999999998889999999999999999998 999996442 122222
Q ss_pred HHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 407 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.... . ...... ..++. .+.+++.+||+.||.+||++.++++.|+..
T Consensus 253 ~~~~-~-----~~~~~~-~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 253 KLPQ-G-----YRLEKP-LNCDD---EVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HGGG-T-----CCCCCC-TTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Hhhc-C-----CCCCCC-CCCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2211 1 011111 11333 344588899999999999999999999753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=351.33 Aligned_cols=258 Identities=20% Similarity=0.330 Sum_probs=191.8
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh--hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ--AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
.++|++.+.||+|+||+||+|.+. +++.||||++...... ..+.+.+|+++++.++||||+++++++.++...++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 357999999999999999999965 6888999998654322 2356778999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC-----CCCCceEeecccc
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-----KQWNPKLSDFGLA 336 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~-----~~~~vkL~DFGla 336 (521)
||+++ +|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++ +++.+||+|||++
T Consensus 113 e~~~~-~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 113 EYAEN-DLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp ECCSE-EHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred ecCCC-CHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99974 999999875 4689999999999999999999999 999999999999994 4556999999999
Q ss_pred eecCCCCcceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhc---c
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN---R 412 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~ 412 (521)
+...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .+.+...... .
T Consensus 185 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 185 RAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE------IDQLFKIFEVLGLP 257 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCC
T ss_pred cccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH------HHHHHHHHHHhCCC
Confidence 8764332 223445789999999998774 589999999999999999999999964321 1111211110 0
Q ss_pred cccc-----------CCCcccCCCccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 413 NAEG-----------VLDPRLQEKPCSR-----ALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 413 ~~~~-----------~~d~~l~~~~~~~-----~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.... ...+.+....... ....+.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 0000011110010 1234566888999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=340.63 Aligned_cols=247 Identities=24% Similarity=0.387 Sum_probs=203.5
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
..++|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+++++.++||||+++++++.+....++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 3457999999999999999999976 57789999986532 2234678899999999999999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 92 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp EECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 99999999999999765 4689999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ..+........ +
T Consensus 165 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~-------~ 228 (284)
T 2vgo_A 165 PSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS------HTETHRRIVNV-------D 228 (284)
T ss_dssp SSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTT-------C
T ss_pred cccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC------HhHHHHHHhcc-------c
Confidence 4322 234579999999999999999999999999999999999999996432 12222222211 1
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
..+.. ..+. .+.+++.+||+.||.+||++.++++
T Consensus 229 ~~~~~-~~~~---~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 LKFPP-FLSD---GSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCCCT-TSCH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCC-cCCH---HHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 11111 1233 3445888999999999999999984
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=340.44 Aligned_cols=256 Identities=28% Similarity=0.452 Sum_probs=200.6
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
...+.|.....||+|+||.||+|.+. ++..||+|.+........+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 34456677779999999999999975 57889999997766666678999999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-CCCceEeecccceecC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFGLAKLLG 340 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~-~~~vkL~DFGla~~~~ 340 (521)
||+++++|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++...
T Consensus 99 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp ECCSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EeCCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 99999999999986532 34567899999999999999999998 9999999999999987 8999999999998764
Q ss_pred CCCcceeecccccccccccccccCCC--CCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCC
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (521)
.... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... .......... ..
T Consensus 175 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~------~~ 243 (295)
T 2clq_A 175 GINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP----QAAMFKVGMF------KV 243 (295)
T ss_dssp C------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH----HHHHHHHHHH------CC
T ss_pred CCCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch----hHHHHhhccc------cc
Confidence 3322 233457999999999987643 889999999999999999999999643211 1111111111 01
Q ss_pred CcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 419 d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.+.+.. ..+. .+.+++.+||+.||++||++.++++
T Consensus 244 ~~~~~~-~~~~---~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 HPEIPE-SMSA---EAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCT-TSCH---HHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccc-cCCH---HHHHHHHHHccCChhhCCCHHHHhc
Confidence 111211 1233 3445888999999999999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=358.67 Aligned_cols=199 Identities=26% Similarity=0.377 Sum_probs=168.7
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC-----Ce
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AH 256 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----~~ 256 (521)
.++|.+.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+++|+.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 458999999999999999999975 5788999999653 333456788999999999999999999999776 56
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.|+||||++ |+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999986 5999999764 5699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCc---------------------ceeecccccccccccccc-cCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 009979 337 KLLGAERS---------------------YVTTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRNPVD 391 (521)
Q Consensus 337 ~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwS~Gvvl~elltG~~Pf~ 391 (521)
+....... ...+..+||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 97643321 123567899999999985 56679999999999999999998666554
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=345.89 Aligned_cols=254 Identities=28% Similarity=0.416 Sum_probs=198.0
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC-CeeeE
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-AHRML 259 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-~~~~l 259 (521)
+.+..++|++.+.||+|+||.||+|.+. ++.||+|.+.... ..+.+.+|+++++.++||||+++++++.+. ...++
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence 3455678999999999999999999885 8899999986543 456788999999999999999999997654 47899
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp EECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred EEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 999999999999997641 22478899999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCC
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (521)
... .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||...... ... ..... . .
T Consensus 168 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~---~~~~~-~-----~ 231 (278)
T 1byg_A 168 SST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV---PRVEK-G-----Y 231 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHH---HHHTT-T-----C
T ss_pred ccc----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHH---HHHhc-C-----C
Confidence 332 223467899999999998999999999999999999998 99999754321 111 11111 1 0
Q ss_pred CcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 419 d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.+... ..++.. +.+++.+||+.||++||++.++++.|+..
T Consensus 232 ~~~~~-~~~~~~---l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 232 KMDAP-DGCPPA---VYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCCCC-TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCc-ccCCHH---HHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 11111 113333 44588899999999999999999999764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=342.45 Aligned_cols=249 Identities=20% Similarity=0.336 Sum_probs=204.5
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
.++|.+.+.||+|+||.||+|.+. +++.||+|.+... .....+.+..|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 457899999999999999999976 4778999988654 234456788999999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 9999999999998764 4689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ..+......... .
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~-------~ 232 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------LKETYLRIKKNE-------Y 232 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTTC-------C
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhhcc-------C
Confidence 3222 2334679999999999999999999999999999999999999996432 122222222111 0
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+.. ..+. .+.+++.+||+.||++|||+.++++.
T Consensus 233 ~~~~-~~~~---~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 SIPK-HINP---VAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CCCT-TSCH---HHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCcc-ccCH---HHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1111 1223 34458889999999999999999854
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=365.38 Aligned_cols=249 Identities=22% Similarity=0.350 Sum_probs=197.6
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
++|.+.+.||+|+||+||+|.+. ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 47999999999999999999976 68889999987543 2335778899999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC---CCceEeecccceec
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ---WNPKLSDFGLAKLL 339 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~---~~vkL~DFGla~~~ 339 (521)
||++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.. +.+||+|||+++..
T Consensus 117 ~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 117 CYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999988765 4689999999999999999999999 99999999999999764 45999999999876
Q ss_pred CCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
.... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.... ..+.+........ ....
T Consensus 190 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~~~~--~~~~ 258 (494)
T 3lij_A 190 ENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT------DQEILRKVEKGKY--TFDS 258 (494)
T ss_dssp BTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCC--CCCS
T ss_pred CCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCC--CCCc
Confidence 5432 234567999999999886 569999999999999999999999996433 2222232222111 1111
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
+... ..+ ..+.+++.+||+.||.+|||+.++++
T Consensus 259 ~~~~--~~s---~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 259 PEWK--NVS---EGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GGGT--TSC---HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcc--cCC---HHHHHHHHHHCCCChhhCccHHHHhc
Confidence 1111 122 33455888999999999999999984
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=350.53 Aligned_cols=248 Identities=21% Similarity=0.340 Sum_probs=204.4
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
.++|.+.+.||+|+||.||++.+. +++.||+|.+... .....+.+..|+.+++.++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 457999999999999999999976 4778999998654 234457788999999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999998764 4689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+......... .
T Consensus 193 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~-------~ 258 (335)
T 2owb_A 193 YDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------LKETYLRIKKNE-------Y 258 (335)
T ss_dssp STT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHTC-------C
T ss_pred cCc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC------HHHHHHHHhcCC-------C
Confidence 332 22344679999999999999999999999999999999999999996432 222222222111 0
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.+.. ..+.. +.+++.+||+.||++||++.++++
T Consensus 259 ~~~~-~~~~~---~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 SIPK-HINPV---AASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CCCT-TSCHH---HHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCc-cCCHH---HHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 12333 445888999999999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=341.75 Aligned_cols=253 Identities=20% Similarity=0.305 Sum_probs=199.2
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
..++|++.+.||+|+||.||+|.+. ++..||+|.+........+.+..|+++++.++||||+++++++......++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4568999999999999999999986 488899999877666667889999999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+++++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred eCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999998764 35689999999999999999999998 9999999999999999999999999998643211
Q ss_pred Ccceeecccccccccccccc-----cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 343 RSYVTTRVMGTFGYVAPEYA-----STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
........||+.|+|||++ .+..++.++||||||+++|||++|+.||.... ..+........... ..
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~-~~ 242 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN------PMRVLLKIAKSDPP-TL 242 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCCC-CC
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC------HHHHHHHHhccCCc-cc
Confidence 1112345789999999988 46778999999999999999999999996432 22222222221110 11
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
......+. .+.+++.+||+.||++|||+.++++
T Consensus 243 ----~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 ----LTPSKWSV---EFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ----SSGGGSCH---HHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ----CCccccCH---HHHHHHHHHcccChhhCCCHHHHhc
Confidence 11111233 3455888999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=364.70 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=200.9
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh-------------hhHHHHHHHHHHHhcCCCCCeeeEEE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-------------QAEKEFKVEVEAIGRVRHKNLVRLLG 249 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~Ei~~l~~l~hpniv~l~~ 249 (521)
..++|.+.+.||+|+||+||+|... ++..||+|++..... ...+.+.+|+.+|+.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3568999999999999999999976 578899999865431 23467889999999999999999999
Q ss_pred EEeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC---
Q 009979 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW--- 326 (521)
Q Consensus 250 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~--- 326 (521)
++.+....++|||||++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 999999999999999999999998765 4689999999999999999999999 999999999999998775
Q ss_pred CceEeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHH
Q 009979 327 NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLK 406 (521)
Q Consensus 327 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~ 406 (521)
.+||+|||+++...... ......||+.|+|||++. +.++.++|||||||++|+|++|..||.... ..+.+.
T Consensus 187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~ 257 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN------DQDIIK 257 (504)
T ss_dssp SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHH
T ss_pred cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHH
Confidence 69999999999764432 234567999999999986 468999999999999999999999996432 222233
Q ss_pred HHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 407 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
....... ..+. .........+.+++.+||+.||.+|||+.|++++
T Consensus 258 ~i~~~~~---~~~~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 258 KVEKGKY---YFDF----NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHCCC---CCCH----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHcCCC---CCCc----cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 3222110 0000 0001122345568889999999999999999853
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=350.12 Aligned_cols=263 Identities=25% Similarity=0.410 Sum_probs=199.4
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357999999999999999999976 488999999865433 33466788999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 104 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999999998887654 4689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCcceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH------------
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM------------ 408 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~------------ 408 (521)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+...
T Consensus 177 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 177 PG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI---DQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCHHHHHHH
T ss_pred Cc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCChhhhhHh
Confidence 32 223445799999999998775 7899999999999999999999999654321 111111100
Q ss_pred hhccccccCCCcccCCCc-----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 409 VTNRNAEGVLDPRLQEKP-----CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 409 ~~~~~~~~~~d~~l~~~~-----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
...........+.+.... .+.....+.+++.+||+.||++|||+.|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 001111111111111111 11123456668889999999999999999853
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=340.89 Aligned_cols=247 Identities=23% Similarity=0.441 Sum_probs=202.5
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEee-----------
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE----------- 253 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~----------- 253 (521)
++|++.+.||+|+||.||+|.+. +++.||+|.+.... +.+.+|+++++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 47899999999999999999986 68999999987543 346679999999999999999998854
Q ss_pred -----CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCc
Q 009979 254 -----GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP 328 (521)
Q Consensus 254 -----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~v 328 (521)
....++||||+++++|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence 445799999999999999997642 35789999999999999999999998 99999999999999999999
Q ss_pred eEeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH
Q 009979 329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408 (521)
Q Consensus 329 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 408 (521)
||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|..||.. ........
T Consensus 162 kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--------~~~~~~~~ 231 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--------TSKFFTDL 231 (284)
T ss_dssp EECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--------HHHHHHHH
T ss_pred EECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--------HHHHHHHh
Confidence 999999998765432 23345799999999999999999999999999999999999988731 11111111
Q ss_pred hhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCC
Q 009979 409 VTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEF 464 (521)
Q Consensus 409 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 464 (521)
... .+. ...+.. +.+++.+||+.||.+||++.++++.|+....
T Consensus 232 -~~~----~~~-----~~~~~~---~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 232 -RDG----IIS-----DIFDKK---EKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp -HTT----CCC-----TTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred -hcc----ccc-----ccCCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 111 111 112333 3458889999999999999999999986543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=356.26 Aligned_cols=265 Identities=22% Similarity=0.279 Sum_probs=195.5
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEee------
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE------ 253 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~------ 253 (521)
++...++|++.+.||+|+||+||+|.+. +++.||||++...... ..+|+++|+.++||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 3456779999999999999999999974 6899999998654332 2369999999999999999999844
Q ss_pred --------------------------------CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 009979 254 --------------------------------GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301 (521)
Q Consensus 254 --------------------------------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~ 301 (521)
....++||||++ |+|.+.+.........+++..+..++.|++.||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 334789999997 58888776533335689999999999999999999
Q ss_pred HHhcCCCCeeecCCCCCCeEeC-CCCCceEeecccceecCCCCcceeecccccccccccccccCC-CCCCcccchhHHHH
Q 009979 302 LHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGIL 379 (521)
Q Consensus 302 LH~~~~~~iiHrDik~~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvv 379 (521)
||+. +|+||||||+|||++ .++.+||+|||+++.+..... .....||+.|+|||++.+. .++.++|||||||+
T Consensus 157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9998 999999999999997 688999999999997644332 3345789999999988765 49999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcccHHHHHHHHh---------hccccccCCCcccCCCc-----cHHHHHHHHHHHHhccCCC
Q 009979 380 IMEVISGRNPVDYSRPPGEVNLVEWLKTMV---------TNRNAEGVLDPRLQEKP-----CSRALKRALLVALRCVDPN 445 (521)
Q Consensus 380 l~elltG~~Pf~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~d~~l~~~~-----~~~~~~~~~~li~~cl~~d 445 (521)
+|||++|+.||...... ..+...++..- .........-+.+.... .......+.+++.+||+.|
T Consensus 232 l~ell~g~~pf~~~~~~--~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 232 FGELILGKPLFSGETSI--DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 99999999999744311 11111111100 00001111111111111 0112234556888999999
Q ss_pred CCCCCCHHHHHH
Q 009979 446 AHKRPKMGHVIH 457 (521)
Q Consensus 446 P~~RPt~~evl~ 457 (521)
|++|||+.|+++
T Consensus 310 P~~R~t~~e~l~ 321 (383)
T 3eb0_A 310 PDLRINPYEAMA 321 (383)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999984
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=347.38 Aligned_cols=262 Identities=26% Similarity=0.408 Sum_probs=204.5
Q ss_pred hhcCCCccccceEccCCcEEEEEEEE------cCCcEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~ 254 (521)
++..++|++.+.||+|+||.||+|.+ .++..||||.+... .......+..|+.+++.++||||+++++++.+.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 34567899999999999999999983 24678999998654 334456788999999999999999999999999
Q ss_pred CeeeEEEEeccCCchHHhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---CCCc
Q 009979 255 AHRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNP 328 (521)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~---~~~v 328 (521)
...++||||+++++|.+++..... ....+++..++.++.|++.||.|||+. +|+||||||+|||++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999987532 124589999999999999999999999 9999999999999984 4569
Q ss_pred eEeecccceecCCCCc-ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHH
Q 009979 329 KLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLK 406 (521)
Q Consensus 329 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~ 406 (521)
||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.... ..+...
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------~~~~~~ 256 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS------NQEVLE 256 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHHHHH
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC------HHHHHH
Confidence 9999999986533222 22234568999999999988999999999999999999998 999996432 122222
Q ss_pred HHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 407 TMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 407 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
....... +.. ...++.. +.+++.+||+.||.+||++.++++.|+..
T Consensus 257 ~~~~~~~------~~~-~~~~~~~---l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 257 FVTSGGR------MDP-PKNCPGP---VYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHHTTCC------CCC-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcCCC------CCC-CCCCCHH---HHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 2222111 011 1123333 44588899999999999999999999854
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=351.16 Aligned_cols=265 Identities=25% Similarity=0.366 Sum_probs=205.4
Q ss_pred chhhhhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC
Q 009979 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG 254 (521)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~ 254 (521)
.+.++++..++|++.+.||+|+||.||+|.+.+ .+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 367778889999999999999999999999853 59999886532 22335677899999999999999999999999
Q ss_pred CeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecc
Q 009979 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (521)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFG 334 (521)
...++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCS
T ss_pred CceEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecC
Confidence 9999999999999999999765 35688999999999999999999999 999999999999998 6799999999
Q ss_pred cceecCCCC----cceeecccccccccccccccC---------CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccH
Q 009979 335 LAKLLGAER----SYVTTRVMGTFGYVAPEYAST---------GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNL 401 (521)
Q Consensus 335 la~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~ 401 (521)
+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~ 248 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP------A 248 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC------H
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC------H
Confidence 987653211 112233568999999998864 457889999999999999999999996432 1
Q ss_pred HHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCC
Q 009979 402 VEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP 465 (521)
Q Consensus 402 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 465 (521)
.......... ..+.......+.. +.+++.+||+.||++|||+.+++++|+.....
T Consensus 249 ~~~~~~~~~~------~~~~~~~~~~~~~---l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 249 EAIIWQMGTG------MKPNLSQIGMGKE---ISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HHHHHHHHTT------CCCCCCCSSCCTT---HHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred HHHHHHhccC------CCCCCCcCCCCHH---HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 1222222211 1111111122333 44488899999999999999999999876543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=335.65 Aligned_cols=249 Identities=24% Similarity=0.392 Sum_probs=198.4
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEee----CCee
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE----GAHR 257 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~----~~~~ 257 (521)
.+.|.+.+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 345788899999999999999975 57789999986542 3445778899999999999999999999865 3567
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeEeC-CCCCceEeecc
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK--VVHRDIKSSNILLD-KQWNPKLSDFG 334 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~--iiHrDik~~NILl~-~~~~vkL~DFG 334 (521)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+. + |+||||||+|||++ .++.+||+|||
T Consensus 105 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 9999999999999999764 4689999999999999999999998 7 99999999999997 78999999999
Q ss_pred cceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... +............
T Consensus 178 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~~~-- 246 (290)
T 1t4h_A 178 LATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRRVTSGV-- 246 (290)
T ss_dssp GGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHHHTTTC--
T ss_pred Cccccccc---ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC-----cHHHHHHHHhccC--
Confidence 99754332 2334579999999998864 58999999999999999999999996432 2222222222111
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
....+... .+ ..+.+++.+||+.||.+|||+.+++++
T Consensus 247 ---~~~~~~~~-~~---~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 247 ---KPASFDKV-AI---PEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---CCGGGGGC-CC---HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---CccccCCC-CC---HHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11111111 22 235558889999999999999999853
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=338.73 Aligned_cols=248 Identities=25% Similarity=0.413 Sum_probs=204.4
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
+.|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 46899999999999999999965 58899999986543 34457889999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++++|.+++.. ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999864 3689999999999999999999999 99999999999999999999999999998764432
Q ss_pred cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..+........ . .+.+.
T Consensus 174 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~-~-----~~~~~ 240 (303)
T 3a7i_A 174 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH------PMKVLFLIPKN-N-----PPTLE 240 (303)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHS-C-----CCCCC
T ss_pred -cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC------HHHHHHHhhcC-C-----CCCCc
Confidence 22344679999999999999999999999999999999999999996432 11222221111 1 11111
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
. ..+.. +.+++.+||+.||++|||+.+++++
T Consensus 241 ~-~~~~~---l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 241 G-NYSKP---LKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp S-SCCHH---HHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred c-ccCHH---HHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1 12333 4458889999999999999999854
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=339.94 Aligned_cols=257 Identities=23% Similarity=0.334 Sum_probs=190.4
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
++..++|++.+.||+|+||+||+|.+. +++.||+|++..... ...+.+..+...++.++||||+++++++.++...+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 456678999999999999999999974 688899999865422 22244555666688899999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+||||++ |+|.+++.........+++..++.++.|++.||+|||++. +|+||||||+|||++.++.+||+|||+++.
T Consensus 83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999997 5988887653333568999999999999999999999843 899999999999999999999999999987
Q ss_pred cCCCCcceeecccccccccccccc----cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 339 LGAERSYVTTRVMGTFGYVAPEYA----STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
..... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.... .....+........
T Consensus 160 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~- 231 (290)
T 3fme_A 160 LVDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG-----TPFQQLKQVVEEPS- 231 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS-----CHHHHHHHHHHSCC-
T ss_pred ccccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC-----chHHHHHHHhccCC-
Confidence 64332 22334799999999996 56678999999999999999999999996432 12222233322211
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
+.......+. .+.+++.+||+.||++|||+.++++
T Consensus 232 -----~~~~~~~~~~---~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 -----PQLPADKFSA---EFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -----CCCCTTTSCH---HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCcccccCCH---HHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1111112333 3455888999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=367.47 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=204.4
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457999999999999999999976 68899999986542 33457789999999999999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe---CCCCCceEeecccce
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAK 337 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl---~~~~~vkL~DFGla~ 337 (521)
|||+.+|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 105 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999999765 5689999999999999999999999 99999999999999 567899999999998
Q ss_pred ecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
.+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ..+.+........
T Consensus 178 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~~~~---- 244 (484)
T 3nyv_A 178 HFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN------EYDILKKVEKGKY---- 244 (484)
T ss_dssp HBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCC----
T ss_pred Eccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHcCCC----
Confidence 764432 2344679999999999866 68999999999999999999999996432 2222333222111
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
. +...........+.+++.+||+.||.+|||+.+++++
T Consensus 245 -~--~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 245 -T--FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -C--CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -C--CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0 0111111222345558889999999999999999853
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=363.71 Aligned_cols=244 Identities=16% Similarity=0.212 Sum_probs=189.8
Q ss_pred cCCCccccceEccCCcEEEEEEEE-cCCcEEEEEEeccC---ChhhHHHHHHHH---HHHhcCCCCCeeeEE-------E
Q 009979 184 STNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNN---RGQAEKEFKVEV---EAIGRVRHKNLVRLL-------G 249 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~Ei---~~l~~l~hpniv~l~-------~ 249 (521)
..++|.+.+.||+|+||+||+|.+ .+++.||||++... .....+.+.+|+ ++++.++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 456899999999999999999995 46899999998743 334557888999 555566899999998 6
Q ss_pred EEeeCC-----------------eeeEEEEeccCCchHHhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 009979 250 YCAEGA-----------------HRMLVYEYIDNGNLEQWLHGDVG---PHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309 (521)
Q Consensus 250 ~~~~~~-----------------~~~lV~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~ 309 (521)
++.+.+ ..||||||+ +|+|.+++..... ....+++..++.|+.|++.||+|||++ +
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 666553 278999999 6799999976411 112344588889999999999999999 9
Q ss_pred eeecCCCCCCeEeCCCCCceEeecccceecCCCCcceeecccccccccccccccCC-----------CCCCcccchhHHH
Q 009979 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-----------MLNERSDVYSFGI 378 (521)
Q Consensus 310 iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwS~Gv 378 (521)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999986432 3345678 999999999877 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 379 LIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 379 vl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
++|||++|+.||.......... .+.. . ....+.. +.+++.+||+.||++||++.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~---------------~~~~-~--~~~~~~~---~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSE---------------WIFR-S--CKNIPQP---VRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCSG---------------GGGS-S--CCCCCHH---HHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccchh---------------hhhh-h--ccCCCHH---HHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999996543221110 0000 0 0123333 445888999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=352.14 Aligned_cols=272 Identities=19% Similarity=0.229 Sum_probs=207.5
Q ss_pred cchhhhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCC--------CCCeee
Q 009979 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR--------HKNLVR 246 (521)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--------hpniv~ 246 (521)
+.+.-.++..++|++.+.||+|+||+||+|.+. +++.||||++... ....+.+.+|+++++.++ |+||++
T Consensus 27 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 27 HLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp CSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred eEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 334444555679999999999999999999965 5788999998643 344567888999999885 788999
Q ss_pred EEEEEe----eCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe
Q 009979 247 LLGYCA----EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL 322 (521)
Q Consensus 247 l~~~~~----~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl 322 (521)
+++++. +....++||||+ +++|.+++... ....+++..++.++.|++.||+|||+++ +|+||||||+|||+
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll 180 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILL 180 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEE
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeE
Confidence 999987 556789999999 55776666544 2357999999999999999999999853 79999999999999
Q ss_pred CCCC-------------------------------------------------CceEeecccceecCCCCcceeeccccc
Q 009979 323 DKQW-------------------------------------------------NPKLSDFGLAKLLGAERSYVTTRVMGT 353 (521)
Q Consensus 323 ~~~~-------------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~gt 353 (521)
+.++ .+||+|||+++..... .....||
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt 256 (397)
T 1wak_A 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQT 256 (397)
T ss_dssp CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSC
T ss_pred eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCC
Confidence 8775 7999999999876432 2345799
Q ss_pred ccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh---c---------cccccCCCc-
Q 009979 354 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT---N---------RNAEGVLDP- 420 (521)
Q Consensus 354 ~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---~---------~~~~~~~d~- 420 (521)
+.|+|||++.+..++.++|||||||++|||+||+.||..............+..+.. . .........
T Consensus 257 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 336 (397)
T 1wak_A 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK 336 (397)
T ss_dssp GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred CcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence 999999999999999999999999999999999999986654433222222222111 0 000000000
Q ss_pred -------ccC-----------CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 421 -------RLQ-----------EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 421 -------~l~-----------~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 0113445567778999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=338.07 Aligned_cols=251 Identities=22% Similarity=0.376 Sum_probs=196.7
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
.+..++|.+.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+....
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 345568999999999999999999976 68899999986532 22346788999999999999999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 87 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 159 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSN 159 (276)
T ss_dssp EEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred EEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccc
Confidence 9999999999999999765 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcceeecccccccccccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
...... ......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||.... ..+........ ..
T Consensus 160 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~-~~-- 228 (276)
T 2h6d_A 160 MMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH------VPTLFKKIRGG-VF-- 228 (276)
T ss_dssp CCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHC-CC--
T ss_pred ccCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc------HHHHHHHhhcC-cc--
Confidence 764322 2234578999999999987765 689999999999999999999996432 12222222211 10
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+. ...+.. +.+++.+||+.||++|||+.+++++
T Consensus 229 ----~~~-~~~~~~---l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 ----YIP-EYLNRS---VATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----CCC-TTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----cCc-hhcCHH---HHHHHHHHccCChhhCCCHHHHHhC
Confidence 011 112333 4458889999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=377.19 Aligned_cols=246 Identities=28% Similarity=0.449 Sum_probs=195.5
Q ss_pred ceEccCCcEEEEEEEEc---CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 192 NVIGEGGYGIVYHGVLE---DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
+.||+|+||.||+|.+. .++.||||++..... ...+++.+|+++|++++|||||++++++.. ...+|||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 457899999875432 335789999999999999999999999965 557899999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcc-
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY- 345 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~- 345 (521)
|+|.++++.. ..+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.+......
T Consensus 454 g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 9999999765 5789999999999999999999999 9999999999999999999999999999876543322
Q ss_pred -eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 346 -VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 346 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
......||+.|+|||++.+..++.++|||||||+||||++ |+.||..... .+... .+..... ...
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------~~~~~-~i~~~~~-----~~~- 593 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------SEVTA-MLEKGER-----MGC- 593 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHH-HHHTTCC-----CCC-
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHH-HHHcCCC-----CCC-
Confidence 2233457889999999999999999999999999999998 9999964432 12222 2222111 111
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
...++.. +.+++.+||+.||++||++.+|++.|+.
T Consensus 594 p~~~~~~---l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 594 PAGCPRE---MYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CTTCCHH---HHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1123444 4458889999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=349.75 Aligned_cols=262 Identities=19% Similarity=0.293 Sum_probs=200.0
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEee--------C
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--------G 254 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--------~ 254 (521)
++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+++++.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 47999999999999999999974 688999999865432 234677889999999999999999999987 3
Q ss_pred CeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecc
Q 009979 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (521)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFG 334 (521)
...++||||+++ +|.+.+... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999975 888887665 35699999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCC---cceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh
Q 009979 335 LAKLLGAER---SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410 (521)
Q Consensus 335 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (521)
+++.+.... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... ......+.....
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~ 246 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE---QHQLALISQLCG 246 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhC
Confidence 998764322 222344678999999998876 5689999999999999999999999975432 112222222111
Q ss_pred ccccccCCCc-------------ccCCCccHHH------HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 411 NRNAEGVLDP-------------RLQEKPCSRA------LKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 411 ~~~~~~~~d~-------------~l~~~~~~~~------~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.... ..... .......... ...+.+++.+||+.||++|||+.|++++
T Consensus 247 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 247 SITP-EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCCT-TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCh-hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1000 00000 0000001111 1235678999999999999999999854
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=359.61 Aligned_cols=260 Identities=19% Similarity=0.233 Sum_probs=206.7
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCC-CCeeeEEEEEeeCCeeeEEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH-KNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-pniv~l~~~~~~~~~~~lV~e 262 (521)
.++|++.++||+|+||.||+|.+. +++.||||++..... ...+..|+++++.++| +++..+..++.+....+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 468999999999999999999974 688999998764432 2357789999999986 566667777788888999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe---CCCCCceEeecccceec
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl---~~~~~vkL~DFGla~~~ 339 (521)
|+ +++|.+++... ...+++..++.|+.||+.||+|||++ +|+||||||+|||| +.++.+||+|||+++.+
T Consensus 84 ~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 88999999864 35799999999999999999999999 99999999999999 68899999999999987
Q ss_pred CCCCcc------eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccc
Q 009979 340 GAERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (521)
Q Consensus 340 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (521)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||............+.+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 543321 12356799999999999999999999999999999999999999987655443333332222211111
Q ss_pred cccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 414 ~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
... +. ..++ .++.+++.+||+.||++||++.+|+++|+..
T Consensus 237 ~~~-----l~-~~~p---~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 237 IEA-----LC-RGYP---TEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHH-----HH-TTSC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHH-----Hh-cCCc---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 000 00 0122 3455688899999999999999999988753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=363.02 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=201.0
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
++|.+.+.||+|+||+||+|... +++.||||++.... ......+.+|++++++++||||+++++++.+....++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 47999999999999999999976 68899999985432 2345678899999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC---CCCCceEeecccceec
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD---KQWNPKLSDFGLAKLL 339 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~---~~~~vkL~DFGla~~~ 339 (521)
||.+|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||+++..
T Consensus 102 ~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 102 LYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999998765 4689999999999999999999999 999999999999995 5567999999999866
Q ss_pred CCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ..+.+........ .
T Consensus 175 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~~~~-----~ 240 (486)
T 3mwu_A 175 QQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN------EYDILKRVETGKY-----A 240 (486)
T ss_dssp CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCC-----C
T ss_pred CCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCC-----C
Confidence 4332 2345679999999999875 58999999999999999999999996432 2233333322111 0
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
+...........+.+++.+||+.||.+|||+.+++++
T Consensus 241 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 241 --FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp --SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred --CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0001111222345558889999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=344.03 Aligned_cols=259 Identities=27% Similarity=0.409 Sum_probs=199.8
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEee--
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAE-- 253 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~-- 253 (521)
+.++....++|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+..|+.+++++ +||||+++++++..
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 4445556789999999999999999999974 68899999986543 3456788999999999 79999999999976
Q ss_pred ----CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCce
Q 009979 254 ----GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK 329 (521)
Q Consensus 254 ----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vk 329 (521)
....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEE
Confidence 467899999999999999998652 35789999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCcceeeccccccccccccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHH
Q 009979 330 LSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEW 404 (521)
Q Consensus 330 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~ 404 (521)
|+|||++....... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||..... ...
T Consensus 170 l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~ 242 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRA 242 (326)
T ss_dssp ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHH
T ss_pred EeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHH
Confidence 99999998764322 1223457999999999986 56789999999999999999999999964321 111
Q ss_pred HHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 405 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
........ .+.+.....+..+ .+++.+||+.||.+||++.+++++
T Consensus 243 ~~~~~~~~------~~~~~~~~~~~~l---~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 243 LFLIPRNP------APRLKSKKWSKKF---QSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHHHHSC------CCCCSCSCSCHHH---HHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhhcCc------cccCCccccCHHH---HHHHHHHhccChhhCCCHHHHhhC
Confidence 12211111 1112222234444 447889999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=350.59 Aligned_cols=269 Identities=23% Similarity=0.284 Sum_probs=198.2
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCCh-----------hhHHHHHHHHHHHhcCCCCCeee
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG-----------QAEKEFKVEVEAIGRVRHKNLVR 246 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~Ei~~l~~l~hpniv~ 246 (521)
+.++....++|.+.+.||+|+||.||+|...++..||||++..... ...+.+.+|+++++.++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 5667778899999999999999999999988899999999854322 12377899999999999999999
Q ss_pred EEEEEee-----CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeE
Q 009979 247 LLGYCAE-----GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321 (521)
Q Consensus 247 l~~~~~~-----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NIL 321 (521)
+++++.. ....++||||++ |+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 9999854 336799999997 5999988754 35799999999999999999999999 9999999999999
Q ss_pred eCCCCCceEeecccceecCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCccc
Q 009979 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVN 400 (521)
Q Consensus 322 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~ 400 (521)
++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~ 241 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF---YN 241 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HH
T ss_pred EcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH---HH
Confidence 999999999999999864332 22344678999999998876 7799999999999999999999999975431 11
Q ss_pred HHHHHHHHhhccc-----------cccCCCccc---CCC----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 401 LVEWLKTMVTNRN-----------AEGVLDPRL---QEK----PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 401 ~~~~~~~~~~~~~-----------~~~~~d~~l---~~~----~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
....+........ ....+...+ ... ..+.....+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 1111111110000 000000000 000 011112345568889999999999999999854
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=336.22 Aligned_cols=250 Identities=26% Similarity=0.389 Sum_probs=199.3
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
..++|++.+.||+|+||.||+|.+. +++.||+|.+.... ..+.+..|+.+++.++||||+++++++......++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4568999999999999999999976 48899999986543 34678899999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+++++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 105 ~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999743 35789999999999999999999998 9999999999999999999999999999876433
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
. .......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ........... .+.+
T Consensus 179 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~------~~~~ 245 (314)
T 3com_A 179 M-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP------MRAIFMIPTNP------PPTF 245 (314)
T ss_dssp B-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC------CCCC
T ss_pred c-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCC------Cccc
Confidence 2 223345789999999999999999999999999999999999999964321 11111111111 1111
Q ss_pred C-CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 423 Q-EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 423 ~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
. ....+. .+.+++.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~---~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 RKPELWSD---NFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp SSGGGSCH---HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCcccCCH---HHHHHHHHHccCChhhCcCHHHHHh
Confidence 1 111233 3455888999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=354.19 Aligned_cols=252 Identities=11% Similarity=0.035 Sum_probs=179.9
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHH---HHHhcCCCCCeeeEE-------EEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEV---EAIGRVRHKNLVRLL-------GYC 251 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei---~~l~~l~hpniv~l~-------~~~ 251 (521)
..|.+.+.||+|+||+||+|.+. +++.||||++..... ...+.+..|+ ++|+. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 35889999999999999999975 688999999977543 3345677785 45555 799988755 444
Q ss_pred eeC-----------------CeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCC
Q 009979 252 AEG-----------------AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR------MNIILGTAKGLTYLHEGLEP 308 (521)
Q Consensus 252 ~~~-----------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~------~~i~~~ia~al~~LH~~~~~ 308 (521)
... ...||||||++ |+|.+++.... ..+.+..+ +.++.|++.||+|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 433 33799999998 89999998641 23344455 67789999999999999
Q ss_pred CeeecCCCCCCeEeCCCCCceEeecccceecCCCCcceeecccccccccccccccC--CCCCCcccchhHHHHHHHHHhC
Q 009979 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISG 386 (521)
Q Consensus 309 ~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~elltG 386 (521)
+|+||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||+||
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999976422 224567899999999987 7799999999999999999999
Q ss_pred CCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 387 RNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 387 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
+.||....+..... .............+....+......+.+++.+||+.||++|||+.++++
T Consensus 290 ~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99998664321110 0000000011111111111122334555888999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=347.77 Aligned_cols=252 Identities=22% Similarity=0.370 Sum_probs=202.2
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--------hhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeC
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEG 254 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~ 254 (521)
.++|.+.+.||+|+||.||+|.+. +|+.||||++..... ...+.+..|+.+++.+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 457999999999999999999986 689999999865431 1235678899999999 799999999999999
Q ss_pred CeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecc
Q 009979 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (521)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFG 334 (521)
...++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecC
Confidence 9999999999999999999764 4689999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCcceeecccccccccccccccC------CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH
Q 009979 335 LAKLLGAERSYVTTRVMGTFGYVAPEYAST------GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408 (521)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~ 408 (521)
++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ....+...
T Consensus 246 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~------~~~~~~~i 317 (365)
T 2y7j_A 246 FSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR------QILMLRMI 317 (365)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHH
T ss_pred cccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC------HHHHHHHH
Confidence 998765432 2345679999999998853 368899999999999999999999996432 12222222
Q ss_pred hhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 409 VTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 409 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.... . ....+.. ...+ ..+.+++.+||+.||++|||+.+++++
T Consensus 318 ~~~~-~-~~~~~~~--~~~~---~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 318 MEGQ-Y-QFSSPEW--DDRS---STVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHTC-C-CCCHHHH--SSSC---HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhCC-C-CCCCccc--ccCC---HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2111 0 0000000 0112 335558889999999999999999863
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=347.57 Aligned_cols=262 Identities=24% Similarity=0.324 Sum_probs=197.0
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh-----hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ-----AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
..++|++.+.||+|+||.||+|.+. +++.||||++...... ....+.+|+++++.++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3468999999999999999999975 5889999998653221 124678899999999999999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999976 899988765 35688889999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhc---cc
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN---RN 413 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~~ 413 (521)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|..||..... .+.+...... ..
T Consensus 161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~------~~~~~~i~~~~~~~~ 233 (346)
T 1ua2_A 161 SFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD------LDQLTRIFETLGTPT 233 (346)
T ss_dssp TTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCCC
T ss_pred eccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHHHcCCCC
Confidence 764332 223456799999999998654 589999999999999999999999864321 1222222111 00
Q ss_pred cccCC------C----cccCCCc----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 414 AEGVL------D----PRLQEKP----CSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 414 ~~~~~------d----~~l~~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
..... + ......+ .......+.+++.+||+.||++|||+.|++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 00000 0 0000000 011224556688899999999999999998654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=335.66 Aligned_cols=246 Identities=21% Similarity=0.314 Sum_probs=197.6
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|++.+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+..+..+ +||||+++++++.+....++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 47899999999999999999976 68999999987542 33456788899999999 8999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-----------------
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK----------------- 324 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~----------------- 324 (521)
||+++++|.+++.........+++..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999999999976432235789999999999999999999999 9999999999999984
Q ss_pred --CCCceEeecccceecCCCCcceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccH
Q 009979 325 --QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNL 401 (521)
Q Consensus 325 --~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~ 401 (521)
...+||+|||++....... ...||+.|+|||.+.+. .++.++|||||||++|||++|..|+... ..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------~~ 236 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------DQ 236 (289)
T ss_dssp --CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS------HH
T ss_pred CCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch------hH
Confidence 4479999999998764432 23589999999998765 5678999999999999999998876422 11
Q ss_pred HHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 402 VEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 402 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
. .... .... +.+.. ..+.. +.+++.+||+.||++|||+.+++++
T Consensus 237 ~---~~~~-~~~~-----~~~~~-~~~~~---~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 W---HEIR-QGRL-----PRIPQ-VLSQE---FTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp H---HHHH-TTCC-----CCCSS-CCCHH---HHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred H---HHHH-cCCC-----CCCCc-ccCHH---HHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1 1111 1111 11111 13333 4458889999999999999999743
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=348.53 Aligned_cols=257 Identities=25% Similarity=0.307 Sum_probs=192.0
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC------
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------ 255 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~------ 255 (521)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999975 5888999998653 2334567889999999999999999999997654
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..++||||+++ +|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 67999999975 88888853 478999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhc----
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN---- 411 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---- 411 (521)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.+......
T Consensus 174 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~~~ 245 (371)
T 2xrw_A 174 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH------IDQWNKVIEQLGTP 245 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHC-CCCC
T ss_pred ccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCC
Confidence 9875432 223456799999999999999999999999999999999999999975431 1111111110
Q ss_pred ------------------ccc------ccCCCccc-CCC--ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 412 ------------------RNA------EGVLDPRL-QEK--PCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 412 ------------------~~~------~~~~d~~l-~~~--~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
... ........ ... ........+.+|+.+||+.||++|||+.|++++-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 000 00000000 000 0112245567799999999999999999998643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=348.33 Aligned_cols=257 Identities=22% Similarity=0.322 Sum_probs=193.8
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC------
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------ 255 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~------ 255 (521)
.++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 458999999999999999999975 6889999998543 2334467889999999999999999999997653
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..|+||||+ +++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 78999999753 689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc--
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR-- 412 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-- 412 (521)
++..... .+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+.......
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKVTGTPPA 247 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCH
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCH
Confidence 9975432 345678999999998876 78999999999999999999999999744311 1111111100000
Q ss_pred ----------------ccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 413 ----------------NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 413 ----------------~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.........+.. ........+.+++.+||+.||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000001100 011122345568889999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=373.57 Aligned_cols=252 Identities=21% Similarity=0.291 Sum_probs=205.5
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCe
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAH 256 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~ 256 (521)
.+..++|++.++||+|+||.||+|.+. +++.||||++.+.. ....+.+..|..++..+ +||||+++++++.+...
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 345678999999999999999999976 57789999987532 23346678899999988 79999999999999999
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
+||||||+++|+|.++++.. ..+++..++.++.||+.||+|||+. +|+||||||+||||+.++++||+|||++
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred EEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeeccee
Confidence 99999999999999999865 4689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
+..... .......+||+.|+|||++.+..|+.++|||||||+||||++|+.||...+ ..+.+.......
T Consensus 490 ~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~------~~~~~~~i~~~~---- 558 (674)
T 3pfq_A 490 KENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED------EDELFQSIMEHN---- 558 (674)
T ss_dssp EECCCT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHSSC----
T ss_pred eccccC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC------HHHHHHHHHhCC----
Confidence 864332 223456789999999999999999999999999999999999999996432 223333333211
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM-----GHVIHM 458 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~-----~evl~~ 458 (521)
..+... .+ .++.+|+.+||+.||++||++ .+|+++
T Consensus 559 ---~~~p~~-~s---~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 559 ---VAYPKS-MS---KEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ---CCCCTT-SC---HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ---CCCCcc-CC---HHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 111111 22 345558889999999999997 777643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=354.57 Aligned_cols=261 Identities=25% Similarity=0.323 Sum_probs=195.2
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC------Ceee
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------AHRM 258 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------~~~~ 258 (521)
.+|++.+.||+|+||.||+|.+. +++.||||++..... .+.+|+++|+.++||||++++++|... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 36899999999999999999985 588999999865432 234699999999999999999998542 2367
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC-CCceEeecccce
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFGLAK 337 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~-~~vkL~DFGla~ 337 (521)
+||||+++ +|.+++.........+++..++.++.|++.||+|||++ +|+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999976 77776654222346799999999999999999999998 99999999999999955 568999999999
Q ss_pred ecCCCCcceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH-------h
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM-------V 409 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~-------~ 409 (521)
.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+.++++.. +
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCSCCHHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHH
Confidence 7643322 2345789999999998764 799999999999999999999999975421 11222222210 0
Q ss_pred h--ccccccCCCcccCCCcc-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 410 T--NRNAEGVLDPRLQEKPC-----SRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 410 ~--~~~~~~~~d~~l~~~~~-----~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
. .........+.+...+. .....++.+|+.+||+.||.+||++.|++++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 11111111222221111 1122456668899999999999999999854
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=334.31 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=202.4
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---------hhhHHHHHHHHHHHhcCC-CCCeeeEEEEEee
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---------GQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAE 253 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~ 253 (521)
.++|.+.+.||+|+||.||+|.+. +++.||||.+.... ....+.+..|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468999999999999999999976 57889999986543 122356788999999996 9999999999999
Q ss_pred CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeec
Q 009979 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (521)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DF 333 (521)
....++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999764 4689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCcceeeccccccccccccccc------CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 009979 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYAS------TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407 (521)
Q Consensus 334 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 407 (521)
|++....... ......||+.|+|||++. ...++.++||||||+++|||++|+.||.... .......
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~ 240 (298)
T 1phk_A 169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK------QMLMLRM 240 (298)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHH
T ss_pred cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc------HHHHHHH
Confidence 9998764432 234457899999999884 5568899999999999999999999996432 1222222
Q ss_pred HhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 408 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
..... . . ............+.+++.+||+.||++|||+.++++
T Consensus 241 ~~~~~-~-~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 IMSGN-Y-Q-----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHTC-C-C-----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhcCC-c-c-----cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 22211 1 0 011111122234555888999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=339.46 Aligned_cols=258 Identities=20% Similarity=0.282 Sum_probs=198.0
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCCeeeEEEEEee--CCeeeEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAE--GAHRMLV 260 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~--~~~~~lV 260 (521)
.++|++.+.||+|+||+||+|.+. +++.||+|++... ..+.+.+|+++++.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 467999999999999999999964 6889999998643 3467889999999997 9999999999987 5678999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC-CceEeecccceec
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKLL 339 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~-~vkL~DFGla~~~ 339 (521)
|||+++++|.+++. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++..
T Consensus 112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999999885 378899999999999999999999 999999999999999766 8999999999876
Q ss_pred CCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH--------Hhh
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT--------MVT 410 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~--------~~~ 410 (521)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...+...... .+.
T Consensus 182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHHHHCHHHHHHHHH
T ss_pred CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHHHHhcCCchhhhHHH
Confidence 54332 334578999999999876 67999999999999999999999999543221 1111111100 000
Q ss_pred cccc--------------ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 411 NRNA--------------EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 411 ~~~~--------------~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.... ...................+.+++.+||+.||++|||+.|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 00000001111111123445668889999999999999999853
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=338.15 Aligned_cols=258 Identities=24% Similarity=0.377 Sum_probs=197.6
Q ss_pred cCCCccccceEccCCcEEEEEEEEc--CCc--EEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE--DNT--NVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 256 (521)
..++|++.+.||+|+||+||+|.+. +++ .||+|.+... .....+.+.+|+++++.++||||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 4468999999999999999999864 233 5899988654 2344577889999999999999999999998765
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccc
Confidence 88999999999999999764 24689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcce--eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccc
Q 009979 337 KLLGAERSYV--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (521)
Q Consensus 337 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (521)
.......... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.... ..+.+........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~~~~~~~~~ 242 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN------GSQILHKIDKEGE 242 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTSCC
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC------HHHHHHHHHccCC
Confidence 8875433221 234567889999999988889999999999999999999 999996442 2222333222211
Q ss_pred cccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 414 ~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
. .. .....+.. +.+++.+||+.||++||++.++++.|+...
T Consensus 243 ~-----~~-~~~~~~~~---l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 243 R-----LP-RPEDCPQD---IYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp C-----CC-CCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred C-----CC-CCcCcCHH---HHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 0 00 11123333 445888999999999999999999998653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=343.10 Aligned_cols=264 Identities=23% Similarity=0.380 Sum_probs=185.6
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
+.+..++|.+.+.||+|+||.||+|.+. +++.||||.+.... ....+.+.+|+.+++.++||||+++++++......+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 3556789999999999999999999854 68899999886443 234567888999999999999999999999999999
Q ss_pred EEEEeccCCchHHhhhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecc
Q 009979 259 LVYEYIDNGNLEQWLHGD----VGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~----~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFG 334 (521)
+||||+++++|.+++... ......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999999998641 11235689999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCc----ceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHh
Q 009979 335 LAKLLGAERS----YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409 (521)
Q Consensus 335 la~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 409 (521)
++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... . .....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~---~~~~~ 240 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---V---LMLTL 240 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---H---HHHHH
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---H---HHHHh
Confidence 9986543221 11234579999999999865 568999999999999999999999997543221 1 11111
Q ss_pred hcccc---ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 410 TNRNA---EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 410 ~~~~~---~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
..... ....++.... ..+. .+.+++.+||+.||.+||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~-~~~~---~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 241 QNDPPSLETGVQDKEMLK-KYGK---SFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TSSCCCTTC-----CCCC-CCCH---HHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCCCccccccccchhhh-hhhH---HHHHHHHHHccCChhhCcCHHHHhh
Confidence 11100 0011111111 1233 3445888999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=342.89 Aligned_cols=251 Identities=22% Similarity=0.363 Sum_probs=196.2
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--------hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 256 (521)
++|.+.+.||+|+||.||+|.+. +++.||||.+..... .....+..|+++++.++||||+++++++..+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 47899999999999999999975 578899999865321 12245788999999999999999999987655
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCC---ceEeec
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN---PKLSDF 333 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~---vkL~DF 333 (521)
.++||||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+||
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 89999999999999998754 5789999999999999999999998 9999999999999987654 999999
Q ss_pred ccceecCCCCcceeeccccccccccccccc---CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh
Q 009979 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410 (521)
Q Consensus 334 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (521)
|+++..... .......||+.|+|||++. ...++.++|||||||++|+|++|+.||....... .+...+..
T Consensus 162 g~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~--- 234 (322)
T 2ycf_A 162 GHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITS--- 234 (322)
T ss_dssp TTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHHH---
T ss_pred ccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHHh---
Confidence 999876432 2223457999999999873 5678999999999999999999999997554322 22222211
Q ss_pred ccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 411 ~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.... ..+.. .......+.+++.+||+.||++||++.+++++
T Consensus 235 -~~~~--~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 235 -GKYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp -TCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -Cccc--cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 1100 00100 11122345568889999999999999999853
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=343.58 Aligned_cols=262 Identities=21% Similarity=0.319 Sum_probs=205.7
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhh-----------------HHHHHHHHHHHhcCCCCCe
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQA-----------------EKEFKVEVEAIGRVRHKNL 244 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~Ei~~l~~l~hpni 244 (521)
....++|++.+.||+|+||.||+|.+ +++.||+|.+....... .+.+.+|+++++.++||||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 34457899999999999999999999 89999999986432211 1789999999999999999
Q ss_pred eeEEEEEeeCCeeeEEEEeccCCchHHh------hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCC
Q 009979 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQW------LHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKS 317 (521)
Q Consensus 245 v~l~~~~~~~~~~~lV~e~~~~g~L~~~------l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~iiHrDik~ 317 (521)
+++++++.+....++||||+++|+|.++ +... ....+++..++.++.|++.||+|||+ . +|+||||||
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p 180 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKP 180 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCG
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCCh
Confidence 9999999999999999999999999998 5442 24689999999999999999999998 8 999999999
Q ss_pred CCeEeCCCCCceEeecccceecCCCCcceeecccccccccccccccCC-CCCC-cccchhHHHHHHHHHhCCCCCCCCCC
Q 009979 318 SNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNE-RSDVYSFGILIMEVISGRNPVDYSRP 395 (521)
Q Consensus 318 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwS~Gvvl~elltG~~Pf~~~~~ 395 (521)
+|||++.++.+||+|||++...... ......||+.|+|||.+.+. .++. ++|||||||++|||++|+.||.....
T Consensus 181 ~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 181 SNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp GGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred HhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9999999999999999999876433 34456799999999999877 6666 99999999999999999999975433
Q ss_pred CCcccHHHHHHHHhhccccccC------CCcccCC---CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 396 PGEVNLVEWLKTMVTNRNAEGV------LDPRLQE---KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~------~d~~l~~---~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
. .+....... ...... ..+.... .........+.+++.+||+.||.+||++.+++++
T Consensus 258 ~-----~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 258 L-----VELFNNIRT-KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp S-----HHHHHHHTS-CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred H-----HHHHHHHhc-cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 122222221 111000 0000000 0001122344558889999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=350.89 Aligned_cols=261 Identities=25% Similarity=0.334 Sum_probs=194.1
Q ss_pred CCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC------eeeE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------HRML 259 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~------~~~l 259 (521)
.+|++.+.||+|+||+||+|.+..+..||+|++...... ..+|+++|+.++||||+++++++.... ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 479999999999999999999987778999998754332 235999999999999999999986543 3789
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC-CCCCceEeeccccee
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKL 338 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~-~~~~vkL~DFGla~~ 338 (521)
||||+++ ++...+.........+++..+..++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||+++.
T Consensus 116 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 116 VLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 9999987 44444332212246789999999999999999999999 999999999999998 799999999999997
Q ss_pred cCCCCcceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH-------h-
Q 009979 339 LGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM-------V- 409 (521)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~-------~- 409 (521)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.+.++.. +
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI--DQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHH
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHH
Confidence 644332 2345789999999998664 5999999999999999999999999754311 1111211110 0
Q ss_pred -hccccccCCCcccCCCccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 410 -TNRNAEGVLDPRLQEKPCS-----RALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 410 -~~~~~~~~~d~~l~~~~~~-----~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.........-+.....+.. .....+.+++.+||+.||++|||+.|++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0001111111111111111 122356668889999999999999999854
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=344.68 Aligned_cols=262 Identities=22% Similarity=0.321 Sum_probs=200.2
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC-----Cee
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHR 257 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----~~~ 257 (521)
.++|++.+.||+|+||.||+|.+. ++..||||++.... ....+.+.+|+++++.++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 358999999999999999999975 57789999987543 33347788999999999999999999999765 367
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||++ |+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999997 5999998754 589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcce--eeccccccccccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 338 LLGAERSYV--TTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 338 ~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
......... .....||+.|+|||++. +..++.++|||||||++|||++|+.||....... ....+.........
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQ 253 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HHHHHHHHHCSCCH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHHHhCCCCH
Confidence 765432221 24468999999999864 4568999999999999999999999997554222 11111111100000
Q ss_pred ---------------ccCCCcccCC--CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 415 ---------------EGVLDPRLQE--KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 415 ---------------~~~~d~~l~~--~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.....+.... ...+.....+.+++.+||+.||++|||+.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 0001112345668889999999999999999854
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=337.08 Aligned_cols=250 Identities=22% Similarity=0.318 Sum_probs=197.5
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC----hhhHHHHHHHHHHHhcCCCCCeeeEEEEEe--eCCeee
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVRHKNLVRLLGYCA--EGAHRM 258 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~--~~~~~~ 258 (521)
++|.+.+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+++++.++||||+++++++. +....+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 58999999999999999999964 57899999986542 234577899999999999999999999984 455789
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+||||++++ |.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 85 lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 999999875 777776542 45789999999999999999999999 999999999999999999999999999987
Q ss_pred cCCC-CcceeecccccccccccccccCCC--CCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 339 LGAE-RSYVTTRVMGTFGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 339 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
.... .........||+.|+|||++.+.. ++.++||||||+++|||++|+.||.... ..+........ ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~i~~~-~~- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IYKLFENIGKG-SY- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHC-CC-
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHHhcC-CC-
Confidence 6432 222234567999999999987643 4779999999999999999999996432 22222222221 10
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+. ..++.. +.+++.+||+.||.+|||+.+++++
T Consensus 231 -----~~~-~~~~~~---l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 -----AIP-GDCGPP---LSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -----CCC-SSSCHH---HHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----CCC-CccCHH---HHHHHHHHccCChhhCCCHHHHhcC
Confidence 111 113333 4458889999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=372.38 Aligned_cols=262 Identities=22% Similarity=0.377 Sum_probs=206.9
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEcC----CcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEe
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLED----NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~ 252 (521)
..++++..++|++.+.||+|+||.||+|.+.. +..||+|.+.... ....+.+..|+.+++.++||||+++++++.
T Consensus 382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 34556677889999999999999999999742 4568999886543 334477899999999999999999999985
Q ss_pred eCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEee
Q 009979 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (521)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~D 332 (521)
+ +..++||||+++|+|.++++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 462 ~-~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~D 534 (656)
T 2j0j_A 462 E-NPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 534 (656)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred c-CceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEe
Confidence 4 5689999999999999999865 34689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhc
Q 009979 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTN 411 (521)
Q Consensus 333 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (521)
||+++..............||+.|+|||++.+..++.++|||||||++|||++ |..||..... .+.+......
T Consensus 535 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~------~~~~~~i~~~ 608 (656)
T 2j0j_A 535 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN------NDVIGRIENG 608 (656)
T ss_dssp CCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHHT
T ss_pred cCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHcC
Confidence 99998775544444445667899999999998999999999999999999997 9999964321 2222222221
Q ss_pred cccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 412 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
... .+. ..++.. +.+++.+||+.||++||++.++++.|+..
T Consensus 609 ~~~------~~~-~~~~~~---l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 609 ERL------PMP-PNCPPT---LYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp CCC------CCC-TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC------CCC-ccccHH---HHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 110 111 123333 44588899999999999999999999764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=353.60 Aligned_cols=200 Identities=21% Similarity=0.291 Sum_probs=173.9
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcC------CCCCeeeEEEEEeeCC
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV------RHKNLVRLLGYCAEGA 255 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l------~hpniv~l~~~~~~~~ 255 (521)
....+|++.+.||+|+||+||+|.+. +++.||||++... ......+..|+++++.+ +|+||+++++++....
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 34568999999999999999999976 4788999998653 33345677788888776 5779999999999999
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCC--ceEeec
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN--PKLSDF 333 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~--vkL~DF 333 (521)
..++||||+. ++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+||
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred eEEEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeec
Confidence 9999999996 59999998762 34689999999999999999999999 9999999999999999887 999999
Q ss_pred ccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 009979 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393 (521)
Q Consensus 334 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~ 393 (521)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 247 G~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 247 GSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 999865332 23457999999999999999999999999999999999999999754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=336.61 Aligned_cols=260 Identities=20% Similarity=0.337 Sum_probs=200.7
Q ss_pred cchhhhhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCC--CCCeeeEEEEE
Q 009979 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVR--HKNLVRLLGYC 251 (521)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--hpniv~l~~~~ 251 (521)
+.+..+.+..++|++.+.||+|+||.||+|.+.+++.||+|++... .....+.+.+|+++++.++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3456667778899999999999999999999888999999998654 3344577899999999997 59999999999
Q ss_pred eeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEe
Q 009979 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLS 331 (521)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~ 331 (521)
.+....++||| +.+++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||+++ +.+||+
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~ 168 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLI 168 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEEC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEe
Confidence 99999999999 5578999999865 4789999999999999999999999 9999999999999965 789999
Q ss_pred ecccceecCCCCcc-eeecccccccccccccccC-----------CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 009979 332 DFGLAKLLGAERSY-VTTRVMGTFGYVAPEYAST-----------GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEV 399 (521)
Q Consensus 332 DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~ 399 (521)
|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----- 243 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII----- 243 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH-----
Confidence 99999876433222 2234579999999999865 478889999999999999999999996432
Q ss_pred cHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 400 NLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.....+........ ...+.. .++. .+.+++.+||+.||++||++.++++.
T Consensus 244 ~~~~~~~~~~~~~~-----~~~~~~-~~~~---~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 244 NQISKLHAIIDPNH-----EIEFPD-IPEK---DLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp SHHHHHHHHHCTTS-----CCCCCC-CSCH---HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHhccc-----ccCCcc-cchH---HHHHHHHHHccCCcccCcCHHHHhcC
Confidence 12222222222111 111111 1233 34458889999999999999999854
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=339.38 Aligned_cols=264 Identities=18% Similarity=0.271 Sum_probs=203.8
Q ss_pred hhhhcCCCccccceEccCCcEEEEEEEE-c-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCC------CeeeEEEEE
Q 009979 180 ELEVSTNGFADENVIGEGGYGIVYHGVL-E-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK------NLVRLLGYC 251 (521)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hp------niv~l~~~~ 251 (521)
..++..++|++.+.||+|+||.||+|.+ . +++.||+|++... ....+.+..|+++++.++|+ +++++++++
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 3445567999999999999999999987 3 5788999998643 33456788899999988665 499999999
Q ss_pred eeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-------
Q 009979 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK------- 324 (521)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~------- 324 (521)
.+....++||||+ +++|.+++.... ..++++..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEE
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecccccccc
Confidence 9999999999999 889999998752 34789999999999999999999999 9999999999999987
Q ss_pred ------------CCCceEeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCC
Q 009979 325 ------------QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDY 392 (521)
Q Consensus 325 ------------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~ 392 (521)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 678999999999875332 2345789999999999999999999999999999999999999975
Q ss_pred CCCCCcccHHHHHHHHhhc--------cccccC---------------------CCccc-CCCccHHHHHHHHHHHHhcc
Q 009979 393 SRPPGEVNLVEWLKTMVTN--------RNAEGV---------------------LDPRL-QEKPCSRALKRALLVALRCV 442 (521)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~--------~~~~~~---------------------~d~~l-~~~~~~~~~~~~~~li~~cl 442 (521)
.... .....+...... ...... ..+.. ...........+.+++.+||
T Consensus 237 ~~~~---~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 313 (339)
T 1z57_A 237 HDSK---EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313 (339)
T ss_dssp SCHH---HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CChH---HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHh
Confidence 4321 111111111100 000000 00000 00011233455667899999
Q ss_pred CCCCCCCCCHHHHHH
Q 009979 443 DPNAHKRPKMGHVIH 457 (521)
Q Consensus 443 ~~dP~~RPt~~evl~ 457 (521)
+.||++|||+.|+++
T Consensus 314 ~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 314 EYDPAKRITLREALK 328 (339)
T ss_dssp CSSTTTSCCHHHHTT
T ss_pred CcCcccccCHHHHhc
Confidence 999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=343.87 Aligned_cols=207 Identities=23% Similarity=0.304 Sum_probs=176.1
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCC-CC-----CeeeEEEE
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HK-----NLVRLLGY 250 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hp-----niv~l~~~ 250 (521)
+...+...++|++.+.||+|+||+||+|.+. +++.||||++... ......+..|+++++.++ |+ +|++++++
T Consensus 46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 4445556789999999999999999999976 5778999998643 334566778999988885 44 49999999
Q ss_pred EeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC--CCCCc
Q 009979 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD--KQWNP 328 (521)
Q Consensus 251 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~--~~~~v 328 (521)
+......++||||+. |+|.+++.... ...+++..+..++.|++.||.|||++ +.+|+||||||+|||++ .++.+
T Consensus 125 ~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~ 200 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI 200 (382)
T ss_dssp EEETTEEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCE
T ss_pred eccCCceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcE
Confidence 999999999999996 59999998752 35689999999999999999999952 23899999999999994 57889
Q ss_pred eEeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 009979 329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393 (521)
Q Consensus 329 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~ 393 (521)
||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 201 kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 201 KIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp EECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999876432 23467999999999999999999999999999999999999999754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=333.68 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=191.3
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEee-----------
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE----------- 253 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~----------- 253 (521)
++|++.+.||+|+||.||+|... +++.||||.+... ....+.+.+|+++++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 46899999999999999999975 6889999998543 3445778899999999999999999998865
Q ss_pred --CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEe
Q 009979 254 --GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLS 331 (521)
Q Consensus 254 --~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~ 331 (521)
....++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence 35679999999999999999864 34678899999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCC-------------cceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCC
Q 009979 332 DFGLAKLLGAER-------------SYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPG 397 (521)
Q Consensus 332 DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~ 397 (521)
|||+++...... ........||+.|+|||++.+. .++.++|||||||++|||++ ||..
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~----- 230 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST----- 230 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS-----
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC-----
Confidence 999998754221 1122345799999999998764 78999999999999999998 5531
Q ss_pred cccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 398 EVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.....+....... .. ....+.+ .......+.+++.+||+.||.+|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~-~~--~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 231 GMERVNILKKLRS-VS--IEFPPDF----DDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHHHHHS-TT--CCCCTTC----CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred chhHHHHHHhccc-cc--cccCccc----cccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1122222222221 11 1111111 12222334558889999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=346.60 Aligned_cols=258 Identities=22% Similarity=0.326 Sum_probs=181.7
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC------C
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------A 255 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------~ 255 (521)
.++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 368999999999999999999965 5889999998653 233456788999999999999999999998654 5
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..|+||||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 6799998864 3689999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccc-
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN- 413 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~- 413 (521)
++..... .+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+........
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGTPGA 251 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCH
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCH
Confidence 9865322 344679999999999876 6799999999999999999999999965432 111111111111000
Q ss_pred --cccCCC----------cccCCCcc----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 414 --AEGVLD----------PRLQEKPC----SRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 414 --~~~~~d----------~~l~~~~~----~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
...+.. +....... ......+.+|+.+||+.||++|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000 00000000 0112345668889999999999999999854
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=350.09 Aligned_cols=202 Identities=22% Similarity=0.363 Sum_probs=155.2
Q ss_pred Cccc-cceEccCCcEEEEEEEEc---CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEee--CCeeeEE
Q 009979 187 GFAD-ENVIGEGGYGIVYHGVLE---DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLV 260 (521)
Q Consensus 187 ~~~~-~~~LG~G~fG~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~~lV 260 (521)
.|.+ .++||+|+||+||+|.+. ++..||+|++.... ....+.+|+++|+.++||||+++++++.. ....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 4555 458999999999999975 47789999986543 23567889999999999999999999954 6788999
Q ss_pred EEeccCCchHHhhhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe----CCCCCceEe
Q 009979 261 YEYIDNGNLEQWLHGDV-----GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL----DKQWNPKLS 331 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl----~~~~~vkL~ 331 (521)
|||+. |+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+|||| +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99996 58888875321 1223589999999999999999999999 99999999999999 778899999
Q ss_pred ecccceecCCCCc--ceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCC
Q 009979 332 DFGLAKLLGAERS--YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSR 394 (521)
Q Consensus 332 DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~ 394 (521)
|||+++.+..... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9999987643221 22345689999999999877 459999999999999999999999997543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=333.64 Aligned_cols=259 Identities=22% Similarity=0.352 Sum_probs=193.1
Q ss_pred CCCccccceEccCCcEEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEe-----------
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCA----------- 252 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~----------- 252 (521)
.++|.+.+.||+|+||.||+|.+.. ++.||+|++........+.+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999999864 8899999998776666788999999999999999999999873
Q ss_pred ---eCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC-CCCCc
Q 009979 253 ---EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNP 328 (521)
Q Consensus 253 ---~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~-~~~~v 328 (521)
+....++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence 3467899999997 599999864 4688999999999999999999999 999999999999997 56789
Q ss_pred eEeecccceecCCCCc--ceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH
Q 009979 329 KLSDFGLAKLLGAERS--YVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL 405 (521)
Q Consensus 329 kL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~ 405 (521)
||+|||+++....... .......||..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .+..
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~ 234 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE------LEQM 234 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH------HHHH
Confidence 9999999987643211 12234567999999998765 6789999999999999999999999975432 1111
Q ss_pred HHHhhcccc------------------ccCCCcccCC-CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 406 KTMVTNRNA------------------EGVLDPRLQE-KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 406 ~~~~~~~~~------------------~~~~d~~l~~-~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
......... .....+.... .........+.+++.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 111110000 0000000000 0001122345568889999999999999999853
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=329.33 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=200.4
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 358999999999999999999976 68899999986532 234577889999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC---CCceEeeccccee
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ---WNPKLSDFGLAKL 338 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~---~~vkL~DFGla~~ 338 (521)
||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||++..
T Consensus 101 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 101 ELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 999999999988764 4689999999999999999999999 99999999999999754 4699999999986
Q ss_pred cCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCC
Q 009979 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (521)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (521)
..... ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.... ..+.......... . ..
T Consensus 174 ~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~-~-~~ 242 (287)
T 2wei_A 174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN------EYDILKRVETGKY-A-FD 242 (287)
T ss_dssp BCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCC-C-CC
T ss_pred ecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC------HHHHHHHHHcCCC-C-CC
Confidence 54332 2234568999999998865 48999999999999999999999996432 2222232222111 0 00
Q ss_pred CcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 419 d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.+.. ...+ ..+.+++.+||+.||++|||+.++++
T Consensus 243 ~~~~--~~~~---~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 LPQW--RTIS---DDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp SGGG--TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhh--hhcC---HHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0000 1122 34455888999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=332.68 Aligned_cols=263 Identities=26% Similarity=0.363 Sum_probs=197.6
Q ss_pred cCCCccccceEccCCcEEEEEEEE--cCCcEEEEEEeccCChh--hHHHHHHHHHHHhcC---CCCCeeeEEEEEe----
Q 009979 184 STNGFADENVIGEGGYGIVYHGVL--EDNTNVAVKNLLNNRGQ--AEKEFKVEVEAIGRV---RHKNLVRLLGYCA---- 252 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~--~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l---~hpniv~l~~~~~---- 252 (521)
..++|++.+.||+|+||.||+|.+ .+++.||+|++...... ....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 346899999999999999999997 35788999998643221 223456677777666 8999999999987
Q ss_pred -eCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEe
Q 009979 253 -EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLS 331 (521)
Q Consensus 253 -~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~ 331 (521)
.....++||||++ |+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999997 59999998753 34589999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhc
Q 009979 332 DFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN 411 (521)
Q Consensus 332 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (521)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+......
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~ 237 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGL 237 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCC
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHcCC
Confidence 999998754322 23446789999999999999999999999999999999999999974431 1111111111110
Q ss_pred cccccC----CCc--ccC-------CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 412 RNAEGV----LDP--RLQ-------EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 412 ~~~~~~----~d~--~l~-------~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
...... ..+ .+. ..........+.+++.+||+.||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 000 000 0000112233445888999999999999999984
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=342.04 Aligned_cols=266 Identities=19% Similarity=0.244 Sum_probs=186.5
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe----
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH---- 256 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~---- 256 (521)
....++|.+.+.||+|+||.||+|.+. ++..||||++...... ...+..+++.++.++||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 345578999999999999999999975 5889999998654332 3445668888899999999999999865433
Q ss_pred ---eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeeecCCCCCCeEeCC-CCCceE
Q 009979 257 ---RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH--EGLEPKVVHRDIKSSNILLDK-QWNPKL 330 (521)
Q Consensus 257 ---~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH--~~~~~~iiHrDik~~NILl~~-~~~vkL 330 (521)
.++||||+++ +|...+.........+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEE
T ss_pred ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEE
Confidence 7899999976 655554432223467899999999999999999999 77 9999999999999996 899999
Q ss_pred eecccceecCCCCcceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHh
Q 009979 331 SDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409 (521)
Q Consensus 331 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 409 (521)
+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+....
T Consensus 174 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~~~~~~ 248 (360)
T 3e3p_A 174 CDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA---GQLHEIVRVL 248 (360)
T ss_dssp CCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHH
T ss_pred eeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH---HHHHHHHHHc
Confidence 9999998765433 23345789999999988654 4899999999999999999999999754321 1111111111
Q ss_pred hc------------cccccCCCcc------cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 410 TN------------RNAEGVLDPR------LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 410 ~~------------~~~~~~~d~~------l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.. .......+.. ............+.+++.+||+.||.+|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 0000000000 000001112345667889999999999999999984
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=336.05 Aligned_cols=253 Identities=19% Similarity=0.255 Sum_probs=171.6
Q ss_pred CCCcccc-ceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEee----CCeee
Q 009979 185 TNGFADE-NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRM 258 (521)
Q Consensus 185 ~~~~~~~-~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~----~~~~~ 258 (521)
.++|.+. +.||+|+||.||+|.+. +++.||||++.... .........++.+.||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 3478885 46999999999999976 68899999986532 222223344667799999999999876 45579
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---CCCceEeeccc
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFGL 335 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~---~~~vkL~DFGl 335 (521)
+||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 103 lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999998652 35799999999999999999999999 9999999999999976 45599999999
Q ss_pred ceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
++..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ............
T Consensus 178 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~- 250 (336)
T 3fhr_A 178 AKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS---PGMKRRIRLGQY- 250 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred ceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh---hhHHHhhhcccc-
Confidence 9875432 233457899999999998889999999999999999999999999654322110 000111100000
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
....+ .....+. .+.+++.+||+.||++|||+.+++++
T Consensus 251 ~~~~~--~~~~~~~---~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 251 GFPNP--EWSEVSE---DAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp CCCTT--TSTTCCH---HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccCch--hhccCCH---HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 0011233 34558889999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=337.48 Aligned_cols=262 Identities=20% Similarity=0.307 Sum_probs=197.3
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC-----Cee
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AHR 257 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----~~~ 257 (521)
.++|.+.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+++++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999976 58889999986543 33446788999999999999999999998764 678
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+. ++|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 5999998753 689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCcc---------eeeccccccccccccccc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 009979 338 LLGAERSY---------VTTRVMGTFGYVAPEYAS-TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407 (521)
Q Consensus 338 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 407 (521)
........ ......||+.|+|||++. +..++.++|||||||++|||++|+.||...... .....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR---HQLLLIFG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHH
Confidence 76432211 122357899999999875 477899999999999999999999999754311 11111111
Q ss_pred HhhccccccCC----C----------cccCCCc----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 408 MVTNRNAEGVL----D----------PRLQEKP----CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 408 ~~~~~~~~~~~----d----------~~l~~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
........... . +...... .+.....+.+++.+||+.||++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11000000000 0 0000000 01122345568889999999999999999853
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=341.18 Aligned_cols=254 Identities=23% Similarity=0.346 Sum_probs=194.2
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee----
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR---- 257 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~---- 257 (521)
.++|.+.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 368999999999999999999975 58899999997542 33357788999999999999999999999877655
Q ss_pred --eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 258 --MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 258 --~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
++||||+. ++|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 59988874 3489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+.+.........
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~~ 260 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY------LDQLTQILKVTGV 260 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCC
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHhCC
Confidence 9865332 344678999999999877 7899999999999999999999999964321 1111111110000
Q ss_pred ------ccC-----------CCcccCCC---ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 415 ------EGV-----------LDPRLQEK---PCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 415 ------~~~-----------~d~~l~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
..+ +....... ..+.....+.+++.+||+.||++|||+.|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000 00000000 001112345668889999999999999999854
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=337.76 Aligned_cols=265 Identities=20% Similarity=0.267 Sum_probs=199.6
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCC-----------CCCeeeEEEEE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-----------HKNLVRLLGYC 251 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------hpniv~l~~~~ 251 (521)
..++|.+.+.||+|+||+||+|.+. +++.||||++... ....+.+..|+++++.++ ||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 4568999999999999999999974 6888999998643 334567888999999886 89999999998
Q ss_pred eeCC----eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC----
Q 009979 252 AEGA----HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD---- 323 (521)
Q Consensus 252 ~~~~----~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~---- 323 (521)
.... ..++||||+ +++|.+++.... ...+++..++.++.|++.||+|||+++ +|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence 7654 789999999 889999998752 346899999999999999999999843 899999999999994
Q ss_pred --CCCCceEeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccH
Q 009979 324 --KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNL 401 (521)
Q Consensus 324 --~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~ 401 (521)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4457999999999876432 2345789999999999999999999999999999999999999976543222212
Q ss_pred HHHHHHHhhc-cc-----------------cccCCCc----cc---------CCCccHHHHHHHHHHHHhccCCCCCCCC
Q 009979 402 VEWLKTMVTN-RN-----------------AEGVLDP----RL---------QEKPCSRALKRALLVALRCVDPNAHKRP 450 (521)
Q Consensus 402 ~~~~~~~~~~-~~-----------------~~~~~d~----~l---------~~~~~~~~~~~~~~li~~cl~~dP~~RP 450 (521)
.+.+...... +. ....... .. ...........+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 2222211110 00 0000000 00 0012244556777899999999999999
Q ss_pred CHHHHHHH
Q 009979 451 KMGHVIHM 458 (521)
Q Consensus 451 t~~evl~~ 458 (521)
|+.|++++
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999853
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=335.22 Aligned_cols=261 Identities=28% Similarity=0.378 Sum_probs=179.6
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh-hhHHHHHHHHH-HHhcCCCCCeeeEEEEEeeCCee
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVE-AIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~-~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
+++..++|++.+.||+|+||.||+|.+. +++.||||++..... .....+..|+. +++.++||||+++++++.+.+..
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~ 96 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC 96 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence 4566789999999999999999999975 688999999976432 33345555665 77888999999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 258 MLVYEYIDNGNLEQWLHGDV-GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
++||||+++ +|.+++.... .....+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++
T Consensus 97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 999999975 8888775311 11357899999999999999999999842 8999999999999999999999999999
Q ss_pred eecCCCCcceeecccccccccccccc----cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYA----STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (521)
+...... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||...... .+.+....
T Consensus 174 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~--- 243 (327)
T 3aln_A 174 GQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-----FDQLTQVV--- 243 (327)
T ss_dssp CC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCC---
T ss_pred eeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-----HHHHHHHh---
Confidence 8764322 22344799999999998 4667899999999999999999999999643211 01000000
Q ss_pred ccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 413 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
....+.+...........+.+++.+||+.||++||++.++++
T Consensus 244 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 244 ---KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ---CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 001111111111112234455888999999999999999974
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=340.24 Aligned_cols=250 Identities=25% Similarity=0.403 Sum_probs=199.4
Q ss_pred chhhhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh------hHHHHHHHHHHHhcCC--CCCeeeE
Q 009979 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ------AEKEFKVEVEAIGRVR--HKNLVRL 247 (521)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~--hpniv~l 247 (521)
...+.+...++|++.+.||+|+||.||+|.+. +++.||||.+...... ....+..|+.+++.++ |+||+++
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 34555667789999999999999999999964 6888999998654321 2245667999999996 5999999
Q ss_pred EEEEeeCCeeeEEEEeccC-CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC-CC
Q 009979 248 LGYCAEGAHRMLVYEYIDN-GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQ 325 (521)
Q Consensus 248 ~~~~~~~~~~~lV~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~-~~ 325 (521)
++++.+....++||||+.+ ++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++ ++
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNR 186 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTT
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCC
Confidence 9999999999999999976 8999999764 5689999999999999999999998 999999999999999 78
Q ss_pred CCceEeecccceecCCCCcceeecccccccccccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHH
Q 009979 326 WNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEW 404 (521)
Q Consensus 326 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~ 404 (521)
+.+||+|||+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... +
T Consensus 187 ~~~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~- 254 (320)
T 3a99_A 187 GELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------E- 254 (320)
T ss_dssp TEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H-
T ss_pred CCEEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------h-
Confidence 89999999999876432 2234579999999999876665 678999999999999999999995321 1
Q ss_pred HHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 009979 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459 (521)
Q Consensus 405 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L 459 (521)
..... .. +. ...+.. +.+++.+||+.||++|||+.++++.-
T Consensus 255 ---~~~~~---~~----~~-~~~~~~---~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 255 ---IIRGQ---VF----FR-QRVSSE---CQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp ---HHHCC---CC----CS-SCCCHH---HHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred ---hhccc---cc----cc-ccCCHH---HHHHHHHHccCChhhCcCHHHHhcCH
Confidence 11110 01 11 112333 44588899999999999999998754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=349.94 Aligned_cols=253 Identities=23% Similarity=0.276 Sum_probs=186.6
Q ss_pred CCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+..|+++++.+ +||||+++++++.++...+||||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345667889999999998776678999999998653 235677899999876 8999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCC-------------CCc
Q 009979 265 DNGNLEQWLHGDVGPHSP---LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQ-------------WNP 328 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~---l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~-------------~~v 328 (521)
. |+|.+++......... .++..++.++.|++.||+|||++ +|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 6999999865321111 12334578999999999999999 99999999999999654 479
Q ss_pred eEeecccceecCCCCcc---eeecccccccccccccccC-------CCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 009979 329 KLSDFGLAKLLGAERSY---VTTRVMGTFGYVAPEYAST-------GMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPG 397 (521)
Q Consensus 329 kL~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~ 397 (521)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~- 246 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR- 246 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-
Confidence 99999999987543322 1234679999999999865 678999999999999999999 99999643221
Q ss_pred cccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 398 EVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.... ..... ..+.............+.+++.+||+.||.+|||+.++++
T Consensus 247 ---~~~i----~~~~~----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 ---ESNI----IRGIF----SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---HHHH----HHTCC----CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHH----hcCCC----CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111 11110 0011111112344556677999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=334.16 Aligned_cols=256 Identities=22% Similarity=0.315 Sum_probs=193.9
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe-----
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH----- 256 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~----- 256 (521)
.++|.+.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 358999999999999999999975 58899999986542 2334678899999999999999999999987654
Q ss_pred -eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 257 -RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 257 -~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
.++||||+. ++|.+++. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 59988774 2489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc--
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR-- 412 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-- 412 (521)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+.......
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGT 245 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---HHHHHHHHHHCBCCH
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCH
Confidence 9865322 234578999999998876 67899999999999999999999999754321 1111111110000
Q ss_pred ----------------ccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 413 ----------------NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 413 ----------------~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.......+.+.. ........+.+++.+||+.||++|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000011110 011223345558889999999999999999854
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=331.90 Aligned_cols=263 Identities=18% Similarity=0.257 Sum_probs=201.0
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEc-CC-cEEEEEEeccCChhhHHHHHHHHHHHhcCCCCC------eeeEEEEEe
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLE-DN-TNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN------LVRLLGYCA 252 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn------iv~l~~~~~ 252 (521)
.+...++|++.+.||+|+||.||+|... ++ ..||+|.+... ....+.+..|+++++.++|++ ++.+++++.
T Consensus 14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 3445679999999999999999999975 34 67999998643 344567888999999987665 999999999
Q ss_pred eCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe----------
Q 009979 253 EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL---------- 322 (521)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl---------- 322 (521)
.....++||||+ +++|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||+
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEEC
T ss_pred eCCeEEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccc
Confidence 999999999999 567777776542 35789999999999999999999998 99999999999999
Q ss_pred ---------CCCCCceEeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Q 009979 323 ---------DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393 (521)
Q Consensus 323 ---------~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~ 393 (521)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 56789999999999875332 23457999999999999999999999999999999999999999744
Q ss_pred CCCCcccHHHHHHHHhhcc--------cc-ccCCCc---------------------ccCCCccHHHHHHHHHHHHhccC
Q 009979 394 RPPGEVNLVEWLKTMVTNR--------NA-EGVLDP---------------------RLQEKPCSRALKRALLVALRCVD 443 (521)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~--------~~-~~~~d~---------------------~l~~~~~~~~~~~~~~li~~cl~ 443 (521)
... .....+....... .. ...... .............+.+++.+||+
T Consensus 243 ~~~---~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 243 ENR---EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp SHH---HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CHH---HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 321 1111111111000 00 000000 00000112234456679999999
Q ss_pred CCCCCCCCHHHHHH
Q 009979 444 PNAHKRPKMGHVIH 457 (521)
Q Consensus 444 ~dP~~RPt~~evl~ 457 (521)
.||++|||+.|+++
T Consensus 320 ~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 320 FDPAQRITLAEALL 333 (355)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred CChhhCcCHHHHhc
Confidence 99999999999974
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=326.67 Aligned_cols=253 Identities=24% Similarity=0.365 Sum_probs=182.4
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh--hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ--AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
....++|++.+.||+|+||.||+|.+. +++.||||.+...... ..+.+..+..+++.++||||+++++++.+....+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 445568999999999999999999975 6889999999754322 2244555666788899999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
+||||+ ++.+..++... ...+++..++.++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||++.
T Consensus 101 lv~e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 173 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISG 173 (318)
T ss_dssp EEECCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred EEEecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCch
Confidence 999999 55666665443 3578999999999999999999998 5 89999999999999999999999999998
Q ss_pred ecCCCCcceeeccccccccccccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (521)
...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||.... ...+.+.......
T Consensus 174 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~ 246 (318)
T 2dyl_A 174 RLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK-----TDFEVLTKVLQEE 246 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHHHSC
T ss_pred hccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC-----ccHHHHHHHhccC
Confidence 654322 233457999999999984 5678899999999999999999999996432 1222233333221
Q ss_pred ccccCCCcccCC-CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 413 NAEGVLDPRLQE-KPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 413 ~~~~~~d~~l~~-~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
. +.+.. ...+.. +.+++.+||+.||.+||++.++++
T Consensus 247 ~------~~~~~~~~~~~~---l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 P------PLLPGHMGFSGD---FQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C------CCCCSSSCCCHH---HHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C------CCCCccCCCCHH---HHHHHHHHccCChhHCcCHHHHhh
Confidence 1 11111 112333 445888999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=345.38 Aligned_cols=252 Identities=27% Similarity=0.357 Sum_probs=187.4
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeEE
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV 260 (521)
.+...+|...+.||+|+||+||.....+++.||||++...... .+.+|+++|+.+ +||||+++++++.+....|||
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 3455679999999999999976555567999999998654322 355799999999 799999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-----CCCceEeeccc
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-----QWNPKLSDFGL 335 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~-----~~~vkL~DFGl 335 (521)
||||. |+|.+++.... ..+.+..++.++.|++.||+|||+. +|+||||||+|||++. ...+||+|||+
T Consensus 97 ~E~~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp EECCS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred EECCC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 99996 59999998763 2344445678999999999999999 9999999999999943 33578999999
Q ss_pred ceecCCCCc--ceeeccccccccccccccc---CCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHh
Q 009979 336 AKLLGAERS--YVTTRVMGTFGYVAPEYAS---TGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMV 409 (521)
Q Consensus 336 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 409 (521)
++....... .......||+.|+|||++. ...++.++|||||||++|||+| |..||..... .......
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-------~~~~~~~ 242 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-------RQANILL 242 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-------HHHHHHT
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-------HHHHHHh
Confidence 987653321 2234567999999999997 4567889999999999999999 9999953321 1111111
Q ss_pred hccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 410 TNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 410 ~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.... .+ ... +.......+.+++.+||+.||.+|||+.++++
T Consensus 243 ~~~~----~~-~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 243 GACS----LD-CLH--PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TCCC----CT-TSC--TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCC----cc-ccC--ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111 01 111 11222334556888999999999999999984
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=331.15 Aligned_cols=244 Identities=28% Similarity=0.419 Sum_probs=189.3
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh------hHHHHHHHHHHHhcC----CCCCeeeEEEE
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ------AEKEFKVEVEAIGRV----RHKNLVRLLGY 250 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l----~hpniv~l~~~ 250 (521)
+...++|++.+.||+|+||.||+|.+. +++.||+|.+...... ....+..|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 344568999999999999999999864 6889999998654322 223455688888888 89999999999
Q ss_pred EeeCCeeeEEEEe-ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC-CCCCc
Q 009979 251 CAEGAHRMLVYEY-IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNP 328 (521)
Q Consensus 251 ~~~~~~~~lV~e~-~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~-~~~~v 328 (521)
+...+..++|||| +.+++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++ .++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 9999999999999 7899999999865 4689999999999999999999999 999999999999999 88999
Q ss_pred eEeecccceecCCCCcceeecccccccccccccccCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 009979 329 KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN-ERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407 (521)
Q Consensus 329 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 407 (521)
||+|||+++...... .....||+.|+|||++.+..+. .++|||||||++|||++|+.||.... +.
T Consensus 180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~--- 245 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------EI--- 245 (312)
T ss_dssp EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HH---
T ss_pred EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------HH---
Confidence 999999998765432 3345799999999998776664 58999999999999999999995321 11
Q ss_pred HhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 408 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
... . ..+.. ..+. .+.+++.+||+.||++||++.+++++
T Consensus 246 -~~~-~------~~~~~-~~~~---~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 246 -LEA-E------LHFPA-HVSP---DCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -HHT-C------CCCCT-TSCH---HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -hhh-c------cCCcc-cCCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110 0 01111 1223 34458889999999999999999864
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=355.82 Aligned_cols=241 Identities=21% Similarity=0.352 Sum_probs=193.6
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc--CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe--
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE--DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH-- 256 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~-- 256 (521)
++..++|++.+.||+|+||.||+|.+. +++.||||++.... ......+..|+++++.++||||+++++++.....
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 445679999999999999999999975 57899999886543 3445678899999999999999999999987665
Q ss_pred ---eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeec
Q 009979 257 ---RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (521)
Q Consensus 257 ---~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DF 333 (521)
.||||||++|++|.+++.. .+++..++.++.|++.||.|||++ +|+||||||+|||++.+ .+||+||
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DF 225 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDL 225 (681)
T ss_dssp CEEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCC
T ss_pred CceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEec
Confidence 6999999999999987643 689999999999999999999999 99999999999999985 8999999
Q ss_pred ccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccc
Q 009979 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (521)
Q Consensus 334 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (521)
|+++..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||......
T Consensus 226 G~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------- 282 (681)
T 2pzi_A 226 GAVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD----------------- 282 (681)
T ss_dssp TTCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-----------------
T ss_pred ccchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc-----------------
Confidence 999876433 3457999999999987654 88999999999999999999888532110
Q ss_pred cccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHhhc
Q 009979 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK-MGHVIHMLEA 461 (521)
Q Consensus 414 ~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt-~~evl~~L~~ 461 (521)
.+. ...+.......+.+++.+||+.||++||+ +.++.+.|..
T Consensus 283 --~~~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 283 --GLP----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp --SCC----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --ccc----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 000 11112222345566888999999999995 5666665553
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=312.68 Aligned_cols=232 Identities=13% Similarity=0.106 Sum_probs=181.5
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
..++|++.+.||+|+||.||+|.+. +++.||||.+..... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 4468999999999999999999976 488999999975432 334778899999999999999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
||||++|++|.++++.. .....+..++.|++.||+|||++ +|+||||||+|||++.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 99999999999999542 34557888999999999999999 99999999999999999999998543
Q ss_pred CCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
|++| ++.++|||||||++|||+||+.||............ ..........
T Consensus 175 ----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-------~~~~~~~~~~ 224 (286)
T 3uqc_A 175 ----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-------ERDTAGQPIE 224 (286)
T ss_dssp ----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-------CBCTTSCBCC
T ss_pred ----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-------HHHhccCCCC
Confidence 3333 688999999999999999999999865432211000 0000000000
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
+.......+. .+.+++.+||+.||++| |+.|+++.|+...
T Consensus 225 ~~~~~~~~~~---~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 225 PADIDRDIPF---QISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HHHHCTTSCH---HHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred hhhcccCCCH---HHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 0000011233 34558889999999999 9999999998643
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=352.31 Aligned_cols=259 Identities=23% Similarity=0.344 Sum_probs=196.2
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEee------CCee
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE------GAHR 257 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~------~~~~ 257 (521)
++|++.+.||+|+||.||+|.+. ++..||||++... .....+.+..|+++++.++||||+++++++.. +...
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 58999999999999999999964 5889999988654 33445778999999999999999999999765 6678
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCC---ceEeecc
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWN---PKLSDFG 334 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~---vkL~DFG 334 (521)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 99999999999999998753 234688899999999999999999998 9999999999999987665 8999999
Q ss_pred cceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH------
Q 009979 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM------ 408 (521)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~------ 408 (521)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....|....
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-----~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-----QPVQWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-----HHHHSSTTCC-----
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-----chhhhhhhhhcccch
Confidence 998764432 2345679999999999999999999999999999999999999996432 111111000
Q ss_pred --hhccccccC--CCccc--CCCccHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 009979 409 --VTNRNAEGV--LDPRL--QEKPCSRALKRALLVALRCVDPNAHKRPKMGHV 455 (521)
Q Consensus 409 --~~~~~~~~~--~d~~l--~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~ev 455 (521)
......... ....+ ...........+.+++.+||+.||++|||+.++
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000000000 00000 111123344556678889999999999999764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=334.75 Aligned_cols=244 Identities=17% Similarity=0.195 Sum_probs=181.3
Q ss_pred hcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhcCCC-CCe-------------
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRH-KNL------------- 244 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h-pni------------- 244 (521)
.....|...+.||+|+||+||+|.+. +++.||||++..... ...+.+.+|+.+++.++| +|.
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 34456888999999999999999965 688999999874322 235779999999999987 221
Q ss_pred --------eeEEEEEee-----CCeeeEEEEeccCCchHHhhhcC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 009979 245 --------VRLLGYCAE-----GAHRMLVYEYIDNGNLEQWLHGD---VGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308 (521)
Q Consensus 245 --------v~l~~~~~~-----~~~~~lV~e~~~~g~L~~~l~~~---~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~ 308 (521)
..+..++.. ....+++|+++ +++|.+++... ......+++..++.++.|++.||+|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 230 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--- 230 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 111111221 12356777776 67999988421 11245678889999999999999999999
Q ss_pred CeeecCCCCCCeEeCCCCCceEeecccceecCCCCcceeecccccccccccccc----------cCCCCCCcccchhHHH
Q 009979 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA----------STGMLNERSDVYSFGI 378 (521)
Q Consensus 309 ~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwS~Gv 378 (521)
+|+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 9999999999999999999999999999875432 445678 999999998 5666889999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccCC-CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 379 LIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE-KPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 379 vl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
++|||+||+.||......... +..+.. ...+ ..+.+++.+||+.||++||++.++++
T Consensus 306 il~elltg~~Pf~~~~~~~~~-------------------~~~~~~~~~~~---~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGGS-------------------EWIFRSCKNIP---QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSCS-------------------GGGGSSCCCCC---HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHCCCCCCCcchhhhH-------------------HHHHhhcccCC---HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999999754322111 111110 1123 34555888999999999999888754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=311.26 Aligned_cols=228 Identities=19% Similarity=0.265 Sum_probs=176.0
Q ss_pred Ccccc-ceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHH-hcCCCCCeeeEEEEEee----CCeeeE
Q 009979 187 GFADE-NVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAI-GRVRHKNLVRLLGYCAE----GAHRML 259 (521)
Q Consensus 187 ~~~~~-~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l-~~l~hpniv~l~~~~~~----~~~~~l 259 (521)
+|.+. +.||+|+||.||+|.+. +++.||+|.+... ..+.+|++++ +.++||||+++++++.. ....++
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 56666 78999999999999974 6889999998542 4566788887 66699999999999876 677899
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---CCCceEeecccc
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFGLA 336 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~---~~~vkL~DFGla 336 (521)
||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||++
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999998752 35799999999999999999999999 9999999999999987 788999999999
Q ss_pred eecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
.... +..++.++|||||||++|||++|+.||........ .......
T Consensus 168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~ 213 (299)
T 3m2w_A 168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTR 213 (299)
T ss_dssp EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCS
T ss_pred cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHH
Confidence 7542 23467889999999999999999999964432110 0000001
Q ss_pred CCCcccCCCc--cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 417 VLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 417 ~~d~~l~~~~--~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
+......... .......+.+++.+||+.||++|||+.|++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1111111100 01123345568889999999999999999853
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=325.44 Aligned_cols=242 Identities=15% Similarity=0.167 Sum_probs=185.1
Q ss_pred cCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCCh--------hhHHHHHHHHHHHhcCC---------CCCeee
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG--------QAEKEFKVEVEAIGRVR---------HKNLVR 246 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~---------hpniv~ 246 (521)
..++|++.+.||+|+||+||+|++ +++.||||++..... ...+.+.+|+.+++.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 345789999999999999999998 689999999975432 22377888999998885 888888
Q ss_pred EEEEEe------------------------------eCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 009979 247 LLGYCA------------------------------EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296 (521)
Q Consensus 247 l~~~~~------------------------------~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia 296 (521)
+.+++. +....||||||+++|++.+.+.+ ..+++..++.++.|++
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 877643 26788999999999977666643 3579999999999999
Q ss_pred HHHHHHH-hcCCCCeeecCCCCCCeEeCCCC--------------------CceEeecccceecCCCCcceeeccccccc
Q 009979 297 KGLTYLH-EGLEPKVVHRDIKSSNILLDKQW--------------------NPKLSDFGLAKLLGAERSYVTTRVMGTFG 355 (521)
Q Consensus 297 ~al~~LH-~~~~~~iiHrDik~~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~gt~~ 355 (521)
.||+||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+.
T Consensus 172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 88 999999999999999887 8999999999876432 3479999
Q ss_pred ccccccccCCCCCCcccchhHHHH-HHHHHhCCCCCCCCCCCCcccHHHHH-HHHhhccccccCCCcccCCCccHHHHHH
Q 009979 356 YVAPEYASTGMLNERSDVYSFGIL-IMEVISGRNPVDYSRPPGEVNLVEWL-KTMVTNRNAEGVLDPRLQEKPCSRALKR 433 (521)
Q Consensus 356 y~aPE~~~~~~~~~~sDvwS~Gvv-l~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 433 (521)
|+|||++.+.. +.++||||||++ .+++++|..||.. ......+ ........ ...............+
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~------~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN------VLWLHYLTDKMLKQMT----FKTKCNTPAMKQIKRK 311 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH------HHHHHHHHHHHHHTCC----CSSCCCSHHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc------hhhhhHHHHhhhhhhc----cCcccchhhhhhcCHH
Confidence 99999998766 889999998777 7788889999831 0000111 11111111 1111111123345567
Q ss_pred HHHHHHhccCCCCCCCCCHHHHH
Q 009979 434 ALLVALRCVDPNAHKRPKMGHVI 456 (521)
Q Consensus 434 ~~~li~~cl~~dP~~RPt~~evl 456 (521)
+.+|+.+||+.| |+.|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 778999999976 999987
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=294.86 Aligned_cols=185 Identities=14% Similarity=0.073 Sum_probs=131.8
Q ss_pred eEccCCcEEEEEEE-EcCCcEEEEEEeccCC----------hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeeeEE
Q 009979 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR----------GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 193 ~LG~G~fG~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~lV 260 (521)
.++.|++|.+..++ +-.|+.||||.+.+.. ....++|.+|+++|+++ .|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46677777777655 3358889999986542 12336799999999999 699999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||++|++|.++|... .+++.. .|+.||+.||+|||++ |||||||||+||||+++|++||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999999865 456654 5889999999999999 99999999999999999999999999998764
Q ss_pred CCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCC
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~P 389 (521)
... ...+..+||+.|||||++.+ .+..++|+||+|++++++.++..|
T Consensus 391 ~~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 432 23455789999999999865 467789999999998887665544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-29 Score=266.38 Aligned_cols=185 Identities=17% Similarity=0.227 Sum_probs=146.9
Q ss_pred cccceEccCCcEEEEEEEEcCCcEEEEEEeccCChh--------hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEE
Q 009979 189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ--------AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 189 ~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV 260 (521)
...+.||+|+||.||+|.+ .+..+++|+....... ..+.+.+|+++|++++||||+++..++......|||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999955 5788999987543211 134578999999999999999666666677778999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
|||+++++|.+++.. +..++.|++.||+|||++ +|+||||||+|||++. ++||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999865 458899999999999999 9999999999999999 99999999999875
Q ss_pred CCCcce------eecccccccccccccccC--CCCCCcccchhHHHHHHHHHhCCCCCC
Q 009979 341 AERSYV------TTRVMGTFGYVAPEYAST--GMLNERSDVYSFGILIMEVISGRNPVD 391 (521)
Q Consensus 341 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~elltG~~Pf~ 391 (521)
...... .....||+.|||||++.. ..|+..+|+|+..+-..+-+.++-+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 432221 235789999999999976 668889999999998888888877763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7e-25 Score=216.21 Aligned_cols=152 Identities=18% Similarity=0.101 Sum_probs=121.2
Q ss_pred hhhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCCh------------------hhHHHHHHHHHHHhcCCC
Q 009979 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG------------------QAEKEFKVEVEAIGRVRH 241 (521)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~h 241 (521)
.+......|.+.+.||+|+||.||+|.+.+++.||+|.+..... .....+.+|+++|+.++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 33444556778899999999999999997789999999864321 13456889999999999
Q ss_pred CCeeeEEEEEeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeE
Q 009979 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNIL 321 (521)
Q Consensus 242 pniv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NIL 321 (521)
| +++.+++.. +..++||||++||+|.+ +.. .....++.|++.||.|||+. +|+||||||+|||
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL 225 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 225 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence 4 555555443 55699999999999998 421 12346899999999999998 9999999999999
Q ss_pred eCCCCCceEeecccceecCCCCcceeecccccccccccccccC
Q 009979 322 LDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364 (521)
Q Consensus 322 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 364 (521)
++ ++.+||+|||+++. +..|+|||++..
T Consensus 226 l~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp EE-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred EE-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 99 99999999999973 445789998743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.4e-20 Score=182.96 Aligned_cols=137 Identities=21% Similarity=0.168 Sum_probs=107.0
Q ss_pred CccccceEccCCcEEEEEEEE-cCCcE--EEEEEeccCChh------------------------hHHHHHHHHHHHhcC
Q 009979 187 GFADENVIGEGGYGIVYHGVL-EDNTN--VAVKNLLNNRGQ------------------------AEKEFKVEVEAIGRV 239 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~l 239 (521)
-|.+.+.||+|+||.||+|.+ .+|+. ||||++...... ....+..|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999997 67888 999987543111 123678899999999
Q ss_pred CCCCe--eeEEEEEeeCCeeeEEEEeccC-C----chHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCee
Q 009979 240 RHKNL--VRLLGYCAEGAHRMLVYEYIDN-G----NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH-EGLEPKVV 311 (521)
Q Consensus 240 ~hpni--v~l~~~~~~~~~~~lV~e~~~~-g----~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH-~~~~~~ii 311 (521)
.|+++ ..++++ ...+|||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---giv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence 88754 444443 346899999942 4 67766432 123456789999999999999 88 999
Q ss_pred ecCCCCCCeEeCCCCCceEeecccceec
Q 009979 312 HRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 312 HrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
||||||+|||+++ .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=4.7e-17 Score=165.25 Aligned_cols=139 Identities=13% Similarity=0.085 Sum_probs=101.9
Q ss_pred cCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChh--------------hH--------HHHHHHHHHHhcCCC
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQ--------------AE--------KEFKVEVEAIGRVRH 241 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~--------------~~--------~~~~~Ei~~l~~l~h 241 (521)
...-|.+.+.||.|+||.||+|...+|+.||||++...... .. -....|...|.++.+
T Consensus 93 rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~ 172 (397)
T 4gyi_A 93 RKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE 172 (397)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence 33458999999999999999999888999999987432100 00 112346677777754
Q ss_pred CCee--eEEEEEeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 009979 242 KNLV--RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSN 319 (521)
Q Consensus 242 pniv--~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~N 319 (521)
.++. ..+++ . ..+|||||++|++|.++... .....++.|++.+|.|||+. +||||||||.|
T Consensus 173 ~gv~vp~p~~~--~--~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~N 235 (397)
T 4gyi_A 173 EGFPVPEPIAQ--S--RHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFN 235 (397)
T ss_dssp TTCSCCCEEEE--E--TTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred cCCCCCeeeec--c--CceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHH
Confidence 4432 23322 2 23799999999888765421 12356788999999999998 99999999999
Q ss_pred eEeCCCCC----------ceEeecccceec
Q 009979 320 ILLDKQWN----------PKLSDFGLAKLL 339 (521)
Q Consensus 320 ILl~~~~~----------vkL~DFGla~~~ 339 (521)
||+++++. +.|+||+-+...
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred EEEeCCCCcccccccccceEEEEeCCcccC
Confidence 99987763 889999977653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=9.6e-13 Score=127.43 Aligned_cols=143 Identities=16% Similarity=0.082 Sum_probs=112.3
Q ss_pred CCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCeeeEEEEec
Q 009979 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
..|++...++.|+++.||++... +..+++|............+..|+++++.+. +..+.++++++.+.+..|+||||+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 36778888999999999999754 6889999886432223346888999999884 677889999999888999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL-------------------------------------- 306 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-------------------------------------- 306 (521)
+|.+|.+.+... .....++.+++.+|..||+..
T Consensus 93 ~G~~l~~~~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 93 DGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp SSEEHHHHCCTT---------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred CCeehhhccCCc---------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999998763211 123467789999999999810
Q ss_pred ------------------CCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 307 ------------------EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 307 ------------------~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
.+.++|+|+++.|||++++..+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13599999999999998765667999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.30 E-value=6.6e-12 Score=120.87 Aligned_cols=137 Identities=17% Similarity=0.135 Sum_probs=100.1
Q ss_pred CccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCC--eeeEEEEEeeCCeeeEEEEec
Q 009979 187 GFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn--iv~l~~~~~~~~~~~lV~e~~ 264 (521)
.+.+....+.|..+.||++...+|..+++|..... ....+..|+.+++.+.+.+ +.++++++..++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34433333455569999998766788999987543 2345778999998886444 566888888877889999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL-------------------------------------- 306 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-------------------------------------- 306 (521)
+|.+|. ... .. ...++.+++..|..||+..
T Consensus 98 ~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 98 PGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp SSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred CCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 998884 211 11 1256677888888888641
Q ss_pred -----------------CCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 307 -----------------EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 307 -----------------~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
...++|+|++|.|||+++++.+.|+|||.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999998864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.12 E-value=1.5e-10 Score=117.46 Aligned_cols=142 Identities=11% Similarity=0.164 Sum_probs=107.1
Q ss_pred ccceEccCCcEEEEEEEEcCCcEEEEEEec--cCC-hhhHHHHHHHHHHHhcCC--CCCeeeEEEEEeeC---CeeeEEE
Q 009979 190 DENVIGEGGYGIVYHGVLEDNTNVAVKNLL--NNR-GQAEKEFKVEVEAIGRVR--HKNLVRLLGYCAEG---AHRMLVY 261 (521)
Q Consensus 190 ~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~Ei~~l~~l~--hpniv~l~~~~~~~---~~~~lV~ 261 (521)
..+.|+.|.++.||+.... +..+++|+.. ... ......+..|+.+++.+. +..+.+++.++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4567899999999999875 4678888765 322 122356788999999987 45688999998776 3478999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL----------------------------------- 306 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~----------------------------------- 306 (521)
||++|..+.+.. ...++...+..++.+++..|+.||+..
T Consensus 121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999997775421 234677888899999999999999731
Q ss_pred --------------------CCCeeecCCCCCCeEeCCCCC--ceEeeccccee
Q 009979 307 --------------------EPKVVHRDIKSSNILLDKQWN--PKLSDFGLAKL 338 (521)
Q Consensus 307 --------------------~~~iiHrDik~~NILl~~~~~--vkL~DFGla~~ 338 (521)
.+.++|+|+++.|||++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999987653 68999999975
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.08 E-value=6.7e-11 Score=117.15 Aligned_cols=183 Identities=19% Similarity=0.188 Sum_probs=122.6
Q ss_pred cceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCC--eeeEEEEEeeCC---eeeEEEEec
Q 009979 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKN--LVRLLGYCAEGA---HRMLVYEYI 264 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpn--iv~l~~~~~~~~---~~~lV~e~~ 264 (521)
.+.++.|.+..||+.. ..+++|.... ......+..|+++|+.+. +.. +.+++.+..... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 5688997542 234567889999998873 322 445655544333 348999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG--------------------------------------- 305 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~--------------------------------------- 305 (521)
+|.+|.+... ..++...+..++.+++..|+.||+.
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9988875432 2356777788888888888888861
Q ss_pred ----------------CCCCeeecCCCCCCeEeCC--CCCceEeecccceecCCCCcceeecccccccc---cccccccC
Q 009979 306 ----------------LEPKVVHRDIKSSNILLDK--QWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY---VAPEYAST 364 (521)
Q Consensus 306 ----------------~~~~iiHrDik~~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y---~aPE~~~~ 364 (521)
..+.++|+|+++.||++++ ...+.|+||+.+..-...... .....+ ..|+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-----~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-----ISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-----HTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-----HHHHhhccccCHHHHHH
Confidence 0245899999999999988 556789999998764221110 001111 12221100
Q ss_pred -----CCC---------CCcccchhHHHHHHHHHhCCCCC
Q 009979 365 -----GML---------NERSDVYSFGILIMEVISGRNPV 390 (521)
Q Consensus 365 -----~~~---------~~~sDvwS~Gvvl~elltG~~Pf 390 (521)
+.. ....+.|+++.++|.+.+|..+|
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 000 11258999999999999998775
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=3.6e-07 Score=90.37 Aligned_cols=137 Identities=17% Similarity=0.160 Sum_probs=96.5
Q ss_pred cceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCC---CeeeEEEEEe-eCCeeeEEEEeccC
Q 009979 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK---NLVRLLGYCA-EGAHRMLVYEYIDN 266 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hp---niv~l~~~~~-~~~~~~lV~e~~~~ 266 (521)
.+.++.|....||+. +..+++|+- ........+..|+++|+.+.+. .+.+++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888999999988 567888874 2334456788999999998642 3567777764 44567899999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG----------------------------------------- 305 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~----------------------------------------- 305 (521)
..|.+... ..++......++.+++..|..||+.
T Consensus 98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 88876321 1234445555555555555555542
Q ss_pred ----------------CCCCeeecCCCCCCeEeCC---CCCc-eEeecccceec
Q 009979 306 ----------------LEPKVVHRDIKSSNILLDK---QWNP-KLSDFGLAKLL 339 (521)
Q Consensus 306 ----------------~~~~iiHrDik~~NILl~~---~~~v-kL~DFGla~~~ 339 (521)
..+.++|+|+++.|||++. ++.+ .|+||+.+..-
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1235799999999999987 4554 89999988753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=7.7e-07 Score=85.92 Aligned_cols=135 Identities=17% Similarity=0.106 Sum_probs=97.7
Q ss_pred eEccCCcE-EEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCeeeEEEEeccCCch
Q 009979 193 VIGEGGYG-IVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYIDNGNL 269 (521)
Q Consensus 193 ~LG~G~fG-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~~~g~L 269 (521)
.+..|..| .||+.... ++..+++|.-.. ....++..|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 44556555 69987754 466788887543 24567888999998874 33477889999998999999999999888
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 009979 270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL------------------------------------------- 306 (521)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~------------------------------------------- 306 (521)
.+..... ......+..+++..|..||...
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 7765332 1123345666777777777321
Q ss_pred ------------CCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 307 ------------EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 307 ------------~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
.+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12389999999999999877777999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=4.4e-07 Score=91.51 Aligned_cols=80 Identities=10% Similarity=0.027 Sum_probs=55.4
Q ss_pred cceE-ccCCcEEEEEEEEc-------CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCC-C--CCeeeEEEEEeeC--
Q 009979 191 ENVI-GEGGYGIVYHGVLE-------DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVR-H--KNLVRLLGYCAEG-- 254 (521)
Q Consensus 191 ~~~L-G~G~fG~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-h--pniv~l~~~~~~~-- 254 (521)
.+.| +.|....+|+.... ++..+++|...... ......+..|+.+++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 88989999998754 25678888754322 101245677888888774 2 3577888887665
Q ss_pred -CeeeEEEEeccCCchH
Q 009979 255 -AHRMLVYEYIDNGNLE 270 (521)
Q Consensus 255 -~~~~lV~e~~~~g~L~ 270 (521)
...++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3468999999986654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.11 E-value=1.4e-05 Score=79.53 Aligned_cols=143 Identities=18% Similarity=0.228 Sum_probs=80.3
Q ss_pred cceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCC-----CCCeeeEE-E--EEeeCCeeeEEEE
Q 009979 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-----HKNLVRLL-G--YCAEGAHRMLVYE 262 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----hpniv~l~-~--~~~~~~~~~lV~e 262 (521)
.+.|+.|..+.||+....++ .+++|..... ...+..|+.+++.+. .|.++... | +....+..++||+
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34566677889999987544 5899988652 233344555555442 34444311 1 1234567789999
Q ss_pred eccCCchH--------------HhhhcCCC-C--C-------CCCCHHHH------------------------------
Q 009979 263 YIDNGNLE--------------QWLHGDVG-P--H-------SPLTWEIR------------------------------ 288 (521)
Q Consensus 263 ~~~~g~L~--------------~~l~~~~~-~--~-------~~l~~~~~------------------------------ 288 (521)
|++|..+. ..+|.... . . ....|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986432 11222100 0 0 01122211
Q ss_pred -HHHHHHHHHHHHHHHh----------cCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 289 -MNIILGTAKGLTYLHE----------GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 289 -~~i~~~ia~al~~LH~----------~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
..+...+..++++|++ .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111123345666663 0234899999999999998888999999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=1.2e-05 Score=82.31 Aligned_cols=75 Identities=16% Similarity=0.175 Sum_probs=49.3
Q ss_pred cceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh-------hhHHHHHHHHHHHhcCCC--C-CeeeEEEEEeeCCeeeE
Q 009979 191 ENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-------QAEKEFKVEVEAIGRVRH--K-NLVRLLGYCAEGAHRML 259 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~h--p-niv~l~~~~~~~~~~~l 259 (521)
.+.||.|.++.||++... ++..+++|....... .....+..|.++|+.+.. + .+.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567999999999999743 467899997643211 123456778888887732 3 34456654 3445689
Q ss_pred EEEeccCC
Q 009979 260 VYEYIDNG 267 (521)
Q Consensus 260 V~e~~~~g 267 (521)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.06 E-value=2.2e-05 Score=76.58 Aligned_cols=80 Identities=20% Similarity=0.254 Sum_probs=58.9
Q ss_pred CCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCC---CCeeeEEEEEeeCCeeeEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH---KNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h---pniv~l~~~~~~~~~~~lV~ 261 (521)
.....-.+.+|.|..+.||+....+|+.|++|+...........|..|+..|+.+.- --+.+++++. ..++||
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 345556788999999999999999999999998655444444568889998887742 2345566543 237999
Q ss_pred EeccCCc
Q 009979 262 EYIDNGN 268 (521)
Q Consensus 262 e~~~~g~ 268 (521)
||++++.
T Consensus 90 e~l~~~~ 96 (288)
T 3f7w_A 90 EWVDERP 96 (288)
T ss_dssp ECCCCCC
T ss_pred EeecccC
Confidence 9998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.93 E-value=2.1e-05 Score=81.09 Aligned_cols=78 Identities=9% Similarity=0.106 Sum_probs=49.0
Q ss_pred CCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcceeecccc--cccccccccccCCC---CCCcccchhHHHHHH
Q 009979 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMG--TFGYVAPEYASTGM---LNERSDVYSFGILIM 381 (521)
Q Consensus 307 ~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~sDvwS~Gvvl~ 381 (521)
.+.++|+|+++.|||++.++ ++|+||+.+..-...... ....+ ...|++|+...... -....++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl--a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI--GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH--HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH--HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 34899999999999998776 999999999864221111 11111 24567776653211 111244557777788
Q ss_pred HHHhCC
Q 009979 382 EVISGR 387 (521)
Q Consensus 382 elltG~ 387 (521)
+.+++.
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 877653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.92 E-value=5.4e-05 Score=74.76 Aligned_cols=141 Identities=14% Similarity=0.119 Sum_probs=92.9
Q ss_pred cccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCC---CCCeeeEEEEEeeCCeeeEEEEecc
Q 009979 189 ADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR---HKNLVRLLGYCAEGAHRMLVYEYID 265 (521)
Q Consensus 189 ~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---hpniv~l~~~~~~~~~~~lV~e~~~ 265 (521)
...+.|+.|.+..+|+... ++..+++|..... ....+..|++.|+.+. ...+.+++.++...+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3456799999999999876 4678899976432 3567888999888874 3568889988887788999999999
Q ss_pred CCchH-----------HhhhcCCC-C-C----------------CCCCHHHHH---HHH----------------HHHHH
Q 009979 266 NGNLE-----------QWLHGDVG-P-H----------------SPLTWEIRM---NII----------------LGTAK 297 (521)
Q Consensus 266 ~g~L~-----------~~l~~~~~-~-~----------------~~l~~~~~~---~i~----------------~~ia~ 297 (521)
+..+. ..||.... . . -.-+|.... ++. ..++.
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 87541 12333211 0 0 011343221 111 11111
Q ss_pred H-HHHHHh-cCCCCeeecCCCCCCeEeCCCCCceEeecc
Q 009979 298 G-LTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (521)
Q Consensus 298 a-l~~LH~-~~~~~iiHrDik~~NILl~~~~~vkL~DFG 334 (521)
. ...|.. ...+.++|+|+.+.|++++.++ +.|+||.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 223321 2356899999999999999887 8899984
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00021 Score=70.02 Aligned_cols=140 Identities=14% Similarity=0.091 Sum_probs=75.6
Q ss_pred cceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCe-eeEEEEEeeCCeeeEEEEec-cCCc
Q 009979 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYI-DNGN 268 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpni-v~l~~~~~~~~~~~lV~e~~-~~g~ 268 (521)
.+.|+.|....+|+. ..+++|........ ......|+.+++.+...++ .++++++ ...-++|+||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 678999999999998 56888877543211 1123457777766642222 4566554 33347999999 6644
Q ss_pred hHH------------------hhhcCCCC-CCCCCH-HHHHHHHH--------------HHHHHH----HHHHh-cCCCC
Q 009979 269 LEQ------------------WLHGDVGP-HSPLTW-EIRMNIIL--------------GTAKGL----TYLHE-GLEPK 309 (521)
Q Consensus 269 L~~------------------~l~~~~~~-~~~l~~-~~~~~i~~--------------~ia~al----~~LH~-~~~~~ 309 (521)
|.. .+|..... ...... .....+.. .+...+ +.|.. .....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 421 11221100 000111 11111100 011111 11111 12345
Q ss_pred eeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 310 iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
++|+|+.+.||+ ..++.+.|+||..+..-
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 899999999999 55667899999988753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00033 Score=72.36 Aligned_cols=73 Identities=18% Similarity=0.218 Sum_probs=49.8
Q ss_pred cceEccCCcEEEEEEEEcC--------CcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCC-eeeEEEEEeeCCeeeEEE
Q 009979 191 ENVIGEGGYGIVYHGVLED--------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn-iv~l~~~~~~~~~~~lV~ 261 (521)
.+.|+.|....||++...+ +..+++|+.... .....+..|+.+++.+...+ ..++++.+.+ .+||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4578888899999998753 467889987432 11244557888888875333 3567776643 3899
Q ss_pred EeccCCch
Q 009979 262 EYIDNGNL 269 (521)
Q Consensus 262 e~~~~g~L 269 (521)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.0007 Score=67.11 Aligned_cols=143 Identities=14% Similarity=0.089 Sum_probs=73.0
Q ss_pred ceEccCCcEE-EEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCC--CCeeeEEEEEeeCCeeeEEEEeccCCc
Q 009979 192 NVIGEGGYGI-VYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH--KNLVRLLGYCAEGAHRMLVYEYIDNGN 268 (521)
Q Consensus 192 ~~LG~G~fG~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--pniv~l~~~~~~~~~~~lV~e~~~~g~ 268 (521)
+.|+.|+... +|+....++..+++|....... ..+..|+.+++.+.. -.+.+++.+..+.+ ++|||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4566565554 6677654466777775433221 234446666665532 23556776644333 78999997766
Q ss_pred hHHhhhcC---------------------CCC-CCCCCHHHHH-------H-H------------HHHHHHHHHHHHh--
Q 009979 269 LEQWLHGD---------------------VGP-HSPLTWEIRM-------N-I------------ILGTAKGLTYLHE-- 304 (521)
Q Consensus 269 L~~~l~~~---------------------~~~-~~~l~~~~~~-------~-i------------~~~ia~al~~LH~-- 304 (521)
+.+++... ... ...+...... . + ...+...++.|.+
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65443211 000 1112211100 0 0 0011112222211
Q ss_pred -cCCCCeeecCCCCCCeEeCCC----CCceEeecccceec
Q 009979 305 -GLEPKVVHRDIKSSNILLDKQ----WNPKLSDFGLAKLL 339 (521)
Q Consensus 305 -~~~~~iiHrDik~~NILl~~~----~~vkL~DFGla~~~ 339 (521)
.....++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 123479999999999999874 67899999998753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00062 Score=67.03 Aligned_cols=145 Identities=14% Similarity=0.132 Sum_probs=79.9
Q ss_pred cceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCC--eeeEEEE------EeeCCeeeEEEE
Q 009979 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN--LVRLLGY------CAEGAHRMLVYE 262 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn--iv~l~~~------~~~~~~~~lV~e 262 (521)
.+.|+.|....+|+....++ .+++|..... .....+..|+.+++.+...+ +.+++.. ....+..+++|+
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 45678888899999987655 6889987542 12234556777776663211 2233311 122356789999
Q ss_pred eccCCchHH--------------hhhcCC-CCCCC----CC---HHHHHH------------HHHHHHHHHHHHHhc---
Q 009979 263 YIDNGNLEQ--------------WLHGDV-GPHSP----LT---WEIRMN------------IILGTAKGLTYLHEG--- 305 (521)
Q Consensus 263 ~~~~g~L~~--------------~l~~~~-~~~~~----l~---~~~~~~------------i~~~ia~al~~LH~~--- 305 (521)
|++|..+.. .+|... ....+ .. |..... +...+...+++++..
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 998854311 122211 00000 11 221100 001134455566532
Q ss_pred -CCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 306 -LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 306 -~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
....++|+|+.+.|||++++..+.|+||+.+..
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 134799999999999998876568999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0011 Score=68.88 Aligned_cols=74 Identities=12% Similarity=0.071 Sum_probs=47.8
Q ss_pred cceEccCCcEEEEEEEEcC-CcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCe-eeEEEEEeeCCeeeEEEEeccCCc
Q 009979 191 ENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL-VRLLGYCAEGAHRMLVYEYIDNGN 268 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpni-v~l~~~~~~~~~~~lV~e~~~~g~ 268 (521)
.+.|+.|-...+|++...+ +..+++|+....... .-+...|+.+++.+...++ .++++++.+ .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 4578888899999998864 467888876432211 1112568888888864444 567777632 36999998754
Q ss_pred h
Q 009979 269 L 269 (521)
Q Consensus 269 L 269 (521)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0014 Score=64.62 Aligned_cols=143 Identities=15% Similarity=0.138 Sum_probs=80.8
Q ss_pred ceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCC--CeeeEEEE-----EeeCCeeeEEEEec
Q 009979 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHK--NLVRLLGY-----CAEGAHRMLVYEYI 264 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hp--niv~l~~~-----~~~~~~~~lV~e~~ 264 (521)
..|+ |....||+....+|+.+++|...... .....+..|..+++.+... .+++++.. ....+..++||+|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 78889999877667789999875332 1335566788877776421 23344332 12244567899999
Q ss_pred cCCchH-----Hh---------hhcCC---C--CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 009979 265 DNGNLE-----QW---------LHGDV---G--PHSPLTWEIR----MNI---------------ILGTAKGLTYLHEG- 305 (521)
Q Consensus 265 ~~g~L~-----~~---------l~~~~---~--~~~~l~~~~~----~~i---------------~~~ia~al~~LH~~- 305 (521)
+|..+. .+ +|... . .....++... ..+ ...+...++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875432 10 12110 0 0111222110 001 00111223333321
Q ss_pred ---CCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 306 ---LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 306 ---~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00074 Score=68.42 Aligned_cols=142 Identities=17% Similarity=0.131 Sum_probs=82.2
Q ss_pred ceEccCCcEEEEEEEEc--------CCcEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCeeeEEEE
Q 009979 192 NVIGEGGYGIVYHGVLE--------DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV~e 262 (521)
+.|..|-...+|++... ++..+++|+.-. .......+.+|.++++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 46777888899998864 246788887532 1223455668999888774 3223667777654 39999
Q ss_pred eccCCchHH-----------------hhhcCCC-CCCCCC--HHHHHHHHHHHH-------------------HHHHHHH
Q 009979 263 YIDNGNLEQ-----------------WLHGDVG-PHSPLT--WEIRMNIILGTA-------------------KGLTYLH 303 (521)
Q Consensus 263 ~~~~g~L~~-----------------~l~~~~~-~~~~l~--~~~~~~i~~~ia-------------------~al~~LH 303 (521)
|++|..|.. .||.... ...... +..+.++..++. ..+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999855431 1122211 111222 344444443321 1223332
Q ss_pred ----hc-CCCCeeecCCCCCCeEeCCC----CCceEeeccccee
Q 009979 304 ----EG-LEPKVVHRDIKSSNILLDKQ----WNPKLSDFGLAKL 338 (521)
Q Consensus 304 ----~~-~~~~iiHrDik~~NILl~~~----~~vkL~DFGla~~ 338 (521)
.. ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 13469999999999999876 7899999998864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00096 Score=67.24 Aligned_cols=74 Identities=15% Similarity=0.056 Sum_probs=43.8
Q ss_pred cceEccCCcEEEEEEEEcC---------CcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCC-eeeEEEEEeeCCeeeEE
Q 009979 191 ENVIGEGGYGIVYHGVLED---------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn-iv~l~~~~~~~~~~~lV 260 (521)
.+.|+.|....+|+....+ +..+++|+...... .......|.++++.+...+ ..++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3567788888999998753 26788887643221 1112356888887774333 44666554 2 2789
Q ss_pred EEeccCCch
Q 009979 261 YEYIDNGNL 269 (521)
Q Consensus 261 ~e~~~~g~L 269 (521)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.00092 Score=44.40 Aligned_cols=33 Identities=12% Similarity=0.169 Sum_probs=15.5
Q ss_pred hhHHHHHHHHH-HHHHHHHHHHHHhhhccccccc
Q 009979 21 RLWVVLGICVG-AGIVLVLFLISLWFTSKRNSNN 53 (521)
Q Consensus 21 ~~~~~i~i~~g-~~~v~~l~~l~~~~~~rr~~~~ 53 (521)
+.-.+++.++| ++++++++++.+|++|||++++
T Consensus 8 ~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 8 RTPLIAAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp SSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred CcceEEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 33344544454 5555444444445555444433
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0061 Score=60.63 Aligned_cols=31 Identities=23% Similarity=0.327 Sum_probs=28.0
Q ss_pred CCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 308 PKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 308 ~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999988775
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.92 E-value=0.005 Score=56.62 Aligned_cols=102 Identities=18% Similarity=0.095 Sum_probs=66.8
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
-+|.+.|... ..+++++++|.++.|.+.+|.-+-... .-..+=+.+..|++..+|+|-+.+ +.+.
T Consensus 33 vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc---------
Confidence 4899999876 579999999999999999987762111 111333456899999999887764 1111
Q ss_pred eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCC
Q 009979 347 TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRN 388 (521)
Q Consensus 347 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~ 388 (521)
.....+.|||... ...+++.=|||+|+++|..+-=..
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1133467888763 345678889999999999886333
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0012 Score=43.77 Aligned_cols=28 Identities=25% Similarity=0.297 Sum_probs=14.5
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHhhhccc
Q 009979 22 LWVVLGICVGAGIVLVLFLISLWFTSKR 49 (521)
Q Consensus 22 ~~~~i~i~~g~~~v~~l~~l~~~~~~rr 49 (521)
.-.++++++|+++++++.++.+++.|||
T Consensus 11 ~~~Ia~~vVGvll~vi~~l~~~~~~RRR 38 (44)
T 2jwa_A 11 LTSIISAVVGILLVVVLGVVFGILIKRR 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHHHHHHHHHhheehh
Confidence 4456788888654444433333333333
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.76 E-value=0.00093 Score=44.49 Aligned_cols=28 Identities=21% Similarity=0.173 Sum_probs=14.7
Q ss_pred HHHHHHHHHHHHHHHHHHHhhhcccccc
Q 009979 25 VLGICVGAGIVLVLFLISLWFTSKRNSN 52 (521)
Q Consensus 25 ~i~i~~g~~~v~~l~~l~~~~~~rr~~~ 52 (521)
..|++.|++++++++++.+|++|||+++
T Consensus 14 A~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 14 ATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 3455555655555545555555555443
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=96.26 E-value=0.005 Score=39.68 Aligned_cols=30 Identities=17% Similarity=0.186 Sum_probs=20.1
Q ss_pred cchhHHHHHHHHHHHHHHHHHHH-HHhhhcc
Q 009979 19 GLRLWVVLGICVGAGIVLVLFLI-SLWFTSK 48 (521)
Q Consensus 19 g~~~~~~i~i~~g~~~v~~l~~l-~~~~~~r 48 (521)
|+.-..+.||++|+++.++|+.. ++|++||
T Consensus 7 ~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 7 GLTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 67778889999998765554444 4444444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.96 E-value=0.021 Score=58.46 Aligned_cols=142 Identities=15% Similarity=0.134 Sum_probs=83.0
Q ss_pred cceEccCCcEEEEEEEEcC--------CcEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCeeeEEE
Q 009979 191 ENVIGEGGYGIVYHGVLED--------NTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV~ 261 (521)
.+.|..|-...+|+....+ +..+++++.-... ...-+..+|..+++.+. +.-..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 4567778888999998753 5778888764322 11122356777777774 222455665442 27899
Q ss_pred EeccCCchHH--------------h---hhcCC------C---CCCCCCHHHHHHHHHHH-------------------H
Q 009979 262 EYIDNGNLEQ--------------W---LHGDV------G---PHSPLTWEIRMNIILGT-------------------A 296 (521)
Q Consensus 262 e~~~~g~L~~--------------~---l~~~~------~---~~~~l~~~~~~~i~~~i-------------------a 296 (521)
||++|..|.. . ||... . ...+..+..+..+..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999865421 0 11110 0 11122233333333221 1
Q ss_pred HHHHHHHhc---------------------CCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 297 KGLTYLHEG---------------------LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 297 ~al~~LH~~---------------------~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
..+..|.+. ....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 223333211 1236899999999999 8888999999998875
|
| >2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B | Back alignment and structure |
|---|
Probab=95.50 E-value=0.017 Score=35.84 Aligned_cols=31 Identities=26% Similarity=0.439 Sum_probs=25.9
Q ss_pred ccchhHHHHHHHHHHHHHHHHHHHHHhhhcc
Q 009979 18 FGLRLWVVLGICVGAGIVLVLFLISLWFTSK 48 (521)
Q Consensus 18 ~g~~~~~~i~i~~g~~~v~~l~~l~~~~~~r 48 (521)
.+++...+.||++|.++..+++.+.+|+++|
T Consensus 2 ~~L~~gaIaGIVvgdi~~t~~i~~~vy~~~r 32 (33)
T 2l34_A 2 STVSPGVLAGIVVGDLVLTVLIALAVYFLGR 32 (33)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred cccCcceEEeEeHHHHHHHHHHHHHHhheec
Confidence 3678889999999999888888888888765
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.30 E-value=0.015 Score=38.35 Aligned_cols=27 Identities=30% Similarity=0.508 Sum_probs=13.1
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHhhhcc
Q 009979 22 LWVVLGICVGAGIVLVLFLISLWFTSK 48 (521)
Q Consensus 22 ~~~~i~i~~g~~~v~~l~~l~~~~~~r 48 (521)
.++++++++|+++++++++++++++||
T Consensus 13 ~~I~~~vv~Gv~ll~~iv~~~~~~~rR 39 (41)
T 2k9y_A 13 LAVIGGVAVGVVLLLVLAGVGFFIHRR 39 (41)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHSSSSS
T ss_pred EEEEeehhHHHHHHHHHHHHheeEeee
Confidence 445566666665543243444444433
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.52 E-value=0.048 Score=37.68 Aligned_cols=26 Identities=31% Similarity=0.778 Sum_probs=19.5
Q ss_pred cchhHHHHHHHHHHHHHHHHHHHHHh
Q 009979 19 GLRLWVVLGICVGAGIVLVLFLISLW 44 (521)
Q Consensus 19 g~~~~~~i~i~~g~~~v~~l~~l~~~ 44 (521)
+..+|++++.++|.+++++|+.+++|
T Consensus 6 ~vp~WiIi~svl~GLLLL~Lii~~Lw 31 (54)
T 2l8s_A 6 RVPLWVILLSAFAGLLLLMLLILALW 31 (54)
T ss_dssp CCCTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cCchHHHHHHHHHHHHHHHHHHHHHH
Confidence 67899998888887777666666555
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.11 E-value=0.069 Score=37.07 Aligned_cols=26 Identities=23% Similarity=0.731 Sum_probs=19.5
Q ss_pred cchhHHHHHHHHHHHHHHHHHHHHHh
Q 009979 19 GLRLWVVLGICVGAGIVLVLFLISLW 44 (521)
Q Consensus 19 g~~~~~~i~i~~g~~~v~~l~~l~~~ 44 (521)
+..+|++++.++|.++++.|+.+++|
T Consensus 9 ~vp~wiIi~svl~GLllL~li~~~Lw 34 (54)
T 2knc_A 9 AIPIWWVLVGVLGGLLLLTILVLAMW 34 (54)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcchHHHHHHHHHHHHHHHHHHHHHH
Confidence 67899998888887777666665555
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.09 E-value=0.36 Score=48.87 Aligned_cols=30 Identities=30% Similarity=0.424 Sum_probs=25.5
Q ss_pred CeeecCCCCCCeEe------CCCCCceEeeccccee
Q 009979 309 KVVHRDIKSSNILL------DKQWNPKLSDFGLAKL 338 (521)
Q Consensus 309 ~iiHrDik~~NILl------~~~~~vkL~DFGla~~ 338 (521)
.++|+|+.+.|||+ +++..++++||-+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999998875
|
| >2k1a_A Integrin alpha-IIB; single-PASS transmembrane segment, alternative splicing, calcium, cell adhesion, cleavage on PAIR of basic residues; NMR {Homo sapiens} PDB: 2k9j_A | Back alignment and structure |
|---|
Probab=93.24 E-value=0.13 Score=33.73 Aligned_cols=26 Identities=23% Similarity=0.731 Sum_probs=19.7
Q ss_pred cchhHHHHHHHHHHHHHHHHHHHHHh
Q 009979 19 GLRLWVVLGICVGAGIVLVLFLISLW 44 (521)
Q Consensus 19 g~~~~~~i~i~~g~~~v~~l~~l~~~ 44 (521)
+..+|++++.++|.++++.++.+++|
T Consensus 7 ~vp~wiIi~s~l~GLllL~li~~~Lw 32 (42)
T 2k1a_A 7 AIPIWWVLVGVLGGLLLLTILVLAMW 32 (42)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcchHHHHHHHHHHHHHHHHHHHHHH
Confidence 67899998888887777666666655
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=90.63 E-value=0.1 Score=32.63 Aligned_cols=26 Identities=19% Similarity=0.415 Sum_probs=11.1
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhhccc
Q 009979 24 VVLGICVGAGIVLVLFLISLWFTSKR 49 (521)
Q Consensus 24 ~~i~i~~g~~~v~~l~~l~~~~~~rr 49 (521)
.++..++|+++++++.+.+.++.|||
T Consensus 9 sIaagVvglll~vii~l~~~~~iRRr 34 (35)
T 1iij_A 9 FIIATVVGVLLFLILVVVVGILIKRR 34 (35)
T ss_dssp HHHHHHHHHHHHHHHTTTTTHHHHHC
T ss_pred EeHHHHHHHHHHHHHHHHhheEEeec
Confidence 34555556444433333333333333
|
| >2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.49 E-value=0.41 Score=34.22 Aligned_cols=6 Identities=0% Similarity=0.346 Sum_probs=2.5
Q ss_pred HHHHHh
Q 009979 39 FLISLW 44 (521)
Q Consensus 39 ~~l~~~ 44 (521)
+++++|
T Consensus 24 ~glcI~ 29 (70)
T 2klu_A 24 IGLGIF 29 (70)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 344444
|
| >2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.57 E-value=0.35 Score=36.63 Aligned_cols=27 Identities=30% Similarity=0.443 Sum_probs=16.8
Q ss_pred cchhHHHHHHHHHHHHHHHHHHHHHhh
Q 009979 19 GLRLWVVLGICVGAGIVLVLFLISLWF 45 (521)
Q Consensus 19 g~~~~~~i~i~~g~~~v~~l~~l~~~~ 45 (521)
..++|.+++.++|++++++|++|++|.
T Consensus 7 ~~n~~~Iv~gvi~gilliGllllliwk 33 (79)
T 2knc_B 7 GPDILVVLLSVMGAILLIGLAALLIWK 33 (79)
T ss_dssp SSCSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCchhhHHHHHHHHHHHHHHHHHHHH
Confidence 456777776666666666665555554
|
| >1q55_A EP-cadherin, C-cadherin; trans interaction, desmosome, junction, adhesion, structural protein; HET: NAG NDG; 30.00A {Mus musculus} SCOP: i.20.1.1 PDB: 1q5a_A* 1q5b_A* 1q5c_A* | Back alignment and structure |
|---|
Probab=87.94 E-value=0.098 Score=58.72 Aligned_cols=33 Identities=30% Similarity=0.462 Sum_probs=0.0
Q ss_pred cccchhHHHHHHHHHHHHHHHHHHHHHhhhccc
Q 009979 17 IFGLRLWVVLGICVGAGIVLVLFLISLWFTSKR 49 (521)
Q Consensus 17 ~~g~~~~~~i~i~~g~~~v~~l~~l~~~~~~rr 49 (521)
-.||.+|.+|+|++|++++++++++++++++||
T Consensus 699 ~~~l~~~aii~il~~~~~ll~~~ll~~~~~~~~ 731 (880)
T 1q55_A 699 VGGFDLPIILVILGSVLALLILFLLLLLFLKRK 731 (880)
T ss_dssp ---------------------------------
T ss_pred ccCccHHHHHHHHHHHHHHHHHHHHHHhhhhhc
Confidence 468999999999999988777766666665444
|
| >2k9j_B Integrin beta-3; transmembrane complex, cell adhesion, cleavage on basic residues, disease mutation, glycoprotein, pyrrolidone carboxylic acid; NMR {Homo sapiens} PDB: 2rmz_A 2rn0_A 2l91_A | Back alignment and structure |
|---|
Probab=87.91 E-value=0.62 Score=30.77 Aligned_cols=27 Identities=30% Similarity=0.443 Sum_probs=17.8
Q ss_pred cchhHHHHHHHHHHHHHHHHHHHHHhh
Q 009979 19 GLRLWVVLGICVGAGIVLVLFLISLWF 45 (521)
Q Consensus 19 g~~~~~~i~i~~g~~~v~~l~~l~~~~ 45 (521)
+.+.+.+++.++|++++++++++.+|-
T Consensus 6 ~~n~~~Iv~gvi~~ivliGl~lLliwk 32 (43)
T 2k9j_B 6 GPDILVVLLSVMGAILLIGLAALLIWK 32 (43)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCEeehHHHHHHHHHHHHHHHHHHHH
Confidence 347777776666666666666666554
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.67 E-value=1.2 Score=40.68 Aligned_cols=116 Identities=11% Similarity=0.153 Sum_probs=79.2
Q ss_pred CCCCCeeeEEEEEeeCCeeeEEEEeccCC-chHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 009979 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNG-NLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKS 317 (521)
Q Consensus 239 l~hpniv~l~~~~~~~~~~~lV~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~ 317 (521)
..||+++.. .+-.+++.+.+.++.-+.+ ++.. + ..++...+++++.+++....+++.. +|--|.|
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P 107 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAP 107 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEec
Confidence 368988876 5666667766767654432 2332 3 3467788999999999888666643 7888999
Q ss_pred CCeEeCCCCCceEeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCC
Q 009979 318 SNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391 (521)
Q Consensus 318 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~ 391 (521)
+||+++.++.+++.-.|+-.. ++|.- +++..=+-.+=|++..+++++..|+
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~------------------l~P~~-----~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNV------------------VDPLP-----VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GGEEECTTSCEEESCCEETTT------------------BSCCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred ceEEEcCCCCEEEEEccCccC------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999987665432 22221 1111113356788899999998884
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.57 E-value=2 Score=39.37 Aligned_cols=114 Identities=8% Similarity=0.048 Sum_probs=76.5
Q ss_pred CCCCeeeEEEEEeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeeecCCCCC
Q 009979 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT-YLHEGLEPKVVHRDIKSS 318 (521)
Q Consensus 240 ~hpniv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~-~LH~~~~~~iiHrDik~~ 318 (521)
.||++ -..+-.+++.+.+.++.-+++.-...++ .++...+++++.+++.... +++. -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 67888 3445567777777777654443333343 4577889999988887766 5553 477789999
Q ss_pred CeEeCCCCCceEeecccceecCCCCcceeecccccccccccccccCCCCCCccc-chhHHHHHHHHHhCCCCCC
Q 009979 319 NILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSD-VYSFGILIMEVISGRNPVD 391 (521)
Q Consensus 319 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD-vwS~Gvvl~elltG~~Pf~ 391 (521)
||++|.++.+++.-.|+-.. ++|.-+. ..| +-.+=|++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~------------------lpP~e~~------ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKES------------------LPPDEWD------DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTT------------------BSSCSCC------HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCccc------------------CCCCCCC------HHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999987765432 3332211 112 2346678888888887773
|
| >2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.25 E-value=0.56 Score=33.51 Aligned_cols=34 Identities=21% Similarity=0.226 Sum_probs=25.0
Q ss_pred hHHHHHHHHHHHHHHHHHHH-HHhhhcccccccch
Q 009979 22 LWVVLGICVGAGIVLVLFLI-SLWFTSKRNSNNSK 55 (521)
Q Consensus 22 ~~~~i~i~~g~~~v~~l~~l-~~~~~~rr~~~~~~ 55 (521)
+.+++|-++|.++++++.++ ++-+++||++..+.
T Consensus 10 ~LivlGg~~~lll~~glcI~ccvkcrhRrrqAeRM 44 (70)
T 2klu_A 10 ALIVLGGVAGLLLFIGLGIFFSVRSRHRRRQAERM 44 (70)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHSSCCSSSCTTS
T ss_pred HHHHHhHHHHHHHHHHHHHHHhhHHHHHHHHHHHH
Confidence 33788999999999999999 56566666655544
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.89 E-value=0.13 Score=53.30 Aligned_cols=61 Identities=5% Similarity=-0.033 Sum_probs=18.4
Q ss_pred cccceEccCCcEEEEEEEEcC-CcEEEE------EEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEe
Q 009979 189 ADENVIGEGGYGIVYHGVLED-NTNVAV------KNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCA 252 (521)
Q Consensus 189 ~~~~~LG~G~fG~Vy~~~~~~-~~~vav------K~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~ 252 (521)
.+.+.|| ||.||+|.+.. ..+||+ |....... +....+..|..+++.++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 4456776 99999999754 467888 76544222 22346778999999999999999988754
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=80.46 E-value=1.6 Score=27.96 Aligned_cols=26 Identities=23% Similarity=0.466 Sum_probs=19.8
Q ss_pred cchhHHHHHHHHHHHHHHHHHHHHHh
Q 009979 19 GLRLWVVLGICVGAGIVLVLFLISLW 44 (521)
Q Consensus 19 g~~~~~~i~i~~g~~~v~~l~~l~~~ 44 (521)
|--.-++||+++|++++++++++.+.
T Consensus 11 GaIAGiVvG~v~gv~li~~l~~~~~r 36 (38)
T 2k1k_A 11 GEIVAVIFGLLLGAALLLGILVFRSR 36 (38)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred CceeeeehHHHHHHHHHHHHHHHHee
Confidence 44466889999998888888777765
|
| >1q90_G Cytochrome B6F complex subunit PETG; membrane protein complex, photosynthesis, electron transfer, oxydoreductase, chlorophyll; HET: HEM CL1 BCR TDS SQD LFA LMG; 3.10A {Chlamydomonas reinhardtii} SCOP: f.23.26.1 | Back alignment and structure |
|---|
Probab=80.43 E-value=2.2 Score=26.57 Aligned_cols=28 Identities=18% Similarity=0.370 Sum_probs=16.9
Q ss_pred HHHHHHHHHHHH-HHHHHHHHhhhccccc
Q 009979 24 VVLGICVGAGIV-LVLFLISLWFTSKRNS 51 (521)
Q Consensus 24 ~~i~i~~g~~~v-~~l~~l~~~~~~rr~~ 51 (521)
++-||++|.+-+ ++.+++..|+.+||-+
T Consensus 5 lL~GIVlGlipvtlaGLfv~Ay~QyrRg~ 33 (37)
T 1q90_G 5 LLCGIVLGLVPVTIAGLFVTAYLQYLRGD 33 (37)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHC---
T ss_pred hhhhHHHhhHHHHHHHHHHHHHHHHhhcc
Confidence 567899998643 3333455888877753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 521 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-71 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-67 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-63 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 2e-71
Identities = 75/287 (26%), Positives = 131/287 (45%), Gaps = 26/287 (9%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
+ E+ IG G +G VY G + V + N+ Q + FK EV + +
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
RH N++ +GY +V ++ + +L LH + ++I TA+G+
Sbjct: 62 RHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGM 117
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG-AERSYVTTRVMGTFGYVA 358
YLH ++HRD+KS+NI L + K+ DFGLA + S+ ++ G+ ++A
Sbjct: 118 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 359 PEYAST---GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415
PE + +SDVY+FGI++ E+++G+ P +N + + MV
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMV----GR 224
Query: 416 GVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
G L P L + C +A+KR + C+ +RP ++ +E
Sbjct: 225 GYLSPDLSKVRSNCPKAMKR---LMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 2e-67
Identities = 68/281 (24%), Positives = 122/281 (43%), Gaps = 22/281 (7%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
E EV +G G +G V+ G +T VAVK L + F E + ++
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVK-SLKQGSMSPDAFLAEANLMKQL 65
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
+H+ LVRL + ++ EY++NG+L +L G LT +++ A+G+
Sbjct: 66 QHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGM 122
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
++ E +HRD++++NIL+ + K++DFGLA+L+ + AP
Sbjct: 123 AFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419
E + G +SDV+SFGIL+ E+++ P + E ++ +
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRI-----PYPGMTNPEVIQNLERGY------- 227
Query: 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
++ C L + + C RP ++ +LE
Sbjct: 228 RMVRPDNCPEELYQ---LMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 2e-64
Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 30/293 (10%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
+ IG+G +G V+ G VAVK + ++R + + E+ +RH+N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 251 CAEG----AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
+ LV +Y ++G+L +L+ +T E + + L TA GL +LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 307 -----EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV---TTRVMGTFGYVA 358
+P + HRD+KS NIL+ K ++D GLA + + +GT Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 359 PEYASTGM------LNERSDVYSFGILIMEVISGRNP----VDYSRPPGEVNLVEWLKTM 408
PE + +R+D+Y+ G++ E+ + DY P ++ +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 409 VTNRNAEGVLDPRLQEKPCSRALKRALL-VALRCVDPNAHKRPKMGHVIHMLE 460
+ E L P + + S R + + C N R + L
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 7e-64
Identities = 71/269 (26%), Positives = 123/269 (45%), Gaps = 22/269 (8%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
IG G +G+V+ G + VA+K + +E++F E E + ++ H LV+L G C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
E A LV+E++++G L +L G + E + + L +G+ YL E V+
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLEE---ACVI 123
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
HRD+ + N L+ + K+SDFG+ + + ++ +T + +PE S + +S
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 372 DVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRAL 431
DV+SFG+L+ EV S +R E +VE + + PRL S +
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDI------STGFRLYKPRL----ASTHV 231
Query: 432 KRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+ + C RP ++ L
Sbjct: 232 YQ---IMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 205 bits (523), Expect = 6e-63
Identities = 76/303 (25%), Positives = 133/303 (43%), Gaps = 39/303 (12%)
Query: 176 YTLRELEVSTNGFADE---------NVIGEGGYGIVYHGVLEDNTN----VAVKNL-LNN 221
+T + + FA E VIG G +G V G L+ VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 222 RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS 281
+ ++F E +G+ H N++ L G + M++ E+++NG+L+ +L + G
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 282 PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341
T + ++ G A G+ YL + VHRD+ + NIL++ K+SDFGL++ L
Sbjct: 126 --TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 342 ERSYVTTR----VMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPG 397
+ S T + APE SDV+S+GI++ EV+S P
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER-----PYW 235
Query: 398 EVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457
++ + + + + +D C AL + + L C + + RPK G +++
Sbjct: 236 DMTNQDVINAIEQDYRLPPPMD-------CPSALHQ---LMLDCWQKDRNHRPKFGQIVN 285
Query: 458 MLE 460
L+
Sbjct: 286 TLD 288
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 9e-63
Identities = 56/269 (20%), Positives = 109/269 (40%), Gaps = 22/269 (8%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
+G G +G+V +G +VA+K ++ +E EF E + + + H+ LV+L G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
+ ++ EY+ NG L +L + + + + + YL + +
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES---KQFL 122
Query: 312 HRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERS 371
HRD+ + N L++ Q K+SDFGL++ + + + + PE + +S
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 372 DVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRAL 431
D+++FG+L+ E+ S P E + + P L S +
Sbjct: 183 DIWAFGVLMWEIYSLGKM-----PYERFTNSETAEHIAQGLRLY---RPHL----ASEKV 230
Query: 432 KRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+ C A +RP ++ +
Sbjct: 231 YT---IMYSCWHEKADERPTFKILLSNIL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-61
Identities = 71/281 (25%), Positives = 121/281 (43%), Gaps = 22/281 (7%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRV 239
E+ E +G+G +G V+ G T VA+K L + + F E + + ++
Sbjct: 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK-TLKPGTMSPEAFLQEAQVMKKL 69
Query: 240 RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
RH+ LV+L +E +V EY+ G+L +L G+ G + +++ A G+
Sbjct: 70 RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLR--LPQLVDMAAQIASGM 126
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
Y+ VHRD++++NIL+ + K++DFGLA+L+ + AP
Sbjct: 127 AYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419
E A G +SDV+SFGIL+ E+ + E V ++ G
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------VLDQVERGYRM 233
Query: 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
P E C +L + +C +RP ++ LE
Sbjct: 234 PCPPE--CPESLHD---LMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 6e-61
Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 11/213 (5%)
Query: 181 LEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGR 238
+E+ + F + +G G G+V+ +A K + L + + E++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
+V G + E++D G+L+Q L + +I + + KG
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKG 116
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
LTYL E + K++HRD+K SNIL++ + KL DFG++ L +GT Y++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMS 171
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVD 391
PE + +SD++S G+ ++E+ GR P+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 4e-60
Identities = 78/311 (25%), Positives = 128/311 (41%), Gaps = 34/311 (10%)
Query: 179 RELEVSTNGFA-DENVIGEGGYGIVYHGVL---EDNTNVAVKNLLNNRGQAE-KEFKVEV 233
++L + + + +G G +G V GV + +VA+K L +A+ +E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 234 EAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL 293
+ + ++ + +VRL+G C + MLV E G L ++L G + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116
Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR--VM 351
+ G+ YL E VHRD+ + N+LL + K+SDFGL+K LGA+ SY T R
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 352 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVT 410
+ APE + + RSDV+S+G+ + E +S G+ P + P + +E K M
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 233
Query: 411 NRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDER 470
C L + C RP V + A +
Sbjct: 234 PPE-------------CPPELYA---LMSDCWIYKWEDRPDFLTVEQRMRA---CYYSLA 274
Query: 471 RAGREHGRSPH 481
H H
Sbjct: 275 SKVEGHHHHHH 285
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (503), Expect = 5e-60
Identities = 74/313 (23%), Positives = 117/313 (37%), Gaps = 50/313 (15%)
Query: 178 LRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNL-LNNRGQAEKEFK 230
L LE N IGEG +G V+ E T VAVK L + +F+
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 231 VEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG--------------- 275
E + + N+V+LLG CA G L++EY+ G+L ++L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 276 -----DVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKL 330
PL+ ++ I A G+ YL E K VHRD+ + N L+ + K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181
Query: 331 SDFGLAKLL-GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNP 389
+DFGL++ + A+ ++ PE SDV+++G+++ E+ S
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 390 VDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAH 447
Y EV V D + P C L + C
Sbjct: 242 PYYGMAHEEV--------------IYYVRDGNILACPENCPLELYN---LMRLCWSKLPA 284
Query: 448 KRPKMGHVIHMLE 460
RP + +L+
Sbjct: 285 DRPSFCSIHRILQ 297
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 197 bits (501), Expect = 8e-60
Identities = 61/282 (21%), Positives = 117/282 (41%), Gaps = 22/282 (7%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLED-NTNVAVKNLLNNRGQAEKEFKVEVEAIGR 238
+ E+ ++ +G G YG VY GV + + VAVK L + + E EF E +
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE 69
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
++H NLV+LLG C ++ E++ GNL +L ++ + + + +
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSA 127
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
+ YL + +HRD+ + N L+ + K++DFGL++L+ + + A
Sbjct: 128 MEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418
PE + + +SDV++FG+L+ E+ + +V +L
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---------------YELL 229
Query: 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+ + + ++ + C N RP + E
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 3e-59
Identities = 71/287 (24%), Positives = 130/287 (45%), Gaps = 29/287 (10%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTN-----VAVKNLLNNRGQAEK-EFKVEVEA 235
E+ + + VIG G +G VY G+L+ ++ VA+K L + ++ +F E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 236 IGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGT 295
+G+ H N++RL G ++ M++ EY++NG L+++L + + ++ G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGI 119
Query: 296 AKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGT 353
A G+ YL VHRD+ + NIL++ K+SDFGL+++L E +Y T+
Sbjct: 120 AAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 354 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413
+ APE S SDV+SFGI++ EV++ + EV
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-------------- 222
Query: 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
++ + + ++C +RPK ++ +L+
Sbjct: 223 -MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 4e-59
Identities = 78/280 (27%), Positives = 126/280 (45%), Gaps = 30/280 (10%)
Query: 191 ENVIGEGGYGIVYHGVLEDNTN----VAVKNLLNNRGQAE-KEFKVEVEAIGRVRHKNLV 245
VIG G +G VYHG L DN AVK+L E +F E + H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 246 RLLGYCAEG-AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
LLG C ++V Y+ +G+L ++ + T + + L AKG+ +L
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLAS 148
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL---GAERSYVTTRVMGTFGYVAPEY 361
K VHRD+ + N +LD+++ K++DFGLA+ + + + T ++A E
Sbjct: 149 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421
T +SDV+SFG+L+ E+++ P P +VN + ++ R
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGR-------RL 253
Query: 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461
LQ + C L V L+C P A RP ++ + A
Sbjct: 254 LQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 5e-59
Identities = 70/280 (25%), Positives = 109/280 (38%), Gaps = 28/280 (10%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH 241
++ IG+G +G V G VAVK + + F E + ++RH
Sbjct: 3 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRH 59
Query: 242 KNLVRLLGYCAEGAHRM-LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
NLV+LLG E + +V EY+ G+L +L S L + + L + +
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAME 117
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPE 360
YL VHRD+ + N+L+ + K+SDFGL K S + APE
Sbjct: 118 YLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPE 170
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
+ +SDV+SFGIL+ E+ S P + L + + + +
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVPRVEKGYKMD----- 220
Query: 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
C A+ V C +A RP + LE
Sbjct: 221 --APDGCPPAVYE---VMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 3e-57
Identities = 69/310 (22%), Positives = 123/310 (39%), Gaps = 47/310 (15%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDNTN------VAVKNLLNNRGQAEKE-FKVEVE 234
E V+G G +G V + + VAVK L +E+E E++
Sbjct: 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 92
Query: 235 AIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHS------------ 281
+ ++ H+N+V LLG C L++EY G+L +L S
Sbjct: 93 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 282 -------PLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334
LT+E + AKG+ +L VHRD+ + N+L+ K+ DFG
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 335 LAKLLGAERSYVT-TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393
LA+ + ++ +YV ++APE G+ +SDV+S+GIL+ E+ S
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN---- 265
Query: 394 RPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP-CSRALKRALLVALRCVDPNAHKRPKM 452
P + + ++ N ++ + + + + C ++ KRP
Sbjct: 266 -PYPGIPVDANFYKLIQN-------GFKMDQPFYATEEIYI---IMQSCWAFDSRKRPSF 314
Query: 453 GHVIHMLEAE 462
++ L +
Sbjct: 315 PNLTSFLGCQ 324
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 3e-57
Identities = 70/280 (25%), Positives = 113/280 (40%), Gaps = 34/280 (12%)
Query: 190 DENVIGEGGYGIVYHGVLEDNTN---VAVKNLLN--NRGQAEKEFKVEVEAIGRVRHKNL 244
++ +G G +G V G + VAVK L N N + E E + ++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
VR++G C E MLV E + G L ++L + + + + ++ + G+ YL E
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTR--VMGTFGYVAPEYA 362
VHRD+ + N+LL Q K+SDFGL+K L A+ +Y + + APE
Sbjct: 126 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422
+ + +SDV+SFG+L+ E S EV +
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--------------TAMLEKGER 228
Query: 423 QEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
P C R + + C + RP V L
Sbjct: 229 MGCPAGCPREMYD---LMNLCWTYDVENRPGFAAVELRLR 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 6e-57
Identities = 62/272 (22%), Positives = 108/272 (39%), Gaps = 24/272 (8%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
IG G YG D + K + + ++ EV + ++H N+VR
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 249 GYCAEGAHRML--VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
+ + L V EY + G+L + L E + ++ L H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 307 E--PKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
+ V+HRD+K +N+ LD + N KL DFGLA++L + S+ +GT Y++PE +
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQMNR 188
Query: 365 GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQE 424
NE+SD++S G L+ E+ + P + E + R
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFT------AFSQKELAGKIREG-------KFRRIP 235
Query: 425 KPCSRALKRALLVALRCVDPNAHKRPKMGHVI 456
S L + R ++ + RP + ++
Sbjct: 236 YRYSDELNE---IITRMLNLKDYHRPSVEEIL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (482), Expect = 8e-57
Identities = 66/272 (24%), Positives = 105/272 (38%), Gaps = 34/272 (12%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKN 243
F+D IG G +G VY + ++ VA+K + + ++ EV + ++RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
++ G LV EY + PL + G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLH 132
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
++HRD+K+ NILL + KL DFG A ++ +GT ++APE
Sbjct: 133 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVIL 184
Query: 364 T---GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
G + + DV+S GI +E+ + P +N + L + N P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK------PPLFNMNAMSALYHIAQNE------SP 232
Query: 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKM 452
LQ S + C+ RP
Sbjct: 233 ALQSGHWSEYFRN---FVDSCLQKIPQDRPTS 261
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 7e-56
Identities = 63/296 (21%), Positives = 123/296 (41%), Gaps = 37/296 (12%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVLEDN---TNVAVKNL-LNNRGQAEKEFKVEVEAIG 237
+ N ++VIGEG +G V ++ + + A+K + ++F E+E +
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65
Query: 238 RV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG------------DVGPHSPLT 284
++ H N++ LLG C + L EY +GNL +L S L+
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 285 WEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344
+ ++ A+G+ YL + + +HRD+ + NIL+ + + K++DFGL++
Sbjct: 126 SQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 182
Query: 345 YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEW 404
T ++A E + + SDV+S+G+L+ E++S P + E
Sbjct: 183 --KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAEL 235
Query: 405 LKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+ + E L+ C + + +C ++RP ++ L
Sbjct: 236 YEKLPQGYRLEKPLN-------CDDEVYD---LMRQCWREKPYERPSFAQILVSLN 281
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 9e-56
Identities = 68/305 (22%), Positives = 114/305 (37%), Gaps = 40/305 (13%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNLLNNRGQAEKE-FKV 231
+ E N + +G G +G V + VAVK L + E+E
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 232 EVEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHG--------------D 276
E++ + + H N+V LLG C G +++ EY G+L +L
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 277 VGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336
L E ++ AKG+ +L +HRD+ + NILL K+ DFGLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 337 KLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRP 395
+ + + +Y V ++APE + SDV+S+GI + E+ S + P
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHV 455
M+ L + + + C D + KRP +
Sbjct: 253 V-----DSKFYKMIKEG------FRMLSPEHAPAEMYD---IMKTCWDADPLKRPTFKQI 298
Query: 456 IHMLE 460
+ ++E
Sbjct: 299 VQLIE 303
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-55
Identities = 64/275 (23%), Positives = 114/275 (41%), Gaps = 31/275 (11%)
Query: 191 ENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRL 247
+ IG G + VY G+ E VA L + + + FK E E + ++H N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 248 LGYCAEGA----HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
+LV E + +G L+ +L + ++ + KGL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH 129
Query: 304 EGLEPKVVHRDIKSSNILL-DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
P ++HRD+K NI + + K+ D GLA L A V+GT ++APE
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMY 185
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422
+E DVY+FG+ ++E+ + P N + + + + + P
Sbjct: 186 E-EKYDESVDVYAFGMCMLEMATSEYP-----YSECQNAAQIYRRVTSG------VKPAS 233
Query: 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457
+K +K + C+ N +R + +++
Sbjct: 234 FDKVAIPEVKE---IIEGCIRQNKDERYSIKDLLN 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 4e-54
Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 31/281 (11%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN----VAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNL 244
+G+G +G+V G + + VAVK L + ++ +A +F EV A+ + H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
+RL G +M V E G+L L G + A+G+ YL
Sbjct: 74 IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLES 129
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL--GAERSYVTTRVMGTFGYVAPEYA 362
+ +HRD+ + N+LL + K+ DFGL + L + + F + APE
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422
T + SD + FG+ + E+ + P +N + L + EG PR
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDK----EGERLPRP 237
Query: 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHML-EAE 462
++ C + + V ++C RP + L EA+
Sbjct: 238 ED--CPQDIYN---VMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 5e-54
Identities = 67/285 (23%), Positives = 114/285 (40%), Gaps = 38/285 (13%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLN---NRGQAEKEFKV 231
+ L + E+ +G+G +G VY + +A+K L + E + +
Sbjct: 3 WALEDFEI-------GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 55
Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
EVE +RH N++RL GY + L+ EY G + + L S +
Sbjct: 56 EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATY 111
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM 351
I A L+Y H +V+HRDIK N+LL K++DFG + + R T +
Sbjct: 112 ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLC 165
Query: 352 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN 411
GT Y+ PE M +E+ D++S G+L E + G+ P + + +
Sbjct: 166 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--------- 216
Query: 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVI 456
E + + + R + N +RP + V+
Sbjct: 217 SRVEFTFPDF-----VTEGARD---LISRLLKHNPSQRPMLREVL 253
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-53
Identities = 64/299 (21%), Positives = 113/299 (37%), Gaps = 33/299 (11%)
Query: 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTN----VAVKNLLNNRGQAEKE-FKVEVE 234
+ E+ IGEG +G V+ G+ N VA+K N + +E F E
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 235 AIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILG 294
+ + H ++V+L+G E ++ E G L +L L +
Sbjct: 61 TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQ 116
Query: 295 TAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTF 354
+ L YL + VHRDI + N+L+ KL DFGL++ + Y ++
Sbjct: 117 LSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 355 GYVAPEYASTGMLNERSDVYSFGILIMEVI-SGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413
++APE + SDV+ FG+ + E++ G P + + +E + + N
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 233
Query: 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFRDERRA 472
C L + +C + +RP+ + L +E +A
Sbjct: 234 -------------CPPTLYS---LMTKCWAYDPSRRPRFTELKAQLST----ILEEEKA 272
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-53
Identities = 59/267 (22%), Positives = 107/267 (40%), Gaps = 27/267 (10%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
+G+G +G VY E + A K + + +++ VE++ + H N+V+LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
+ ++ E+ G ++ + PLT + T L YLH + K+
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLH---DNKI 131
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGML--- 367
+HRD+K+ NIL + KL+DFG++ + + GT ++APE
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDR 190
Query: 368 --NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425
+ ++DV+S GI ++E+ P P + + A+ Q
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI-----------AKSEPPTLAQPS 239
Query: 426 PCSRALKRALLVALRCVDPNAHKRPKM 452
S K L +C++ N R
Sbjct: 240 RWSSNFKDFL---KKCLEKNVDARWTT 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 3e-53
Identities = 69/281 (24%), Positives = 122/281 (43%), Gaps = 31/281 (11%)
Query: 188 FADENVIGEGGYGIVYHGVLEDN-----TNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRH 241
F V+G G +G VY G+ VA+K L +A KE E + V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
++ RLLG C L+ + + G L ++ + +N + AKG+ Y
Sbjct: 71 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIG---SQYLLNWCVQIAKGMNY 126
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPE 360
L + ++VHRD+ + N+L+ + K++DFGLAKLLGA E+ Y ++A E
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
+ +SDV+S+G+ + E+++ P + + +++
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFG------SKPYDGIPASEISSILEK-------GE 230
Query: 421 RLQEKP-CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
RL + P C+ + + ++C +A RPK +I
Sbjct: 231 RLPQPPICTIDVYM---IMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 8e-52
Identities = 68/268 (25%), Positives = 105/268 (39%), Gaps = 25/268 (9%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNL-LNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
+GEG YG V V VAVK + + + K E+ + H+N+V+ G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
+ EG + L EY G L + P + G+ YLH
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLH---GIG 123
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA-ERSYVTTRVMGTFGYVAPEYASTGMLN 368
+ HRDIK N+LLD++ N K+SDFGLA + R + ++ GT YVAPE +
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 369 -ERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPC 427
E DV+S GI++ +++G P D + + + K
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSD-----------SCQEYSDWKEKKTYLNPWKKI 232
Query: 428 SRALKRALLVALRCVDPNAHKRPKMGHV 455
A L + + N R + +
Sbjct: 233 DSAPLALL---HKILVENPSARITIPDI 257
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 8e-52
Identities = 70/310 (22%), Positives = 127/310 (40%), Gaps = 36/310 (11%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVL------EDNTNVAVKNL-LNNRGQAEKE 228
Y E EV+ +G+G +G+VY GV E T VA+K + + E
Sbjct: 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 69
Query: 229 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLH------GDVGPHSP 282
F E + ++VRLLG ++G +++ E + G+L+ +L + +P
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 283 LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342
+ + + A G+ YL+ K VHRD+ + N ++ + + K+ DFG+ + +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186
Query: 343 RSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNL 401
Y + + +++PE G+ SDV+SFG+++ E+ + +V
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-- 244
Query: 402 VEWLKTMVTNRNAEGVLDPRLQEKP--CSRALKRALLVALRCVDPNAHKRPKMGHVIHML 459
V++ L +KP C L + C N RP +I +
Sbjct: 245 ------------LRFVMEGGLLDKPDNCPDMLFE---LMRMCWQYNPKMRPSFLEIISSI 289
Query: 460 EAEEFPFRDE 469
+ E P E
Sbjct: 290 KEEMEPGFRE 299
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 3e-51
Identities = 68/263 (25%), Positives = 112/263 (42%), Gaps = 26/263 (9%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGY 250
IG+G G VY + + VA++ + + ++ E+ + ++ N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310
G +V EY+ G+L + + + + + L +LH +V
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNER 370
+HRDIKS NILL + KL+DFG + E+S +T V GT ++APE + +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 196
Query: 371 SDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKP-CSR 429
D++S GI+ +E+I G P N + L + TN P LQ S
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYL------NENPLRALYLIATNGT------PELQNPEKLSA 244
Query: 430 ALKRALLVALRCVDPNAHKRPKM 452
+ L RC+D + KR
Sbjct: 245 IFRDFL---NRCLDMDVEKRGSA 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 171 bits (433), Expect = 3e-49
Identities = 70/333 (21%), Positives = 133/333 (39%), Gaps = 31/333 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
+G G +G+V+ N A K ++ ++ + E++ + +RH LV L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
+ +++YE++ G L + + + H+ ++ + + + KGL ++HE V
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYV 146
Query: 312 HRDIKSSNILLDKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
H D+K NI+ + + KL DFGL L ++S T GT + APE A +
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGY 204
Query: 370 RSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429
+D++S G+L ++SG +P +T+ ++ + +D S
Sbjct: 205 YTDMWSVGVLSYILLSGLSPFGGENDD---------ETLRNVKSCDWNMDDSAFSG-ISE 254
Query: 430 ALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFP-FRDERRAGREHGRSPHNGIKGRL 488
K + + + + + R + +A E P GR+ K R
Sbjct: 255 DGKDFI---RKLLLADPNTRMTIH------QALEHPWLTPGNAPGRDSQIPSSRYTKIRD 305
Query: 489 MEKGVSESGDSSGYESGVQTNKPLWRKLEPEEQ 521
K ++ G +N RK P+E
Sbjct: 306 SIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEY 338
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 5e-49
Identities = 68/302 (22%), Positives = 123/302 (40%), Gaps = 41/302 (13%)
Query: 182 EVSTNGFADENVIGEGGYGIVYHGVL--------EDNTNVAVKNLLNNRGQAE-KEFKVE 232
E+ + +GEG +G V T VAVK L ++ + + + E
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 233 VEAIGRV-RHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLH------------GDVGP 279
+E + + +HKN++ LLG C + ++ EY GNL ++L P
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 280 HSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339
L+ + ++ A+G+ YL K +HRD+ + N+L+ + K++DFGLA+ +
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 340 GAERSYVTTRV-MGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGE 398
Y T ++APE + +SDV+SFG+L+ E+ + P
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG------GSPYP 239
Query: 399 VNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458
VE L ++ + + C+ L + C +RP ++
Sbjct: 240 GVPVEELFKLLKEGH------RMDKPSNCTNELYM---MMRDCWHAVPSQRPTFKQLVED 290
Query: 459 LE 460
L+
Sbjct: 291 LD 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 4e-48
Identities = 72/307 (23%), Positives = 116/307 (37%), Gaps = 39/307 (12%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGV------LEDNTNVAVKNLLNNRGQAE-KE 228
Y + E + +G G +G V VAVK L +E +
Sbjct: 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 62
Query: 229 FKVEVEAIGR-VRHKNLVRLLGYCAE-GAHRMLVYEYIDNGNLEQWLHGDVGPHSP---- 282
E++ + H N+V LLG C + G M++ E+ GNL +L P
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 283 --------LTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334
LT E + AKG+ +L K +HRD+ + NILL ++ K+ DFG
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 335 LAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYS 393
LA+ + + YV ++APE + +SDV+SFG+L+ E+ S
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---- 235
Query: 394 RPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMG 453
P V + E + R + + + + L C +RP
Sbjct: 236 -PYPGVKIDEEFCRRLKEGT-----RMRAPDY-TTPEMYQ---TMLDCWHGEPSQRPTFS 285
Query: 454 HVIHMLE 460
++ L
Sbjct: 286 ELVEHLG 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 161 bits (407), Expect = 3e-46
Identities = 68/281 (24%), Positives = 117/281 (41%), Gaps = 31/281 (11%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
++G GG V+ L + +VAVK L L F+ E + + H +V
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 247 LLGYCAE----GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
+ G +V EY+D L +H P+T + + +I + L +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFS 127
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV--TTRVMGTFGYVAPE 360
H+ ++HRD+K +NI++ K+ DFG+A+ + + V T V+GT Y++PE
Sbjct: 128 HQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 361 YASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420
A ++ RSDVYS G ++ EV++G P + V V E + P
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSVAYQHVR----EDPIPP 234
Query: 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPK-MGHVIHMLE 460
+ + S L + L+ + N R + + L
Sbjct: 235 SARHEGLSADLDAVV---LKALAKNPENRYQTAAEMRADLV 272
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 161 bits (409), Expect = 8e-46
Identities = 53/263 (20%), Positives = 102/263 (38%), Gaps = 24/263 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
+G G +G+V+ V K + + K E+ + ++ H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
+ +L+ E++ G L + ++ +N + +GL ++H E +V
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMH---EHSIV 149
Query: 312 HRDIKSSNILLDKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
H DIK NI+ + + K+ DFGLA L + + T + APE +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGF 207
Query: 370 RSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429
+D+++ G+L ++SG +P GE + L+T+ + + D S
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPF-----AGE----DDLETLQNVKRCDWEFDEDAFSS-VSP 257
Query: 430 ALKRALLVALRCVDPNAHKRPKM 452
K + + KR +
Sbjct: 258 EAKDFI---KNLLQKEPRKRLTV 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 1e-45
Identities = 55/281 (19%), Positives = 103/281 (36%), Gaps = 29/281 (10%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAE---KEFKVEVEAIGRVRHKNLVR 246
++GEG + V L + A+K L E E + + R+ H V+
Sbjct: 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 247 LLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL 306
L + Y NG L +++ L YLH
Sbjct: 73 LYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG-- 126
Query: 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE-RSYVTTRVMGTFGYVAPEYASTG 365
++HRD+K NILL++ + +++DFG AK+L E + +GT YV+PE +
Sbjct: 127 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 366 MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425
+ SD+++ G +I ++++G P ++ + + D +
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEY-----------LIFQKIIKLEYDF---PE 231
Query: 426 PCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPF 466
+ + + + +A KR + + PF
Sbjct: 232 KFFPKARDLV---EKLLVLDATKRLGCEEMEGYGPLKAHPF 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (403), Expect = 8e-45
Identities = 59/279 (21%), Positives = 105/279 (37%), Gaps = 32/279 (11%)
Query: 184 STNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRV 239
+ N F+ +IG GG+G VY + A+K L R Q E E + V
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61
Query: 240 R---HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
+V + + + ++ G+L L H +
Sbjct: 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEII 117
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGY 356
GL ++H VV+RD+K +NILLD+ + ++SD GLA ++ +GT GY
Sbjct: 118 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGY 171
Query: 357 VAPEYASTGM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415
+APE G+ + +D +S G ++ +++ G +P + + + TM
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------- 224
Query: 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGH 454
S L+ L + + ++R
Sbjct: 225 ----AVELPDSFSPELRSLL---EGLLQRDVNRRLGCLG 256
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-44
Identities = 50/263 (19%), Positives = 99/263 (37%), Gaps = 25/263 (9%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYC 251
+G G +GIV+ V K + +G + K E+ + RH+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 252 AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVV 311
++++E+I ++ + ++ L ++ + + L +LH +
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLH---SHNIG 124
Query: 312 HRDIKSSNILLDKQWNP--KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
H DI+ NI+ + + K+ +FG A+ L ++ Y APE +++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVST 182
Query: 370 RSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSR 429
+D++S G L+ ++SG NP + + NAE D K S
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENI---------MNAEYTFDEEA-FKEISI 232
Query: 430 ALKRALLVALRCVDPNAHKRPKM 452
+ R + R
Sbjct: 233 EAMDFV---DRLLVKERKSRMTA 252
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (387), Expect = 4e-43
Identities = 60/279 (21%), Positives = 107/279 (38%), Gaps = 27/279 (9%)
Query: 179 RELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQ-AEKEFKVEVEAI 236
++ E + + +V+G G + V VA+K + + E + E+ +
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 237 GRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTA 296
+++H N+V L G H L+ + + G L + T +I
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVL 117
Query: 297 KGLTYLHEGLEPKVVHRDIKSSNILL---DKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
+ YLH + +VHRD+K N+L D+ +SDFGL+K+ + V + GT
Sbjct: 118 DAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGT 172
Query: 354 FGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413
GYVAPE + ++ D +S G++ ++ G P K
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---------KLFEQILK 223
Query: 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM 452
AE D + S + K + ++ + KR
Sbjct: 224 AEYEFDSPYWDD-ISDSAKDFI---RHLMEKDPEKRFTC 258
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 151 bits (382), Expect = 1e-42
Identities = 57/279 (20%), Positives = 106/279 (37%), Gaps = 39/279 (13%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNL---------LNNRGQAEKEFKVEVEAIGRVR 240
+ ++G G +V + AVK + + + EV+ + +V
Sbjct: 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 67
Query: 241 -HKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGL 299
H N+++L LV++ + G L +L L+ + I+ + +
Sbjct: 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVI 123
Query: 300 TYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
LH+ +VHRD+K NILLD N KL+DFG + L + V GT Y+AP
Sbjct: 124 CALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAP 178
Query: 360 EYASTGMLNER------SDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413
E M + D++S G+++ +++G P + + L+ +++
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR------KQMLMLRMIMSGN- 231
Query: 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM 452
+ S +K + R + KR
Sbjct: 232 ---YQFGSPEWDDYSDTVKDLV---SRFLVVQPQKRYTA 264
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 150 bits (379), Expect = 3e-42
Identities = 51/275 (18%), Positives = 104/275 (37%), Gaps = 21/275 (7%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
IGEG YG+VY A+K L E+ + ++H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPK 309
+LV+E++D + L + +L G+ Y H+ +
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHD---RR 120
Query: 310 VVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNE 369
V+HRD+K N+L++++ K++DFGLA+ G T ++ + + +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 370 RSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD--------PR 421
D++S G + E+++G ++ + + ++N V +
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 422 LQEKPCSRALKRALLVAL----RCVDPNAHKRPKM 452
+ P LK + + + + ++R
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 5e-42
Identities = 59/265 (22%), Positives = 101/265 (38%), Gaps = 30/265 (11%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRV-RHKNLV 245
++G+G +G V+ + N A+K L + + + VE + H L
Sbjct: 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
+ + V EY++ G+L + GL +LH
Sbjct: 67 HMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS- 121
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
+V+RD+K NILLDK + K++DFG+ K + T GT Y+APE
Sbjct: 122 --KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQ 178
Query: 366 MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEK 425
N D +SFG+L+ E++ G++P G+ + E ++ + P
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSP-----FHGQ-DEEELFHSIRMDN-------PFYPRW 225
Query: 426 PCSRALKRALLVALRCVDPNAHKRP 450
+ K L ++ KR
Sbjct: 226 -LEKEAKDLL---VKLFVREPEKRL 246
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (373), Expect = 6e-41
Identities = 68/279 (24%), Positives = 114/279 (40%), Gaps = 39/279 (13%)
Query: 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNL---LNNRGQAEKEFKV 231
Y+L++ ++ +G G +G V+ + A+K L + R + +
Sbjct: 1 YSLQDFQI-------LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53
Query: 232 EVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNI 291
E + V H ++R+ G + ++ +YI+ G L L +P+ +
Sbjct: 54 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 113
Query: 292 ILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVM 351
L L +++RD+K NILLDK + K++DFG AK + +
Sbjct: 114 CL-------ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLC 162
Query: 352 GTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN 411
GT Y+APE ST N+ D +SFGILI E+++G P S +KT
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---------MKTYEKI 213
Query: 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP 450
NAE P + +K L R + + +R
Sbjct: 214 LNAELRFPPF-----FNEDVKDLL---SRLITRDLSQRL 244
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (370), Expect = 9e-41
Identities = 47/281 (16%), Positives = 91/281 (32%), Gaps = 29/281 (10%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
IG G +G +Y G + VA+K + +E + ++ + +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTIR 69
Query: 250 YC-AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
+C AEG + ++V E + + + + + + + + Y+H
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS---K 122
Query: 309 KVVHRDIKSSNIL---LDKQWNPKLSDFGLAKLLGAERSYV------TTRVMGTFGYVAP 359
+HRD+K N L K + DFGLAK R++ + GT Y +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419
+ R D+ S G ++M G P + + E + +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS------TP 236
Query: 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
+ K L C +P ++ +
Sbjct: 237 IEVLCKGYPSEFATYL---NFCRSLRFDDKPDYSYLRQLFR 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-40
Identities = 59/285 (20%), Positives = 104/285 (36%), Gaps = 33/285 (11%)
Query: 181 LEVSTNGFAD-----ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVE 234
L++ N D V+G G G V A+K +L + +A +E ++
Sbjct: 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWR 60
Query: 235 AIGRVRHKNLVRLLGYC----AEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMN 290
A + ++VR++ A ++V E +D G L + T
Sbjct: 61 AS---QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASE 115
Query: 291 IILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNP---KLSDFGLAKLLGAERSYVT 347
I+ + + YLH + HRD+K N+L + KL+DFG AK + S T
Sbjct: 116 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 172
Query: 348 TRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407
T YVAPE ++ D++S G+++ ++ G P + +
Sbjct: 173 --PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPG 224
Query: 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM 452
M T P + S +K + + +R +
Sbjct: 225 MKTRIRMGQYEFPNPEWSEVSEEVKMLI---RNLLKTEPTQRMTI 266
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-40
Identities = 62/287 (21%), Positives = 120/287 (41%), Gaps = 23/287 (8%)
Query: 185 TNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAE-KEFKVEVEAIGRVRHK 242
+ + + IGEG YG+V + VA+K + Q + E++ + R RH+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 243 NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
N++ + + Y+ + L+ + L+ + + +GL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVT--TRVMGTFGYVAPE 360
H V+HRD+K SN+LL+ + K+ DFGLA++ + + T + T Y APE
Sbjct: 126 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 361 YASTGMLNERS-DVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419
+S D++S G ++ E++S R ++N + + + + +++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 420 ----------PRLQEKPCSRALKRALLVAL----RCVDPNAHKRPKM 452
P + P +R A AL + + N HKR ++
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 289
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 8e-40
Identities = 65/280 (23%), Positives = 108/280 (38%), Gaps = 24/280 (8%)
Query: 192 NVIGEGGYGIVYHGVLEDNTN--VAVKNLLNNRGQAEKEFKVEVEA-----IGRVRHKNL 244
IGEG YG V+ N VA+K + G+ E + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQW--LHGDVGPHSPLTWEIRMNIILGTAKGLTYL 302
VRL C + +++Q + D P + E +++ +GL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 303 HEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
H +VVHRD+K NIL+ KL+DFGLA++ + + T V+ T Y APE
Sbjct: 133 HS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVL 187
Query: 363 STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLV----------EWLKTMVTNR 412
D++S G + E+ + S ++ + +W + + R
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKM 452
A + EK + + + L+C+ N KR
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 2e-39
Identities = 55/271 (20%), Positives = 103/271 (38%), Gaps = 33/271 (12%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNL------LNNRGQAEKEFKVEVEAIGRVRHKNLV 245
+G G + +V A K + + RG + ++ + EV + ++H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
L +L+ E + G L +L LT E + G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLH-- 130
Query: 306 LEPKVVHRDIKSSNILLDKQWNP----KLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEY 361
++ H D+K NI+L + P K+ DFGLA + + + GT +VAPE
Sbjct: 131 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEI 187
Query: 362 ASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421
+ L +D++S G++ ++SG +P + +
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----------ETLANVSAVNYEFE 236
Query: 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKM 452
+ + AL + + R + + KR +
Sbjct: 237 DEYFSNTSALAKDFI--RRLLVKDPKKRMTI 265
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 143 bits (360), Expect = 2e-39
Identities = 43/283 (15%), Positives = 87/283 (30%), Gaps = 31/283 (10%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH-KNLVRLL 248
IGEG +G+++ G L +N VA+K R + + E + + +
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
+ EG H +LV + + + + + + +HE
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHE---K 120
Query: 309 KVVHRDIKSSNILLDKQWNP-----KLSDFGLAKLLGAERS------YVTTRVMGTFGYV 357
+V+RDIK N L+ + + + DFG+ K + + GT Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 358 APEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417
+ + R D+ + G + M + G P + E + +
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS------ 234
Query: 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460
R + + P ++ +
Sbjct: 235 TPLRELCAGFPEEFYK---YMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 3e-39
Identities = 54/280 (19%), Positives = 101/280 (36%), Gaps = 21/280 (7%)
Query: 188 FADENVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNL 244
F IGEG YG+VY VA+K L E+ + + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 245 VRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE 304
V+LL LV+E++ + D + + + + + +GL + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 305 GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAST 364
+V+HRD+K N+L++ + KL+DFGLA+ G T V+ +
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 365 GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD----- 419
+ D++S G + E+++ R ++ + GV
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 420 ---PRLQEKPCSRALKRALLVAL----RCVDPNAHKRPKM 452
P+ + S+ + + + + +KR
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-39
Identities = 58/283 (20%), Positives = 105/283 (37%), Gaps = 29/283 (10%)
Query: 188 FADENVIGEGGYGIVYHGVL-EDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVR 246
+ D VIG G +G+VY L + VA+K +L + ++ E++ + ++ H N+VR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVR 77
Query: 247 LLGYCAEGAHRM------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
L + + LV +Y+ H L + + L
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPVIYVKLYMYQLFRSLA 136
Query: 301 YLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAP 359
Y+H + HRDIK N+LLD KL DFG AK L + + +
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRYYRAPE 192
Query: 360 EYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT-------NR 412
DV+S G ++ E++ G+ ++ + + T N
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 413 NAEGVLDPRLQEKPCSRALKR-----ALLVALRCVDPNAHKRP 450
N P+++ P ++ + A+ + R ++ R
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 8e-39
Identities = 58/279 (20%), Positives = 103/279 (36%), Gaps = 26/279 (9%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVK-----NLLNNRGQAEKEFKVEVEAIGRVRHKNLV 245
+ +GEG + VY N VA+K + + + E++ + + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 246 RLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEG 305
LL ++ LV+++++ LT +L T +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQ- 118
Query: 306 LEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTG 365
++HRD+K +N+LLD+ KL+DFGLAK G+ T +V T Y APE
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 366 ML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD----- 419
+ D+++ G ++ E++ + ++ + T +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 420 --PRLQEKPCSRALKRALLVAL----RCVDPNAHKRPKM 452
P A L N R
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 274
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-36
Identities = 63/275 (22%), Positives = 96/275 (34%), Gaps = 29/275 (10%)
Query: 183 VSTNGFADENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGR 238
V+ N F ++G+G +G V A+K L A+ E E +
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 239 VRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKG 298
RH L L V EY + G L L T E
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSA 117
Query: 299 LTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVA 358
L YLH VV+RDIK N++LDK + K++DFGL K ++ + GT Y+A
Sbjct: 118 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLA 173
Query: 359 PEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418
PE D + G+++ E++ GR P + + ++
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILME------- 220
Query: 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMG 453
+ R S K L + + +R G
Sbjct: 221 EIRFPRT-LSPEAKSLL---AGLLKKDPKQRLGGG 251
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-36
Identities = 58/277 (20%), Positives = 103/277 (37%), Gaps = 23/277 (8%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
IGEG YG V+ E + VA+K L ++ E+ + ++HKN+VRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
LV+E+ D + + + L EI + + KGL + H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHS---R 120
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
V+HRD+K N+L+++ KL++FGLA+ G + V+ + + +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 369 ERSDVYSFGILIMEVISGRNPVDYSRPPGEV--NLVEWLKTMVTNRNAEGVLDPRLQEKP 426
D++S G + E+ + P+ + + L T + P + P
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 427 CSRALKRALLVA-----------LRCVDPNAHKRPKM 452
A + V + N +R
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-35
Identities = 63/271 (23%), Positives = 105/271 (38%), Gaps = 43/271 (15%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKE------FKVEVEAIGRVR--HKN 243
++G GG+G VY G+ + DN VA+K++ +R E +EV + +V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 244 LVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
++RLL + +L+ E + + L E+ + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCH 127
Query: 304 EGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYA 362
V+HRDIK NIL+D + KL DFG LL + V T GT Y PE+
Sbjct: 128 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWI 181
Query: 363 STGMLNERS-DVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421
+ RS V+S GIL+ +++ G P + + E +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE--------------------HDEEIIRGQV 221
Query: 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKM 452
+ S + + C+ RP
Sbjct: 222 FFRQRVSSECQHLI---RWCLALRPSDRPTF 249
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-34
Identities = 56/291 (19%), Positives = 111/291 (38%), Gaps = 37/291 (12%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVKNLL--NNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
IG+G +G V+ + VA+K +L N + E++ + ++H+N+V L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 249 GYCAEGAHRM--------LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLT 300
C A LV+++ ++ + T ++ GL
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLY 131
Query: 301 YLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS---YVTTRVMGTFGYV 357
Y+H K++HRD+K++N+L+ + KL+DFGLA+ ++ T + T Y
Sbjct: 132 YIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 358 APEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416
PE D++ G ++ E+ + + + ++ L+ L +T
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 417 VLDPRLQEK---------------PCSRALKRALLVALRCVDPNAHKRPKM 452
V + L EK AL + + + + +R
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-34
Identities = 54/298 (18%), Positives = 109/298 (36%), Gaps = 27/298 (9%)
Query: 176 YTLRELEVSTNGFAD----ENVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKE 228
+ +E+ + +G G YG V V VA+K K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 229 FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIR 288
E+ + +RH+N++ LL ++ G + H L +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 289 MNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTT 348
++ KGL Y+H ++HRD+K N+ +++ K+ DFGLA+ +E T
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TG 177
Query: 349 RVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM 408
V+ + + + D++S G ++ E+I+G+ S ++ + +
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 409 VTNRNAEGVLD----------PRLQEKPCSRALKRALLVAL----RCVDPNAHKRPKM 452
+ + P L++K + L A +A+ + + +A +R
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (317), Expect = 7e-33
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 16/247 (6%)
Query: 147 AAGSHHGSGDQTVAAAITPEVSHLGWGHWYTLRELEVSTNGFADENVIGEGGYGIVYHGV 206
AA + GS ++V + W T + + F +G G +G V
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFL-KKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 207 -LEDNTNVAVKNLLNNRGQAEKE---FKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262
E + A+K L + K+ E + V LV+L + ++ +V E
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121
Query: 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL 322
Y+ G + L + YLH +++RD+K N+L+
Sbjct: 122 YVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 323 DKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIME 382
D+Q +++DFG AK T + GT +APE + N+ D ++ G+LI E
Sbjct: 175 DQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 383 VISGRNP 389
+ +G P
Sbjct: 231 MAAGYPP 237
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 1e-30
Identities = 63/283 (22%), Positives = 114/283 (40%), Gaps = 31/283 (10%)
Query: 183 VSTNGFADENVIGEGGYGIVYHGVL----EDNTNVAVKNL----LNNRGQAEKEFKVEVE 234
V F V+G G YG V+ + A+K L + + + + + E +
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 235 AIGRVRHK-NLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIIL 293
+ +R LV L L+ +YI+ G L L T +
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVG 136
Query: 294 GTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGT 353
L +LH+ +++RDIK NILLD + L+DFGL+K A+ + GT
Sbjct: 137 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 193
Query: 354 FGYVAPEYASTGM--LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN 411
Y+AP+ G ++ D +S G+L+ E+++G +P ++ + + E + ++ +
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKS 251
Query: 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGH 454
+P ++ S K + R + + KR G
Sbjct: 252 -------EPPYPQE-MSALAKDLI---QRLLMKDPKKRLGCGP 283
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 117 bits (293), Expect = 7e-30
Identities = 49/224 (21%), Positives = 94/224 (41%), Gaps = 24/224 (10%)
Query: 175 WYTLRELEVSTNGFAD---ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFK 230
++ V D +G G Y V+ + + +N V VK L + +K+ K
Sbjct: 21 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIK 77
Query: 231 VEVEAIGRVR-HKNLVRLLGYCAEGAHRM--LVYEYIDNGNLEQWLHGDVGPHSPLTWEI 287
E++ + +R N++ L + R LV+E+++N + +Q LT
Sbjct: 78 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYD 130
Query: 288 RMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLLGAERSYV 346
+ K L Y H ++HRD+K N+++D + +L D+GLA+ + Y
Sbjct: 131 IRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY- 186
Query: 347 TTRVMGTFGYVAPE-YASTGMLNERSDVYSFGILIMEVISGRNP 389
+ + + PE M + D++S G ++ +I + P
Sbjct: 187 -NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 4e-28
Identities = 45/201 (22%), Positives = 83/201 (41%), Gaps = 9/201 (4%)
Query: 192 NVIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLL 248
+ +G G YG V + VAVK + K E+ + ++H+N++ LL
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEP 308
+ +L ++ LT + +I +GL Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 140
Query: 309 KVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLN 368
++HRD+K SN+ +++ K+ DFGLA+ E T V + + N
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWMHYN 197
Query: 369 ERSDVYSFGILIMEVISGRNP 389
+ D++S G ++ E+++GR
Sbjct: 198 QTVDIWSVGCIMAELLTGRTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 7e-27
Identities = 53/206 (25%), Positives = 83/206 (40%), Gaps = 21/206 (10%)
Query: 193 VIGEGGYGIVYHGV-LEDNTNVAVK--NLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
IG G GIV + NVA+K + K E+ + V HKN++ LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 250 YCA------EGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH 303
E LV E +D + E ++ G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQMLCGIKHLH 136
Query: 304 EGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYAS 363
++HRD+K SNI++ K+ DFGLA+ G S++ T + T Y APE
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVIL 191
Query: 364 TGMLNERSDVYSFGILIMEVISGRNP 389
E D++S G ++ E++ +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (261), Expect = 3e-25
Identities = 42/234 (17%), Positives = 81/234 (34%), Gaps = 18/234 (7%)
Query: 191 ENVIGEGGYGIVYHGV-LEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLG 249
+G G + V+ + +NT+VA+K ++ + + E++ + RV + +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 250 YCAEGAHRMLVYEYIDNGNLEQW------------LHGDVGPHSPLTWEIRMNIILGTAK 297
A ++L + N H + I
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 298 GLTYLHEGLEPKVVHRDIKSSNILLDKQ-WNPKLSDFGLAKLLGAERSYVT-TRVMGTFG 355
GL Y+H ++H DIK N+L++ L +A L A T + T
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 356 YVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMV 409
Y +PE +D++S LI E+I+G + + + ++
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.8 bits (222), Expect = 2e-21
Identities = 27/163 (16%), Positives = 52/163 (31%), Gaps = 21/163 (12%)
Query: 192 NVIGEGGYGIVYHGVLEDNTNVAVK----------NLLNNRGQAEKEFKVEVEAIGRVRH 241
++GEG V++ E VK + R + F V R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 242 KNLVRLLGYCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTY 301
+ L +L G VY + N L + + + ++ + +
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118
Query: 302 LHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344
+ +VH D+ N+L+ + + DF + +G E
Sbjct: 119 FY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGW 157
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 521 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.63 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.18 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.62 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.95 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.87 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.73 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=424.04 Aligned_cols=261 Identities=29% Similarity=0.486 Sum_probs=206.2
Q ss_pred hhhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 180 ELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
+|++..++|++.+.||+|+||+||+|+++ ..||||++... .....+.|.+|+++|++++|||||++++++.+ ...
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence 45788899999999999999999999864 46999998644 34455789999999999999999999999865 568
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
+||||||++|+|.++++.. ...+++..++.++.|++.||+|||++ +|+||||||+||||+.++++||+|||+|+
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLAT 152 (276)
T ss_dssp EEEEECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred EEEEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcccccee
Confidence 9999999999999999765 35799999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCC-cceeecccccccccccccccC---CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccc
Q 009979 338 LLGAER-SYVTTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (521)
Q Consensus 338 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (521)
...... ....+...||+.|||||++.+ ..|+.++|||||||+||||+||+.||...... ..+...+...
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~------~~~~~~~~~~- 225 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIFMVGRG- 225 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHHT-
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH------HHHHHHHhcC-
Confidence 764432 233456789999999999864 45899999999999999999999999754321 1112222211
Q ss_pred cccCCCcccC--CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 414 AEGVLDPRLQ--EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 414 ~~~~~d~~l~--~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
...+.+. ...++..+. +++.+||+.||++|||+.+|+++|+..
T Consensus 226 ---~~~p~~~~~~~~~~~~l~---~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 226 ---YLSPDLSKVRSNCPKAMK---RLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp ---SCCCCGGGSCTTCCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCcchhccccchHHHH---HHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1122111 122444444 488899999999999999999999753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-54 Score=419.81 Aligned_cols=256 Identities=26% Similarity=0.454 Sum_probs=200.8
Q ss_pred cCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
..++|++.+.||+|+||+||+|.+.+++.||||++.... ...++|.+|++++++++|||||+++|+|.++...++||||
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 346899999999999999999999888899999987543 3457799999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
|++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++++||+|||+++......
T Consensus 82 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred cCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9999999998765 45789999999999999999999998 99999999999999999999999999999875554
Q ss_pred cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhC-CCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG-RNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
........||+.|+|||++.+..++.++|||||||++|||+|+ +.||... +..+.+....... ....|
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~------~~~~~~~~i~~~~---~~~~p-- 224 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR------SNSEVVEDISTGF---RLYKP-- 224 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC------CHHHHHHHHHHTC---CCCCC--
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC------CHHHHHHHHHhcC---CCCCc--
Confidence 4444556799999999999999999999999999999999995 5555322 2223333322211 11111
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
..++.. +.+++.+||+.||++||||++|+++|+..
T Consensus 225 --~~~~~~---l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 225 --RLASTH---VYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp --TTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --cccCHH---HHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 223343 44588899999999999999999999753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=422.22 Aligned_cols=262 Identities=25% Similarity=0.407 Sum_probs=214.8
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
-+++++..++|++.+.||+|+||+||+|.+++++.||||++.... ...+.|.+|+++|++++|||||+++|++.+ +..
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~ 82 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI 82 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCe
Confidence 356778889999999999999999999999888899999986543 345679999999999999999999998865 567
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
+||||||++|+|.+++.... ...+++..++.|+.|++.||+|||++ +|+||||||+||||++++.+||+|||+|+
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLAR 157 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceE
Confidence 99999999999999876542 34689999999999999999999998 99999999999999999999999999999
Q ss_pred ecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
..............||+.|+|||++.++.++.++|||||||++|||+||..|+.... +..+.+.......
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-----~~~~~~~~i~~~~----- 227 (272)
T d1qpca_ 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLERGY----- 227 (272)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHHTTC-----
T ss_pred EccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHhcC-----
Confidence 876655555556789999999999999999999999999999999999665543221 2222222222211
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
.+.. +..++.. +.+|+.+||+.||++||||.+|++.|+.
T Consensus 228 -~~~~-p~~~~~~---l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 228 -RMVR-PDNCPEE---LYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp -CCCC-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCC-cccChHH---HHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 1111 1224444 4458889999999999999999999975
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-54 Score=425.88 Aligned_cols=264 Identities=23% Similarity=0.393 Sum_probs=218.3
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCe
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAH 256 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~ 256 (521)
+++|++..++|++.+.||+|+||+||+|.+. +++.||||++.... ...++|.+|+++|++++|||||+++++|.+++.
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 4566788889999999999999999999986 47889999986543 345679999999999999999999999999999
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.+||||||++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||||++++++||+|||++
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred eEEEeecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccce
Confidence 999999999999999997652 46899999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
+..............||+.|+|||++.++.|+.++|||||||++|||++|..||.... +..+.. ..+..+.
T Consensus 163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-----~~~~~~-~~i~~~~--- 233 (287)
T d1opja_ 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVY-ELLEKDY--- 233 (287)
T ss_dssp TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHHHHH-HHHHTTC---
T ss_pred eecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc-----hHHHHH-HHHhcCC---
Confidence 9876555555555678999999999999999999999999999999999877764322 122222 2222211
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.+... ..++.. +.+|+.+||+.||++|||+.+|++.|+..
T Consensus 234 --~~~~~-~~~~~~---l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 234 --RMERP-EGCPEK---VYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp --CCCCC-TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred --CCCCC-ccchHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11111 123344 44588899999999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=419.70 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=208.3
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
.++|++.+.||+|+||+||+|.+. +|+.||||++........+.+.+|+++|+.++|||||++++++.+++..||||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 357999999999999999999964 6899999999766555667899999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
|+||+|.+++.+. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++.+....
T Consensus 99 ~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 9999999988754 689999999999999999999999 99999999999999999999999999999875433
Q ss_pred cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
......+||+.|+|||++.+..|+.++|||||||++|||+||+.||.... ..+.+......... .+ ..
T Consensus 171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~~~~~~~~-~~---~~- 238 (293)
T d1yhwa1 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN------PLRALYLIATNGTP-EL---QN- 238 (293)
T ss_dssp -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHHCSC-CC---SS-
T ss_pred -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC------HHHHHHHHHhCCCC-CC---CC-
Confidence 23455689999999999999999999999999999999999999996432 22222332222111 11 00
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
....+. .+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~s~---~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 PEKLSA---IFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGGSCH---HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccCCH---HHHHHHHHHccCChhHCcCHHHHhc
Confidence 011233 3445888999999999999999874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-54 Score=420.48 Aligned_cols=252 Identities=27% Similarity=0.374 Sum_probs=202.3
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
.++|++.+.||+|+||+||+|++. +++.||||++.... .+..+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357999999999999999999975 68899999986543 2334678899999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
||++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||+++++++||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 99999999999754 5799999999999999999999999 9999999999999999999999999999976433
Q ss_pred C-cceeecccccccccccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 343 R-SYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 343 ~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
. ....+..+||+.|+|||++.+..+ +.++|||||||++|||+||+.||........ . ......... .
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~---~~~~~~~~~---~--- 225 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--E---YSDWKEKKT---Y--- 225 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--H---HHHHHTTCT---T---
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--H---HHHHhcCCC---C---
Confidence 2 223455789999999999988775 6789999999999999999999975442211 1 111111110 0
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
..+.......+.+|+.+||+.||++|||+.|+++
T Consensus 226 ---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111112234455888999999999999999863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-53 Score=410.45 Aligned_cols=255 Identities=22% Similarity=0.382 Sum_probs=214.5
Q ss_pred cCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
..++|++.++||+|+||+||+|+++++..||||++..... ..++|.+|++++++++||||++++|+|.++...++||||
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 3468999999999999999999998888999999876543 356899999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+++|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 81 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CTTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred cCCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 9999999997765 35788999999999999999999998 99999999999999999999999999998776555
Q ss_pred cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 344 SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
........||+.|+|||++.+..++.++|||||||++|||+| |+.||.... ..+...... ... ....|
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~------~~~~~~~i~-~~~--~~~~p-- 223 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT------NSETAEHIA-QGL--RLYRP-- 223 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC------HHHHHHHHH-TTC--CCCCC--
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC------HHHHHHHHH-hCC--CCCCc--
Confidence 444556779999999999999999999999999999999998 899996443 222222222 211 11111
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
..++.. +.+++.+||+.||++|||+.+|+++|..
T Consensus 224 --~~~~~~---l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 --HLASEK---VYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp --TTCCHH---HHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred --ccccHH---HHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 223444 4458889999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=415.55 Aligned_cols=245 Identities=27% Similarity=0.436 Sum_probs=205.3
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|++.+.||+|+||+||+|++. +++.||+|++.+.. ....+.+.+|+++++.++|||||++++++.++...||||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46899999999999999999985 58899999986432 233567889999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
|||++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 999999999999865 5799999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
. ......||+.|+|||++.+..++.++|||||||+||||+||+.||.... ..+.+...... . ..
T Consensus 159 ~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~-~------~~ 222 (263)
T d2j4za1 159 S---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------YQETYKRISRV-E------FT 222 (263)
T ss_dssp C---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTT-C------CC
T ss_pred C---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC------HHHHHHHHHcC-C------CC
Confidence 2 2345689999999999999999999999999999999999999996432 22223332221 1 11
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
+.. ..+.. +.+++.+||+.||++|||+.|+++
T Consensus 223 ~p~-~~s~~---~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 FPD-FVTEG---ARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCT-TSCHH---HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCc-cCCHH---HHHHHHHHccCCHhHCcCHHHHHc
Confidence 111 13333 445888999999999999999985
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-53 Score=419.40 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=198.8
Q ss_pred hcCCCccccceEccCCcEEEEEEEEcC-C---cEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 183 VSTNGFADENVIGEGGYGIVYHGVLED-N---TNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 183 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
+..++|++.++||+|+||+||+|.+.. + ..||||.+.... ....+.|.+|+++|++++|||||+++|+|.+++..
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 344678889999999999999999753 2 248899886543 34457799999999999999999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++|||||++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||||+.++++||+|||+++
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp EEEEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccce
Confidence 9999999999999998865 35799999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCcce----eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhcc
Q 009979 338 LLGAERSYV----TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (521)
Q Consensus 338 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (521)
.+....... .....||+.|+|||++.++.++.++|||||||+||||+| |+.||.... ..+.+.......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~------~~~~~~~i~~~~ 250 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT------NQDVINAIEQDY 250 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTTC
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCC
Confidence 765432221 123468999999999999999999999999999999998 899996443 222223222211
Q ss_pred ccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 413 NAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 413 ~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
. . .. ...++.. +.+|+.+||+.||++|||+.||++.|+..
T Consensus 251 ~----~--~~-~~~~~~~---l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 251 R----L--PP-PMDCPSA---LHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp C----C--CC-CTTCCHH---HHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C----C--CC-CccchHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 0 11 1123444 44588899999999999999999999753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=415.16 Aligned_cols=255 Identities=24% Similarity=0.337 Sum_probs=193.9
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEee--CCeeeEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--GAHRMLV 260 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--~~~~~lV 260 (521)
++|++.+.||+|+||+||+|++. +|+.||||.+.... ....+.+.+|+++|++++|||||++++++.+ +..+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999975 68899999986543 3334678899999999999999999999865 4568999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL--EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~--~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
||||++|+|.+++.+.......+++..++.++.|++.||+|||+.. ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999754333568999999999999999999999861 11499999999999999999999999999997
Q ss_pred cCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCC
Q 009979 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (521)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (521)
+.... .......||+.|+|||++.+..|+.++|||||||++|||+||+.||.... ..+....... ....
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~------~~~~~~~i~~-~~~~--- 232 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS------QKELAGKIRE-GKFR--- 232 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHH-TCCC---
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC------HHHHHHHHHc-CCCC---
Confidence 65432 23345789999999999999999999999999999999999999996432 2222222222 1111
Q ss_pred CcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 419 d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.+. ...+.. +.+++.+||+.||++|||+.|+++
T Consensus 233 --~~~-~~~s~~---l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 --RIP-YRYSDE---LNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --CCC-TTSCHH---HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCC-cccCHH---HHHHHHHHcCCChhHCcCHHHHHh
Confidence 111 113334 445888999999999999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-53 Score=416.47 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=205.9
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
+.|++.+.||+|+||+||+|.+. ++..||||++........+.+.+|+++|++++|||||++++++.+++..+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999975 58889999998766666778999999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCc
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERS 344 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~ 344 (521)
++|+|.+++.+. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+|+..... .
T Consensus 92 ~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~ 164 (288)
T d2jfla1 92 AGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-I 164 (288)
T ss_dssp TTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-H
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC-c
Confidence 999999998754 35799999999999999999999999 9999999999999999999999999999865322 1
Q ss_pred ceeeccccccccccccccc-----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 345 YVTTRVMGTFGYVAPEYAS-----TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 345 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
.......||+.|+|||++. +..|+.++|||||||++|||+||+.||....+. . .+........ ..+.
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~---~~~~i~~~~~-~~~~- 236 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---R---VLLKIAKSEP-PTLA- 236 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---G---HHHHHHHSCC-CCCS-
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---H---HHHHHHcCCC-CCCC-
Confidence 2234568999999999883 556899999999999999999999999754321 1 1222222111 1110
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.....+. ++.+|+.+||+.||++|||+.|+++
T Consensus 237 ---~~~~~s~---~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 ---QPSRWSS---NFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ---SGGGSCH---HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---ccccCCH---HHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111233 4455888999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-53 Score=421.74 Aligned_cols=203 Identities=26% Similarity=0.415 Sum_probs=180.4
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
++..++|++.+.||+|+||+||+|++. +++.||+|++.... ....+.+.+|+++|+.++|||||+++++|.++.+.||
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 456778999999999999999999975 68889999986543 3345678999999999999999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
|||||++|+|.+++.+. ..+++..+..++.|++.||.|||+ + +|+||||||+||||+.++++||+|||+|+.
T Consensus 82 VmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154 (322)
T ss_dssp EEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence 99999999999999865 468999999999999999999996 5 899999999999999999999999999987
Q ss_pred cCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Q 009979 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSR 394 (521)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~ 394 (521)
+... ..+..+||+.|+|||++.+..|+.++|||||||++|||++|+.||....
T Consensus 155 ~~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 155 LIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp HHHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred cCCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 5332 2345689999999999999999999999999999999999999997543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=411.12 Aligned_cols=257 Identities=27% Similarity=0.451 Sum_probs=207.8
Q ss_pred hcCCCccccce-EccCCcEEEEEEEEc---CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 183 VSTNGFADENV-IGEGGYGIVYHGVLE---DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 183 ~~~~~~~~~~~-LG~G~fG~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
+..++|.+.+. ||+|+||+||+|.+. ++..||||++.... ....+.|.+|+++|++++|||||+++|+|.. +..
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 45567777774 999999999999864 34579999997543 3345789999999999999999999999975 467
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
|||||||++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 84 ~lvmE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 157 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSK 157 (285)
T ss_dssp EEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhh
Confidence 9999999999999998654 35799999999999999999999998 99999999999999999999999999999
Q ss_pred ecCCCCcce--eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 338 LLGAERSYV--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 338 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
.+....... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||...... +.... +..+..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~------~~~~~-i~~~~~ 230 (285)
T d1u59a_ 158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------EVMAF-IEQGKR 230 (285)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH------HHHHH-HHTTCC
T ss_pred cccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH------HHHHH-HHcCCC
Confidence 875543322 234568999999999999999999999999999999998 99999754321 22222 222211
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
+.+. ..++.. +.+|+.+||+.||++||||.+|++.|+..
T Consensus 231 -----~~~p-~~~~~~---l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 231 -----MECP-PECPPE---LYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp -----CCCC-TTCCHH---HHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCC-CcCCHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111 224444 44588899999999999999999998753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=412.15 Aligned_cols=263 Identities=25% Similarity=0.387 Sum_probs=207.0
Q ss_pred hhhhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 179 RELEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 179 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
.++++..++|++.+.||+|+||+||+|+++++..||||++.... ...+.|.+|+.+|++++|||||+++|+|.+ +..+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~ 87 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 87 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence 34467788999999999999999999999888899999986543 345779999999999999999999999965 5679
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
+|||||++|+|..++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||||+++++||+|||+++.
T Consensus 88 lv~Ey~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp EEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEEEecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhh
Confidence 9999999999999887542 34699999999999999999999998 999999999999999999999999999998
Q ss_pred cCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCC
Q 009979 339 LGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (521)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (521)
.............||+.|+|||++.++.++.++|||||||++|||+||..||.... ...+.+.......
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-----~~~~~~~~i~~~~------ 231 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-----VNREVLDQVERGY------ 231 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHHTTC------
T ss_pred ccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-----CHHHHHHHHHhcC------
Confidence 75555445556789999999999999999999999999999999999766654322 2222233222211
Q ss_pred CcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccC
Q 009979 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEE 463 (521)
Q Consensus 419 d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~ 463 (521)
.+... ..++.. +.+++.+||+.||++||++.+|+++|+...
T Consensus 232 ~~~~~-~~~~~~---l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 232 RMPCP-PECPES---LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCCCC-TTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCC-cccCHH---HHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 11111 123444 445888999999999999999999998743
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-53 Score=422.65 Aligned_cols=262 Identities=26% Similarity=0.406 Sum_probs=209.4
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEcCC------cEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCCeeeEEEEEe
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDN------TNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYCA 252 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~ 252 (521)
+++..++|++.++||+|+||+||+|++... ..||+|.+.... ......+.+|+.+|.++ +|||||+++++|.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 467778999999999999999999996532 258999886543 33446788999999998 8999999999999
Q ss_pred eCCeeeEEEEeccCCchHHhhhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 009979 253 EGAHRMLVYEYIDNGNLEQWLHGDVG-------------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHR 313 (521)
Q Consensus 253 ~~~~~~lV~e~~~~g~L~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHr 313 (521)
+.+..+||||||++|+|.++|+.... ....+++..++.++.|++.||+|||++ +|+||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence 99999999999999999999976532 124689999999999999999999998 99999
Q ss_pred CCCCCCeEeCCCCCceEeecccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCC
Q 009979 314 DIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVD 391 (521)
Q Consensus 314 Dik~~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~ 391 (521)
||||+|||++.++++||+|||+|+........ ......||+.|||||++.++.++.++|||||||+||||+| |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876544332 2345678999999999999999999999999999999998 899997
Q ss_pred CCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 009979 392 YSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLE 460 (521)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~ 460 (521)
..... +.+...+.... .+.. +..++.. +.+|+.+||+.||++|||++||+++|.
T Consensus 269 ~~~~~------~~~~~~~~~~~-----~~~~-p~~~~~~---l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVD------ANFYKLIQNGF-----KMDQ-PFYATEE---IYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCS------HHHHHHHHTTC-----CCCC-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHH------HHHHHHHhcCC-----CCCC-CCcCCHH---HHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 54332 11222222221 1111 1223444 445888999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-52 Score=408.37 Aligned_cols=259 Identities=28% Similarity=0.481 Sum_probs=201.7
Q ss_pred hhcCCCccccceEccCCcEEEEEEEEcCC-----cEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC
Q 009979 182 EVSTNGFADENVIGEGGYGIVYHGVLEDN-----TNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (521)
Q Consensus 182 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 255 (521)
++..+.|+..++||+|+||+||+|.+++. ..||||++..... ....+|.+|+++|++++|||||+++|++.+..
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 45566899999999999999999997542 3699999865433 33467899999999999999999999999999
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..++|||||.+|++.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred ceEEEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccch
Confidence 999999999999999988765 35799999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCc--ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccc
Q 009979 336 AKLLGAERS--YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (521)
Q Consensus 336 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (521)
++.+..... .......||+.|+|||++.++.++.++|||||||++|||+||..|+.... +..+.++.... +.
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-----~~~~~~~~i~~-~~ 230 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-----SNHEVMKAIND-GF 230 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHHT-TC
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-----CHHHHHHHHhc-cC
Confidence 987644322 22334568999999999999999999999999999999999766654322 22222222222 11
Q ss_pred cccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 414 ~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
.+... ..++.. +.+|+.+||+.||++||||.||+++|+.
T Consensus 231 -----~~~~~-~~~~~~---l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 231 -----RLPTP-MDCPSA---IYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp -----CCCCC-TTCBHH---HHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -----CCCCc-hhhHHH---HHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 11111 123344 4458889999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-53 Score=416.01 Aligned_cols=249 Identities=22% Similarity=0.310 Sum_probs=203.8
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|++.+.||+|+||+||+|.+. +++.||||++.+.. ....+.+.+|+++|++++||||+++++++.+++..||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999975 68899999986432 233467899999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
|||++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 999999999998865 5799999999999999999999999 999999999999999999999999999998754
Q ss_pred CC-cceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 342 ER-SYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 342 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
.. .......+||+.|+|||++.+..|+.++|||||||++|||+||+.||.... ..+........ . .
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~~~~~~~i~~~-~------~ 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN------EYLIFQKIIKL-E------Y 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHTT-C------C
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC------HHHHHHHHHcC-C------C
Confidence 32 223345689999999999999999999999999999999999999996432 22223332221 1 1
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.+... .+. ++.+|+.+||+.||++|||+.|++..
T Consensus 228 ~~p~~-~s~---~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 DFPEK-FFP---KARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CCCTT-CCH---HHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CCCcc-CCH---HHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 11111 223 34558889999999999999987543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=402.09 Aligned_cols=247 Identities=25% Similarity=0.419 Sum_probs=196.5
Q ss_pred ccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEee----CCeeeEE
Q 009979 188 FADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE----GAHRMLV 260 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~----~~~~~lV 260 (521)
|++.++||+|+||+||+|.+. ++..||+|++.... ....+.|.+|+++|++++|||||++++++.+ +...|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 366778999999999999976 57889999986542 3345678999999999999999999999865 3467999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC-CCCCceEeecccceec
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD-KQWNPKLSDFGLAKLL 339 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~-~~~~vkL~DFGla~~~ 339 (521)
||||++|+|.+++++. ..+++..++.++.|++.||+|||++ .++|+||||||+|||++ +++.+||+|||+++..
T Consensus 91 mE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 9999999999999865 5789999999999999999999998 12299999999999996 5789999999999864
Q ss_pred CCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
... .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.... +..+..+.... . ...
T Consensus 166 ~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-----~~~~~~~~i~~-~----~~~ 231 (270)
T d1t4ha_ 166 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRRVTS-G----VKP 231 (270)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHHHTT-T----CCC
T ss_pred cCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-----cHHHHHHHHHc-C----CCC
Confidence 322 2345689999999999865 59999999999999999999999996332 22222222222 1 111
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
+.+... .+.. +.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~-~~~~---~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 ASFDKV-AIPE---VKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGGGC-CCHH---HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcc-CCHH---HHHHHHHHccCCHhHCcCHHHHhC
Confidence 112111 2333 445888999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-51 Score=417.20 Aligned_cols=252 Identities=21% Similarity=0.352 Sum_probs=210.0
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
++|++.+.||+|+||+||+|++. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 47999999999999999999975 68899999998776666788999999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC--CCCCceEeecccceecCCC
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD--KQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~--~~~~vkL~DFGla~~~~~~ 342 (521)
+||+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++.+...
T Consensus 106 ~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 106 SGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999654 35799999999999999999999999 999999999999995 4678999999999987544
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
.. .....||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+.+........ .+
T Consensus 180 ~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~~~-------~~ 244 (350)
T d1koaa2 180 QS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN------DDETLRNVKSCDW-------NM 244 (350)
T ss_dssp SC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCC-------CS
T ss_pred cc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCC-------CC
Confidence 32 345689999999999999999999999999999999999999996432 2233333322111 11
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
...........+.+|+.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111112222345558889999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-52 Score=412.10 Aligned_cols=252 Identities=22% Similarity=0.324 Sum_probs=189.8
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
.+.|++.+.||+|+||+||+|++. +++.||||.+..... .....+.+|+++|+.++|||||++++++.+++..|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 457999999999999999999976 588899999875432 234567889999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC---CCCCceEeecccceec
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD---KQWNPKLSDFGLAKLL 339 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~---~~~~vkL~DFGla~~~ 339 (521)
||+||+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||+. +++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999764 5799999999999999999999999 999999999999994 5789999999999876
Q ss_pred CCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
.... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.... ..+......... . ..+
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~~~~~~~i~~~~-~--~~~ 229 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN------DAKLFEQILKAE-Y--EFD 229 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHTTC-C--CCC
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC------HHHHHHHHhccC-C--CCC
Confidence 4332 2345689999999999999999999999999999999999999996432 122222222211 0 011
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.... ...+ .++.+++.+||+.||++|||+.|++++
T Consensus 230 ~~~~-~~~s---~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 230 SPYW-DDIS---DSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTT-TTSC---HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred Cccc-cCCC---HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111 1122 344558889999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4e-51 Score=413.77 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=208.9
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEec
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
++|++.+.||+|+||+||+|.+. +|+.||||++........+.+.+|+++|++++|||||++++++.++...|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 47999999999999999999975 68999999998766666678889999999999999999999999999999999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC--CCCCceEeecccceecCCC
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD--KQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~--~~~~vkL~DFGla~~~~~~ 342 (521)
+||+|.+++... ..++++..++.++.||+.||+|||++ +|+||||||+||||+ .++.+||+|||+|+.+...
T Consensus 109 ~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999987654 35799999999999999999999998 999999999999997 6789999999999987544
Q ss_pred CcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCccc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRL 422 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 422 (521)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+.+........ .+
T Consensus 183 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~i~~~~~-------~~ 247 (352)
T d1koba_ 183 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED------DLETLQNVKRCDW-------EF 247 (352)
T ss_dssp S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS------HHHHHHHHHHCCC-------CC
T ss_pred C--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCC-------CC
Confidence 3 2345679999999999999999999999999999999999999996432 2222333222110 11
Q ss_pred CCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 423 QEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 423 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
..........++.+|+.+||+.||.+|||+.|++++
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111122334558889999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=402.18 Aligned_cols=246 Identities=28% Similarity=0.445 Sum_probs=197.3
Q ss_pred ceEccCCcEEEEEEEEcC---CcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEeccC
Q 009979 192 NVIGEGGYGIVYHGVLED---NTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEYIDN 266 (521)
Q Consensus 192 ~~LG~G~fG~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~ 266 (521)
++||+|+||+||+|.+.+ ++.||||++.... ....+.|.+|+++|++++|||||+++|+|.. +..+||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998653 4579999986543 2334679999999999999999999999965 457899999999
Q ss_pred CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCCcce
Q 009979 267 GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSYV 346 (521)
Q Consensus 267 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~~ 346 (521)
|+|.++++.. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 9999999865 5799999999999999999999998 99999999999999999999999999999875443322
Q ss_pred --eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcccC
Q 009979 347 --TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQ 423 (521)
Q Consensus 347 --~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 423 (521)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+... .+..+.. +..
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~------~~~~~~-~i~~~~~-----~~~- 231 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK------GSEVTA-MLEKGER-----MGC- 231 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHH-HHHTTCC-----CCC-
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC------HHHHHH-HHHcCCC-----CCC-
Confidence 234578999999999999999999999999999999998 899997432 122222 2222211 111
Q ss_pred CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 424 EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 424 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
+..++..+ .+|+.+||+.||++|||+.+|++.|+.
T Consensus 232 p~~~~~~~---~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 232 PAGCPREM---YDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CTTCCHHH---HHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CcccCHHH---HHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 12244444 458889999999999999999998875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=403.48 Aligned_cols=259 Identities=22% Similarity=0.377 Sum_probs=199.2
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEcC----CcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLED----NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA 255 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~ 255 (521)
+++..++|++.+.||+|+||.||+|.+.. +..||||.+.... ....+.|.+|+++|++++|||||+++|++.+ +
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~ 80 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N 80 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 56778899999999999999999998653 3458899886543 3345679999999999999999999999964 6
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---
T ss_pred eEEEEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchh
Confidence 789999999999999988765 35789999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
++..........+...||+.|+|||++.+..++.++|||||||++|||+| |..||...... .+. ..... ...
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~---~~i~~-~~~ 227 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVI---GRIEN-GER 227 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHH---HHHHT-TCC
T ss_pred heeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHH---HHHHc-CCC
Confidence 99876555555566779999999999999999999999999999999998 89999755432 222 22222 111
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
+.+. ..++.. +.+|+.+||+.||++|||+.||++.|+..
T Consensus 228 -----~~~~-~~~~~~---~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 228 -----LPMP-PNCPPT---LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp -----CCCC-TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCC-CCCCHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111 123444 44588899999999999999999998753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-51 Score=406.61 Aligned_cols=244 Identities=27% Similarity=0.391 Sum_probs=201.4
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
.|+..+.||+|+||+||+|++. +++.||||++..... ...+.+.+|+++|++++|||||++++++.++...|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 5899999999999999999975 678899999875432 334678899999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
||.+|+|..++... .++++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 96 ~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 99999998776554 5799999999999999999999999 9999999999999999999999999999865332
Q ss_pred CcceeecccccccccccccccC---CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 343 RSYVTTRVMGTFGYVAPEYAST---GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||.... ..+.+....... .
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~------~~~~~~~i~~~~------~ 231 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNE------S 231 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSC------C
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhCC------C
Confidence 34579999999999853 568999999999999999999999996432 223333333221 1
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
+.+....++..+ .+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~s~~~---~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 PALQSGHWSEYF---RNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCCSCTTSCHHH---HHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCCHHH---HHHHHHHCcCChhHCcCHHHHHh
Confidence 122222234444 44788999999999999999976
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-51 Score=402.40 Aligned_cols=250 Identities=22% Similarity=0.315 Sum_probs=205.3
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh------hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeee
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG------QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~ 258 (521)
++|++.+.||+|+||+||+|++. +|+.||||++.+... ...+.+.+|+++|++++|||||++++++.+....|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57999999999999999999975 688999999864322 23578999999999999999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC----CceEeecc
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW----NPKLSDFG 334 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~----~vkL~DFG 334 (521)
||||||++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 90 iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999765 4799999999999999999999999 999999999999998766 59999999
Q ss_pred cceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+.+.......
T Consensus 163 ~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~~~~~~~i~~~~-- 232 (293)
T d1jksa_ 163 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT------KQETLANVSAVN-- 232 (293)
T ss_dssp TCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHTTC--
T ss_pred hhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC------HHHHHHHHHhcC--
Confidence 999864432 2345679999999999999999999999999999999999999996432 222222222211
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
..+...........+.+++.+||+.||++|||+.|+++
T Consensus 233 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 -----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -----CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111001112234556888999999999999999985
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-51 Score=408.61 Aligned_cols=250 Identities=24% Similarity=0.274 Sum_probs=207.5
Q ss_pred cCCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
..++|++.+.||+|+||.||+|+.. +++.||||++.+.. ....+.+.+|+++|+.++||||+++++++.+...+|+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 3457999999999999999999975 68999999996542 2334678899999999999999999999999999999
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
|||||+||+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.+|++||+|||+|+..
T Consensus 83 v~ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred ceeccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccc
Confidence 99999999999999875 5789999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD 419 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 419 (521)
... .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+ ..+..+......
T Consensus 156 ~~~-~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~------~~~~~~~i~~~~------- 221 (337)
T d1o6la_ 156 ISD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HERLFELILMEE------- 221 (337)
T ss_dssp CCT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCC-------
T ss_pred ccC-CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC------HHHHHHHHhcCC-------
Confidence 432 223455789999999999999999999999999999999999999997543 222233322211
Q ss_pred cccCCCccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 009979 420 PRLQEKPCSRALKRALLVALRCVDPNAHKRPK-----MGHVIHM 458 (521)
Q Consensus 420 ~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~ 458 (521)
..+... .+. ++.+|+.+||+.||.+||+ +.|++++
T Consensus 222 ~~~p~~-~s~---~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 IRFPRT-LSP---EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCCTT-SCH---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCcc-CCH---HHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 111111 233 3445888999999999995 8888754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-51 Score=403.90 Aligned_cols=266 Identities=26% Similarity=0.395 Sum_probs=214.6
Q ss_pred hhhhhhcCCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCCh-hhHHHHHHHHHHHhcCCCCCeeeEEEE
Q 009979 178 LRELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNRG-QAEKEFKVEVEAIGRVRHKNLVRLLGY 250 (521)
Q Consensus 178 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~hpniv~l~~~ 250 (521)
+.+++++.++|++.+.||+|+||+||+|++. +++.||||++..... +..++|.+|+++|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 5678889999999999999999999999964 346799999865433 345779999999999999999999999
Q ss_pred EeeCCeeeEEEEeccCCchHHhhhcCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 009979 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVG--------------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKV 310 (521)
Q Consensus 251 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~i 310 (521)
|.+....++||||+++|+|.++++.... ....+++..++.|+.|++.||+|||++ +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 9999999999999999999999975321 234589999999999999999999998 99
Q ss_pred eecCCCCCCeEeCCCCCceEeecccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCC-C
Q 009979 311 VHRDIKSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR-N 388 (521)
Q Consensus 311 iHrDik~~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~-~ 388 (521)
+||||||+|||||.++++||+|||+++........ ..+...||+.|+|||.+.+..|+.++|||||||++|||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 99999999999999999999999999876443322 234567899999999999999999999999999999999986 5
Q ss_pred CCCCCCCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 389 PVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 389 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
||... +..+....... +... ... ..++. ++.+|+.+||+.||++||||.||+++|+..
T Consensus 242 p~~~~------~~~e~~~~v~~-~~~~-----~~p-~~~~~---~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 242 PYYGM------AHEEVIYYVRD-GNIL-----ACP-ENCPL---ELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTTS------CHHHHHHHHHT-TCCC-----CCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCC------CHHHHHHHHHc-CCCC-----CCC-ccchH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 66533 22233333222 2111 111 12333 455688899999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=398.15 Aligned_cols=254 Identities=28% Similarity=0.421 Sum_probs=199.8
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEee-CCeeeE
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-GAHRML 259 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-~~~~~l 259 (521)
|++..++|++.+.||+|+||.||+|.++ |+.||||++.+. ...+.|.+|++++++++||||++++|+|.+ ....++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence 4667778999999999999999999985 788999998654 344779999999999999999999999865 456899
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
||||+++|+|.++|.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++..
T Consensus 79 v~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp EECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred EEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceec
Confidence 999999999999997641 24589999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccCC
Q 009979 340 GAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVL 418 (521)
Q Consensus 340 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (521)
... .....+|..|+|||++.++.++.++|||||||++|||+| |+.||...... +....+ .+. .
T Consensus 154 ~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i----~~~-----~ 217 (262)
T d1byga_ 154 SST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----EKG-----Y 217 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH----TTT-----C
T ss_pred CCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----HcC-----C
Confidence 332 234568999999999999999999999999999999998 78887644322 222221 111 1
Q ss_pred CcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 419 DPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 419 d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.+.+.. .++.. +.+|+.+||+.||++|||+.+++++|+..
T Consensus 218 ~~~~~~-~~~~~---~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 218 KMDAPD-GCPPA---VYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CCCCCT-TCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCc-cCCHH---HHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 122222 13333 44588899999999999999999999753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-49 Score=397.79 Aligned_cols=245 Identities=25% Similarity=0.341 Sum_probs=204.8
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|++.+.||+|+||+||+|++. +|+.||||++.+.. ....+.+.+|+.+|+.++|||||++++++.++...|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46889999999999999999975 68999999986532 233567889999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
|||+||+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+||||+.++++||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccccc----ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 999999999998875 5688899999999999999999999 999999999999999999999999999998643
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
. ....+||+.|+|||++.+..|+.++|||||||++|||+||+.||.... ..+.......... .
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~~~-------~ 219 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKILNAEL-------R 219 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHCCC-------C
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC------HHHHHHHHHcCCC-------C
Confidence 2 345689999999999999999999999999999999999999996432 2333333332210 1
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~ 458 (521)
+.. ..+. ++.+++.+||+.||.+|+ |+++++++
T Consensus 220 ~p~-~~s~---~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 FPP-FFNE---DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CCT-TSCH---HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCC-CCCH---HHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 111 1223 344588899999999996 89999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=397.19 Aligned_cols=267 Identities=25% Similarity=0.361 Sum_probs=202.0
Q ss_pred chhhhhhcCCCccccceEccCCcEEEEEEEEcC------CcEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCCeeeEE
Q 009979 177 TLRELEVSTNGFADENVIGEGGYGIVYHGVLED------NTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLL 248 (521)
Q Consensus 177 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~ 248 (521)
...++++..++|++.++||+|+||.||+|.+.. ++.||||++.... ....+.+..|..++.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 466778888999999999999999999999642 3579999986543 33446677788888776 689999999
Q ss_pred EEEeeC-CeeeEEEEeccCCchHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 009979 249 GYCAEG-AHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDI 315 (521)
Q Consensus 249 ~~~~~~-~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDi 315 (521)
+++.+. ...++|||||++|+|.++++.... ....+++..++.++.|++.||+|||++ +|+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence 998664 468999999999999999975421 134689999999999999999999998 9999999
Q ss_pred CCCCeEeCCCCCceEeecccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCC-CCCCCC
Q 009979 316 KSSNILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR-NPVDYS 393 (521)
Q Consensus 316 k~~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~-~Pf~~~ 393 (521)
||+||||++++++||+|||+|+........ ......||+.|+|||++.++.++.++|||||||++|||+||. .||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876443332 234567999999999999999999999999999999999964 577544
Q ss_pred CCCCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 394 RPPGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
... +.+...+..+.. +... ..++.. +.+++.+||+.||++|||+.||+++|+.
T Consensus 241 ~~~------~~~~~~~~~~~~-----~~~~-~~~~~~---l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 241 KID------EEFCRRLKEGTR-----MRAP-DYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp CCS------HHHHHHHHHTCC-----CCCC-TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHH------HHHHHHHhcCCC-----CCCC-ccCCHH---HHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 322 112222222111 1111 123333 4558889999999999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.4e-49 Score=387.37 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=201.2
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC----e
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA----H 256 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~----~ 256 (521)
.++|++.+.||+|+||+||+|.+. +++.||||++.... ....+.+.+|+++|+.++||||+++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 357999999999999999999975 68899999997543 233467899999999999999999999987654 3
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.|||||||+||+|.+++... .++++..++.++.|++.||+|||++ +|+||||||+|||++.++.++|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 78999999999999998765 5799999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCc--ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 337 KLLGAERS--YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 337 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
+....... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+.+........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~~~~~~~- 231 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDP- 231 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCC-
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC------HHHHHHHHHhcCC-
Confidence 86543322 23345689999999999999999999999999999999999999996432 2333333333221
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhhc
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP-KMGHVIHMLEA 461 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RP-t~~evl~~L~~ 461 (521)
..+.......+..+ .+++.+||+.||++|| |++++++.|..
T Consensus 232 ---~~~~~~~~~~s~~l---~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 232 ---IPPSARHEGLSADL---DAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ---CCGGGTSSSCCHHH---HHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---CCCchhccCCCHHH---HHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 11111112233444 4478899999999999 89999888764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3e-49 Score=387.11 Aligned_cols=252 Identities=22% Similarity=0.328 Sum_probs=204.8
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh---------hHHHHHHHHHHHhcCC-CCCeeeEEEEEee
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ---------AEKEFKVEVEAIGRVR-HKNLVRLLGYCAE 253 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~ 253 (521)
.++|++.+.||+|+||+||+|++. +++.||||++...... ..+.+.+|+.+|++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 468999999999999999999974 6889999998654321 2245788999999997 9999999999999
Q ss_pred CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeec
Q 009979 254 GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDF 333 (521)
Q Consensus 254 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DF 333 (521)
++..|||||||++|+|.++++.. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CcceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccc
Confidence 99999999999999999999765 5799999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCcceeeccccccccccccccc------CCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHH
Q 009979 334 GLAKLLGAERSYVTTRVMGTFGYVAPEYAS------TGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKT 407 (521)
Q Consensus 334 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~ 407 (521)
|+++...... ..+...||+.|+|||++. ...++.++||||+||++|||+||+.||.... ..+..+.
T Consensus 155 G~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~------~~~~~~~ 226 (277)
T d1phka_ 155 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK------QMLMLRM 226 (277)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHH
T ss_pred hheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC------HHHHHHH
Confidence 9999875433 234568999999999874 3457889999999999999999999997432 2222222
Q ss_pred HhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 408 MVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 408 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
..... .. +..........++.+++.+||+.||++|||+.||+++
T Consensus 227 i~~~~-~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 227 IMSGN-YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHTC-CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhCC-CC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 22221 11 1111112223445568889999999999999998743
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=392.49 Aligned_cols=255 Identities=24% Similarity=0.378 Sum_probs=197.4
Q ss_pred CCCccccceEccCCcEEEEEEEEcC--C--cEEEEEEeccC---ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLED--N--TNVAVKNLLNN---RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
.++|++.+.||+|+||+||+|++.. + ..||||++.+. .....++|.+|+++|++++||||++++|+|.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 4579999999999999999998642 2 36899988654 23345789999999999999999999999976 467
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred heeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence 8999999999999988765 35699999999999999999999998 99999999999999999999999999999
Q ss_pred ecCCCCcce--eecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 338 LLGAERSYV--TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 338 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
......... .....||..|+|||++.+..++.++|||||||++|||+| |+.||... +..+.+..+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~------~~~~~~~~i~~~~~~ 233 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL------NGSQILHKIDKEGER 233 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHTSCCC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc------CHHHHHHHHHhCCCC
Confidence 875443322 234568889999999999999999999999999999998 89999633 333333444333211
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
+.. ...++.. +.+|+.+||+.||++||||.+|++.|+.
T Consensus 234 -----~~~-~~~~~~~---l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 234 -----LPR-PEDCPQD---IYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -----CCC-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCC-cccccHH---HHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111 1123444 4458889999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-50 Score=399.62 Aligned_cols=254 Identities=27% Similarity=0.458 Sum_probs=200.5
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCc----EEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNT----NVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~l 259 (521)
++|++.++||+|+||+||+|.+. +|+ +||+|++... .....++|.+|+++|++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999975 343 5889988653 334467899999999999999999999999875 5678
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
+|||+.+|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||||+.++++||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 89999999999988765 46799999999999999999999998 9999999999999999999999999999987
Q ss_pred CCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCCCcccHHHHHHHHhhccccccC
Q 009979 340 GAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV 417 (521)
Q Consensus 340 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (521)
...... ......||+.|+|||++.++.++.++|||||||++|||+| |..||...... .+...+. .+..
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~~i~----~~~~--- 231 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILE----KGER--- 231 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHHHHH----HTCC---
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHH----cCCC---
Confidence 543332 2344578999999999999999999999999999999999 78898754322 2222221 1110
Q ss_pred CCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 418 LDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 418 ~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
+.. +..++.. +.+|+.+||+.||++|||+.||++.|+..
T Consensus 232 --~~~-p~~~~~~---~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 232 --LPQ-PPICTID---VYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp --CCC-CTTBCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCC-CcccCHH---HHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 011 1223444 44588899999999999999999998753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=396.16 Aligned_cols=252 Identities=18% Similarity=0.267 Sum_probs=205.8
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
.++|++.+.||+|+||+||+|.+. +++.||||.+..... ....+.+|+++|+.++|||||++++++.+++.+||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999976 578899999876543 345688999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC--CCCceEeecccceecCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK--QWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~--~~~vkL~DFGla~~~~~ 341 (521)
|+||+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++. ...+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 9999999999765 34799999999999999999999999 9999999999999974 45799999999997644
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
.. ......||+.|+|||.+.+..|+.++|||||||++|||++|+.||.... ..+.+........ .
T Consensus 157 ~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~------~~~~~~~i~~~~~-------~ 221 (321)
T d1tkia_ 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET------NQQIIENIMNAEY-------T 221 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHTCC-------C
T ss_pred CC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCC-------C
Confidence 32 2344678999999999999999999999999999999999999996443 2222232222110 0
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
+..........++.+++.+||+.||++|||+.|++++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1100011122345568889999999999999999873
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=394.35 Aligned_cols=273 Identities=24% Similarity=0.421 Sum_probs=219.9
Q ss_pred cchhhhhhcCCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEE
Q 009979 176 YTLRELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLL 248 (521)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~ 248 (521)
|--++|++..++|++.+.||+|+||+||+|.+. +++.||||++.... ......|.+|++++++++|||||+++
T Consensus 10 ~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence 334567888899999999999999999999863 25689999996543 33345689999999999999999999
Q ss_pred EEEeeCCeeeEEEEeccCCchHHhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEe
Q 009979 249 GYCAEGAHRMLVYEYIDNGNLEQWLHGDV------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILL 322 (521)
Q Consensus 249 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl 322 (521)
++|..+...++|||||++|+|.++++... .....+++..+..++.|++.||.|||++ +|+||||||+|||+
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 166 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceee
Confidence 99999999999999999999999986431 2335679999999999999999999998 99999999999999
Q ss_pred CCCCCceEeecccceecCCCCcce-eecccccccccccccccCCCCCCcccchhHHHHHHHHHhCC-CCCCCCCCCCccc
Q 009979 323 DKQWNPKLSDFGLAKLLGAERSYV-TTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR-NPVDYSRPPGEVN 400 (521)
Q Consensus 323 ~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~-~Pf~~~~~~~~~~ 400 (521)
++++++||+|||+++.+....... .....||+.|+|||.+.++.++.++|||||||++|||+||. .||.. .+
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~------~~ 240 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG------LS 240 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT------SC
T ss_pred cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC------CC
Confidence 999999999999998764433322 33457899999999999999999999999999999999985 66643 23
Q ss_pred HHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhccCCCch
Q 009979 401 LVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAEEFPFR 467 (521)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 467 (521)
..+.+........ .+ . +..++.. +.+++.+||+.||++|||+.+|+++|+....+..
T Consensus 241 ~~~~~~~i~~~~~----~~--~-p~~~~~~---l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~ 297 (308)
T d1p4oa_ 241 NEQVLRFVMEGGL----LD--K-PDNCPDM---LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297 (308)
T ss_dssp HHHHHHHHHTTCC----CC--C-CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred HHHHHHHHHhCCC----CC--C-cccchHH---HHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 3444444333211 11 1 1123344 4458889999999999999999999998765553
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.6e-49 Score=398.96 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=200.1
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh---hhHHHH---HHHHHHHhcCCCCCeeeEEEEEeeCCee
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG---QAEKEF---KVEVEAIGRVRHKNLVRLLGYCAEGAHR 257 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~---~~Ei~~l~~l~hpniv~l~~~~~~~~~~ 257 (521)
.++|++.++||+|+||.||+|++. +|+.||||++.+... .....+ ..|+++++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 468999999999999999999976 589999999854321 112223 3457788888999999999999999999
Q ss_pred eEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccce
Q 009979 258 MLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAK 337 (521)
Q Consensus 258 ~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~ 337 (521)
|||||||+||+|.++|... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 83 ~ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceee
Confidence 9999999999999999765 5688999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccccc
Q 009979 338 LLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEG 416 (521)
Q Consensus 338 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (521)
.+.... ....+||+.|+|||++.. ..|+.++|||||||+||||+||+.||........ ....+ .....
T Consensus 156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~~~-~~~~~---- 224 (364)
T d1omwa3 156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDR-MTLTM---- 224 (364)
T ss_dssp ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---HHHHH-HSSSC----
T ss_pred ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH-hcccC----
Confidence 765432 345689999999999864 5689999999999999999999999976543322 11111 11111
Q ss_pred CCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 009979 417 VLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPK-----MGHVIHM 458 (521)
Q Consensus 417 ~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~evl~~ 458 (521)
...+.. ..+.. +.+|+.+||+.||++||| ++|++++
T Consensus 225 --~~~~~~-~~s~~---~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 225 --AVELPD-SFSPE---LRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp --CCCCCS-SSCHH---HHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred --CCCCCC-CCCHH---HHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 111111 12333 445888999999999999 6888754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=391.70 Aligned_cols=265 Identities=24% Similarity=0.348 Sum_probs=200.9
Q ss_pred CCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC----eeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA----HRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~----~~~lV~ 261 (521)
++|.+.+.||+|+||+||+|++ +|+.||||++.... ........|+..+..++|||||+++++|.+.. ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 3677889999999999999997 58899999985432 22222334555556789999999999997654 578999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL-----EPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-----~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
|||++|+|.++|++. .+++..++.++.|++.||+|||+.. +.+|+||||||+||||+.++++||+|||++
T Consensus 81 Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999864 5899999999999999999999631 349999999999999999999999999999
Q ss_pred eecCCCCcc---eeecccccccccccccccCCC------CCCcccchhHHHHHHHHHhCCCCCCCCCCCC---------c
Q 009979 337 KLLGAERSY---VTTRVMGTFGYVAPEYASTGM------LNERSDVYSFGILIMEVISGRNPVDYSRPPG---------E 398 (521)
Q Consensus 337 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~---------~ 398 (521)
+........ ......||+.|+|||++.+.. ++.++|||||||+||||+||..||....... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 987543322 234568999999999987643 6778999999999999999998875432111 1
Q ss_pred ccHHHHHHHHhhccccccCCCcccCCCc-cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 399 VNLVEWLKTMVTNRNAEGVLDPRLQEKP-CSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
... +........ ..++|.+.... .......+.+|+.+||+.||++|||+.||+++|+..
T Consensus 236 ~~~-~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 236 PSV-EEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCH-HHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred chH-HHHHHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 122 222222222 22333332221 334555677799999999999999999999999753
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-50 Score=397.81 Aligned_cols=264 Identities=24% Similarity=0.371 Sum_probs=212.1
Q ss_pred hhhhcCCCccccceEccCCcEEEEEEEEc------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcC-CCCCeeeEEEEE
Q 009979 180 ELEVSTNGFADENVIGEGGYGIVYHGVLE------DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRV-RHKNLVRLLGYC 251 (521)
Q Consensus 180 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~ 251 (521)
.+++..++|++.++||+|+||.||+|++. +++.||||++.... .....+|.+|+.+++.+ +|||||+++++|
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 35677889999999999999999999862 35679999997643 33446788999999999 699999999999
Q ss_pred eeCCeeeEEEEeccCCchHHhhhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 009979 252 AEGAHRMLVYEYIDNGNLEQWLHGDVG--------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKS 317 (521)
Q Consensus 252 ~~~~~~~lV~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~ 317 (521)
.+....+||||||++|+|.++++.... ....+++..+..++.|++.||+|||++ +|+||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence 999999999999999999999976532 234689999999999999999999999 999999999
Q ss_pred CCeEeCCCCCceEeecccceecCCCCc-ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhC-CCCCCCCCC
Q 009979 318 SNILLDKQWNPKLSDFGLAKLLGAERS-YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISG-RNPVDYSRP 395 (521)
Q Consensus 318 ~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG-~~Pf~~~~~ 395 (521)
+|||++.++.+||+|||+++....... ...+...||+.|+|||++.++.++.++|||||||++|||+|+ ..||.....
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999998754433 333457899999999999999999999999999999999995 444543322
Q ss_pred CCcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 396 PGEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
. +.+...+..+. .+.. +...+. .+.+|+.+||+.||++||||.+|+++|+.
T Consensus 254 ~------~~~~~~i~~~~-----~~~~-~~~~~~---~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 254 D------SKFYKMIKEGF-----RMLS-PEHAPA---EMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp S------HHHHHHHHHTC-----CCCC-CTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H------HHHHHHHhcCC-----CCCC-cccccH---HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1 11222222211 1111 112333 34558889999999999999999999975
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-49 Score=401.82 Aligned_cols=245 Identities=21% Similarity=0.261 Sum_probs=205.0
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~ 261 (521)
++|++.+.||+|+||.||+|++. +|+.||||++.+.. ....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999975 68999999986432 233467889999999999999999999999999999999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGA 341 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~ 341 (521)
||+.+|+|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+||||+.++++||+|||+|+.+..
T Consensus 121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999999765 4789999999999999999999999 999999999999999999999999999998643
Q ss_pred CCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCcc
Q 009979 342 ERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDPR 421 (521)
Q Consensus 342 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 421 (521)
. .....||+.|||||++.+..++.++|||||||++|||+||+.||... +............ +.
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~------~~~~~~~~i~~~~-------~~ 256 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD------QPIQIYEKIVSGK-------VR 256 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCC-------CC
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc------CHHHHHHHHhcCC-------CC
Confidence 2 23468999999999999999999999999999999999999999643 2233333333221 01
Q ss_pred cCCCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 009979 422 LQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIHM 458 (521)
Q Consensus 422 l~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~~ 458 (521)
+.. ..+. ++.+++.+||+.||.+|+ |+.+++++
T Consensus 257 ~p~-~~s~---~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 257 FPS-HFSS---DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCT-TCCH---HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCc-cCCH---HHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 111 1233 344588899999999994 89999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=393.10 Aligned_cols=263 Identities=26% Similarity=0.431 Sum_probs=207.9
Q ss_pred hhhcCCCccccceEccCCcEEEEEEEEcC--------CcEEEEEEeccCCh-hhHHHHHHHHHHHhcC-CCCCeeeEEEE
Q 009979 181 LEVSTNGFADENVIGEGGYGIVYHGVLED--------NTNVAVKNLLNNRG-QAEKEFKVEVEAIGRV-RHKNLVRLLGY 250 (521)
Q Consensus 181 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~hpniv~l~~~ 250 (521)
++++.++|++.+.||+|+||.||+|++.. +..||||++..... ....++..|+..+.++ +|||||+++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 56778899999999999999999998542 24699999876543 3347788899999888 79999999999
Q ss_pred EeeCCeeeEEEEeccCCchHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 009979 251 CAEGAHRMLVYEYIDNGNLEQWLHGDVG------------PHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSS 318 (521)
Q Consensus 251 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~ 318 (521)
|.++...++|||||++|+|.++|+.... ....+++..++.++.|++.||+|||+. +|+||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccc
Confidence 9999999999999999999999976532 235689999999999999999999999 9999999999
Q ss_pred CeEeCCCCCceEeecccceecCCCCcc-eeecccccccccccccccCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCCC
Q 009979 319 NILLDKQWNPKLSDFGLAKLLGAERSY-VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVIS-GRNPVDYSRPP 396 (521)
Q Consensus 319 NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~ellt-G~~Pf~~~~~~ 396 (521)
|||++.++.+||+|||+++........ ......||+.|+|||.+.++.|+.++|||||||++|||+| |..||.....
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~- 243 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 243 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-
Confidence 999999999999999999977543322 2344678999999999999999999999999999999998 7888864332
Q ss_pred CcccHHHHHHHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 397 GEVNLVEWLKTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
.+ +...+..+. .+... ..++.. +.+|+.+||+.||++|||+.||+++|+..
T Consensus 244 -----~~-~~~~i~~~~-----~~~~p-~~~~~~---l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 244 -----EE-LFKLLKEGH-----RMDKP-SNCTNE---LYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp -----HH-HHHHHHTTC-----CCCCC-SSCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HH-HHHHHHcCC-----CCCCC-ccchHH---HHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 12 222222221 11111 123344 44588899999999999999999999753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-49 Score=390.29 Aligned_cols=252 Identities=29% Similarity=0.464 Sum_probs=201.2
Q ss_pred ccceEccCCcEEEEEEEEcCC----cEEEEEEeccC-ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEee-CCeeeEEEEe
Q 009979 190 DENVIGEGGYGIVYHGVLEDN----TNVAVKNLLNN-RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE-GAHRMLVYEY 263 (521)
Q Consensus 190 ~~~~LG~G~fG~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~-~~~~~lV~e~ 263 (521)
+.++||+|+||+||+|.+.++ ..||||++... .....+.|.+|+++|++++||||++++|++.+ +...++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 367899999999999997532 25899998643 44455789999999999999999999999875 4578999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
|++|+|.++++.. ...+++..++.++.|++.||.|||+. +|+||||||+||||++++.+||+|||+++......
T Consensus 111 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 111 MKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred eecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999999865 45778899999999999999999998 99999999999999999999999999999765432
Q ss_pred cc---eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 344 SY---VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 344 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
.. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||.... +..++......... ...
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~-----~~~~~~~~i~~g~~---~~~- 255 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----NTFDITVYLLQGRR---LLQ- 255 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTTCC---CCC-
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHcCCC---CCC-
Confidence 22 2233578999999999999999999999999999999999888875332 12222222222211 111
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
+..++.. +.+|+.+||+.||++||+|.||+++|+..
T Consensus 256 ---p~~~~~~---l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 256 ---PEYCPDP---LYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp ---CTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cccCcHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1223444 44588899999999999999999999865
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-49 Score=394.60 Aligned_cols=252 Identities=21% Similarity=0.274 Sum_probs=198.3
Q ss_pred CCccccc-eEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhc-CCCCCeeeEEEEEee----CCeee
Q 009979 186 NGFADEN-VIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGR-VRHKNLVRLLGYCAE----GAHRM 258 (521)
Q Consensus 186 ~~~~~~~-~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~-l~hpniv~l~~~~~~----~~~~~ 258 (521)
++|.+.+ .||+|+||+||+|++. +++.||||++... ..+.+|++++.+ .+|||||+++++|.+ +..+|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 4788765 6999999999999974 6889999998542 456779988655 589999999999865 46789
Q ss_pred EEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC---CCCceEeeccc
Q 009979 259 LVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK---QWNPKLSDFGL 335 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~---~~~vkL~DFGl 335 (521)
||||||+||+|.++|.... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++ .+.+||+|||+
T Consensus 86 ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence 9999999999999998642 35799999999999999999999999 9999999999999975 56799999999
Q ss_pred ceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccc
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAE 415 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (521)
++...... .....+||+.|+|||++.+..|+.++|||||||+||||+||+.||......... ..+......
T Consensus 161 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~~---- 231 (335)
T d2ozaa1 161 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRM---- 231 (335)
T ss_dssp CEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCS----
T ss_pred eeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHHHHhc----
Confidence 99765433 234568999999999999999999999999999999999999999755432111 111110000
Q ss_pred cCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 416 GVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 416 ~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
....+..........++.+|+.+||+.||++|||+.|++++
T Consensus 232 --~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 232 --GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp --CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 01111222223334556678899999999999999999873
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=393.13 Aligned_cols=258 Identities=24% Similarity=0.400 Sum_probs=202.8
Q ss_pred cCCCccccceEccCCcEEEEEEEEcC-Cc--EEEEEEeccC-ChhhHHHHHHHHHHHhcC-CCCCeeeEEEEEeeCCeee
Q 009979 184 STNGFADENVIGEGGYGIVYHGVLED-NT--NVAVKNLLNN-RGQAEKEFKVEVEAIGRV-RHKNLVRLLGYCAEGAHRM 258 (521)
Q Consensus 184 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~hpniv~l~~~~~~~~~~~ 258 (521)
..++|++.++||+|+||+||+|.+.+ +. .||||++... .....+.|.+|+++|+++ +|||||+++|+|.++...+
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 34688899999999999999999753 44 4778887543 333456799999999999 7999999999999999999
Q ss_pred EEEEeccCCchHHhhhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC
Q 009979 259 LVYEYIDNGNLEQWLHGDV------------GPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW 326 (521)
Q Consensus 259 lV~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~ 326 (521)
+||||+++|+|.++|+... .....+++..++.++.|++.||.|||+. +|+||||||+|||++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCC
Confidence 9999999999999997642 2346799999999999999999999999 999999999999999999
Q ss_pred CceEeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCC-CCCCCCCCCCcccHHHHH
Q 009979 327 NPKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGR-NPVDYSRPPGEVNLVEWL 405 (521)
Q Consensus 327 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~-~Pf~~~~~~~~~~~~~~~ 405 (521)
.+||+|||+++..... .......||..|+|||.+.++.++.++|||||||++|||++|. .||... +..+..
T Consensus 165 ~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~------~~~~~~ 236 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM------TCAELY 236 (309)
T ss_dssp CEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHH
T ss_pred ceEEcccccccccccc--ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC------CHHHHH
Confidence 9999999999865322 2223456899999999999999999999999999999999976 466433 222322
Q ss_pred HHHhhccccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhcc
Q 009979 406 KTMVTNRNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEAE 462 (521)
Q Consensus 406 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~~ 462 (521)
..... +. .+... ..++..+. +|+.+||+.||++||||.||++.|+..
T Consensus 237 ~~i~~-~~-----~~~~~-~~~~~~~~---~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 237 EKLPQ-GY-----RLEKP-LNCDDEVY---DLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HHGGG-TC-----CCCCC-TTBCHHHH---HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHh-cC-----CCCCC-ccCCHHHH---HHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 22222 11 11111 12344444 488899999999999999999998764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=397.74 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=201.3
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC---hhhHHHHHHHHHHHh-cCCCCCeeeEEEEEeeCCeeeEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR---GQAEKEFKVEVEAIG-RVRHKNLVRLLGYCAEGAHRMLV 260 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~-~l~hpniv~l~~~~~~~~~~~lV 260 (521)
++|++.+.||+|+||+||+|++. +++.||||++.+.. ....+.+..|..++. .++|||||++++++.++...|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999976 68889999996532 223345666776654 68999999999999999999999
Q ss_pred EEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecC
Q 009979 261 YEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~ 340 (521)
||||++|+|.++++.. ..+++..++.++.|++.||+|||++ +|+||||||+|||+++++++||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 9999999999999865 5689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCCc
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLDP 420 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 420 (521)
... ...+...||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+........ .+
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~-------~~ 220 (320)
T d1xjda_ 155 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD------EEELFHSIRMD-------NP 220 (320)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHC-------CC
T ss_pred ccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC------HHHHHHHHHcC-------CC
Confidence 332 33455689999999999999999999999999999999999999997432 12222222211 11
Q ss_pred ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 009979 421 RLQEKPCSRALKRALLVALRCVDPNAHKRPKMG-HVIH 457 (521)
Q Consensus 421 ~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~-evl~ 457 (521)
.+.. ..+.. +.+|+.+||+.||++||++. ++++
T Consensus 221 ~~p~-~~s~~---~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 FYPR-WLEKE---AKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCT-TSCHH---HHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCc-cCCHH---HHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1111 12333 45588899999999999985 6654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=386.64 Aligned_cols=257 Identities=23% Similarity=0.281 Sum_probs=194.3
Q ss_pred ccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh-----hHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 190 DENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ-----AEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 190 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
.+++||+|+||+||+|++. +|+.||||++...... ..+.+.+|+++|++++|||||++++++.++++.||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999965 6889999998654322 134688999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+.++++..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9988777665433 5788899999999999999999999 99999999999999999999999999998764433
Q ss_pred cceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccCCC---
Q 009979 344 SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGVLD--- 419 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--- 419 (521)
. .....+||+.|+|||++.. ..|+.++|||||||++|||+||+.||..... .+....+.+...........+
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~---~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 155 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred c-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH---HHHHHHHHHhcCCCChhhccchhc
Confidence 2 2344679999999998865 4689999999999999999999999964321 111111212111100000000
Q ss_pred -------cccCCCcc----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 420 -------PRLQEKPC----SRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 420 -------~~l~~~~~----~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
......+. ......+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00011100 112245667889999999999999999985
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-48 Score=380.97 Aligned_cols=264 Identities=22% Similarity=0.356 Sum_probs=198.7
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
++|++.+.||+|+||+||+|++. +++.||||++..... ...+.+.+|+++|++++|||||++++++.++.+.|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999974 689999999965432 235778899999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
|+.+ ++.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++++||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9975 555555433 246799999999999999999999999 9999999999999999999999999999876443
Q ss_pred CcceeecccccccccccccccCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccc-----ccc
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN-----AEG 416 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~ 416 (521)
. .......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+.. ..+............ ...
T Consensus 156 ~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 156 V-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp S-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH--HHHHHHHHhcCCCchhhcccccc
Confidence 2 2334467999999999876655 588999999999999999999999644211 111111111100000 000
Q ss_pred C--CCc---ccCCCc----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 417 V--LDP---RLQEKP----CSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 417 ~--~d~---~l~~~~----~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
. ... ...... ......++.+|+.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 000 000110 11122455668889999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-47 Score=377.42 Aligned_cols=261 Identities=20% Similarity=0.317 Sum_probs=198.9
Q ss_pred CCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCCh--hhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEEe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG--QAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e~ 263 (521)
++|++.++||+|+||+||+|++++++.||||++..... ...+.+.+|+.+|++++|||||++++++.+++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 58999999999999999999999899999999965432 2347889999999999999999999999999999999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCCC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAER 343 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~~ 343 (521)
+.++.+..+.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9876666665443 6799999999999999999999998 99999999999999999999999999998764432
Q ss_pred cceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccccccC-----
Q 009979 344 SYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNAEGV----- 417 (521)
Q Consensus 344 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 417 (521)
.......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...................
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH---HHHHHHHHHhhCCCChhhccchhh
Confidence 22344568999999998865 5679999999999999999999999964431 1111111111111000000
Q ss_pred ---CCcccC---C----CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 418 ---LDPRLQ---E----KPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 418 ---~d~~l~---~----~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
.+..+. . .........+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 0 001112234556888999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=380.73 Aligned_cols=240 Identities=25% Similarity=0.420 Sum_probs=195.0
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChh------hHHHHHHHHHHHhcCC--CCCeeeEEEEEeeCCe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQ------AEKEFKVEVEAIGRVR--HKNLVRLLGYCAEGAH 256 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~--hpniv~l~~~~~~~~~ 256 (521)
++|++.+.||+|+||+||+|++. +++.||||++.+.... ....+.+|+.+|++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999975 6899999998653211 1234667999999986 8999999999999999
Q ss_pred eeEEEEeccC-CchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-CCCceEeecc
Q 009979 257 RMLVYEYIDN-GNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-QWNPKLSDFG 334 (521)
Q Consensus 257 ~~lV~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~-~~~vkL~DFG 334 (521)
.++||||+.+ +++.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 6888888764 5799999999999999999999999 9999999999999985 5789999999
Q ss_pred cceecCCCCcceeecccccccccccccccCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhccc
Q 009979 335 LAKLLGAERSYVTTRVMGTFGYVAPEYASTGML-NERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRN 413 (521)
Q Consensus 335 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 413 (521)
+++..... ..+...||+.|+|||++.+..+ +.++|||||||++|||+||+.||.... + .....
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~----i~~~~- 220 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------E----IIRGQ- 220 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H----HHHCC-
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------H----Hhhcc-
Confidence 99875432 2345689999999999977665 677999999999999999999996321 1 11110
Q ss_pred cccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 414 AEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 414 ~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
. .+... .+.. +.+++.+||+.||++|||+.|++++
T Consensus 221 --~----~~~~~-~s~~---~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 --V----FFRQR-VSSE---CQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --C----CCSSC-CCHH---HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --c----CCCCC-CCHH---HHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1 11111 2333 4458889999999999999999863
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-47 Score=376.85 Aligned_cols=263 Identities=25% Similarity=0.325 Sum_probs=194.3
Q ss_pred CCCccccceEccCCcEEEEEEEEc-C-CcEEEEEEeccCCh--hhHHHHHHHHHHHhcC---CCCCeeeEEEEEee----
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-D-NTNVAVKNLLNNRG--QAEKEFKVEVEAIGRV---RHKNLVRLLGYCAE---- 253 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~hpniv~l~~~~~~---- 253 (521)
.++|++.+.||+|+||+||+|++. + ++.||||++..... .....+.+|+.+|+.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 368999999999999999999974 4 55689999864322 2223455677776655 79999999999853
Q ss_pred -CCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEee
Q 009979 254 -GAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSD 332 (521)
Q Consensus 254 -~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~D 332 (521)
....+++|||++++++....... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 34678999999987776554443 46789999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcc
Q 009979 333 FGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNR 412 (521)
Q Consensus 333 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 412 (521)
||+++..... .......||+.|+|||++.+..|+.++|||||||++|||+||+.||..... ......+.......
T Consensus 160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLP 234 (305)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCC
T ss_pred hhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhhCCC
Confidence 9999865332 234557899999999999999999999999999999999999999974432 11111111111100
Q ss_pred ccccC----------CCcccC---CCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 413 NAEGV----------LDPRLQ---EKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 413 ~~~~~----------~d~~l~---~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
..... ...... ..........+.+|+.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 000000 00011112344558889999999999999999753
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-45 Score=365.66 Aligned_cols=258 Identities=19% Similarity=0.221 Sum_probs=196.0
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCC-eeeEEEEEeeCCeeeEEEEe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKN-LVRLLGYCAEGAHRMLVYEY 263 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpn-iv~l~~~~~~~~~~~lV~e~ 263 (521)
++|++.+.||+|+||+||+|++. +++.||||.+..... ...+..|+++++.++|+| |+.+.+++.++...++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 47999999999999999999975 588999998765432 245788999999998766 55556666788888999999
Q ss_pred ccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeC---CCCCceEeecccceecC
Q 009979 264 IDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLD---KQWNPKLSDFGLAKLLG 340 (521)
Q Consensus 264 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~---~~~~vkL~DFGla~~~~ 340 (521)
+ +++|.+.+... ...+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+.+.
T Consensus 85 ~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 85 L-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp C-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred c-CCchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9 45777766554 35799999999999999999999999 999999999999985 45679999999999875
Q ss_pred CCCcc------eeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 341 AERSY------VTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 341 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
..... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 43321 234567999999999999999999999999999999999999999765543332222211111100000
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
+.+. ..++. ++.+++.+||+.||++||++.++.+.|+.
T Consensus 238 -----~~~~-~~~p~---~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 238 -----EVLC-KGYPS---EFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp -----HHHT-TTSCH---HHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred -----hHhc-cCCCH---HHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 0011 11333 34458889999999999999999888764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=371.87 Aligned_cols=263 Identities=19% Similarity=0.273 Sum_probs=195.0
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEee--------C
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE--------G 254 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~--------~ 254 (521)
++|++.+.||+|+||+||+|++. +|+.||||++... .......+.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 58999999999999999999975 6899999998543 23344678899999999999999999998855 3
Q ss_pred CeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecc
Q 009979 255 AHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFG 334 (521)
Q Consensus 255 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFG 334 (521)
...++||||+.++.+..+... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 457899999987666654433 35788999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCcc---eeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhh
Q 009979 335 LAKLLGAERSY---VTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVT 410 (521)
Q Consensus 335 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 410 (521)
+++.+...... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~---~~~~~~i~~~~~ 239 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE---QHQLALISQLCG 239 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH---HHHHHHHHHhcC
Confidence 99876533221 12335799999999998755 689999999999999999999999964321 111122222211
Q ss_pred cccc---ccCC--------C-cccCCCccHHH------HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 411 NRNA---EGVL--------D-PRLQEKPCSRA------LKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 411 ~~~~---~~~~--------d-~~l~~~~~~~~------~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.... .... . ........... ...+++|+.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 1000 0000 0 00000111111 2245668999999999999999999854
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.8e-45 Score=363.51 Aligned_cols=259 Identities=17% Similarity=0.205 Sum_probs=205.7
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCC-CCeeeEEEEEeeCCeeeEEEE
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRH-KNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-pniv~l~~~~~~~~~~~lV~e 262 (521)
.++|++.+.||+|+||+||+|++. +++.||||.+.... ....+..|+++++.++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999975 58899999875432 23457779999999975 899999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCC-----CCCceEeecccce
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDK-----QWNPKLSDFGLAK 337 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~-----~~~vkL~DFGla~ 337 (521)
|+ +++|.++++.. ...++...+..++.|++.||+|||++ +|+||||||+|||++. .+.+||+|||+|+
T Consensus 82 ~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 67999998765 35789999999999999999999999 9999999999999964 5779999999999
Q ss_pred ecCCCCc------ceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhc
Q 009979 338 LLGAERS------YVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN 411 (521)
Q Consensus 338 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 411 (521)
.+..... .......||+.|||||.+.+..++.++|||||||++|||+||+.||..............+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 8643321 1233467999999999999999999999999999999999999999866554443333222221111
Q ss_pred cccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhc
Q 009979 412 RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHMLEA 461 (521)
Q Consensus 412 ~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~L~~ 461 (521)
.... .+. ..++.. +..++..|++.+|++||+++.+.+.|+.
T Consensus 235 ~~~~-----~l~-~~~p~~---l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 235 TPLR-----ELC-AGFPEE---FYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp SCHH-----HHT-TTSCHH---HHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred CChH-----Hhc-CCCCHH---HHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1100 111 112333 4457789999999999999998887764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=376.18 Aligned_cols=260 Identities=25% Similarity=0.307 Sum_probs=190.9
Q ss_pred CccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC------CeeeE
Q 009979 187 GFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG------AHRML 259 (521)
Q Consensus 187 ~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~------~~~~l 259 (521)
+|+..++||+|+||+||+|++. +++.||||++...... +.+|+++|++++||||++++++|... .+.+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888999999999999999975 5889999999765432 34699999999999999999998543 35789
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC-CceEeeccccee
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKL 338 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~-~vkL~DFGla~~ 338 (521)
|||||+++.+..+.+ .......+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 999998754443332 112346799999999999999999999998 999999999999999765 899999999997
Q ss_pred cCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH-------hh
Q 009979 339 LGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM-------VT 410 (521)
Q Consensus 339 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~-------~~ 410 (521)
...... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+..+++.. +.
T Consensus 173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~--~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 173 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--HHHHHHHHHHCCCCHHHHH
T ss_pred ccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH--HHHHHHHHHhCCChHHhhh
Confidence 654332 334579999999998764 57899999999999999999999999644311 1111111100 00
Q ss_pred --ccccccCCCcccCC-----CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 411 --NRNAEGVLDPRLQE-----KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 411 --~~~~~~~~d~~l~~-----~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
........-+.... ........++.+|+.+||+.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000011100 0011122345568889999999999999999853
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-46 Score=374.35 Aligned_cols=262 Identities=22% Similarity=0.332 Sum_probs=194.6
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC----eeeE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR-GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA----HRML 259 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~----~~~l 259 (521)
.+|++.+.||+|+||+||+|++. +++.||||++.+.. ....+.+.+|+++|+.++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 47999999999999999999964 78999999996543 334567889999999999999999999987643 2345
Q ss_pred EEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceec
Q 009979 260 VYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLL 339 (521)
Q Consensus 260 V~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~ 339 (521)
+++|+.+|+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 88 l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 55667799999999753 689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcc--eeecccccccccccccc-cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc--
Q 009979 340 GAERSY--VTTRVMGTFGYVAPEYA-STGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA-- 414 (521)
Q Consensus 340 ~~~~~~--~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-- 414 (521)
...... .....+||+.|+|||++ .+..++.++||||+||++|||++|+.||........ .............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQED 236 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH---HHHHhhhccCCChhh
Confidence 443222 23456799999999988 455678999999999999999999999965432111 1100000000000
Q ss_pred -----------ccCCCcccCCCcc----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 415 -----------EGVLDPRLQEKPC----SRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 415 -----------~~~~d~~l~~~~~----~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
.....+.....+. +....++.+|+.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000001 1112345668899999999999999999854
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=371.51 Aligned_cols=252 Identities=24% Similarity=0.318 Sum_probs=202.4
Q ss_pred CCccccceEccCCcEEEEEEEEc----CCcEEEEEEeccCC----hhhHHHHHHHHHHHhcCCC-CCeeeEEEEEeeCCe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE----DNTNVAVKNLLNNR----GQAEKEFKVEVEAIGRVRH-KNLVRLLGYCAEGAH 256 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h-pniv~l~~~~~~~~~ 256 (521)
++|++.+.||+|+||+||+|... +|+.||||.+.... ....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 57999999999999999999852 47889999986432 2234567889999999976 899999999999999
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.++||||+.+|+|.+++... ..+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999999876 4678899999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcceeecccccccccccccccCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTG--MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA 414 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 414 (521)
+.+............||+.|+|||.+.+. .++.++|||||||+||||+||+.||........ .....+......
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~--~~~i~~~~~~~~-- 252 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE-- 252 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHCC--
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcccCC--
Confidence 98765555555667899999999998654 478899999999999999999999976644332 222222222111
Q ss_pred ccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 009979 415 EGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRP-----KMGHVIH 457 (521)
Q Consensus 415 ~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~evl~ 457 (521)
+.+.. ..+. ++.+++.+||+.||++|| |++|+++
T Consensus 253 -----~~~~~-~~s~---~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 -----PPYPQ-EMSA---LAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -----CCCCT-TSCH---HHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----CCCcc-cCCH---HHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11111 1233 444588899999999999 4788875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-45 Score=358.68 Aligned_cols=263 Identities=20% Similarity=0.279 Sum_probs=203.4
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCCeeeEEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGAHRMLVYE 262 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~~~~lV~e 262 (521)
++|++.++||+|+||+||+|++. +++.||||++.... ......+.+|+.+|+.++||||+++++++.+....++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999975 68889999986543 2345788899999999999999999999999999999999
Q ss_pred eccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccceecCCC
Q 009979 263 YIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLAKLLGAE 342 (521)
Q Consensus 263 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla~~~~~~ 342 (521)
++.+++|..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 99999998887654 5788999999999999999999998 9999999999999999999999999999987543
Q ss_pred CcceeecccccccccccccccCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc------c
Q 009979 343 RSYVTTRVMGTFGYVAPEYASTGM-LNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA------E 415 (521)
Q Consensus 343 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------~ 415 (521)
.. ......+++.|+|||.+.... ++.++|||||||++|||++|+.||..... .......+......... .
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhhhh
Confidence 32 233456788999999887654 68999999999999999999999853321 11222222221111000 0
Q ss_pred cCCC---------cccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 416 GVLD---------PRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 416 ~~~d---------~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
...+ ..-...........+.+|+.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 000000111222345568889999999999999999753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-45 Score=369.33 Aligned_cols=257 Identities=22% Similarity=0.324 Sum_probs=192.2
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeCC------
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN--RGQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEGA------ 255 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~~------ 255 (521)
.++|++.+.||+|+||+||+|.+. +++.||||++... .....+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 568999999999999999999975 5899999998653 2233467889999999999999999999997654
Q ss_pred eeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeeccc
Q 009979 256 HRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGL 335 (521)
Q Consensus 256 ~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGl 335 (521)
+.|+||||+ +.+|..+++. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 469999999 6688887764 3699999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcceeecccccccccccccccC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhc---
Q 009979 336 AKLLGAERSYVTTRVMGTFGYVAPEYAST-GMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTN--- 411 (521)
Q Consensus 336 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--- 411 (521)
++..... .+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ............
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKVTGTPPA 240 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCH
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH---HHHHHHHhccCCCcH
Confidence 9976432 345679999999998865 46789999999999999999999999654311 111111100000
Q ss_pred ---------------cccccCCCcccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 412 ---------------RNAEGVLDPRLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 412 ---------------~~~~~~~d~~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
..........+... .......+.+|+.+||..||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASI-LTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGT-CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhcchhhhhhhccCCcccccchHHh-ccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000000000 01112344568889999999999999999874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.4e-44 Score=361.38 Aligned_cols=255 Identities=20% Similarity=0.288 Sum_probs=194.8
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeC--CeeeEEE
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEG--AHRMLVY 261 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~--~~~~lV~ 261 (521)
++|++.++||+|+||+||+|++. +++.||||++.... .+.+.+|+++|+.++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999974 68889999986533 457888999999995 99999999998743 4689999
Q ss_pred EeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCC-CceEeecccceecC
Q 009979 262 EYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQW-NPKLSDFGLAKLLG 340 (521)
Q Consensus 262 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~-~vkL~DFGla~~~~ 340 (521)
|||.+++|..+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+|+...
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence 999999998764 3589999999999999999999999 999999999999998655 59999999999765
Q ss_pred CCCcceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHH---------hh
Q 009979 341 AERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTM---------VT 410 (521)
Q Consensus 341 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~---------~~ 410 (521)
.... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||....... .....+... ..
T Consensus 182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~--~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 182 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHH
T ss_pred CCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH--HHHHHHHHHHCCchhhhhhh
Confidence 4332 3456799999999997664 57999999999999999999999997543211 111001100 00
Q ss_pred ccc------cccCCCc--------ccCCCccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 009979 411 NRN------AEGVLDP--------RLQEKPCSRALKRALLVALRCVDPNAHKRPKMGHVIH 457 (521)
Q Consensus 411 ~~~------~~~~~d~--------~l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~ 457 (521)
... ....... ............++.+|+.+||..||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000000 0011111122345667889999999999999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=358.40 Aligned_cols=258 Identities=24% Similarity=0.286 Sum_probs=188.8
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEee------CCe
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAE------GAH 256 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~------~~~ 256 (521)
++|++.++||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.+|++++|||||+++++|.. ..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999976 58999999997543 3344678899999999999999999999963 367
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.|+|||||.++ +.+.+. ..+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 89999999764 445443 3578999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHH-----------
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWL----------- 405 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~----------- 405 (521)
+..... ...+...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~---~~~~~~i~~~~~~~~~~~ 241 (355)
T d2b1pa1 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTPCPEF 241 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCHHH
T ss_pred hccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH---HHHHHHHHHhccCCCHHH
Confidence 875432 234556799999999999999999999999999999999999999964321 1111100
Q ss_pred --------HHHhhccc-cc-----cCCCccc-CC--CccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 406 --------KTMVTNRN-AE-----GVLDPRL-QE--KPCSRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 406 --------~~~~~~~~-~~-----~~~d~~l-~~--~~~~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
........ .. ....... .. .........+.+|+.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00011000 00 0000000 00 0122345567789999999999999999999844
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=359.60 Aligned_cols=258 Identities=22% Similarity=0.305 Sum_probs=192.9
Q ss_pred CCCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhcCCCCCeeeEEEEEeeC-----Ce
Q 009979 185 TNGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNR--GQAEKEFKVEVEAIGRVRHKNLVRLLGYCAEG-----AH 256 (521)
Q Consensus 185 ~~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~hpniv~l~~~~~~~-----~~ 256 (521)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++|+.++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999975 68999999987543 23446788999999999999999999998643 34
Q ss_pred eeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCceEeecccc
Q 009979 257 RMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPKLSDFGLA 336 (521)
Q Consensus 257 ~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vkL~DFGla 336 (521)
.+++|+|+.+|+|.++++. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 4677788889999999864 3699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcceeecccccccccccccccCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHHHHHHHhhcccc-
Q 009979 337 KLLGAERSYVTTRVMGTFGYVAPEYASTG-MLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVEWLKTMVTNRNA- 414 (521)
Q Consensus 337 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~- 414 (521)
..... ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...+. ......+.........
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~---~~~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGTPGAE 241 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCHH
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCChH
Confidence 86432 23446799999999986654 568999999999999999999999964421 1111111111100000
Q ss_pred -------------ccCCCcccCCCcc----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 009979 415 -------------EGVLDPRLQEKPC----SRALKRALLVALRCVDPNAHKRPKMGHVIHM 458 (521)
Q Consensus 415 -------------~~~~d~~l~~~~~----~~~~~~~~~li~~cl~~dP~~RPt~~evl~~ 458 (521)
...+ +....... ......+.+|+.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 242 LLKKISSESARNYIQSL-TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHTTCCCHHHHHHHTTS-CCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred Hhhhccchhhhhhhhhc-ccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000 00000000 0112345568889999999999999999853
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.1e-39 Score=326.47 Aligned_cols=263 Identities=19% Similarity=0.209 Sum_probs=190.3
Q ss_pred CCccccceEccCCcEEEEEEEEc-CCcEEEEEEeccCChhhHHHHHHHHHHHhcCC-----------CCCeeeEEEEEee
Q 009979 186 NGFADENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-----------HKNLVRLLGYCAE 253 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------hpniv~l~~~~~~ 253 (521)
++|++.++||+|+||+||+|+.. +|+.||||++.+... ..+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 46999999999999999999975 689999999875432 3456778999888775 5789999998764
Q ss_pred C--CeeeEEEEeccCCchHHh-hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCCeEeCCCCC--
Q 009979 254 G--AHRMLVYEYIDNGNLEQW-LHGDVGPHSPLTWEIRMNIILGTAKGLTYLHE-GLEPKVVHRDIKSSNILLDKQWN-- 327 (521)
Q Consensus 254 ~--~~~~lV~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~-~~~~~iiHrDik~~NILl~~~~~-- 327 (521)
. ...+++|+++..+..... .... ....+++..+..++.|++.||+|||+ . +|+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred ccccceeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence 3 456677777655443332 2222 34678899999999999999999998 5 9999999999999976554
Q ss_pred ----ceEeecccceecCCCCcceeecccccccccccccccCCCCCCcccchhHHHHHHHHHhCCCCCCCCCCCCcccHHH
Q 009979 328 ----PKLSDFGLAKLLGAERSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGILIMEVISGRNPVDYSRPPGEVNLVE 403 (521)
Q Consensus 328 ----vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS~Gvvl~elltG~~Pf~~~~~~~~~~~~~ 403 (521)
+|++|||.+...... ....+||+.|+|||++.+..++.++||||+||+++||++|+.||............+
T Consensus 167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 999999999865332 245679999999999999999999999999999999999999997554332222222
Q ss_pred HHHHHhh-----------c----------cccccCCCc-c---------cCCCccHHHHHHHHHHHHhccCCCCCCCCCH
Q 009979 404 WLKTMVT-----------N----------RNAEGVLDP-R---------LQEKPCSRALKRALLVALRCVDPNAHKRPKM 452 (521)
Q Consensus 404 ~~~~~~~-----------~----------~~~~~~~d~-~---------l~~~~~~~~~~~~~~li~~cl~~dP~~RPt~ 452 (521)
.+...+. . ......+.. . ............+.+|+.+||+.||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 2111110 0 000000000 0 0112234566678889999999999999999
Q ss_pred HHHHHH
Q 009979 453 GHVIHM 458 (521)
Q Consensus 453 ~evl~~ 458 (521)
.|++++
T Consensus 323 ~e~L~H 328 (362)
T d1q8ya_ 323 GGLVNH 328 (362)
T ss_dssp HHHHTC
T ss_pred HHHhcC
Confidence 999843
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=7e-25 Score=201.30 Aligned_cols=164 Identities=18% Similarity=0.155 Sum_probs=121.5
Q ss_pred ccccceEccCCcEEEEEEEEcCCcEEEEEEeccCCh------------------hhHHHHHHHHHHHhcCCCCCeeeEEE
Q 009979 188 FADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRG------------------QAEKEFKVEVEAIGRVRHKNLVRLLG 249 (521)
Q Consensus 188 ~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~hpniv~l~~ 249 (521)
+.+.++||+|+||+||+|.+.+|+.||||++..... ........|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 356789999999999999988899999998743211 01133456888999999999999887
Q ss_pred EEeeCCeeeEEEEeccCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeEeCCCCCce
Q 009979 250 YCAEGAHRMLVYEYIDNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGLEPKVVHRDIKSSNILLDKQWNPK 329 (521)
Q Consensus 250 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~~~~iiHrDik~~NILl~~~~~vk 329 (521)
+.. .++||||+++..+.++ +......++.|++.+|+|||++ +|+||||||+|||+++++ ++
T Consensus 82 ~~~----~~lvme~~~~~~~~~l-----------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~~-~~ 142 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYRV-----------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEEG-IW 142 (191)
T ss_dssp EET----TEEEEECCCCEEGGGC-----------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETTE-EE
T ss_pred ecC----CEEEEEeeccccccch-----------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCCC-EE
Confidence 642 3799999988665442 2233567889999999999998 999999999999999754 89
Q ss_pred EeecccceecCCCCcceeeccccccccccc------ccccCCCCCCcccchhHHHHH
Q 009979 330 LSDFGLAKLLGAERSYVTTRVMGTFGYVAP------EYASTGMLNERSDVYSFGILI 380 (521)
Q Consensus 330 L~DFGla~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~sDvwS~Gvvl 380 (521)
|+|||+|......... .|... +. ....|+.++|+||..--+
T Consensus 143 liDFG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 9999999876433211 11111 11 135688899999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.63 E-value=6.5e-08 Score=90.76 Aligned_cols=143 Identities=15% Similarity=0.072 Sum_probs=99.0
Q ss_pred CCccccceEccCCcEEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCeeeEEEEec
Q 009979 186 NGFADENVIGEGGYGIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVYEYI 264 (521)
Q Consensus 186 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~ 264 (521)
+.|+..+..+.+....||+... +++.+++|+...........+..|...+..+. +--+.+++.++.+++..++||+++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l 92 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred hceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence 4565555544444568998864 56678889876554444456777888887764 444677888888888899999999
Q ss_pred cCCchHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 009979 265 DNGNLEQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLHEGL-------------------------------------- 306 (521)
Q Consensus 265 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH~~~-------------------------------------- 306 (521)
+|.++.+..... . ....++.+++..+..||+..
T Consensus 93 ~G~~~~~~~~~~------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 93 DGVLCSEEYEDE------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp SSEEHHHHTTTC------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred cccccccccccc------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 998886644221 1 12234455666666666321
Q ss_pred ------------------CCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 307 ------------------EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 307 ------------------~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
.+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999876677999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.18 E-value=5.7e-06 Score=76.56 Aligned_cols=131 Identities=17% Similarity=0.136 Sum_probs=86.0
Q ss_pred eEccCCc-EEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCC--CCCeeeEEEEEeeCCeeeEEEEeccCCch
Q 009979 193 VIGEGGY-GIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVR--HKNLVRLLGYCAEGAHRMLVYEYIDNGNL 269 (521)
Q Consensus 193 ~LG~G~f-G~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--hpniv~l~~~~~~~~~~~lV~e~~~~g~L 269 (521)
.+..|.. ..||+....++..+++|...... ...+..|+..++.+. .-.+.+++.++.+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445553 58999988777778888764432 234666777777663 33467788888888888999999988665
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH----------------------------------------------
Q 009979 270 EQWLHGDVGPHSPLTWEIRMNIILGTAKGLTYLH---------------------------------------------- 303 (521)
Q Consensus 270 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~al~~LH---------------------------------------------- 303 (521)
.+.. ... ..++.+++..|.-||
T Consensus 94 ~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 94 LSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred cccc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 3310 111 111223333344444
Q ss_pred -----hcC----CCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 304 -----EGL----EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 304 -----~~~----~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
... .+.++|+|+.+.|||++++..+-|+||+.+..
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 111 22489999999999999876678999998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.62 E-value=0.0001 Score=72.86 Aligned_cols=76 Identities=17% Similarity=0.200 Sum_probs=47.9
Q ss_pred cceEccCCcEEEEEEEEc-CCcEEEEEEeccC-------ChhhHHHHHHHHHHHhcCC-C--CCeeeEEEEEeeCCeeeE
Q 009979 191 ENVIGEGGYGIVYHGVLE-DNTNVAVKNLLNN-------RGQAEKEFKVEVEAIGRVR-H--KNLVRLLGYCAEGAHRML 259 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~Ei~~l~~l~-h--pniv~l~~~~~~~~~~~l 259 (521)
.+.||.|....||+.... +++.+++|.-... -.........|.+.|+.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 456899999999999854 3667899965321 0112234556777777652 2 345666655 3445689
Q ss_pred EEEeccCCc
Q 009979 260 VYEYIDNGN 268 (521)
Q Consensus 260 V~e~~~~g~ 268 (521)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.95 E-value=0.001 Score=63.44 Aligned_cols=136 Identities=15% Similarity=0.178 Sum_probs=76.7
Q ss_pred EEEEEEEEcCCcEEEEEEeccCChhhHHHHHHHHHHHhcCCCCCe--eeEE-----EEEeeCCeeeEEEEeccCCchH--
Q 009979 200 GIVYHGVLEDNTNVAVKNLLNNRGQAEKEFKVEVEAIGRVRHKNL--VRLL-----GYCAEGAHRMLVYEYIDNGNLE-- 270 (521)
Q Consensus 200 G~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~hpni--v~l~-----~~~~~~~~~~lV~e~~~~g~L~-- 270 (521)
-.||++..++|+.|++|...... ...+++..|...+..|...++ +..+ ..+......+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 48999999899999999876542 234667778888877642221 1111 1233456678899998763321
Q ss_pred ---Hh---------hhc----CC-CCCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----cCCCCe
Q 009979 271 ---QW---------LHG----DV-GPHSPLTWE-------------------IRMNIILGTAKGLTYLHE----GLEPKV 310 (521)
Q Consensus 271 ---~~---------l~~----~~-~~~~~l~~~-------------------~~~~i~~~ia~al~~LH~----~~~~~i 310 (521)
.+ +|. .. ......+.. ....+...+...++.+.. ....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 10 111 10 001111111 111111122223333322 224479
Q ss_pred eecCCCCCCeEeCCCCCceEeeccccee
Q 009979 311 VHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 311 iHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
||+|+.+.|||++++ ..++||+.+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 46899998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.87 E-value=0.0029 Score=61.89 Aligned_cols=73 Identities=18% Similarity=0.181 Sum_probs=48.8
Q ss_pred cceEccCCcEEEEEEEEcCC--------cEEEEEEeccCChhhHHHHHHHHHHHhcCC-CCCeeeEEEEEeeCCeeeEEE
Q 009979 191 ENVIGEGGYGIVYHGVLEDN--------TNVAVKNLLNNRGQAEKEFKVEVEAIGRVR-HKNLVRLLGYCAEGAHRMLVY 261 (521)
Q Consensus 191 ~~~LG~G~fG~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-hpniv~l~~~~~~~~~~~lV~ 261 (521)
.+.|+.|---.+|++...++ ..|.+++.-. ....-...+|..+++.+. +.-..++++++.+ .+||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 35788888889999987543 3466665432 222344567888888875 4334578887754 6899
Q ss_pred EeccCCch
Q 009979 262 EYIDNGNL 269 (521)
Q Consensus 262 e~~~~g~L 269 (521)
||++|..|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.73 E-value=0.0059 Score=57.44 Aligned_cols=32 Identities=25% Similarity=0.238 Sum_probs=27.9
Q ss_pred CCCeeecCCCCCCeEeCCCCCceEeeccccee
Q 009979 307 EPKVVHRDIKSSNILLDKQWNPKLSDFGLAKL 338 (521)
Q Consensus 307 ~~~iiHrDik~~NILl~~~~~vkL~DFGla~~ 338 (521)
..++||+|+.++||+++++...-|+||+.+..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCcchhhhhcccccceeEeccccccc
Confidence 34799999999999999887778999998864
|